{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2411ee64",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Connecting to the db\n",
    "import lib.handle_db as dbh\n",
    "\n",
    "# read and write csv files\n",
    "import lib.handle_csv as csv_rw\n",
    "\n",
    "# date functions\n",
    "from datetime import datetime, date, timedelta\n",
    "\n",
    "# use habanero to query crossref api\n",
    "from habanero import Crossref\n",
    "cr = Crossref()\n",
    "\n",
    "# search for UKCH Awards in CR record\n",
    "def award_in_crossref(aw):\n",
    "    ukch_wks =[]\n",
    "    not_revised = []\n",
    "    for wk in aw:      \n",
    "        awd_list = []\n",
    "        if 'funder' in wk.keys():\n",
    "            for fdr in wk['funder']:\n",
    "                if 'award' in fdr.keys():\n",
    "                   awds = 0\n",
    "                   for awd in fdr['award']:\n",
    "                        if awd in ['EP/R026939/1', 'EP/R026815/1', 'EP/R026645/1', 'EP/R027129/1', 'EP/M013219/1',\n",
    "                                  'EP/K014706/2', 'EP/K014668/1', 'EP/K014854/1', 'EP/K014714/1']:\n",
    "                            awd_list.append(awd)\n",
    "        else:\n",
    "            not_revised.append(wk)\n",
    "        if len(awd_list) > 0:\n",
    "            ukch_wks.append(wk)\n",
    "    return ukch_wks, not_revised\n",
    "\n",
    "# search for UKCH Affiliation in CR record\n",
    "def affi_in_crossref(aw):\n",
    "    ukch_wks = []\n",
    "    for wk in aw:\n",
    "        ukch_affiliation = False\n",
    "        if 'author' in wk.keys():\n",
    "            for autr in wk['author']:\n",
    "                if 'affiliation' in autr.keys():\n",
    "                    for affi in autr['affiliation']:\n",
    "                        if \"UK Catalysis Hub\" in affi['name']:\n",
    "                            ukch_affiliation = True\n",
    "                            break\n",
    "                    if ukch_affiliation:\n",
    "                        ukch_wks.append(wk)\n",
    "                        break\n",
    "    return  ukch_wks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "15d8279c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "From: 2021-01-01 to 2021-01-10\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-01-01', 'until-deposit-date': '2021-01-10'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-01-11 to 2021-01-20\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-01-11', 'until-deposit-date': '2021-01-20'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-01-21 to 2021-01-30\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-01-21', 'until-deposit-date': '2021-01-30'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-01-31 to 2021-02-09\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-01-31', 'until-deposit-date': '2021-02-09'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-02-10 to 2021-02-19\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-02-10', 'until-deposit-date': '2021-02-19'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-02-20 to 2021-03-01\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-02-20', 'until-deposit-date': '2021-03-01'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-03-02 to 2021-03-11\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-03-02', 'until-deposit-date': '2021-03-11'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-03-12 to 2021-03-21\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-03-12', 'until-deposit-date': '2021-03-21'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-03-22 to 2021-03-31\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-03-22', 'until-deposit-date': '2021-03-31'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-04-01 to 2021-04-10\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-04-01', 'until-deposit-date': '2021-04-10'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-04-11 to 2021-04-20\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-04-11', 'until-deposit-date': '2021-04-20'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-04-21 to 2021-04-30\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-04-21', 'until-deposit-date': '2021-04-30'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-05-01 to 2021-05-10\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-05-01', 'until-deposit-date': '2021-05-10'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-05-11 to 2021-05-20\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-05-11', 'until-deposit-date': '2021-05-20'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-05-21 to 2021-05-30\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-05-21', 'until-deposit-date': '2021-05-30'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-05-31 to 2021-06-09\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-05-31', 'until-deposit-date': '2021-06-09'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-06-10 to 2021-06-19\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-06-10', 'until-deposit-date': '2021-06-19'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-06-20 to 2021-06-29\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-06-20', 'until-deposit-date': '2021-06-29'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-06-30 to 2021-07-09\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-06-30', 'until-deposit-date': '2021-07-09'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-07-10 to 2021-07-19\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-07-10', 'until-deposit-date': '2021-07-19'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-07-20 to 2021-07-29\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-07-20', 'until-deposit-date': '2021-07-29'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-07-30 to 2021-08-08\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-07-30', 'until-deposit-date': '2021-08-08'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-08-09 to 2021-08-18\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-08-09', 'until-deposit-date': '2021-08-18'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-08-19 to 2021-08-28\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-08-19', 'until-deposit-date': '2021-08-28'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-08-29 to 2021-09-07\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-08-29', 'until-deposit-date': '2021-09-07'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-09-08 to 2021-09-17\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-09-08', 'until-deposit-date': '2021-09-17'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-09-18 to 2021-09-27\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-09-18', 'until-deposit-date': '2021-09-27'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-09-28 to 2021-10-07\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-09-28', 'until-deposit-date': '2021-10-07'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-10-08 to 2021-10-17\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-10-08', 'until-deposit-date': '2021-10-17'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-10-18 to 2021-10-27\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-10-18', 'until-deposit-date': '2021-10-27'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-10-28 to 2021-11-06\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-10-28', 'until-deposit-date': '2021-11-06'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-11-07 to 2021-11-16\n",
      "{'has_funder': 'true', 'from-deposit-date': '2021-11-07', 'until-deposit-date': '2021-11-16'}\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "Results: 500\n",
      "From: 2021-11-17 to 2021-11-26\n"
     ]
    },
    {
     "ename": "KeyError",
     "evalue": "'items'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-2-0b92bc6149ee>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      9\u001b[0m     \u001b[0mcr_filter\u001b[0m \u001b[1;33m=\u001b[0m  \u001b[1;33m{\u001b[0m\u001b[1;34m'has_funder'\u001b[0m\u001b[1;33m:\u001b[0m \u001b[1;32mTrue\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'from-pub-date'\u001b[0m\u001b[1;33m:\u001b[0m\u001b[0mstr\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mstart_date\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'until-pub-date'\u001b[0m\u001b[1;33m:\u001b[0m\u001b[0mstr\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mend_date\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m}\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     10\u001b[0m     \u001b[0mcr_filter\u001b[0m \u001b[1;33m=\u001b[0m  \u001b[1;33m{\u001b[0m\u001b[1;34m'has_funder'\u001b[0m\u001b[1;33m:\u001b[0m \u001b[1;32mTrue\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'from-deposit-date'\u001b[0m\u001b[1;33m:\u001b[0m\u001b[0mstr\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mstart_date\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'until-deposit-date'\u001b[0m\u001b[1;33m:\u001b[0m\u001b[0mstr\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mend_date\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m}\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 11\u001b[1;33m     \u001b[0mresult\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mcr\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mworks\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfilter\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mcr_filter\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcursor\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;34m\"*\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mlimit\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;36m500\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     12\u001b[0m     \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mcr_filter\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     13\u001b[0m     \u001b[1;31m#print (result)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\habanero\\crossref\\crossref.py\u001b[0m in \u001b[0;36mworks\u001b[1;34m(self, ids, query, filter, offset, limit, sample, sort, order, facet, select, cursor, cursor_max, progress_bar, **kwargs)\u001b[0m\n\u001b[0;32m    361\u001b[0m             )\n\u001b[0;32m    362\u001b[0m         \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 363\u001b[1;33m             return Request(\n\u001b[0m\u001b[0;32m    364\u001b[0m                 \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmailto\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    365\u001b[0m                 \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mua_string\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\habanero\\request_class.py\u001b[0m in \u001b[0;36mdo_request\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m     98\u001b[0m         \u001b[0mcu\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mjs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"next-cursor\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     99\u001b[0m         \u001b[0mmax_avail\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mjs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"total-results\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 100\u001b[1;33m         \u001b[0mres\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_redo_req\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mjs\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mpayload\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcu\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmax_avail\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    101\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mres\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    102\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\habanero\\request_class.py\u001b[0m in \u001b[0;36m_redo_req\u001b[1;34m(self, js, payload, cu, max_avail)\u001b[0m\n\u001b[0;32m    127\u001b[0m                 \u001b[0mcu\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mout\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"next-cursor\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    128\u001b[0m                 \u001b[0mres\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mout\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 129\u001b[1;33m                 \u001b[0mtotal\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0msum\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mz\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"items\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mz\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mres\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    130\u001b[0m                 \u001b[1;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mprogress_bar\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    131\u001b[0m                     \u001b[0mpbar\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mupdate\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\habanero\\request_class.py\u001b[0m in \u001b[0;36m<listcomp>\u001b[1;34m(.0)\u001b[0m\n\u001b[0;32m    127\u001b[0m                 \u001b[0mcu\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mout\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mget\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"next-cursor\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    128\u001b[0m                 \u001b[0mres\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mout\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 129\u001b[1;33m                 \u001b[0mtotal\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0msum\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mz\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"message\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m\"items\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mz\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mres\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    130\u001b[0m                 \u001b[1;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mprogress_bar\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    131\u001b[0m                     \u001b[0mpbar\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mupdate\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mKeyError\u001b[0m: 'items'"
     ]
    }
   ],
   "source": [
    "start_date = date(2021, 1, 1)\n",
    "end_date = date(2021, 1, 1)\n",
    "\n",
    "pubs_with_award = []\n",
    "skiped_works =[]\n",
    "while end_date < datetime.now().date():\n",
    "    end_date = start_date + timedelta(days=9)\n",
    "    print (\"From:\", str(start_date), \"to\",  str(end_date))\n",
    "    cr_filter =  {'has_funder': True, 'from-pub-date':str(start_date), 'until-pub-date':str(end_date)}\n",
    "    cr_filter =  {'has_funder': True, 'from-deposit-date':str(start_date), 'until-deposit-date':str(end_date)}\n",
    "    result = cr.works(filter = cr_filter, cursor = \"*\", limit = 500)\n",
    "    print(cr_filter)\n",
    "    #print (result)\n",
    "    for res_500 in result:\n",
    "        print(\"Results:\",len(res_500['message']['items']))\n",
    "        pubs_found, wks_ignored = award_in_crossref(res_500['message']['items'])\n",
    "        pubs_with_award += pubs_found\n",
    "        skiped_works += wks_ignored\n",
    "    start_date = end_date + timedelta(days=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "4e101eca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Hinde, , Christopher S., Gill, Arran M., Wells, Peter P., Hor, T. S. Andy, Raja, Robert | 2015 | Utilizing Benign Oxidants for Selective Aerobic Oxidations Using Heterogenized Platinum Nanoparticle Catalysts | 10.1002/cplu.201500195 | EP/K014668/1, EP/K014854/1, EP/K014714/1\n",
      "Lim, , Jason Y. C., Yuntawattana, Nattawut, Beer, Paul D., Williams, Charlotte K. | 2019 | Isoselective Lactide Ring Opening Polymerisation using [2]Rotaxane Catalysts | 10.1002/ange.201901592 | EP/K014668/1\n",
      "Malta, , G., Kondrat, S. A., Freakley, S. J., Davies, C. J., Dawson, S., Liu, X., Lu, L., Dymkowski, K., Fernandez-Alonso, F., Mukhopadhyay, S., Gibson, E. K., Wells, P. P., Parker, S. F., Kiely, C. J., Hutchings, G. J. | 2018 | Deactivation of a Single-Site Gold-on-Carbon Acetylene Hydrochlorination Catalyst: An X-ray Absorption and Inelastic Neutron Scattering Study | 10.1021/acscatal.8b02232 | EP/K014668/1, EP/K014714/1, EP/M013219/1, EP/K014854/1\n",
      "[{'indexed': {'date-parts': [[2021, 11, 2]], 'date-time': '2021-11-02T17:07:03Z', 'timestamp': 1635872823737}, 'publisher': 'James S. McDonnell Foundation', 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award': '2020-1456', 'DOI': '10.37717/2020-1456', 'type': 'grant', 'created': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T15:52:55Z', 'timestamp': 1610121175000}, 'source': 'Crossref', 'prefix': '10.37717', 'member': '24568', 'project': [{'project-title': [{'title': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], 'project-description': [{'description': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Stefany', 'family': 'Moreno-Gámez', 'affiliation': [{'name': 'Massachusetts Institute of Technology'}]}], 'award-amount': {'amount': 200000.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2023, 1, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Postdoctoral Fellowship Award', 'award-amount': {'amount': 200000.0, 'currency': 'USD', 'percentage': 100}, 'funder': {'name': 'James S. McDonnell Foundation', 'id': [{'id': '10.13039/100000913', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T15:52:56Z', 'timestamp': 1610121176000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.37717/2020-1456'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513527}, 'publisher': 'Wellcome', 'award': '223024', 'DOI': '10.35802/223024', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deciphering the heterogeneity of early-onset type 2 diabetes using epidemiological and genetic approaches'}], 'project-description': [{'description': 'Background: Early-onset type 2 diabetes (diagnosed <40-years), is a severe presentation with excess risk of complications, cardiovascular events and early death, compared to later-onset disease. UK south Asian populations have an unexplained higher prevalence of this diagnosis. Studies of later-onset type 2 diabetes reveal heterogeneity in phenotype associating with complication risk, raising the possibility that targeting this variation with specific treatments could improve outcomes. These methods have not been extended to early-onset type 2 diabetes. Goal: I will decipher heterogeneity of early-onset type 2 diabetes in white and south Asian individuals using epidemiological and genetic approaches. Proposal: - Determine whether early-onset type 2 diabetes is enriched for sub-phenotypes contributing to higher risk, using analysis of large datasets to examine ethnic differences in presentation and progression by age-at-diagnosis with application of supervised and unsupervised statistical methods. - Determine if the higher risk of early-onset type 2 diabetes in south Asian individuals is driven by excess polygenic risk, by undertaking a cohort study with application of trans-ancestry polygenic scores compared to controls. Summary: This broad population-level study together with deep genotyping and phenotyping of affected individuals has the potential to produce new insights leading to better surveillance, earlier therapies, and fewer complications.', 'language': 'en'}, {'description': 'Background: Type 2 diabetes is typically diagnosed later in life but early-onset cases (before 40-years) are increasing, particularly in south Asian people. This is concerning as early-onset type 2 diabetes carries a higher risk of complications and early death. We don’t know what explains this higher risk or why some ethnicities are more affected. My approach: I will study early-onset type 2 diabetes in two ways; 1) studying large databases of cases comparing features and progression of early versus later-onset type 2 diabetes and its ethnic differences using different statistical methods; 2) by recruiting a new cohort of south Asian individuals with early-onset type 2 diabetes to determine if excess genetic risk for type 2 diabetes explains the earlier presentation. Impact: These studies will shed light on the features of early-onset type 2 diabetes and provide new insights into how we might better target prevention and treatments to improve outcomes.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2886-0726', 'authenticated-orcid': False, 'given': 'Shivani', 'family': 'Misra', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 1096432.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 1]]}, 'award-end': {'date-parts': [[2026, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1096432.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:57Z', 'timestamp': 1636383537000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223024'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513532}, 'publisher': 'Wellcome', 'award': '215105', 'DOI': '10.35802/215105', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structural studies of the galactose/N-acetylgalactosamine lectin from Entamoeba histolytica'}], 'project-description': [{'description': 'Entamoeba histolytica is a parasite which causes human amoebiasis, a common intestinal disease in countries that lack good sanitation practices. It is estimated to affect more than 50 million people and leads to around 100,000 deaths worldwide annually. Although it is considered as a major health issue, no vaccine is currently available. Originally ingested via contaminated food or water, the parasites reach the gut, attach to the mucosal wall of the epithelium and destroy the colonic tissue. The initial adhesion process is mediated by a lectin, a molecule which interacts with the sugar coat of host cells. Blocking parasites at this stage could prevent the subsequent steps of virulence. Therefore, the lectin is considered as the most promising vaccine candidate against amoebiasis. We aim at uncovering how the lectin mediates host cell adhesion at the molecular level. We will work out what the lectin looks like and how it binds to the sugar coat. We will identify the sugar recognition domains of the protein and raise antibodies against it. Eventually, solving structures of antibodies in complex with parts of the lectin that mediate virulence will help us design a vaccine against amoebiasis.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2842-0360', 'authenticated-orcid': False, 'given': 'Samuel', 'family': 'Gerard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:44Z', 'timestamp': 1636383224000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513599}, 'publisher': 'Wellcome', 'award': '221367', 'DOI': '10.35802/221367', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A multi-contrast X-ray nanoscope for multidisciplinary research'}], 'project-description': [{'description': 'We are seeking to acquire the resources to develop a unique X-ray 3D nanoscope. We will need: custom-source, isolation, manipulators, custom-detector, radiation-safe enclosure, two PDRAs (hardware- and software-focussed) and 1year system engineer for the transition to the long-term maintenance/management of the instrument. We plan to build a nano-resolution multi-contrast 3D scanner with transformative potential across diverse disciplines, including cellular structural biology, pathology, musculoskeletal and respiratory medicine, tissue engineering and child health. This will create a multi-user tool, benefitting researchers across multiple specialties. The simultaneous attainment of nano-scale resolution, unprecedented scale range (six orders of magnitude,5cm/50nm), multi-contrasts and a wide energy range will make the X-ray nanoscope proposed here a unique non-destructive 3D imaging tool. Its key advancements will be ultra-high-resolution zoom-ins on intact samples, whose entire structure is measured at a lower resolution, combined with multi-contrast modes arising from phase effects. A simple analogy of this new X-ray tomography paradigm is the way we navigate digital maps. We use coarse resolution at large scales, blowing-up in precise locations of interest. Both capabilities must be concurrently present: it would not be useful to navigate large areas at highest resolution (lost in space) and having only coarse resolution would lack invaluable insights.', 'language': 'en'}, {'description': 'We propose a technology development leading to a new paradigm in three-dimensional volumetric imaging. This new concept has an analogy in the way we navigate digital maps, where we use a coarse resolution to move efficiently over large areas, then blow up specific locations to visualise details of interest. We plan to use X-rays, for their ability to propagate through thick and opaque samples and quantitatively measure their three-dimensional internal structure. X-ray microscopy techniques were pioneered at synchrotron facilities, where they have led to significant breakthroughs in many diverse areas of science. Our aim is to develop a table-top instrument, easily deployable in a standard laboratory, which enables quantitative imaging of label-free samples across a vast range of scales. This will bridge the resolution gap between other well-established microscopy techniques, such as electron and visible light microscopy, and become a platform catalysing collaborative projects among scientists from diverse backgrounds.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2070-326X', 'authenticated-orcid': False, 'given': 'Anna', 'family': 'Franz', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4945-0171', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Lythgoe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1370-9417', 'authenticated-orcid': False, 'given': 'Rachel', 'family': 'Chambers', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Paolo', 'family': 'De Coppi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-7150-2951', 'authenticated-orcid': False, 'given': 'Alessandro', 'family': 'Olivo', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1688-5360', 'authenticated-orcid': False, 'family': 'Moosajee', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-3898-8881', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Lee', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-8054-2293', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Jacob', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Charlotte', 'family': 'Hagen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7810-2301', 'authenticated-orcid': False, 'given': 'Marco', 'family': 'Endrizzi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1288017.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 1288017.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:03Z', 'timestamp': 1636383123000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:17Z', 'timestamp': 1636456517471}, 'publisher': 'Wellcome', 'award': '052856', 'DOI': '10.35802/052856', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The functional and neural bases of human memory:Electrophysiological and functional neuroimaging studies.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Rugg', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1346694.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 1346694.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:40Z', 'timestamp': 1636382920000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/052856'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:17Z', 'timestamp': 1636456517536}, 'publisher': 'Wellcome', 'award': '051936', 'DOI': '10.35802/051936', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Purinergic control of spinal motor pattern generation.'}], 'lead-investigator': [{'given': 'Nicholas', 'family': 'Dale', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 138358.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 11, 17]]}, 'award-end': {'date-parts': [[2001, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 138358.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:06Z', 'timestamp': 1636382946000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 11, 17]]}, 'URL': 'http://dx.doi.org/10.35802/051936'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:19Z', 'timestamp': 1636456519103}, 'publisher': 'Wellcome', 'award': '060729', 'DOI': '10.35802/060729', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic and phenotypic characterisation of 1918 infuenza virus.'}], 'lead-investigator': [{'given': 'John', 'family': 'Oxford', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 145154.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 145154.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:53Z', 'timestamp': 1636382873000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060729'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:19Z', 'timestamp': 1636456519163}, 'publisher': 'Wellcome', 'award': '064827', 'DOI': '10.35802/064827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Somal translocation: a distinct mode of neuronal migration in the developing cerebral cortex.'}], 'investigator': [{'family': 'Coffin', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'John', 'family': 'Parnavelas', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 211385.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 211385.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:51Z', 'timestamp': 1636382871000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:20Z', 'timestamp': 1636456520128}, 'publisher': 'Wellcome', 'award': '063505', 'DOI': '10.35802/063505', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular characterisation of native H3 Histamine receptors expressed in the mammalian striatum.'}], 'lead-investigator': [{'given': 'Paul', 'family': 'Chazot', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'award-amount': {'amount': 48112.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 7, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 48112.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:35Z', 'timestamp': 1636382975000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063505'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522434}, 'publisher': 'Wellcome', 'award': '067383', 'DOI': '10.35802/067383', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution towards the annual meeting of the Bone and Tooth Society to be held in Cardiff on June 24 - 26, 2002.'}], 'lead-investigator': [{'family': 'Evans', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2002, 6, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:05Z', 'timestamp': 1636382825000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067383'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522462}, 'publisher': 'Wellcome', 'award': '213608', 'DOI': '10.35802/213608', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mapping dynamic trajectories of development in autism spectrum disorder: gaining new insights into aetiology and heterogeneity'}], 'project-description': [{'description': 'Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterised by substantial behavioural heterogeneity. Although differences in neurobiological functioning are found in individuals with ASD, much of the extant work has used cross-sectional designs and is therefore ill-equipped to answer questions of directionality. I will use advanced statistical techniques to model directional pathways between brain functioning, cognition and behavioural outcomes. First, I will obtain a detailed characterisation of brain functioning across the early developmental period in infants at high and low risk for developing ASD (Objective 1). I will model different trajectories of early brain development that may precede a diagnosis of ASD, and test whether these differ from those found in individuals without a diagnosis, and whether they predict later profiles of cognitive functioning and behavioural symptoms. Next, I will integrate one sample from Objective 1 with longitudinal data from a large sample of individuals with an established diagnosis of ASD to comprehensively test uni- vs. bi-directional pathways between neurobiological functioning, cognition and behavioural symptoms (Objective 2). Better understanding of these pathways may allow for interventions to be targeted towards mechanisms underpinning specific symptoms, rather than global diagnosis. Given the heterogeneity within ASD, this may lead to more effective interventions.', 'language': 'en'}, {'description': 'Autism spectrum disorder (ASD) is characterised by difficulties in social communication, repetitive behaviours and restrictive interests. The presentation of ASD can vary enormously from person to person, with variation in the types of symptoms they may display, their intellectual ability, and whether or not they experience additional psychiatric symptoms. I will combine advanced statistical models with sensitive measurements of brain functioning, to better map the links between brain functioning, cognition and behaviour in ASD across the lifespan. First, I will model pathways of early brain development in infants at risk of ASD, and map these trajectories of brain development onto later cognitive functioning and ASD symptoms in toddlerhood. Second, I will delineate the directional pathways between brain functioning, cognition and behavioural symptoms in individuals with an established diagnosis of ASD. Increased understanding of the neurobiological mechanisms that underpin the symptoms of ASD may help to identify new targets for intervention.', 'language': 'en'}], 'investigator': [{'given': 'Andrew', 'family': 'Pickles', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Mayada', 'family': 'Elsabbagh', 'affiliation': [{'name': 'McGill University', 'country': 'CA'}]}, {'given': 'Emily', 'family': 'Jones', 'affiliation': [{'name': 'Birkbeck University of London', 'country': 'GB'}]}, {'given': 'Shafali', 'family': 'Jeste', 'affiliation': [{'name': 'University of California', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7455-5514', 'authenticated-orcid': False, 'given': 'Virginia', 'family': 'Carter Leno', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:50Z', 'timestamp': 1636383050000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213608'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522626}, 'publisher': 'Wellcome', 'award': '215307', 'DOI': '10.35802/215307', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of RNMT-RAM in pluripotency gene expression'}], 'project-description': [{'description': 'Embryonic stem cells (ESCs) have the potential to become any cell in the body. They retain this potential through the expression of pluripotency factors. Capping of RNA facilitates processing and translation of the RNA to protein. RNMT-RAM, a complex involved in creating the mRNA cap has been found to have an important role during ESC differentiation. Highly expressed in ESCs, RAM downregulation during neural differentiation negatively effects expression of pluripotency factors and appears to be necessary for neural differentiation. How RNMT-RAM is controlling transcription is unknown. I aim to investigate which gene sets are being controlled by RNMT-RAM. I will also look for how RNMT-RAM is controlling transcription by investigating protein interactors. Are there interactions with transcription factors or the RNA polymerase II which may be recruiting RNMT-RAM in ESCs?', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4851-6658', 'authenticated-orcid': False, 'given': 'Lydia', 'family': 'Hepburn', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2022, 4, 14]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:24Z', 'timestamp': 1636383264000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/215307'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522631}, 'publisher': 'Wellcome', 'award': '215146', 'DOI': '10.35802/215146', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chronic imaging of the fruit fly brain : investigating sleep homeostasis'}], 'project-description': [{'description': 'All animals sleep, the question “why” is still without an answer. If there might be more than one explanation, one of the most convincing theory is about the possible role of sleep in clearing the brain from molecules that at high concentration can cause damage to the brain. The numerous family of molecules that can damage the brain can be represented by the so-called ROS: reactive oxygen species. Among all the different animal models, the fruit fly Drosophila melanogaster has been proved to be the most useful to study the mechanic of sleep homeostasis. The fundamental features that characterize sleep in mammals are found in fruit flies too. I aim to chronically image the movement of ions in some population of neurons involved in the sleep homeostasis, in Drosophila, during natural sleep: wake cycles or a period of controlled insomnia. I will then try to see if a correlation could be drawn between this movement of ions and predicted changes in the level of ROS in the brain. I will finally focus on imaging the cellular dynamic of Sandman, an ion channel responsible for the switch between the states: sleep and vigilance.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8104-4464', 'authenticated-orcid': False, 'given': 'Giacomo', 'family': 'Bertuzzi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215146'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522654}, 'publisher': 'Wellcome', 'award': '217099', 'DOI': '10.35802/217099', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental Mechanisms of Motor Network Tuning'}], 'project-description': [{'description': 'Activity is required for correct development of neural circuits and emergence of appropriate behaviour. At early stages activity is spontaneously generated, and then superseded by patterned network activity as sensory afferents become active. A period of maximal plasticity, termed critical period, generally spans these two phases. Significantly, aberrant activity during neural circuit development, especially when occurring in the critical period, can lead to network errors that become ‘locked in’ and may contribute to neurological disorders in later life. Whilst a requirement for activity is universal for circuit development, important questions remain unanswered. We have identified a comparable requirement for activity in the development of the motor circuit of Drosophila larvae. Notably, perturbation of activity leads to permanent and significant errors in circuit function. This system is composed of identifiable, tractable neurons of defined connectivity. These advantages allow us to study fundamental questions in ways not possible in higher organisms. Exploiting this exceptional level of resolution, our overall goal is: to generate detailed understanding of the cellular and molecular processes that underlie normal network tuning and lead to errors following early activity perturbation; further, to determine in this tractable circuit the capability of homeostatic mechanisms to compensate for early induced perturbations.', 'language': 'en'}, {'description': 'Developing neural circuits are reliant on activity for appropriate development. Moreover, abnormal activity levels are now believed to produce errors in development that can be ‘locked-in’ contributing to diseases such as epilepsy, autism and schizophrenia. Whilst activity is required through much of neural circuit development, periods of heightened plasticity, termed critical periods, during which activity has maximal effect have been identified. How activity tunes a developing neural circuit and the specific events that occur during a critical period, is poorly understood. The potential for neural circuits to rectify errors induced by altered activity during development is also unknown. We address these issues, using larvae of the fruitfly Drosophila. Its nervous system forms within a few hours, has a defined developmental timeline and exhibits critical periods. The tractability of this insect nervous system will allow us to identify how activity refines the development of a neural circuit to ensure appropriate function.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8571-4376', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Baines', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5142-1997', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Landgraf', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1866822.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2025, 4, 6]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 1866822.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217099'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522674}, 'publisher': 'Wellcome', 'award': '219906', 'DOI': '10.35802/219906', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Investigating Neuron-Microglia Interactions in Alzheimer's Disease\"}], 'project-description': [{'description': 'Microglia, the resident immune cells of the brain, play an important role in synapse elimination within specific brain regions at early, pre-plaque stages of Alzheimer’s disease (AD). One such region impacted is the hippocampal formation, which is vital for the production of new memories, a process adversely affected early in AD pathology. Hyperactivity of hippocampal neurons has also been observed during early AD. We hypothesize that this hyperactivity could mobilize microglia toward synaptic elimination in a circuit-specific manner in response to ‘tagging’ of synapses with the AD-associated synaptotoxic protein species, amyloid-beta (Aβ). In order to address this research question, we will first use immunohistochemistry to visualize synapse loss in AD mouse model hippocampal layers as well as synaptic engulfment by microglia via viral tracing of neurons. We will employ optogenetic techniques in wild type mice to activate specific hippocampal neurons and determine whether these overactive synapses alone are targeted for elimination by microglia. Finally, we aim to elucidate the exact mechanisms by which this microglial activation occurs using knockout genetic mouse models and pharmacological manipulation. These studies will further our understanding of the key role played by microglia during early AD and isolate new potential functions for the Aβ peptide.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0436-1332', 'authenticated-orcid': False, 'given': 'Gerard', 'family': 'Crowley', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:15Z', 'timestamp': 1636383255000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219906'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522665}, 'publisher': 'Wellcome', 'award': '215158', 'DOI': '10.35802/215158', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of tissue mechanics in (human) lung branching morphogenesis and cell fate decisions'}], 'project-description': [{'description': 'It is increasingly apparent that forces such as stretching and stiffness can affect how our organs develop. This is intuitively obvious in the developing lung where the foetus is known to make breathing movements and inhale amniotic fluid and serious congenital lung abnormalities can develop if this process is blocked. Even though these forces are clinically- important very little is known about how they actually affect lung cells leading to normal maturation and development of the lung. In this project I will use fragments of human embryonic lungs, and organoids derived from them, to assess the affects of stretching and stiffness on human lung development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8344-6299', 'authenticated-orcid': False, 'given': 'Vanesa', 'family': 'Sokleva', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:05Z', 'timestamp': 1636383305000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215158'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522803}, 'publisher': 'Wellcome', 'award': '222749', 'DOI': '10.35802/222749', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular and cellular mechanisms directing neuronal microtubule rearrangements during vertebrate CNS development'}], 'project-description': [{'description': 'Polarity, the asymmetric organisation of cellular components, is crucial for the function of many cell types. Newborn neurons in the developing spinal cord shed their tips to move to their final location, causing them to lose polarity and the ability to distinguish their front from their back. These neurons must then regain polarity to extend a long process, called an axon, which makes connections with other neurons. In the developing embryo, neurons polarise in response to external cues from the surrounding tissue, which determine the orientation in which the axon will form, and therefore the direction it will grow in, or if it forms at all. Thus, neuron polarisation is essential for the formation of neuronal circuitry; however, the mechanisms of vertebrate neuron polarisation within tissue are unclear. I will study the molecular and cellular mechanisms that direct this key cell-biological process using cutting-edge live imaging and super-resolution microscopy of developing neurons in the embryonic chick spinal cord. Not only will this work help us understand how the nervous system is built, but it will also enrich our understanding of the general cellular mechanisms of polarity transition in development and disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2457-8005', 'authenticated-orcid': False, 'given': 'Victoria', 'family': 'Higgs', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2023, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:09Z', 'timestamp': 1636383489000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222749'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522804}, 'publisher': 'Wellcome', 'award': '220083', 'DOI': '10.35802/220083', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating macrophage behaviour and interactions in normal and pathophysiological erythropoiesis'}], 'project-description': [{'description': 'Macrophages are known to be intrinsically involved in nurturing erythroid cells within the bone marrow. They regulate and enhance erythropoiesis, the production of Red Blood Cells (RBCs), through maintenance of the haematopoietic stem cell (HSC) niche and erythroblastic islands (EBIs). Understanding the cellular interactions involved in EBI formation and maintenance is crucial for investigating disease and improving in vitro erythropoiesis. Polycythemia Vera (PV) is a disease involving increased differentiation of progenitor cells towards the RBC lineage, and subsequent overproduction of RBCs. The genetic component, caused by a single acquired mutation in the tyrosine kinase JAK2, is well established. However, current treatments experience issues with resistance and intolerance, and the involvement of other cell types remains largely under-studied. Importantly, recent studies have implicated a role for macrophages in PV. I aim to further elucidate the molecular basis and cellular interactions that underly the role macrophages play in normal erythropoiesis and PV. CD14+ macrophages from PV and normal patients will be isolated to investigate phenotypic changes, including secreted cytokine profile, proteomic profile and mutations in JAK2. Image analysis will be conducted to probe whether there are changes in interactions between macrophages, progenitors, and erythroblasts within the normal and disease contexts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2618-101X', 'authenticated-orcid': False, 'given': 'Tiah', 'family': 'Oates', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:48Z', 'timestamp': 1636383288000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220083'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522854}, 'publisher': 'Wellcome', 'award': '222049', 'DOI': '10.35802/222049', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Disorders of human pubertal timing'}], 'project-description': [{'description': 'My proposal is focused on understanding the genetic basis, and consequently the pathophysiology, underpinning disordered human puberty. Pubertal disorders are common, but associated with severe comorbidities. Delayed puberty presents a diagnostic challenge in adolescence, as conditions of gonadotropin deficiency and isolated delayed puberty display the same clinical and biochemical phenotype. However, correct management is vital because the former is associated with infertility and requires intensive reproductive therapy, whereas the latter is self-limiting but associated with a shortened reproductive lifespan. The biological mechanisms of precocious puberty, a condition associated with increased long-term cardiovascular and cancer risk and thus with significant impact on public health, remain similarly opaque. The identification of causal genetic defects in disordered puberty allows interrogation of the key regulators of human puberty. I will use whole genome sequencing, comparative transcriptomics and methylomics studies in my large human cohort with disordered puberty, to define shared exonic and regulatory mutations resulting in delayed and precocious puberty. I aim to characterise the biological mechanisms underlying pubertal disorders through functional characterisation of novel genomic defects using cellular assays and animal models. These findings will ultimately translate to improved diagnostics, tailored therapeutic management and improved long-term outcomes for patients with disorders of puberty.', 'language': 'en'}, {'description': 'Puberty is the essential period of physical and psychological change from a child to an adult. Disturbances of pubertal timing are common, and are associated with increased risk of obesity, type 2 diabetes and in severe cases infertility. Moreover, both early and delayed puberty are associated with early menopause. While we know that these conditions often run in families, we still understand very little about how they occur and which gene changes are responsible. Currently, it can be difficult to distinguish which patients with early or late puberty need intensive treatment and follow up. I will use up-to-date genetic, cell and animal experiments to identify gene defects in our patient families with early and late puberty, and to understand how these inherited changes influence the timing and progress of puberty. This knowledge will enable us to improve diagnosis, allow tailored treatment and direct careful long-term follow up for our patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9295-3594', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Caulfield', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2706-8139', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Oakey', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6698-903X', 'authenticated-orcid': False, 'given': 'Sasha', 'family': 'Howard', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 611636.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 611636.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:30Z', 'timestamp': 1636383150000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222049'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522833}, 'publisher': 'Wellcome', 'award': '219979', 'DOI': '10.35802/219979', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rebuilding a superenhancer to investigate the additive and synergistic effects of its individual components'}], 'project-description': [{'description': 'Every cell in the body contains the same DNA; however each cell type \"reads\" and interprets DNA differently. Different regions of the DNA have different functions: some (genes) provide cells with instructions to make specific components, whereas others are regulatory, and simply tell cells which genes they should “read” and express. Enhancers are one category of regulatory DNA feature. They are regions of DNA which increase the expression of other specific genes, even when they are located a long way from one another. Superenhancers are groups of enhancers which combine to up-regulate expression of target genes to an even higher extent. Superenhancers often act to increase the expression of genes which are only active in certain tissues, for example we are studying the α-globin superenhancer which up-regulates α-globin, a gene which is only active in red blood cells. Currently, it is unknown exactly how the different enhancers within one superenhancer associate to increase target gene expression. We will study this by stripping down and rebuilding the α-globin superenhancer. This is particularly important, as most genetic diseases are caused by mutations in regulatory elements like enhancers, and mutations at the α-globin superenhancer are responsible for diseases such as α-thalassaemia.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6722-3215', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Blayney', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 30]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:19Z', 'timestamp': 1636383319000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 30]]}, 'URL': 'http://dx.doi.org/10.35802/219979'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:23Z', 'timestamp': 1636456523484}, 'publisher': 'Wellcome', 'award': '222528', 'DOI': '10.35802/222528', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Defining the functional basis of the enhanced survival and replication of African Salmonella in human phagocytic cells'}], 'project-description': [{'description': 'Invasive non-typhoidal Salmonella disease (iNTS) has emerged as a major killer in sub-Saharan Africa, responsible for ~500,000 deaths since 20091. The disease primarily affects people who are immunocompromised by HIV, malaria, anaemia or malnourishment2, and has a high case-fatality-rate (14.5%1). In Africa, iNTS is caused by one clade of S.Typhimurium and two clades of S.Enteritidis3–5. Despite many decades of research on gene function and infection biology of Salmonella, the pathoadaptive mutations that have driven the emergence of African clades are unknown. Such knowledge is vital to decipher iNTS pathogenesis and develop control strategies in the future. To address this knowledge gap, I will decipher the mechanisms that African and gastroenteritis-associated Salmonella employ to survive and replicate within a core niche, human phagocytic cells. I will achieve this using our powerful combination of comparative genomics and transcriptomics, plus new innovations in experimental evolution and genome-wide, high-throughput fitness assays. By understanding the molecular basis of the intra-macrophage lifestyle, I will determine whether these neglected African-Salmonella pathovariants have used common or divergent approaches to combat the antibacterial properties of human cells. My Research Question is: How do African Salmonella pathovariants survive and replicate so effectively in human macrophages?', 'language': 'en'}, {'description': 'We normally think about Salmonella as a bacterium that is responsible for severe gastroenteritis. But two new types of Salmonella called Typhimurium and Enteritidis have recently emerged in Africa, and are causing a bloodstream infection called iNTS that is currently killing about 49,000 people a year. No-one has done experimental comparisons between African Typhimurium and Enteritidis before. I will investigate the bacteria while they are growing inside human cells, and using a range of innovative approaches. Other scientists are working on prophylactic approaches, and vaccines to target iNTS are currently in development. My research will contribute fundamental knowledge concerning the ability of African Salmonella to thrive inside human cells, which may reveal an unexpected Achilles’ heel of this dangerous pathogen. how Salmonella evolved from causing gastroenteritis in Europe and USA to become a pathogen responsible for bloodstream infections in Africa, we will be better prepared for future epidemics.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2671-6026', 'authenticated-orcid': False, 'given': 'Jay', 'family': 'Hinton', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 1671997.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 5, 1]]}, 'award-end': {'date-parts': [[2027, 4, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1671997.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:32Z', 'timestamp': 1636383512000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222528'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:23Z', 'timestamp': 1636456523483}, 'publisher': 'Wellcome', 'award': '221650', 'DOI': '10.35802/221650', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of novel computational approaches for human cardiac mapping data - Improving understanding and treatment of atrial fibrillation'}], 'project-description': [{'description': 'Cardiac arrhythmias are a common pathway for multiple cardiovascular diseases, the leading cause of death in the world. Ablation of cardiac arrhythmias is a recommended and common treatment option for arrhythmia patients, but success rates are poor. Cardiac electroanatomical mapping systems (EAMs) are used to identify ablation targets. EAMs generate a wealth of raw data that is ideal for developing algorithms to tailor treatments to an individual patients’ pathophysiology and improve treatment options. However, no platform exists for developing and testing algorithms. Specific groups have developed closed-source software to identify ablation targets however, these results have not been widely reproducible. There is an acute need for an open-source and cross-vendor EAM analysis software to facilitate sharing methods, increase rigor and transparency and increase access to advanced processing tools. I will develop expandable open-source software for analysis of EAM data. I will incorporate established and novel analysis methodologies, including machine learning approaches. Algorithms will be robustly validated using clinical, pre-clinical and in silico datasets. The software I will develop will enable myself and others to utilise routinely collected clinical data, to better treat cardiac arrhythmia. I will apply these approaches to identify mechanistic drives of atrial fibrillation as an exemplar application.', 'language': 'en'}, {'description': \"Cardiac arrhythmias, diseases where the heart beats irregularly, present a huge healthcare burden. Atrial fibrillation (AF) for example is an arrhythmia that affects over 30 million people worldwide. In AF, the heart's two upper chambers contract randomly and quickly. People with AF are at higher risk of stroke, heart attack and sudden death, so live with huge anxiety. A common treatment is “ablation”. Here we stop part of the heart working. Alas, this fails approximately half the time, so AF recurs. We don’t know why this happens. Electrical maps of the heart during ablation may hold the answer. But we don’t have the tools to effectively explore these data. I aim to develop new software for this. My software will be state-of-the-art and freely available. This will help us improve AF treatment. That will make patient quality of life better and reduce stroke, heart attack and sudden death.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6237-1902', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Bishop', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Davor', 'family': 'Pavlovic', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}, {'given': 'Igor', 'family': 'Efimov', 'affiliation': [{'name': 'George Washington University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3030-7364', 'authenticated-orcid': False, 'given': 'Christopher', 'family': \"O'Shea\", 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 1]]}, 'award-end': {'date-parts': [[2025, 4, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:13Z', 'timestamp': 1636383133000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221650'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527250}, 'publisher': 'Wellcome', 'award': '092406', 'DOI': '10.35802/092406', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People Award.'}], 'lead-investigator': [{'given': 'Nigel', 'family': 'Thrift', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2010, 10, 1]]}, 'award-end': {'date-parts': [[2012, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:18Z', 'timestamp': 1636382958000}, 'score': 0.0, 'issued': {'date-parts': [[2010, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/092406'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527802}, 'publisher': 'Wellcome', 'award': '221548', 'DOI': '10.35802/221548', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A modern cryo-EM instrument for biological samples at Imperial College London'}], 'project-description': [{'description': 'The Centre for Structural Biology at Imperial College London includes a heavily-used electron microscopy facility on the South Kensington campus that features four electron microscopes for single particle and tomographic analysis of biological samples. A large and rapidly-growing Imperial- and London-based user community spanning molecular biology, chemical biology, and drug development, uses these instruments for sample screening, optimisation, and data collection. These instruments, however, are all based on 20+ year-old archetype, resulting in rising maintenance costs and risk become irreparable any day due to inability to source replacement parts. These machines are also bottlenecks, incapable of providing high-throughput screening, optimisation, and data collection needed to feed high-resolution data collection instruments such as Titan Krioses accessible at various UK-based facilities. Our community is in urgent need of a contemporary electron microscope such as a Talos Arctica capable of both single particle and tomography cryoEM, equipped with technology for rapid screening and optimisation and compatibility with Krios sample handling. The instrument will be embedded and managed within the CSB EM facility and accessible by all CSB users on an hourly user rate basis to guarantee full cost recovery, a company-based service contract, and long-term sustainability.', 'language': 'en'}, {'description': 'Imperial College London harbours a Facility for electron microscopy (EM), which allows structural analysis of biological samples down to a scale of near-atomic resolution. In the past 5-10 years, EM underwent a dramatic technical revolution with strong influence on biology, medicine and chemistry. It today allows researchers to get atomic scale-resolved structures of highly complex molecules or cellular sub-structures, in remarkably short time. Our Facility currently has four electron microscopes, which are all technically outdated (pre-2000) and which also increasingly started showing technical issues. These problems sometimes became impossible to repair, due to non-availability of spare parts or service contracts for antiquated equipment. For our very large (>70), mostly College-based crowd of EM users this makes research much less efficient and much less competitive in the fast advancing, international research context. In this application we are therefore requesting financial support for a modern electron microscope for biological samples.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9786-7038', 'authenticated-orcid': False, 'given': 'Xiaodong', 'family': 'Zhang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0786-6726', 'authenticated-orcid': False, 'given': 'Dale', 'family': 'Wigley', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6646-1692', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Speck', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1226-3217', 'authenticated-orcid': False, 'given': 'Harry', 'family': 'Low', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8241-9697', 'authenticated-orcid': False, 'given': 'Doryen', 'family': 'Bubeck', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8789-9546', 'authenticated-orcid': False, 'given': 'Alfonso', 'family': 'De Simone', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0662-6664', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Aylett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6413-9835', 'authenticated-orcid': False, 'given': 'Morgan', 'family': 'Beeby', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2716-9669', 'authenticated-orcid': False, 'given': 'Tiago', 'family': 'Costa', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3364-3320', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Meier', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 997614.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'equipment', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 997614.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:08Z', 'timestamp': 1636383128000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221548'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527782}, 'publisher': 'Wellcome', 'award': '219998', 'DOI': '10.35802/219998', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of RNA Methylation (m6A) in Chikungunya virus replication'}], 'project-description': [{'description': 'Chikungunya virus (CHIKV) is an emerging human pathogen, which is transmitted by mosquitos. CHIKV has a widening distribution due to the impact of globalization, including changing land use and international travel and trade. Viruses manipulate host cells in a variety of ways, including through gene expression. Genome modifications have been shown to play a role in a range of other viruses’ lifecycles, including the closely related Zika virus (ZIKV). We seek to build a more comprehensive understanding of CHIKV biology in both their insect and mammal hosts, from the point of RNA modifications which has been shown to regulate replication of related viruses. We aim to dissect the extent and function of virus and host-cell genome modificationson CHIKV replication, to better understand the basic biology of the virus in its varied host environments and identify potential therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4746-3331', 'authenticated-orcid': False, 'given': 'Veronica', 'family': 'DeJesus', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:06Z', 'timestamp': 1636383306000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219998'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528744}, 'publisher': 'Wellcome', 'award': '221538', 'DOI': '10.35802/221538', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Live cell imaging capability for research on pathogenic viruses'}], 'project-description': [{'description': 'We request a 75% contribution to purchase two IncuCyte S3 Live-Cell Analysis Systems, together with archive data storage capacity (£189,485). These instruments are designed to acquire real-time growth, migration, morphology, phenotypic and gene expression data from virus-infected cells in microplates. They will be located in newly-opened Biological Safety Level 3 (BSL3) and BSL2 laboratories, transforming existing capacity for real-time analysis of virus-infected cells and enabling ambitious plans for expansion of virology research. The overall aims of the research supported by these instruments are: 1) to understand the molecular mechanisms by which viruses enter cells, replicate their genomes and assemble into infectious virions, and 2) to drive early-stage development of new anti-viral therapeutics (eg screening compound libraries). The IncuCyte instruments will facilitate both work streams. They will be housed in standard cell culture incubators and can be remote controlled allowing the analysis of cell parameters over time safely without disturbance. In order to effectively train users, provide technical advice, oversee usage and manage the instruments, we also request funding for 10% of the salary of the current BSL2/BSL3 laboratory manager, and 5% of the BioImaging facility support scientist over 5 years (£31,390).', 'language': 'en'}, {'description': 'Viruses must infect living cells in order to multiply. Virus multiplication cycles take many hours, during which time they hijack cellular machinery and change the inner workings of the cell to favour their own growth. To better understand how these processes occur, it is important to study the events that occur in virus-infected cells throughout the complete multiplication cycle, and the requested IncuCyte instruments will allow us to do this. Additionally, when studying viruses that cause human or animal disease we need to work safely. At Leeds, we have just invested in state-of-the-art laboratories designed for safe work with pathogenic viruses, this is where the IncuCyte instruments will be located. As well as enabling us to better understand virus growth and effects on cells, the IncuCyte instruments will allow us to establish efficient screening programmes for the identification of new anti-viral drugs, with potential long-term benefits for patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1360-2751', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Stockley', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3866-7110', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Whitehouse', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1146-5519', 'authenticated-orcid': False, 'given': 'Nicola Jane', 'family': 'Stonehouse', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9035-2039', 'authenticated-orcid': False, 'given': 'John', 'family': 'Barr', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-5978-4693', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Macdonald', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9084-2927', 'authenticated-orcid': False, 'given': 'Juan', 'family': 'Fontana', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2524-707X', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Tuplin', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8626-6787', 'authenticated-orcid': False, 'given': 'Morgan Reece', 'family': 'Herod', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4325-3687', 'authenticated-orcid': False, 'given': 'Jamel', 'family': 'Mankouri', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9821-1003', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Harris', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 189485.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'equipment', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 189485.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:07Z', 'timestamp': 1636383127000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/221538'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528725}, 'publisher': 'Wellcome', 'award': '220472', 'DOI': '10.35802/220472', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding host restriction following bacterial phagosome rupture'}], 'project-description': [{'description': 'Professional phagocytes engulf bacteria inside phagosomes that mediate cargo degradation via lysosome fusion. Some intracellular pathogens evade this fate by disrupting the phagosomal membrane, which triggers antibacterial autophagy. While autophagy may eliminate bacteria for host defence, more recent studies have demonstrated that autophagy can also promote intracellular bacterial survival or be irrelevant for bacterial restriction. Recently, Endosomal Sorting Complex Required for Transport (ESCRT) proteins have been shown to repair small membrane disruptions, potentially providing an alternative pathway for bacterial restriction. The interplay between autophagy and ESCRT machinery during phagosomal damage, the factors triggering each pathway and their contribution to intracellular bacterial killing are poorly understood. Using the important human pathogen Staphylococcus aureus, I will: (1) investigate the interplay between autophagy and ESCRT machinery; (2) identify novel bacterial components that modulate autophagy and ESCRT recruitment; and (3) uncover unknown host regulators of autophagy, ESCRT and cell-autonomous immunity. To complete these objectives, I will use high-resolution microscopy to follow bacteria recruiting autophagy and / or ESCRT machinery at the single bacterial cell level. Additionally, I will use high-content genetic screens to discover novel bacterial (using transposon libraries) and host factors (using CRISPR/Cas9) shaping host-pathogen interactions.', 'language': 'en'}, {'description': 'Immune cells engulf and kill microorganisms inside phagosomes. However, some microorganisms avoid their destruction by damaging the phagosomal membrane. This activates autophagy, which can sometimes clear the infection, but might also be irrelevant or beneficial for bacterial survival. Potentially providing a restriction alternative is the ESCRT machinery, which has been proposed to repair membrane disruptions. I want to investigate the interplay between ESCRTs and autophagy during Staphylococcus aureus infection. Advanced optical microscopy will enable me to follow both machineries in high resolution and may help to understand factors triggering each pathway and their contribution to intracellular bacterial killing. It will also be important to identify bacterial factors that can modify autophagy and / or ESCRT recruitment. Moreover, I aim to discover unknown host regulators of autophagy, ESCRT and cellular immunity that enhance bacterial restriction and might offer potential targets for new therapeutic regimes for infection control.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2188-5659', 'authenticated-orcid': False, 'given': 'Andres', 'family': 'Floto', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6088-0711', 'authenticated-orcid': False, 'given': 'Aurelien', 'family': 'Roux', 'affiliation': [{'name': 'University of Geneva', 'country': 'CH'}]}, {'given': 'Michael', 'family': 'Otto', 'affiliation': [{'name': 'National Institute of Allergy and Infectious Diseases', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1153-4089', 'authenticated-orcid': False, 'given': 'Sina', 'family': 'Krokowski', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2024, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:45Z', 'timestamp': 1636383105000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220472'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528744}, 'publisher': 'Wellcome', 'award': '222811', 'DOI': '10.35802/222811', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Using genetics to stratify patients and improve prediction of clinically relevant outcomes in psychiatry and neurology'}], 'project-description': [{'description': 'This project investigates the genetic basis of psychiatric disorders and neurological diseases with three key goals. First, to gain insight into the molecular mechanisms underlying genetic associations with these outcomes through the integration of genome-wide association study (GWAS) summary statistics with a range of newly released functional genomic annotations. These include variant-level annotations such as the effect of genetic variation on gene expression, methylation and chromosome structure within relevant tissues and cell types, as well as gene-level annotations such as expression profiles across tissues, cell types and developmental stages. Second, functionally informed polygenic scores, such as imputed and observed gene expression risk scores, will be stratified by enriched functional genomic annotations and used for clustering patients into aetiological subtypes, which will then be characterised using sociodemographic and clinical variables. Lastly, this study will evaluate the utility of machine learning models containing functionally informed polygenic scores and cluster membership information for prediction of diagnosis, prognosis and treatment response. I will use data from a range of ancestral populations to improve the accuracy of genetic predictors in all populations. Together this project can inform novel drug development, identify clinical subgroups, and promote personalised medicine through improved prediction of clinically relevant outcomes.', 'language': 'en'}, {'description': 'Background: Many genetic variants have been linked to psychiatric and neurological problems. However, the biological mechanisms by which these genetic variants cause these problems are unclear, limiting the extent to which these findings can be used to improve clinical care. My approach: Recently, our understanding of how genetic variation affects biological processes in the brain has progressed significantly. I will use this knowledge to uncover biological processes by which genetic variation cause psychiatric and neurological problems. I will then attempt to separate patients into subgroups based on the specific biological processes driving their condition. I will then test whether this information can be used to improve prediction of clinical outcomes. Impact: My work will provide insight into the biology of neurological and psychiatric problems, allowing us to separate patients into more specific groups to provide personalised healthcare and so improve prevention, diagnosis, and treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5680-3281', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Pain', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 28]]}, 'award-end': {'date-parts': [[2025, 10, 27]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:33Z', 'timestamp': 1636383513000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222811'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:29Z', 'timestamp': 1636456529394}, 'publisher': 'Wellcome', 'award': '222842', 'DOI': '10.35802/222842', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of RUNX1 regulation in human developmental haematopoiesis and childhood leukaemia'}], 'project-description': [{'description': 'All adult blood cells are derived from prenatal blood stem cells produced in the embryo, where the process is dependent on a gene named RUNX1. Blood cell formation and the development of various blood cancers (leukaemia) are sensitive to RUNX1 levels. In my DPhil, I will characterise the mechanisms regulating RUNX1 levels in normal and malignant human blood cell formation. I will use a “test tube” experimental approach to model human fetal blood cell formation, by differentiating stem cells into immature blood cells (progenitors). I will characterize the dynamic regulatory changes in the RUNX1 genomic region at distinct blood progenitor stages. These data will form the benchmark for the examination of RUNX1 regulation in primary human blood progenitor cells and childhood acute lymphoblastic leukaemia (ALL) samples. Lastly, RUNX1 regulation will be perturbed through genetic and epigenetic engineering, to identify the contribution of aberrant RUNX1 expression to the development of childhood leukaemia. This comparative approach will help us understand not only regulatory mechanisms of normal human blood cell formation, and how well this process can be modelled in a test tube, but also how altered regulation of RUNX1 affects leukaemia development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0135-0032', 'authenticated-orcid': False, 'given': 'Alessandro', 'family': 'Cavallo', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 1, 17]]}, 'award-end': {'date-parts': [[2024, 1, 16]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:01Z', 'timestamp': 1636383481000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 17]]}, 'URL': 'http://dx.doi.org/10.35802/222842'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:31Z', 'timestamp': 1636456531519}, 'publisher': 'Wellcome', 'award': '223762', 'DOI': '10.35802/223762', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring options for government support for charity-funded medical research'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5058-2200', 'authenticated-orcid': False, 'given': 'Catriona', 'family': 'Manville', 'affiliation': [{'name': 'Association of Medical Research Charities', 'country': 'GB'}]}], 'award-amount': {'amount': 30000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 28]]}, 'award-end': {'date-parts': [[2021, 9, 9]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 30000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:39Z', 'timestamp': 1636383519000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 28]]}, 'URL': 'http://dx.doi.org/10.35802/223762'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:12Z', 'timestamp': 1636456452724}, 'publisher': 'Wellcome', 'award': '061548', 'DOI': '10.35802/061548', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional and effective connectivity within visuomotor intergration.'}], 'project-description': [{'description': 'Functional and Effective connectivity within Visuomotor Integration The everyday action of reaching and grasping an object requires the transformation of the visual information about the object in the workspace to a series of co-ordinated motor commands. Such visuomotor integration requires the coupling and coordination of many distinct cortical structures. The anatomical and physiological connections in the distributed system connecting the visual and motor cortical areas have been extensively studied. However, the functional interactions within and between these interconnected regions are still a matter of speculation. I propose to use electrophysiological (EEG) and functional neuroimaging (fMRI) techniques in normal human subjects to assess the nature and task-dependence of functional and effective connectivity within and between the neural systems involved in visuomotor integration. Kinematic and electrophysiological recordings will be carried out in the Institute of Cognitive Science, Lyon, France with Dr D Boussaoud in collaboration with Dr Y Paulignan and Prof. M Jeannerod in years 1-2. Further electroencephalography (EEG) and the functional magnetic resonance imaging (fMRI) recordings will be performed at the Wellcome Department of Cognitive Neurology, London, with Prof. K Friston in collarboration with Prof. M Rugg, in year 3. Cortical connectivity will be assessed using two different approaches. Firstly I will study synchronous and asynchronous couplings between oscillatory neuronal populations and secondly I will assess the functional and effective connectivity using nonlinear analysis techniques. Using EEG in normal human subjects a number of recent studies have reported synchronous oscillatory activity between different cortical areas. Such oscillatory activity could reflect a functional mode of brain operation, acting as an integrative mechanism that can link the processing of related neuronal information carried out in different cortical systems. Such a strategy would be ideally suited to solve the binding problem in the distributed systems serving vision and movement where hierarchical and parallel operations coexist. I propose to (i) study synchronous, linear, couplings during visuomotor tasks between distinct cortical systems, recorded using EEG, using standard first, second and third order spectral analysis. (ii) develop non-linear techniques to study asynchronous couplings among oscillatory neuronal populations involved in visuomotor integration. (iii) assess the relative contributions of synchronous and asynchronous couplings between different cortical areas and (iv) assess whether such couplings, either synchronous or asynchronous, are related to any behavioural event or are modulated by visual or motor task-dependent parameters. This work would take place during the first two years of the Fellowship. In the third and final year I will assess connectivity from time-series data recorded using both EEG and fMRI. Neuroimaging studies have been very effective in terms of elucidating functional neuroanatomy in human subjects, identifying cortical and sub-cortical structures that are engaged by different aspects of a given task. However, a critical question is how are these different structures connected and how do they interact. This is particularly pertinent to the study of visuomotor integration where it has been proposed there exist two independent visuomotor processing pathways. I propose to (i) use non-linear techniques to characterise the functional integration and to assess the effective and functional connectivity within and between the ventral and dorsal visuomotor streams. (ii) simultaneously record whole head EEG and fMRI data series and apply the effective connectivity modelling to the EEG data and (iii) study the relationship between the evoked electrical changes and the slower haemodynamic response.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6632-6797', 'authenticated-orcid': False, 'given': 'James', 'family': 'Kilner', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 111221.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 111221.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061548'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:12Z', 'timestamp': 1636456452730}, 'publisher': 'Wellcome', 'award': '059418', 'DOI': '10.35802/059418', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuroscience: four year doctoral programme.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2673-274X', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Grubb', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 99858.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 99858.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:19Z', 'timestamp': 1636383199000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059418'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:16Z', 'timestamp': 1636456456911}, 'publisher': 'Wellcome', 'award': '061064', 'DOI': '10.35802/061064', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'European study group of cardiovascular oscillations - 1st meeting in Cardiff between 30 March and 1 April 2000.'}], 'lead-investigator': [{'given': 'Tudor', 'family': 'Griffith', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 1]]}, 'award-end': {'date-parts': [[2000, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:32Z', 'timestamp': 1636382852000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061064'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:18Z', 'timestamp': 1636456458793}, 'publisher': 'Wellcome', 'award': '063342', 'DOI': '10.35802/063342', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Transgenic studies into the functional importance of hypothalamic leptin receptors in metabolism and obesity control.'}], 'lead-investigator': [{'given': 'Nina', 'family': 'Balthasar', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 82562.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82562.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:19Z', 'timestamp': 1636382959000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063342'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:18Z', 'timestamp': 1636456458799}, 'publisher': 'Wellcome', 'award': '063353', 'DOI': '10.35802/063353', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Adrenomedullin, calcitonin receptor-like, receptor activity modifying proteins and endometrial angiogenesis.'}], 'lead-investigator': [{'given': 'Constance', 'family': 'Rees', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 150215.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 17]]}, 'award-end': {'date-parts': [[2005, 2, 16]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 150215.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:46Z', 'timestamp': 1636382926000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 17]]}, 'URL': 'http://dx.doi.org/10.35802/063353'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:22Z', 'timestamp': 1636456462361}, 'publisher': 'Wellcome', 'award': '054606', 'DOI': '10.35802/054606', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular genetic analysis of the neuronal ceroid lipofuscinoses.'}], 'investigator': [{'given': 'Mark', 'family': 'Gardiner', 'affiliation': [{'name': 'Oxford Brookes University', 'country': 'GB'}]}, {'family': 'Williams', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4385-4957', 'authenticated-orcid': False, 'given': 'Sara', 'family': 'Mole', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 238556.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 8, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 238556.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:01Z', 'timestamp': 1636383001000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054606'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463265}, 'publisher': 'Wellcome', 'award': '215095', 'DOI': '10.35802/215095', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A shifting landscape: Recovering homeostasis in the intestinal crypt and the point of no return'}], 'project-description': [{'description': 'Understanding how normal, homeostatic small and large intestine crypt structures form and are regulated by the surrounding environmental pressures is important to establish a baseline for clinicians and researchers. Through the combination of experimental methodologies, bioinformatics analysis, and mechanistic, agent-based modeling I aim to elucidate the selective pressures acting in the intestine to maintain a disease-free morphology. This work will contribute to our understanding of mutational processes, burdens, and turnover as a function of the microenvironmental regulators. Establishing this baseline allows us to explore how loss/alterations of these homeostatic pressures may lead to the development of various disease states, especially lesion formation. This work consists of understanding four primary aims: (1) stabilizing selection acting during homeostasis, (2) how a shifting microenvironmental landscape alters selective pressures leading to increased incidence of intestinal cancers, (3) how does therapeutic intervention act to rescue homeostasis through selection of homeostatic cellular phenotypes, and (4) when early therapeutic interventions fail, how are the selective pressures maintaining homeostasis altered such that the epithelium is beyond rescue and is this reflected in the mutation spectra.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0294-0106', 'authenticated-orcid': False, 'given': 'Ryan', 'family': 'Schenck', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:07Z', 'timestamp': 1636383247000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215095'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463272}, 'publisher': 'Wellcome', 'award': '065423', 'DOI': '10.35802/065423', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuroscience.'}], 'lead-investigator': [{'given': 'Anh-Vu Muly', 'family': 'Tham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 78792.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2002, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 78792.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:18Z', 'timestamp': 1636383198000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065423'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463322}, 'publisher': 'Wellcome', 'award': '108869', 'DOI': '10.35802/108869', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Infection, Immunology and Translational Medicine 4 year PhD programme.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2126-5142', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'McShane', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3312-5929', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Powrie', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8366-3245', 'authenticated-orcid': False, 'given': 'Christoph', 'family': 'Tang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2809988.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2720000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:38Z', 'timestamp': 1636383218000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108869'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463494}, 'publisher': 'Wellcome', 'award': '066733', 'DOI': '10.35802/066733', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '2nd International Arylamine N-Acetyltransferase Workshop to be held in Oxfordshire on 5th and 6th October 2001.'}], 'lead-investigator': [{'given': 'Edith', 'family': 'Sim', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2001, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066733'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:24Z', 'timestamp': 1636456464836}, 'publisher': 'Wellcome', 'award': '060853', 'DOI': '10.35802/060853', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Relieving a bottleneck in structural and functional genomics: the preparation of genome-scale libraries of stably folded, expressible and affinity-tagged protein domains.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7476-4148', 'authenticated-orcid': False, 'given': 'Ernest', 'family': 'Laue', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'family': 'Davies', 'affiliation': [{'name': 'University of Sussex', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0394-3202', 'authenticated-orcid': False, 'given': 'Dek', 'family': 'Woolfson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 86557.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 27]]}, 'award-end': {'date-parts': [[2002, 10, 26]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 86557.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:40Z', 'timestamp': 1636382800000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 27]]}, 'URL': 'http://dx.doi.org/10.35802/060853'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:24Z', 'timestamp': 1636456464837}, 'publisher': 'Wellcome', 'award': '016668', 'DOI': '10.35802/016668', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A study of the pathogenic role of pore-forming toxins of the immune system.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4075-7676', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Morgan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2132684.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1987, 10, 1]]}, 'award-end': {'date-parts': [[2002, 11, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Default Stream', 'award-amount': {'amount': 2132684.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:04Z', 'timestamp': 1636382944000}, 'score': 0.0, 'issued': {'date-parts': [[1987, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/016668'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:26Z', 'timestamp': 1636456466950}, 'publisher': 'Wellcome', 'award': '108903', 'DOI': '10.35802/108903', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'the Wellcome Trust Doctoral Training Centre in Public Health Economocs and Decision Science (PHEDS)'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8645-4780', 'authenticated-orcid': False, 'given': 'John', 'family': 'Brazier', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1486-8233', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Strong', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3691-1888', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Goyder', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1025-312X', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Brennan', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Campbell', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5354-1933', 'authenticated-orcid': False, 'given': 'Petra', 'family': 'Meier', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 1465471.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2024, 2, 17]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1404000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108903'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:26Z', 'timestamp': 1636456466923}, 'publisher': 'Wellcome', 'award': '216665', 'DOI': '10.35802/216665', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How do males of South Asian origin with long-term conditions understand, experience and seek help for emotional distress?'}], 'project-description': [{'description': 'One of the greatest challenges facing healthcare today is treating people with multiple long-term health conditions, a term known as multimorbidity. People with multimorbidity of both physical and mental illness fare worse; they have a worse quality of life and die earlier. People from ethnic minority communities are more vulnerable to mental illnesses such as depression and anxiety; they are under-diagnosed, under-treated and health outcomes are worse. South Asians (SAs) are the largest minority group in the UK and are at a much higher risk of certain conditions such as diabetes and heart disease. Little is known how SAs with long-term conditions understand, experience and seek help for emotional distress, in particular for SA males. A systematic review will initially be undertaken to summarise the current research around SAs with long-term conditions and their experiences of depression of anxiety. A qualitative study will then be done, interviewing SA males with long-term conditions and primary care clinicians in areas with high numbers of SAs. The research will explore how SA males understand, experience and seek help for emotional distress, and what the facilitators and barriers are to primary care clinicians in treating them.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8025-0426', 'authenticated-orcid': False, 'given': 'Hassan', 'family': 'Awan', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 24]]}, 'award-end': {'date-parts': [[2022, 12, 23]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:06Z', 'timestamp': 1636383246000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 24]]}, 'URL': 'http://dx.doi.org/10.35802/216665'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:27Z', 'timestamp': 1636456467834}, 'publisher': 'Wellcome', 'award': '051410', 'DOI': '10.35802/051410', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Transcriptional regulation of thyroid transcription factor 1 (TTF-1)'}], 'lead-investigator': [{'given': 'Joanna', 'family': 'Whitehouse', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 192705.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2001, 6, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 192705.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:06Z', 'timestamp': 1636382886000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051410'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:27Z', 'timestamp': 1636456467829}, 'publisher': 'Wellcome', 'award': '062111', 'DOI': '10.35802/062111', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Biochemistry of cellular systems: Macromolecular Assemblies'}], 'lead-investigator': [{'given': 'Donna M', 'family': 'Fullerton', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 118092.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 118092.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:08Z', 'timestamp': 1636383188000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062111'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:28Z', 'timestamp': 1636456468559}, 'publisher': 'Wellcome', 'award': '215141', 'DOI': '10.35802/215141', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of calmodulin and L-type calcium channels in cardiac arrhythmia'}], 'project-description': [{'description': 'Long-QT syndrome (LQTS) is a disease which can cause irregular heartbeats and in the most dangerous cases even cardiac arrest. Recent studies in affected patients have identified mutations in a protein called calmodulin, suggesting that calmodulin dysfunction is responsible for the disease. However the underlying mechanisms responsible are still unclear. The aim of this project is to assess the effect of the mutations on calmodulin function. In particular, we will determine how the properties of these mutants differ from the unmutated protein and how they affect calcium channel activity, a key player in cardiac muscle contraction, as excessive calcium entry in to heart cells is known to cause LQTS. This will be achieved by using diverse cutting-edge biophysical, physiological and imaging techniques. Understanding the precise role of calmodulin in LQTS will aid in the development of new avenues of research to target and treat the condition in human patients.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3885-2500', 'authenticated-orcid': False, 'given': 'Nitika', 'family': 'Gupta', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:53Z', 'timestamp': 1636383293000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215141'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:28Z', 'timestamp': 1636456468908}, 'publisher': 'Wellcome', 'award': '070563', 'DOI': '10.35802/070563', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Highgate Place- associated costs'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Bennish', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'award-amount': {'amount': 4693.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 11, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4693.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:01Z', 'timestamp': 1636382941000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070563'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:29Z', 'timestamp': 1636456469598}, 'publisher': 'Wellcome', 'award': '059448', 'DOI': '10.35802/059448', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Predisposing factors for asthma and poor lung function in Chile.'}], 'lead-investigator': [{'family': 'Rona', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 131620.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 6, 1]]}, 'award-end': {'date-parts': [[2004, 6, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 131620.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059448'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:29Z', 'timestamp': 1636456469609}, 'publisher': 'Wellcome', 'award': '064344', 'DOI': '10.35802/064344', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The contral of polyphosphoinositide and Ca2+ release during the cell cycle in eggs and early embryos.'}], 'investigator': [{'given': 'John', 'family': 'Carroll', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-9420-4626', 'authenticated-orcid': False, 'given': 'John', 'family': 'Parrington', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Karl', 'family': 'Swann', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 162812.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2005, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 162812.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:46Z', 'timestamp': 1636382866000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064344'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470057}, 'publisher': 'Wellcome', 'award': '065067', 'DOI': '10.35802/065067', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Computer modelling of bio-material interfaces.'}], 'lead-investigator': [{'given': 'Nora', 'family': 'De Leeuw', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 38200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 1]]}, 'award-end': {'date-parts': [[2003, 1, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 38200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:06Z', 'timestamp': 1636382946000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065067'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470065}, 'publisher': 'Wellcome', 'award': '074047', 'DOI': '10.35802/074047', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell-based drug discovery against novel intracellular targets'}], 'project-description': [{'description': 'University Translation Award Cell-based Drug Discovery Against Novel Intracellular Targets It is well established that the translocation of numerous proteins between cell compartments is key to their biological function. Several Pleckstrin Homology (PH) domains confer on their cognate proteins an ability to undergo translocation from the cytoplasm to the plasma membrane where their ligand, a phosphoinositide (PI), is formed in response to PI3-kinase activation. Interfering in PI-binding by PH domains, as a method of inhibiting protein translocation, and hence activation of downstream signalling pathways, has the potential to offer novel therapeutic routes for the treatment of cancer, inflammation and other diseases. Importantly, PH domains possess deep electrostatic PI-binding pockets making them highly suited to modulation by low molecular weight drugs. ProXara has developed state-of-the-art cell-based High Content Screening technologies to measure intracellular protein translocation through the integration of proprietary image analysis techniques with advanced cell biology. In a preliminary screen of 8,000 compounds, four inhibitors of the translocation of the protein kinase Ba (PKBa/Akt1) PH domain were identified, all of which possessed core structural similarity. These inhibitors blocked PKB activation in PTEN-null tumour cells. The Company now intends to exploit this novel technology to discover drugs against therapeutically relevant intracellular signalling proteins focussing initially on inhibitors of PKB and Gab2 translocation. The Company seeks funds to screen a significantly larger compound library and undertake initial medicinal chemistry optimisation. This will result in the identification of early lead chemical series allowing the Company to secure £5m+ Series A funding in 2005.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Paul', 'family': 'England', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2034-9969', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 593852.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 2, 1]]}, 'award-end': {'date-parts': [[2005, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 593852.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:54Z', 'timestamp': 1636382874000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/074047'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470073}, 'publisher': 'Wellcome', 'award': '062768', 'DOI': '10.35802/062768', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD in Infection and Immunity'}], 'lead-investigator': [{'family': 'Brode', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 126732.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 126732.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:45Z', 'timestamp': 1636383165000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062768'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470270}, 'publisher': 'Wellcome', 'award': '216298', 'DOI': '10.35802/216298', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution of specific brain circuits to impaired awareness of hypoglycaemia'}], 'project-description': [{'description': \"Impaired awareness of hypoglycaemia or 'hypo unawareness', is a condition in which the brain cannot sense when blood glucose levels are going low - known as hypoglycaemia. In people without diabetes, a fall in blood glucose is sensed by the brain and warning symptoms are triggered. These symptoms may include hunger, sweating, tremors and alert the individual to eat something to raise their glucose levels or to seek help. Unfortunately, in a quarter of patients with type 1 diabetes, the brain no-longer senses when blood glucose falls and warning symptoms are not triggered. These patients suffer from impaired awareness of hypoglycaemia and are at an increased risk of loss of consciousness, collapse and other long-term health problems. Sadly, a cure for this condition has not been discovered and we believe that understanding how this condition occurs may provide answers. Our research focuses on uncovering the cells which are responsible for sensing low blood glucose levels in an area of the brain called the hypothalamus. We wish to understand why these cells lose their sensitivity and how this could be prevented. We hope that this work could develop new ways to prevent or treat impaired awareness of hypoglycaemia in the future.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7032-1238', 'authenticated-orcid': False, 'given': 'Adhithya', 'family': 'Sankar', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:09Z', 'timestamp': 1636383249000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216298'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470280}, 'publisher': 'Wellcome', 'award': '219980', 'DOI': '10.35802/219980', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating Centriole Positioning and Orientation Within Cells'}], 'project-description': [{'description': 'Our bodies are made of cells positioned relative to each other in order to make functioning tissues and organs. Within each cell is a pair of barrel-shaped structures called centrioles that help form the “skeleton” of each cell, giving the cell structural integrity as well as positioning information. “Top” and “bottom” of each cell is distinct (i.e. the cell is polar), therefore they are able to pattern themselves appropriately to form larger scale structures. My project centres around how centrioles orient themselves within a cell, such that the cell achieves proper polarity allowing certain structures, like cilia, to form in the right place relative to other cells. To do this I will use the Drosophilaembryo which has many centrioles, all aligned with one end facing the cell cortex with each centriole appearing as a ring. By measuring the percentage of oriented ring-like centrioles upon introduction of genetic mutations and injected drugs, I will elucidate the key proteins and/or cellular pathways that keep centrioles oriented, allowing them to then establish and maintain cell polarity.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0946-7021', 'authenticated-orcid': False, 'given': 'Nicole', 'family': 'Liew', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:27Z', 'timestamp': 1636383327000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219980'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470306}, 'publisher': 'Wellcome', 'award': '071111', 'DOI': '10.35802/071111', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '3rd Annual Meeting of the complex traits consortium to be held at the University of Oxford on 1-3rd July 2003.'}], 'project-description': [{'description': '3rd Annual Meeting of The Complex Traits Consortium The Complex Trait Consortium (CTC) was formed 3 years ago by the growing community of researchers working with animal models of complex and quantitative traits (ie quantitative phenotypes with multiple genetic basis), to promote the exchange of information and resources. A central component of this process has been a series of meetings. This application is for funding to support the 3rd annual CTC meeting of the CTC in Oxford, from 1-3 July 2003. The previous CTC meeting in Memphis, TN (May 2002) was very successful with over 100 attendees. QTL mapping is a hard but important problem; it is essential that leading researchers in the field are able to meet regularly to share their expertise and to provide a focus and leadership within the QTL mapping community. With the publication of the draft Mouse genome, mouse genetics is now at a crucial phase and it is therefore very suitable to organise such a meeting at this time, in order to set the agenda for the next 2-3 years. Four particular foci for the Oxford meeting are: (1) How best to exploit the draft mouse genome sequence. The recent publication of the sequence should help accelerate the identification of QTLs. It is therefore very timely to meet and consider how to identify the molecular basis of QTLs. (2) The design and production of shared genetic resources such as Recombinant Inbred Lines (RIL), derived from crosses between inbred mouse lines, that will enable researchers to map quantitative trait Loci (QTL) as efficiently (in terms of both time and cost, as further genotyping is unnecessary) as possible. (3) The definition of the experimental/statistical criteria necessary for publication of QTL. A major concern has been that while it is hard to establish exactly the mutations giving rise to a quantitative trait, strong supporting evidence for a particular gene being associated with the trait can be established more easily. Consequently both researchers and journal editors require appropriate guidelines. (4) Methods for identifying susceptibility loci for disease including cancer. Other topics will include: (5) Results of current QTL mapping projects. (6) Methods for QTL fine-mapping. (7) Mapping projects in non-rodents, eg cattle, plants.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9427-4429', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Flint', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1022-9330', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Mott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 7, 1]]}, 'award-end': {'date-parts': [[2003, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 5000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071111'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470349}, 'publisher': 'Wellcome', 'award': '218518', 'DOI': '10.35802/218518', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Integrative Infection Biology - Mechanisms and Control of Disease'}], 'project-description': [{'description': 'The mission of the proposed IIB Programme is to inspire the next generation of innovative world-class researchers to tackle global infection challenges. We will achieve this by shaping excellent PhD projects that build synergistic collaborations across the University of Glasgow and our partner institutes. Our aim is to give all students an exceptional experience, driving them to build their careers with the ability, confidence and integrity to make transformative contributions to global health. Our principles are promoting inquisitive and rigorous science, imparting technological and analytical skills, and reinforcing personal well-being. Our graduates will be ‘Scientists without Boundaries’ at ease with the implementation of far-reaching interdisciplinary concepts on the local and global stage. The IIB Programme is integrated around Glasgow’s core of global excellence across infectious disease research, including pathogen biology, pathogen-host interaction, epidemiology, ecology and transmission control, encompassing >25 Wellcome Trust-funded investigators. We have partnered with key institutions in Europe and Africa, to offer PhD students exceptional opportunities in all areas of infection biology. UoG funding will add 2 students from Africa each year, making 7 altogether. Students will select projects after laboratory rotations and be fully mentored through to a ‘PhD-Plus Year’ fostering the transition to their post-doctoral career.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4760-8382', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Maizels', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8900-2982', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Waters', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7007-4070', 'authenticated-orcid': False, 'given': 'Massimo', 'family': 'Palmarini', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0150-5049', 'authenticated-orcid': False, 'given': 'Annette', 'family': 'MacLeod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6654-7346', 'authenticated-orcid': False, 'given': 'Gillian', 'family': 'Douce', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1843-8580', 'authenticated-orcid': False, 'given': 'Megan', 'family': 'MacLeod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1040-9566', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Marti', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:56Z', 'timestamp': 1636383296000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218518'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470471}, 'publisher': 'Wellcome', 'award': '220108', 'DOI': '10.35802/220108', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the acute and chronic effects of E-cigarettes on human lungs, examining functional and mechanistic outcomes.'}], 'project-description': [{'description': 'E-cigarettes vaporise nicotine-containing fluid for inhalation and have become an increasingly popular alternative to tobacco. The effects of e-cigarettes on the human lung are incompletely characterised. Preliminary evidence indicates that healthy vapers and smokers have similarly protease rich lung environments. This supports evidence from our lab, demonstrating that e-cigarette exposed alveolar macrophages(AM) increase protease output. I aim to understand the effects of e-cigarettes on the cells of the human lung. Lung resection tissue from never smokers/vapers/smokers/ex-smokers will be used to source AM and type-II alveolar cells, as well as precision cut lung slices (PCLS). Effects will be assessed using techniques to assess viability, proinflammatory mediator production/ROS/protease output, wound repair, phagocytosis and efferocytosis. Simple monocultures/co-cultures will provide initial evidence of e-cigarette effects, whilst PCLS and PCLS/AM cultures will allow effects to be examined in the context of the complex cellular architecture of the lung. In addition, I aim to identify the mechanism(s) of action through which these effects are mediated. Candidate mechanisms will first be tested in co-culture models before validation using our human PCLS model. These studies will help characterise how and why e-cigarettes affect the lungs. This may help inform regulatory decisions and mitigate risks associated with e-cigarette use.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8597-7747', 'authenticated-orcid': False, 'given': 'Lauren', 'family': 'Davis', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:52Z', 'timestamp': 1636383292000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220108'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470513}, 'publisher': 'Wellcome', 'award': '220291', 'DOI': '10.35802/220291', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of reading development in deaf children'}], 'project-description': [{'description': 'Many severely and profoundly deaf children struggle to learn to read because written text is a visual representation of spoken language, to which they have limited access. I have shown that speechreading (lipreading) relates to deaf children’s reading development. Fully understanding the mechanisms underlying the speechreading-reading relationship is fundamental to harnessing speechreading as a tool to improve deaf children’s reading. My goal is to investigate this mechanism in 1) a longitudinal study, to determine the relationships between speechreading, phonological skills, language skills and reading over time and 2) in neuroimaging studies with deaf children and adults to investigate neural representations of visual speech and written text and the relationships between them. All deaf participants involved in the studies above will use speechreading. A subset will also have learned British Sign Language from an early age. Good quality early sign language exposure is beneficial to reading development in profoundly deaf children. However, the mechanism underlying this relationship is unclear. I will employ parallel methods to those used in the speechreading studies to examine 1) the longitudinal relationships between sign language, fingerspelling and reading and 2) the neural representation of these visual language inputs in deaf children and adults.', 'language': 'en'}, {'description': 'Many deaf children struggle to learn to read. This is because text is a visual representation of a spoken language, to which many deaf children have reduced access. I aim to understand the mechanisms underlying the relationships between language skills, phonological skills (understanding the structure of a spoken word), lipreading, and reading ability in deaf children. I will examine the interplay of the relationships between these factors over time, from 3yrs to 7yrs old. I will also examine the relationship between representations of these different language inputs in the brain in deaf children and adults. A better understanding of how and when different language factors impact literacy development in deaf children will mean we are better placed to intervene to improve these skills. Understanding how these broad language skills can contribute to reading development may also inform interventions with hearing children who are struggling to read.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2315-3507', 'authenticated-orcid': False, 'given': 'Mairead', 'family': 'MacSweeney', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1580335.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 12, 15]]}, 'award-end': {'date-parts': [[2026, 12, 14]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 1580335.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:40Z', 'timestamp': 1636383100000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 12, 15]]}, 'URL': 'http://dx.doi.org/10.35802/220291'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470979}, 'publisher': 'Wellcome', 'award': '064663', 'DOI': '10.35802/064663', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '10/66 Dementia Research Group China and SEAsian Regional Network meeting in Chinese University of Hong Kong 22-24 April 2001.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1379-7146', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Prince', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4800.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2001, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4800.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:49Z', 'timestamp': 1636382929000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064663'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471024}, 'publisher': 'Wellcome', 'award': '068244', 'DOI': '10.35802/068244', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The evaluation of adjunctive beta radiation for trabeculectomy in South Africa - does it enhance success in glaucoma management?'}], 'project-description': [{'description': \"Glaucoma is the most common cause of irreversible blindness worldwide and is particularly prevalent in Africa. Trabeculectomy remains the only realistic option for control of this condition. We have undertaken a randomised, placebo-controlled, double-blind surgical intervention trial of per-operative beta-irradiation in trabeculectomies for glaucoma in Africans, based in South Africa. The primary outcome measure in the trial is intraocular pressure control at 12 months. Secondary outcome measures include post-operative complications, visual function and subsequent eye-health seeking behaviour. Local ophthalmologists conduct the trail with overall coordination performed by a UK-based research ophthalmologist. To date the project is making excellent progress with three caveats; recruitment is behind schedule, follow-up rates could be improved and our primary endpoint (failure of traveculectomy) occurs less frequently than anticipated. This application is for funding to enable this study to achieve completion. Modeling of overall data illustrates the trial, if completed, has sufficient power to demonstrate a clinically important impact on surgical success (90% success vs 74% success with 80% power). This method of treatment has major health service implications for improved management of glaucoma throughout sub-Saharan Africa. It is particularly appealing because there is 20 years' use from the 'one off' investment for an applicator. A model of compliance for glaucoma therapy in those with unsuccessful primary trabeculectomy will help in the construction of cost effectiveness studies and health care provision strategies.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8087-2268', 'authenticated-orcid': False, 'given': 'Peng tee', 'family': 'Khaw', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'family': 'Stulting', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}, {'family': 'Cook', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}, {'family': 'Roux', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}], 'lead-investigator': [{'family': 'Murdoch', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 99170.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 10, 1]]}, 'award-end': {'date-parts': [[2004, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 99170.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:29Z', 'timestamp': 1636382849000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068244'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471023}, 'publisher': 'Wellcome', 'award': '102172', 'DOI': '10.35802/102172', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cellular and molecular physiology'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8172-7513', 'authenticated-orcid': False, 'given': 'Alexei', 'family': 'Tepikin', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4055-5161', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Prior', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 2469886.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2014, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 2385000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2014, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/102172'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471800}, 'publisher': 'Wellcome', 'award': '059691', 'DOI': '10.35802/059691', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Funding for the Africa Centre research base at Somkhele.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Bennish', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'award-amount': {'amount': 1105637.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1105637.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:01Z', 'timestamp': 1636382941000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059691'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471966}, 'publisher': 'Wellcome', 'award': '216452', 'DOI': '10.35802/216452', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of anti-inflammatory drugs on emotional and reward processing'}], 'project-description': [{'description': 'The purpose of these studies is to investigate whether anti-inflammatory drugs change how the brain deals with emotional and rewarding information, with a view to improve treatments for people suffering from depression. There is growing scientific evidence that some people who do not respond to conventional antidepressants may benefit from taking anti-inflammatory drugs. Our research has previously shown that antidepressants affect how people experience certain kinds of information, for example by making them focus on positive facial expressions more than negative ones. These effects on ‘emotional processing’ can be found very early on in treatment, even before a patient ‘feels better’; however, we can measure these early changes and use this information to predict whether the treatment will actually help people feel better in the long term. The drugs we are investigating are called tofacitinib and atorvastatin. These are licensed drugs which has been shown to be generally safe and well-tolerated. We will test whether tofacitinib and atorvastatin can alter emotional processing in the same way as standard antidepressant drugs, comparing them with placebo (dummy tablet). Since reward processing and inflammation have been linked to depression, we will assess the effects of these drugs on these measures too.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5984-8696', 'authenticated-orcid': False, 'given': 'Riccardo', 'family': 'De Giorgi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:16Z', 'timestamp': 1636383256000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216452'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472040}, 'publisher': 'Wellcome', 'award': '220573', 'DOI': '10.35802/220573', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the interplay between interleukin-11 (IL-11) and senescence in cardio-renal aging.'}], 'project-description': [{'description': 'As chronological age increases, even in the absence of disease, vital organs accumulate changes which cause them to function less efficiently. Impaired efficiency of organs such as the heart or kidney are particularly common in older people causing the development of symptoms and require medical attention or hospital admissions. Cells accumulate damage to their DNA with age which causes these cells to enter a protective dormant state known as senescence. This prevents these cells from dividing and passing on the damaged DNA, however, senescent cells release molecules which cause neighbouring cells to produce scar tissue called fibrosis which impairs the efficiency of these organs. Interleukin-11 is one of these molecules which is known to cause fibrosis in multiple different diseases and blocking its effects reduces the amount of fibrosis. We plan to use treatments to block Interleukin-11 in ageing mice to identify the effect this has on the health of these mice and the amount of fibrotic tissue that they develop. We will also analyse the effects of senescent cells on the surrounding tissues to identify the benefit of treatments which specifically remove these cells or stop their contribution to scar formation.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5098-0076', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Sweeney', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 3]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:50Z', 'timestamp': 1636383470000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 3]]}, 'URL': 'http://dx.doi.org/10.35802/220573'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472209}, 'publisher': 'Wellcome', 'award': '061937', 'DOI': '10.35802/061937', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Neuroscience.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2316-7714', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Hall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 114290.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 114290.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:07Z', 'timestamp': 1636383187000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472245}, 'publisher': 'Wellcome', 'award': '053511', 'DOI': '10.35802/053511', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation and manipulation of indirect alloresponse in transplant rejection.'}], 'lead-investigator': [{'given': 'Wan', 'family': 'Ng', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 166683.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 8, 1]]}, 'award-end': {'date-parts': [[2002, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 166683.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:07Z', 'timestamp': 1636382827000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/053511'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472516}, 'publisher': 'Wellcome', 'award': '108864', 'DOI': '10.35802/108864', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mathematical genomics and medicine'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2740-8148', 'authenticated-orcid': False, 'given': 'John', 'family': 'Todd', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6883-6168', 'authenticated-orcid': False, 'given': 'Gos', 'family': 'Micklem', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-9755-1703', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Wallace', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1529-1862', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Gaffney', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9130-1006', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Durbin', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Simon', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 2602959.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 2490000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:17Z', 'timestamp': 1636383317000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108864'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472694}, 'publisher': 'Wellcome', 'award': '224685', 'DOI': '10.35802/224685', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developing small molecules to dissect the function and mechanism of m6Am methylation'}], 'project-description': [{'description': 'RNA are widely modified and the modifications have a range of effects. One such modification found in animals is the m6A modification. It is found in wide variety of different types of RNA & is the most common modification in messenger RNA. While the modification has been known about for 30 years, modern methods have only just identified the enzymes that create it. I aim to study a couple of these newly discovered enzymes. We will look into their enzymology making use of the existing x-ray structures. We hope to develop small molecule inhibitors for the enzymes. I hope to apply these inhibitors & the enzymology to cell assays. We might then better understand why the m6A modification is made and what effect it has.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8250-7627', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Harris', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 4, 19]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:57Z', 'timestamp': 1636383477000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 19]]}, 'URL': 'http://dx.doi.org/10.35802/224685'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472710}, 'publisher': 'Wellcome', 'award': '222391', 'DOI': '10.35802/222391', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Interplay between Nod-like receptor apoptosis inhibitory proteins and prostaglandins in colonic infection, inflammation and cancer'}], 'project-description': [{'description': 'Maintenance of gut health is dependent on the complex interactions between different cell types in the intestines and the immune system. Communication between these cells ensures that the barrier between the body and the gut contents is not disrupted and enables threats, such as harmful bacteria, to be detected by one cell subset and eliminated by another. The interactions between these cell types are disrupted during inflammation and disease, such as colitis, cancer, and infection. Understanding these signals and how they are perturbed during disease is vital. Certain bacteria are detected using receptors called NAIPs; we aim to understand how activation of NAIPs subsequently affects the rest of the immune system and how this impacts disease development. We will delete NAIPs from epithelial cells in the gut and identify resultant changes in immune cells. We will test this in models of colitis, colorectal cancer and Salmonella infection. I will look at changes in gene expression following NAIP deletion and identify the soluble mediators which influence the immune response. This project will aid our understanding of NAIPs during inflammatory disease development and thus generate potential targets for treating these diseases in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7769-2346', 'authenticated-orcid': False, 'given': 'Lisa', 'family': 'Scarfe', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:37Z', 'timestamp': 1636383397000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222391'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473183}, 'publisher': 'Wellcome', 'award': '066818', 'DOI': '10.35802/066818', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Meeting entitled 'Frontiers in ocular immunology, inflammation and transplantation', University of London, Senate House, 16-18 June 2002.\"}], 'project-description': [{'description': \"The University College London, Institute of Ophthalmology and its partner the Moorfields Eye Hospital, NHS Trust will host this symposium on Frontiers in Ocular Immunology, Inflammation and Transplantation to stimulate research in this area at the Institute/Hospital, and throughout the UK. The Institute of Ophthalmology now has eight basic and/or clinical laboratories pursuing research in all aspects of ocular immunology, and further growth in the Institute's Department of Immunology is an objective of the Institute's strategic plan. This symposium will stimulate the existing research programmes at the Institute/Hospital by bringing together the leaders in the field to London. During the invited lectures, poster sessions and informal gatherings, cutting edge information will be made available to interested investigators at the Institute/Hospital, and to any other interested groups within the UK. It is anticipated that existing collaborations will be strengthened, and new interactions formed during the symposium. The symposium will also facilitate the growth of immunology research at the Institute of Ophthalmology, University College London. New laboratory space for future immunology recruits to the Institute will become available in late 2002/early 2003, when the new research building (funded by the Trust's JIF award) is completed. Additional funding provided by Fight for Sight and GlaxoSmithKline will underwrite expenses associated with the recruitment of new researchers to the Institute. Professor Ono's recruitment from the Committee on Immunology at Harvard and its Schepens Eye Research Institute to the new GlaxoSmithKline Chair is an example of how such funds will be used to recruit other immunologists to the Institute. It is likely that future recruits in immunology will either be among the invited speakers or within their departments/laboratories. The symposium will therefore contribute directly to the growth of this department and thus the discipline. Of course, the primary objective of the symposium is to advance the field of ocular immunology, a meeting of investigators focused on issues relevant to diseases of the eye is essential due to the unique nature of immune responses in this organ. The invited speakers will discuss the following topics central to the field: The molecular and cellular basis of immune privilege and tolerance. Mechanisms of autoimmunity in the eye (focus on uveitis and keratitis). Immunologic parameters to corneal and retinal transplantation. Control of acute and late phase inflammation in vernal conjunctivitis. Mechanisms of ocular defenses to viral infection.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Santa', 'family': 'Ono', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:12Z', 'timestamp': 1636383012000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066818'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473215}, 'publisher': 'Wellcome', 'award': '063738', 'DOI': '10.35802/063738', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of post adhesive events in the pathophysiology of cerebral malaria.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1897-1978', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'White', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Kevin', 'family': 'Gatter', 'affiliation': [{'name': 'Misc Thailand', 'country': 'TH'}]}], 'lead-investigator': [{'given': 'Gareth', 'family': 'Turner', 'affiliation': [{'name': 'Misc Thailand', 'country': 'TH'}]}], 'award-amount': {'amount': 293566.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2003, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 293566.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:21Z', 'timestamp': 1636382841000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063738'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473353}, 'publisher': 'Wellcome', 'award': '222731', 'DOI': '10.35802/222731', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does wound inflammation impact on other cell lineages at the repair site – in vitro and live imaging studies in zebrafish'}], 'project-description': [{'description': 'Wound healing is the process by which skin integrity is restored following injury. At any site of tissue damage, the body activates a complex series of events to heal the wound. Each stage is necessary for effective tissue repair. Inflammation has evolved to prevent infection by pathogens. Besides killing bacteria, signals from inflammatory cells also coordinate other aspects of wound healing. However, these signals may also have negative consequences such a scarring, and if inflammation is not resolved, this can lead to chronic wounds such as diabetic foot ulcers can result. During my PhD I will investigate how inflammation impacts on three lesser studied cell types in wound healing, melanocytes (pigment cells), adipocytes (fat cells) and the cutaneous nerves in skin. It is thought these three cells could play interesting, but as yet unknown roles in wound repair, which may aid repair or be pathological. I will use live imaging in the translucent zebrafish to look at how these cells interact with inflammation, and what signals may cause this. This work could reveal the impacts of inflammation at the wound repair site, which could have impact on wound treatment in the clinic.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6822-8154', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'George', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 23]]}, 'award-end': {'date-parts': [[2023, 9, 22]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:01Z', 'timestamp': 1636383301000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 23]]}, 'URL': 'http://dx.doi.org/10.35802/222731'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473615}, 'publisher': 'Wellcome', 'award': '059601', 'DOI': '10.35802/059601', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Untitled grant'}], 'investigator': [{'given': 'Stacey', 'family': 'Efstathiou', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Philip', 'family': 'Stevenson', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 301492.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 301492.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:31Z', 'timestamp': 1636382971000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059601'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:36Z', 'timestamp': 1636456476520}, 'publisher': 'Wellcome', 'award': '220126', 'DOI': '10.35802/220126', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Protein Interactomes of Alzheimer’s Disease Risk Genes in Microglia'}], 'project-description': [{'description': \"Alzheimer's disease is a fatal condition with currently no cure. In our aging population, it is more important than ever to find ways to treat Alzheimer's, or even prevent it. Understanding the biology of Alzheimer's is a key step to understanding the disease and finding the best possible treatment and preventions. Previous research has found mutations in key genes, mostly expressed in microglia (the brain's immune cells) that increase a person's risk of developing Alzheimer's. Our work will focus on 3 of these genes (ABI3, TREM2, and PLCG2) and will look at how the proteins they code for interact with other proteins within cells. We will do this by mapping which proteins interact with our proteins of interest, both the normal and mutant versions, then compare these interactomes. We will then investigate the function of any new proteins found in these results and finally assess if these new proteins also contain mutations that carry a risk for Alzheimer's. This impact of this research will be to broaden our understanding of how these mutations increase the risk of Alzheimer's and may highlight potentially druggable targets to treat or reduce the risk of developing Alzheimer's.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2041-4361', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Widnall', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:08Z', 'timestamp': 1636383308000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220126'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:36Z', 'timestamp': 1636456476539}, 'publisher': 'Wellcome', 'award': '220597', 'DOI': '10.35802/220597', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Integration of kinases with membrane trafficking machinery'}], 'project-description': [{'description': 'Endocytosis is a highly dynamic process that determines the composition of the plasma membrane (PM). The dysfunction of endocytic pathways is a causal factor behind a number of human genetic diseases, and its dys-regulation can contribute to neurodegeneration. Despite the critical role that endocytosis plays in health and disease, surprisingly little is known about how it is regulated. A major potential regulation point is the dynamic phosphorylation of endocytic components by kinases. However, it is poorly understood which kinases (and phosphatases) control endocytosis and the PM proteome, even though they represent potential targets for disease-modifying therapies. My long-term vision is to understand the integration of protein kinases within membrane-trafficking machinery. My starting focus is on the Numb-associated kinase family (NAK). NAKs were identified as a susceptibility factor in Parkinson’s disease and neuropathic pain but the molecular mechanisms behind this are not clear. I will elucidate the key cellular functions of NAKs: (1) which cellular processes and substrates are associated with NAKs (2) the consequences of their activity for cellular physiology and (3) the regulatory processes and interaction partners which govern NAK activity states.', 'language': 'en'}, {'description': 'All living cells are surrounded by cell membranes. These are essential to keep the inside of the cell separate from its outside surroundings, but are also very dynamic, controlled structures to make sure that the cell remains healthy and functioning within its outside environment. Problems in the functioning of cell membranes can result in disease. It is therefore important to understand the complex processes which control cell membrane structure and function. I am studying the process of ‘endocytosis’ – an important way for cell membranes to transport materials from outside to inside. My research is focused on a group of proteins called ‘NAKs’. Using cells grown in dishes, I will measure the exact mechanisms of NAKs to control endocytosis. NAK proteins may also have a role in some diseases of the nervous system, and so my research will inform efforts to discover and develop new treatments targeting NAKs.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9835-1014', 'authenticated-orcid': False, 'given': 'Julian', 'family': 'Rayner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6335-1105', 'authenticated-orcid': False, 'given': 'Zuzana', 'family': 'Kadlecova', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 1178961.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 31]]}, 'award-end': {'date-parts': [[2025, 12, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1178961.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:49Z', 'timestamp': 1636383109000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 31]]}, 'URL': 'http://dx.doi.org/10.35802/220597'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:37Z', 'timestamp': 1636456477779}, 'publisher': 'Wellcome', 'award': '215170', 'DOI': '10.35802/215170', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the relationship between schizophrenia risk genes and adult hippocampal plasticity'}], 'project-description': [{'description': 'Schizophrenia is a debilitating psychiatric condition which affects around 1% of the general population. It is a highly heritable condition, and several genetic changes have been linked to the development of the disorder. Copy Number Variations, or CNVs, are one such group of genetic changes in which microscopic pieces of DNA are deleted or duplicated, leading to altered gene dosage. Previously, large-scale analyses have linked CNVs with an increased risk of developing schizophrenia. Similarly, work from our lab has found that schizophrenia associated CNVs have a particular effect on pathways activated during extinction learning in the CA1 region of the hippocampus. The aim of this project is to further investigate the association between genetic risk for schizophrenia and extinction learning, using large-scale analyses and behavioural learning in rats. I will extend previous work by examining other sub-fields of the hippocampus and the prefrontal cortex, regions which are thought to be important in schizophrenia. Further, I will directly compare RNA expression from the post-mortem brains of human patients with RNA expression from learning tasks. These studies will help to further elucidate the molecular pathways acted upon by genetic risk variants, and may provide targets for treatment development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3272-855X', 'authenticated-orcid': False, 'given': 'Natalie', 'family': 'Wellard', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:21Z', 'timestamp': 1636383441000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215170'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478213}, 'publisher': 'Wellcome', 'award': '072854', 'DOI': '10.35802/072854', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The 12th London Muscle Conference'}], 'project-description': [{'description': 'The 12th London Muscle Conference The London Muscle Conference, which was initiated by Professor John Square about 15 years ago at Imperial College London, has been run very successfully for most years since then, with the location being shared by a few sites in London. Muscle research has progressed a long way since the initial formulation of the sliding filament model nearly 50 years ago. Not only are modern techniques throwing light on the ultrastructure of the vertebrate striated muscle sarcomere and the properties of individual muscle motors, but the latest methods of molecular biology, together with the elucidation of the human genome, are throwing light on the molecular basis of many of the well-known muscular diseases, including those of the heart such as hypertrophic cardiomyopathy and dilated cardiomyopathy. The field is moving forward an at ever increasing rate and the need to be able to keep up with the latest advances has never been stronger. Of particular importance is for those in disparate disciplines, e.g. molecular biologists, structural biologists and physiologists, to explain what they are doing to others not in the same field. Such cross-fertilisation is a natural by-product of Conferences of this kind. The London Muscle Conference, the only open annual muscle conference held in the United Kingdom, serves the essential purpose for UK scientists of presenting as invited lectures many of the latest results in particular areas. In addition there is an opportunity for a much wider scope of presentations in poster form with time set aside to study these and to have discussions with the authors of the posters. The conference also provides a set of abstracts; an excellent continuing source of information in the field. With the setting up of the Imperial Muscle Initiative, which has its own website, these abstracts (with the authors permission) can also be made available to the wider scientific community.', 'language': 'en'}], 'lead-investigator': [{'given': 'John', 'family': 'Squire', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 9, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/072854'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478430}, 'publisher': 'Wellcome', 'award': '215100', 'DOI': '10.35802/215100', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Inhibitory Superagonistic Antibodies as Novel Therapeutics'}], 'project-description': [{'description': 'The immune response is finely balanced to eliminate infection while avoiding doing damage to the body. Immune cells have receptors which fine tune their response for this purpose. These receptors come in two types activatory and inhibitory. Activatory receptors cause a more powerful immune response with a greater ability to eliminate infection. In contrast, inhibitory receptors dampen the immune response to prevent damage to the body. We aim to harness the capacity of inhibitory receptors to dampen the immune response by using antibodies to trigger this effect. This would be useful for treating diseases in which the immune system is causing damage (autoimmune diseases). More specifically we aim to make antibodies capable of binding two different targets at the same time. With this aim we hope to achieve two things. Firstly, we hope to be able to signal through inhibitory receptors which are composed of two parts. These cannot be targeted by current antibodies only able to target one half of the receptor at a time. Secondly, we will try and target the inhibitory receptors locally in the tissue being damaged by immune cells in autoimmune diseases so that the rest of the body is not left vulnerable to infection.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3432-5690', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Donat', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:49Z', 'timestamp': 1636383289000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215100'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478627}, 'publisher': 'Wellcome', 'award': '222308', 'DOI': '10.35802/222308', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution of macrophages to the different clinical manifestations of cutaneous leishmaniasis caused by Leishmania aethiopica'}], 'project-description': [{'description': 'Cutaneous leishmaniasis (CL) is a neglected tropical disease with about 1 million new cases per year. It is caused by parasites that are transmitted by sandflies. There are a number of different forms of the disease, ranging from small, self-healing lesions on the skin, to permanently disfiguring facial lesions. It is not well understood how the parasite can result in such a wide range of outcomes. Our aim is to gain a better understanding of the interaction between the human immune system and the parasite. We are doing this by investigating how key immune cells called macrophages interact with parasites isolated from different patients. This may reveal key differences between the different forms of CL. We are achieving this through a highly collaborative approach with experts in different fields. We hope that this research will shed light on our understanding of the diversity of CL as a disease and why some patients develop severe, life-changing lesions.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2805-3396', 'authenticated-orcid': False, 'given': 'Edward', 'family': 'Cruz Cervera', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 8]]}, 'award-end': {'date-parts': [[2023, 10, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:28Z', 'timestamp': 1636383388000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 8]]}, 'URL': 'http://dx.doi.org/10.35802/222308'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478651}, 'publisher': 'Wellcome', 'award': '220052', 'DOI': '10.35802/220052', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'New approach to identifying epistasis using harmonic mean p-value'}], 'project-description': [{'description': 'Epistasis refers to the phenomenon where the effect of one gene in a given trait is dependent on other genes. The effect of such interaction between genes is often ignored in studies that try to identify genetic risk factors in diseases and only the effects of individual genes are considered. Such an approach resulted in missing information and the heritability of genetic risks is only partially explained by these association studies. It is proposed that epistasis might be the missing piece of this puzzle. However, taking epistasis into account would increase the number of candidates dramatically. This presents a statistical challenge as the difficulty to find true signal grows when the number of candidates to be considered increases. In this project, we will leverage a recently published statistical method by Prof Daniel Wilson that can combine numerous signals into one representing signal and thereby reduce the number of candidates to overcome the challenge posts by epistasis. We hope to develop a framework to efficiently and flexibly identify genetic risk factors that includes epistasis in different human diseases.', 'language': 'en'}], 'lead-investigator': [{'given': 'Shang-Kuan', 'family': 'Lin', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:02Z', 'timestamp': 1636383302000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220052'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:39Z', 'timestamp': 1636456479562}, 'publisher': 'Wellcome', 'award': '062827', 'DOI': '10.35802/062827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Fourier Transform Infra Red (FTIR) and ATR (Attenuated Total Reflectance)-FTIR studies of cytochrome c oxidase.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Rich', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 130154.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 130154.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:48Z', 'timestamp': 1636382988000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482691}, 'publisher': 'Wellcome', 'award': '220711', 'DOI': '10.35802/220711', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the Role of MITOchondrial ImmunoMETAbolism in Neuroinflammation: Mechanisms and New Targets for Progressive MS Treatment (MITO_META)'}], 'project-description': [{'description': 'People with progressive multiple sclerosis (P-MS) have substantial unmet clinical needs. While current therapies for MS are focused on manipulating the activity of the adaptive immune system, they have limited applicability for P-MS where a switch towards the chronic activation of innate immune cells, such as mononuclear phagocytes (MPs), occurs. MITO_META aims to test the hypothesis that the detrimental activation of MPs in P-MS is dependent on their mitochondrial metabolism and that targeting mitochondrial complex I (CI) activity in MPs will lead to novel therapeutic approaches for P-MS. To achieve this aim, I will adopt a combination of animal models and post-mortem biological samples obtained from MS patients. I will initially use the experimental autoimmune encephalomyelitis (EAE) mouse model of MS to study the effect of removing Complex I from MPs during neuroinflammation (Aim 1). I will then analyse how the metabolism of MPs changes during neuroinflammation, and compare these findings to those obtained from post-mortem analysis of people with progressive MS (Aim 2). Elucidating the role of mitochondrial function in MPs during chronic neuroinflammation will advance our understanding of P-MS and lead to new therapies to interfere with the progression of disability.', 'language': 'en'}, {'description': 'In multiple sclerosis (MS), the immune system attacks the central nervous system causing acute clinical symptoms, or relapses. Although there are therapies to stop relapses, most patients still develop a secondary progressive form of MS (P-MS) causing chronic disability, for which there is no cure. The damage in P-MS is caused by immune cells called mononuclear phagocytes (MPs). The aim of MITO_META is to reduce the harmful activation of MPs by targeting the way they produce energy (metabolism) in their powerhouse (mitochondria). I plan to use mouse models of MS (i) to abolish the harmful expression of a mitochondrial protein in MPs, and (ii) to investigate their changes in metabolism. I will then compare these findings to post-mortem data of people with progressive MS. This multi-step approach will lead to significant advances in our understanding of P-MS and allow us to develop new therapies to stop progression.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1115-9618', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Murphy', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6267-9472', 'authenticated-orcid': False, 'given': 'Stefano', 'family': 'Pluchino', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-3293-7397', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Frezza', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0795-3467', 'authenticated-orcid': False, 'given': 'Zoltan', 'family': 'Takats', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9396-5607', 'authenticated-orcid': False, 'given': 'Luca', 'family': 'Peruzzotti-Jametti', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 446707.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2023, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 446707.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:52Z', 'timestamp': 1636383112000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220711'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482866}, 'publisher': 'Wellcome', 'award': '220105', 'DOI': '10.35802/220105', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the function and regulation of surface molecules in the reaction to predation by Gram-negative bacteria during predation by the predatory bacterium Bdellovibrio bacteriovorus in host-appropriate settings.'}], 'project-description': [{'description': 'The number of infections caused by bacteria that are resistant to antibiotic treatment is increasing, potentially threating the treatment of infectious disease and other illnesses. New treatment approaches are therefore desperately needed, one of which involves the application of the predatory bacteria Bdellovibrio bacteriovorus. B. bacteriovorus is a bacterium that is able to prey upon a wide range of these antibiotic resistant organisms, potentially providing an alternative treatment for infections. This work builds on previous work with other clinically relevant bacteria to further characterise the mechanisms behind the prey recognition and invasion of bacteria by B. bacteriovorus predators and how this interaction is affected by components of the host immune system (1, 2) and prey surface factors (3). By looking at the factors that may prevent or decrease predation and experimentally removing them, we can characterise the mechanisms behind this interaction further and aid the potential application of B. bacteriovorus as a novel antimicrobial therapy in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0990-3260', 'authenticated-orcid': False, 'given': 'Callum', 'family': 'Clark', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:47Z', 'timestamp': 1636383287000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482895}, 'publisher': 'Wellcome', 'award': '214560', 'DOI': '10.35802/214560', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How do people get multi-drug resistant tuberculosis?'}], 'project-description': [{'description': 'Recent data suggests that most isoniazid resistant strains have been circulating for decades. The global diagnostic focus on rifampicin resistance has meant that isoniazid mono-resistant strains are systematically being treated with first-line therapy. With MDR-TB incidence rising despite overall TB incidence falling, the concern is that we are selecting for rifampicin resistance. The alternative explanation, that MDR-TB is transmitting more successfully, seems unlikely, but possible. The hypothesis I will test is that most isoniazid resistance is acquired through transmission whereas most rifampicin resistance evolves de novoin patients with undiagnosed, pre-existing isoniazid resistance. I will investigate the following research questions in Vietnam: (i) What is the proportion of transmitted versus newly evolved MDR-TB? (ii) What is the prevalence of isoniazid resistance among patients never previously exposed to the drug, and what proportion of patients with unsuccessful treatment outcomes evolve isoniazid resistance? (iii) What is the risk of evolving rifampicin resistance by treating isoniazid resistant strains with first-line drugs? What proportion of patients who evolve rifampicin resistance after exposure to first-line drugs also evolved isoniazid resistance? (iv) Do host genotype and variable anti-tuberculosis drug pharmacokinetics contribute to evolving drug resistance? The findings will inform policy on diagnostics, treatment protocols and disease control.', 'language': 'en'}, {'description': 'Multi-Drug resistance tuberculosis (MDR-TB) is defined as resistance to the two most important TB antibiotics, isoniazid and rifampicin. It is harder to treat and patient outcomes are much worse. Unfortunately, MDR-TB rates are rising as drug-susceptible TB rates are falling. It remains unclear why. I plan to investigate whether people get MDR-TB from other infected patients, or whether drug-resistance more commonly evolves within patients after they are exposed to antibiotics. To do this I will determine the DNA sequence of all MDR-TB strains in Ho Chi Minh City, Vietnam, and build a family tree from these data to determine which strains are related through transmission. I will also focus on patients who aren’t cured by antibiotics or get disease a second time, asking whether their treatment failed because they were given too few effective antibiotics, or the wrong dose of antibiotics, and whether this in turn led to resistance.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0421-9264', 'authenticated-orcid': False, 'given': 'Timothy', 'family': 'Walker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1526714.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 6, 1]]}, 'award-end': {'date-parts': [[2024, 6, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1526714.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:27Z', 'timestamp': 1636383027000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/214560'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484859}, 'publisher': 'Wellcome', 'award': '222061', 'DOI': '10.35802/222061', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Innovations Translational Partnership Award (Manchester)'}], 'project-description': [{'description': 'Following on from our current award and informed by a University-wide survey, we will use TPA funding to address four aims: - SUPPORT translational research: by providing direct and indirect support for translational research. - CONNECT across disciplines: by removing barriers between disciplines and creating better links between science, technology and innovation. - INNOVATE with industry: by promoting commercialisation activities and enable collaborations with industry. - CHANGE the culture: by embedding translational research across the University. We will expand the TPA team (with a Support Officer and a Bioinformatician) to tackle translational research bottlenecks and enable the progression of projects along the translational research pipeline. We will directly support investigators with our pump-priming funding schemes and introduce new initiatives to engage early career researchers. We will devise a comprehensive programme of bespoke training for researchers and staff supporting researchers. Working with colleagues from Business Engagement, we will run Innovation Labs, to help researchers and industry partners forge new collaborations with seed-corn funding. Finally, we will directly support activities that facilitate access to patient data/tissues by exploiting the potential of the Translation Manchester Research Network and by developing a tool to enable researchers to identify collaborators across the University and our partner NHS trusts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3324-4955', 'authenticated-orcid': False, 'given': 'Luke', 'family': 'Georghiou', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 2397523.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 9]]}, 'award-end': {'date-parts': [[2024, 11, 8]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 2397523.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:31Z', 'timestamp': 1636383151000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 9]]}, 'URL': 'http://dx.doi.org/10.35802/222061'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484850}, 'publisher': 'Wellcome', 'award': '221574', 'DOI': '10.35802/221574', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Longitudinal Population Study COVID-19 Steering Group and Secretariat'}], 'project-description': [{'description': 'Our objective is to provide an efficient coordinating body (“secretariat”) for the continued development, deployment, collection and analysis of a shared COVID-19 questionnaire across UK cohorts. The value of undertaking this in multiple longitudinal UK cohorts is that data can be collected in extremely well characterised members of the population across a wide demographic range who are already engaged in research, who have had data and biological samples collected on them, who have an established collection of record linked data already record linked and who sit behind supported infrastructure able to undertake novel data collection and research. Each of these cohorts is research active and collectively offers a depth or domain expertise not available within any one cohort, including that of UK Biobank. In this first coordination of COVID-19 research in deeply characterised UK cohorts, we identified the added value of a core questionnaire prospectively aligned to capture data pertinent to understanding COVID-19, as well as the direct and indirect consequences of the pandemic on health, wellbeing, social and economic outcomes.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7141-9189', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Timpson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 120585.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 7, 1]]}, 'award-end': {'date-parts': [[2021, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 120585.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:09Z', 'timestamp': 1636383129000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221574'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484832}, 'publisher': 'Wellcome', 'award': '221507', 'DOI': '10.35802/221507', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Improving mental health for marginalised groups at Oxford's Wellcome Centres\"}], 'project-description': [{'description': 'This proposal will address the intersection of mental health and Equality, Diversity & Inclusion (EDI) within Oxford’s three Wellcome Centres. Mental health concerns permeate a broad range of challenges relevant to EDI, including social exclusion, chronic illness and disability, and minoritised populations (detailed below) that are disproportionately affected by mental ill-health. By identifying specific mental health challenges that different groups face, we can improve equality. Through normalisation of discussions around mental health in the workplace, and building an appreciation for how these issues affect people differently, we foster inclusion. If we can recruit and retain a broader range of researchers further into their careers, we improve diversity, and therefore our science. An increasingly inclusive, fair and kind research culture will lower the risk of mental ill-health for all our team and staff members within the high-impact but high-pressure academic environment. Our specific objectives are to: (i) Conduct an in-depth, expert review of mental health as it relates to EDI within our Centre work environments. (ii) Implement recommendations arising from this review relating to policies, communication and practices. (iii) Build a broad, cross-Centre programme promoting positive research change around mental health and EDI.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4134-9730', 'authenticated-orcid': False, 'given': 'Heidi', 'family': 'Johansen-Berg', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 77068.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2022, 7, 31]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 77068.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:06Z', 'timestamp': 1636383126000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221507'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484863}, 'publisher': 'Wellcome', 'award': '220906', 'DOI': '10.35802/220906', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Preventable axon degeneration in human disease'}], 'project-description': [{'description': 'Programmed axon degeneration (or Wallerian degeneration; WD) is a preventable and druggable mechanism of axon loss. WD is well-characterised in animals and highly conserved. Blocking WD alleviates axon loss and symptoms in multiple disease models, suggesting a common, downstream mechanism. Human data are essential to confirm the role of WD in specific human diseases, ensuring drugs under development are tested in highly-relevant disorders and patients. We reported mutations in rare human axonopathies that aberrantly activate WD, and lifelong rescue of a related mouse model. Our programme determines the wider involvement of WD in rare and common human disorders, specifically peripheral neuropathies and ALS, where axon degeneration is important. We use online resources (100,000 Genomes, Project MinE, UK Biobank, etc.) and targeted sequencing of well-phenotyped cohorts and test roles of gene variants in causation, risk and severity. We determine their functional impact using complementary human iPSC and mouse modelling and develop specific biomarkers of WD for clinical samples. This project will provide insight into pathogenic mechanisms and a firm platform for developing and testing therapeutics. Our team, a world leader in Wallerian degeneration and leading neurogeneticists in rare and common neuropathies and human iPSC modelling, is uniquely placed to deliver this.', 'language': 'en'}, {'description': 'Nerve cells have long, thin structures (axons), that project around our brain and spinal cord, and to skin, muscles and other organs. Axons make connections that control our bodies. They are lost early in many disorders causing pain, paralysis, spasticity, tremor, memory deficits or blindness. We identified, and characterised along with other scientists, a preventable axon degeneration mechanism common to many diseases. Here, we will use the extensive knowledge gained animal studies to test for human diseases involving this degeneration mechanism. This is important to known which diseases may respond to drugs that block it. We will use human genome sequences, stem cell- and neuron cultures to study rare, inherited disorders, motor neuron disease, and peripheral neuropathies caused by diabetes or cancer chemotherapy. This study, together with ongoing drug development, could result in major improvements for some rare disease patients, and may lead to widely-applicable therapies in neurodegenerative disorders.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7996-2696', 'authenticated-orcid': False, 'given': 'David', 'family': 'Bennett', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1215-3373', 'authenticated-orcid': False, 'given': 'Ahmet', 'family': 'Hoke', 'affiliation': [{'name': 'Johns Hopkins University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-0686-905X', 'authenticated-orcid': False, 'given': 'Mary', 'family': 'Reilly', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9354-532X', 'authenticated-orcid': False, 'given': 'Michael Philip', 'family': 'Coleman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 3640891.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2026, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 3640891.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:58Z', 'timestamp': 1636383118000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220906'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485841}, 'publisher': 'Wellcome', 'award': '221410', 'DOI': '10.35802/221410', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Enabling research uptake through integrating networks and communities of practice'}], 'project-description': [{'description': 'Findings from health research should be translated into recommendations that can be implemented within policy and practice if research is to deliver its maximum impact and ability to change health outcomes. Currently research ‘success’ typically concludes with the publishing of papers in high impact journals with less attention to how, and indeed whether, those findings are made visible and accessible to those tasked with decision making that should be changing their practice on the basis of these new findings. Compounding this is the current difficulty for these practice and policy decision-makers to easily be made aware, find, access and synthesise new research recommendations. The Global Health Network seeks to address this by bringing researchers and decision makers together to find new tools and mechanisms for researchers to present their outcomes as recommendations that can be readily discoverable and put into practice. This proposal will firstly, establish a community of practice for researchers and decision-makers to share knowledge and develop resources, processes and mechanisms that can support turning results into discoverable, practical and usable recommendations. Secondly, to deliver an advanced digital database which enables rapid synthesis of the available research recommendations to drive improvements in uptake.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2273-5975', 'authenticated-orcid': False, 'given': 'Trudie', 'family': 'Lang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 285830.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 5]]}, 'award-end': {'date-parts': [[2022, 10, 4]]}, 'funding': [{'type': 'award', 'scheme': 'Social Science and Bioethics', 'award-amount': {'amount': 142915.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:04Z', 'timestamp': 1636383124000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 5]]}, 'URL': 'http://dx.doi.org/10.35802/221410'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485876}, 'publisher': 'Wellcome', 'award': '220400', 'DOI': '10.35802/220400', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the crosstalk between adipocytes and macrophages during wound repair'}], 'project-description': [{'description': 'Our immune system exists to help our bodies fight infection, heal wounds and remove unhealthy cells. In order to gain as much information as possible about this complex system, it is vital to investigate immunological processes in the context of a living animal. Despite evolutionary divergence from humans, the fruit fly Drosophila melanogaster contains a relevant immune cell type, making it an ideal model in which to investigate immune cell functions, such as damage signalling, cell corpse recognition and immune cell memory. It has recently emerged that fat cells also play a role in wound healing, and this project seeks to elucidate the mechanism by which fat cells contribute to the immune response. The tractable genetics of Drosophila will allow us to identify potential candidate genes by screening for which genes are “turned on” in cells that are responding to laser induced wounds. We will then increase or decrease the level of expression of these candidate genes and use real time imaging in the living Drosophila pupae to identify the effect that these genes have on immune cell and fat cell migration to wounds.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0744-4301', 'authenticated-orcid': False, 'given': 'Henry', 'family': 'Todd', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 5]]}, 'award-end': {'date-parts': [[2022, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:23Z', 'timestamp': 1636383443000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220400'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485887}, 'publisher': 'Wellcome', 'award': '220497', 'DOI': '10.35802/220497', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Spineless in the gut - intestinal function of the aryl hydrocarbon receptor from flies to mammals'}], 'project-description': [{'description': 'The aryl hydrocarbon receptor (AHR) has essential functions in the intestine, protecting mice from infection and cancer. However, the underlying mechanisms are still unclear as research has been hindered by the complex regulation and multiple feedback loops governing mammalian AHR. I will therefore use a simpler model system. Spineless, the homolog of AHR in Drosophila, binds the same DNA motif as AHR, but is regulated only on the gene expression level. My preliminary data suggest that Spineless may have similar functions to AHR, influencing epithelial regeneration and survival during infection. I will take advantage of this simpler pathway and the genetic tools and ease of manipulation in the fly in order to rapidly dissect how AHR/Spineless expression is regulated and to systematically analyse its target genes. I will first generate the necessary tools and then answer three main questions: what are the target genes of Spineless, how is Spineless gene expression regulated, and how does Spineless function in the context of intestinal infection. Results obtained from these experiments will be compared with existing data from the Stockinger group on AHR in mice to advance our understanding of intestinal physiology and the critical functions of AHR/Spineless that are conserved across species.', 'language': 'en'}, {'description': 'The aryl hydrocarbon receptor (AHR) has essential functions in the gut, protecting mice from infection and cancer. However, the underlying mechanisms are still unclear as research has been hindered by the complex regulation of AHR. I will therefore use a simpler model system. I found that the equivalent of AHR in fruit flies, Spineless, also seems to be important during infection in the gut, but its regulation is less complicated. I will take advantage of the ease and speed of genetic manipulation in fruit flies to answer three main questions: what are the target genes of Spineless, how is Spineless regulated, and what is the function of Spineless in the context of intestinal infection. Results obtained from these experiments will be compared with existing data from the Stockinger lab on AHR to advance our understanding of intestinal physiology and critical, evolutionary conserved functions of AHR/Spineless in this context.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8781-336X', 'authenticated-orcid': False, 'given': 'Brigitta', 'family': 'Stockinger', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7970-1667', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Lemaitre', 'affiliation': [{'name': 'ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE', 'country': 'CH', 'id': [{'id': 'https://ror.org/02s376052', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9145-5216', 'authenticated-orcid': False, 'given': 'Nicola', 'family': 'Diny', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2024, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:46Z', 'timestamp': 1636383106000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:46Z', 'timestamp': 1636456486241}, 'publisher': 'Wellcome', 'award': '223061', 'DOI': '10.35802/223061', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Elucidating the interactome and molecular pharmacology of the VEGFR-3 receptor compared to other VEGFR homodimers and heterodimers in vitro and in vivo.'}], 'project-description': [{'description': 'Vascular endothelial growth factor receptor 3 (VEGFR3) is a transmembrane protein found on the surface of cells that line the lymphatic vessels of the body. Its primary role is regulating the growth of new lymph vessels by interacting with its ligands, vascular endothelial growth factor (VEGF) C and D. Recently, VEGFR3 was reported to function in blood vessel development, particularly in cancer (cancer angiogenesis), supporting tumour growth and metastasis. However, our coverage of VEGFR3 pharmacology and signalling in living cells, is poor. Although typically assembled in homodimers, VEGFR3 can also form heterodimers with a different VEGFR isoform, VEGFR2. Comparative analyses of homodimer versus heterodimer configuration, relating to protein signalling and pharmacology is limited due to the difficulty in defining specific complexes. This project will combine the use of two powerful analytical tools, bioluminescence resonance energy transfer (BRET) and BioID to further understanding of the molecular pharmacology of the VEGFRs including Neuropilin receptors. These complementary approaches will allow the interaction of fluorescently labelled VEGF with VEGFR3 to be characterised in real time in living cells with the VEGFR3 ‘interactome’ to mapped, in vivo. Split tags of BioID and NanoBRET will also be used to define the molecular pharmacology of VEGFR2/3 heterodimers.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7142-6410', 'authenticated-orcid': False, 'given': 'George', 'family': 'Coney', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:42Z', 'timestamp': 1636383402000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223061'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:46Z', 'timestamp': 1636456486559}, 'publisher': 'Wellcome', 'award': '220031', 'DOI': '10.35802/220031', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Oligodendroglial Dysfunction in Huntington's Disease\"}], 'project-description': [{'description': 'Huntington’s disease (HD) is a genetic neurodegenerative disease causing long term disability and life-threatening complications. It is well known that the loss of particular types of nerve cells in the brain causes the main symptoms of HD, but there is evidence that a different type of brain cell, oligodendrocytes, are also involved. Recent evidence has shown that human oligodendrocytes are heterogeneous, suggesting that their functions vary and that these are altered in disease. In this project I will investigate whether oligodendrocyte states are different in HD. I will analyse and validate the heterogeneity of oligodendrocytes in post mortem brain tissue from HD patients, as well as in oligodendrocyte cultures generated from human stem cells. Furthermore, I will investigate whether certain dysfunctional oligodendrocyte states are shared across different diseases by comparing the heterogeneity of oligodendrocytes in HD and Multiple Sclerosis. Finally, I will investigate whether targeting the cause of HD, a mutation in the huntingtin gene, can change oligodendrocyte states to become more like healthy cells. Together these approaches will establish whether and how oligodendrocyte dysfunction is a pathological feature of HD and will provide insight into common oligodendrocyte states across disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1689-8583', 'authenticated-orcid': False, 'given': 'Sunniva', 'family': 'Bøstrand', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:00Z', 'timestamp': 1636383480000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220031'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:47Z', 'timestamp': 1636456487116}, 'publisher': 'Wellcome', 'award': '223541', 'DOI': '10.35802/223541', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'What influences cancer services uptake in Ghana and how can this information support policy-making?'}], 'project-description': [{'description': 'My research is about what influences people in Ghana to use cancer services. Cancer is an increasing problem in Ghana due to changes to lifestyle and population age. Many things influence cancer services use including, disease beliefs, stigma, healthcare trust, and costs. The Ghanaian health system seeks to expand cancer services in a way that benefits as many as possible, but challenges remain in understanding why some patients do not attend. I plan to use mixed methods to explore what influences cancer service use and how this information can be useful for Ghanaian policymakers. A key stage will involve surveying public members’ beliefs and behaviours. I will analyse data collected to see how information about age, gender and job relate to peoples’ views and might influence whether they would use cancer services; I also hope to build profiles of types of people to help policymakers target help to those most in need. To further understand and check the analysis, I will use narrative interviews with a range of the public to listen to what they think and why they act as they do. I will bring together the findings and discuss with policymakers how this could help inform their decision-making.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3525-6295', 'authenticated-orcid': False, 'given': 'Chloe', 'family': 'Tuck', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 2]]}, 'award-end': {'date-parts': [[2023, 9, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:04Z', 'timestamp': 1636383424000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/223541'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:47Z', 'timestamp': 1636456487122}, 'publisher': 'Wellcome', 'award': '221690', 'DOI': '10.35802/221690', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Myocardial energy starvation and ketone metabolism in patients with type 2 diabetes'}], 'project-description': [{'description': 'Patients with type 2 diabetes(T2D) are ‘cardiac energy-deficient’ and this deficiency contributes to their excess heart failure(HF) risk. The key mechanisms for cardiac energy deficiency are reduced myocardial blood flow, loss of metabolic flexibility over the choice of energy fuels and mitochondrial dysfunction. The contribution of these changes to the development of HF has not been systematically studied.Recent studies have highlighted the potential role of ketone bodies as a significant fuel source, and suggested an association between mild ketosis and improved clinical outcome in T2D. Two work packages will be performed. Work-package1 aims to: - Elucidate the mechanisms of the energy-starved state of the heart in diabetes; - Determine how alterations of cardiac energy metabolism differ between prediabetes, T2D, and concomitant T2D and HF; - Determine if ketones induce a differential response in mitochondrial respiration and whether this differential response varies along the continuum of diabetic heart disease. Data will be acquired from patients undergoing aortic valve surgery for comprehensive assessments including: cardiovascular magnetic resonance imaging and spectroscopy; coronary sinus sampling studies; high resolution respirometry and liquid chromatography-triple quadrupole-mass spectrometry metabolomics from heart samples. Work-package 2 will explore the impact of ketone infusion on cardiac energy generation and contractile function in T2D patients.', 'language': 'en'}, {'description': 'Diabetes increases the risk of heart failure. Once the heart failure is established, only one in five patients survive beyond five years. This high risk of death is alarming and highlights the importance of preventing the development of heart failure in diabetes patients. One efficient way to treat or prevent heart failure is increasing the energy available for heart muscle to pump. For this we first need to better understand why diabetes patients have low energy levels in their heart. Moreover, in diabetes, heart muscle uses more ketone as an energy fuel,but it is unknown if this change aims to improve energy generation.Seeking to answer these questions, using MR scans, heart biopsy samples and special blood tests, I will pursue the problem of excess heart failure risk in diabetes, exploring new and more efficient treatment options to mitigate this risk, with results relevant for 400 million people living with diabetes.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0997-4384', 'authenticated-orcid': False, 'given': 'Sven', 'family': 'Plein', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7683-9422', 'authenticated-orcid': False, 'given': 'David', 'family': 'Beech', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3799-7102', 'authenticated-orcid': False, 'given': 'Eylem', 'family': 'Levelt', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 807333.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 3, 1]]}, 'award-end': {'date-parts': [[2025, 2, 28]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 807333.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:15Z', 'timestamp': 1636383135000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221690'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:48Z', 'timestamp': 1636456488323}, 'publisher': 'Wellcome', 'award': '220885', 'DOI': '10.35802/220885', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Population genomic analysis of HIV transmission fitness'}], 'project-description': [{'description': 'This proposal concerns the identification of genetic polymorphisms which alter the fitness of Human Immunodeficiency Virus (HIV-1), the robust estimation of virus fitness, and the characterization of how polymorphisms influence replicative fitness within hosts versus transmission to new hosts. HIV evolves to evade the immune system, resist antiviral medications, and maximize its rate of replication within infected hosts. But at the epidemic level, natural selection promotes evolution of variants which are more transmissible. Natural selection within and between hosts can act in opposing directions, and evolutionary trends have been discerned from population based sampling of HIV such as a hypothetical transmission/virulence tradeoff. Because HIV evolves at multiple scales, the fitness of a particular polymorphism should be characterized along multiple dimensions including its impact on replication within hosts and transmission to new hosts. We will develop a framework for characterizing genetic fitness along multiple dimensions by building on theory developed for estimating state-dependent speciation rates. These methods will be applied to several large population-based samples of whole-genome deep sequencing (WGDS) of HIV. The outcome of this analysis will be an unprecedentedly detailed characterization of how particular genetic substitutions influence HIV pathogenesis and transmission at the epidemic level.', 'language': 'en'}, {'description': 'HIV evolves to maximize replication within hosts and transmit to new uninfected individuals, but we currently lack a detailed understanding of how changes in the HIV genome alter the ability of HIV to reproduce and spread. To understand how beneficial mutations spread at the epidemic level requires a deeper understanding of how mutations impact transmissibility of the virus. We will develop new bioinformatic methods to estimate fitness along multiple dimensions associated with replication and transmission. We will identify new mutations which are associated with gain or loss of transmission fitness. These methods will be applied to new large population-based samples of whole HIV genomes across sub-Saharan Africa. These findings will have relevance for vaccine design and forecasting the future evolution of the HIV epidemic, and the potential for therapeutic vaccines to modify the transmissibility of HIV will be explored.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6268-8937', 'authenticated-orcid': False, 'given': 'Erik', 'family': 'Volz', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 654391.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 654391.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:57Z', 'timestamp': 1636383117000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220885'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:49Z', 'timestamp': 1636456489397}, 'publisher': 'Wellcome', 'award': '223619', 'DOI': '10.35802/223619', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Progressing existing snake venom toxin-specific antibodies into humanised, thermostable monoclonal therapies for preclinical manufacture and clinical trials in Africa and India'}], 'project-description': [{'description': 'Antivenom treatment of snakebite is failing to reduce the annual 138,000 deaths - predominantly in impoverished tropical communities. With a focus upon the most medically-important African and Indian snake venoms, we are developing toxin-neutralising, recombinant, humanised, thermostable monoclonal antibodies (mAbs) that will be more dose- and polyspecifically-effective, affordable and safer than antivenoms, and possess critical economies of scale and manufacturing incentives to secure sustained production/delivery. We have collected sera and B cells (producing immunoglobulins of distinct structure and therapeutic/mAb-development promise) from: - multi-envenomed humans - cows, camels, baboons, mice immunised with the most pathogenic African and Indian venom toxins - horses used to manufacture African or Indian antivenoms. Using High-Throughput platforms, we will rank B cells producing these globally-unique animal and human antibodies by in vitro toxin-binding affinity and toxin-function neutralisation, prioritising cross-generic/continental functionality. Genes from top-ranked B cells will be processed into recombinant mAbs (220-500). Subsequent rounds of in vitro and in vivo (neutralisation of venom-induced lethality in a mouse model of envenoming) down-selection will output 20-40 mAbs for gene-manipulation to deliver ‘humanised’ and thermostable mAbs. A final round of in vitro/in vivo selection will deliver 5-10 mAbs/3 mAb mixtures of proven pan-Africa/India polyspecific efficacy for downstream preclinical manufacture and clinical trials.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8035-4719', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Casewell', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9354-1740', 'authenticated-orcid': False, 'given': 'Devin', 'family': 'Sok', 'affiliation': [{'name': 'International AIDS Vaccine Initiative', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-0998-1581', 'authenticated-orcid': False, 'given': 'Kartik', 'family': 'Sunagar', 'affiliation': [{'name': 'Indian Institute of Science', 'country': 'IN'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9842-5573', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Harrison', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 455998.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 7, 19]]}, 'award-end': {'date-parts': [[2023, 7, 18]]}, 'funding': [{'type': 'award', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 455998.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:34Z', 'timestamp': 1636383514000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 7, 19]]}, 'URL': 'http://dx.doi.org/10.35802/223619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:49Z', 'timestamp': 1636456489539}, 'publisher': 'Wellcome', 'award': '224075', 'DOI': '10.35802/224075', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Probing chromatin states with single molecule microscopy'}], 'project-description': [{'description': 'Recent research showed that the emergence of resistance in fungi can be linked to epigenetic mutations. Those are not changes in the DNA sequence, but rather in the chromatin environment. Some parts of the genome are packaged in heterochromatin: in those areas, the DNA is bunched up much more tightly and thus not easily accessible, so genes are repressed. We want to investigate how specific heterochromatin regions are formed and removed. I am especially interested to find out why two seemingly identical cells can acquire differences in their epigenetic landscape and thus develop different phenotypes. To visualise cell-to-cell variations, I plan on using real-time fluorescent imaging, to track different proteins that are known to regulate heterochromatin. From the amount of protein and the movement of the fluorescent molecules, we can better understand how the heterochromatin distribution in individual cells changes in response to stress. Additionally, I am developing a probe, which can differentiate between different chromatin environments at specific locations. Understanding the development of these epigenetic differences is important, as they are likely involved in the development of antifungal resistance in pathogenic fungi.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2466-400X', 'authenticated-orcid': False, 'given': 'Elisabeth', 'family': 'Gaberdiel', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 3, 29]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:33Z', 'timestamp': 1636383453000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 29]]}, 'URL': 'http://dx.doi.org/10.35802/224075'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:59Z', 'timestamp': 1636456499505}, 'publisher': 'Wellcome', 'award': '062236', 'DOI': '10.35802/062236', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'G protein-coupled receptor desensitization in mature, brain neurones.'}], 'investigator': [{'given': 'Eamonn', 'family': 'Kelly', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Graeme', 'family': 'Henderson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 261504.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 14]]}, 'award-end': {'date-parts': [[2004, 10, 13]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 261504.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:58Z', 'timestamp': 1636382818000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 14]]}, 'URL': 'http://dx.doi.org/10.35802/062236'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:59Z', 'timestamp': 1636456499531}, 'publisher': 'Wellcome', 'award': '057088', 'DOI': '10.35802/057088', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular responses to adenosine in genetically-modified mice lacking the adenosine A2A receptor.'}], 'lead-investigator': [{'given': 'Susanna', 'family': 'Hourani', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 184798.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 8, 1]]}, 'award-end': {'date-parts': [[2002, 9, 14]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 184798.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:08Z', 'timestamp': 1636383008000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/057088'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:00Z', 'timestamp': 1636456500706}, 'publisher': 'Wellcome', 'award': '063010', 'DOI': '10.35802/063010', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Restriction enzymes with novel reaction mechanisms.'}], 'investigator': [{'given': 'Stephen', 'family': 'Halford', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Virginijus', 'family': 'Siksnys', 'affiliation': [{'name': 'Misc Lithuania', 'country': 'LT'}]}], 'award-amount': {'amount': 108025.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 3, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 108025.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:08Z', 'timestamp': 1636383008000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063010'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:02Z', 'timestamp': 1636456502342}, 'publisher': 'Wellcome', 'award': '062443', 'DOI': '10.35802/062443', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification and functional analysis of SCL gene regulatory elements.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8342-0606', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Chapman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 179038.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 179038.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:43Z', 'timestamp': 1636382923000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062443'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:04Z', 'timestamp': 1636456504061}, 'publisher': 'Wellcome', 'award': '204300', 'DOI': '10.35802/204300', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Open Science Prize'}], 'lead-investigator': [{'given': 'Jessica', 'family': 'Chong', 'affiliation': [{'name': 'University of Washington', 'country': 'US'}]}], 'award-amount': {'amount': 55659.92, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 7, 26]]}, 'award-end': {'date-parts': [[2016, 11, 30]]}, 'funding': [{'type': 'prize', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 55659.92, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:13Z', 'timestamp': 1636382893000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 7, 26]]}, 'URL': 'http://dx.doi.org/10.35802/204300'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:09Z', 'timestamp': 1636456509364}, 'publisher': 'Wellcome', 'award': '215096', 'DOI': '10.35802/215096', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering genetic drivers of longitudinal electronic health records'}], 'project-description': [{'description': 'The accumulation of electronic health records (EHRs) carries great promise for accelerating clinical research, while the sequencing of a vast number of genomes provides us information to discover genetic factors affecting these health-related records. We now have EHRs containing phenotypes and the genetics of individuals which we could use find the underlying genetic structure of disease. In our project, we will be focusing on analysing the development of disease using multiple machine learning methods. We propose a multi-view deep learning framework which incorporates embedding learning, recurrent neural networks, representation learning and weighted-averaging techniques. Our goal is to find the genetic factors which impact the progression of disease, not just the onset of disease. Consequently, our model will look into the time dimension of disease using multimodal data in huge datasets like the UK Biobank. Our results will contribute to our understanding of underlying systems and processes that can impact multiple diseases, which can support clinical diagnosis and drug discovery.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6773-9182', 'authenticated-orcid': False, 'given': 'Xilin', 'family': 'Jiang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:49Z', 'timestamp': 1636383289000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215096'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:02Z', 'timestamp': 1636443902620}, 'publisher': 'Wellcome', 'award': '060163', 'DOI': '10.35802/060163', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'NGF regulation in dorsal root ganglia neurons involved in the signalling of pain.'}], 'lead-investigator': [{'family': 'Huerta Lopez', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 100679.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 100679.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:03Z', 'timestamp': 1636382883000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:02Z', 'timestamp': 1636443902680}, 'publisher': 'Wellcome', 'award': '063086', 'DOI': '10.35802/063086', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Regulation of Rho GTPases by growth factors'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2331-4729', 'authenticated-orcid': False, 'given': 'Julian', 'family': 'Downward', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Laszlo', 'family': 'Buday', 'affiliation': [{'name': 'Cancer Research UK', 'country': 'GB'}]}], 'award-amount': {'amount': 91050.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 91050.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:08Z', 'timestamp': 1636382768000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063086'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:05Z', 'timestamp': 1636443905065}, 'publisher': 'Wellcome', 'award': '056586', 'DOI': '10.35802/056586', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A molecular analysis of Streptococcus pneumonia virulence.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5650-5361', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Brown', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 242126.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 6, 21]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 242126.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 6, 21]]}, 'URL': 'http://dx.doi.org/10.35802/056586'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:11Z', 'timestamp': 1636443911913}, 'publisher': 'Wellcome', 'award': '060937', 'DOI': '10.35802/060937', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Regional differences in excitation-contraction mechanisms in the mammalian heart.'}], 'lead-investigator': [{'family': 'Wallis', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 116852.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 116852.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:11Z', 'timestamp': 1636443911930}, 'publisher': 'Wellcome', 'award': '092421', 'DOI': '10.35802/092421', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People Award.'}], 'lead-investigator': [{'given': 'Colin', 'family': 'Riordan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 250000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2010, 10, 1]]}, 'award-end': {'date-parts': [[2012, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 250000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:32Z', 'timestamp': 1636383032000}, 'score': 0.0, 'issued': {'date-parts': [[2010, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/092421'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:23Z', 'timestamp': 1636443923667}, 'publisher': 'Wellcome', 'award': '059272', 'DOI': '10.35802/059272', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Segregation of mtDNA in oocytes and embryos in humans and in a mouse model of mtDNA disease.'}], 'investigator': [{'given': 'Richard', 'family': 'Gardner', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'David', 'family': 'Barlow', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2460-5587', 'authenticated-orcid': False, 'given': 'Joanna', 'family': 'Poulton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 204618.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 204618.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:45Z', 'timestamp': 1636382805000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059272'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:26Z', 'timestamp': 1636443926097}, 'publisher': 'Wellcome', 'award': '067037', 'DOI': '10.35802/067037', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Applying fMRI to understand pharmacological analgesia in the human brain.'}], 'lead-investigator': [{'given': 'Richard', 'family': 'Wise', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 201020.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 201020.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:43Z', 'timestamp': 1636383043000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067037'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:32Z', 'timestamp': 1636443932686}, 'publisher': 'Wellcome', 'award': '060288', 'DOI': '10.35802/060288', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Therapeutic vaccination for chronic hepatitis B virus infection in Africa.'}], 'project-description': [{'description': 'Not available', 'language': 'en'}], 'lead-investigator': [{'given': 'Samuel', 'family': 'McConkey', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}], 'award-amount': {'amount': 340926.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 340926.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:17Z', 'timestamp': 1636383017000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060288'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:38Z', 'timestamp': 1636443938434}, 'publisher': 'Wellcome', 'award': '061739', 'DOI': '10.35802/061739', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of event related functional MRI techniques to study auditory-verbal processes: overcoming confounding effects of acoustic scanner noise.'}], 'lead-investigator': [{'family': 'Amaro', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 97928.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 9]]}, 'award-end': {'date-parts': [[2003, 1, 8]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 97928.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 9]]}, 'URL': 'http://dx.doi.org/10.35802/061739'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:39Z', 'timestamp': 1636443939152}, 'publisher': 'Wellcome', 'award': '064085', 'DOI': '10.35802/064085', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structure and mechanism of the twin-arginine translocation (Tat) system.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-3893-360X', 'authenticated-orcid': False, 'given': 'Paula', 'family': 'Booth', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-8147-1127', 'authenticated-orcid': False, 'given': 'Per', 'family': 'Bullough', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Colin', 'family': 'Robinson', 'affiliation': [{'name': 'University of Kent', 'country': 'GB'}]}], 'award-amount': {'amount': 180855.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 11, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 180855.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:15Z', 'timestamp': 1636382775000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064085'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:39Z', 'timestamp': 1636443939198}, 'publisher': 'Wellcome', 'award': '066657', 'DOI': '10.35802/066657', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Meeting of the British Isles Ocular Motor Group to be held at Imperial CollegeSchool of Medicine on 3rd December 2001.'}], 'lead-investigator': [{'given': 'Christopher', 'family': 'Kennard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3045.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 12, 3]]}, 'award-end': {'date-parts': [[2002, 1, 2]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3045.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:23Z', 'timestamp': 1636382783000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 12, 3]]}, 'URL': 'http://dx.doi.org/10.35802/066657'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:48Z', 'timestamp': 1636443948209}, 'publisher': 'Wellcome', 'award': '062752', 'DOI': '10.35802/062752', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of the underlying basis for the emergence of dengue haemorrhagic fever in Cuba.'}], 'investigator': [{'given': 'William', 'family': 'James', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Ernest', 'family': 'Gould', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}, {'given': 'Gustavo', 'family': 'Kouri', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}], 'lead-investigator': [{'given': 'Maria', 'family': 'Guzman', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}], 'award-amount': {'amount': 158902.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 158902.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062752'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:49Z', 'timestamp': 1636443949774}, 'publisher': 'Wellcome', 'award': '210789', 'DOI': '10.35802/210789', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Malaria Controlled Human Infection Model - application development'}], 'project-description': [{'description': 'We wish to apply for funds to develop the malaria CHIM application. These are for a Co-investigators/stakeholders meeting to be held in Bangkok, Thailand, on 30th and 31st January 2018 and to support a writing meeting of the PIs in February 2018 in Kilifi, Kenya.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2309-1171', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Day', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 22186.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 12, 10]]}, 'award-end': {'date-parts': [[2018, 4, 10]]}, 'funding': [{'type': 'award', 'scheme': 'Vaccines', 'award-amount': {'amount': 22186.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:16Z', 'timestamp': 1636382956000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 12, 10]]}, 'URL': 'http://dx.doi.org/10.35802/210789'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:52Z', 'timestamp': 1636443952811}, 'publisher': 'Wellcome', 'award': '063936', 'DOI': '10.35802/063936', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'To support the transfer of the parallel processing computer to Imperial College.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1154-8093', 'authenticated-orcid': False, 'given': 'Neil', 'family': 'Ferguson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'given': 'Geoff', 'family': 'Garnett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Roy', 'family': 'Anderson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 171861.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 12, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 171861.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:15Z', 'timestamp': 1636382835000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063936'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958206}, 'publisher': 'Wellcome', 'award': '069020', 'DOI': '10.35802/069020', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effect of antenatal endotoxaemia on cerebal metabolism and cell death during and after hypoxia in the chick embryo.'}], 'project-description': [{'description': 'Injury to the brain around the time of birth is an important cause of longterm disability. Epidemiological data suggest that in 25% of cases there is a combination of antenatal and intrapartum aetiological factors. This study will investigate the hypothesis that antenatal exposure to bacterial endotoxin sensitises the brain to subsequent hypoxia and reduces the hypoxic threshold at which cerebral metabolism fails and cell death occurs. We will study the effects of hypoxia of different degrees of severity and lipopolysaccharide, both individually and in combination, on the brain of the chick embryo in ovo towards the end of incubation. Preliminary studies demonstrate the feasibility of measuring changes in the cerebral concentrations of lactate, creatine and N-acetyl-aspartate using magnetic resonance (MR) proton spectroscopy and changes in apparent diffusion coefficient of water, a putative indirect marker of cellular energy metabolism, using diffusion weighted imaging in the chick embryo brain. These modalities will be used to quantify the metabolic effects of acute hypoxia and endotoxaemia. In vivo measurements will be correlated with markers of CNS inflammation including microglial cell activation, astrogliosis and granulocyte recruitment using immunohistochemistry. Dying cells will be detected using standard histological stains and TUNEL staining for DNA fragmentation.', 'language': 'en'}], 'investigator': [{'given': 'Gennadij', 'family': 'Raivich', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Roger', 'family': 'Ordidge', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'family': 'Cady', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Donald', 'family': 'Peebles', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 179011.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 7, 1]]}, 'award-end': {'date-parts': [[2006, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 179011.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:40Z', 'timestamp': 1636382800000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069020'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958265}, 'publisher': 'Wellcome', 'award': '071219', 'DOI': '10.35802/071219', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Bioarchaeology without fossils or artefacts: Every contact leaves a trace.'}], 'project-description': [{'description': 'Ancient DNA studies have promised to bring a new era to bioarchaeological research, yet due to difficulties caused by pervasive contamination of specimens with modern human DNA, and the limitations of skeletal and pathogen preservation, the impact has so far been slight. We outline a radical new approach to studies of genetic change through time that negates most of these limitations, and provides a novel and detailed way to re-examine important archaeological sites. Preliminary data has shown that frozen or cold sediments contain a genetic record of the local mammalian, plant and bacterial inhabitants over quite remarkable time periods - eg >350 Kyr. This means that DNA preservation can occur without macrofossils, and that sediment from cold archaeological sites is likely to contain high concentrations of DNA from humans, along with their domesticates and pathogens. Stratified sediments also allow DNA to be dated and placed into an archaeological context, finally allowing association of artefacts with genetic markers. Furthermore, samples removed from cores drilled deep into archaeological sediments provide a means to obtain material free from modern human DNA, and multiple cores will allow stratigraphic continuity and localised contamination to be monitored. We will use coring to retrieve DNA from sediments around important early human occupation sites in the Holarctic and New World. We will use stratigraphic data to examine the time of first appearance of humans, domesticates, and pathogens, and record their subsequent changes in genetic diversity and composition through time. We will also use the DNA to examine food (animals, plants) and paleoenvironmental changes (plants, bacteria), and relate this to cultural horizons or other archaeological markers. In recognition of the importance of this technique, we have gained permission to core some of the most important and enigmatic archaeological sites known, including very early Siberian and New World sites (Diring, Bluefish, Meadowcroft), Neanderthal caves (Mezmaiskaya, Scladina, Anghilak), and important modern archaeological sites such as Pompeii. We will use established drilling techniques to obtain and store cores (frozen or chilled as necessary), and return them for analysis at the Henry Wellcome Ancient Biomolecules Centre. The Centre is essential for providing the specialised equipment and extremely low background contamination levels necessary for such a complex study. A variety of established PCR primers (specific and general) will be used to amplify DNA, followed by extensive cloning to measure the genetic diversity and composition of targeted taxa at different points in the stratigraphic record.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7081-6748', 'authenticated-orcid': False, 'given': 'Eske', 'family': 'Willerslev', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 224664.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 8, 1]]}, 'award-end': {'date-parts': [[2006, 7, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 224664.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:05Z', 'timestamp': 1636382825000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071219'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958305}, 'publisher': 'Wellcome', 'award': '065496', 'DOI': '10.35802/065496', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of chemokines in the adhesion of monocytes to human atherosclerotic plaques: investigation by an in-vitro adhesion assay.'}], 'lead-investigator': [{'given': 'Robin', 'family': 'Poston', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 19408.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 7, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 19408.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065496'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:06Z', 'timestamp': 1636454646243}, 'publisher': 'Wellcome', 'award': '222312', 'DOI': '10.35802/222312', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating mechanisms and rescue of a novel microgliopathy caused by dysfunctional LRRC33/NRROS'}], 'project-description': [{'description': 'Recent discoveries have suggested a dysfunctional immune system of the brain plays a significant role in a set of diseases known as microgliopathies. New disorders of this type are still being identified, but ones which have so far been uncovered lead to significant brain damage and decreased lifespan. Our group has discovered a developmental microgliopathy-like disease in a patient caused by a defect in a protein named LRRC33. However, we do not fully understand the impact this defect has on the brain’s immune system, how it affects different types of brain cells, and how it leads to disease onset. We aim to investigate these questions using a combination of animal models and patient post-mortem tissue. We will also seek to determine whether we can repair brain damage in our animal disease model by suppressing the brain’s immune system. Strategies such as these, along with improved knowledge of the biology of the disease, could potentially lay the foundations for development of treatments for these microgliopathies, of which there are currently none.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0113-6551', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Sewell', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:37Z', 'timestamp': 1636383397000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222312'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:07Z', 'timestamp': 1636454647337}, 'publisher': 'Wellcome', 'award': '059897', 'DOI': '10.35802/059897', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Distribution and functional expression of two cloned mouse calcium-activated chloride channels.'}], 'investigator': [{'given': 'Paul', 'family': 'Chazot', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'John', 'family': 'Winpenny', 'affiliation': [{'name': 'University of East Anglia', 'country': 'GB'}]}], 'award-amount': {'amount': 51620.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 51620.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:10Z', 'timestamp': 1636382890000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059897'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:07Z', 'timestamp': 1636454647868}, 'publisher': 'Wellcome', 'award': '223058', 'DOI': '10.35802/223058', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding how chromatin organisation facilitates DNA virus persistence and innate immune system evasion.'}], 'project-description': [{'description': 'Many people (>95%) will be infected with Epstein Barr Virus (EBV) at some stage in their lives making it one of the most successful human-infecting viruses but accumulating evidence implicates EBV as a contributing cause of some common immune diseases. How EBV can be so successful (as a virus) but trigger immune damage in some people remains a stubborn mystery. Once EBV infects someone, it hides inside certain immune cells for the rest of that person’s life, and currently no drugs can combat the infection. In persisting, EBV needs to keep a low profile; it physically tethers itself to human-host DNA, whilst silencing most of its own genes. The virus then makes a lot of a substance called RNA, but it is not clear why. It has recently been discovered that RNA may act as a “glue” within the cells. We plan to investigate whether this viral “glue”, an understudied aspect of the biology of EBV, helps it evade detection. EBV is an expert manipulator of human cells, understanding it may lead to better understanding of some fundamental aspects of how our genes are switched on and off, and also might generate new ideas for how to treat viral infections.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0053-4200', 'authenticated-orcid': False, 'given': 'Patrick', 'family': 'Kearns', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2022, 8, 1]]}, 'award-end': {'date-parts': [[2025, 7, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:00Z', 'timestamp': 1636383420000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223058'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:08Z', 'timestamp': 1636454648501}, 'publisher': 'Wellcome', 'award': '075578', 'DOI': '10.35802/075578', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD programme costs'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3618-0843', 'authenticated-orcid': False, 'given': 'David', 'family': 'Attwell', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 500.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 7, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 500.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:24Z', 'timestamp': 1636383204000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/075578'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:12Z', 'timestamp': 1636454652964}, 'publisher': 'Wellcome', 'award': '060051', 'DOI': '10.35802/060051', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Purchase of a confocal microscope.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7631-8352', 'authenticated-orcid': False, 'given': 'Vladimir', 'family': 'Buchman', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5841-8176', 'authenticated-orcid': False, 'given': 'Alun', 'family': 'Davies', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 274493.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 274493.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:08Z', 'timestamp': 1636382768000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060051'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:12Z', 'timestamp': 1636454652977}, 'publisher': 'Wellcome', 'award': '051846', 'DOI': '10.35802/051846', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural mechanisms regulating basal and stress-induced hypothalamo-pituitary-adrenal activity: role of limbic and hypothalamic inputs to the paraventricular nucleus.'}], 'investigator': [{'given': 'Colin', 'family': 'Ingram', 'affiliation': [{'name': 'Newcastle University', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8546-9646', 'authenticated-orcid': False, 'given': 'Stafford', 'family': 'Lightman', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1058824.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 3, 1]]}, 'award-end': {'date-parts': [[2003, 10, 18]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1058824.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:10Z', 'timestamp': 1636382770000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051846'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653173}, 'publisher': 'Wellcome', 'award': '216424', 'DOI': '10.35802/216424', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Age-related changes in oocyte quality and implications for early pregnancy failure using a horse model'}], 'project-description': [{'description': \"Advanced maternal age is a highly important clinical issue in human fertility. My overall aim is to determine and then modify the age-related decline in oocyte quality, which is the primary factor for early embryonic loss. The equine is an excellent model for this, showing very comparable changes with age to human. However, the cause for the age-related changes in oocyte quality have not been identified. My first objective is to define the differences between the transcriptome of old and young equine oocytes using next generation RNA sequencing. The oocyte is reliant on support from surrounding granulosa and cumulus cells during development. Therefore, my second objective is to determine how young somatic cells modify the development of old oocytes. My third objective is to analyse pregnancy outcome using these 'modified' older eggs using in-vivo model. Modified older eggs will be fertilised by established methods and implanted into the equine uterus. The resultant embryos will be recovered and analysed at 15 days gestation to determine quality. Together, these studies will enhance our understanding of oocyte-somatic cell interactions on oocyte quality and subsequent pregnancy failure in older mothers thus making a significant contribution to equine fertility as well as translational reproductive research.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9001-661X', 'authenticated-orcid': False, 'given': 'Lindsay', 'family': 'Baxter', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2019, 5, 29]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:42Z', 'timestamp': 1636383402000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216424'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653190}, 'publisher': 'Wellcome', 'award': '070193', 'DOI': '10.35802/070193', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The interaction between surfactant proteins A and d with Mycobacterium tuberculosis.'}], 'project-description': [{'description': 'Tuberculosis is a leading cause of morbidity and mortality worldwide. Approximately one-third of the world population is infected by the causative microbial pathogen, Mycobacterium tuberculosis. Of all infected persons, only 5 to 10% develops active disease. Both innate and adaptive immunity play a role in the defense of the host against active disease. Innate immunity is most important in the early stages of the infection. Apparently, the mycobacteria are able to counter the initial innate defence mechanisms. The uptake of M. tuberculosis by alveolar macrophages is mediated through several different receptors, and is facilitated by opsonisation of the bacteria with complement component C3. Binding of mycobacterial to macrophages is also influenced by specific lectins, the so-called collectins, members of the family of C-type lectins. Human collectins include mannose-binding lectin, the complement component C1q, and the surfactant proteins A and D (SP-A and SP-D). SP-A and SP-D play an important role in the innate immune response of the lung against invading microorganisms. In summary, SP-A and SP-D bind to mycobacteria and affect the interaction of these bacteria with alveolar macrophages in opposite ways; the role of this differential interaction in the innate immune defence of the lung is as yet unknown. The binding appears mediated through the lipoglycans of the mycobacteria but here too, the role of different carbohydrate residues present on these molecules in enhancing or inhibiting the binding to the two surfactant proteins is not clear. The concentration of SP-A and SP-D in the lung is altered in lung disease and infection, and the levels of SP-A have been shown to vary widely. We hypothesize that the susceptibility to infection by M. tuberculosis and the development of active tuberculosis is determined by the balance between SP-A and SP-D in the lungs.', 'language': 'en'}], 'lead-investigator': [{'family': 'Vandenbroucke-Grauls', 'affiliation': [{'name': 'Medical Research Council', 'country': 'GB'}]}], 'award-amount': {'amount': 11740.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2003, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 11740.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:31Z', 'timestamp': 1636383031000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070193'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653235}, 'publisher': 'Wellcome', 'award': '220019', 'DOI': '10.35802/220019', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolution of cell shape: epithelial-mesenchymal transition during gastrulation in insects'}], 'project-description': [{'description': 'Cell shape plays a critical role in animal development and physiology. Consequently, shape deregulation can lead to pathological disorders. Epithelial-mesenchymal transition (EMT) is an evolutionarily conserved process in which epithelial cells, tightly connected to each other, transdifferentiate into more motile and spread mesenchymal cells. It is key to numerous developmental processes, such as heart formation, but it is also involved in cancer metastasis and organ fibrosis. The master genes controlling EMT are well characterised in many species and are relatively well conserved. However, how they drive the reorganisation of the cytoskeleton and the resulting shape change is poorly understood. Furthermore, the level of conservation of the downstream molecular pathways involved in cytoskeleton remodelling, and of the shape change itself, has not been investigated. The aim of my project is to investigate the evolutionary conservation of the morphological changes underlying EMT during mesoderm gastrulation, a process of cell internalisation in the early embryo. I will investigate cell shape changes, and cytoskeleton effectors that drive them, in two insects, to detect the level of conservation of the process. My project will shed new light on the evolution of a stereotypical cell shape crucial in both development and diseases.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4962-1305', 'authenticated-orcid': False, 'given': 'Margherita', 'family': 'Battistara', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:13Z', 'timestamp': 1636383433000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220019'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653386}, 'publisher': 'Wellcome', 'award': '215492', 'DOI': '10.35802/215492', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'SUNRISE cluster RCT: Scaling Up Nurturing care, a Radio Intervention to Stimulate Early child development in Burkina Faso'}], 'project-description': [{'description': 'The Nurturing Care Framework (NCF) launched by WHO, UNICEF and the World Bank during the 2018 World Health Assembly argued that “Investing in early child development (ECD) is one of the best investments a country can make to boost economic growth, promote peaceful and sustainable societies, and eliminate extreme poverty and inequality.” 250 million children under five in low and middle-income countries are at risk of not reaching their developmental potential with adverse consequences for their learning and adult prosperity. The NCF is a roadmap for action, focussing on pregnancy and the first 3 years of life as the foundation for wellbeing throughout the life-course. It includes interventions promoting responsive caregiving and early learning, known to improve ECD outcomes when delivered in face-to-face or group sessions with parents and children. However, doing this at the scale needed presents enormous challenges, as many health systems are over-stretched and under-resourced. Mass media may provide a more effective way forward. We plan to explore this by developing a nurturing care radio campaign built on principles of Saturation and Interactivity informed by clinical psychology, behavioural science and epidemiologic evidence, and to evaluate the impact on ECD outcomes using a cluster randomised trial design.', 'language': 'en'}, {'description': 'Almost 250 million children under-five-years of age in low and middle income countries are at risk of not reaching their developmental potential. These children are more likely to do poorly in school, have lower incomes and poorer life chances. Between 0-3 years of age the brain develops quickly, and studies have shown that improving caregiver interactions and learning opportunities at this time can positively impact child development, with effects lasting into adulthood. Although impactful, these interventions can be labour intensive and delivering them within current health systems is challenging. We plan to test whether a mass media campaign can improve care-giving behaviours, learning opportunities and consequently child development in Burkina Faso. Unlike the current interventions mass media can deliver messages to millions of people several times per day. It has the potential to shift social norms and attitudes, model skills and create an enabling environment for behaviour change.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1847-8443', 'authenticated-orcid': False, 'given': 'Pasco', 'family': 'Fearon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Zelee', 'family': 'Hill', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-8633-0208', 'authenticated-orcid': False, 'given': 'Jolene', 'family': 'Skordis-Worrall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Bassirou', 'family': 'Kagone', 'affiliation': [{'name': 'Development Media International CIC', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5274-6072', 'authenticated-orcid': False, 'given': 'Betty', 'family': 'Kirkwood', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'given': 'Roy', 'family': 'Head', 'affiliation': [{'name': 'Development Media International CIC', 'country': 'GB'}]}], 'award-amount': {'amount': 4136494.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 1]]}, 'award-end': {'date-parts': [[2025, 5, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 2068247.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:53Z', 'timestamp': 1636383053000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215492'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653406}, 'publisher': 'Wellcome', 'award': '108871', 'DOI': '10.35802/108871', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of inflammatory disease.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-5364-1838', 'authenticated-orcid': False, 'given': 'Robin', 'family': 'May', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7846-7423', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Watson', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-amount': {'amount': 2727210.2, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 25]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2640000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:40Z', 'timestamp': 1636383220000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108871'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654190}, 'publisher': 'Wellcome', 'award': '053835', 'DOI': '10.35802/053835', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dissection of the unfolding and folding pathways of microsomal cytochrome b5 using mutagenic and spectroscopic technique.'}], 'lead-investigator': [{'family': 'Whitford', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 180450.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 3, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 180450.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:42Z', 'timestamp': 1636382802000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/053835'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654249}, 'publisher': 'Wellcome', 'award': '050014', 'DOI': '10.35802/050014', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in the cellular and molecular basis of disease.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4760-8382', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Maizels', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Andrew', 'family': 'Wyllie', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Jonathan', 'family': 'Bard', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8600-0372', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Bird', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5150-6624', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Seckl', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3447-3570', 'authenticated-orcid': False, 'given': 'Eleanor', 'family': 'Riley', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8649-5408', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Millar', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-4902-5797', 'authenticated-orcid': False, 'given': 'Aziz', 'family': 'Aboobaker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Katherine', 'family': 'Giles', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'family': 'Lad', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'family': 'Millband', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 507353.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2006, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 507353.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:42Z', 'timestamp': 1636383162000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050014'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654258}, 'publisher': 'Wellcome', 'award': '058620', 'DOI': '10.35802/058620', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Influence of local production of complement on T-cell alloreactivity in renal transplantation.'}], 'investigator': [{'given': 'Stipo', 'family': 'Jurcevic', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Steven', 'family': 'Sacks', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 167569.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 6, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 167569.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:21Z', 'timestamp': 1636383021000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/058620'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656273}, 'publisher': 'Wellcome', 'award': '055257', 'DOI': '10.35802/055257', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural correlates of defective verbal self-monitoring in schizophrenia.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4313-3500', 'authenticated-orcid': False, 'given': 'Cynthia', 'family': 'Fu', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 120755.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 10, 1]]}, 'award-end': {'date-parts': [[2001, 3, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 120755.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:11Z', 'timestamp': 1636382771000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/055257'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656299}, 'publisher': 'Wellcome', 'award': '061900', 'DOI': '10.35802/061900', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Insect population control using a dominant, repressible, lethal genetic system.'}], 'lead-investigator': [{'given': 'Helen', 'family': 'White-Cooper', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 206164.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 206164.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:42Z', 'timestamp': 1636383042000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061900'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656472}, 'publisher': 'Wellcome', 'award': '066191', 'DOI': '10.35802/066191', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Symposium support for 'Brain-Immune Interactions in Stress'to be held at Bristol on 30th November 2002.\"}], 'lead-investigator': [{'given': 'David', 'family': 'Jessop', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 4000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 10]]}, 'award-end': {'date-parts': [[2002, 10, 9]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:47Z', 'timestamp': 1636382807000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 10]]}, 'URL': 'http://dx.doi.org/10.35802/066191'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656477}, 'publisher': 'Wellcome', 'award': '062450', 'DOI': '10.35802/062450', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetics studies of GAP proteins in synaptic plasticity.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8732-8735', 'authenticated-orcid': False, 'given': 'Seth', 'family': 'Grant', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 312677.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 312677.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:14Z', 'timestamp': 1636383014000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062450'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656692}, 'publisher': 'Wellcome', 'award': '061729', 'DOI': '10.35802/061729', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'X-ray diffraction and 3D modelling of vertebrate skeletal (fish) muscle in defined static states.'}], 'lead-investigator': [{'given': 'John', 'family': 'Squire', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 219957.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 219957.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:50Z', 'timestamp': 1636382870000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061729'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656723}, 'publisher': 'Wellcome', 'award': '066074', 'DOI': '10.35802/066074', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Scanning the human genome for high content screens.'}], 'project-description': [{'description': 'Not available', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Paul', 'family': 'England', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2034-9969', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 574532.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 12, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 574532.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:54Z', 'timestamp': 1636382874000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066074'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656708}, 'publisher': 'Wellcome', 'award': '065813', 'DOI': '10.35802/065813', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic modifiers and phenotypic variation in hypertropic cardiomyopathy.'}], 'lead-investigator': [{'given': 'Javed', 'family': 'Ehtisham', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 141948.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 141948.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:57Z', 'timestamp': 1636382877000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065813'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656734}, 'publisher': 'Wellcome', 'award': '063228', 'DOI': '10.35802/063228', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular control of the age-dependent retardation of axonal and synaptic degeneration in Wlds mice.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9354-532X', 'authenticated-orcid': False, 'given': 'Michael Philip', 'family': 'Coleman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2670-6995', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Ribchester', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 18000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 18000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:02Z', 'timestamp': 1636382942000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063228'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660360}, 'publisher': 'Wellcome', 'award': '067614', 'DOI': '10.35802/067614', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Between epidemiology and the deep blue sea.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0611-7272', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Hay', 'affiliation': [{'name': 'University of Washington', 'country': 'US'}]}, {'given': 'Sarah', 'family': 'Randolph', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Allen', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'David', 'family': 'Rogers', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 125000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 125000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:48Z', 'timestamp': 1636382808000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067614'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660568}, 'publisher': 'Wellcome', 'award': '209916', 'DOI': '10.35802/209916', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Unravelling the regulatory mechanisms underlying expression of COL5A1 in human cornea in health and disease'}], 'project-description': [{'description': 'Keratoconus is the most common corneal dystrophy. Patients with keratoconus experience corneal thinning and bowing of the cornea causing problems with vision. The condition usually effects both eyes where moderate to severe cases require corneal transplant to improve vision. Unfortunately, diagnosis proves as challenging, where early disease is difficult to recognise. Mild to moderate disease can be treated with glasses or contact lenses to improve vision, although subjective vision gain is variable depending on level of astigmatism. The underlying process that leads to keratoconus and corneal thinning is unknown. Research suggests that there is a strong genetic component underlying the pathogenesis of corneal thinning and disease. Recent work from the Vitart lab has identified genetic regions that may be implicated in corneal thinning and keratoconus. Some of these regions are near a gene that codes for a type of collagen called COL5A1. We are interested to see if these regions have a role in regulating this gene, thereby implicating its importance in variation of central corneal thickness and keratoconus. This research will look at unlocking those complex genetic mechanisms by use of a cell line and a mouse model.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5763-9716', 'authenticated-orcid': False, 'given': 'Zuhair', 'family': 'Mustafa', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 8, 2]]}, 'award-end': {'date-parts': [[2021, 2, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:50Z', 'timestamp': 1636383230000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 8, 2]]}, 'URL': 'http://dx.doi.org/10.35802/209916'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660596}, 'publisher': 'Wellcome', 'award': '211033', 'DOI': '10.35802/211033', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a patient reported outcome measure for polymyalgia rheumatica'}], 'project-description': [{'description': 'Polymyalgia rheumatica affects people in older age groups causing pain, stiffness and disability. It is mainly treated with steroid medication which itself can cause significant side effects.1 It is an under-researched condition with wide variations in treatment.2,3 More research is needed to inform clinical practice and improve patient care. Patient reported outcome measures (PROMs) can be used to guide assessment and treatment and support aspects of care that patients value. PMR is particularly well suited to being assessed by patient reported outcomes given the effects of the condition, its varied course and the difficult balance between benefits versus side effects of treatment. A provisional set of outcome measures to be used in clinical trials for PMR published recently highlighted the limited ability of the existing measures to assess the effects of PMR on patients’ lives.4 We carried out a study of patient experiences of having PMR5 and used data from this to develop a draft PROM. This study continues the development process, testing the validity and reliability of the questionnaire and improving it according to response data. The resulting PMR-specific PROM will be a useful outcome measure in future clinical trials, improving the evidence base for management of the condition.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8781-1268', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Twohig', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 25]]}, 'award-end': {'date-parts': [[2022, 3, 24]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:02Z', 'timestamp': 1636383422000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 25]]}, 'URL': 'http://dx.doi.org/10.35802/211033'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661257}, 'publisher': 'Wellcome', 'award': '218642', 'DOI': '10.35802/218642', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuro-computational mechanisms of information acquisition and integration in social contexts'}], 'project-description': [{'description': 'Understanding the social cognitive mechanisms that enable people to learn from and interact with others has been of considerable interest to psychologists and neuroscientists for decades. Yet, the mechanisms underlying our ability to gather information from other people and to learn from them by integrating this information into our beliefs remain to be elucidated. Here, I proposed to use a neuro-computational approach, combining behavioural experiments, neuroimaging, brain stimulation, and computational modelling to provide an integrated framework of how information acquisition and integration are influenced by social contexts. Three key questions form the core of this proposal: How are choices of information sources influenced by social confirmation bias? How do people learn from misinformation in social contexts? How do these social influences interact with anxiety? Across four studies in three international sites, this research will (i) further our understanding of the behavioural and neural mechanistic computations underlying these processes, (ii) determine the causality of the neural mechanisms, and (iii) elucidate how these computations vary with psychiatric symptoms. Addressing these questions will not only contribute to advancing multiple disciplines, from social neuroscience to behavioural economics, but also has potential implications for wider societal questions, from mental health to policy&minus;making.', 'language': 'en'}, {'description': 'We live in a connected world where our social environment vastly shapes how we behave as individuals. Such social influences can be beneficial, allowing us to learn from others, collaborate and live in groups; but they can also be detrimental and anxiety-inducing, as seen with the rise of fake news propagation, social media abuse, and social groups polarisation. In this project, I plan to develop mathematical models of human behaviour, combined with brain imaging techniques, to understand how social influences work when we seek information from others, and when we use that information to learn and make decisions. I will also examine how these behaviours may go awry in individuals with anxiety and other psychiatric symptoms. This work has the long-term potential of contributing to issues faced by our modern societies, such as policies to reduce the spread of misinformation and interventions to improve social behaviour in mental disorders.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3555-2732', 'authenticated-orcid': False, 'given': 'Benedetto', 'family': 'De Martino', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-0016-3531', 'authenticated-orcid': False, 'given': 'John', 'family': \"O'Doherty\", 'affiliation': [{'name': 'California Institute of Technology', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-3964-2364', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Ruff', 'affiliation': [{'name': 'University of Zurich', 'country': 'CH'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7283-0738', 'authenticated-orcid': False, 'given': 'Caroline', 'family': 'Charpentier', 'affiliation': [{'name': 'California Institute of Technology', 'country': 'US'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 1]]}, 'award-end': {'date-parts': [[2024, 5, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:13Z', 'timestamp': 1636383073000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218642'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661314}, 'publisher': 'Wellcome', 'award': '222407', 'DOI': '10.35802/222407', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Manufacture of a GMP SARS-CoV-2 challenge agent'}], 'project-description': [{'description': 'In the current COVID-19 emergency, a controlled SARS-COV-2 human infection model (CHIM) has the potential to accelerate the understanding of pathogenesis, induction of immunity and immune mechanisms of resistance to disease, as well as a means to test novel diagnostics and treatments, especially between waves of the pandemic, when occurrence of natural disease is relatively uncommon. A large number of SARS-COV-2 vaccine candidates are at various stages of development internationally including those which have recently entered mid-late stage clinical testing in field studies. In order to make the greatest public health impact, there is an urgent need to select the most promising vaccines in the shortest possible timeframe. In addition, human infection challenge can contribute to the identification of correlates and mechanisms of protection against infection and shedding of virus in vaccinated volunteers. Finally, the model may be useful in the determination of the durability of protection in seropositive individuals with documented prior wild type infection. This proposal is a dose titration study to generate two GMP challenge agents and establish the safety of a wild-type SARS-COV-2 controlled infection in the upper respiratory tract of young healthy volunteers that will allow swift and robust assessment of vaccine efficacy.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3948-0895', 'authenticated-orcid': False, 'given': 'Wendy', 'family': 'Barclay', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2126-5142', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'McShane', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7220-2555', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Openshaw', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0914-920X', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Chiu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 4178641.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 2]]}, 'award-end': {'date-parts': [[2023, 7, 2]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 4178641.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:35Z', 'timestamp': 1636383575000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 2]]}, 'URL': 'http://dx.doi.org/10.35802/222407'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661873}, 'publisher': 'Wellcome', 'award': '054109', 'DOI': '10.35802/054109', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of the aetiology of obstetric cholestasis.'}], 'lead-investigator': [{'given': 'Catherine', 'family': 'Williamson', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 366231.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 18]]}, 'award-end': {'date-parts': [[2003, 4, 16]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 366231.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:18Z', 'timestamp': 1636382778000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 18]]}, 'URL': 'http://dx.doi.org/10.35802/054109'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:23Z', 'timestamp': 1636454663574}, 'publisher': 'Wellcome', 'award': '048858', 'DOI': '10.35802/048858', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Calcium microdomains and gradients in cell physiology and pathophysiology - application for a UV and argon-kryton confocal imaging system.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2548-4294', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Duchen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 354755.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 1, 1]]}, 'award-end': {'date-parts': [[2002, 3, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 354755.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:34Z', 'timestamp': 1636382914000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048858'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:23Z', 'timestamp': 1636454663627}, 'publisher': 'Wellcome', 'award': '059710', 'DOI': '10.35802/059710', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD programme in cellular and molecular physiology.'}], 'lead-investigator': [{'family': 'Mcmichael', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 115374.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 115374.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:47Z', 'timestamp': 1636383167000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059710'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664189}, 'publisher': 'Wellcome', 'award': '061307', 'DOI': '10.35802/061307', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Protection of Na,K-ATPase and other membrane proteins in red cell ghosts by a lens molecular chaperone.'}], 'lead-investigator': [{'family': 'Harding', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 87153.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2003, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 87153.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:07Z', 'timestamp': 1636382887000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061307'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664209}, 'publisher': 'Wellcome', 'award': '060800', 'DOI': '10.35802/060800', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Control of ocular HSV-1 infection using mucosal vaccination strategies which stimulate Th1 or Th2 dominated immune responses.'}], 'investigator': [{'given': 'Neil', 'family': 'Williams', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'family': 'Hill', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Claire', 'family': 'Richards', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 275762.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 275762.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:26Z', 'timestamp': 1636382786000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060800'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664450}, 'publisher': 'Wellcome', 'award': '220584', 'DOI': '10.35802/220584', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Respiratory immune responses and their interaction in control of nasal colonization with Bordetella pertussis and Staphylococcus aureus in humans'}], 'project-description': [{'description': 'This research study is designed to examine how the human immune system responds to different types of vaccines and to bacteria that commonly live in the nose, in particular Bordetella pertussis and Staphylococcus aureus. Infection with the bacteria Bordetella pertussis (‘B.pertussis’) causes whooping cough. Vaccines are routinely given in childhood to prevent whooping cough. If you received routine childhood vaccinations you will have received one of two B.pertussis vaccines depending on your year of birth. This study aims to look at how the human immune system responds to different types of B.pertussis vaccines that are or were in routine use. Another important bacteria which may cause disease in humans is Staphylococcus aureus (‘S.aureus’). Approximately 20-30% of healthy people carry these bacteria in their nose without it causing infection. This is called colonisation. However, in some people, infection with S.aureus can be potentially serious and require prompt treatment. This study aims to look at the differences in how human immune system responds in people who are colonised with S.aureus and those who are not. It is hoped that this research will contribute to future work on vaccines that may benefit vulnerable patients susceptible to serious infections with both S.aureus and B.Pertussis.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9334-1661', 'authenticated-orcid': False, 'given': 'Karen', 'family': 'McCarthy', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2019, 7, 8]]}, 'award-end': {'date-parts': [[2022, 7, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:24Z', 'timestamp': 1636383444000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 7, 8]]}, 'URL': 'http://dx.doi.org/10.35802/220584'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664484}, 'publisher': 'Wellcome', 'award': '221716', 'DOI': '10.35802/221716', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developing the next generation of anti-venoms to improve management of cobra poisonings in low and middle incoming countries'}], 'project-description': [{'description': 'We propose a different approach to antivenoms, based on recombinant nanobodies (Nbs), targeting the lethal cobra toxins, to reduce morbidity and mortality. Nbs have a high affinity for selected epitopes, allowing rapid recognition of antigens even if bound to cholinergic receptors, combined with a capacity to dislocate neurotoxin from the receptor. This COBRA-NGaV project brings together research teams with extensive experience in venomics and antivenomics to provide the proof-of-concept (PoC) for cobra toxin-specific Nb candidates as a novel generation of antivenoms and to address the dual obstacle to neutralise cobra toxins: weak immunogenicity and fast diffusion. Preliminary results have been obtained so far: i) strong and specific responses were elicited in dromedaries immunised against the toxic fractions of N. legionis, N. haje and N. oxiana; ii) phage display screenings were adopted to rescue strong Nb binders specific towards relevant N. l., N. h. and N. o. toxins; iii) several clusters of Nb sequences specifically binding cobra toxins have been identified. Herein, Nb selections and combinations for optimal synergic effects and best cross-species performances will be generated. Best-in-class candidates will be tested in a pre-clinical study in mice and sheep according to GMP rules. Cost effectiveness will be established.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4178-0763', 'authenticated-orcid': False, 'given': 'Mohamed', 'family': 'HAMMADI', 'affiliation': [{'name': 'Arid Regions Institute', 'country': 'TN'}]}, {'ORCID': 'http://orcid.org/0000-0002-9066-8666', 'authenticated-orcid': False, 'given': 'Delavar', 'family': 'Shahbazzadeh', 'affiliation': [{'name': 'Pasteur Institute of Iran', 'country': 'IR'}]}, {'ORCID': 'http://orcid.org/0000-0002-5761-1342', 'authenticated-orcid': False, 'given': 'Pierre', 'family': 'Lafaye', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Salma', 'family': 'Djilani', 'affiliation': [{'name': 'Institut Pasteur of Algeria', 'country': 'DZ'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3147-245X', 'authenticated-orcid': False, 'given': 'Balkiss', 'family': 'Bouhaouala-Zahar', 'affiliation': [{'name': 'Institut Pasteur de Tunis', 'country': 'TN'}]}], 'award-amount': {'amount': 1340491.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 1197348.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:37Z', 'timestamp': 1636383517000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221716'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664624}, 'publisher': 'Wellcome', 'award': '211166', 'DOI': '10.35802/211166', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Co-evolution of tumour mutational and CD4 T-cell differentiation landscapes'}], 'project-description': [{'description': \"Lung cancer is the second most commonly diagnosed cancer in the UK and the greatest cause of cancer-related death. A type of this disease called non-small cell lung cancer (NSCLC) accounts for the majority (85%) of cases. T-lymphocyte cells (T-cells) of the immune system patrol the body and can recognise and destroy cancer cells by recognising mutated proteins (neoantigens) on them. Despite this, the majority of patients with advanced lung cancer die of the disease, indicating the ineffective function of the immune system. In particular, little is known about the role of a particular group of immune cells called T-helper cells that are thought to be important. In chronic infections where T-cells are constantly exposed to their targets, they become less responsive as younger cells are driven to turn into later ones more rapidly. As younger cells are lost, the body's ability to fight the infection reduces. In cancer, it is possible that mutations drive a similar problem. Using lung cancer specimens from patients on a clinical trial and animal models of cancer, we propose to study the question of whether and how mutations can paralyse the ability of T-helper cells to fight the disease.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5373-5762', 'authenticated-orcid': False, 'given': 'Ehsan', 'family': 'Ghorani', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2021, 3, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:44Z', 'timestamp': 1636383224000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/211166'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665317}, 'publisher': 'Wellcome', 'award': '063952', 'DOI': '10.35802/063952', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Aciduric bacteria and root caries.'}], 'lead-investigator': [{'given': 'David', 'family': 'Beighton', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 231253.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 231253.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:46Z', 'timestamp': 1636382806000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063952'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665365}, 'publisher': 'Wellcome', 'award': '062069', 'DOI': '10.35802/062069', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The neurobiology of speech perception: functional subsystems in the human brain, the role of attention, and recovery from aphasic stroke.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7510-6297', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Scott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 358376.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 358376.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:18Z', 'timestamp': 1636383018000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062069'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665553}, 'publisher': 'Wellcome', 'award': '061104', 'DOI': '10.35802/061104', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the cost of the VIth International Workshop on scleroderma research to be held at Keble College Oxford on 31/7/00 to 2/8/00.'}], 'lead-investigator': [{'given': 'Carol', 'family': 'Black', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2000, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 5000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:09Z', 'timestamp': 1636382769000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061104'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665606}, 'publisher': 'Wellcome', 'award': '065278', 'DOI': '10.35802/065278', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deciphering the pathways that control and promote the processing of recombination intermediates in the fission yeast Schizosaccharomyces pombe.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0951-3374', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Whitby', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 165849.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 165849.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:51Z', 'timestamp': 1636382931000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065278'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665612}, 'publisher': 'Wellcome', 'award': '061962', 'DOI': '10.35802/061962', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Neuroscience'}], 'lead-investigator': [{'given': 'Laura', 'family': 'Von Hertzen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 116393.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 116393.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:22Z', 'timestamp': 1636383202000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061962'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665775}, 'publisher': 'Wellcome', 'award': '222348', 'DOI': '10.35802/222348', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovery and impact of schizophrenia rare genetic variation using next-generation sequencing'}], 'project-description': [{'description': 'Schizophrenia is a psychiatric disorder which affects around 1% of the population. There is no one single cause of schizophrenia, but genetics is known to play a substantial role. The genes involved in risk for the disorder span many different genes. Mutations thought to be linked to schizophrenia are often seen in individuals without a schizophrenia diagnosis, and I plan to investigate the impact these mutations have on an individual’s characteristics. I will use large-scale datasets in which every protein-coding base pair has been sequenced, highlighting any mutations. I will use information on an individual’s characteristics along with this genetic data to investigate the impacts of mutations in schizophrenia associated genes in both people with a schizophrenia diagnosis, and in those without. I also aim to discover new genes linked to schizophrenia, which will provide insights into the underlying biology of the disorder.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6946-5768', 'authenticated-orcid': False, 'given': 'Eilidh', 'family': 'Fenner', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2020, 10, 24]]}, 'award-end': {'date-parts': [[2023, 10, 23]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:57Z', 'timestamp': 1636383357000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 24]]}, 'URL': 'http://dx.doi.org/10.35802/222348'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665813}, 'publisher': 'Wellcome', 'award': '221575', 'DOI': '10.35802/221575', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'AVID-CC Adalimumab for COVID19 in community care'}], 'project-description': [{'description': 'While the first wave of COVID-19 is passing, we have yet to identify effective treatments. Most treatments have been used late in the illness. There is a pressing need to identify treatments delivered in community settings that avoid hospital admission. Novel immunomodulatory treatments have a well understood safety profile but are not suitable for studies such as Principle which rely on remote assessment. Hospital at home is a developing networ; teams of consultant physicians and nurses deliver high intensity care in community settings, commonly using point of care diagnostics. This provides a suitable framework for evaluation of novel therapies. This approach has parallels with healthcare systems employed in low and middle income countries and so the results will directly inform the delivery of interventions in these settings. Multiple strands of evidence identify TNFa as an important mediator of the hyperinflammatory state that is associated with poor outcome. Early intervention with anti-TNF therapy has the potential to substantially mitigate its effects and improve outcomes. Adalimumab is an established subcutaneous anti-TNF therapy. We propose a randomised dose ranging study in community settings to establish whether it can mitigate progression to respiratory failure (requirement for oxygen, non invasive and invasive ventilation) or death.', 'language': 'en'}], 'investigator': [{'given': 'Marc', 'family': 'Feldmann', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4156-6989', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Cook', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8763-6818', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Rowland', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8274-5580', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Lasserson', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8093-7084', 'authenticated-orcid': False, 'given': 'Duncan', 'family': 'Richards', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1495762.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 1495762.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:49Z', 'timestamp': 1636383049000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221575'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:26Z', 'timestamp': 1636454666065}, 'publisher': 'Wellcome', 'award': '062958', 'DOI': '10.35802/062958', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chemical neuroanatomy of the midbrain limbic system and its role in mediating serotonin levels in the raphe complex.'}], 'lead-investigator': [{'family': 'Flumerfelt', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 7213.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2000, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 7213.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:02Z', 'timestamp': 1636382762000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062958'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667279}, 'publisher': 'Wellcome', 'award': '223642', 'DOI': '10.35802/223642', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Research on Research Institute – CWTS-Leiden Costs - 2021'}], 'lead-investigator': [{'given': 'Sarah', 'family': 'de Rijcke', 'affiliation': [{'name': 'University of Leiden', 'country': 'NL'}]}], 'award-amount': {'amount': 46904.48, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2021, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 39956.11, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:40Z', 'timestamp': 1636383580000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223642'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667299}, 'publisher': 'Wellcome', 'award': '224006', 'DOI': '10.35802/224006', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'ENTHUSE Charitable Trust Proposal to The Welcome Trust, May 2021'}], 'project-description': [{'description': \"The ENTHUSE Charitable Trust's charitable purpose is to improve science education, or related subjects, for young people, through the professional development of teachers. Over the period to 2023, ENTHUSE will: - continue to provide science CPD accessible by all teachers and others from state-funded schools, with a particular focus on engaging schools, colleges, teachers and young people most in need of STEM education support so helping close the achievement gap and promote social mobility while raising standards across the board; - build strong, visionary leadership in STEM teaching across primary, secondary and post-16 settings to achieve sustained system-wide improvement, raising standards and expectations; - encourage a culture of career-long, STEM-specific professional learning across the teaching profession, raising morale, and enhancing retention; - significantly raise awareness among schools, colleges, teachers, young people and families of the value of STEM study and STEM-related research and careers, and of the academic, technical and apprentice routes into those roles. The ENTHUSE Charitable Trust is seeking a budget of £3.136m, with the deployment of Wellcome funding part of a wider mix of income, aligned to the above priorities.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Rosie', 'family': 'Bailey', 'affiliation': [{'name': 'ENTHUSE Charitable Trust', 'country': 'GB'}]}], 'award-amount': {'amount': 3136000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'award', 'scheme': 'Education', 'award-amount': {'amount': 3136000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:25Z', 'timestamp': 1636383565000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/224006'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667538}, 'publisher': 'Wellcome', 'award': '061287', 'DOI': '10.35802/061287', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic analysis of annexin function.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7304-8879', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Moss', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 329560.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 329560.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:09Z', 'timestamp': 1636383009000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061287'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667550}, 'publisher': 'Wellcome', 'award': '041392', 'DOI': '10.35802/041392', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'For a study of neural control of the cranial circulation and its implications for migraine.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3260-5904', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Goadsby', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4162769.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1995, 1, 1]]}, 'award-end': {'date-parts': [[2006, 4, 12]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 4162769.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:39Z', 'timestamp': 1636382979000}, 'score': 0.0, 'issued': {'date-parts': [[1995, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/041392'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667910}, 'publisher': 'Wellcome', 'award': '054737', 'DOI': '10.35802/054737', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular genetics of Fraser syndrome.'}], 'lead-investigator': [{'family': 'Mcgregor', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 156709.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 11]]}, 'award-end': {'date-parts': [[2002, 9, 10]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 156709.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:24Z', 'timestamp': 1636382904000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 11]]}, 'URL': 'http://dx.doi.org/10.35802/054737'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667955}, 'publisher': 'Wellcome', 'award': '050015', 'DOI': '10.35802/050015', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in molecular functions in disease.'}], 'investigator': [{'given': 'David', 'family': 'Barry', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'John', 'family': 'Coggins', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'family': 'Stewart', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'family': 'Murnaghan', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Kirsty', 'family': 'Brown', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Claire J', 'family': 'Ackerman', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Marie A', 'family': \"O'Donnell\", 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 449105.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 449105.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:41Z', 'timestamp': 1636383161000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050015'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:28Z', 'timestamp': 1636454668148}, 'publisher': 'Wellcome', 'award': '218520', 'DOI': '10.35802/218520', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dundee Training Programme in Integrated Molecular, Cellular and Translational Biology'}], 'project-description': [{'description': 'The proposed programme reflects the vision of University of Dundee to drive social change locally and transform lives globally through the creation, sharing and application of knowledge. A diverse cohort of students will flourish in a culture of excellence, developing research skills and attaining competencies in leadership, management and communication. They will experience world-leading life sciences research in a first-class training environment, with excellent core facilities and well-funded research groups, whilst enhancing research outputs with their energy and innovation. Students will participate in multidisciplinary research in Cellular Regulation, Protein Modification, Infection and Immunity and Drug Discovery and Translation. The flexible PhD programme will provide structured training in experimental design, data handling and processing, basic bio-computational skills and ethical standards in scientific research. By the end of year 1, students will have selected their research project and will have 3 years to consolidate their core bioscience skills, carrying out and documenting their research. There is the option for a career enhancement placement in year 3, while year 4 will support students in career choices and thesis submission. After thesis submission, flexible funding may be used to facilitate paper writing/completion or allow students to undertake a project in our Drug Discovery Unit.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8135-1958', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Arthur', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-9733-2404', 'authenticated-orcid': False, 'given': 'Miratul', 'family': 'Muqit', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0808-1875', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Coulthurst', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7113-9024', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Hay', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 5]]}, 'award-end': {'date-parts': [[2028, 10, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 5]]}, 'URL': 'http://dx.doi.org/10.35802/218520'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669526}, 'publisher': 'Wellcome', 'award': '062133', 'DOI': '10.35802/062133', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of the novel Leber congenital amaurosis gene, AIPL1.'}], 'lead-investigator': [{'given': 'Jacqueline', 'family': 'van der Spuy', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 92245.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 92245.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:53Z', 'timestamp': 1636382873000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062133'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669526}, 'publisher': 'Wellcome', 'award': '063040', 'DOI': '10.35802/063040', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular Functions in Disease.'}], 'lead-investigator': [{'family': 'Mauger', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 109077.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 109077.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:10Z', 'timestamp': 1636383190000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063040'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669534}, 'publisher': 'Wellcome', 'award': '066732', 'DOI': '10.35802/066732', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell division in bacillus subtilis: genetic and structural studies of proteins involved.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4577-9479', 'authenticated-orcid': False, 'given': 'Anthony', 'family': 'Wilkinson', 'affiliation': [{'name': 'University of York', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Imrich', 'family': 'Barak', 'affiliation': [{'name': 'Misc Slovak Republic', 'country': 'SK'}]}], 'award-amount': {'amount': 84800.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 4, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 84800.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:44Z', 'timestamp': 1636382864000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066732'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:30Z', 'timestamp': 1636454670241}, 'publisher': 'Wellcome', 'award': '066294', 'DOI': '10.35802/066294', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional annotation of the human genome: developing a \"disease-locus view\" of the human genome within a distributed controlled-term environment.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-4393-0510', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'McCarthy', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Winston', 'family': 'Hide', 'affiliation': [{'name': 'University of the Western Cape', 'country': 'ZA'}]}], 'award-amount': {'amount': 94458.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 94458.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:47Z', 'timestamp': 1636382927000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066294'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671395}, 'publisher': 'Wellcome', 'award': '065310', 'DOI': '10.35802/065310', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'IoP/Univeristy of Addis Ababa collaborative mental health program.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1379-7146', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Prince', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3920.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2001, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3920.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:49Z', 'timestamp': 1636382929000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065310'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671628}, 'publisher': 'Wellcome', 'award': '220527', 'DOI': '10.35802/220527', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploiting Radiogenomics for Evaluating Intratumoural Heterogeneity and Therapy Response in Soft Tissue Sarcoma'}], 'project-description': [{'description': 'Soft tissue sarcomas (STS) are a rare group of cancers that can develop throughout the body. There are over 100 subtypes, which often exhibit different tissue compositions across a single tumour. STS tumours therefore behave variably to treatment, and predicting patient response to pre-operative therapy is challenging. Advancements in MRI provide insight into the behaviour of tumours without needing an invasive biopsy. However, we lack research comparing MRI with tumour tissue to allow confidence in MRI interpretation. This project seeks to gain a better understanding of the differences seen in STS, and establish if imaging can reflect the underlying biology of these differences. I aim to match image-guided sampling of multiple regions of STS tumours with molecular analysis. The analysis will investigate the DNA, RNA and proteins within the tumour tissues and how this relates to MRI. We will assess whether integrating molecular and imaging data can improve our understanding of whether tumours are responding to treatment. My research will increase our understanding of the complex nature of STS and why distinct tumour regions behave differently. This will impact clinical practice by enhancing our ability to accurately measure and predict responses to pre-operative therapy and facilitate delivery of precision medicine.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5087-2243', 'authenticated-orcid': False, 'given': 'Amani', 'family': 'Arthur', 'affiliation': [{'name': 'Institute of Cancer Research', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 19]]}, 'award-end': {'date-parts': [[2023, 2, 17]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:31Z', 'timestamp': 1636383331000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 19]]}, 'URL': 'http://dx.doi.org/10.35802/220527'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671638}, 'publisher': 'Wellcome', 'award': '202974', 'DOI': '10.35802/202974', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '(Pilot) Performance of EArly Retinal Laser (PEARL)'}], 'project-description': [{'description': \"The prevalence of diabetes in China has risen tenfold since 1981. Virtually all of China's 114 million diabetic persons willdevelop diabetic retinopathy (DR) eventually, and timely laser treatment reduces blindness by 50%. Still, only 10% of ruralpersons with DR in China receive treatment, partly because current care requires them to be followed for several yearsbefore reaching treatment criteria, during which many are lost.Our recent review suggests that earlier treatment, which could reduce the compliance burden, may be clinically efficaciousand cost effective, but current evidence is insufficient. Our pilot work confirms rural patients find long-term adherencedifficult, and earlier treatment is acceptable to patients and providers. We now propose a pilot randomised trial to determinewhether earlier laser treatment improves outcomes and compliance among those with diabetic retinopathy in China.Patients will be recruited from one of China's largest hospitals, and treated after training provided by the top-ranked eyehospital in the country. Participants with severe non-proliferative diabetic retinopathy (NPDR) in both eyes will berandomized to receive: pan-retinal photocoagulation (PRP) applied immediately in one eye at random and PRP in thefellow eye only when proliferative diabetic retinopathy (PDR) develops (Early Intervention-n=100) or PRP at the PDR stagein both eyes (Standard Care group-n=100). The latter group is needed in particular, to test whether early laser treatmenthas an effect on adherence.At 1 year follow-up, the primary outcome will be progression to PDR, with secondary outcomes including loss of vision,complications, quality of life and cost effectiveness. In addition to informing a full trial, this study will address questions of importance to diabetic eye care in low resourcesettings by validating physician clinical diagnosis of DR compared to more expensive technologies and testing a simplifieddefinition of severe NPDR.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9866-3416', 'authenticated-orcid': False, 'given': 'Nathan', 'family': 'Congdon', 'affiliation': [{'name': \"Queen's University Belfast\", 'country': 'GB'}]}], 'award-amount': {'amount': 29026.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 4, 1]]}, 'award-end': {'date-parts': [[2019, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 29026.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:15Z', 'timestamp': 1636382955000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/202974'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671656}, 'publisher': 'Wellcome', 'award': '068516', 'DOI': '10.35802/068516', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Long term hospital utilisation and costs of preterm and low birthweight infants.'}], 'project-description': [{'description': \"The high rates of morality and morbidity arising from preterm birth and low birthweight impose an immense burden on the health services. Additional costs to the health service associated with preterm and low birthweight infants may be between £7748 and £63,300 each in their first year (1998 prices). However, since the early 1990's when studies in this area were conducted, both the incidence and survival rates of preterm birth and low birthweight have increased. This study will estimate the utilisation and cost of hospital services for preterm and low birthweight infants born in Oxfordshire and West Berkshire between 1970-94 with follow-up of hospitalisation to 1999. This will be done using data from the Oxford Record Linkage Study (ORLS), a very large database, with linked hospital records which provide person based records of hospital admissions. Data from the ORLS include basic demographic, obstetric and neonatal data, dates, diagnoses and procedures in the initial and all subsequent hospitalisations up to age ten years, except for the recent cohorts. ORLS data will be combined with specialty specific unit costs and data from the National Reference Costs to obtain estimates of likely expenditure for different groups. The analysis will estimate hospital utilisation and costs in different gestational age and birthweight groups over time.\", 'language': 'en'}], 'investigator': [{'given': 'Stavros', 'family': 'Petrou', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}, {'family': 'Davidson', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}], 'lead-investigator': [{'family': 'Henderson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 30449.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 1, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 30449.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:56Z', 'timestamp': 1636382876000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068516'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671868}, 'publisher': 'Wellcome', 'award': '068420', 'DOI': '10.35802/068420', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of hypoxia on the response of cells to oxidised low density lipoprotein.'}], 'investigator': [{'given': 'Giovanni', 'family': 'Mann', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'David', 'family': 'Leake', 'affiliation': [{'name': 'University of Reading', 'country': 'GB'}]}], 'award-amount': {'amount': 102000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 102000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:41Z', 'timestamp': 1636382801000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068420'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673005}, 'publisher': 'Wellcome', 'award': '066920', 'DOI': '10.35802/066920', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Control of microglial neurotoxicity by modulation of metabotropic glutamate receptors - a strategy for protection in neurodegenerative disease.'}], 'lead-investigator': [{'given': 'Jennifer', 'family': 'Pocock', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 187451.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 5, 1]]}, 'award-end': {'date-parts': [[2005, 4, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 187451.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:51Z', 'timestamp': 1636382871000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066920'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673005}, 'publisher': 'Wellcome', 'award': '211022', 'DOI': '10.35802/211022', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Social anxiety in adolescents: Testing aspects of the cognitive model and developing an Internet version of Cognitive Therapy.'}], 'project-description': [{'description': 'While it is common for teenagers to report feeling somewhat self-conscious and worried about what others think of them, for some adolescents social anxiety can be overwhelming and markedly interfere with their day-to-day life. Around 4% of young people experience clinical levels of social anxiety by the age of 18. Their success at school and their relationships with family and friends are all seriously affected. It is therefore essential that we have effective treatments for this disorder. Unfortunately, evidence suggests that many young people do not get better with the talking treatments that are available. In contrast we know that Cognitive Therapy (a type of talking treatment) is very effective with socially anxious adults. Cognitive Therapy was developed to target key factors that cause and maintain the illness in adults. I would therefore like to answer two questions in my research. First, are the factors that are important in maintaining social anxiety in adults also important in adolescent social anxiety? Second, can we develop an accessible and effective version of Cognitive Therapy for adolescents online? We will test if Cognitive Therapy works by comparing its effects to online stress management.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2756-3770', 'authenticated-orcid': False, 'given': 'Eleanor', 'family': 'Leigh', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:05Z', 'timestamp': 1636383245000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211022'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673031}, 'publisher': 'Wellcome', 'award': '068724', 'DOI': '10.35802/068724', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Recognition motifs for cell-surface receptors and matrix proteins within the triple-helical domains of collagens.'}], 'project-description': [{'description': 'Triple-helical peptides which mimic the secondary structure of collages have proved invaluable in locating recognition sites within collagen for the platelet receptors, integrin alpha2beta1 and glycoprotein (Gp) VI. Some progress has been made applying the same approach to non-receptor proteins, von Willebrand factor and MMP-9. As a first round of peptide synthesis, we will construct the entire sequence of the fibrillar collagens, types II and III, and use these to locate recognition sites for a series of cardiovascular and other proteins. These will include collagen receptors on platelets (CD36, GpV) and other cells (alpha10beta1, alpha11beta1, DDRs), and non-receptor collagen-binding proteins (vWf, MMP-9, decorin, opticin, matrillins, fibronectin). When binding sites have been mapped, sequence alignment and analysis will support a second round of peptide synthesis which will allow recognition motifs to be identified. This information will allow the integrin-specificity of different motifs to be determined, novel therapeutic targets to be identified, and will provide fundamental insight into the interaction of collagen-binding proteins with the triple-helical structure.', 'language': 'en'}], 'investigator': [{'family': 'Knight', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Richard', 'family': 'Farndale', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 148489.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 3, 17]]}, 'award-end': {'date-parts': [[2005, 3, 16]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 148489.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:20Z', 'timestamp': 1636382780000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 3, 17]]}, 'URL': 'http://dx.doi.org/10.35802/068724'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673029}, 'publisher': 'Wellcome', 'award': '069759', 'DOI': '10.35802/069759', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Interactions between hypercapnia and hypoxia in the pulmonary circulation.'}], 'project-description': [{'description': 'Respiratory disease can cause the patient to become hypoxemic, both in the short term and over long periods. Acute hypoxia causes the pulmonary arteries to constrict (hypoxic pulmonary vasoconstriction, HPV) and therefore increase pulmonary vascular resistance (PVR). Chronic hypoxia causes the pulmonary vasculature to remodel, causing a fixed increase in PVR that can not be immediately reversed by oxygen, and changes in vascular reactivity. The mechanisms that cause these effects are not known completely , but reactive oxygen species from mitochondria and oxidant stress are thought to play an important role in causing both the acute HPV, and tissue damage or changes associated with chronic pulmonary hypertension. Respiratory disease often however also causes hypercapnia. Recent evidence from our laboratories and elsewhere has shown that hypercapnia can protect against some of the changes associated with chronic hypoxia. Also, hypercapnia has been shown to inhibit HPV in a way that is not due to acidosis. There is published evidence that CO2 can reduce oxidant stress and release of reactive oxygen species from the mitochondria and possibly other sources. In this project I therefore wish to test the hypothesis that CO2 suppresses hypoxic pulmonary vasoconstriction by interfering with the increase in mitrochondrial reactive oxygen species generation during hypoxia in a pH independent manner. I will do this by studying the effects of CO2 in conditions of normal pH on HPV in isolated pulmonary arteries and cells, and on the intracellular level of Ca2+, reactive oxygen species and NADH during hypoxia using arteries and cells loaded with Fura-2 and DCF. Also, I will test the effect of inhibition of carbonic anhydrase on HPV, as this should increase local CO2 carbonic anhydrase inhibition has been shown to inhibit HPV.', 'language': 'en'}], 'lead-investigator': [{'given': 'Marie', 'family': 'Vankova', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 53807.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 6, 1]]}, 'award-end': {'date-parts': [[2004, 5, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 53807.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:46Z', 'timestamp': 1636382926000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069759'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673055}, 'publisher': 'Wellcome', 'award': '215165', 'DOI': '10.35802/215165', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The Synaptic Organisation of the Hippocampus : VTA loop'}], 'project-description': [{'description': 'When making decisions, it is advantageous to use past experience to help choose the best option. For example, when deciding whether to drink a strong coffee late in the evening, it is beneficial to weigh up what happened when you drank some previously: that coffee increased your alertness to help you get through that last hour or work; but also that you struggled to sleep later in the day. These kinds of decisions are thought to be determined by the activity of distinct populations of neurons. An example of this are neurons in the hippocampus and ventral tegmental area (VTA), which together have been suggested to form predictions about the results of our decisions. If this is the case, it would be extremely important, as problems in these processes result in an enormous variety of disorders including depression, anxiety and drug abuse. However, because these two areas are connected by very complex circuitry, it has been difficult to find out how they carry out their role. In this proposal our goal is to understand how the neurons in the hippocampus and VTA work together to make these decisions, so we can work out how they go wrong and cause disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0996-790X', 'authenticated-orcid': False, 'given': 'Karyna', 'family': 'Mishchanchuk', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:45Z', 'timestamp': 1636383225000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215165'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673244}, 'publisher': 'Wellcome', 'award': '218726', 'DOI': '10.35802/218726', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identifying the genetic determinants of Fusobacterium associated with diarrhoeal disease and colorectal cancer in Vietnam'}], 'project-description': [{'description': 'The gut microbiome and its dysbiosis play a central role in understanding infectious and non-infectious conditions. Evidence suggests Fusobacterium nucleatum, an oral anaerobic bacterial pathobiont, potentiates colonic tumourigenesis. My recent work in Vietnam indicates that Fusobacterium, including F. nucleatum, is also enriched in the gut microbiome of children during infectious diarrhoea. My aim is to define the role of Fusobacterium in the resolution of infectious diarrhoea and the development of colorectal cancer, through integrating 16S rRNA-based metagenomics in two distinct clinical studies in Vietnam. I will examine the impact of Fusobacterium gastrointestinal overgrowth and microbiome dysbiosis on diarrhoeal duration in children. Additionally, I will measure the prevalence and distribution of F. nucleatum in the microbiomes of gut mucosa taken from colorectal cancer patients. I will perform whole genome sequencing on the F. nucleatum isolated from collected saliva, diarrhoea stools, and colonic tumour mucosa. Using genomics and phylogenetic analyses, I aim to identify genetic factors associated with F. nucleatum colonization in different human body compartments (oral, colonic) and pathological states (tumour, non-tumour). These findings will enable future in-depth studies, contributing to the development of non-invasive diagnostic marker for colorectal cancer and targeted Fusobacterium therapies in these two diseases.', 'language': 'en'}, {'description': 'The bacterium Fusobacterium nucleatum commonly resides in the human mouth, but its presence in the gut could contribute to the development of colorectal cancer in adults and potentially the resolution of diarrhoea in children. Here, I will investigate whether Fusobacterium overgrowth in the gut affects the duration of childhood diarrhoea and measure the prevalence of F. nucleatum in the gut of colorectal cancer patients in Vietnam. I will study the bacterial communities in clinical samples (saliva, stool, gut tissue) by analysing the composition of a bacterial barcode gene (16S rRNA). I will grow F. nucleatum from collected samples and compare these organisms’ genetic content, to assess which F. nucleatum genes are associated with colonization in colorectal tumours and different human organs (mouth, gut). My project will define the role of Fusobacterium in these two critical diseases, and help designing effective therapies to counter Fusobacterium colonization in the human gut.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2858-2087', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Thwaites', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8938-5709', 'authenticated-orcid': False, 'given': 'Lindsay', 'family': 'Hall', 'affiliation': [{'name': 'Quadram Institute Bioscience', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5634-7220', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Slade', 'affiliation': [{'name': 'Virginia Tech', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4028-4074', 'authenticated-orcid': False, 'given': 'Hao', 'family': 'Chung', 'affiliation': [{'name': 'Oxford Clinical Research Unit - Vietnam', 'country': 'VN'}]}], 'award-amount': {'amount': 289561.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 6, 1]]}, 'award-end': {'date-parts': [[2023, 6, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 223772.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:22Z', 'timestamp': 1636383082000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218726'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673262}, 'publisher': 'Wellcome', 'award': '220562', 'DOI': '10.35802/220562', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Working memory impairment in temporal lobe epilepsy'}], 'project-description': [{'description': 'This project examines how temporal lobe epilepsy (TLE) disrupts specific memory processes, through the integrated study of behaviour, neurophysiology, and multi-modal imaging . This is important because, within the peak age group 60–90 years of developing TLE, up to 60% of individuals demonstrate objective memory dysfunction, before starting anti-seizure medication. At present, there are no specific treatment targets for this significant problem. Two factors which are associated with memory problems in TLE are higher number of seizures and co-existing cerebrovascular disease. However, it remains unknown how these two factors impact memory, whether they interact, and whether they both act by disrupting function of the hippocampus- our memory organ. I plan to: - use a novel cognitive task to assess how TLE perturbs two specific facets of memory that are known to be less efficient with ageing and Alzheimer’s disease. - establish the mechanistic contributions of electrical disruption and structural white matter abnormalities to memory impairment. These cognitive processes, if affected, could explain memory deficits caused by acute and long-term effects of seizures. Ultimately, this project may help inform clinical assessment and guide specific management of sub-clinical seizure activity and vascular risk factors, to improve memory co-morbidity and quality of life in TLE.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7333-2204', 'authenticated-orcid': False, 'given': 'Xin You', 'family': 'Tai', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 11, 6]]}, 'award-end': {'date-parts': [[2023, 2, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:32Z', 'timestamp': 1636383452000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 11, 6]]}, 'URL': 'http://dx.doi.org/10.35802/220562'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673658}, 'publisher': 'Wellcome', 'award': '211411', 'DOI': '10.35802/211411', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How Does the Interplay of PI3-kinases at the Phagosomal Membrane Co-ordinate Pathogen Killing?'}], 'project-description': [{'description': 'Animals (including humans) are protected from bacterial infection by patrolling innate immune cells. Neutrophils (the most abundant phagocytes) engulf their prey into membrane-bound phagosomes, enabling targeted, segregated and highly concentrated microbicidal activity. Phosphoinositide 3-hydroxykinase (PI3K) signalling regulates many aspects of neutrophil function and PI3K-derived phospholipid mediators accumulate at the phagosomal membrane to facilitate killing. However, the identity of the PI3K isoform(s) involved, the mode of delivery to the phagosome, and the extent to which pathogens subvert this process have not been determined. Our novel preliminary data show that the lipid messenger PIP3 (a product of PI3K activity) waxes and wanes at the phagosomal membrane, reflecting ‘quantal’ delivery from an unidentified cellular organelle, with subsequent changes in phagosomal pH. I will undertake a detailed exploration of this critical process using the genetically tractable zebrafish, which allows high resolution in vivo imaging of neutrophils in relevant infection models. I will determine the dynamics of PI3K signalling in response to a range of pathogens,quantifying PI3K-derived phospholipids at the phagosomal membrane. My results will inform our knowledge of PI3K signalling in neutrophil bactericidal activity, and may suggest how these processes might be manipulated to enhance pathogen killing.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4371-5976', 'authenticated-orcid': False, 'given': 'Clare', 'family': 'Muir', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 1, 2]]}, 'award-end': {'date-parts': [[2021, 1, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:46Z', 'timestamp': 1636383406000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 1, 2]]}, 'URL': 'http://dx.doi.org/10.35802/211411'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674110}, 'publisher': 'Wellcome', 'award': '220283', 'DOI': '10.35802/220283', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Long-term vascular health effects of cancer and its treatment'}], 'project-description': [{'description': 'There is increasing concern about the long-term vascular health of the large and growing population of cancer survivors. I recently showed that survivors of most types of cancer have increased risks of one or more cardiovascular diseases, beyond those explained by shared risk factors such as smoking. The key priorities now are to understand (i) the drivers of these increased risks, and thus how and when we can most effectively intervene; and (ii) whether broader vascular-related outcomes, in particular dementia and kidney disease, are also affected. In this fellowship I will address these two priorities by conducting analyses underpinned by cutting-edge statistical and epidemiological methods, and capitalising on rich UK and international e-Health datasets, including game-changing new cancer treatment data. I will investigate in detail the role of anti-cancer treatments (e.g. chemotherapies/radiotherapy) and changes in traditional vascular risk factors (e.g. blood pressure, BMI) in driving late cardiovascular risk. I will then investigate whether, and through what mechanisms, cancer history affects risk of vascular dementia, chronic kidney disease, and pre-clinical cognitive and renal outcomes (uniquely identifiable in the 500,000-strong UK Biobank cohort). Throughout, this research will contribute actionable evidence informing clinical/public health policies to improve the long-term outlook of cancer survivors.', 'language': 'en'}, {'description': 'I recently showed that survivors of most cancers have raised risks of heart/circulatory diseases. The key priorities now are to understand (i) why these risks are increased, so that we can work out how best to reduce and manage risk; and (ii) whether cancer survivors are also at increased risks of other circulation-related diseases. I will address these questions by applying cutting-edge statistical methods to analyse large-scale UK and international data sources, capturing detailed information on prescriptions, diagnoses, hospitalisations, and deaths. I will investigate the role of potentially cardio-toxic anti-cancer treatments, and changes in cardiovascular risk factors (e.g. blood pressure), in determining long-term cardiovascular risks. I will then explore whether, and through what mechanisms, having had cancer previously affects long-term risks of two key circulation-related diseases, kidney disease and dementia. These studies will help inform treatment and monitoring guidelines to improve the outlook of cancer survivors.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5364-8757', 'authenticated-orcid': False, 'given': 'Krishnan', 'family': 'Bhaskaran', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 1773692.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 3, 31]]}, 'award-end': {'date-parts': [[2026, 3, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1773692.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:27Z', 'timestamp': 1636383567000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 31]]}, 'URL': 'http://dx.doi.org/10.35802/220283'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674118}, 'publisher': 'Wellcome', 'award': '220421', 'DOI': '10.35802/220421', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The NCEMA study: Neutrophils in Cerebral Malaria'}], 'project-description': [{'description': 'Every year half of the world’s population is at risk of getting malaria, caused by the Plasmodium parasite, and almost half a million people die; mostly children in sub-Saharan Africa. Some infected children are at a higher risk of death since malaria can damage their brains as part of a severe complication called cerebral malaria (CM). Neutrophils are one of the first lines of defence against fighting infections by damaging cells, yet their involvement during CM is not entirely understood. We hypothesise that neutrophils interact with Plasmodium affecting the blood vessels of the brain and initiate or promote the progression to CM. We aim to perform a detailed analysis of the role of neutrophils in CM, using prospectively collected blood from children with CM, archival post-mortem brain tissue, blood vessel cell cultures and a mouse model. With the exception of the mouse model our project will be based in Malawi, a country endemic for malaria. Our findings will allow us to understand if neutrophils cause damage to the brain blood vessels leading to CM. This could provide the basis of a search for novel prevention and treatment strategies that can potentially decrease the high rates of death of this disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6039-6586', 'authenticated-orcid': False, 'given': 'Charalampos', 'family': 'Attipa', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2023, 3, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:31Z', 'timestamp': 1636383271000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220421'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674364}, 'publisher': 'Wellcome', 'award': '223195', 'DOI': '10.35802/223195', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Finding treatments for COVID-19: A phase 2 multi-centre adaptive platform trial to assess antiviral pharmacodynamics in early symptomatic COVID-19 (PLAT-COV)'}], 'project-description': [{'description': 'We propose to set up and validate a pharmacometric platform to provide quantitative assessment of antiviral effects in low risk adult patients with recent onset uncomplicated COVID-19 and high viral burdens. This assessment is based on measurement of oropharyngeal viral clearance rates. This will be a randomised, open label, group sequential adaptive platform trial to quantitate the antiviral activity of currently available potential (i.e. repurposed) treatments in low-risk adult patients with early COVID-19, through adjusted qPCR of serial oropharyngeal samples. It will be a mainly outpatient study conducted in three locations; one each in the Americas, Europe and Asia. The interventions to be evaluated in this first phase are hydroxychloroquine, lopinavir/ritonavir, ivermectin, miglustat, remdesivir, intranasal heparin, with the Regeneron monoclonal antibody cocktail or Peginterferon-lambda as a \"positive control\". This will identify drugs with a >90% probability of accelerating virus clearance compared to no treatment and will reject drugs with <10% corresponding probability. Drugs identified as accelerating viral clearance will undergo a further nested pharmacometric evaluation to characterise exposure–response relationships and inform dosing. This study will provide a platform for choosing antiviral drugs for phase 3 clinical trials. Once validated the platform can be used to evaluate new antivirals.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2309-1171', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Day', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6236-0464', 'authenticated-orcid': False, 'given': 'Walter', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5190-2395', 'authenticated-orcid': False, 'given': 'Arjen', 'family': 'Dondorp', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0001-5524-0325', 'authenticated-orcid': False, 'given': 'James', 'family': 'Watson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6328-8748', 'authenticated-orcid': False, 'given': 'William', 'family': 'Schilling', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0001-8393-8536', 'authenticated-orcid': False, 'given': 'Cintia', 'family': 'Cruz', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0002-3218-2166', 'authenticated-orcid': False, 'given': 'James', 'family': 'Callery', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1897-1978', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'White', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3728812.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 3728812.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:31Z', 'timestamp': 1636383571000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223195'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:55Z', 'timestamp': 1636454635731}, 'publisher': 'Wellcome', 'award': '056591', 'DOI': '10.35802/056591', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of alpha-synuclein in the pathogenesis of neuro- degeneration associated with Lewy bodies.'}], 'lead-investigator': [{'given': 'Damian', 'family': 'Crowther', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 206653.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 2, 4]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 206653.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:50Z', 'timestamp': 1636382810000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 2, 4]]}, 'URL': 'http://dx.doi.org/10.35802/056591'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:55Z', 'timestamp': 1636454635803}, 'publisher': 'Wellcome', 'award': '055887', 'DOI': '10.35802/055887', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular Initiative - four year PhD studentship.'}], 'lead-investigator': [{'family': 'Gordon', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 95253.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 10, 1]]}, 'award-end': {'date-parts': [[2002, 10, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 95253.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:59Z', 'timestamp': 1636383179000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/055887'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:56Z', 'timestamp': 1636454636379}, 'publisher': 'Wellcome', 'award': '033734', 'DOI': '10.35802/033734', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'a study of the mechanisms of neurodegeneration in human motor neurone disease.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8925-2567', 'authenticated-orcid': False, 'given': 'Pamela', 'family': 'Shaw', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-amount': {'amount': 1430290.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1992, 5, 1]]}, 'award-end': {'date-parts': [[2002, 12, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 1430290.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:33Z', 'timestamp': 1636382973000}, 'score': 0.0, 'issued': {'date-parts': [[1992, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/033734'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637263}, 'publisher': 'Wellcome', 'award': '062362', 'DOI': '10.35802/062362', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Scientific Symposium on progress in Neuropathology to be held on 10 January 2001 at the Royal Institution, London.'}], 'lead-investigator': [{'family': 'Lantos', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3940.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 10]]}, 'award-end': {'date-parts': [[2001, 2, 9]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3940.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:21Z', 'timestamp': 1636382961000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 10]]}, 'URL': 'http://dx.doi.org/10.35802/062362'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637251}, 'publisher': 'Wellcome', 'award': '061244', 'DOI': '10.35802/061244', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'To provide support for Dr C D T Bratten for twenty seven months during vacation time between April 2000 and July 2002.'}], 'lead-investigator': [{'given': 'Clive', 'family': 'Orchard', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 13279.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 20]]}, 'award-end': {'date-parts': [[2002, 7, 19]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 13279.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:27Z', 'timestamp': 1636382787000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 20]]}, 'URL': 'http://dx.doi.org/10.35802/061244'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637269}, 'publisher': 'Wellcome', 'award': '060965', 'DOI': '10.35802/060965', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A role for TNF-alpha in triggering the development of gestational diabetes via metabolic programming of cytokine phenotype?'}], 'investigator': [{'given': 'Mark', 'family': 'Holness', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Mary', 'family': 'Sugden', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 98286.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 98286.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:33Z', 'timestamp': 1636382913000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060965'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637440}, 'publisher': 'Wellcome', 'award': '062258', 'DOI': '10.35802/062258', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of hypovolaemia in the acidosis of severe malaria in children.'}], 'investigator': [{'given': 'Kevin', 'family': 'Marsh', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6999-5507', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Newton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2767-6919', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Levin', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'family': 'Nadel', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0007-0645', 'authenticated-orcid': False, 'given': 'Kathryn', 'family': 'Maitland', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 101309.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 101309.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:28Z', 'timestamp': 1636382788000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062258'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637990}, 'publisher': 'Wellcome', 'award': '061366', 'DOI': '10.35802/061366', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Contribution towards the 5th meeting of the UK Glial Cell Club 'From stem cells to glia: molecules and mechanisms' to be held at Brunei Gallery at the School of Oriental and African Studies of London University.\"}], 'investigator': [{'given': 'Kristjan', 'family': 'Jessen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Rhona', 'family': 'Mirsky', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4460.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2000, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4460.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:14Z', 'timestamp': 1636382894000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061366'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638018}, 'publisher': 'Wellcome', 'award': '064624', 'DOI': '10.35802/064624', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'In vitro investigation of the antimicrobial and wound healing properties of Spathodia campanulata(Bignoniaceae), Secamone afezelii (Asclepiadaceae) and Commelina diffusa (Commelinaceae).'}], 'lead-investigator': [{'family': 'Mensah', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 40050.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 40050.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:53Z', 'timestamp': 1636382753000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064624'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638257}, 'publisher': 'Wellcome', 'award': '062414', 'DOI': '10.35802/062414', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Corticosteroid therapy and respiratory muscle strength in chronic obstructive pulmonary disease (COPD)'}], 'investigator': [{'given': 'John', 'family': 'Moxham', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Michael', 'family': 'Polkey', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 185391.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 185391.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:09Z', 'timestamp': 1636382889000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062414'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638409}, 'publisher': 'Wellcome', 'award': '217123', 'DOI': '10.35802/217123', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PRECISE-DYAD: linking maternal and infant health trajectories in sub-Saharan Africa'}], 'project-description': [{'description': 'PRECISE-DYAD will extend the ongoing PRECISE network study [PRECISEnetwork.org] of 6,000 pregnant women and their infants (dyads); it will provide a greater epidemiological and mechanistic understanding of health and disease pathways in the sub-Saharan African context (The Gambia and Kenya), following uncomplicated pregnancies and those complicated by pregnancy hypertension, fetal growth restriction, stillbirth, and/or preterm birth. For women, we aim to determine if, and how, these pregnancy events identify those more likely to avoid complications in subsequent pregnancies, mental ill-health, or early onset of cardiometabolic diseases. For their children, we will assess the impact of these pregnancy disorders on their physical, mental, and neurodevelopmental health to 2-3 years of age. We will explore the consequences for maternal health trajectories of caring for children with moderate-to-severe neurodevelopmental delay resulting from complicated pregnancies, and will interrogate interactions with social determinants of health, including environmental exposures on maternal and infant health. We will develop a rich database and a large sample biorepository for future studies. Thereby, PRECISE-DYAD aims to achieve an overarching understanding of the factors that contribute to optimal maternal and child health within these contexts. Ultimately, the goal is to design interventions to optimise health of mothers and their children.', 'language': 'en'}, {'description': 'PRECISE-DYAD extends the ongoing PRECISE study of pregnant women and their infants (dyads) in two sub-Saharan African countries, The Gambia and Kenya, especially after pregnancies complicated by high blood pressure, birth of a smaller-than-expected baby, stillbirth, or premature birth. For women, we want to know if these pregnancy events, or caring for children with delayed brain development due to these events, can cause similar complications in future pregnancies, influence mental health, or increase the risk of heart or breathing disease or diabetes. For their children, do these pregnancy complications change physical and mental health and brain development at two years of age? We will ask if these links are altered by social and environmental adversity, including environmental pollution. Our database and bank of biological samples will help us understand the processes behind whether women and their babies do well or poorly to help us design future preventative and treatment strategies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1650-3238', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Moore', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-5983-0426', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Barratt', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2579-9301', 'authenticated-orcid': False, 'given': 'Melissa', 'family': 'Gladstone', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1355-610X', 'authenticated-orcid': False, 'given': 'Laura', 'family': 'Magee', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4573-1443', 'authenticated-orcid': False, 'given': 'Joy', 'family': 'Lawn', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7220-4382', 'authenticated-orcid': False, 'given': 'Joel', 'family': 'Singer', 'affiliation': [{'name': 'University of British Columbia', 'country': 'CA'}]}, {'ORCID': 'http://orcid.org/0000-0002-3686-7904', 'authenticated-orcid': False, 'given': 'Amina', 'family': 'Abubakar', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4136-3070', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'von Dadelszen', 'affiliation': [{'name': \"King's College London School of Medicine\", 'country': 'GB'}]}], 'award-amount': {'amount': 4016242.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 2008121.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217123'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639472}, 'publisher': 'Wellcome', 'award': '219666', 'DOI': '10.35802/219666', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Human monoclonal antibodies against Shigella (ShiMabs), for therapy and vaccine acceleration'}], 'project-description': [{'description': 'The project is expected to contribute significantly to a flagship approach to Shigella and to accelerate the development of an ultimate remedy to shigellosis. This will be done by i) developing human monoclonal antibodies (mAbs) against Shigella that overcome antimicrobial resistance (AMR) and are affordable in low- and middle-income countries (LMIC); ii) establishing standard correlates of protection which will accelerate development and recommendation of antibodies and vaccines; iii) providing the bases for universal vaccines by identifying novel protective antigens common to all serotypes or common epitopes present in the lipopolysaccharide of all serotypes. We will take advantage of the recent possibility of high-throughput cloning of human B cells from convalescent or vaccinated people to find targets difficult or impossible to be discovered using conventional technologies. We will apply for the first time high-content confocal microscopy screening of human mAbs interacting with bacteria and we will use machine Learning and artificial intelligence to analyze high-quality digital images to detect antibodies that bind, intoxicate or kill bacteria. The development of effective mAbs and vaccines against AMR bacteria is one of the best approaches to fight AMR since they can reduce the overall use of antibiotics and decrease the incidence of resistant infections.', 'language': 'en'}, {'description': 'Shigella, a gram negative bacterium with more than 50 different serotypes, is a major global health problem in low-income countries where it causes more than 93 million episodes of diarrhea and 238,000 deaths, 92,700 of which are children under 5 years of age. The problem is exacerbated by the widespread antimicrobial resistance (AMR), which makes the bacterium increasingly difficult to treat. There are several vaccines in development, however they face the challenging need to cover a vast number of serotypes and the absence of correlates of protection. We propose to isolate human monoclonal antibodies (mAbs) from B cells collected from people previously exposed to Shigella, or vaccinated with experimental vaccines, with the overarching goal to provide new therapeutic solutions to Shigella infections. mAbs can overcome AMR and will be selected and engineered to have high potency and low cost to make them affordable to low- and middle-income countries. The project includes the establishment of correlates of protection that will facilitate vaccine development and licensure, and the identification of antigens common to all or to most of the serotypes to underpin the development of universal vaccines. To identify potent antibodies we will screen for their ability to bind, intoxicate or kill bacteria using a novel high-throughput microscopy platform that captures digital images as well as conventional technologies such as bactericidal, opsono-phagocytosis and FACS assays. The selected antibodies will be expressed as full-length molecules, engineered to maximize their therapeutic properties and tested for protection in assays that correlate with protection in humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8827-254X', 'authenticated-orcid': False, 'given': 'Rino', 'family': 'Rappuoli', 'affiliation': [{'name': 'Fondazione Toscana Life Sciences', 'country': 'IT'}]}], 'award-amount': {'amount': 4202058.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 8]]}, 'award-end': {'date-parts': [[2024, 2, 7]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 3532625.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:39Z', 'timestamp': 1636383519000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 8]]}, 'URL': 'http://dx.doi.org/10.35802/219666'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639954}, 'publisher': 'Wellcome', 'award': '204845', 'DOI': '10.35802/204845', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Institutional Strategic Support Fund'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9383-1054', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Lehner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 5000000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 1, 1]]}, 'award-end': {'date-parts': [[2021, 9, 29]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 5000000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:43Z', 'timestamp': 1636382983000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/204845'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639959}, 'publisher': 'Wellcome', 'award': '219812', 'DOI': '10.35802/219812', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Reducing antibiotic prescribing through a prioritized vaccination strategy'}], 'project-description': [{'description': 'Prioritizing vaccine development to focus on pathogens that drive the most antibiotic prescribing will have multiple advantages: reducing the burden of disease, reducing the extent of antibiotic use, and thus reducing the selective pressures driving antimicrobial resistance. In this proposal, we will (1) test the hypothesis that recent declines in outpatient antibiotic prescribing in the US are associated with reductions in pneumococcal disease attributable to PCV13 uptake and (2) estimate the antibiotic prescribing attributable to the most common pathogens and variation by age, demographic, and geography. To do so, we will use large representative nationwide datasets from the US, including insurance claims, public health surveillance, and a national immunization survey. The deliverables from this project will include estimates of the impact of PCV13 on outpatient prescribing and quantification of the expected reductions in antibiotic prescribing given vaccines for common pathogens. We expect that the results from these studies will establish (1) robust estimates of the reductions in outpatient antibiotic prescribing achieved by PCV13, as an exemplar of what vaccines can accomplish; and (2) priorities for vaccines to target in terms of impact on antibiotic prescribing and thus on antimicrobial resistance.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1504-9213', 'authenticated-orcid': False, 'given': 'Marc', 'family': 'Lipsitch', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-2223-1582', 'authenticated-orcid': False, 'given': 'Ateev', 'family': 'Mehrotra', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-4884-6609', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Barnett', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5646-1314', 'authenticated-orcid': False, 'given': 'Yonatan', 'family': 'Grad', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}], 'award-amount': {'amount': 300517.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2022, 3, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 232238.8, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:34Z', 'timestamp': 1636383094000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219812'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641137}, 'publisher': 'Wellcome', 'award': '216363', 'DOI': '10.35802/216363', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of antipsychotics on glial cells, neuroinflammation and demyelination.'}], 'project-description': [{'description': 'Schizophrenia is a severe mental disorder that affects how a person thinks, feels and behaves. It can be very disabling and reportedly one percent of the population is diagnosed with the condition worldwide. It, as well as other mental health conditions can be treated with antipsychotic medication. There are many different antipsychotics, all appear to function by changing the level of the neurotransmitter (a signalling chemical released by nerve cells) dopamine. However, their exact mechanism of action is still unknown. Other non-nerve cell types called glia play a role in schizophrenia and may be effected by antipsychotic medication. These cells serve many functions in the brain including supporting nerve cells, forming myelin (an insulating sheath around nerves) and influencing immune responses. I aim to examine the effects of antipsychotic medication on glial cells with the goal of understanding and exploring the ways these drugs may act via non-nerve cells. I will especially look to see whether these drugs influence the development of myelin and/or protect against demyelination. The overall ambition of this work is to elucidate new molecular and cellular pathways that may guide future antipsychotic drug research and development eventually benefiting patients with schizophrenia and other neuropsychiatric disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6980-4926', 'authenticated-orcid': False, 'given': 'Kapil', 'family': 'Sharma', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2018, 7, 9]]}, 'award-end': {'date-parts': [[2022, 1, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:15Z', 'timestamp': 1636383255000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 7, 9]]}, 'URL': 'http://dx.doi.org/10.35802/216363'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641697}, 'publisher': 'Wellcome', 'award': '220058', 'DOI': '10.35802/220058', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterising the regulators of trypanosome development and virulence in selected and natural parasite isolates'}], 'project-description': [{'description': 'Trypanosoma brucei, the causative agent of human and animal trypanosomiasis, has two distinct life stages. The proliferative ‘slender’ bloodstream-form morphs into a transmissible ‘stumpy’ form, which is adapted to surviving in its vector’s (Glossina spp.) midgut. The transition occurs in a density-dependent quorum sensing (QS) like process which is initiated by a ‘stumpy induction factor’ (SIF). I propose to use a wide diversity of pleomorphic (capable of morphing from slender to stumpy) field and laboratory strains of T. brucei to generate, via multiple passages, monomorphic cells (unable to become stumpy). I will create genomic, transcriptomic and epigenetic data from these cells at the beginning and end of the selection in an attempt to determine the cause of monomorphism, and therefore, the integral components of the QS process. By performing the study on diverse T. brucei cell lines, it will be possible to establish if the monomorphic phenotype can arise via convergent evolution. Alongside the genomes produced during this project, publicly available trypanosomatid genomes will be collated to identify conserved genes associated with increased virulence and monomorphism.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1428-0608', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Oldrieve', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:58Z', 'timestamp': 1636383418000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220058'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641730}, 'publisher': 'Wellcome', 'award': '218510', 'DOI': '10.35802/218510', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dynamic Molecular Cell Biology'}], 'project-description': [{'description': 'Identifying disease-associated genes, mutations and perturbed expression is only the first stage towards understanding human disease and the development of therapeutics. In Bristol we aspire to understand gene function and the proteins they encode across spatial scales, from the molecular level through to functional studies in cells, tissues and organisms. Since proteins, cells and tissues are all dynamic, wherever possible these processes need to be studied through multiple timescales. Advances in spatial and temporal resolution of microscopy provide opportunities to study processes at an unprecedented level across molecular and cellular scales. Only by combining these approaches will we truly understand organismal-level health, the pathoetiology of diseases and provide rational therapeutic routes to relieve them. This relies on biologists operating at the interface between molecular and cell biology. Our Wellcome programme will recruit, support and train a new generation of PhD students in Biomedical Research, with a broad base and understanding of molecular cell biology techniques coupled with world-class expertise in their PhD topic. These students will be trained to become future leaders in a wide range of careers, founded upon a holistic and rounded personal and professional development, which incorporates the best practice in PhD training.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8186-5708', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'Ridley', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-3931-0503', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Collinson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2665-5086', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Martin', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 21]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:06Z', 'timestamp': 1636383246000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 21]]}, 'URL': 'http://dx.doi.org/10.35802/218510'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641749}, 'publisher': 'Wellcome', 'award': '218481', 'DOI': '10.35802/218481', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Four Year PhD Programme in Stem Cell Biology and Medicine'}], 'project-description': [{'description': 'Specialist post-graduate training in Stem Cell Biology and Medicine is essential to produce a stream of highly skilled and innovative investigators equipped with a deep understanding of stem cell science and its significance for future medicine. In this context, the Wellcome PhD Programme in Stem Cell Biology and Medicine is unique in the UK in focus and scope. The enduring popularity of the programme, which receives on average 200 applications per year, and the quality of research outputs and next destinations are testament to both the calibre of students we are able to recruit and to the high-quality training they receive. Our programme provides an environment that is intellectually rigorous and personally supportive for students, enabling them to set and attain research objectives. The programme is designed to develop analytical and critically-minded individuals. Since its inception in 2008, the PhD Programme has evolved in response to the expressed needs of students and continuous developments in modern Stem Cell Biology. Our overarching goal is to produce well-trained and rounded PhD graduates who have generated significant and original research findings and are fully prepared for an ambitious and challenging career, whether continuing in stem cell science or moving to another profession.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-0312-161X', 'authenticated-orcid': False, 'given': 'Brian', 'family': 'Huntly', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0231-3073', 'authenticated-orcid': False, 'given': 'Brian', 'family': 'Hendrich', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 6051821.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 6051821.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:05Z', 'timestamp': 1636383245000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218481'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641751}, 'publisher': 'Wellcome', 'award': '220343', 'DOI': '10.35802/220343', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A high-quality connectome of the complete adult Drosophila central nervous system'}], 'project-description': [{'description': 'Building on advances during our successful connectomics collaboration (2016-20), we now propose a very ambitious new goal: a complete, high-quality connectome for the male Drosophila central nervous system (CNS). With Wellcome support and leveraging Janelia’s unique electron microscopy imaging capability, we could turn image data into a fully analysed connectome. This would be the first CNS connectome of an animal with complex motor and cognitive behaviours. In contrast to existing fly datasets, it will be bilaterally complete, include brain and nerve cord and have intact sensory-motor connectivity. This connectome should have an enormous impact on the understanding of CNS-spanning circuitry underlying complex behaviour. We will publicly release initial draft and high-quality versions as soon as they are complete. We will immediately use it to study multisensory integration, memory recall, decision making, modification of brain states, the flexible organisation of motor behaviour, and sexually dimorphic circuits. It will provide a critical resource for >200 labs worldwide studying Drosophila neurobiology (with impacts on developmental biology and molecular cell atlases) and provide new opportunities for theoretical neuroscientists to study complete, biologically-defined neural networks in a richly investigated organism. We expect general principles, applicable to all nervous systems, including those of humans, to emerge.', 'language': 'en'}, {'description': 'Our brain and spinal cord contain a complex network of nerve cells that lets us feel, think and control our bodies. One powerful approach to understand how this works is mapping the connectome: the complete wiring diagram of connections in this network. However these connections are tiny (order 1/10,000th of a millimetre) and can only be revealed by powerful electron microscopes. Only 2 complete connectomes have ever been described, for tiny invertebrates with a few hundred nerve cells – our brain has 100 billion. Using the latest technology, we will obtain the brain and nerve cord connectome of a male Drosophila fly. This will be the first complete connectome for an animal with eyes and legs, whose nervous system shares many features with our own. We will rapidly share this with other scientists and use it to understand how nerve cells integrate sensory information, make decisions and control behaviour.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4503-6229', 'authenticated-orcid': False, 'given': 'Scott', 'family': 'Waddell', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5142-1997', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Landgraf', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7679-3639', 'authenticated-orcid': False, 'given': 'Gwyneth', 'family': 'Card', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}, {'given': 'Gerald', 'family': 'Rubin', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0587-9355', 'authenticated-orcid': False, 'given': 'Gregory', 'family': 'Jefferis', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 4119965.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 4119965.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:41Z', 'timestamp': 1636383101000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220343'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641754}, 'publisher': 'Wellcome', 'award': '222310', 'DOI': '10.35802/222310', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating microglial senescence in central nervous system health and disease'}], 'project-description': [{'description': 'Neurodegenerative diseases cause progressive loss of nerve cells in the brain, resulting in impaired cognition and/or movement. There are currently no treatments for these diseases and therefore, another approach to developing treatments is required. With ageing, dysfunctional or “senescent” cells accumulate in the body and are involved in various neurodegenerative diseases. Microglia are specialised immune cells in the brain responsible for keeping surrounding nerve cells healthy. Microglia can become senescent, meaning they struggle to maintain nerve cell health. We hypothesise that senescent microglia regulate neurodegeneration. However, how senescent microglia differ in ageing and neurodegenerative disease is unknown and it is unclear how senescent microglia contribute to neurodegeneration. I will explore this using immunofluorescence, whereby senescent microglia and associated neurodegeneration can be identified by staining cells with specific markers. I will also induce and prevent microglial senescence specifically, using two specially designed mouse models, and assess neurodegeneration. It is also unknown what causes microglial senescence but ageing and long-term inflammation throughout the body likely contribute. I will investigate how microglia become senescent in mouse models undergoing ageing or long-term inflammation. This work aims to improve understanding of the role of senescent microglia in neurodegeneration and provide alternative targets for treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8545-3724', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Kent', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:34Z', 'timestamp': 1636383394000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222310'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641776}, 'publisher': 'Wellcome', 'award': '222825', 'DOI': '10.35802/222825', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Study of the dark proteome in innate immunity'}], 'project-description': [{'description': 'Intrinsically disordered proteins/domains (IDPs/IDRs) are highly flexible and lack a defined secondary or tertiary structure. Their highly reactive and versatile interaction surface contains diverse small linear motifs that enable IDP/IDRs to act as key regulatory protein interaction and signalling hubs. In addition, a new set of small proteins have recently emerged by the identification of thousands of microproteins or smORF-encoded peptides (sPEPs) from which a few validated sPEPs play crucial regulatory roles via protein-protein interactions and add a new regulatory dimension to multiple cellular processes. Due to the size of sPEPs and high flexibility of IDPs, conventional tagging, biochemical and cell biological approaches are not suitable for the study of these type of proteins. I will overcome this by implementing a pipeline to achieve the orthogonal site-specific incorporation of minimally invasive non-canonical amino acids in IDPs and sPEPs. With this approach I aim to study the protein-protein interaction networks, localization and function of IDPs and sPEPs involved in innate immune processes such as the antiviral response or neutrophil defense mechanisms against pathogen invasion.', 'language': 'en'}, {'description': 'The innate immune system is comprised of different cell types which contain diverse evolutionary adapted protein-protein interaction networks that sense and trigger tailored responses to identified threats. These processes require a tight regulation in order to achieve an adequate immune defence and avoid immune-mediated pathology due to an uncontrolled immune response. Intrinsically disordered proteins/regions (IDP/IDRs) are highly dynamic flexible proteins that lack a defined structure and have been shown to be key signalling and protein interaction hubs due to their large interaction surface enriched in small linear binding motifs. Multiple proteins involved in the innate immune response contain IDRs of variable lengths. However, very little is known of their functional role and their interactome. I plan to use state-of-the-art chemical biology, biochemical and cell biological approaches to understand the functional relevance of IDPs in innate immunity which could lead to the finding of new therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2363-4770', 'authenticated-orcid': False, 'given': 'Iker', 'family': 'Valle Aramburu', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:11Z', 'timestamp': 1636383551000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222825'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:03Z', 'timestamp': 1636454643415}, 'publisher': 'Wellcome', 'award': '061839', 'DOI': '10.35802/061839', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Effect of early treatment of permanent childhood hearing impairment on outcome at 5 to 8 years.'}], 'investigator': [{'given': 'Stavros', 'family': 'Petrou', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Campbell', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'James', 'family': 'Stevenson', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Colin', 'family': 'Kennedy', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}], 'award-amount': {'amount': 371251.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 371251.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:31Z', 'timestamp': 1636382791000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061839'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:04Z', 'timestamp': 1636454644459}, 'publisher': 'Wellcome', 'award': '220776', 'DOI': '10.35802/220776', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanism of cell-to-cell transmission of flaviviruses'}], 'project-description': [{'description': 'This proposal will investigate the mechanism of cell-to-cell transmission and spread of flaviviruses using Dengue and Zika as model systems. We will therefore address a longstanding debate on how they exit from infected cells, and preferentially spread into specific cell types. Dengue and Zika are the two most prevalent flaviviruses worldwide, sharing significant overlap in their genome architecture and biology. Dengue infects >50 million people annually, causing severe pathologies. Zika too has emerged as a global threat with recent outbreaks linked to serious neuro-developmental complications in children and Guillain Barré syndrome in adults. No vaccines or therapeutics exist for these viruses, and our current understanding on mechanisms of their transmission and spread is severely limited. Viral infections spread by overcoming multiple barriers to move from cell to cell. Viral progenies can move across extracellular space either as free particles via fluid phase diffusion, within vesicles, or by cell-cell contacts. To understand transmission, we will therefore address: (i) characteristics of the extracellular virus populations, (ii) whether multiple transmission routes exist (iii) whether the viral envelope is the primary determinant of transmissibility. This proposal builds on our previously published and ongoing studies on viral manipulation of autophagy for assembly and spread.', 'language': 'en'}, {'description': 'In this study we will determine how flaviviruses, in particular Dengue and Zika, which share significant similarities are transmitted between cells and spread into specific tissues. Dengue and Zika viruses have huge health implications - Dengue alone infects >50 million people worldwide annually; Zika is a closely related emerging virus that causes severe neurological damage in new-borns and adults. How they spread into specific organs in infected individuals is not understood. Our proposal aims to address this gap in knowledge. We will determine exactly how virus progeny particles are released from infected cells and transported into neighbouring recipient cells. We will identify the host genes that are involved in this process. We will also address which viral protein determines virus transmissibility. The mechanism of transmission of virus particles dictates spread, tissue tropism and pathogenesis. We will therefore add critical information on how to target this process and block disease progression.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6230-5366', 'authenticated-orcid': False, 'given': 'Sumana', 'family': 'Sanyal', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1567546.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2025, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1567546.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:53Z', 'timestamp': 1636383113000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220776'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:04Z', 'timestamp': 1636454644498}, 'publisher': 'Wellcome', 'award': '220008', 'DOI': '10.35802/220008', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Use of 'Axon-like' Nanofibers to quantify Glioblastoma cells migration\"}], 'project-description': [{'description': 'Background: Out of all brain tumours types in adults, Glioblastoma Multiforme (GBM) is the most common and aggressive. Migrating GBM cells infiltrate brain tissue by spreading along nerves and render therapeutical intervention and surgery problematic. Novel approaches are desperately needed to target these cells and that’s our focus. Approach: My project aims to mirror the internal conditions that a cancer cell ‘experiences’ in the human brain with artificial nerve-like substrates. We will first measure the capacity of GBM cells to migrate on human nerve fibres. Then we will investigate the relevant biological signals needed for GBM cells migration. Finally, we will mirror these signals with proteins and coat plastic material in the form of fibres acting as ‘fake-nerve’ tracks for cell migration. Impact: This artificial material will enable us to study how GBM cells differ from healthy cells and from patients to patients. This will be used for future screens to identify novel therapeutics by slowing down the migration of the GBM cells. Moreover, combined with existing catheters in clinical use, the fibres will form the basis for novel medical devices. They could act as a ‘decoy nerve trap’ to extract the infiltrating cancer cells for diagnostics and for therapies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0422-7371', 'authenticated-orcid': False, 'given': 'Victoria', 'family': 'Tsang', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:48Z', 'timestamp': 1636383408000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220008'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:38Z', 'timestamp': 1636454678186}, 'publisher': 'Wellcome', 'award': '220011', 'DOI': '10.35802/220011', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional Characterization of Jagged1 (Jag1) Expressing Skin-resident Regulatory T Cells (Tregs) in Epithelial Stem Cell Homeostasis'}], 'project-description': [{'description': 'Regulatory T-cells (Tregs) are famous for their immunosuppressive functions and induce tolerance. Only recently, we come to realise they can also function as stem cells regulators, and maintain tissue homeostasis1. Recently, our lab has demonstrated that skin Tregs are functionally required for hair regeneration, by regulating hair follicle stem cells (HFSCs) activity via Notch ligand Jagged1 (Jag1)3, irrespective of their well-known immunosuppressive role. Yet, the functional mechanisms of this skin Treg subset (Jag1+Tregs) remain laregely unknown. We seek to understand if Jag1+Tregs directly regulate HFSCs, via Jag1-induced Notch signalling. Since Notch signalling requires direct cell-cell contact, we first ask if Jag1 regulates skin Tregs physical proximity to Notch receptor-expressing cells (such as HFSCs) using immunofluorescence staining. By comparing the transcriptome profiles of Tregs and HFSCs from wildtype control against those from Jag1 conditional knockout model, we determine how Jag1+Tregs self-regulate and HFSCs function. Finally, using a combination of immunofluorescence staining and murine knockout models, we will define tissue-resident cells induce and maintain Jag1 expression in skin Tregs. This project will advance our understanding of how Jag1 facilitates immune-stem cells crosstal,k and subsequently regulates murine hair regeneration. It may reveal if skin-resident Tregs can be used as therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2562-5261', 'authenticated-orcid': False, 'given': 'Prudence', 'family': 'Lui', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:35Z', 'timestamp': 1636383335000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220011'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:40Z', 'timestamp': 1636454680055}, 'publisher': 'Wellcome', 'award': '222955', 'DOI': '10.35802/222955', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The genetic epidemiology of lung scarring'}], 'project-description': [{'description': 'Idiopathic Lung Fibrosis (IPF) is a disease which leads to death three years after diagnosis in half of cases. IPF is a complex genetic disease - variants of DNA that contribute to disease risk have been identified, though we have yet to fully understand how these risk factors lead to lung scarring. A Genome-Wide Association Study (GWAS) can be used to determine which regions of DNA are associated with disease. GWAS can be used to look at individual variant sites in the DNA called Single Nucleotide Polymorphisms (SNPs). By comparing the entire DNAs (Genomes) of people with and without IPF, we can narrow down the suspected sequences that may contribute to the development of the disease to very fine resolution. Once SNPs associated with IPF are identified, we then need to understand why they are associated. Determining which SNP leads to IPF requires 1) Linking SNPs to genes, 2) finding biochemical pathways associated with these genes, and 3) finding drugs that can be used to target the biochemical pathways. These steps enable us to understand the pathology of IPF and could lead to the identification of potential drug treatments for this currently incurable disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7349-895X', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Chin', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:47Z', 'timestamp': 1636383407000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222955'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:46Z', 'timestamp': 1636454686695}, 'publisher': 'Wellcome', 'award': '222911', 'DOI': '10.35802/222911', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Building positive self-concept in patients with psychosis: an interventionist-causal test.'}], 'project-description': [{'description': 'Building positive self-concept in patients with psychosis Background to the research problem Our self-concept is how we perceive ourselves. Lacking a positive self-concept is a putative contributory causal factor in mental health problems, including psychotic symptoms. Patients recognise its importance for recovery. Yet treatment is lacking. Our approach Our aim is to develop treatments that successfully target the key factors that underlie mental health problems. In this work, we will develop and test a treatment to build positive self-concept and hence reduce psychotic symptoms and improve wellbeing. We will work with people with lived experience of psychosis to develop a brief, manualised intervention. Drawing on psychological theory the treatment will 1) identify positive cognitions and generate evidence through in-vivo learning and meaningful activity; 2) strengthen cognitions via imagery; and, 3) shift attentional focus through savouring. We will use an adaptive-design to test which techniques are most effective. The 8-session intervention will be tested in a randomised trial with 80 patients. The comparator will be usual-care. Assessments will be conducted at baseline, mid-treatment, post-treatment, and follow-up. Expected impact of our work We will produce an effective treatment to increase positive self-concept. The intervention may be of benefit across mental health problems.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2749-1386', 'authenticated-orcid': False, 'given': 'Felicity', 'family': 'Waite', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:39Z', 'timestamp': 1636383399000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222911'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:48Z', 'timestamp': 1636454688969}, 'publisher': 'Wellcome', 'award': '048376', 'DOI': '10.35802/048376', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'characterisation of the polycystic disease 1 (PKD1) protien, polycys tin, and indentification of its ligands.'}], 'lead-investigator': [{'family': 'Ward', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 353997.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1996, 10, 1]]}, 'award-end': {'date-parts': [[2001, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 353997.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:40Z', 'timestamp': 1636383040000}, 'score': 0.0, 'issued': {'date-parts': [[1996, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048376'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:49Z', 'timestamp': 1636454689008}, 'publisher': 'Wellcome', 'award': '053347', 'DOI': '10.35802/053347', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of placenta growth factor (PIGF) in retinal neovascularisation.'}], 'lead-investigator': [{'given': 'Asif', 'family': 'Ahmed', 'affiliation': [{'name': 'Aston University', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Boulton', 'affiliation': [{'name': 'University Of Florida', 'country': 'US'}]}], 'award-amount': {'amount': 196231.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 8, 16]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 196231.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:50Z', 'timestamp': 1636382750000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 8, 16]]}, 'URL': 'http://dx.doi.org/10.35802/053347'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:48Z', 'timestamp': 1636454688993}, 'publisher': 'Wellcome', 'award': '052149', 'DOI': '10.35802/052149', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms of endosome to Golgi retrieval.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9916-3245', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Seaman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 350273.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 4, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 350273.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:04Z', 'timestamp': 1636382944000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/052149'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696325}, 'publisher': 'Wellcome', 'award': '060678', 'DOI': '10.35802/060678', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Plasmodium falciparum infected erythrocyte surafce antigens: characterisation of epitopes displayed by parasites causing severe malaria.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7674-6752', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Bull', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 218022.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 9, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 218022.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:38Z', 'timestamp': 1636382978000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060678'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696324}, 'publisher': 'Wellcome', 'award': '048066', 'DOI': '10.35802/048066', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'functional studies on human patients with visual dysfunction of corticol and retinal origin.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6754-5545', 'authenticated-orcid': False, 'given': 'Antony', 'family': 'Morland', 'affiliation': [{'name': 'University of York', 'country': 'GB'}]}], 'award-amount': {'amount': 306509.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 1, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 306509.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:45Z', 'timestamp': 1636382745000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048066'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696378}, 'publisher': 'Wellcome', 'award': '063717', 'DOI': '10.35802/063717', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of antiviral natural killer cells in atopic asthma.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7220-2555', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Openshaw', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3009-9200', 'authenticated-orcid': False, 'given': 'Sebastian', 'family': 'Johnston', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'family': 'Stanciu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 35504.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 35504.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:25Z', 'timestamp': 1636382905000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063717'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:59Z', 'timestamp': 1636454699687}, 'publisher': 'Wellcome', 'award': '063859', 'DOI': '10.35802/063859', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intracellular mechanisms underlying the interactions between nerve cells and eosinophils.'}], 'lead-investigator': [{'given': 'Richard', 'family': 'Costello', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}, {'family': 'Mclean', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 178927.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2003, 9, 26]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 178927.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:55Z', 'timestamp': 1636382995000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063859'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:59Z', 'timestamp': 1636454699678}, 'publisher': 'Wellcome', 'award': '066619', 'DOI': '10.35802/066619', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Study of clinical and molecular genetic pathogenesis of hypertrophic cardiomyopathy.'}], 'lead-investigator': [{'given': 'Edward', 'family': 'Blair', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 76185.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 15]]}, 'award-end': {'date-parts': [[2003, 10, 14]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 76185.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:19Z', 'timestamp': 1636382779000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 15]]}, 'URL': 'http://dx.doi.org/10.35802/066619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:00Z', 'timestamp': 1636454700341}, 'publisher': 'Wellcome', 'award': '066995', 'DOI': '10.35802/066995', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of the GTPase Rac-1 in pre-T cells.'}], 'lead-investigator': [{'family': 'Lightfoot', 'affiliation': [{'name': 'Cancer Research UK', 'country': 'GB'}]}], 'award-amount': {'amount': 110666.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2004, 6, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 110666.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:22Z', 'timestamp': 1636382902000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066995'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:02Z', 'timestamp': 1636454702312}, 'publisher': 'Wellcome', 'award': '067727', 'DOI': '10.35802/067727', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chimeraplast-medicated gene targeting in mouse embryos.'}], 'investigator': [{'given': 'James', 'family': 'Owen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Jonathan', 'family': 'Simons', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 125000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 16]]}, 'award-end': {'date-parts': [[2004, 9, 15]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 125000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:50Z', 'timestamp': 1636382870000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 16]]}, 'URL': 'http://dx.doi.org/10.35802/067727'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:03Z', 'timestamp': 1636454703633}, 'publisher': 'Wellcome', 'award': '206598', 'DOI': '10.35802/206598', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A cell culture model to find drugs that may be useful to treat dementia.'}], 'project-description': [{'description': 'I am an undergraduate Neuroscience Msci student studying at the University of Bristol. I am undergoing an industrial trainee year, with Alzheimer’s Research UK University College London drug discovery institute (AR-UK UCL DDI), as part of my course. The AR-UK UCL DDI is a newly established unit in UCL, with core funding from Alzheimer’s Research UK. Its goal is to discover new approaches and therapies for dementia, a core symptom of a number of important diseases (“neurodegenerative diseases” of the brain such as Alzheimer’s disease). With the increasing aging population these neurodegenerative diseases are becoming a huge individual, societal and economic problem. The AR-UK UCL DDI currently has 12 scientists and will increase to about 24, and is equipped to enable the scientific experiments and studies to be performed.My industrial trainee year with the AR-UK UCL DDI will allow me to experience neuroscience in the research setting with an opportunity to use techniques commonly used in the field. The placement will provide a very practical learning in a professional environment, challenging me both personally and academically. It will also expose me to the process of working towards developing new therapies. I will be able to develop my interpersonal skills alongside vital experience working in lab with experienced colleagues. I will take the confidence and skills built during the placement into my final year and in my future studies and career as I hope to do a PhD after my undergraduate course.Project details: Neurons are key cells of the brain. Synapses are the key points that neurons communicate to each other, and are thought to be the basis of learning and memory. In neurodegeneration the neurons and the synapses decrease in number and ability to function, leading to progressive memory loss, dementia and eventually, death. Therefore ways of protecting the neurons and synapses, and maintaining their function, could be useful therapeutic approaches. The project will involve growing neurons in a cell culture dish; it is possible to do this by obtaining the neurons from mouse brains. The neurons are able to form synapses in the culture dish, which mimic the synapses that would be naturally formed in the mouse brain. I will use these cultured neurons to develop ways of measuring the number of synapses. It will be possible to measure the number of synapses by using fluorescently tagged antibodies that bind specifically to neuronal proteins that localise to synapses, and then use microscopy to count the number of those synapses. Once I have set up this system, I will be able to add various small molecules (compounds) and drugs and identify any that are able to increase the number of the synapses. Such small molecules or drugs could be the starting point for developing new therapies for dementia.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4121-1379', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Whiting', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 7000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 3, 1]]}, 'award-end': {'date-parts': [[2017, 8, 1]]}, 'funding': [{'type': 'award', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 7000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:32Z', 'timestamp': 1636382972000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/206598'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:04Z', 'timestamp': 1636454704921}, 'publisher': 'Wellcome', 'award': '218462', 'DOI': '10.35802/218462', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Trust Doctoral Training Centre in Public Health, Economics and Decision Science (PHEDS): Assessing the effectiveness and cost-effectiveness of policies and prevention strategies that reduce noncommunicable disease burden and health inequity'}], 'project-description': [{'description': 'With ever scarcer resources for public health policies and programmes, high-quality scientific evidence on the cost-effectiveness and long-term benefits of alternative public health intervention options will become increasingly important for future decision-making. To our knowledge, PHEDS is one of just a handful of Doctoral Training Centres dedicated to Public Health Economics and Decision Science in the world. Wellcome Trust investment will allow us to grow, focus and strengthen ScHARR’s doctoral training in this area, broadening its scientific remit from health behaviours to also include research into the cost-effectiveness of policy options that address the social determinants of health (e.g. economic conditions, housing, employment) to reduce NCD and tackle health inequalities. Through the synergy of several cohorts of PhD researchers conducting cutting-edge research into these challenges at the same time with expert supervision, the programme aims to substantially increase the momentum of scientific discovery. Equipped with 4 years of experience in interdisciplinary collaborative working environments and with strong analytic skills, our graduates will be excellently placed to forge influential careers as leaders in academia and governmental and non-governmental organisations promoting evidence-based decisions about resource allocation in public health and tackling disease burden in the UK and beyond.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1486-8233', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Strong', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3691-1888', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Goyder', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1025-312X', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Brennan', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8467-0471', 'authenticated-orcid': False, 'given': 'Tracey', 'family': 'Bradburn', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'Penny', 'family': 'Breeze', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8024-7801', 'authenticated-orcid': False, 'given': 'Tessa', 'family': 'Peagood', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9283-2151', 'authenticated-orcid': False, 'given': 'John', 'family': 'Holmes', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-amount': {'amount': 5249785.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 5249785.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:04Z', 'timestamp': 1636383244000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218462'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:07Z', 'timestamp': 1636454707623}, 'publisher': 'Wellcome', 'award': '220071', 'DOI': '10.35802/220071', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The use of machine learning techniques to assess the quality of mammalian pre-implantation embryos'}], 'project-description': [{'description': 'The popularity of in vitro fertilisation (IVF) is growing with techniques improving over the last few decades. Nevertheless, current success rates remain low, which is partly due to difficulty in selecting the best embryos to be used, as we lack a comprehensive understanding of the visual attributes of a healthy embryo. The aim of this PhD is to develop techniques that will improve the chances of selecting a healthy embryo after IVF procedures, based on a video of the first 5 days of its life. We plan to achieve this using machine learning, an artificial intelligence approach that allows computers to learn from available data. We will follow two approaches; 1) attempt to predict the quality of a human embryo using videos provided by an IVF clinic, and 2) create mouse embryos with abnormalities in genetic material, record their development and develop an algorithm capable of identifying the reasons behind developmental failure from image / video data. If we can correctly predict the viability of an embryo and genetic issues impacting on this, it will pave the way for the development of improved detection and diagnosis systems to support human IVF treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0600-4526', 'authenticated-orcid': False, 'given': 'Camilla', 'family': 'Mapstone', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:20Z', 'timestamp': 1636383440000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220071'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:09Z', 'timestamp': 1636454709610}, 'publisher': 'Wellcome', 'award': '220260', 'DOI': '10.35802/220260', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Towards a thorough mechanistic understanding of endosomal cargo sorting.'}], 'project-description': [{'description': 'An intracellular nexus for regulating the membrane trafficking of many of the 5,000+ integral proteins encoded by the human genome is the endosomal network. Composed of vesicular and tubular early and late endosomes, the network’s principal role is to sort integral proteins (termed ‘cargoes’) arriving from the cell surface and the biosynthetic pathway between two fates: either sorting to the lysosome for degradation, or retrieval from this fate for export to the cell surface, the biosynthetic pathway or other specialised organelles. Whilst the molecular details of degradative cargo sorting have been well documented, those events that conduct cargo retrieval and export remain poorly understood. Our research has sought to fill this fundamental void in metazoan cell biology. A master conductor of endosomal retrieval and export is the retromer pathway - in human cells this orchestrates the sorting of >900 cargoes. Establishing how this pathway functions is central to understanding the evolution, organisation and activity of endosomal sorting. With Wellcome support we will address two integrated questions: - The fundamental question of how the retromer pathway is organised and integrated with other pathways to orchestrate global endosomal cargo sorting. - How understanding of retromer pathway function may provide vital insight into neurodegenerative diseases.', 'language': 'en'}, {'description': \"For over ten years my laboratory has been identifying the mechanistic basis by which proteins and lipids are sorted through a specific aspect of the human cell's intracellular membraneous maze, the endosomal network. We have studied a number of ancient, highly conserved protein complexes that act as molecular machines to orchestrate protein and lipid transport through this network. One of these is the retromer complex. Our research, and that of others, is defining retromer function and is revealing its importance in a variety of cellular processes that are vital for normal cell function. Furthermore, it has become apparent that defects in retromer underlie a variety of human diseases including age-related neurodegenerative diseases such as Parkinson disease and Alzheimer disease. With Wellcome funding we will address new fundamental questions arising from this research, thereby providing greater fundamental insight into retromer's many roles in normal physiology and its deregulation in pathophysiology.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1914685.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2025, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1914685.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:39Z', 'timestamp': 1636383099000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220260'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:14Z', 'timestamp': 1636454714232}, 'publisher': 'Wellcome', 'award': '220514', 'DOI': '10.35802/220514', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Proof-of-Concept for α5-GABAAR PAMs in the treatment of psychosis'}], 'project-description': [{'description': 'This project aims to validate the hypothesis that a small molecule that is a positive allosteric modulator (PAM) of α5-subunit-containing GABAARs (α5-GABAARs) can attenuate striatal dopaminergic hyperfunction in the methylazoxymethanol (MAM) rat model of schizophrenia. If successful, this project will then form the platform to secure additional funding for the further preclinical drug discovery and development activities required to identify a first-in-human-ready drug. At that point, we will seek the additional funding (either by partnering with a pharma company or securing VC investment to form a spin-out company) required for the clinical development of a novel, first-in-class antipsychotic with a mechanism that is clearly differentiated from existing dopamine D2 receptor antagonist-based antipsychotics. Such a drug is expected to deliver patient benefit for those individuals with psychoses in whom existing antipsychotics are either poorly tolerated and/or have significant side effects or have limited efficacy.', 'language': 'en'}, {'description': 'Recent evidence suggests that a part of the brain called the hippocampus is responsible for the increase in dopamine in a different part of the brain, the striatum, known to cause psychosis. Our hypothesis is that by attenuating activity within the hippocampus, we will then be able to reduce the increase in dopamine associated with psychosis. In order to do this, we plan to target the GABA chemical signalling pathway which inhibitis nerve cell excitability. More specifically, we aim to increase the inhibitory actions of the so-called α5-GABAAR protein, which is highly expressed within the hippocampus and is therefore ideally placed to control overall hippocampal activity. In this proposal, we will identify molecules that selectively enhance the function of GABA at α5-GABAARs and then test representative compounds in an animal model of schizophrenia to see if they do indeed attenuate increased dopamine activity.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-4204-3602', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Lambert', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8745-8377', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Ward', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1067-1230', 'authenticated-orcid': False, 'given': 'Olivera', 'family': 'Grubisha', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3410-791X', 'authenticated-orcid': False, 'given': 'John', 'family': 'Atack', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 500971.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 500971.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:47Z', 'timestamp': 1636383107000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220514'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:15Z', 'timestamp': 1636454715236}, 'publisher': 'Wellcome', 'award': '222546', 'DOI': '10.35802/222546', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Unravelling the whipworm niche at the host intestinal epithelia'}], 'project-description': [{'description': 'Whipworms infect hundreds of millions of people causing trichuriasis, a major neglected disease. Whipworms are large metazoan parasites that inhabit a multi-intracellular niche within their host caecal epithelia, where they manipulate mucosal physiology and inflammation through interactions with the intestinal epithelial cells and stem cell niche. These interactions enable chronic infections where whipworms are tolerated for years; but at a mechanistic level, how they operate is not understood. My research aims to define these interactions and bring a mechanistic understanding to how they underpin whipworm invasion, colonisation and persistence in their mucosal niche. This work will build upon a novel model I developed using caecal organoids (termed caecaloids), the first to reproduce whipworm infections in vitro, to address two fundamental aims. First, to determine how whipworms invade and colonise intestinal epithelia using imaging and transcriptomic analyses of infected caecaloids. Second, to define how whipworms impact stem cell niche remodelling to promote their persistence using microscopy, FACS and transcriptomics of infected caecaloids and chronically-infected mice. This research will transform our understanding of the whipworm mucosal niche potentially yielding new targets for anti-parasitic therapies, and provide novel insights into how the intestinal epithelia repairs damage with relevant application toward intestinal inflammatory diseases.', 'language': 'en'}, {'description': 'Whipworms are parasites that live inside the gut lining of 500 million people worldwide causing the disease Trichuriasis. Whipworms remain in their host for years by interacting with the gut lining and surrounding cells to manipulate gut structure and immune responses. How the parasite mediates these interactions is not understood. I aim to determine how whipworms invade, colonise and persist in the gut. Using a new model I developed based on “mini-guts”, the first to mimic whipworm infections in a lab dish, together with microscopy and sequencing, I will characterise: 1) the molecular and cellular changes that happen in the whipworm and the gut lining and surrounding cells when the parasite enters and colonises the gut and; 2) the interactions that allow the parasite to persist and the gut lining to repair during chronic infections. This knowledge will open new avenues to eradicate whipworm infections and control gut inflammatory diseases.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9581-0377', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Berriman', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0567-0412', 'authenticated-orcid': False, 'given': 'Maria', 'family': 'Duque Correa', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 1176163.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 1, 10]]}, 'award-end': {'date-parts': [[2027, 1, 9]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 1176163.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:41Z', 'timestamp': 1636383521000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 1, 10]]}, 'URL': 'http://dx.doi.org/10.35802/222546'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:05Z', 'timestamp': 1636460045486}, 'publisher': 'Wellcome', 'award': '035783', 'DOI': '10.35802/035783', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'For a study of the molecular basis of Salmonella virulence.'}], 'lead-investigator': [{'given': 'Gordon', 'family': 'Dougan', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1643264.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1992, 9, 1]]}, 'award-end': {'date-parts': [[2002, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1643264.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:23Z', 'timestamp': 1636382843000}, 'score': 0.0, 'issued': {'date-parts': [[1992, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/035783'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:07Z', 'timestamp': 1636460047571}, 'publisher': 'Wellcome', 'award': '051008', 'DOI': '10.35802/051008', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of WNT factors in developing neurons.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5748-083X', 'authenticated-orcid': False, 'given': 'Patricia', 'family': 'Salinas', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 241262.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2002, 3, 14]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 241262.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:30Z', 'timestamp': 1636382970000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051008'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:09Z', 'timestamp': 1636460049452}, 'publisher': 'Wellcome', 'award': '220887', 'DOI': '10.35802/220887', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rhomboid-like proteins: from molecular principles to pathophysiological significance'}], 'project-description': [{'description': 'The goal of this proposal is to transform our understanding of both the molecular mechanisms and the pathophysiological roles of members of the rhomboid-like superfamily. At the mechanistic level, our long-term research into this group of polytopic membrane proteins has led us to the hypothesis that the core function of the rhomboid-like domain is specific TMD recognition of substrates (of the rhomboid intramembrane serine proteases) and clients (of the non-protease members of the clan). Using a structural and biochemical approach, we seek to understand the molecular details of how this specific recognition is achieved. Biologically, rhomboid-like proteins have many functions, but we still have little understanding of their role in mammals, particularly of the rhomboid proteases. Building on our mechanistic aims, we plan to break this log-jam by pioneering systematic methods of substrate identification. We already know that iRhoms, catalytically inactive homologues of rhomboids, regulate inflammation, growth factor signalling and, as we have recently discovered, tumour growth. We plan to further elucidate these roles, both at the level of fundamental cell biology but also with a goal to reveal their potential medical significance. By the end of this work we expect to know which rhomboid-like proteins are useful therapeutic targets.', 'language': 'en'}, {'description': 'Cells are the fundamental unit which form all organisms. They are responsible for how animals work, and their malfunction underlies almost all human disease. Our overall goal is to understand the molecular details of how cells communicate with each other, and how this signalling controls their behaviour. We focus on the rhomboid-like family of proteins, which we discovered. Our discovery was important because these proteins are present in all organisms. Since then we have researched how they work and their biological role in cell communication – both as a basic biological problem but also because there is good evidence that they are relevant to a wide range of human diseases. In this proposal we aim to answer questions about both their fundamental biology and their medical relevance, with a particular goal of transforming our understanding of rhomboid-like proteins in mammals, including humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0410-5451', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Freeman', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2276736.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2025, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 2276736.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:57Z', 'timestamp': 1636383117000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220887'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:15Z', 'timestamp': 1636460055056}, 'publisher': 'Wellcome', 'award': '213542', 'DOI': '10.35802/213542', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Advancing Implementation of Market Incentives for Antimicrobials'}], 'project-description': [{'description': 'To help facilitate progress on a path to implementation and global coordination of promising market entry rewards, such as the PAVE Award, or other incentive models, Duke-Margolis proposes to advance the conversations and develop implementation approaches. This project has three primary goals: 1) to develop and refine technical details for incentive models, such as the PAVE Award, needed for implementation in the United States (US) market, 2) to identify broader options to support the sustainability of such reward models, and 3) to support development of principles and approaches for global coordination.', 'language': 'en'}], 'lead-investigator': [{'given': 'Gregory', 'family': 'Daniel', 'affiliation': [{'name': 'Duke University', 'country': 'US'}]}], 'award-amount': {'amount': 302591.94, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 8, 1]]}, 'award-end': {'date-parts': [[2020, 2, 1]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 302591.94, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:31Z', 'timestamp': 1636382851000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213542'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058410}, 'publisher': 'Wellcome', 'award': '060263', 'DOI': '10.35802/060263', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Adaptive control in the respiratory system: implications for understanding long-term regulation of basal ventilation and the sensitivity of the chemoreflexes.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Robbins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 498964.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 498964.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:41Z', 'timestamp': 1636382981000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060263'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058419}, 'publisher': 'Wellcome', 'award': '060686', 'DOI': '10.35802/060686', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms of Pelizaeus-Merzbacher disease caused by dosage effects of the PLP gene.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Scambler', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 166747.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 7]]}, 'award-end': {'date-parts': [[2004, 10, 6]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 166747.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:31Z', 'timestamp': 1636382971000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 7]]}, 'URL': 'http://dx.doi.org/10.35802/060686'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058433}, 'publisher': 'Wellcome', 'award': '060492', 'DOI': '10.35802/060492', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Sequencing the genome of the human gastrointestinal pathogen Yersinia enterocloitica 8081 (serotype 0:8 biotype IB).'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1117-2388', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Prentice', 'affiliation': [{'name': 'University College Cork', 'country': 'IE'}]}], 'lead-investigator': [{'given': 'Barclay', 'family': 'Barrell', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 393752.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 393752.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:00Z', 'timestamp': 1636382760000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060492'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058447}, 'publisher': 'Wellcome', 'award': '060551', 'DOI': '10.35802/060551', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Signal transduction mechanisms in the regulation of cyclooxygenase-2 expression in human myometrium.'}], 'investigator': [{'given': 'Giovanni', 'family': 'Mann', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Phillip', 'family': 'Bennett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Simon', 'family': 'Bartlett', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 174090.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 174090.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:27Z', 'timestamp': 1636382847000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060551'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058767}, 'publisher': 'Wellcome', 'award': '071922', 'DOI': '10.35802/071922', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Towards revealling new metabolic pathways involved in neuronal maintenance: a Drosophila model for infantile onset.'}], 'project-description': [{'description': 'Many hereditary human neurological disorders result from progressive degeneration of specific neuronal subpopulations. Identifying single gene and thereafter protein defects in them forms the basis for modelling the disease mechanisms in experimental organisms, in turn providing clues of molecular backgrounds leading to pathogenic states. Studying the consequences of disease-causing mutations in molecular, cellular and tissue levels in animal models thus improves our basic understanding on the function of the nervous system and on the pathogenesis of the disorders in question, and finally is expected to reveal new therapeutic targets. The major aim of this research work is to identify molecular and cellular mechanisms involved in neuronal development and maintenance, by studying a gene defective in a severe recessive human neurodegenerative disease, infantile onset spinocerebellar ataxia (IOSCA; MIM 271245). Recently , we have cloned the human gene mutated in IOSCA, based on its location in the human genome. The human IOSCA gene codes for a protein with a putative role in the mitochondrial function. It has been highly conserved during evolution, reflecting the fact that the gene and the protein it encodes play an important role in the maintenance of specific neuronal cells. For revealing the basic cellular roles of the gene and the protein it encodes, and the functional consequences of the major IOSCA mutation, the gene function should now be modelled in the fruit fly Drosophila melanogaster, currently an organism of choice in neuronal research. The fly being a multicellular organism with the genome thoroughly sequenced, the knowledge obtained from fly models is easily applied for studying the gene and protein in higher organisms also.', 'language': 'en'}], 'lead-investigator': [{'given': 'Anna-Kaisu', 'family': 'Nikali', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 67989.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 1, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 67989.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:16Z', 'timestamp': 1636382896000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071922'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058823}, 'publisher': 'Wellcome', 'award': '215309', 'DOI': '10.35802/215309', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the function of intraepithelial lymphocytes (IEL) in the small intestine'}], 'project-description': [{'description': 'Intraepithelial lymphocytes (IEL) are a highly specialised, diverse group of T lymphocytes residing in the intestinal epithelium. Evidence suggests that they are important in early protection against foodborne pathogens, however the exact function of IEL remains incompletely understood. I will use a novel mouse model that allows for inducible deletion of all IEL subsets from the small intestine, which has not been possible to date. We will then challenge these IEL-depleted mice with oral infections to dissect the importance of IEL in protection against such infections. These studies will give us a clearer understanding of the mechanisms of IEL activation and function in the gut. In addition to serving as an immunological barrier against pathogens, IEL may also be directly or indirectly regulated by dietary composition such as fat, fibre and starch. Evidence suggests that crucial immune-relevant molecules that are necessary for maintaining IEL are missing from research diets and therefore the role of IEL in obesity and metabolic research may be underestimated. I will use highly defined research diets to explore diet-induced effects on IEL function and composition in the gut, allowing me to address how these cells contribute to metabolic and obesity-related disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4294-7855', 'authenticated-orcid': False, 'given': 'Olivia', 'family': 'James', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2022, 3, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:53Z', 'timestamp': 1636383233000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/215309'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:20Z', 'timestamp': 1636460060014}, 'publisher': 'Wellcome', 'award': '220218', 'DOI': '10.35802/220218', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Ivermectin Safety in Small Children'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4807-9681', 'authenticated-orcid': False, 'given': 'Kevin', 'family': 'Kobylinski', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 510000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2023, 4, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 510000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:37Z', 'timestamp': 1636383097000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220218'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:45Z', 'timestamp': 1636460025354}, 'publisher': 'Wellcome', 'award': '097827', 'DOI': '10.35802/097827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Institutional Strategic Support Fund 2011/12.'}], 'project-description': [{'description': '- Capacity building through our investment in people, supporting our very best non-clinical and clinical post-doctoral fellows through transition funding - Interdisciplinary secondments through discipline-hopping schemes that will cross between Universities and industry or medical technology partners - Underpinning resource to maximize opportunities around our recent successes in capital infrastructure funding where support staff with core skills are essential for success - Patient and Public Engagement activity in Biomedical research and Medical Humanities, the latter part of the University’s new broad commitment to incorporating Arts/Humanities and Social Sciences within medical research', 'language': 'en'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Arthur', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1500000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2011, 10, 1]]}, 'award-end': {'date-parts': [[2016, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 1500000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:46Z', 'timestamp': 1636382986000}, 'score': 0.0, 'issued': {'date-parts': [[2011, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/097827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:45Z', 'timestamp': 1636460025402}, 'publisher': 'Wellcome', 'award': '062204', 'DOI': '10.35802/062204', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dynamics of ionotropic glutamate receptor subunits expression in organotypic hippocampal slice cultures.'}], 'lead-investigator': [{'given': 'Cezar', 'family': 'Tigaret', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 48030.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2001, 7, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 48030.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:16Z', 'timestamp': 1636382776000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062204'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:46Z', 'timestamp': 1636460026331}, 'publisher': 'Wellcome', 'award': '060588', 'DOI': '10.35802/060588', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Role of B-cells in the modulation of T-cell dependent acquired resistance of salmonella infections.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3838-4962', 'authenticated-orcid': False, 'given': 'Pietro', 'family': 'Mastroeni', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 196068.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 196068.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:45Z', 'timestamp': 1636382985000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060588'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027646}, 'publisher': 'Wellcome', 'award': '221521', 'DOI': '10.35802/221521', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Expanding the proteomics and establishing top-down capabilities for the UCL Mass Spectrometry Science Technology Platform.'}], 'project-description': [{'description': 'The requested equipment is the ThermoFisher Orbitrap Eclipse Tribrid Mass Spectrometer with an Ultimate3000 LC system. This new instrument is designed for high-end proteomics, top-down protein characterisation, and crosslinking analysis and is equipped with the latest Orbitrap analyser, which offers higher resolution, sensitivity and acquisition rates compared to previous Orbitraps. These features result in improvements to both limit of detection and quantification of peptides, ultimately leading to enhanced quantitative proteomics and crosslinking analysis. Its atypical geometry allows multistage fragmentation of ions (MSn), which is necessary for multiplexed proteomics experiments and for advanced crosslinking analyses using cleavable crosslinkers. Combined with a novel in-built real-time search algorithm, fragment ions of interest e.g. crosslinked peptides can be preferentially selected, further increasing the depth of analysis. The Eclipse is also capable of top-down proteomics experiments which is an ideal method for the study of proteoforms and labile post-translational modifications. We will use the Eclipse to study the biological processes underpinning viral secondary envelopment, type 2 diabetes, cell responses to protein misfolding and cell competition; these studies are challenging due to the low amounts of sample available. The sensitivity and robustness in protein quantitation provided by the requested instrument will be key for their success.', 'language': 'en'}, {'description': 'Proteins are a crucial class of biomolecules which carry out most of the essential functions within our cells. The amount of each protein, how they interact with other proteins, and whether they are modified, comprises important information that enable us to understand how cells and organisms work and how perturbation in any of these can lead to disease. Mass spectrometry is one of the best methods to study proteins, their interactions and modifications. Improvements in mass spectrometry instrumentation, namely speed, selectivity and sensitivity, will allow us to study more proteins than ever before. We propose to purchase the latest such mass spectrometry instrument, Orbitrap Eclipse, capable of such analyses. We will use it to increase our understanding of several pathologies such as Huntington’s disease, neuropathies as well as fundamental biological processes such as cell competition and protein trafficking between cells.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-6429-654X', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Cheetham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4319-8745', 'authenticated-orcid': False, 'given': 'Giampietro', 'family': 'Schiavo', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2716-2045', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Tabrizi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-3248-7493', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Raleigh', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-1334-9258', 'authenticated-orcid': False, 'given': 'Frances', 'family': 'Brodsky', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-0558-3597', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Lowe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5072-8428', 'authenticated-orcid': False, 'given': 'Konstantinos', 'family': 'Thalassinos', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 674756.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'equipment', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 674756.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:06Z', 'timestamp': 1636383126000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221521'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027627}, 'publisher': 'Wellcome', 'award': '220463', 'DOI': '10.35802/220463', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Artificial intelligence for rapid epidemic analysis'}], 'project-description': [{'description': 'The aim of this fellowship is to accelerate detection of and response to infectious disease outbreaks, particularly where surveillance, diagnosis, and control are under-resourced. My first goal is to develop and validate machine learning methods to rapidly infer outbreak properties. I have demonstrated proof-of-concept for this approach, and I expect to be able to train machine learning models on synthetic outbreak data to infer outbreak properties almost instantaneously from data. By building on this approach, understanding its validity and weaknesses from application to historical data, and creating a database of simulations and trained models, I hope to allow outbreak data to be interpreted more quickly and simply than currently possible. My second goal is to complete and test—first against historical data and then prospectively—algorithms for aetiological identification of outbreaks. These algorithms have the potential to allow outbreaks to be detected and controlled faster, as well as to improve guidelines for syndromic surveillance. Finally, I plan to integrate these analytics for outbreak identification and analysis into lightweight software tools. After testing them in collaboration with field epidemiologists, I hope to enable public health officials to take advantage of epidemiological insights with minimal training, supporting capacity of public health systems.', 'language': 'en'}, {'description': 'Early detection of infectious disease outbreaks can prevent small clusters of cases from becoming costly epidemics. However, many under-resourced health systems lack adequate capacity for rapid laboratory diagnosis, especially for rare and emerging diseases. Instead, many outbreaks are only identified based on symptoms and only fully verified after many months. Furthermore, analytical tools to track and forecast outbreaks are rarely fit for use in low-resource settings. I will develop analytical methods and tools to help identify outbreak causes and respond to outbreaks more quickly and effectively, including by combining public health and data science approaches to rapidly predict the causes and properties of infectious disease outbreaks. Over the course of this fellowship, I will develop these methods, validate them against historical outbreak data, and finally build and field test software tools to be used by public health officials, empowering them to control outbreaks locally without international outbreak responses.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0258-3188', 'authenticated-orcid': False, 'given': 'James', 'family': 'Wood', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2842-3406', 'authenticated-orcid': False, 'given': 'Sebastian', 'family': 'Funk', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9540-1998', 'authenticated-orcid': False, 'given': 'Emma', 'family': 'Glennon', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:45Z', 'timestamp': 1636383105000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220463'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027637}, 'publisher': 'Wellcome', 'award': '068693', 'DOI': '10.35802/068693', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the costs of a symposium entitled \"Workshop on function and dysfunction in the basal ganglia\" to be held at the Institute of Neurology, University College London on 3rd October 2002.'}], 'project-description': [{'description': \"Workshop on function and dysfunction in the basal ganglia, Institute of Neurology, University College London, 3rd October 2002. Findings from basic research into the basal ganglia have proved critical in informing and directing clinical research and practice as exemplified by the development in animal models of a new target for the neurosurgical treatment of Parkinson's disease, -the subthalamic nucleus. Conversely, studies of patients operated in the basal ganglia may provide unique information about the functions of these nuclei in humans. Examples are the direct recording of the basal ganglia activity or clinical observations of the motor and non-motor effects of surgical procedures. This research field is also very fast moving. It is therefore essential for clinicians working and researching in the field of functional neurosurgery and basic scientists working on the basal ganglia of animals to meet the exchange information. The format of this meeting, with a small group of people from various backgrounds, will allow informal and interactive discussion. The overall aim is to provide a forum for integrating findings from basic science and clinical investigation related to basal ganglia function and dysfunction. The following topics will be covered: Recordings from basal ganglia in animals and humans Teaching signals and information processing in the basal ganglia networks of normal and Parkinsonian primates (Prof H Bergman, Israel), Movement related activity in the human basal ganglia (Dr P Brown, London). Functional localisation within the basal ganglia (Prof P Bolam, Oxford). Surgical target localisation of basal ganglia targets in the human Localising functional targets for deep brain stimulation in the basal ganglia (Dr J Yelnik, Paris). Imaging the basal ganglia (Prof T Yousry, London) Function and dysfunction of surgical navigations within the basal ganglia, lessons from the literature (Prof M Hariz, Umea, London). Functions of the basal ganglia Interactions between basal ganglia and frontal cortex (Prof D Passingham, Oxford) Role of basal ganglia in reward processes (Prof W Schultz, Cambridge) Effects of STN lesions in rats (Prof T Robins, Cambridge) Effects of STN stimulation on motor, cognitive and limbic loops in Parkinsonian patients (Dr P Dowsey-Limousin, London).\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5201-3044', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Brown', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:38Z', 'timestamp': 1636382978000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068693'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027809}, 'publisher': 'Wellcome', 'award': '060122', 'DOI': '10.35802/060122', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification of imprinted genes on human chromosome 7.'}], 'investigator': [{'given': 'Philip', 'family': 'Stanier', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2099-3420', 'authenticated-orcid': False, 'given': 'Gudrun', 'family': 'Moore', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 176233.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 9, 4]]}, 'award-end': {'date-parts': [[2004, 5, 3]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 176233.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:32Z', 'timestamp': 1636382852000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/060122'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028003}, 'publisher': 'Wellcome', 'award': '215240', 'DOI': '10.35802/215240', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Forecasting the spread of antibiotic resistance, and targeting public health interventions to counter it'}], 'project-description': [{'description': 'Throughout the 1900s many different varieties of antibiotics, which are used to treat infections with bacteria, were created. However, following the introduction of each antibiotic class, bacteria which were resistant to treatment with that antibiotic emerged. Currently, the prevalence of antibiotic resistant bacteria is increasing rapidly and very few new antibiotics are being produced. The Philippines has a sophisticated surveillance programme for monitoring the spread of antibiotic resistance. The objective of this project is to use data collected by the Filipino Antimicrobial Resistance Surveillance Programme (ARSP) to make predictions about how antibiotic resistance will spread in the future in the country. I will begin by applying techniques developed for economic forecasting to these data and then incorporate data describing the usage of antibiotics in the Philippines to refine my estimates of the future spread of antibiotic resistance. Finally, I will construct a mathematical model of bacterial evolution and use this to experiment with different interventions that could limit the predicted spread of antibiotic resistance. The Sanger Institute is also involved in developing similar surveillance programmes in Colombia, Nigeria and India, and where possible I will test my methods on data from these projects as well.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5757-3278', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Jeffrey', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 10, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:48Z', 'timestamp': 1636383228000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215240'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028410}, 'publisher': 'Wellcome', 'award': '067784', 'DOI': '10.35802/067784', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Symposium entitled 'Australasian Thalassaemia Workshop' to be held in Perth, Australia, 21-22 March 2002.\"}], 'lead-investigator': [{'given': 'Wendy', 'family': 'Erber', 'affiliation': [{'name': 'University of Western Australia', 'country': 'AU'}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 21]]}, 'award-end': {'date-parts': [[2002, 4, 20]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:41Z', 'timestamp': 1636383041000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 21]]}, 'URL': 'http://dx.doi.org/10.35802/067784'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028456}, 'publisher': 'Wellcome', 'award': '204017', 'DOI': '10.35802/204017', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'University of Cambridge PhD Programme for Clinicians'}], 'project-description': [{'description': 'This programme recruits clinicians of outstanding calibre nationwide. With the largest concentration of biomedical science in Europe in laboratories on the Campus or wider Cambridge, we offer research training of highest quality that spans the spectrum from basic science through experimental medicine to epidemiology and public health. Strong, ongoing, mentorship is central to our programme; this, coupled with carefully chosen placements in laboratories empowers fellows to make better-informed choices of research and supervisor, including interdisciplinary projects. During PhD training, we aim to maximise their potential to acquire research skills and achieve a doctorate linked to significant discoveries and publications. With continued, intensive, guidance postdoctorally via established mechanisms, we guide fellows into pathways (e.g. higher research fellowships, clinical lecturer posts) that are tailored to individual progress, balancing re-entry into clinical training with maintaining research momentum. Our vision is to strengthen and broaden this model to include fellowships at veterinary and MBPhD level; and, in partnership with the University of East Anglia, extend opportunities to trainees throughout the region and add research diversity with a new theme in Gastroenterology, Nutrition and Microbiology. The longterm aim of the programme is to produce the next generation of clinical academics.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9383-1054', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Lehner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2654-8854', 'authenticated-orcid': False, 'given': 'Krishna', 'family': 'Chatterjee', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 11175030.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 8, 1]]}, 'award-end': {'date-parts': [[2024, 8, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 6397500.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:41Z', 'timestamp': 1636383221000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/204017'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028646}, 'publisher': 'Wellcome', 'award': '059924', 'DOI': '10.35802/059924', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular Initiative - 4 year PhD programme.'}], 'lead-investigator': [{'given': 'David', 'family': \"O'Regan\", 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 111615.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 111615.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:00Z', 'timestamp': 1636383180000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059924'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029031}, 'publisher': 'Wellcome', 'award': '102161', 'DOI': '10.35802/102161', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'OXION - Membrane Transport in Health and Disease'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6970-1767', 'authenticated-orcid': False, 'given': 'Frances', 'family': 'Ashcroft', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8996-2000', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Tucker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2383719.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2014, 10, 1]]}, 'award-end': {'date-parts': [[2023, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 2228000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:38Z', 'timestamp': 1636383218000}, 'score': 0.0, 'issued': {'date-parts': [[2014, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/102161'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029207}, 'publisher': 'Wellcome', 'award': '221647', 'DOI': '10.35802/221647', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intravital imaging as a platform for screening checkpoint and focal adhesion kinase inhibitors as potential treatment for cancer metastasis'}], 'project-description': [{'description': 'Despite new developments in treatment, cancer remains the second leading cause of death worldwide. Breast cancer is the most common cancer within the UK, with death generally caused by the formation of metastasis. I intend to investigate the hypothesis that immune responses at the metastatic site determine the long-term outcome of therapy. I will compare immune responses at the primary and metastatic sites upon administration of checkpoint inhibitors that have different clinical success rates. Flow cytometry and t-SNE analysis will provide insight into the affected cell populations and timings. I will then utilise newly developed intravital imaging technologies to visualise immune responses in vivo at multiple cancer sites. I will measure cytotoxic cell activity and tumour cell death as indicators for anti-cancer response. Further, I will examine the ability of a combination of checkpoint inhibitor and focal adhesion kinase inhibitor to fully eradicate tumour cells. An inhibitor will be fluorescently tagged to study its access to tissue and interaction with immune cells dependent on combination therapy. The proposed research will help to elucidate the role of immunotherapy on the metastatic foci and will provide the first insights into the benefit and limitations of combination therapy on secondary site immune responses.', 'language': 'en'}, {'description': 'One in six lives are cut short by cancer, with approximately 90% of mortality caused by spreading of the tumour, also called metastasis. I propose to investigate whether cells from our immune system found in secondary tumours contribute to the efficacy of drugs used in breast cancer patients. I will utilise newly developed techniques to visualise how immune cells function in living animal models of breast cancer, and will compare the efficacy of drugs in primary and secondary tumours. I will measure the anti-tumour activity of immune cells as well as how well they bind to tumour cells. Further, I will investigate how therapies that use more than one drug simultaneously act to eradicate metastatic tumours, studying how clinical treatments enter the metastatic site and fulfil their role. My studies will provide insight into the limitations of current therapies to support the design of new, more effective therapies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7778-8794', 'authenticated-orcid': False, 'given': 'Valerie', 'family': 'Brunton', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0422-7264', 'authenticated-orcid': False, 'given': 'David', 'family': 'Entenberg', 'affiliation': [{'name': 'Albert Einstein College Of Medicine', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0605-4582', 'authenticated-orcid': False, 'given': 'Nicole', 'family': 'Barth', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 1]]}, 'award-end': {'date-parts': [[2025, 4, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:13Z', 'timestamp': 1636383133000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221647'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029226}, 'publisher': 'Wellcome', 'award': '215149', 'DOI': '10.35802/215149', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Viral infection and immunomodulation: The implications on ageing, viral serostatus, and vaccine efficacy'}], 'project-description': [{'description': 'Cytomegalovirus (CMV) is a persistent, lifelong infection that is prevalent in 60-100% individuals. CMV infection usually doesn’t cause disease, although can cause serious illness in people with a weakened immune system. Recent research suggests that CMV infection and age reduce vaccine efficacy, and that vaccine trials conducted in Africa show diminished immune responses because of a higher burden of CMV infection. Although this correlation has been identified, there is no mechanism to explain this phenomenon. My project will investigate how CMV infection affects how vaccines work. I will begin by looking at natural killer (NK) cells, of which certain populations are known to expand during CMV infection. This will be conducted in vaccine trial samples from different age categories and worldwide locations. I will also research the immunology of how CMV reduces vaccine efficacy. This will involve infecting mice with murine CMV to develop a model of CMV-associated immune phenotypes in response to vaccination. I will also create an MVA-vectored vaccine that has CMV-like properties. This will aim to use features of CMV that induce non-canonically-restricted T cells. This research will further our understanding into improving vaccine efficacy, and how latent infections reduce vaccine responses.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1194-2429', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Sharpe', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 2]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:16Z', 'timestamp': 1636383376000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/215149'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:44Z', 'timestamp': 1636460024836}, 'publisher': 'Wellcome', 'award': '054525', 'DOI': '10.35802/054525', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular basis of cell behaviour during Drosophila segmentation.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2782-4195', 'authenticated-orcid': False, 'given': 'Bénédicte', 'family': 'Sanson', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 494021.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 11, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 494021.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:07Z', 'timestamp': 1636382767000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054525'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028559}, 'publisher': 'Wellcome', 'award': '060352', 'DOI': '10.35802/060352', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The origin of signals transferred through gap junctions during mechanotransduction in tendon cell structures.'}], 'investigator': [{'family': 'Benjamin', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'family': 'Ralphs', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 167088.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 167088.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:02Z', 'timestamp': 1636382762000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060352'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028594}, 'publisher': 'Wellcome', 'award': '081392', 'DOI': '10.35802/081392', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'VALUE IN PEOPLE AWARD.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Arthur', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2006, 10, 1]]}, 'award-end': {'date-parts': [[2007, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:48Z', 'timestamp': 1636382988000}, 'score': 0.0, 'issued': {'date-parts': [[2006, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/081392'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:52Z', 'timestamp': 1636460032428}, 'publisher': 'Wellcome', 'award': '222425', 'DOI': '10.35802/222425', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of Genomic instability and R-Loops in treatment resistance of HPV positive and HPV negative Oropharyngeal Squamous Cell Carcinoma (OPSCC).'}], 'project-description': [{'description': 'Throat cancer, also known as oropharyngeal cancer, is a common type of cancer that has increased in prevalence over the last few decades. There are two forms of this type of cancer, one associated with a viral infection known as Human Papilloma Virus (shortened to HPV-positive) and one that shows no association with this virus (HPV-negative). HPV-negative cancer typically has a poorer response to treatment compared to HPV-positive cancer, however, there are also reports of patients with HPV-positive cancer whose cancer returns after treatment. All cells contain DNA which provide the instructions for a cell to grow and divide by producing a messenger known as RNA. During production of this message the RNA can become incorrectly stuck on the DNA forming a structure known as a R-loop. R-loops can make the DNA more susceptible to damage and interfere with the instructions from the DNA. The aim of this project is to investigate the role of R-loops in treatment resistance in oropharyngeal cancer. I will use cancer cells grown in the laboratory to investigate the role of R-loops in cells which develop resistance to treatment and investigate potential therapies that could be used in this situation in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1129-0413', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Crane', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 2]]}, 'award-end': {'date-parts': [[2023, 9, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:49Z', 'timestamp': 1636383409000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/222425'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:19Z', 'timestamp': 1636465459237}, 'publisher': 'Wellcome', 'award': '218497', 'DOI': '10.35802/218497', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'UCL Wellcome 4-year PhD in Mental Health Science'}], 'project-description': [{'description': 'Mental illness is a major public health problem, with poorly understood causes and highly variable treatment outcomes. While mental health research training has strength within disciplines, these typically operate in parallel, greatly impeding progress in improving clinical outcomes. The UCL Wellcome 4-Year PhD in Mental Health Science is an interdisciplinary, student-centred programme, which aims to train the next generation of research and policy leaders to succeed within mental health research fields, and foster greater cross-disciplinarity in future researchers. It leverages UCL’s outstanding mental health research environment across three broad Themes: Mechanism, Population Mental Health, and Intervention. In Year 1, students will obtain experience in these different Themes through short rotation projects and courses, including areas outside their academic background; through this they will be exposed to new concepts and techniques, learn to “speak the language” of the different disciplines, and spot the synergistic connections between them. For the main PhD project in Years 2-4, students will select a supervisory team and Thesis Committee across all three Themes, enabling interdisciplinary mentorship. A strong emphasis will be placed on developing a distinct and supportive cohort identity, with continual skills development and preparation for transition following the Programme, whether within or outside academia.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2777-7616', 'authenticated-orcid': False, 'given': 'Claudia', 'family': 'Cooper', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1847-8443', 'authenticated-orcid': False, 'given': 'Pasco', 'family': 'Fearon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8269-1228', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Roiser', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5757810.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2028, 3, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 5757810.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:02Z', 'timestamp': 1636383302000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:19Z', 'timestamp': 1636465459245}, 'publisher': 'Wellcome', 'award': '065650', 'DOI': '10.35802/065650', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the British Society for Population Studies Annual Conference to be held in Leeds during September 2001.'}], 'lead-investigator': [{'given': 'Heather', 'family': 'Joshi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:36Z', 'timestamp': 1636382856000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065650'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:22Z', 'timestamp': 1636465462528}, 'publisher': 'Wellcome', 'award': '060558', 'DOI': '10.35802/060558', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Recombinant multimers of Kv1 a/B subunits/ZIP (zeta-PKC interacting- protein) that mimic neuronal K+ channel subtypes: do these signalling complexes act as redox sensors or voltage-dependent enzymes?'}], 'lead-investigator': [{'given': 'Gordon', 'family': 'Dougan', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 326453.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 326453.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:24Z', 'timestamp': 1636382844000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060558'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:23Z', 'timestamp': 1636465463241}, 'publisher': 'Wellcome', 'award': '066216', 'DOI': '10.35802/066216', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Myocardial viability determined by MR imaging.'}], 'project-description': [{'description': 'Myocardial viability determined by MR imaging Determination of myocardial viability, the differentiation between hibernating/stunned myocardium and scar, remains a diagnostic problem. Current methods, such as nuclear T1 scintigraphy, PET or stress echocardiography have major limitations related to sensitivity, specificity , availability, and costs. Cardiac MR has been used to show that recruitment of inotropic reserve by low-dose dobutamine is a viability criterion with a sensitivity/specificity in the 90% range. Another promising method for viability detection is the determination of \"late signal enhancement\" on 10-15 min post-contrast (Gd-DTPA) MR images, where non-viable myocardium shows signal hyper-enhancement, but viable myocardium does not. A new method for viability detection using intrinsic MR contrast, non-stress and non-contrast agent is Na-MRI. Na MRI allows for cardiac imaging with a resolution in the range of 500 µ1. In the infarcted rat heart, scar tissue exhibits significantly increased total Na content compared to viable myocardium, establishing a biochemical base for viability detection. Dr Selva will implement Na-MRI in patient cohorts with akinetic myocardial regions undergoing PTCA or bypass surgery with comparison to recovery of regional function 6 months after revascularisation. He will evaluate sensitivity and specificity for viability detection for 23Na-MRI and post-Gd DTPA late hyperenhancement images in comparison to T1-scintigraphy. In short, Dr Selva will develop Na MRI into a safe and contrast agent-independent reliable method for clinical viability assessment.', 'language': 'en'}], 'lead-investigator': [{'given': 'Joseph', 'family': 'Selva-Nayagam', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 164334.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 164334.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:14Z', 'timestamp': 1636383014000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066216'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:25Z', 'timestamp': 1636465465828}, 'publisher': 'Wellcome', 'award': '222954', 'DOI': '10.35802/222954', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Must the relatives be told? Legal and ethical issues in relation to the non-disclosure of genetic information by healthcare professionals to relatives'}], 'project-description': [{'description': \"Genetic information is becoming increasingly utilised by healthcare professionals in order to provide patients with more precise diagnosis and treatments. An individual's genetic information may show their risk of inheriting a genetic disorder, and although most individuals would consent to healthcare professionals sharing their genetic information with relatives who may also be at risk, some individuals refuse. It can be argued that a failure to disclose the risks of inheriting genetic disorders to relatives is ethically wrong, because it restricts the autonomy of individuals to make life choices. Alternatively, it can be contended that it is legally wrong for a healthcare professional to not adhere to the duty of confidentiality that they owe to patients. This debate demonstrates the conflict of duties that healthcare professionals face as the use of genetic information in medicine develops, and highlights the need to develop a new legal framework which takes into account the needs of patients, relatives, and healthcare professionals. In order to create an appropriate legal framework, I aim to assess academic commentary, examine case law, and conduct qualitative interviews with healthcare professionals in order to assess scientific opinion, and potentially inform new policy guidance.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7280-0531', 'authenticated-orcid': False, 'given': 'Jasmine', 'family': 'Blow', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:11Z', 'timestamp': 1636383311000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222954'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:25Z', 'timestamp': 1636465465970}, 'publisher': 'Wellcome', 'award': '219880', 'DOI': '10.35802/219880', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of rat Posterior Parietal Cortex in statistical learning'}], 'project-description': [{'description': 'The world around us is complex, but at the same time full of meaningful regularities. We can detect, learn and exploit these regularities automatically in an unsupervised manner, i.e. without any direct instruction or explicit reward. For example, we effortlessly estimate the average tallness of people in a room, or the boundaries between words in a language. These regularities, once learned, can affect the way we acquire and interpret new information to build and update our internal model of the world for future decision-making processes. Despite the ubiquity of passively learning from the structured information in the environment, the mechanisms that support learning from real-world experience are largely unknown. By combining sophisticated cognitive tasks in human and rats, neuronal measurements and perturbations in rat and network modelling, we aim to build a multi-level description of how sensory history is utilised in inferring regularities in temporally extended tasks. The ability to use sensory statistics to update the internal models may be impaired in individuals with dyslexia or with neurodevelopmental disorders, such as autism, or psychosis, such as schizophrenia. Our findings can have immediate application in better understanding and designing more accurate treatments for these disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0324-4222', 'authenticated-orcid': False, 'given': 'Elena', 'family': 'Menichini', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:55Z', 'timestamp': 1636383295000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219880'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:26Z', 'timestamp': 1636465466024}, 'publisher': 'Wellcome', 'award': '060478', 'DOI': '10.35802/060478', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Leucocyte mediated endothelial dysfunction: identification and manipulation of damage and repair mediators.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4974-0344', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Henriksen', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 140075.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 140075.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:37Z', 'timestamp': 1636382857000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060478'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:29Z', 'timestamp': 1636465469332}, 'publisher': 'Wellcome', 'award': '062350', 'DOI': '10.35802/062350', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Accession into NCYC of yeast deletion mutants for functional genomic studies.'}], 'investigator': [{'given': 'Ian', 'family': 'Roberts', 'affiliation': [{'name': 'Quadram Institute Bioscience', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Stephen', 'family': 'Oliver', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 286298.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 29]]}, 'award-end': {'date-parts': [[2004, 11, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 286298.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:43Z', 'timestamp': 1636382863000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 29]]}, 'URL': 'http://dx.doi.org/10.35802/062350'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:33Z', 'timestamp': 1636465473158}, 'publisher': 'Wellcome', 'award': '220041', 'DOI': '10.35802/220041', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Circuit mechanisms underlying spatial navigation deficits in early Alzheimer's disease\"}], 'project-description': [{'description': 'Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions worldwide. AD can only be diagnosed late in its progression, when cognitive symptoms such as memory loss are prominent. Many years before this, the pathological AD processes are active and damaging the brain, but the symptoms at this early stage are subtle, making diagnosis challenging. Focusing on early affected areas in AD could hold the key to early diagnosis. An early affected area is the entorhinal cortex (EC), which supports spatial navigation. Damage here causes spatial navigation deficits. In early AD, these deficits are subtle and require the development of sensitive tests. Our goal is to help inform the development of these tests by understanding how the EC carries out spatial computations, and how they are altered in AD. To do this, we will reverse engineer the EC circuitry using optogenetics and electrophysiology during navigation tasks performed by healthy and AD mice. In conjunction, we will build computational models (virtual EC circuits) that simulate AD pathology and task performance. These studies will help explain how the EC carries out computations that underlie spatial navigation, and how they go wrong during AD, informing the development of sensitive tests for AD.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3574-7812', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Hawes', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:41Z', 'timestamp': 1636383341000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220041'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:37Z', 'timestamp': 1636465477309}, 'publisher': 'Wellcome', 'award': '211161', 'DOI': '10.35802/211161', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of progression to invasive lung cancer: a systems biology approach'}], 'project-description': [{'description': 'Lung cancer remains the leading cancer-related cause of death in the UK. Early detection and treatment are critical to improving outcomes. Our lab has collected a unique set of lung tissue samples from patients with pre-cancerous disease, some of whom have gone on to develop cancer. By studying the genetic and molecular profiles of these samples we aim to elucidate the mechanisms of progression from pre-cancerous disease to invasive cancer. By doing so we can identify future methods of treatment and prevention. My work focuses on analysis of vast quantities of data produced by this program. We have recently studied the genetics of these samples, including which genes are expressed, which are mutated, and how they are regulated. From these complex networks we identify key signals of instability in the genome, which we believe are driving progression to cancer. These data provide a snapshot of early cancer. The first aim of this project is to investigate the dynamics of this process using longitudinally collected samples, and new techniques which can probe these samples on a single-cell level. The second aim is to study the immunological mechanisms by which some pre-invasive lesions regress and do not become invasive cancer.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5836-0250', 'authenticated-orcid': False, 'given': 'Adam', 'family': 'Pennycuick', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 10, 4]]}, 'award-end': {'date-parts': [[2020, 10, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:28Z', 'timestamp': 1636383328000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 4]]}, 'URL': 'http://dx.doi.org/10.35802/211161'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:51Z', 'timestamp': 1636465431981}, 'publisher': 'Wellcome', 'award': '216353', 'DOI': '10.35802/216353', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolution of modern H3N2 influenza A viruses'}], 'project-description': [{'description': 'Influenza poses a significant burden to public heath and the economy. The ability of influenza to escape prior immunity and vaccine response is due to continual evolution of the virus. Deciding which strains of the virus to include in the annual vaccine requires accurate information about the character of the evolving viruses. The more information we can provide, the more likely it is that the choice will result in a vaccine that is well matched against the predominant circulating strains. Mismatch erodes public confidence in vaccination policy and increases the disease burden. Currently the decision is largely based on traditional tests that measure how related the strains are to each other, in other words do antibodies raised to last year’s vaccine cross react with this year’s viruses? But there are other important factors that will determine which of the many different strains will evolve to predominate, such as how well the virus transmits through the air. We propose to generate information that could aid selection of virus strains for the annual influenza vaccine. We will improve experimental models of influenza transmission and incorporate genetic sequencing of the virus and mathematical modelling to enhance our understanding of influenza evolution.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4591-6026', 'authenticated-orcid': False, 'given': 'Ruthiran', 'family': 'Kugathasan', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 17]]}, 'award-end': {'date-parts': [[2022, 3, 2]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:07Z', 'timestamp': 1636383307000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 17]]}, 'URL': 'http://dx.doi.org/10.35802/216353'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:53Z', 'timestamp': 1636465433171}, 'publisher': 'Wellcome', 'award': '222958', 'DOI': '10.35802/222958', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Assessing the contribution of common and rare short tandem repeats (STRs) to the risk of developing idiopathic pulmonary fibrosis (IPF).'}], 'project-description': [{'description': 'Idiopathic Pulmonary Fibrosis (IPF) affects around five people in every 100,000 in the UK and is amongst the most devastating of lung diseases, with a median survival time of 3 years and variable progression. Comparable disease prevalence (6.8 per 100,000 persons) has also been reported in other countries such as the USA, Italy, and Canada. About 5000 cases are detected annually in the UK, and there is rising disease prevalence globally. Despite the substantial disease burden, there is little understanding of the disease etiology, and it has a poor prognosis. Other than a lung transplant, the available drugs are not curative. The majority of cases are diagnosed in patients >50 years and males are disproportionately affected than females. Both genetic and environmental factors have been associated with IPF. The genetic mutations described so far only account for about 19% of genetic risk associated with IPF. Therefore, the analysis of other types of genetic variations is pertinent. In particular, our study will use whole-genome sequences in case-control cohorts to identify other genetic mutations associated with IPF susceptibility. Identifying risky mutations can help understand disease etiology and develop more targeted therapies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8020-0787', 'authenticated-orcid': False, 'given': 'John', 'family': 'Oketch', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 29]]}, 'award-end': {'date-parts': [[2024, 9, 28]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:26Z', 'timestamp': 1636383326000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 29]]}, 'URL': 'http://dx.doi.org/10.35802/222958'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:54Z', 'timestamp': 1636465434533}, 'publisher': 'Wellcome', 'award': '062873', 'DOI': '10.35802/062873', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of the novel RHO GTPase, Rif'}], 'lead-investigator': [{'given': 'Harry', 'family': 'Mellor', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 140464.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 22]]}, 'award-end': {'date-parts': [[2004, 4, 21]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 140464.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 22]]}, 'URL': 'http://dx.doi.org/10.35802/062873'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:55Z', 'timestamp': 1636465435185}, 'publisher': 'Wellcome', 'award': '220553', 'DOI': '10.35802/220553', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering the Genetic Basis of Epilepsies through Computational Analysis of Clinical Phenotype'}], 'project-description': [{'description': \"Background Epilepsy affects 1% of people and empirical treatment benefits only a third. Seizures and their treatments have serious health and socioeconomic consequences. Over a third of epilepsy is thought to arise from variation in the person’s genetic code. However, currently we can only rarely identify what this is, a necessary step towards using it to improve treatment. Studying people grouped by the symptoms of their epilepsy has successfully defined, and discovered the genetic causes of distinctive but rare epilepsies such as Dravet Syndrome, facilitating research that has improved their treatment. Approach The yield of large genetic studies of epilepsy is currently limited by the challenges of combining and interpreting vast quantities of complex information about participants' epilepsy symptoms. We will develop computational methods to make information about the symptoms of participants in Epi25 (the largest ever epilepsy study) more tractable. We will use these to identify new patterns of symptoms and their associated genetic causes. Expected Impact Identifying new genetic causes of epilepsy could help to us to personalise the selection of existing treatments more successfully within a few years, and to design new, precise treatments based upon newly discovered mechanisms. Our methods may be applicable to other diseases.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1735-8178', 'authenticated-orcid': False, 'given': 'David', 'family': 'Lewis-Smith', 'affiliation': [{'name': 'Newcastle University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 1]]}, 'award-end': {'date-parts': [[2022, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:17Z', 'timestamp': 1636383317000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220553'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:59Z', 'timestamp': 1636465439930}, 'publisher': 'Wellcome', 'award': '061150', 'DOI': '10.35802/061150', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Human complement regulator subversion for virus infection and protection of viruses and infected cells.'}], 'lead-investigator': [{'given': 'Owen', 'family': 'Spiller', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 330265.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 330265.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:19Z', 'timestamp': 1636383019000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061150'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:01Z', 'timestamp': 1636465441503}, 'publisher': 'Wellcome', 'award': '054939', 'DOI': '10.35802/054939', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Analysis of the cell signalling molecules that control the phosphorylation of type A gamma-aminobutyric acid receptors.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2748-743X', 'authenticated-orcid': False, 'given': 'Jasmina', 'family': 'Jovanovic', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 124428.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 1]]}, 'award-end': {'date-parts': [[2001, 11, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 124428.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054939'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141891}, 'publisher': 'Wellcome', 'award': '222397', 'DOI': '10.35802/222397', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intratracheal Valve device for intractable aspiration: ITV'}], 'project-description': [{'description': 'We will create the Intra-Tracheal Valve (ITV), a safe and well-tolerated soft robotic intra-tracheal device for persons with failing laryngeal sphincter function. The device will be based on cutting-edge bioengineering, soft robotics and implant technology and comprise a responsive vocal cord unit replacement valve, inserted/replaced endoscopically. The valve will be electromagnetically actuated via novel power transmission, autonomously controlled by sensors that detect decisions to swallow, with full manual override (Fig3). Our device will transform the quality and duration of life of those unable to swallow safely and create a pathway to clinic for a generation of soft-robotics-based solutions to common sphincter disorders such as incontinence. We will (a) trial internal and external power solutions; (b) develop an intelligent control strategy; (c) develop an efficient electrically controlled actuator solution with anti-microbial packaging; (d) include patients and healthcare workers in project planning and management; (e) map a regulatory pathway to the first in human use of this novel implantable device (Fig4). This project will deliver the world’s first soft-robotics-based implantable healthcare solution and provide proof-of-concept for a family of novel solutions to other, diverse and common unmet patient needs, especially those involving sphincters (e.g. urinary and faecal incontinence).', 'language': 'en'}, {'description': 'The larynx is principally a sphincter that prevents food, drink and saliva passing onto the lungs. Common neuromuscular and mechanical disturbances of laryngeal function lead to problems managing secretions, food and drink, causing recurrent pneumonia by “aspiration” (Fig1). 30% of persons with stroke develop aspiration, and it is the commonest cause of death in throat cancer survivors5,7 and those with neuromuscular diseases, including motor neurone and Parkinson’s diseases. We aim to transform the lives of those losing laryngeal sphincter function, by combining the cutting-edge technologies of bioengineering and soft robotics, to create an implantable Intra-Tracheal Valve (ITV). The ITV will enable safe swallowing through intelligent airway protection. Our team partners leading surgeons, engineers and scientists with patients, regulatory and business experts. We combine our implantable sphincter-like valve device and electrical biosensing systems, capable of accurately detecting swallowing, with our biomaterials and clinical expertise to deliver a unique prototype ITV device.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7244-5864', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'Vanhoestenberghe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-8406-472X', 'authenticated-orcid': False, 'given': 'Wenhui', 'family': 'Song', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Justin', 'family': 'Perkins', 'affiliation': [{'name': 'Royal Veterinary College', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2732-4200', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Conn', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9109-9987', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Rossiter', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Miss', 'family': 'Paulraj', 'affiliation': [{'name': 'UCL Business', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9211-1722', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Birchall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 756386.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 756386.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:29Z', 'timestamp': 1636383569000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222397'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141895}, 'publisher': 'Wellcome', 'award': '050013', 'DOI': '10.35802/050013', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in neuroscience.'}], 'investigator': [{'given': 'John', 'family': 'Stein', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Cowey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Susan', 'family': 'Greenfield', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Jeremy', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4134-9730', 'authenticated-orcid': False, 'given': 'Heidi', 'family': 'Johansen-Berg', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Nicholas', 'family': 'Rawlins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Ganter', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Dorette N', 'family': 'Breitkreuz', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Stephanie', 'family': 'Frackowiak', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Bampton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 492394.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 492394.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:42Z', 'timestamp': 1636383162000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050013'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141884}, 'publisher': 'Wellcome', 'award': '216362', 'DOI': '10.35802/216362', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic mechanisms of human ovary development and function: A life course approach'}], 'project-description': [{'description': 'This research focuses on conditions affecting human female reproductive function. These conditions include rare disorders of ovary development in babies, problems with entering puberty in adolescence, and impaired fertility and early menopause in adult women. We aim to enhance our understanding of these conditions by investigating important genetic events underlying their development. Our first aim is to study the dynamic genetic events that occur in the early developing ovary. We then plan to study genetic differences in ovarian follicles before and after puberty, to help us understand how reproductive function changes over a lifecourse and how we may need to adapt our fertility preservation approaches to suit girls and women of different ages. We also intend to perform detailed genetic testing on girls and women with two different reproductive health conditions: Turner syndrome (a condition where a woman has one, rather than two, X chromosomes) and primary ovarian insufficiency (a condition where a woman’s ovaries do not function well). We aim to detect new genetic mechanisms underlying these conditions. This research will allow a more individualised approach to the diagnosis of women with a variety of reproductive health conditions, and pave the way for new treatment approaches.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4289-0852', 'authenticated-orcid': False, 'given': 'Sinead', 'family': 'McGlacken-Byrne', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:14Z', 'timestamp': 1636383434000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216362'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141884}, 'publisher': 'Wellcome', 'award': '216348', 'DOI': '10.35802/216348', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Sampling the human gut-liver axis to probe the role of gamma-delta T-cells in cirrhosis'}], 'project-description': [{'description': 'Non-alcoholic fatty liver disease is estimated to occur in 24% of the global population. The progressive form of disease, non-alcoholic steatohepatitis (NASH), develops in a quarter of these patients, which can lead to irreversible liver damage. Increasing evidence suggests that microbes residing in the gut, collectively termed the gut microbiota, may drive the development of NASH. However, the role that immune cells play within this link has not been defined. Gamma-delta T-cells are immune cells that are enriched in the gut and liver, providing local protection from infection. Recent studies in mice have demonstrated specialised subsets of these immune cells present in the liver but not the blood, that were dependent on the gut microbiota, and accelerated the development of NASH. Through sampling human liver tissue and blood entering and leaving the liver, I aim to study the role that these immune cells play in the progression of NASH, and investigate whether microbes or microbial products that migrate into the liver from the gut are able to alter the immune cells’ function. This could help to explain the link between the gut microbiota and liver disease severity in patients with NASH, providing targets for the development of future treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1167-1160', 'authenticated-orcid': False, 'given': 'Nekisa', 'family': 'Zakeri', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 9, 3]]}, 'award-end': {'date-parts': [[2022, 3, 2]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:06Z', 'timestamp': 1636383426000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 3]]}, 'URL': 'http://dx.doi.org/10.35802/216348'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:34Z', 'timestamp': 1636467154104}, 'publisher': 'Wellcome', 'award': '211163', 'DOI': '10.35802/211163', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Irritability, Reward Processing and Adolescent Depression'}], 'project-description': [{'description': 'Depression is a common mental health problem and a leading cause of disability. Rates of depression increase throughout adolescence, with most adult disorders beginning during this time. Despite this, we do not fully understand why depression increases during adolescence or why some people are more vulnerable than others. Depressed adults show changes in processing of reward related information, which potentially contribute to their risk of depression. Children who are more irritable (i.e. more prone to anger in response to frustration e.g. omission of an expected reward) are more likely to develop depression when older. Such children also show changes in processing of reward. Adolescence is a time of significant social, emotional and cognitive development both biologically and environmentally. I hypothesise that irritability in childhood is a consequence of differences in reward processing that lead to depression in adolescence in the context of the developmental and environmental changes. This study aims to investigate these relationships by looking at childhood irritability, reward processing and depressive symptoms. Depression has a complex multi-factorial aetiology; studying childhood risks for depression will improve our understanding of the mechanisms underlying depression, allowing development of more targeted interventions and preventive strategies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1478-2018', 'authenticated-orcid': False, 'given': 'Ramya', 'family': 'Srinivasan', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:05Z', 'timestamp': 1636383425000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:35Z', 'timestamp': 1636467155729}, 'publisher': 'Wellcome', 'award': '222991', 'DOI': '10.35802/222991', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the impact of mass drug administration on Plasmodium falciparum population structure in the Bijagos Archipelago of Guinea-Bissau.'}], 'project-description': [{'description': 'The World Health Organisation is committed to help reduce malaria deaths by 90% by 2030. Although long-lasting insecticide treated bed nets (LLINs), rapid diagnostic tests (RDTs) and artemisinin-based medicines (ACT) are essential in reducing the death toll, they are insufficient. A cluster randomised trial will assess the impact of mass drug administration (MDA) of an ACT (dihydroartemisinin-piperaquine, DP) and the mosquito-killing drug ivermectin (IVM) to tackle both human and mosquito reservoirs of malaria infection in Guinea-Bissau. Nested within the trial, the proposed study aims to investigate (1) the origins, diversity, and drug resistance of P.falciparum, the malaria parasite, at the trial site before MDA is given, (2) the impact of MDA on parasite transmission and (3) characterisation and tracking of remaining parasites post-MDA. Whole genome sequencing and genotyping - methods to read parasite genes - will be used to characterise and track parasites after MDA. Antibodies to the parasite will also be investigated as a cost-effective alternative endpoint and sustainable surveillance tool. The study hypothesis is that MDA will decrease P.falciparum transmission to very low levels leading to a decrease in the diversity and numbers of different types of P.falciparum parasites at the trial site.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6257-1250', 'authenticated-orcid': False, 'given': 'David', 'family': 'McGregor', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 6, 28]]}, 'award-end': {'date-parts': [[2024, 6, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:14Z', 'timestamp': 1636383494000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222991'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:38Z', 'timestamp': 1636467158791}, 'publisher': 'Wellcome', 'award': '220589', 'DOI': '10.35802/220589', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the contribution of gamma-delta T-cells to immunosurveillance of cancer and response to immunotherapy'}], 'project-description': [{'description': 'Gamma-delta T-cells are critical for protecting against carcinogenesis in mice but clinical associations have been equivocal and human trials of gamma-delta T-cell therapy have been disappointing. Previous studies have been limited by unavailable technologies to describe these cells with sufficient granularity whilst clinical trials have largely focussed on the more numerous V-delta-2 subtype. Using contemporary methods such as TCR-sequencing and ex vivo culture systems to extract gamma-delta T-cells from human tissues, we recently demonstrated that only certain subtypes of these cells, namely the V-delta-1 subtype, are associated with survival in triple-negative breast cancers. This proposal aims to extend our previous findings to a pan-cancer setting by mapping, with greater and necessary detail, these cells in melanoma, breast, lung and other cancers with a particular focus on V-delta subtyping, differential effector functions and cell regulatory axes. Importantly, we will also map gamma-delta T-cell interactions with alpha-beta T-cells as these cells have been established as being critical to cancer immunosurveillance. We will stratify our findings to clinical outcomes to build a novel reference human tumour gamma-delta T-cell atlas to guide ongoing translational efforts in adoptive gamma-delta T-cell therapy. Hence, this proposal may lead to rapid translation into clinical benefit.', 'language': 'en'}, {'description': 'Modifying the immune system, particularly T-cells, can now cure some patients with stage-4 cancer. However, most patients do not benefit. T-cells are white blood cells which can be further divided into alpha-beta and gamma-delta T-cells. Most current therapies work on alpha-beta T-cells. Gamma-delta T-cells can control cancers in mice, but remain under-utilised in human therapy as clinical trials involving these cells have been disappointing. Using modern sequencing and cell-growing technologies previously not widely available, we recently demonstrated that only certain gamma-delta T-cells, the V-delta-1 subtype, predict survival in aggressive breast cancers. Here we will extend the characterisation of these cells, in far greater detail, into a pan-cancer setting to include melanoma, lung, breast and other cancers. By defining what makes these V-delta-1 cells protective, we will instruct ongoing and future gamma-delta T-cell therapy trials and thus open up effective immunotherapy to those who do not benefit from alpha-beta T-cell therapies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9495-5793', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Hayday', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4299-3018', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Swanton', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4080-3935', 'authenticated-orcid': False, 'given': 'Yin', 'family': 'Wu', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 698120.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 698120.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:48Z', 'timestamp': 1636383108000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220589'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:41Z', 'timestamp': 1636467161111}, 'publisher': 'Wellcome', 'award': '215317', 'DOI': '10.35802/215317', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Visualising Mitochondrial Import Defects in Neurodegeneration'}], 'project-description': [{'description': 'Mitochondria are powerful, dynamic organelles that, among other things, provide energy for the cell. To do this, most of their proteins, which are nuclear encoded, must be imported from the cytosol via highly regulated import pathways. This mitochondrial import is a conserved process vital for the correct functioning of the cell. It is especially important in energy intensive cells like nerve cells. Thus, mitochondrial dysfunction and defects in mitochondrial import have been implicated in many neurodegenerative diseases and dementias, including Alzheimer’s and Parkinson’s. Despite these identified links, the precise mechanisms by which mitochondrial import defects lead to neurodegeneration, or indeed how neurodegeneration impacts on mitochondrial function, are poorly understood. This project aims to develop new systems to investigate mitochondrial import in models of neurodegeneration. We will use these systems to investigate the effects of blocking import on neuronal function, and of modelling neurodegeneration on mitochondrial function. We anticipate that this will provide mechanistic details that will allow these pathways to be targeted for therapeutic intervention.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1161-3294', 'authenticated-orcid': False, 'given': 'Hope', 'family': 'Needs', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:33Z', 'timestamp': 1636383273000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215317'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:13:25Z', 'timestamp': 1636467205268}, 'publisher': 'Wellcome', 'award': '220580', 'DOI': '10.35802/220580', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding the gene expression dynamics that regulate glioma stem cell transitions'}], 'project-description': [{'description': 'It is believed that glioblastoma multiforme (GBM), the most aggressive form of adult primary brain cancer, arises from abnormal cells of origin (stem cells) in the brain known as glioma stem cells (GSCs). There is no cure for GBM. Importantly, GSCs can assume either an \"active\" or \"dormant\" state. Research suggests that GSCs in the \"dormant\" state are especially resistant to treatment and when made \"active\" again, result in deadly regrowth of cancer. Findings from my host laboratory suggest that such cell-state transitions are controlled by unique patterns of gene expression (\\'expression\\' being the process by which a gene is converted to its relevant protein) as opposed to genes simply being turned on or off. My research will use cutting edge tools to label genes of interest with markers that give off a fluorescent glow. This will allow us to identify patterns of gene expression that causes changes in GSC states. If this research is successful, future treatments could be developed to give doctors control over these cell states. For example, we might be able to prevent \"dormant\" cells from becoming re-activated. By doing so, we can hopefully change what is currently a deadly disease into a chronic manageable condition.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5473-6038', 'authenticated-orcid': False, 'given': 'Richard Zhiming', 'family': 'Fu', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 2]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:04Z', 'timestamp': 1636383484000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220580'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:13:26Z', 'timestamp': 1636467206295}, 'publisher': 'Wellcome', 'award': '222497', 'DOI': '10.35802/222497', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does the purine metabolic checkpoint FAMIN prevent immunopathology?'}], 'project-description': [{'description': \"Children with Still's disease, the paradigm of autoinflammation-cum-autoimmunity, are predisposed to developing a cytokine storm with excessive activation of T lymphocytes upon viral infection. Loss-of-function of FAMIN is the sole known cause for monogenic Still's disease. We de-orphaned FAMIN as an unprecedented purine nucleoside enzyme that combines ADA-, PNP- and MTAP-like activities with adenosine phosphorolysis – challenging fundamental principles of purine metabolism. Dendritic cells with absent FAMIN activity prime for excess antigen-specific cytotoxicity, IFNγ secretion, and T cell expansion, resulting in exaggerated virus-specific T cell responses and immunopathology. Enhanced priming is already manifest with hypomorphic FAMIN-I254V, for which ~6.3% of mankind is homozygous, and which predisposes for Crohn's disease and leprosy. Here we will address FAMIN biology from virtually atomic to organismal resolution: We will explore how FAMIN operates in a cell, and how it controls energy metabolism, ascertaining redox and pH homeostasis. We will investigate how FAMIN in dendritic cells potently restrains T cell priming, and whether the FAMIN-coordinated biochemical mechanisms are involved in often fatal virus-induced cytokine release syndromes. This work will reveal an ancient biochemical mechanism that potently controls adaptive immune activation at a very fundamental level, providing insight into immunity to pathogens, autoinflammation and autoimmunity.\", 'language': 'en'}, {'description': \"Still's disease is a severe disease in children that starts with daily recurring high fever, a rash and lymph node enlargement, and morphs over weeks into a debilitating arthritis. Worse, virus infection can lead to an often fatal cytokine storm. Loss-of-function of FAMIN is the sole known cause for familial Still's disease. We discovered that FAMIN is an unprecedented enzyme involved in the metabolism of adenine and guanine, hence the nucleobases of the genetic code and energy currency of the cell. FAMIN is very ancient, with predecessors already present in bacteria. Its discovery changes our understanding of a very fundamental process of life. A partially active genetic variant of FAMIN is carried by ~6% of the population, and predisposes for Crohn's disease, an inflammatory bowel disease, and leprosy, a chronic infection. Here we explore how FAMIN defects predispose for these conditions, and how that might be prevented and treated.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1419-3344', 'authenticated-orcid': False, 'given': 'Arthur', 'family': 'Kaser', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 2444805.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2444805.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:28Z', 'timestamp': 1636383568000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:40Z', 'timestamp': 1636465480933}, 'publisher': 'Wellcome', 'award': '222939', 'DOI': '10.35802/222939', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploiting Trained-Immunity and Immunometabolism in Tuberculosis (EXTINCT)'}], 'project-description': [{'description': \"Tuberculosis is a bacterial infection that kills more people than any other infection. It spreads from one person to another through the air when they cough. Treating tuberculosis with antibiotics takes at least six months and sometimes two years. Treatment is becoming more difficult because the antibiotics have stopped working for resistant tuberculosis. The current vaccine does not work well at preventing tuberculosis. We need to find new ways to prevent and treat tuberculosis. Our immune system kills tuberculosis most of the time. The most important part of our immune system for killing tuberculosis are macrophages. Macrophages are cells that live in our lungs. Macrophages ‘eat’ and try to ‘digest’ tuberculosis, which kills it. It might be possible to improve the macrophage's ability to kill tuberculosis. My project will try to improve the macrophage’s ability to kill tuberculosis by changing its energy system, or treating them with vitamin A. This might lead to better treatments. My project also will try to train the macrophages before they encounter tuberculosis. This might lead to a better vaccine.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4930-1560', 'authenticated-orcid': False, 'given': 'Conor', 'family': 'Grant', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2020, 7, 12]]}, 'award-end': {'date-parts': [[2023, 7, 11]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:27Z', 'timestamp': 1636383327000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 12]]}, 'URL': 'http://dx.doi.org/10.35802/222939'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:40Z', 'timestamp': 1636465480963}, 'publisher': 'Wellcome', 'award': '213555', 'DOI': '10.35802/213555', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering how transcription factors define human B cell fate decisions in vivo.'}], 'project-description': [{'description': 'The development of antibody-producing plasma cells and memory B cells (MBCs) is essential for immunological memory, yet the transcriptional mechanisms that regulate these different B cell fates are poorly understood. One reason for this is the highly dynamic and heterogeneous nature of B cell maturation and differentiation. This challenge can be overcome using single-cell genomics approaches to examine gene expression networks within rare transitional cell states and hence identify regulatory transcription factors (TFs) that shape B cell fate decisions. I will therefore apply single-cell approaches to primary human B cells to discover the gene regulatory mechanisms that drive human B cell fate choices. Briefly, I will: - Discover TFs linked with B cell fate decisions in vivo using single-cell genomics - Determine how these TFs compete or work together during cell fate commitment by mapping their genome-binding patterns - Functionally dissect how these TFs drive gene expression to define MBC differentiation This will comprehensively identify the TFs and regulatory mechanisms that define gene expression patterns associated with human B cell fate decisions in vivo and will therefore represent an important advance in our understanding of human B cell biology and how immunological memory is achieved.', 'language': 'en'}, {'description': 'B cells are immune cells that are important to human health. When B cells respond to pathogens they can differentiate to plasma cells, which make antibody, or memory B cells, which protect against future infections. The decision to make a memory B cell or a plasma cell is controlled by transcription factors that regulate gene expression. However, we don’t fully understand the mechanisms by which transcription factors do this. I will use cutting-edge single-cell genomics methods to examine transcription factor activity during human B cell development at unprecedented resolution. This will allow me to discover how different transcription factors regulate gene expression to control B cell fate decisions (ie. memory B cell vs plasma cell) and reveal how different transcription factors work together or compete with another during this process. This will be important to develop methods to modify B cell development to improve vaccine efficiency or treat auto-immune disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5972-8926', 'authenticated-orcid': False, 'given': 'Hamish', 'family': 'King', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 1, 17]]}, 'award-end': {'date-parts': [[2023, 1, 17]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 1, 17]]}, 'URL': 'http://dx.doi.org/10.35802/213555'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:43Z', 'timestamp': 1636465483670}, 'publisher': 'Wellcome', 'award': '061530', 'DOI': '10.35802/061530', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolutionary theory of natural and experimental population of microbes.'}], 'project-description': [{'description': \"Although we are confident that evolution has occurred, and continues to occur, we cannot in general observe evolutionary processes directly. We can only make inferences, based on observations of a few special cases such as laboratory evolution experiments with bacteria and viruses. In generalising these inferences, and for understanding evolutionary processes which we cannot observe at all, we rely on evolutionary theory. Evolutionary theory is based on a few empirically determined principles (e.g. Mendel's laws of segregation) and statistical concepts (e.g. fitness). Much of our classical theory is built upon models of diploid sexual organisms, but recently more attention has focused on evolution of predominantly asexual species. In 1930, Fisher pointed out that in an asexual population, if several different adaptive mutations occur in different individuals, then one ultimately must become established in the population at the expense of the others. It is striking that we still have a poor quantitative understanding of this phenomenon. Severe mathematical difficulties arise in modelling the frequencies of many genotypes which fluctuate randomly and non-independently. Models of asexual evolution have yet to fully incorporate the complexities of natural populations: spatial structure, diverse resources to exploit, and population sizes and environmental conditions which fluctuate irregularly in space and time. In addition, many 'asexual' microbes have 'sex', in the sense that they exchange genes by a variety of mechanisms. This project will develop an improved and more realistic framework of evolutionary theory, and apply it to problems concerning how fast, and in which ways, microbial populations evolve. This body of theory will improve the reliability and generality of conclusions drawn from laboratory evolution experiments, surveys of natural populations, and genome sequence data. An improved theoretical understanding of adaptation in microbial populations is important in tackling problems directly relevant to human health, such as the evolution of novel pathogenic and antibiotic resistant bacterial strains.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Toby', 'family': 'Johnson', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 94430.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 94430.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:24Z', 'timestamp': 1636383024000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061530'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:45Z', 'timestamp': 1636465485778}, 'publisher': 'Wellcome', 'award': '222934', 'DOI': '10.35802/222934', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Defining the pathophysiological mechanisms underlying Low VWF in the Low VWF in Ireland Cohort (LoVIC) study'}], 'project-description': [{'description': 'Von Willebrand Factor (VWF) is a protein that blood needs to clot normally. VWF is made by cells that line our blood vessels called endothelial cells. About 1 in 100 people inherit low levels of Von Willebrand Factor. This means that they have a lifelong bleeding disorder known as Von Willebrand Disease (VWD). People with this disease bruise easily and suffer from nosebleeds. They also sometimes bleed after surgery or after having a tooth removed. We do not fully understand why these patients have low levels of VWF. This is especially true for patients whose levels are only slightly less than usual. This group of patients is known as ‘Low VWF’. People with ‘Low VWF’ also often have bleeding that is more than would be expected. To better understand this disorder, we will study why these patients have low VWF levels. We will study if they are making less VWF or clearing VWF from their circulation too quickly. Finally, we will study why these patients bleed by looking at other parts of the clotting system. This will help improve how we diagnose and treat these patients.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9759-062X', 'authenticated-orcid': False, 'given': 'Dearbhla', 'family': 'Doherty', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2021, 1, 11]]}, 'award-end': {'date-parts': [[2024, 1, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:33Z', 'timestamp': 1636383333000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222934'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:43:25Z', 'timestamp': 1636461805415}, 'publisher': 'Wellcome', 'award': '083345', 'DOI': '10.35802/083345', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental and Stem Cell Biology.'}], 'project-description': [{'description': 'Medicine is changing, most significantly by the onset of new applications of cell and molecular biology to the clinic not only for diagnostic purposes, but more importantly to develop new gene- and cell-based therapies. This defines a growing new area of \"regenerative medicine\". At the root of this new discipline is developmental and stem cell biology. This field is united by the overall aim of understanding, and thus learning to control, the changes in gene expression that govern how cells choose from among a multitude of different fates as well as how they organise themselves into functional tissues and organs (\"tissue and organ engineering\"). Although there has been considerable hope placed upon the uses of stem cells for these purposes, a major challenge remains to be able to control both their differentiation and their proliferation, to obtain the desired cell types and the resulting organs/tissues as well as to prevent them from dividing and differentiating uncontrollably when placed into patients. Although much effort is currently spent on surveys of factors able to regulate stem cell self-renewal, proliferation and developmental potency, it is quickly becoming apparent that considerably more fundamental knowledge of stem cell biology is required before we will be able fully to control their behaviour. As stem cells have many characteristics in common with embryonic cells, the discipline of developmental biology is at the centre of this effort. We will need to understand not only the external signals that can regulate cell behaviour but also the transcription factors, chromatin-remodelling and other epigenetic changes that result in key gene regulators being turned on or off. At present we do not even know what most of the regulatory gene targets are, let alone which factors control them. In addition, since stem cells can be isolated from adults, as well as cultured and maintained indefinitely in vitro, this offers an opportunity to use them as a platform for testing of drugs and other treatments which may be tailored specifically to each patient, as there is huge individual diversity in how patients respond to different treatments.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2544-9117', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Copp', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9907-889X', 'authenticated-orcid': False, 'given': 'Claudio', 'family': 'Stern', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2020, 5, 9]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:27Z', 'timestamp': 1636383207000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083345'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:05Z', 'timestamp': 1636467065190}, 'publisher': 'Wellcome', 'award': '061817', 'DOI': '10.35802/061817', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular dynamics typhoon phosph- and fluorimager.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2104-5430', 'authenticated-orcid': False, 'given': 'David', 'family': 'Sherratt', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Penelope', 'family': 'Handford', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0951-3374', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Whitby', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1395-7173', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Chalmers', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-amount': {'amount': 50000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2001, 12, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 50000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:48Z', 'timestamp': 1636382808000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061817'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:23Z', 'timestamp': 1636467083820}, 'publisher': 'Wellcome', 'award': '063185', 'DOI': '10.35802/063185', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Calcium signalling in cardiac Purkinje and ventricular cells.'}], 'investigator': [{'given': 'Karin', 'family': 'Sipido', 'affiliation': [{'name': 'KATHOLIEKE UNIVERSITEIT LEUVEN', 'country': 'BE', 'id': [{'id': 'https://ror.org/05f950310', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'David', 'family': 'Eisner', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 18000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 18000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:01Z', 'timestamp': 1636382821000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063185'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:35Z', 'timestamp': 1636467095992}, 'publisher': 'Wellcome', 'award': '222400', 'DOI': '10.35802/222400', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Determining the role of ubiquitin in transmission stage Plasmodium'}], 'project-description': [{'description': 'Approximately half of the global population is currently at risk of malaria infection, with an estimated 0.5 million deaths annually. Malaria is caused by Plasmodium parasites, which have a complex life cycle involving a vertebrate host and mosquito vector. Blood stage parasites cause the symptoms of malaria in humans, and are therefore the target of most current therapies. In order to reduce the incidence of malaria, and therefore global disease burden, a drug to block transmission between the host and vector is needed. The complex regulation required in transmission stage parasites remains poorly understood. Ubiquitylation is a well-researched post-translational modification which is commonly associated with protein degradation, but also has a range of effects from protein re-localisation to induction or arrest of cell signalling events. The role of ubiquitin in transmission stage parasite development is unknown. We aim firstly to identify the ‘ubiquitome’ of Plasmodium bergheiparasites during transmission stage development using ubiquitin capture systems and mass spectrometry. We subsequently aim to investigate the role of these ubiquitylated proteins during transmission using genetic engineering. These results will improve our understanding of the role ubiquitin may play in the regulation of transmission stage parasite development, and inform future drug discovery efforts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2496-5053', 'authenticated-orcid': False, 'given': 'Nila', 'family': 'Johnson', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222400'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:44Z', 'timestamp': 1636467104389}, 'publisher': 'Wellcome', 'award': '067802', 'DOI': '10.35802/067802', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Synaptic Plasticity: A Sytems Viewpoint'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2129-2060', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Warburton', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 4550.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 11]]}, 'award-end': {'date-parts': [[2002, 8, 10]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4550.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:57Z', 'timestamp': 1636382817000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 11]]}, 'URL': 'http://dx.doi.org/10.35802/067802'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:46Z', 'timestamp': 1636467106956}, 'publisher': 'Wellcome', 'award': '066577', 'DOI': '10.35802/066577', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A new strategy to identify X-linked disease genes, with particular reference to X-linked mental retardation: Proposal for a pilot study.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2444-3247', 'authenticated-orcid': False, 'given': 'Douglas', 'family': 'Easton', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Martin', 'family': 'Bobrow', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Lucy', 'family': 'Raymond', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 28297.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 11, 1]]}, 'award-end': {'date-parts': [[2003, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 28297.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:52Z', 'timestamp': 1636382812000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066577'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:49Z', 'timestamp': 1636467109972}, 'publisher': 'Wellcome', 'award': '222381', 'DOI': '10.35802/222381', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Hydrodynamic interactions in molecular simulations at the biological mesoscale'}], 'project-description': [{'description': 'Macromolecules under flow at the biological mesoscale (10 nm < L < 1 μm, 1 μs < t < 1 ms) can influence the dynamics of each other via hydrodynamic interactions (HIs), however, there is a dearth of mesoscale simulation tools that consider them. Most simulations that include HIs occupy continuum scales (L > 1 μm, t > 1 μs) whereas atomistic scales (L < 50 nm, t < 1 μs) are too small to model long range effects. Using a test-driven development methodology, I aim to address this capability gap by implementing HIs in the Fluctuating Finite Element Analysis (FFEA) software, which represents biological macromolecules as 3D viscoelastic continuum objects that thermally fluctuate. I will validate FFEA simulations of fibrinogen and ribosome macromolecules by exposing them to large viscous forces in extensional flow device (EFD) experiments. This work will improve our simulation capability at the biological mesoscale, which will complement the burgeoning range of experimental imaging techniques such as cryo-electron microscopy (cryoEM) and x-ray crystallography. Furthering our understanding of HIs is crucial in biomedical topics such as fibrin network formation in blood clots, as well as improving the industrial production of biopharmaceuticals and biomimetic fibres.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9142-8261', 'authenticated-orcid': False, 'given': 'Ryan', 'family': 'Cocking', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:58Z', 'timestamp': 1636383478000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222381'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:12Z', 'timestamp': 1636467132232}, 'publisher': 'Wellcome', 'award': '046122', 'DOI': '10.35802/046122', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD studentship programme in neuroscience.'}], 'investigator': [{'given': 'John', 'family': 'Stein', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Cowey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Susan', 'family': 'Greenfield', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Jeremy', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Guillery', 'affiliation': [{'name': 'University of Wisconsin-Madison', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6844-4984', 'authenticated-orcid': False, 'given': 'Colin', 'family': 'Akerman', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8947-408X', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Mrsic-Flogel', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'John', 'family': 'Chilton', 'affiliation': [{'name': 'Peninsula College of Medicine & Dentistry', 'country': 'GB'}]}, {'given': 'Nicholas', 'family': 'Rawlins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Emma L', 'family': 'Harvey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Nicole K', 'family': 'Mather', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 484343.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1996, 10, 1]]}, 'award-end': {'date-parts': [[2000, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 484343.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:40Z', 'timestamp': 1636383160000}, 'score': 0.0, 'issued': {'date-parts': [[1996, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/046122'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:35Z', 'timestamp': 1636438355538}, 'publisher': 'Wellcome', 'award': '220799', 'DOI': '10.35802/220799', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms determining the polarised synaptic distribution and molecular function of the retrograde endocannabinoid signalling system'}], 'project-description': [{'description': 'The endocannabinoid system (ECS) acts as a negative feedback mechanism to suppress excitatory and inhibitory synaptic transmission. This is critically important for a wide range of brain functions including appetite, pain, and cognition. Moreover, ECS dysfunction is implicated in multiple neuropathologies, and there is increasing scientific and public interest in drugs that target the ECS, including medical marijuana. The molecular organisation of the ECS is highly unusual because, in reverse to other neurotransmitter systems, endocannabinoids are released from the postsynaptic membrane to activate receptors at the presynaptic membrane. Despite its importance, remarkably little is known about how the enzymes and receptors essential for ECS ‘backwards’ transmission are targeted to, and retained at, opposing sides of the synapse. Focusing on the primary cannabinoid receptor CB1R and the major endocannabinoid synthesising enzyme diacylglycerol lipase α (DAGLα) as prototypic examples, we will investigate the protein interactions and pathways that determine the architecture and organisation of the ECS. Our goal is to define how the differentially polarised trafficking of ECS components to synapses is orchestrated. This mechanistic knowledge of the ECS will advance understanding of neuronal protein polarisation and inform the design of future strategies to modulate ECS signalling for therapeutic benefit.', 'language': 'en'}, {'description': \"Cannabis has been used as a medicine for thousands of years. Chemicals in cannabis work by activating a protein in the brain called cannabinoid receptor 1 (CB1R), which is part of a network of proteins called the endocannabinoid signalling system (ECS). The ECS dampens-down brain activity by reducing the amount of neurotransmitter released at connections between nerve cells called synapses. This is a vitally important feedback loop that prevents synaptic activity from spiralling out of control. We want to explore the biochemical 'nuts and bolts' of the cellular machinery that controls proteins critical for ECS function. This will provide important new information on how the ECS works, and how it can go wrong. Because a major role of the ECS is to prevent excessive activity which can kill nerve cells, our findings could eventually lead to new ways of enhancing ECS signalling to protect nerve cells in conditions like epilepsy.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3589-8335', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Henley', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1104076.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2026, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 1104076.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:55Z', 'timestamp': 1636383115000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220799'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:48Z', 'timestamp': 1636438368877}, 'publisher': 'Wellcome', 'award': '220991', 'DOI': '10.35802/220991', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of pre-existing immunity to coronaviruses; implications for immunopathology and pathophysiology of COVID-19 disease'}], 'project-description': [{'description': 'Background; It is unknown how prior exposure to commonly circulating human coronaviruses (HCoV) impacts immunity against highly-pathogenic species (SARS, SARS-CoV-2 & MERS). There are limited data, across Europe, Asia and Africa, on the prevalence of infection and seroconversion against widely circulating and mildly symptomatic HCoVs (229E, NL63, OC43, and HKU1). There is a current supposition that antibody-dependent-enhancement (ADE) may play a role in the pathophysiology of COVID-19. ADE occurs when non-neutralizing antiviral proteins facilitate virus entry into host cells, leading to increased infectivity in the cells. In such cases, higher viremia has been measured and the clinical course of disease can be more severe. In preclinical animal models, immunopathology was observed after challenge following vaccination with some SARS vaccines. Therefore, concerns have been raised regarding the impact of immunopathology and ADE on prophylactic vaccination against SARS and possibly SARS-CoV-2. Goals: to perform detailed systems serology of pre-existing immunity, in children and adults, from the UK and Africa, towards novel and commonly circulating coronaviruses. Impact: These studies highlight the limited knowledge in the field and a need for a systematic approach to investigate cross-reactive humoral immunity against HCoV to inform the immunopathology and pathophysiology of COVID-19.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-0900-9629', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Hill', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7361-719X', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Pollard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2160-567X', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Agoti', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}, {'ORCID': 'http://orcid.org/0000-0002-4911-6333', 'authenticated-orcid': False, 'given': 'George', 'family': 'Warimwe', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}, {'ORCID': 'http://orcid.org/0000-0001-9827-9836', 'authenticated-orcid': False, 'given': 'Katie', 'family': 'Ewer', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Tandakha', 'family': 'Dieye', 'affiliation': [{'name': 'IRESSEF', 'country': 'SN'}]}, {'given': 'Jennifer', 'family': 'Hill', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7711-897X', 'authenticated-orcid': False, 'given': 'Teresa', 'family': 'Lambe', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1217834.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 7, 1]]}, 'award-end': {'date-parts': [[2022, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 755818.1, 'currency': 'GBP', 'percentage': 62}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:59Z', 'timestamp': 1636383119000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220991'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:49Z', 'timestamp': 1636438369613}, 'publisher': 'Wellcome', 'award': '220429', 'DOI': '10.35802/220429', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Making social change happen: What inspires collective action for health and gender equality?'}], 'project-description': [{'description': 'Motivation: Interventions mobilising communities in collective action for their own health are some of the most effective known global health interventions. However, they do not always succeed and we cannot presently predict or explain why this happens. Aim: Taking as an example a community mobilisation programme to prevent violence against women in urban slums in Mumbai, India, I will test theory concerning the drivers of collective action from behavioural economics and social psychology. Method: (1) To unpack how a community mobilisation programme may stimulate collective action in urban India, I will collect and analyse qualitative interview, media and observational data. (2) To uncover the determinants of participation in collective action, I will conduct cross-sectional and difference-in-differences analysis of secondary data from a randomised controlled trial of the same community mobilisation programme. (3) To produce causal evidence for the drivers of collective action, I will conduct a behavioural experiment to test the behavioural effects of changing key messages on programme participants. I will use the answers to (1) and (2) to guide message design. Impact: The study results will be able to guide policy-makers and practitioners on when, how and why complex participatory interventions work to promote health and gender equality.', 'language': 'en'}, {'description': 'Whether to address violence against women, prevent newborns from dying, or hold clinic staff to account for low performance, research shows interventions engaging local people in developing countries in collective action for the common good can have enormous impact. However, results have varied widely. Sometimes, whole communities have rallied in protest and solidarity. At other times, interventions have been abandoned because nobody turned up. We cannot currently predict or explain what happens, because we do not have enough evidence. I aim to find out what inspires people to participate in collective action for their health. Taking as an example a community-based programme to mobilise residents to take action against violence against women in urban slums in Mumbai, India, I will test hypotheses informed by social science using qualitative, survey and experimental methods. My findings will help governments, NGOs and researchers design better programmes to improve people’s health through community participation.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0370-1430', 'authenticated-orcid': False, 'given': 'Ibrahim', 'family': 'Abubakar', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-9691-9684', 'authenticated-orcid': False, 'given': 'David', 'family': 'Osrin', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Nayreen', 'family': 'Daruwalla', 'affiliation': [{'name': 'Society for Nutrition, Education and Health Action (Sneha)', 'country': 'IN'}]}, {'ORCID': 'http://orcid.org/0000-0002-6296-4644', 'authenticated-orcid': False, 'given': 'Beniamino', 'family': 'Cislaghi', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7757-5625', 'authenticated-orcid': False, 'given': 'Matteo', 'family': 'Galizzi', 'affiliation': [{'name': 'London School of Economics and Political Science (LSE)', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3905-0465', 'authenticated-orcid': False, 'given': 'Lu', 'family': 'Gram', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 1]]}, 'award-end': {'date-parts': [[2024, 11, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:43Z', 'timestamp': 1636383103000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220429'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:50Z', 'timestamp': 1636438370318}, 'publisher': 'Wellcome', 'award': '215676', 'DOI': '10.35802/215676', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a cholera rapid diagnostic test that targets both Vibrio cholerae and vibriophage'}], 'project-description': [{'description': 'Rapid diagnostic tests (RDTs) for Vibrio cholerae are screening tools that provide essential data to guide cholera outbreak response and elimination campaigns in settings that do not have access to a conventional microbiology laboratory. Commercial V. cholerae RDTs are immunochromatographic immunoassays that target V. cholerae O1 (and O139) lipopolysaccharide antigens. The sensitivity of theses RDTS is variable for unknown reasons. We have found that lytic vibriophage that can kill V. cholerae during human infection are associated with a failure of RDTs. To address the negative impact of the lytic vibriophage, we propose to develop a new RDT that targets both V. choleare and the dominant lytic vibriophage ICP1 as a proxy for V. cholerae when the bacterium cannot be directly detected. To do this we propose the following specific aims: (i) Identify lytic vibriophage structural and non-structural proteins that are antigenically unique in diarrheal stool matrix. (ii) Produce mAbs against unique lytic vibriophage protein and V. cholerae LPS, and (iii) Produce, test and compare candidate RDTs for highest performance metrics. This proposal will provide a critical tool to the collaborative effort to combat and eliminate cholera as well as set a precedent for similar approaches for other diseases.', 'language': 'en'}, {'description': 'Rapid diagnostic tests (RDTs) for Vibrio cholerae are tools that provide essential data to guide cholera outbreak response and elimination campaigns in settings that do not have access to a conventional microbiology laboratory. However, existing commercial cholera RDTs have had variable perfomance for unknown reason. We have found that a virus (lytic vibriophage) that can kill V. cholerae during human infection is also associated with a failure of RDTs. We propose to develop a new RDT that targets V. choleare and also includes detection for the virus as a proxy for V. cholerae when the bacterium cannot be directly detected. To do this we proposed to develop antibodies that target unique and conserved phage proteins, add these to the RDT, and then validate the new RDT in a clinical study of cholera patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8928-9888', 'authenticated-orcid': False, 'given': 'Firdausi', 'family': 'Qadri', 'affiliation': [{'name': 'International Centre for Diarrhoeal Disease Research, Bangladesh', 'country': 'BD'}]}, {'given': 'Ashraful', 'family': 'Khan', 'affiliation': [{'name': 'International Centre for Diarrhoeal Disease Research, Bangladesh', 'country': 'BD'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2649-2624', 'authenticated-orcid': False, 'given': 'Eric', 'family': 'Nelson', 'affiliation': [{'name': 'University Of Florida', 'country': 'US'}]}], 'award-amount': {'amount': 797228.25, 'currency': 'USD'}, 'award-start': {'date-parts': [[2019, 11, 15]]}, 'award-end': {'date-parts': [[2022, 11, 14]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 582464.2, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:55Z', 'timestamp': 1636383055000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 11, 15]]}, 'URL': 'http://dx.doi.org/10.35802/215676'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:51Z', 'timestamp': 1636438371596}, 'publisher': 'Wellcome', 'award': '221589', 'DOI': '10.35802/221589', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a Universal Group A Streptococcus Glycoconjugate Vaccine'}], 'project-description': [{'description': 'We have recently made the seminal discovery that the Rhamnose-Polysaccharide (RhaPS), a validated vaccine candidate from Group A Streptococcus (GAS), can be recombinantly synthesised using our engineered bacterial glyco-conjugation system. Our vision for the Innovator Award is to translate our proof-of-principle study into late preclinical trials and to develop and validate the first ‘double-hit’ GAS glycoconjugate vaccine candidates. The molecular biology and synthetic biology program focus on optimising protein stability and carbohydrate conjugation to produce for the first-time recombinant GAS glycoconjugate vaccines. The key advantages of our modular designed ‘double-hit’ vaccines include (i) efficacy, (ii) universal protection against all GAS strains and (iii) low-cost production. Lead candidates will be tested for their immunogenicity and the best candidates will be evaluated in two mouse models of GAS infection. We aim to produce at least two vaccine candidates that fulfil the criteria for safety and efficacy. Our vision beyond this 2-year program is to test the best two candidates in clinical trials. We have access to the UCL Vaccine Manufacturing Hub and support from the MSD Wellcome Trust Hillemann Laboratories (for clinical trials and Good Manufacturing Practices for vaccines). We will continue to actively interact with existing industrial partners, including GSK vaccines.', 'language': 'en'}, {'description': 'Group A Streptococcal (GAS) infections kill >500,000 people annually worldwide and currently no vaccine exists. Antimicrobial resistance is emerging globally, and a GAS vaccine is a current global imperative that the WHO has included in its vaccine priority list. An effective GAS vaccine needs to cover all >150 variant strains known and has to be low-cost to be deployed in low income countries where it is most needed. Recently the polyrhamnose sugar backbone that coats GAS cells was validated as vaccine candidate. Sugars are excellent vaccine candidates, particularly when conjugated to carrier proteins, but current methods to achieve this are complex and costly. Using our novel technology, we will conjugate the polyrhamnose sugar to conserved GAS proteins developing a vaccine against all GAS strains. We will use simple E. coli cells that act as mini factories to produce the low-cost vaccine providing the first robust global solution to GAS infection.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6140-9489', 'authenticated-orcid': False, 'given': 'Brendan', 'family': 'Wren', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1288-044X', 'authenticated-orcid': False, 'given': 'Helge', 'family': 'Dorfmueller', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-amount': {'amount': 402298.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 402298.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:10Z', 'timestamp': 1636383130000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221589'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:51Z', 'timestamp': 1636438371618}, 'publisher': 'Wellcome', 'award': '221749', 'DOI': '10.35802/221749', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The dynamics of cell entry and genome replication in a model complex virus'}], 'project-description': [{'description': 'Bluetongue virus (BTV), a complex non-enveloped virus with a genome of ten double-stranded RNA segments, is an important pathogen and model for many similar large non-enveloped viruses (including the medically important rotaviruses). Previous studies have provided a well-understood replication cycle, a large range of research reagents and many novel assay systems, all complemented by high resolution atomic structures of many viral proteins. Notably, the recent structure of the viral polymerase in situ, a critical point of replication, has provided a unique opportunity to investigate many details involved in the virus life cycle. To achieve this we will will use state-of-the-art techniques such as cryoEM, cryo-ET, FCS and FRET in addition to our established in vitro and in vivo assays to determine how BTV entry to the cell causes the polymerase to initiate genome transcription from the 10 genomic dsRNAs and how this process differs from the later process of genome replication which follows the packaging of RNA during assembly. We will define how these processes link to the maturation of newly assembled virus particles and their exit from the cell. Our findings will have the potential to develop laboratory data to translational applications in future design of antiviral and vaccines.', 'language': 'en'}, {'description': 'Viruses enter host cells to establish infection and replicate, i.e. make more copies of their components and assemble into progeny viruses in order to spread. Preventing steps in this process offers the opportunity to control virus disease. Here we focus on Bluetongue virus (a member of a large family of viruses) as a model for complex capsid viruses, to provide answers to fundamental questions of cell entry, genome replication and the generation of new infectious particles. BTV is a pathogenic virus causing economic losses in livestock and the closely related rotavirus causes over 500,000 deaths worldwide through childhood diarrhoea. Using multidisciplinary approaches including state-of-the-art techniques in molecular biology, mutagenesis, super resolution microscopy and cryoEM/ET, we will define the entry and replication processes of these viruses. The results will provide insights into the molecular and structural basis of virus replication and inform rational novel future treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6535-6911', 'authenticated-orcid': False, 'given': 'Polly', 'family': 'Roy', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 1793281.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1793281.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:16Z', 'timestamp': 1636383136000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221749'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:08Z', 'timestamp': 1636438328351}, 'publisher': 'Wellcome', 'award': '221401', 'DOI': '10.35802/221401', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Single Cell Expression Atlas'}], 'project-description': [{'description': 'Single Cell Expression Atlas (https://www.ebi.ac.uk/gxa/sc) is an open science resource that offers powerful searches for a gene expression data in different cell types, across tissues, species and conditions. Since its launch in May 2018, the Single Cell Expression Atlas has annotated and reanalysed 132 single cell RNA-Seq (scRNA-Seq) experiments across 12 different species that can be searched and visualised through its web interfaces. The SCEA is unique in that it reprocesses raw scRNA-Seq data in a standardised way. This proposal aims to keep up with the rapid technology development, expand the resource with new data modalities, continue expanding the species coverage and cross-species mapping and expand the functionality of the resource. In particular, we will integrate single cell data sets from spatial and in-situ transcriptomics technologies, as well as emerging single cell omics protocols. Additionally, we will expand the types of analyses performed to facilitate study integration, cell type discovery and annotation. Finally, we will develop anatomograms at the organ, tissue and cell type level to enable intuitive interpretation of the experimental results and easily integrate the different types of data on the user interface.', 'language': 'en'}, {'description': 'Single Cell Expression Atlas is an open access database providing the ability to perform powerful searches and analysis of single cell gene expression data. Data is generated by re-analysing raw experimental data to high standards. To meet growing demand, we will develop new analysis pipelines to ensure robust results and extend the level of annotation for genes and cell types in new areas of research. Continued web interface improvement will allow researchers to visualise ever more complex data in an easy way to understand. This provides any biological researcher with the ability to reliably reanalyse data from multiple experiments and further progress their research. Increasing numbers of datasets requires changing from a study specific view to that of whole biology. This will be developed alongside a user interface enabling easy interpretation of gene changes at cell level between health and disease and so enable more rapid progress in research areas.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7270-5470', 'authenticated-orcid': False, 'given': 'Irene', 'family': 'Papatheodorou', 'affiliation': [{'name': 'EMBL-EBI', 'country': 'GB', 'id': [{'id': 'https://ror.org/02catss52', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1560990.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1560990.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:04Z', 'timestamp': 1636383124000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/221401'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:11Z', 'timestamp': 1636438331217}, 'publisher': 'Wellcome', 'award': '219762', 'DOI': '10.35802/219762', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Epidemiological and mechanistic studies on the role of pneumococcal conjugate vaccine in antimicrobial resistance in Laos'}], 'project-description': [{'description': 'PCVs prevent pneumonia and invasive pneumococcal disease (IPD). The serotypes contained within PCV are those which carry most antimicrobial resistance (AMR). PCVs reduce the carriage of PCV serotypes, and also limit the use of antibiotics by preventing pneumococcal infections. In the US, the 13-valent PCV (PCV13) reduced childhood IPD AMR by >75%. Despite a high pneumonia burden in Asia, very few countries have adopted PCV into their national immunisation programs. PCV may have a substantial role in reducing AMR and it is vital that the role of PCV in reducing AMR in this region is determined. PCV introduction has also led to serotype replacement with serotypes that are not included in the vaccine (NVTs). It is therefore important to define pneumococcal population changes and identify emergent clones in the post-PCV era. In 2013, we commenced pneumococcal carriage surveillance in Laos in children aged 2- 59 months with acute respiratory infection (ARI). Our proposed study in Laos will: a) determine the PCV13 effectiveness against AMR in pneumococcal carriage isolates; b) determine the AMR and virulence of emerging NVTs; and c) investigate using a life-like system the recombination frequency for the acquisition of resistance genes, and secondary chromosomal insertions, in pneumococcal NVTs.', 'language': 'en'}], 'investigator': [{'given': 'Mayfong', 'family': 'Mayxay', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0002-7620-4822', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Ashley', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0599-8645', 'authenticated-orcid': False, 'given': 'Cattram', 'family': 'Nguyen', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0003-1239-0782', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Simpson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3164-8849', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Satzke', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0003-0573-5658', 'authenticated-orcid': False, 'given': 'Jorge', 'family': 'Vidal', 'affiliation': [{'name': 'University of Mississippi', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3077-9639', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Russell', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}], 'award-amount': {'amount': 760056.0, 'currency': 'AUD'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2023, 3, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 404672.6, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:33Z', 'timestamp': 1636383093000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219762'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:12Z', 'timestamp': 1636438332274}, 'publisher': 'Wellcome', 'award': '215619', 'DOI': '10.35802/215619', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deep conditioning using CRISPR edited T cells'}], 'project-description': [{'description': 'T cells modified to express chimeric antigen receptors (CAR) have been successfully applied to treat B cell malignancies and are now being made more widely available as the first licenced products become available. The application of similar strategies against acute myeloid leukaemia have been challenging, in particular in infants and young children. Mortality is anticipated to be >70% for children who relapse after a first allogeneic transplant in high risk AML, and this reflects a failure to eliminate residual disease with chemotherapy or by anti-leukaemia transplant effects. We propose applying CRISPR base editing tools to generate ‘off the shelf’ T cells expressing CARs against different antigens and aim to secure deep molecular remission during pre-transplant conditioning in children who otherwise face a dismal prognosis. This application seeks to complete preclinical stage investigations of targeted base-conversion by cytidine deamination to disrupt critical genes required to overcome HLA-barriers and allow expression of CARs specific for shared T and myeloid lineage antigens. We propose translational advancement and rapid deployment into a Phase 1 trial in UK and Germany of the most effective available reagents to address unmet clinical need, while continuing development work on additional target antigens and improved editing tools.', 'language': 'en'}, {'description': \"Acute myeloid leukaemia (AML) is a cancer of white blood cells and is treated with chemotherapy, followed by bone marrow transplant from a suitably matched donor. Unfortunately if AML persists through these treatments, the outlook is very poor, with most children succumbing to the disease. We have developed genome engineering techniques to collect and modify healthy donor immune cells (T cells) so that they don't need to be matched to a specific patient, but are armed against AML and can help clear out a patient's bone marrow. This form of 'deep conditioning' uses multiple CARs (Chimeric antigen receptors) to eliminate any AML cells remaining after chemotherapy, and this will then be followed by a second transplant to repopulate the blood and immune system. A similar approach has shown promise against other forms of leukaemia and we believe early application in the highest risk AML children is now justified.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9275-2415', 'authenticated-orcid': False, 'given': 'Farzin', 'family': 'Farzaneh', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Paul', 'family': 'Veys', 'affiliation': [{'name': 'Great Ormond Street Hospital for Children', 'country': 'GB'}]}, {'given': 'Axel', 'family': 'Schambach', 'affiliation': [{'name': 'Hannover Medical School', 'country': 'DE'}]}, {'given': 'Martin', 'family': 'Sauer', 'affiliation': [{'name': 'Hannover Medical School', 'country': 'DE'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8353-4494', 'authenticated-orcid': False, 'given': 'Waseem', 'family': 'Qasim', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4114118.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 12, 1]]}, 'award-end': {'date-parts': [[2023, 12, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 4114118.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:55Z', 'timestamp': 1636383055000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:15Z', 'timestamp': 1636438335836}, 'publisher': 'Wellcome', 'award': '220422', 'DOI': '10.35802/220422', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The evolution of mobile genetic elements in Gram-negative bacteria'}], 'project-description': [{'description': 'I will explore how structural variation can be used to understand the evolution of antimicrobial resistance (AMR) on mobile genetic elements (MGEs). Most previous research is biased towards nucleotide-level variations in the core genome (high-effect SNPs). Now, the availability of complete genomes means that resolving the larger structural variation of MGEs is both possible and increasingly relevant for the spread of AMR. I will develop a framework to model the non-mutational processes which generate this variation, then apply this to the linked evolution of MGEs and their ‘host’ genomes. During this fellowship, I will sequentially: - Aim 1. Develop a tool to quantify structural variation and resolve common blocks around the flanking region of AMR genes, which I have previously shown can be used for phylogenetic reconstruction. - Aim 2. Apply this to longitudinal datasets and obtain rate estimates for non-mutational processes. - Aim 3. Investigate the compensatory evolution of MGEs as they move between genomic backgrounds. Two major applications will be: - Application 1. Small transposons, leading on from my pioneering work on the mcr-1 transposon. - Application 2. Clinical class 1 integrons, which carry multiple AMR genes. This proposal tackles questions of fundamental importance for the evolution of flexible genomes.', 'language': 'en'}, {'description': 'Bacterial genomes can adapt by small changes in individual genes and by structural rearrangements, including new genes which travel between genomes on mobile genetic elements. Structural variation is of particular importance for antimicrobial resistance (AMR). With older DNA sequencing technologies, genomes were incomplete and fragmented. Now, complete genomes are common: the challenge is to understand structural variation. I will use structural variation in bacterial genomes to help us understand their recent evolutionary history. I have developed a promising approach to extract shared sequence patterns from diverse regions around AMR genes. I will extend this and develop models of the underlying processes. I will test specific hypotheses about natural selection in bacterial genomes: between mobile ‘parasites’ and their genome ‘hosts’. By using my computational methods for clinically relevant examples, I will help to understand the evolution and spread of AMR. Making software freely available will allow others to do the same.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7941-813X', 'authenticated-orcid': False, 'given': 'Craig', 'family': 'MacLean', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Richard', 'family': 'Neher', 'affiliation': [{'name': 'University of Basel', 'country': 'CH'}]}, {'given': 'Eduardo', 'family': 'Pimentel Cachapuz Rocha', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7332-0820', 'authenticated-orcid': False, 'given': 'Liam', 'family': 'Shaw', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 5]]}, 'award-end': {'date-parts': [[2025, 1, 4]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:43Z', 'timestamp': 1636383103000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220422'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:12Z', 'timestamp': 1636458252794}, 'publisher': 'Wellcome', 'award': '223535', 'DOI': '10.35802/223535', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'RSTMH small grants for snakebite 2021-23'}], 'project-description': [{'description': 'Snakebite is a strategic priority for RSTMH given its high levels of death and disability. Although there has been an increase in research funding recently, there is still an unmet need to encourage junior researchers to undertake a career in snakebite research. The RSTMH Small Grants Programme is a unique grant funding programme open to early career researchers from anywhere in the world that aims to fill a gap in the research career pathway. RSTMH grants are for up to £5,000 to those early in their careers (e.g. researchers, healthcare professionals, NGO workers, health economists, social scientists) who are working in a field relevant to tropical medicine or global health. These grants typically represent the first time someone has received funding in their own name and helps develop their research and management skills. In 2020, Wellcome piloted a partnership with RSMTH to fund 10 grants in snakebite research. With Wellcome funding, RSTMH awarded grants to African, Asian, South American and European nationals across various snakebite research areas. Following on from the success of the pilot, RSTMH is seeking funding for a 3-year partnership with Wellcome to fund 10 projects per year and up to 30 in total in snakebite research.', 'language': 'en'}], 'lead-investigator': [{'given': 'Tamar', 'family': 'Ghosh', 'affiliation': [{'name': 'Royal Society of Tropical Medicine and Hygiene', 'country': 'GB'}]}], 'award-amount': {'amount': 166200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 18]]}, 'award-end': {'date-parts': [[2024, 6, 17]]}, 'funding': [{'type': 'award', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 166200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:37Z', 'timestamp': 1636383517000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 18]]}, 'URL': 'http://dx.doi.org/10.35802/223535'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:12Z', 'timestamp': 1636458252812}, 'publisher': 'Wellcome', 'award': '220118', 'DOI': '10.35802/220118', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Atomistic Simulations of Cardiac Troponin'}], 'project-description': [{'description': \"Troponin plays an essential role in the skeletal and cardiac muscle contraction process which is mediated by sarcomeric Ca2+ concentration. Phosphorylation on cardiac troponin complex changes troponin's Ca2+ sensitivity hence modulates heart rate. Several point mutations on thin filament disrupt the heart’s normal contractile functionality and eventually lead to inherited cardiomyopathies. It was shown that in the mutated troponin tissues the myofilament Ca2+ sensitivity is not reduced upon phosphorylation by protein kinase A, and this relationship is termed the uncoupling phenomenon. In a recent study of small molecules related to the natural products EGCG and Silybin we found 22 small molecules that were capable of specifically restoring the coupled relationship between Ca2+ sensitivity and phosphorylation state, and these compounds are termed recouplers. In previous studies, our group has attempted at elucidating the changes in protein dynamics introduced by phosphorylation and TNNC1 G159D mutation. In this project, we aim to use molecular dynamics simulations to reveal the underlying mechanisms of recouplers. We hope that with a deeper understanding of the molecular mechanisms of both the disease-causing mutations and the recouplers, we can take a rational approach in designing novel therapeutic compounds that are effective in treating cardiomyopathies while having minimal side-effects.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2957-8063', 'authenticated-orcid': False, 'given': 'Zeyu', 'family': 'Yang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:42Z', 'timestamp': 1636383342000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220118'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:13Z', 'timestamp': 1636458253284}, 'publisher': 'Wellcome', 'award': '223771', 'DOI': '10.35802/223771', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mental Health Science Summit Bursaries'}], 'project-description': [{'description': \"The MQ Mental Health Science Summit, in collaboration with Wellcome, is an interdisciplinary mental health science conference. It brings together people from all disciplines and sectors, focused on transforming mental health. Key to this is the involvement of people with lived experience of mental illness, early career researchers, and delegates from LMICs. Attendance at the Summit is ticketed. Many delegates are attending in a work capacity, and so are both salaried and have their costs covered by their organisation. For certain groups of key delegates, the ticket price is prohibitive. This is particularly true for people with lived experience who often attend such events in a voluntary capacity and some of whom are insecurely employed, early career researchers who often do not have research grants available to cover conference attendance, and delegates from LMICs who are economically less able to have such funds available. Following Wellcome' Cat Sebastian’s contributions to the organising committee, we are applying for £4,000 to enable subsidised places for delegates from these three groups to attend the Summit. This will enable 30 delegates to attend. Aa agreed, any funds not spent on bursaries for this year’s Summit will be used to widen access at subsequent events.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Emily', 'family': 'Wheeler', 'affiliation': [{'name': 'MQ Transforming Mental Health', 'country': 'GB'}]}], 'award-amount': {'amount': 6880.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 12]]}, 'award-end': {'date-parts': [[2021, 6, 11]]}, 'funding': [{'type': 'award', 'scheme': 'Mental Health Priority Area', 'award-amount': {'amount': 6880.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:32Z', 'timestamp': 1636383512000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 12]]}, 'URL': 'http://dx.doi.org/10.35802/223771'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:14Z', 'timestamp': 1636458254914}, 'publisher': 'Wellcome', 'award': '223718', 'DOI': '10.35802/223718', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'DECIPHER'}], 'project-description': [{'description': \"DECIPHER’s mission is to lead an international collaborative effort to collect, annotate, share and aggregate genotypic and phenotypic data on rare disease patients in order to catalyse the discovery of new disorders and to improve clinical diagnostic interpretation of genome variation. It is the only online data-sharing platform which provides live, rich contextualisation of genomic variation and phenotype data in patients undergoing research and diagnostic testing globally, including for underserved areas of the world. Since 2004, collaborating rare disease genomics projects and clinical genetic diagnostic centres have uploaded and openly shared consented data on more than 38,000 patients. Our plans to improve DECIPHER include driving increased global sharing and aggregation of clinical and research data; integrating relevant new research datasets to accelerate discovery science; developing functionality to support variant interpretation of the non-coding genome; and improving gene-phenotype-disease modelling to drive discovery research and drug development. We will migrate DECIPHER from the Wellcome Sanger Institute to EMBL's European Bioinformatics Institute (EMBL-EBI), taking advantage of EMBL-EBI's rich resource environment and expertise in delivering web services and training. DECIPHER will operate and grow in an efficient and sustainable manner, providing an essential bridge to research resources to strengthen their clinical impact.\", 'language': 'en'}, {'description': 'About 6% of individuals have rare genetic disorders, sometimes affecting only dozens of people globally. DECIPHER’s main aims are to enable doctors and researchers worldwide to work together to understand these disorders, to identify new disease-associated genes and potentially to develop new therapies. Our website lets clinical geneticists enter patient data securely and search existing data to find matches amongst other patients with similar rare genetic changes or disorders. A match can provide information on patient outcomes and sometimes a diagnosis or possible treatment. As more genomes are sequenced, we have increased opportunities to find matches between individuals with genetic disorders. Furthermore, we can use information on genetic variation in the wider population so common genetic changes can be ruled out as causes of particular disorders. Our project is truly global: currently, geneticists across more than 200 approved centres in around 40 countries are contributing their patient data to DECIPHER.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6410-0882', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Firth', 'affiliation': [{'name': 'Cambridge University Hospitals NHS Foundation Trust', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7445-2419', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Cunningham', 'affiliation': [{'name': 'European Molecular Biology Laboratory', 'country': 'GB', 'id': [{'id': 'https://ror.org/03mstc592', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1560057.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 4, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1560057.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:28Z', 'timestamp': 1636383568000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223718'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:42Z', 'timestamp': 1636458222054}, 'publisher': 'Wellcome', 'award': '064775', 'DOI': '10.35802/064775', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Electron microscope studies on biological macromolecules.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9445-0069', 'authenticated-orcid': False, 'given': 'Louise', 'family': 'Johnson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 193172.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 193172.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:29Z', 'timestamp': 1636382909000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064775'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:42Z', 'timestamp': 1636458222069}, 'publisher': 'Wellcome', 'award': '083434', 'DOI': '10.35802/083434', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular functions in disease.'}], 'project-description': [{'description': 'Disease may result as a consequence of genetic variation, be acquired through infection, or developed through other interactions with the environment. However, the disease state invariably involves many of these factors interacting in complex interrelated pathways. Understanding the totality of the disease state therefore requires knowledge of the detailed molecular changes that occur and how these impact on cell biology, the tissue and the organism(s). Traditionally, biomedical research has been discipline led and frequently confined within narrow specialisms that offer only a limited perspective. As our understanding of the complexity and interrelatedness of biological systems has increased, it has become clear that a focus on a narrow research field is no longer a tenable approach. It has thus been, and remains, the primary objective of the Molecular Functions in Disease programme to inspire the next generation of biomedical research leaders trained in a broad range of interdisciplinary subjects that will allow them to contribute effectively to research efforts across traditional boundaries.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-7857-4520', 'authenticated-orcid': False, 'given': 'Olwyn', 'family': 'Byron', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2018, 1, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:23Z', 'timestamp': 1636383203000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083434'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225183}, 'publisher': 'Wellcome', 'award': '213494', 'DOI': '10.35802/213494', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Spatiotemporal dynamics of arbovirus transmission: implications for disease control and elimination'}], 'project-description': [{'description': 'This project will better characterise the transmission dynamics of dengue, Chikungunya and Zika viruses, their persistence in the global human population and use the insights gained to refine assessments of the potential impact of interventions. I will develop evidence-synthesis models linking multiple streams of surveillance data to estimate spatiotemporal variations in the reproduction number of Chikungunya and Zika viruses from the recent epidemics in Colombia and Brazil and use age-stratified dengue incidence data to estimate the transmission intensity of dengue. Analyses of geospatial correlation between transmission intensity estimates of the arboviruses will provide insight into transmission similarities and potential immune-mediated interactions. Using advanced inferential techniques, I will characterise climate-dependent entomological and epidemiological parameters, which will be used to produce global dynamic maps of arbovirus transmission intensity. I will then add spatial structure to the dynamical models of arbovirus transmission to explore the extent to which seasonality, immune-mediated interactions, human movement and zoonotic reintroduction determine arbovirus persistence and the feasibility of elimination. Analyses of clinical trial data will provide insights into the immunogenicity, efficacy and mode of action of the Takeda dengue vaccine and inform the targeting and optimisation of vaccination alone and in combination with other interventions in specific locations.', 'language': 'en'}, {'description': 'Every year, hundreds of millions of people are infected by mosquito-borne dengue, Chikungunya, and Zika viruses. New promising vaccines, drugs and other interventions (e.g. making mosquitoes resistant to infection) are in advanced development, but to make best use of these we need to improve our understanding of how these infections are transmitted. We do not yet fully understand how and why transmission varies from place to place and is affected by climate. My research will address these knowledge gaps and will assess how different interventions might reduce or stop disease transmission. I will use mathematics and statistics to analyse case data collected in Latin America to better understand how seasonal changes in climate affect transmission and thus the geographic spread of epidemics and to predict the impact of vaccination alone and in combination with other interventions. This research will inform policymakers on how to best use interventions to prevent disease.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1154-8093', 'authenticated-orcid': False, 'given': 'Neil', 'family': 'Ferguson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9959-0706', 'authenticated-orcid': False, 'given': 'Ilaria', 'family': 'Dorigatti', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 1015573.75, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2025, 3, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 918513.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:49Z', 'timestamp': 1636383049000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213494'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225193}, 'publisher': 'Wellcome', 'award': '220593', 'DOI': '10.35802/220593', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Measuring unmet need in sexual and reproductive health among women under the age of 25'}], 'project-description': [{'description': 'When designing and evaluating health policies, there is a particular challenge that often arises - how do we work out the number of people who need healthcare but haven’t received it? This is often referred to as ‘unmet need’. Although a lot of data are collected regarding the use of healthcare services, by definition, the people who aren’t receiving the services that they require do not contribute to these datasets. My thesis will look at the concept of unmet need through the lens of sexual and reproductive health, attempting to ascertain whether we can calculate levels of unmet need across England using the data that we already have available. Through this project I will attempt to calculate the number of women in England under the age of 25 who did not receive the sexual and reproductive healthcare that they needed between 2010 and 2020. I will then use financial data to work out whether this unmet need was greater in areas that had smaller budgets for sexual and reproductive health during this period.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4177-1832', 'authenticated-orcid': False, 'given': 'Danielle', 'family': 'Solomon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 9, 2]]}, 'award-end': {'date-parts': [[2022, 12, 20]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:30Z', 'timestamp': 1636383330000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220593'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225798}, 'publisher': 'Wellcome', 'award': '216324', 'DOI': '10.35802/216324', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'International Brain Laboratory'}], 'project-description': [{'description': 'Understanding the neural circuit basis of behaviour is one of the great challenges in biology. Yet no single laboratory can study the many brain regions, connections, and cell types working together o coordinate decision-making. There is thus a disparity between the capacity of individual laboratories and the complexity of problems being addressed. The International Brain Laboratory orchestrates the efforts of 21 experimental and theoretical laboratories to understand a single behavior. By standardizing experimental procedures and data pipelines, we enable the data acquired by different laboratories to be assembled into a large combined dataset. Our mouse decision-making task requires valuation of different choices based on sensory evidence, choice selection based on this valuation, and integration of prior experience to update a model of the world. We seek a comprehensive understanding of the neural mechanisms underlying these functions, at scales ranging from single neurons to local microcircuits to inter-area communication. To do so we will harness powerful electrophysiological, optical, and genetic tools, and exploit the rich set of theories and analytical approaches developed in recent years. This large-scale effort will provide the first end-to-end “standard model” of a complex mammalian behavior, and inspire new ways to collaborate on difficult problems in neuroscience.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8947-408X', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Mrsic-Flogel', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-3476-1839', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Dayan', 'affiliation': [{'name': 'Max Planck Institute for Biological Cybernetics', 'country': 'DE'}]}, {'ORCID': 'http://orcid.org/0000-0003-4880-7682', 'authenticated-orcid': False, 'given': 'Matteo', 'family': 'Carandini', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-4921-8521', 'authenticated-orcid': False, 'given': 'Sonja', 'family': 'Hofer', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-5930-6456', 'authenticated-orcid': False, 'given': 'Kenneth', 'family': 'Harris', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7913-9109', 'authenticated-orcid': False, 'given': 'Zachary', 'family': 'Mainen', 'affiliation': [{'name': 'Centro Champalimaud', 'country': 'PT'}]}, {'given': 'Peter', 'family': 'Latham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Alexandre', 'family': 'Pouget', 'affiliation': [{'name': 'University of Geneva', 'country': 'CH'}]}, {'given': 'Jonathan', 'family': 'Pillow', 'affiliation': [{'name': 'Princeton University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-4738-2539', 'authenticated-orcid': False, 'given': 'Ila', 'family': 'Fiete', 'affiliation': [{'name': 'Massachusetts Institute of Technology', 'country': 'US', 'id': [{'id': 'https://ror.org/042nb2s44', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Dora E', 'family': 'Angelaki', 'affiliation': [{'name': 'New York University', 'country': 'US'}]}, {'given': 'Larry', 'family': 'Abbott', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-9318-9636', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Deneve', 'affiliation': [{'name': 'Institut National De La Sante Et Recherche Medicale (INSERM)', 'country': 'FR'}]}, {'given': 'Anthony', 'family': 'Zador', 'affiliation': [{'name': 'Cold Spring Harbor Laboratory', 'country': 'US'}]}, {'given': 'Anne', 'family': 'Churchland', 'affiliation': [{'name': 'Cold Spring Harbor Laboratory', 'country': 'US'}]}, {'given': 'Ilana', 'family': 'Witten', 'affiliation': [{'name': 'Princeton University', 'country': 'US'}]}, {'given': 'Liam', 'family': 'Paninski', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}, {'given': 'Yang', 'family': 'Dan', 'affiliation': [{'name': 'University of California, Berkeley', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-6670-7362', 'authenticated-orcid': False, 'given': 'Karel', 'family': 'Svoboda', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}, {'given': 'Surya', 'family': 'Ganguli', 'affiliation': [{'name': 'Stanford University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2673-8957', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Hausser', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 9599726.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2025, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 9599726.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:00Z', 'timestamp': 1636383060000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216324'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225757}, 'publisher': 'Wellcome', 'award': '222781', 'DOI': '10.35802/222781', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Multiscale computational and experimental investigation of ventricular arrhythmogenesis in diabetes'}], 'project-description': [{'description': 'Ventricular arrhythmia is the leading cause of death in diabetes, but its mechanisms remain poorly understood, leading to suboptimal therapy. I propose an interdisciplinary project to address this unmet need, combining multiscale human cardiac simulations and experimental studies. I will use my recent computational model of a human myocyte ToR-ORd, which was extensively validated for arrhythmia research, disease representation, and drug assessment. Goal 1) To build a computational model of a single diabetic myocyte and use it to elucidate how distinct aspects of diabetic remodelling contribute to arrhythmia, also investigating the role of glucose level disturbance. Goal 2) To demonstrate how remodelling of cardiac sympathetic signalling at the myocyte level affects diabetic arrhythmia vulnerability using simulations informed by newly collected FRET imaging data. Goal 3) To integrate the single-cell results into 3D models of ventricles based on patient-specific clinical imaging data, investigating the diabetic remodelling of cardiac conduction properties. Goal 4) To produce a computational tool to search for new drugs with promising antiarrhythmic effects in diabetes and to assess existing therapies, suggesting their optimisation. In summary, the project is likely to impact future diabetic therapy and to bring new insights into the so-far poorly understood area of diabetic arrhythmogenesis.', 'language': 'en'}, {'description': 'Diabetes mellitus, a metabolic disease characterised by high blood sugar levels, affects 463 million people worldwide. The leading cause of death in diabetes is ventricular arrhythmia, a disturbance of cardiac electrical activity, which remains poorly understood given the difficulty of clinical investigation and lack of translational animal models. I propose to tackle this problem by combining state-of-the-art human-specific computational simulations with new experiments. Building on my recent successful computational model of a human cardiac cell, I will aim to elucidate which aspects of diabetic remodelling promote arrhythmia and how. I will investigate factors such as cell-level remodelling, blood sugar levels, brain-heart communication, and clinically informed structural changes. Ultimately, I will develop new computational methodology to search for promising therapies to treat diabetic arrhythmogenesis. This project will improve our understanding of diabetic arrhythmia and is expected to lead to population-level and personalised translational applications, potentially positively impacting millions of people worldwide.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0157-4386', 'authenticated-orcid': False, 'given': 'Jakub', 'family': 'Tomek', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:04Z', 'timestamp': 1636383544000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222781'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225762}, 'publisher': 'Wellcome', 'award': '222490', 'DOI': '10.35802/222490', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A Suite of Studies Exploring the Impact of Vision Care on Achieving the Sustainable Development Goals in Low and Middle-Income Countries'}], 'project-description': [{'description': \"The following will extend our previous successful trials on impact of vision care on children's education and adult productivity: - CLEVER (Cognitive Level Enhancement through Vision Exams and Refraction): The first randomized trial to assess impact of eye care delivery (near and distance spectacles) on reducing rates of cognitive decline with aging, enrolling 874 participants >= 60 years in Hyderabad, India. - Piloting and delivery of STABLE (Slashing Two-wheeled Accidents By Leveraging Eyecare): The first randomized trial on the impact of vision care (distance spectacles) on traffic safety in a lower-middle income country (Vietnam), involving 875 young myopic motorcycle users. - Piloting and delivery of THRIFT (Transforming Households with Refraction and Innovative Financial Technology): A randomized trial on the impact of free reading glasses to support use of smartphone banking apps in Bangladesh among 400 elderly recipients of government Old Age Allowance payments. - ZEAL (Zimbabwe Eyecare And Learning) formative research on hyperopia and educational outcomes in Zimbabwe: . This work involving 2000 school-aged children in order to prepare for an eventual randomized trial will assess a novel, low cost vision test we have designed to screen for hyperopia, while examining the impact of uncorrected hyperopia on children’s current reading levels.\", 'language': 'en'}, {'description': \"Background: Our past studies have shown that free glasses improve children's studies and adult's work productivity, helping launch large government and industry programs to provide glasses in China and India. We will expand studies to new areas where vision transforms lives. Approach: We will study the impact of giving glasses on: - Slowing cognitive decline in Indian nursing home residents. Three-quarters of them need glasses, and there is evidence vision loss may be linked to cognitive decline, but definite proof is needed. - Improving safety of young motorcycle drivers in Vietnam, who have high rates of both poor vision and accidents. - Enhancing use of smartphone banking apps among the elderly in Bangladesh receiving digital government benefits, who cannot see to use smartphones - Improving learning among far-sighted children in Zimbabwe. Impact: Vision programs launched by successful studies can deliver better mental health in aging, safer streets, enhanced financial resilience and improved children's learning.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9866-3416', 'authenticated-orcid': False, 'given': 'Nathan', 'family': 'Congdon', 'affiliation': [{'name': \"Queen's University Belfast\", 'country': 'GB'}]}], 'award-amount': {'amount': 3100312.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2026, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 3100312.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:37Z', 'timestamp': 1636383577000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222490'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225785}, 'publisher': 'Wellcome', 'award': '222583', 'DOI': '10.35802/222583', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The roles of modern and ancestral visual pathways in the mammalian brain, for defensive behaviours and spatial navigation'}], 'project-description': [{'description': 'In order to survive, animals need to avoid predators and skillfully navigate the environment. These behaviors critically depend on the sense of vision. In mammals, two distinct systems process visual information: the evolutionarily ancient \"superior colliculus\" and the modern \"visual cortex\". We will define their relative functions in two natural behaviors essential for survival: (1)innate defensive responses and (2)spatial navigation. 1)We will study the visual cortex\\'s role in controlling innate defensive behaviors triggered by the superior colliculus. We will focus on the mouse postrhinal-cortex (POR), capitalizing on my discovery that the superior colliculus has, through POR, a dedicated cortical space from which it receives direct excitatory feedback.(Beltramo,Science,2020). We will test the hypothesis that POR, relaying contextual information about the estimated threatening nature of visual stimuli, controls collicular function\\'s plasticity. By silencing distinct cortico-collicular projections, we will determine how the visual cortex shapes the flexibility of colliculus-mediated innate behaviors. 2)We will investigate the contributions of the two visual pathways in spatial navigation, studying how visual input is transformed into the spatial maps found in the entorhinal/hippocampal formation. Perturbing the activity of distinct visual streams, we will establish how the superior colliculus and visual cortex influence the internal maps that guide navigation.', 'language': 'en'}, {'description': 'Our brain is the result of a long evolution. Over time, new brain regions superseded functions originally performed by preexisting areas. Newer structures did not replace older ones but rather integrated with them, increasing circuit complexity. What roles ancient and modern, functionally similar brain regions play in behavior? The visual system offers an ideal model for studying this question. Mammals have two coexisting brain structures processing visual information: the ancient “superior colliculus” and the phylogenetically newer “visual cortex”. We will determine their relative roles in two natural behaviors crucial for survival: (1)innate defensive responses and (2)spatial navigation. Visually-evoked innate defensive behaviors, such as freezing upon detection of distant predators, critically increases survival chances. Equally important is the ability to navigate adroitly, creating internal “spatial maps” of the environment. This project will provide crucial insight into how evolutionarily ancient and modern visual pathways interact to generate complex behaviors essential for survival.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3125-2089', 'authenticated-orcid': False, 'given': 'Riccardo', 'family': 'Beltramo', 'affiliation': [{'name': 'University of California, San Francisco', 'country': 'US'}]}], 'award-amount': {'amount': 1578744.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 7, 15]]}, 'award-end': {'date-parts': [[2026, 7, 14]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 1578744.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:00Z', 'timestamp': 1636383540000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 7, 15]]}, 'URL': 'http://dx.doi.org/10.35802/222583'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:46Z', 'timestamp': 1636458226001}, 'publisher': 'Wellcome', 'award': '222335', 'DOI': '10.35802/222335', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rational engineering of antibody binding kinetics'}], 'project-description': [{'description': 'Therapeutic antibodies – drugs made from defence molecules produced by the body – are becoming increasingly important in treatment of diseases ranging from cancer to hepatitis. These drugs work by binding to the molecules they target called antigens. In order to be effective, an antibody must bind its antigen tightly and this depends in part on how fast it binds the antigen. For example, it has been shown in a set of antibodies against malaria that the ability of antibodies to neutralise the pathogen is highly dependent on the binding rate. Our research will use a multidisciplinary approach to engineer antibodies with the aim of achieving faster binding. Using both computational tools and experiments that characterise the physical properties of antibodies, we aim to identify factors that contribute to the rate of binding. Next, we would like to use this knowledge to generate software to predict changes that can be introduced to an antibody to increase its binding rate. As a way to validate our conclusions, we plan to improve antibodies against malaria. These studies will provide us with insight into the factors that make good therapeutic antibodies and also provide a tool for use by the wider scientific community.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4180-4940', 'authenticated-orcid': False, 'given': 'Bora', 'family': 'Guloglu', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:32Z', 'timestamp': 1636383392000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222335'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227154}, 'publisher': 'Wellcome', 'award': '062242', 'DOI': '10.35802/062242', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD programme in cellular and molecular physiology.'}], 'lead-investigator': [{'family': 'Dolman', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 112596.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 112596.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:46Z', 'timestamp': 1636383166000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062242'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227157}, 'publisher': 'Wellcome', 'award': '060960', 'DOI': '10.35802/060960', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Biological characterisation of cellular senescence.'}], 'lead-investigator': [{'given': 'David', 'family': 'Beach', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 912515.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 912515.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:52Z', 'timestamp': 1636382812000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060960'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227295}, 'publisher': 'Wellcome', 'award': '209513', 'DOI': '10.35802/209513', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of the Durham Centre for Medical Humanities'}], 'project-description': [{'description': 'With the support of the Wellcome Trust, the Durham Centre for Medical Humanities will become a nexus for world class medical humanities research. Spanning disciplines and periods, this research seeks to improve human health through an enhanced understanding of human experience. Over the next five years we will extend the significance and impact of existing medical humanities initiatives at Durham, while also fostering new ideas and projects within four distinct strands of work. Our central goals are to develop more effective ways of understanding human experience; to build interdisciplinary research projects that will enable us to influence clinical and health research, practice and policy; to transform views about and approaches to health care research by involving multiple stakeholders; and to promote and champion our approach across disciplinary, institutional and wider research contexts. Key to achieving these ambitious and longer-term goals will be an application for Wellcome Trust Centre status to continue our work beyond the period of this award.', 'language': 'en'}], 'investigator': [{'given': 'Sarah', 'family': 'McLusky', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7289-4037', 'authenticated-orcid': False, 'given': 'Jane', 'family': 'Macnaughton', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'award-amount': {'amount': 2032905.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 11, 1]]}, 'award-end': {'date-parts': [[2024, 4, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Medical Humanities', 'award-amount': {'amount': 2006948.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:48Z', 'timestamp': 1636383048000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/209513'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227284}, 'publisher': 'Wellcome', 'award': '069242', 'DOI': '10.35802/069242', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The proteome as a multicomponent mixture.'}], 'project-description': [{'description': 'The cytoplasm is a solution of thousands of proteins, as well as other substances such as ions, sugars, etc. Recently, in colloid and polymer physics, theoretical tools have been developed to study solutions with many different species. These solutions with many components are an example of what are called polydisperse mixtures. In parallel with these developments in theoretical physics, information has been obtained through genome projects on the many thousands of different proteins in cells. It is proposed to combine this information, the product of genomics, with theoretical tools developed for polydisperse mixtures, in order to study and understand the basic physical properties of the cytoplasm. Genome data can be used to obtain estimates of the net charges on the proteins in the cytoplasm and the effect of these charges on the thermodynamic stability of the cytoplasm can be calculated using statistical mechanics. As an example of a possible application we suggest the problem of cataracts. At least some cataracts form when some of the protein in the cells of the lens of the eye crystallises. Crystallisation is of course a phase transition, here occurring in vivo. The study of a phase transition in the cytoplasm requires both genomic information about features of the proteins present and the theory developed for polydisperse mixture.', 'language': 'en'}], 'investigator': [{'given': 'Jose', 'family': 'Cuesta', 'affiliation': [{'name': 'Misc Spain', 'country': 'ES'}]}], 'lead-investigator': [{'family': 'Sear', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 12210.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2004, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 12210.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:31Z', 'timestamp': 1636382791000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069242'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:48Z', 'timestamp': 1636458228325}, 'publisher': 'Wellcome', 'award': '222367', 'DOI': '10.35802/222367', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The present is saturated with the past and pregnant with the future: continuous temporal integration of past and future events in the brain'}], 'project-description': [{'description': 'The environment is continuously changing. Our nervous system is capable of integrating these changes over time, facilitating an adaptive interaction with the world. At any moment, our brains are retaining past experiences and estimating future events. In the words of the philosopher Gottfried Leibniz: the present is saturated with the past and pregnant with the future. For example, when two people are having a conversation, retentions of what has just been said are needed in order to construct what will be said in the immediate future. During my doctoral research, I will try to answer the question of whether retention of immediately past events and anticipation of future ones influences present perception both in the visual and in the auditory domains. By manipulating task demands, I also hope to explore whether such effects are flexible and context dependent. To explore how different brain regions across the visual and auditory systems allow for retention and anticipation, I will record electrical brain activity of participants while they observe learned and unlearned sequences of stimuli, such that we can manipulate their anticipation of what is coming . This work will advance the understanding of how events in the environment are integrated in time.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6840-5712', 'authenticated-orcid': False, 'given': 'Irene', 'family': 'Echeverria Altuna', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 11]]}, 'award-end': {'date-parts': [[2023, 10, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:26Z', 'timestamp': 1636383326000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:48Z', 'timestamp': 1636458228338}, 'publisher': 'Wellcome', 'award': '209879', 'DOI': '10.35802/209879', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does in utero exposure to “adverse environments” affect the fetal brain epigenome?'}], 'project-description': [{'description': 'Approximately 10% of pregnant women have diabetes during pregnancy and this is increasing with increasing maternal obesity. Offspring of obese mothers or those with diabetes during pregnancy have increased risk of developing psychiatric disorders and cognitive impairment. However, the mechanism underlying how exposure to maternal diabetes disrupts offspring neurodevelopment remains poorly understood. Epigenetics is a study of changes in gene expression without a change in the primary DNA sequence or cell identity. Epigenetic modification has been shown to occur in offspring of women who are obese or have diabetes in pregnancy, as well as in individuals affected by psychiatric disorders. This project aims to interrogate how the development of the fetus’ brain is affected by exposure to maternal diabetes during pregnancy. Specifically, I will be investigating how gene expression is affected by exposure to hyperglycaemia. I will be using mouse models as well as cell culture models for the study and next-generation sequencing techniques will be used to perform detailed analysis of the epigenome. The findings of my study will be important to further understand how maternal health during pregnancy affects their offspring’s mental health in the short and long term.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3995-0655', 'authenticated-orcid': False, 'given': 'Kahyee', 'family': 'Hor', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 6]]}, 'award-end': {'date-parts': [[2021, 3, 5]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:19Z', 'timestamp': 1636383319000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 6]]}, 'URL': 'http://dx.doi.org/10.35802/209879'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229644}, 'publisher': 'Wellcome', 'award': '083832', 'DOI': '10.35802/083832', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People award.'}], 'lead-investigator': [{'given': 'Colin', 'family': 'Riordan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2007, 11, 1]]}, 'award-end': {'date-parts': [[2009, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:33Z', 'timestamp': 1636383033000}, 'score': 0.0, 'issued': {'date-parts': [[2007, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083832'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229981}, 'publisher': 'Wellcome', 'award': '065515', 'DOI': '10.35802/065515', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The source of excitatory input to the ventral striatal gabaergic local circuit neurons.'}], 'lead-investigator': [{'given': 'Susan', 'family': 'Totterdell', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 200484.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 27]]}, 'award-end': {'date-parts': [[2005, 11, 26]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 200484.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:23Z', 'timestamp': 1636383023000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 27]]}, 'URL': 'http://dx.doi.org/10.35802/065515'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229983}, 'publisher': 'Wellcome', 'award': '215129', 'DOI': '10.35802/215129', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Examining the cumulative effects of stress and immune challenge in early life on the risk of mood disorders in adulthood'}], 'project-description': [{'description': 'Childhood adversity is associated with a raised risk of psychiatric illness, including mood disorders, in adulthood. This is detrimental to the wellbeing and productivity of affected individuals, and costly to health and social services. The type of early-life stress associated with adverse childhood experiences has been found to suppress the immune system, leaving it more vulnerable to illness and infection. Mood disorders are linked to whole-body inflammation. Inflammatory changes in the body are associated with onset of depression; also, depressed people have a higher level of inflammatory markers in their blood than non-depressed people. This suggests that inflammation may play a role in causing and maintaining mood disorders. This makes it possible that as well as directly contributing to the risk of adult mood disorders, childhood adversity makes you vulnerable to illness, which adds a second burden of risk through inflammatory pathways. Identifying the changes in the brain associated with this ‘cumulative risk’ could help identify the best treatment for patients with a history of both childhood adversity and inflammatory illness. This PhD project aims to identify those brain changes at a cellular and molecular level in an animal model, and on a structural level using brain imaging from humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1617-3822', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Madden', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:57Z', 'timestamp': 1636383237000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215129'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:51Z', 'timestamp': 1636458231729}, 'publisher': 'Wellcome', 'award': '222311', 'DOI': '10.35802/222311', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural mechanisms of attachment in early life.'}], 'project-description': [{'description': \"Kin recognition is an organism's ability to distinguish between genetically close or distant individuals1, which facilitates social attachment among kin2. This is crucial after birth when parental care is needed. Kin responsive neurons have been identified in the rat lateral septum3, a brain structure associated with human kin-affiliation4,5. Human and animal data suggest that endogenous opioids in the brain mediate social attachment and an endogenous opioid-releasing circuit extends from the hypothalamus to the lateral septum. 6–8 In my project, I will test to see if this circuit mediates maternal attachment in early life. I will first confirm preliminary findings from our team that opioid action in the septum is necessary for maternal attachment by activating/inhibiting the lateral septal opioid system and characterising the resulting effects on maternal attachment behaviour in rat pups. To understand the cellular mechanisms involved, I will characterise the activity of lateral septum neurons when endogenous opioids are released. Finally, to explore if the findings are translatable to humans, I will investigate associations between attachment types and septal structure and connectivity in infants. These studies may help elucidate the physiology of early attachment and ultimately provide a rationale for improving the environment of care in early life.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9461-0675', 'authenticated-orcid': False, 'given': 'Lorena', 'family': 'Jiménez Sánchez', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:13Z', 'timestamp': 1636383493000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222311'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:52Z', 'timestamp': 1636458232914}, 'publisher': 'Wellcome', 'award': '222326', 'DOI': '10.35802/222326', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Telomeric chromatin and VSG allelic exclusion in African trypanosomes'}], 'project-description': [{'description': 'Trypanosomes are single-celled parasites that causes lethal diseases in humans and livestock. The parasite is covered in variable surface glycoprotein (VSG) that enables host immune system evasion. VSG is often swapped by ‘antigen switching’, which is central for the parasite’s virulence. My group found that the active VSG suppresses expression of other VSGs. As VSG genes are located near the ends of chromosomes, we hypothesise that the characteristic and highly repetitive sequences at chromosome ends are important for suppression. To facilitate studying this, I will manipulate the dosage of these sequences using new genome editing tools (CRISPR/Cas9). Also, I will explore the function of the proteins that package these regions. Again, I will use CRISPR/Cas9 to create parasites with a single copy of each gene encoding these packaging proteins, allowing me to manipulate those genes as well. These proteins impact DNA repair, DNA replication and gene regulation. This project will provide new insight into how chromosome ‘caps’ function, how VSG genes behave at these locations and may also reveal potential drug targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9760-9119', 'authenticated-orcid': False, 'given': 'Marketa', 'family': 'Novotna', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 22]]}, 'award-end': {'date-parts': [[2023, 9, 21]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 22]]}, 'URL': 'http://dx.doi.org/10.35802/222326'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235511}, 'publisher': 'Wellcome', 'award': '066918', 'DOI': '10.35802/066918', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Ist international workshop on simultaneous EEG and fMRI held at the Institute of Neurology on 2nd March 2002.'}], 'lead-investigator': [{'given': 'Louis', 'family': 'Lemieux', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4970.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 2]]}, 'award-end': {'date-parts': [[2002, 4, 1]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4970.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:24Z', 'timestamp': 1636382904000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 2]]}, 'URL': 'http://dx.doi.org/10.35802/066918'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235557}, 'publisher': 'Wellcome', 'award': '215845', 'DOI': '10.35802/215845', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Pathophysiology and prognosis of septic and dengue shock in Vietnam'}], 'project-description': [{'description': 'Shock occurs when severe infection causes low blood pressure and it is life threatening without treatment. In high-income countries shock is usually caused by bacterial infection. But in low/middle-income countries bacteria and viruses like dengue cause shock. In these infections shock occurs, in part, due to fluid leaking from the blood vessels into the tissues. I will investigate whether we can predict which patients are most at risk of developing from dengue shock when they first come to the outpatient clinic. I will then investigate what drives fluid to leak from blood vessels to cause low blood pressure, and whether the mechanisms are different between patients with bacterial versus dengue shock. I will do this by studying 250 adults admitted to intensive care in Vietnam with both conditions. I will measure how leaky their blood vessels are, using blood tests, ultrasound and a specially designed monitor of blood vessel function. I will also calculate the costs of the illness, and follow the patients for 6-months to see if they have persisting ill health, disability or abnormal blood vessel function after discharge. My results may highlight possibilities for new treatments to reduce fluid-leak and thereby reduce deaths from infectious shock.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5507-0415', 'authenticated-orcid': False, 'given': 'Angela', 'family': 'McBride', 'affiliation': [{'name': 'Brighton and Sussex Medical School', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 3]]}, 'award-end': {'date-parts': [[2022, 11, 25]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:44Z', 'timestamp': 1636383464000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 3]]}, 'URL': 'http://dx.doi.org/10.35802/215845'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235983}, 'publisher': 'Wellcome', 'award': '217135', 'DOI': '10.35802/217135', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Fractures in Sub-Saharan Africa: epidemiology, economic impact and ethnography'}], 'project-description': [{'description': 'Sub-Saharan African (SSA) already has twice the number of older adults than northern Europe, with life expectancy rising rapidly. Ageing exponentially increases fracture risk. The WHO have called for action to prevent and manage fragility fractures in SSA in the next decade; there is an urgent and compelling need for research to inform actions to improve healthcare provision. We will establish vertebral fracture prevalence (the commonest fragility fracture), hip fracture incidence (the most life-challenging fragility fracture) and, over 12-months, their impact on survival, disability and health costs. We will examine the contribution of risk factors of importance in the context of SSA, e.g. HIV, body composition. Ethnographic research will inform understanding of fracture care pathways, patient’s beliefs, patterns of health service delivery and factors influencing implementation of fracture services. To ensure success, our collaboration encompasses international expertise in epidemiology, health economics, anthropology/qualitative methodology, HIV medicine, orthopaedic surgery, gerontology, skeletal imaging, and country-specific research experience within Gambia, Zimbabwe and South Africa. This application builds on our recently-completed South African hip fracture incidence study. The myth that fragility fractures are not an African problem is out-dated; high-quality research is needed, to enable a response to the WHO’s call to be realised.', 'language': 'en'}, {'description': 'Background Africa is changing rapidly: people are living longer which brings risks e.g. fractures. Fractures cause pain, disability and sometimes death. HIV infection increases fracture risk and hampers recovery. Fractures strain healthcare services and are expensive. For countries to plan healthcare services they need to understand the scale of the problem and its costs and the resources currently in place. Approach In South Africa, Zimbabwe and The Gambia we will establish how frequently two key age-related fractures occur: spine fractures (the commonest) and hip fractures (the most life-challenging). We will assess recovery, disability and death rates following hip fracture, identifying factors that improve outcomes. We will calculate current and future health service costs for fractures. By talking with patients and healthcare workers we will learn of their experiences, understanding how future care can be improved. Impact Greater understanding of fracture care will inform health service policy and planning in Africa.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-3353-2882', 'authenticated-orcid': False, 'given': 'Rachael', 'family': 'Gooberman-Hill', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7660-9176', 'authenticated-orcid': False, 'given': 'Rashida', 'family': 'Ferrand', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3644-1388', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Costa', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7034-6750', 'authenticated-orcid': False, 'given': 'Kate', 'family': 'Ward', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8011-0722', 'authenticated-orcid': False, 'given': 'Sian', 'family': 'Noble', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0859-868X', 'authenticated-orcid': False, 'given': 'Bilkish', 'family': 'Cassim', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6414-0529', 'authenticated-orcid': False, 'given': 'Celia', 'family': 'Gregson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 3687583.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2025, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1802255.0, 'currency': 'GBP', 'percentage': 49}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217135'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:00Z', 'timestamp': 1636458240013}, 'publisher': 'Wellcome', 'award': '223082', 'DOI': '10.35802/223082', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'TREAT-HD: Delivering therapies to prevent neurodegeneration in Huntington’s disease'}], 'project-description': [{'description': 'Our overarching hypothesis is that mechanistic insights from preclinical models of Huntington’s disease (HD) and their genetic treatment are valid for early human pathogenesis and can therefore be realised as the foundation for transformative, preventive, clinical trials. A major obstacle to treatment is that degenerative conditions are usually diagnosed once compensatory mechanisms have been exhausted and irrecoverable cell death has occurred. TREAT-HD shifts the focus to mechanisms underlying earlier and asymptomatic stages of pathogenesis as a better time to initiate treatment. We test our hypothesis through three inter-linked aims (Figure 1) that establish the earliest consequences of mutant huntingtin protein (mHTT) in cells, mice and humans with the aim of developing novel therapeutics to delay or prevent symptom onset. Aims: 1. Determine molecular mechanisms associated with somatic CAG-repeat expansion as targets for novel therapeutics by examining agents targeting DNA repair pathways in cellular and mouse models of HD 2. Determine early systems-level pathology and impact on symptomatology in young adult HD mutation carriers to test the hypothesis that neurodevelopmental effects on brain structure occur before progressive neurodegeneration 3. Integrate molecular and systems-level insights for therapeutic benefit by identifying and validating target engagement and efficacy markers for future clinical trials', 'language': 'en'}, {'description': 'Huntington’s disease (HD) is caused by a faulty gene resulting in the build-up of a toxic protein. This damages brain cells, leading to problems with movement, thinking and behaviour. We know that the earliest signs of damage occur more than 20 years before the appearance of clinical symptoms. We believe this will be the optimum time to intervene with treatments. To find out if this is true we will: - Examine cell and mouse models to investigate how variability within the HD gene drives disease and whether drugs directed at these celluar processes have therapeutic benefit. - Study a group of young adult gene carriers decades before we expect symptoms to begin. Using brain imaging and assessments of behaviour we will obtain a detailed understanding of how the disease affects the brain over time. - Combine this information to develop measures which will help us determine whether future treatments are effective.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4041-6305', 'authenticated-orcid': False, 'given': 'Gillian', 'family': 'Bates', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-9623-7007', 'authenticated-orcid': False, 'given': 'Geraint', 'family': 'Rees', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7216-8679', 'authenticated-orcid': False, 'given': 'James', 'family': 'Rowe', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-5426-2140', 'authenticated-orcid': False, 'given': 'Hui', 'family': 'Zhang', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2716-2045', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Tabrizi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3313863.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 1, 1]]}, 'award-end': {'date-parts': [[2026, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 3313863.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:33Z', 'timestamp': 1636383573000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223082'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241303}, 'publisher': 'Wellcome', 'award': '222937', 'DOI': '10.35802/222937', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mental and Cognitive Health Effects of Ketamine on Lateral Habenula Activity in Treatment Resistant Depression'}], 'project-description': [{'description': 'Clinical depression often involves by a pessimistic view of things which have happened in the past and an impairment in the ability to experience pleasure or looking forward to things. A licensed drug called ketamine affects the levels of glutamate, a chemical messenger in the brain, and has been used as a treatment particularly for depression which hasn’t got better with other types of medication. Glutamate plays a role in learning and memory so we are interested in understanding how ketamine can affect how we remember our past negative and positive memories processes. We are conducting a series of studies in both depressed participants and healthy volunteers to improve our understanding on how ketamine can influence memory and the way people learn from rewards and punishments. Study participants will undergo medical and psychiatric health screening, drug administration (ketamine or saline), questionnaires and computer tasks, and MRI scans before and after the administration of the study drug. MRI is a type of brain scan that allows us to see how the brain responds during for example memories of things which have happened in the past. This project will help us understand how ketamine may work in depression.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7937-8596', 'authenticated-orcid': False, 'given': 'Sara', 'family': 'Costi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 11]]}, 'award-end': {'date-parts': [[2023, 10, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:17Z', 'timestamp': 1636383377000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241291}, 'publisher': 'Wellcome', 'award': '222949', 'DOI': '10.35802/222949', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Synthesis and evaluation of novel antagonists and fluorescent ligands for the human P2Y2 receptor'}], 'project-description': [{'description': 'The human P2Y2 receptor is one of a large and diverse family of disease-relevant drug targets called G protein-coupled receptors. The P2Y2 receptor is a promising therapeutic target for important conditions, including metastatic cancer. However, no drugs which block the P2Y2 receptor have ever entered clinical trials. The research group recently published an initial study where novel P2Y2 receptor inhibitors, that prevent the action of the receptor, with good biological activity were produced. The project will build on this previous work to design, synthesise and evaluate further inhibitors with improved biological activity and \"drug-like\" properties to make them more clinically viable. The design of these inhibitors will be driven by visualisation of key interactions with the P2Y2 receptor in computational models. Another subsequent part of the project will involve equipping these novel inhibitors with a light emitting fluorescent dye that can be used to investigate their interaction with the P2Y2 receptor in cell and tissue-based experiments with state of the art imaging equipment. Novel, high affinity and drug-like P2Y2 receptor inhibitors and their fluorescently-labelled counterparts would provide a vital tool to further validate the role of P2Y2 in disease and aid in the development of clinically viable drugs.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8344-654X', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Knight', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:16Z', 'timestamp': 1636383436000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222949'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241302}, 'publisher': 'Wellcome', 'award': '222963', 'DOI': '10.35802/222963', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Emergency Efforts to Sustain UK Government Support for ODA'}], 'project-description': [{'description': 'In the 2020 Spending Review HMG signaled its intent to renege on a manifesto commitment and cut ODA form 0.7 to 0.5% of GNI (on top of the budget cut that happened automatically due to economic contraction). To do this, HMG wishes to repeal the relevant in coming months. Work to sustain the Government’s support for ODA is already delivering results with an increasingly credible threat of a government rebellion and sustained media interest. However, increasingly our political intel says we may be at risk of winning the vote and losing the argument. Put simply, ‘hard whipping’ of a rebellion, combined with some horse-trading between different groups, might be enough to carry a vote but it won’t stop the debate flaring back up. This grant would allow us to scale the emergency effort around the legislation while also creating a more enabling environment for the longer team: - by bolstering our public affairs capability in Qs 1/ 2, - by expanding our local organising effort to an additional ten constituencies from Q1-4 and - by expanding our comms plans from Q1-4. A key part of this partnership would be Wellcome’s inclusion in regular political updates, intel and learning sessions.', 'language': 'en'}], 'lead-investigator': [{'given': 'Kirsty', 'family': 'McNeill', 'affiliation': [{'name': 'Save the Children (ELHRA)', 'country': 'GB'}]}], 'award-amount': {'amount': 150000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2022, 2, 28]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 150000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:35Z', 'timestamp': 1636383515000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222963'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243535}, 'publisher': 'Wellcome', 'award': '060632', 'DOI': '10.35802/060632', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution towards a meeting'}], 'lead-investigator': [{'family': 'Collard', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2384.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 1]]}, 'award-end': {'date-parts': [[2000, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2384.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:33Z', 'timestamp': 1636382913000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060632'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243569}, 'publisher': 'Wellcome', 'award': '060565', 'DOI': '10.35802/060565', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Hypoxic pulmonary vasconstriction: the role of an endothelium derived constricting factor.'}], 'investigator': [{'given': 'Philip', 'family': 'Aaronson', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7037-4268', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Ward', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 48106.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 2, 1]]}, 'award-end': {'date-parts': [[2001, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 48106.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060565'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243573}, 'publisher': 'Wellcome', 'award': '062772', 'DOI': '10.35802/062772', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD in Infection and Immunity.'}], 'lead-investigator': [{'given': 'Judith', 'family': 'Philip', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 117049.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 117049.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:08Z', 'timestamp': 1636383188000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062772'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245048}, 'publisher': 'Wellcome', 'award': '061458', 'DOI': '10.35802/061458', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Pathogenesis of Varicella-Zoster virus infection in skin: Glycoprotein C as a virulence determinant and viral immunomodulatory effects on MHC Class 1.'}], 'lead-investigator': [{'family': 'Hinchliffe', 'affiliation': [{'name': 'Stanford University', 'country': 'US'}]}], 'award-amount': {'amount': 82418.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82418.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:22Z', 'timestamp': 1636383022000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061458'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245202}, 'publisher': 'Wellcome', 'award': '208465', 'DOI': '10.35802/208465', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'William Grey Walter and the Burden Neurological Institute'}], 'project-description': [{'description': 'This secondment project seeks to improve the organisation, accessibility, and public knowledge of the objects and papers held by the Science Museum relating to the work of William Grey Walter and his colleagues at the Burden Neurological Institute (BNI). Documenting pioneering work that has left a profound mark on clinical research and practice, the BNI collection constitutes one of the richest archival and material resources in Britain for understanding the development of twentieth-century neuroscience. This project aims to raise the profile of this unique resource in three ways. Firstly, the project will digitise and expand the existing catalogues of the BNI collection, empowering researchers to locate and use materials in new and innovative ways. Secondly, the project will provide fully researched biographies of key personnel for the \\'creators\\' records on the Science Museum\\'s Collections online website. These will provide comprehensive yet accessible introductions to the careers and personalities that shaped the BNI\\'s work. Finally, the project will produce an online visual resource open to both researchers and the public. Using the recorded \"brain waves\" of the electroencephalograph (EEG) as a model, this resource will help users to visualise how the documents, objects, and personalities of the BNI interacted.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4248-5491', 'authenticated-orcid': False, 'given': 'David', 'family': 'Saunders', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 12046.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 10, 25]]}, 'award-end': {'date-parts': [[2018, 1, 25]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Medical Humanities', 'award-amount': {'amount': 12577.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:47Z', 'timestamp': 1636383047000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 25]]}, 'URL': 'http://dx.doi.org/10.35802/208465'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245201}, 'publisher': 'Wellcome', 'award': '065105', 'DOI': '10.35802/065105', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The roles of cytosolic free Ca2+ concentration and PI3kinase gamma in signalling neutrophil shape change.'}], 'lead-investigator': [{'family': 'Tian', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 82276.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 2]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82276.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:26Z', 'timestamp': 1636383026000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245234}, 'publisher': 'Wellcome', 'award': '205000', 'DOI': '10.35802/205000', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Open Science Prize'}], 'lead-investigator': [{'given': 'Roberto', 'family': 'Toro', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 58340.4, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 7, 4]]}, 'award-end': {'date-parts': [[2016, 11, 30]]}, 'funding': [{'type': 'prize', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 58340.4, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 7, 4]]}, 'URL': 'http://dx.doi.org/10.35802/205000'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247725}, 'publisher': 'Wellcome', 'award': '220099', 'DOI': '10.35802/220099', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A global model for the evolutionary dynamics of seasonal influenza'}], 'project-description': [{'description': 'Influenza epidemics infect between 10% and 20% of the global population each year. Infection typically infers a lifetime immunity on an individual, but due to the gradual accumulation of mutations new strains can emerge that evade the host’s immunity and allow repeat infection. This ‘antigenic drift’ of influenza has been well characterised, but the origins of the observations are not well understood. A limited number of models have attempted to explain the observed effects. However, none of the models has included a realistic spatial component or realistic population sizes. The aim of this project will be to develop a computational model of influenza evolution that incorporates realistic population sizes and spatial spread at a global scale. The model will be based on individuals and allow spatially dependent transmission. The model will include a probability of mutation of a strain upon infection of an individual. By tracking each individual’s immune status based on previous infections evolution will naturally occur in the model to evade population immunity. This model will lead to a greater understanding on the complex relationship between human ecology and the evolutionary dynamics of influenza. It is possible it may also inform future surveillance and vaccine protocol.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8086-4495', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Eales', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 2]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:14Z', 'timestamp': 1636383374000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220099'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247767}, 'publisher': 'Wellcome', 'award': '219624', 'DOI': '10.35802/219624', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Full-Waveform Imaging of the Human Brain'}], 'project-description': [{'description': \"The requested funding will enable us to develop, test, refine and deliver a prototype device, generating the world's first three-dimensional in-vivo high-resolution ultrasound image of the adult human brain. We will achieve this by applying full-waveform inversion, a technique well-established in geophysics, to non-invasive transmitted-and-reflected ultrasound data acquired using a three-dimensional stereotactic array of transducers surrounding the head. Our long-term goal is to introduce a new brain-imaging modality with the potential to transform clinical and research practice. This will uniquely enable whole-brain, high-resolution, high-contrast, structural, functional, and angiographic imaging that is fast, safe, portable, universally applicable, and deployable continuously, and of a quality that matches magnetic resonance imaging. Though our method is potentially transformative across the whole of healthcare and neuroscience, we will initially target three key areas of rapid, large-scale impact: - hospital management of acute neurological disorders – stroke, head injury and delirium; - pre-hospital assessment of brain integrity – in the ambulance, and on the sports, industrial or military field; - continuous brain monitoring – intra-operatively and during intensive care. Our vision coheres with the increasing availability, driven by the artificial-intelligence revolution, of high-performance computing within healthcare, enabling high-fidelity biological signals to be extracted from safe, established, well-understood physical methods.\", 'language': 'en'}, {'description': 'Rapid brain imaging is central to the diagnosis and treatment of acute neurological conditions, but existing imaging methods require large, immobile, high-power instruments that are near-impossible to deploy outside specialized environments. We will create a device that can be simply and rapidly applied to any patient, any time, any place, exploiting advances that have already revolutionised imaging in geophysics. We will image the brain using sound waves, transmitted across the head, applying advanced computer modelling to remove the distorting effects of the skull, thereby enabling high-resolution high-contrast imaging of the brain unachievable by conventional ultrasound. Safe, fast, universally applicable, deployable continuously, and above all portable by paramedics, our device will revolutionise brain imaging, in health and disease. The technology has particular relevance to stroke – globally the second-commonest cause of premature death and a major, growing cause of adult disability – and to brain imaging in resource-limited and inaccessible environments.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2718-4423', 'authenticated-orcid': False, 'given': 'Parashkev', 'family': 'Nachev', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7686-425X', 'authenticated-orcid': False, 'given': 'MengXing', 'family': 'Tang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1858-218X', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Warner', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'given': 'Joanna', 'family': 'Morgan', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0526-0640', 'authenticated-orcid': False, 'given': 'Lluis', 'family': 'Guasch', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 755414.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 755414.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:31Z', 'timestamp': 1636383091000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219624'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247749}, 'publisher': 'Wellcome', 'award': '214622', 'DOI': '10.35802/214622', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Examining the economic burden, experiences and coping strategies for patients with hypertension in Kenya'}], 'project-description': [{'description': 'The growing burden of non-communicable diseases (NCDs) has been identified as one of the leading threats to economic growth. Mortality and morbidity due to NCDs result in significant economic impact on households, health systems and societies through draining of household incomes, straining of health system resources, and losses in income, productivity and capital formation. To galvanize support for and inform responses to tackling NCDs, evidence on the economic burden, patient experiences with the health system and coping strategies for these illnesses is needed. In Kenya, this evidence is limited. My proposed study will fill this knowledge gap. I intend to use a mixed-methods approach; employing both quantitative economic methods, and qualitative inquiry through in-depth interviews (IDIs) to examine the economic burden of hypertension to Kenyan households and to assess the experiences and coping strategies for individuals diagnosed with hypertension. To estimate the economic burden of hypertension to households, the study will employ the cost-of-illness approach. To explore the experiences and coping strategies of hypertensive patients, I will collect narratives through in-depth non-structured interviews with participants drawn from different socio-economic quintiles. Evidence from this study will inform health system policy and practice in Kenya and similar settings.', 'language': 'en'}, {'description': 'High blood pressure (hypertension) is increasingly becoming an important health problem in Kenya. Anecdotal evidence suggests that living with hypertension can be a difficult experience. I would like to understand the consequences of living with hypertension for individuals and their families. I will consider what impact the illness has on their personal well-being and financial status, and whether or how they are exposed to financial hardship. I will also examine the strategies they use to cope with their illness. I will ask patients about their health-seeking behavior, associated costs and coping strategies used. I plan to collect data such as medication costs and income loss by patients. Using different methods of data collection will enrich my analysis of the issues at hand. I anticipate that the results will be useful to policy makers seeking to address hypertension in low resource settings like Kenya.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8768-6014', 'authenticated-orcid': False, 'given': 'Robinson', 'family': 'Omondi', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}], 'award-amount': {'amount': 120000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 1, 14]]}, 'award-end': {'date-parts': [[2021, 7, 14]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 120000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:04Z', 'timestamp': 1636383004000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 1, 14]]}, 'URL': 'http://dx.doi.org/10.35802/214622'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247771}, 'publisher': 'Wellcome', 'award': '217163', 'DOI': '10.35802/217163', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'C-type lectins in antifungal immunity'}], 'project-description': [{'description': 'I have established that C-type lectin receptors (CLRs) play a central role in antifungal immunity. In this proposal, I will capitalize on our exciting recent discoveries to address two questions that represent novel aspects of CLR biology: - How do CLRs regulate antifungal adaptive immunity? We discovered dendritic cell expressed CLRs, the KLRs, which regulate the development of adaptive immunity during fungal infection. Our objective is to determine the physiological role of the KLRs, elucidating their cellular expression and function, the nature of their T-cell ligand(s), their influence on T-cell immunity and their importance in anti-fungal immunity. - What is the impact of fungal secondary metabolite recognition by CLRs? We identified two novel CLRs that recognise fungal secondary metabolites, including secreted toxins such as aflatoxin (a major clinically significant fungal-derived carcinogen). Our objective is to gain a definitive understanding of the functions of these receptors and the immunological and physiological impact of their ability to recognise these secreted fungal products. Using a variety of in vivo and in vitro approaches, this research programme will significantly advance our knowledge of the underlying mechanisms of antifungal immunity, and will open new fields of investigation in the areas of adaptive immunity and medical mycology.', 'language': 'en'}, {'description': 'Fungi have a huge impact on human morbidity and mortality. I discovered that C-type lectin receptors (CLRs) are important for controlling these infections, although we do not yet fully understand how these receptors mediate their protective effects. I aim to determine how new CLRs that we have recently identified are able to regulate adaptive immune responses, which are critical for protecting against fungal infections, and mediate responses to secreted fungal products, including carcinogenic compounds such as aflatoxin. Using a variety of cell-based and biochemical approaches, along with comparative in vivo analyses of wild type versus genetically altered mice, I will determine the cellular and immunological roles of these novel receptors. This research programme will significantly advance our understanding of the physiological functions of CLR in antifungal immunity, and open new fields of investigation in immunology and medical mycology.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0287-5383', 'authenticated-orcid': False, 'given': 'Gordon', 'family': 'Brown', 'affiliation': [{'name': 'University of Exeter', 'country': 'GB'}]}], 'award-amount': {'amount': 2275853.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 1, 1]]}, 'award-end': {'date-parts': [[2024, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2275853.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:03Z', 'timestamp': 1636383063000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:11Z', 'timestamp': 1636458251660}, 'publisher': 'Wellcome', 'award': '220788', 'DOI': '10.35802/220788', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Engineering genomic features to better understand the molecular basis of immune mediated diseases and their treatment'}], 'project-description': [{'description': 'Genetic and transcriptional studies have demonstrated that shared aetiology between immune-mediated diseases (IMD) is reflected in shared patterns in both data types, and suggested new targets for treatment. However, the huge number of variants and genes measured mean that only a minority of potential information in these data has been harnessed, and disease prognosis and treatment success remains variable and unpredictable. My goal is to overcome this dimensional challenge by developing genomic feature engineering which exploits these shared patterns, to extract new insight from jointly analysing over a hundred existing datasets. I will generate summary features by tailoring dimension-reduction strategies and applying them to genetic and transcriptomic data from patients and cohorts with related traits measured. I will investigate how each feature contributes to rare and common IMD risk, and prognostic variability within diseases. I will correlate features with molecular measurements and clinical data to understand the gene products they represent, and the situations (cell type, disease state/subtype) in which they are relevant. Finally, through predictive modeling, I will explore the expected impact of targeting these gene products in different diseases and subtypes, to generate, and test, hypotheses about which targets might modify specific IMD activity or progression.', 'language': 'en'}, {'description': 'Genetic and transcriptional studies of immune-mediated diseases (IMD) have demonstrated complex sharing of features between these diseases, suggested new treatments, and collectively generated data on 100,000s of IMD patients. However, successes have been limited because huge sample sizes are required to robustly assess the millions of genetic variants or thousands of genes measured. Disease prognosis and treatment success in IMD remain variable and unpredictable. I will mine these data across diseases, to generate orders of magnitude fewer summary features describing shared IMD factors in a more parsimonious manner. I will use molecular measurements and clinical data to understand the gene products the features represent, and their relevant contexts (cell type, disease state/subtype). Through this targeted feature engineering, I aim to describe the relationships between different IMD, both common and rare, and identify new therapeutic treatment targets or diseases/disease-subtypes where existing treatments may be newly applicable.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9755-1703', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Wallace', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1243595.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2026, 1, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1243595.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:54Z', 'timestamp': 1636383114000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220788'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:11Z', 'timestamp': 1636458251698}, 'publisher': 'Wellcome', 'award': '220536', 'DOI': '10.35802/220536', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The implementation of atrial fibrillation screening in primary care: a mixed-methods process evaluation of the SAFER trial'}], 'project-description': [{'description': 'In atrial fibrillation (AF), the heart beats irregularly. This may produce no symptoms but can cause stroke: 1 in 10 strokes occur in people who do not know that they have AF. Subsequently, there are calls for screening for AF but we first need information on whether screening reduces strokes and is cost-effective. The SAFER trial will study this by comparing the rates of stroke (and other conditions) in general practices that screen to those that do not. Some practices will be given training to perform screening but how they implement it will affect whether screening improves health. I will review evidence for how practices can best implement screening. I will observe how practices implement AF screening by examining training, day-to-day running, consultations, communications, and interviewing staff. I will send quarterly surveys to practices that perform and do not perform screening to see how they differ. I will finally combine my research to discover how best to implement AF screening. My results will guide practitioners and researchers on screening. It will help the trial run AF screening more successfully and explain the trial results more clearly. We can then recommend to screening agencies how AF screening programmes should be run.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9651-6690', 'authenticated-orcid': False, 'given': 'Rakesh', 'family': 'Modi', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:36Z', 'timestamp': 1636383336000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220536'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:15Z', 'timestamp': 1636458195779}, 'publisher': 'Wellcome', 'award': '061390', 'DOI': '10.35802/061390', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Prevention of consequences of upper gastrointestinal bleed in cirrhosis.'}], 'lead-investigator': [{'given': 'Rajiv', 'family': 'Jalan', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 14175.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 14175.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:50Z', 'timestamp': 1636382990000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061390'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:15Z', 'timestamp': 1636458195762}, 'publisher': 'Wellcome', 'award': '083428', 'DOI': '10.35802/083428', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A Clinical PhD Programme at Liverpool University: Health Priorities in the Developing World.'}], 'project-description': [{'description': \"Recent Government papers set out the UK's position concerning Global Health. In the last 12 years, Liverpool has established North-South partnerships and trained clinician-scientists through its Wellcome Trust Tropical Centre (WTTC; 21 Fellows; 23 Fellowships [two people progressed to Intermediate Level Fellowships]; 7/21 completed Doctorates, 7 are in progress, and 7 had Doctorates at the start). Recent Government papers set out the UK's position concerning Global Health. In the last 12 years, Liverpool has established North-South partnerships and trained clinician-scientists through its Wellcome Trust Tropical Centre (WTTC; 21 Fellows; 23 Fellowships [two people progressed to Intermediate Level Fellowships]; 7/21 completed Doctorates, 7 are in progress, and 7 had Doctorates at the start). The Trust has recently affirmed its desire to see the WTTC scheme develop into partnerships with Southern Hemisphere Institutions - Liverpool wishes to participate in this. Our PhD Programme: Rests on WTTC infrastructure. Is integrated into Modernising Medical Careers. Ensures external quality control of Projects. Comprises a year of taught provision and three research years. Ensures preparation of Students for research, and their empowerment to make informed choices in Y1.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4573-449X', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Heyderman', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7680-2200', 'authenticated-orcid': False, 'given': 'David', 'family': 'Lalloo', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2019, 2, 28]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:22Z', 'timestamp': 1636383202000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083428'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199268}, 'publisher': 'Wellcome', 'award': '083473', 'DOI': '10.35802/083473', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental Biology'}], 'project-description': [{'description': 'Developmental Biology is a rapidly expanding, cross-disciplinary area of research that seeks to understand how organisms construct themselves. It is, and will remain, one of the most challenging areas of research because most of the genome is involved in development, much of evolution is expressed through developmental programmes, and a significant component of neural circuitry arises through developmental processes. Furthermore, studies of development continue to shed light on a multitude of human diseases. For example, three key developmental signalling pathways (Wnt, EGFR and Notch) have emerged as major factors in a high proportion of cancers. That Developmental Biology will continue to be a fundamentally interesting challenge into the future should be evident from the tremendous progress over even the past 5 years, such as the recent discovery that microRNAs are key players in regulating the activities of developmentally important genes. Developmental studies will be essential for the elucidation of the pleiotropic activities of genes in the context of the whole organism, and will be invaluable if we are to reap the benefits of the wealth of new sequence information and its implications for our understanding of disease processes.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1642-599X', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Bray', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5582-3301', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'St Johnston', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2019, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:24Z', 'timestamp': 1636383204000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083473'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199691}, 'publisher': 'Wellcome', 'award': '062626', 'DOI': '10.35802/062626', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular Functions in Disease.'}], 'lead-investigator': [{'family': 'Day', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 109077.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 109077.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:20Z', 'timestamp': 1636383200000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062626'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199718}, 'publisher': 'Wellcome', 'award': '083337', 'DOI': '10.35802/083337', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell Biology.'}], 'project-description': [{'description': 'The Wellcome Trust Centre for Cell Biology contains outstanding research groups who are performing cutting edge analyses in many aspects of cell biology. In order to broaden the range of expertise available to the students, the teaching staff on the proposed Cell Biology programme will also include several key scientists from outside the Centre with particular expertise in structural biology, chemical biology, systems biology and translational research. Students in this programme will develop a well-rounded understanding of cellular processes and methods of analysis. We anticipate that these topics will be of increasing importance for future Cell Biologists. The proposal includes three 10-week rotation projects, since it is our opinion that the students learn a great deal more by being exposed to diverse research problems and methodologies. At the end of the first year they will be much better equipped to take on a PhD project - both in terms of their intellectual skills in data assimilation and interpretation, and in their ability to make an informed choice of research topic. To enhance their skills, the programme for the first year includes a symposium series that incorporates a high degree of student participation and a series of courses on important advanced techniques and approaches.', 'language': 'en'}], 'lead-investigator': [{'given': 'Jean', 'family': 'Beggs', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2019, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:28Z', 'timestamp': 1636383208000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083337'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199717}, 'publisher': 'Wellcome', 'award': '074170', 'DOI': '10.35802/074170', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a novel vaccine for periodontopathogen Porphyromonas gingivalis'}], 'project-description': [{'description': 'University Translation Award Development of a novel vaccine for periodontopathogen Porphyromonas gingivalis Porphyromonas gingivalis is an important aetiological agent in destructive periodontal disease. We have characterised a major outer membrane protein of 55kDa in this bacterium, RagB, the expression of which is essential for the pathogenicity of this organism. Hence we believe that RagB may be a potential vaccine candidate for prevention of disease. The rag locus consists of ragB and a co-transcribed upstream gene ragA. Inactivation of ragA or P. gingivalis W50 leads to loss of expression of both proteins and the resultant mutant is significantly attenuated in a murine model of soft tissue destruction. Analysis of restriction enzyme profiles of the rag locus, recently confirmed by sequence analysis, in a wide range of clinical isolates has demonstrated high degree of allelic variation and a similarity of approximately 60%. However, analysis of our worldwide P. gingivalis strain collection and PCR analysis of clinical material from the local periodontal patient population strain indicates that four alleles of this locus predominate. The objectives of this application are to determine the efficacy of immunisation with recombinant RagB from P. gingivalis W50 against challenge with the homologous strain and to establish whether this immunisation will also protect against challenge by P. gingivalis carrying alternative rag alleles. Subsequent experiments will examine whether an immunisation with a mixture of the four major allelic forms of RagB will afford protection against representative strains carrying the different rag loci. The data will establish the potential for RagB to be a candidate immunogen to prevent colonisation by this bacterium in humans and hence act as a vaccine for periodontal disease.', 'language': 'en'}], 'investigator': [{'given': 'Xiaoju', 'family': 'Shi', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Michael', 'family': 'Curtis', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 49758.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 4, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 49758.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:31Z', 'timestamp': 1636382911000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/074170'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:20Z', 'timestamp': 1636458200601}, 'publisher': 'Wellcome', 'award': '108874', 'DOI': '10.35802/108874', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell therapies and regenerative medicine.'}], 'investigator': [{'given': 'Steven', 'family': 'Sacks', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2069-4743', 'authenticated-orcid': False, 'given': 'Graham', 'family': 'Lord', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9151-5154', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Watt', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7094-8188', 'authenticated-orcid': False, 'given': 'Francesca', 'family': 'Spagnoli', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2943936.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 19]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 2850000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:35Z', 'timestamp': 1636383335000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108874'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:22Z', 'timestamp': 1636458202318}, 'publisher': 'Wellcome', 'award': '222304', 'DOI': '10.35802/222304', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Role of the bone marrow niche in regulating the haematopoietic stem cell response to infection'}], 'project-description': [{'description': 'During infections, such as malaria, which is caused by plasmodium parasites, platelets and red blood cells are destroyed. Hematopoietic stem cells, which are responsible for the production of all the cell types of the blood system, are then put under stress to produce high numbers of platelets and red blood cells. Hematopoietic stem cells are found in the bone marrow, surrounded by many types of other cells. This project aims to investigate how only a specific subset of stem cells becomes activated to replenish the platelet cell counts. I will study the expression and function of specific genes in cells of the environment of stem cells and in stem cells themselves using microscopy-based assays on tissue slices and genetically edited cells implanted into mice. I will use intravital microscopy to study behaviours of stem cells such as cell division and movement, in the bone marrow in the skull. The results of this project could lead to the development of improved treatments for malaria patients and patients with bone marrow transplants.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2061-585X', 'authenticated-orcid': False, 'given': 'Marine', 'family': 'Secchi', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2023, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:08Z', 'timestamp': 1636383488000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222304'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204485}, 'publisher': 'Wellcome', 'award': '215706', 'DOI': '10.35802/215706', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Artificial intelligence to automate the use of radiotherapy to treat acute oncological conditions such as severe pain, bleeding and neurological symptoms in patients with advanced cancers'}], 'project-description': [{'description': 'With this funding, we intend to fully automate radiotherapy for the treatment of acute oncological conditions such as severe pain, bleeding and neurological symptoms in patients with a diverse range of advanced cancers. These treatments, which are currently prepared manually, make up around 80% of the indications for radiotherapy in patients presenting for treatment in low- and middle-income countries. Our tools, which include artificial intelligence, will use automated quality assurance to ensure safe, effective, and timely treatments – minimizing reliance on manual checks which are time-consuming and can be inefficient. It is expected that patients can be treated very quickly after receiving a CT scan (minutes), rather than waiting days or weeks. Overall, this project is synergistic with ongoing work in our group focused on automating other radiotherapy planning tasks. Our goal is to make these services available as a cloud-based service for minimal cost for clinics in low- and middle-income countries to rapidly scale up and help deliver affordable and equitable cancer treatment. This supports the overall long term goal of making radiotherapy available to all patients who could benefit (both treating urgent and emergency presentations, as in this proposal, and curative treatments), irrespective of financial status.', 'language': 'en'}, {'description': 'Radiotherapy is both inaccessible and unaffordable for the majority of patients diagnosed with cancer in low and middle income countries due to shortfalls in basic infrastructure, equipment and specialist manpower. Eighty-percent of patients in these settings are diagnosed with locally advanced or widely disseminated cancers. We will use artificial intelligence to automate radiotherapy plan preparation for acute oncological conditions in patients with a diverse range of advanced cancers that are endemic in these country settings such as cervical, breast and head and neck cancers. This will mean that patients can be treated very quickly after receiving a CT scan (10 minutes), rather than waiting days or weeks as is the current norm. This will directly benefit patients in LMICs by increasing the likelihood of palliating symptoms of disseminated malignancy (pain, bleeding, shortness of breath, spinal cord compression), improving long term control of cancer, and reducing the cost of treatment.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9645-6659', 'authenticated-orcid': False, 'given': 'Ajay', 'family': 'Aggarwal', 'affiliation': [{'name': \"Guy's & St Thomas' Hospital Trust\", 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4442-6068', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Simonds', 'affiliation': [{'name': 'University of Stellenbosch', 'country': 'ZA'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3241-6145', 'authenticated-orcid': False, 'given': 'Laurence', 'family': 'Court', 'affiliation': [{'name': 'University of Texas MD Anderson Cancer Center', 'country': 'US'}]}], 'award-amount': {'amount': 1214894.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 6, 1]]}, 'award-end': {'date-parts': [[2022, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 913385.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:57Z', 'timestamp': 1636383057000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215706'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204495}, 'publisher': 'Wellcome', 'award': '220094', 'DOI': '10.35802/220094', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of a host receptor for Plasmodium falciparum-infected erythrocyte rosette formation'}], 'project-description': [{'description': 'Rosetting, the binding of two or more uninfected erythrocytes to an infected erythrocyte, is associated with severe P. falciparum malaria. Therefore, anti-rosetting therapies that reduce microvascular obstruction may be beneficial as adjunctive therapy to reduce severe malaria deaths. Rosettes are formed by an interaction between parasite-derived Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) and host erythrocyte membrane receptors. PfEMP1 is highly polymorphic and therefore a challenging target for vaccines. Recent work by the Rowe lab suggests that PfEMP1 mediates rosetting by an interaction with the Wrightb antigen formed by Band 3 and Glycophorin A. An antibody targeting Wrightb has disrupted rosettes in all P. falciparum strains tested to date, suggesting that this small antibody fragment (BRIC14) has therapeutic potential. I propose to test BRIC14 across a panel of rosetting P. falciparum strains to determine the efficacy of BRIC14 in severe disease states. I aim to characterise the interaction between PfEMP 1 and Wrightb to determine if BRIC14 reduces rosetting by direct inhibition of a ligand-receptor interaction or by altering erythrocyte deformability. The present study aims to characterise a key receptor-ligand interaction implicated in rosetting and determine if a rosette-disrupting antibody has potential as a therapy against disease-causing P. falciparum strains.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6917-3917', 'authenticated-orcid': False, 'given': 'Molly', 'family': 'Carlier', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:39Z', 'timestamp': 1636383339000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220094'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204522}, 'publisher': 'Wellcome', 'award': '222280', 'DOI': '10.35802/222280', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The mechanical regulation of chemical signaling in axon pathfinding in the developing Xenopus laevis brain'}], 'project-description': [{'description': 'During nervous system development, neurons extend their axons over long distances to predefined targets. Research from the last decade has revealed a plethora of chemical signals that are involved in instructing axon guidance. However, it is now becoming increasingly evident that axons also respond to the mechanical environment that they grow in and this affects axon guidance. Moreover, crosstalk occurs between chemical and mechanical signalling. Thus, a holistic understanding of axon guidance would involve understanding both chemical and mechanical guidance cues and the crosstalk between them. A variety of chemical signalling cues which mediate attraction or repulsion are known to regulate axon pathfinding. These include Slits, Semaphorins, Netrins and Ephrins. However, chemical guidance cues do not act alone. The mechanical environment that the axons grow in, also influences axon pathfinding. One of the ways axons respond to the mechanical environment is through mechanosensitive ion channels (e.g. Piezo1). My PhD project aims at exploring the crosstalk between mechanical and chemical signalling in axon pathfinding, using the optic tract (OT) of Xenopus laevis as a model system.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3209-7399', 'authenticated-orcid': False, 'given': 'Sudipta', 'family': 'Mukherjee', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:03Z', 'timestamp': 1636383423000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222280'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204516}, 'publisher': 'Wellcome', 'award': '211162', 'DOI': '10.35802/211162', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating prevention of cervical cancer, disease burden, and opportunities for improvement in inclusion health women (IHW)'}], 'project-description': [{'description': 'Cervical cancer is preventable due to screening and vaccination against human papillomavirus (HPV), the main cause of cervical cancer. However, there were 3,224 new cases and 890 deaths in the UK in 2014. By 2035, this is predicted to rise by 43% due to screening non-attendance. Living in a deprived area increases cervical cancer rates and non-attendance at screening. Inclusion health addresses needs of groups frequently underserved by health services who have worse overall health than people in deprived areas. These include homeless people, migrants, substance misusers, prisoners, and sex workers. It is likely that they engage the least with cervical cancer prevention and have the greatest need for intervention. Unfortunately, they are rarely included in cervical cancer prevention research. This fellowship will fill this knowledge gap. I will measure disease levels, engagement in prevention, and find ways to improve outcomes in inclusion health women. This is needed to eliminate cervical cancer. I will achieve this in three ways: (1) a review of existing studies on inclusion health and cervical cancer (2) a study linking information on 1.6 million migrants to cervical screening and vaccination data and (3) a survey and HPV testing of inclusion health women attending outreach services.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1077-5358', 'authenticated-orcid': False, 'given': 'Neha', 'family': 'Pathak', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 12, 1]]}, 'award-end': {'date-parts': [[2021, 5, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211162'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205429}, 'publisher': 'Wellcome', 'award': '220658', 'DOI': '10.35802/220658', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Optimising seasonal malaria chemoprevention and seasonal vaccination in childhood to address the resurgent malaria burden in Africa'}], 'project-description': [{'description': 'Almost half of the 435,000 malaria deaths each year occur in countries of the Sahel region of Africa, and the majority of these deaths occur during the three-four month rainy season. Monthly seasonal malaria chemoprevention (SMC) is highly effective in these areas, reducing malaria cases by 75-80% in trials, and malaria-specific mortality by 40-50% under programmatic conditions. However, malaria remains a leading cause of disease and death in several countries deploying SMC. The key goals are therefore to understand how to 1) maximise the impact of SMC as currently designed (e.g. by timing it more accurately in different areas), 2) modify the SMC strategy to make it more effective (e.g. by identifying the causes of severe malaria in the context of SMC), 3) use other control tools, including seasonally-targeted vaccination, alongside SMC and 4) understand how improving malaria prevention in childhood would affect naturally-acquired immunity. Analysis of data from a comprehensive evaluation of SMC in 7 countries, an SMC trial in 20,000 children, and the first-ever trial of seasonally-targeted vaccination alongside SMC provides a unique opportunity to answer these questions. Mathematical models incorporating these results will enable malaria prevention packages to be optimised according to the local epidemiology.', 'language': 'en'}, {'description': 'Around 400,000 malaria deaths occur worldwide each year. About half of these occur in the Sahel region of Africa, mostly during a short, intense rainy season. Monthly courses of antimalarial drugs (seasonal malaria chemoprevention, SMC) is highly effective in these areas. However, malaria remains a leading cause of child deaths in several countries with SMC programmes. I will analyse data from a large SMC programme across seven countries and two large clinical trials of SMC to understand 1) exactly when SMC should be delivered in different areas to maximise its impact, 2) which children get malaria despite SMC (which will indicate how SMC could be improved), 3) how best to use seasonally-targeted malaria vaccination alongside SMC and 4) how improved malaria prevention might affect naturally-acquired immunity. Development of computer-based simulations incorporating these results will enable malaria prevention packages to be targeted to local transmission patterns, maximising their impact on malaria.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9168-6022', 'authenticated-orcid': False, 'given': 'Liam', 'family': 'Smeeth', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1068-9713', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Cairns', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 916159.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 916159.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:50Z', 'timestamp': 1636383110000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/220658'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205421}, 'publisher': 'Wellcome', 'award': '220704', 'DOI': '10.35802/220704', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterization of the phenotypic and transcriptional profiles of B cells that encode broadly neutralizing antibodies against HIV'}], 'project-description': [{'description': 'HIV induces B-cell defects that could impair the development of effective antibody responses, such as broadly neutralizing antibodies (bNAbs). However, some rare patients still develop anti-HIV bNAbs. Such responses can be mimicked with vaccines for protection against HIV. The B cells that develop breadth despite the ongoing HIV-induced immune defects could have unique profiles that enable their survival and functionality. The aim of this work is to characterize the transcriptional and phenotypic profiles of B cells that encode for anti-HIV bNAbs and their precursors/intermediates. I will use longitudinal clinical samples from well characterized HIV-infected individuals who have broadly neutralizing sera. I have already isolated a bNAb from this cohort by FACS-sorting of epitope specific memory B cells and cloning the immunoglobulin genes. I am currently isolating bNAbs from the other individuals. This will create a platform for subsequent characterization of the B cells that encode for the bNAbs. I will then characterize the phenotypic and transcriptional profiles of epitope specific memory B cells that encode for the bNAbs lineages using paired flow cytometry, cloning and single cell RNA-seq. This will reveal the profiles that, if induced with appropriate adjuvants, could promote elicitation of protective anti-HIV bNAbs after vaccination.', 'language': 'en'}, {'description': 'HIV impairs multiple aspects of the immune response to evade immune-mediated clearance. As such, broadly neutralizing anti-HIV antibodies are rare. HIV-induced B-cell defects are thought to impair the development of broadly neutralizing antibodies. However, a rare group of patients still make highly effective broadly neutralizing antibodies that could protect uninfected individuals if induced with a vaccine before exposure to HIV. The relevant B cells in such individuals could have special characteristics that enable good responses despite HIV-induced impairments. I will utilize clinical samples from individuals who make broadly neutralizing antibodies to study the nature of the B cells that can produce broadly neutralizing antibodies. Together with traditional methods, I will utilize a cutting edge technology, single cell RNA-seq, to determine their global gene expression patterns. The new knowledge will reveal immune profiles that can be induced with appropriate vaccine adjuvants in HIV vaccine strategies to elicit broadly neutralizing antibodies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2962-3992', 'authenticated-orcid': False, 'given': 'Thumbi', 'family': \"Ndung'u\", 'affiliation': [{'name': 'Africa Health Research Institute', 'country': 'ZA'}]}, {'given': 'Alex', 'family': 'Shalek', 'affiliation': [{'name': 'Massachusetts Institute of Technology', 'country': 'US', 'id': [{'id': 'https://ror.org/042nb2s44', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7995-1682', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Muema', 'affiliation': [{'name': 'Africa Health Research Institute', 'country': 'ZA'}]}], 'award-amount': {'amount': 298082.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 241244.7, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:51Z', 'timestamp': 1636383111000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220704'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205423}, 'publisher': 'Wellcome', 'award': '220081', 'DOI': '10.35802/220081', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mycobacterial drug target deconvolution using Genetic, Phenotypic and Proteomic approaches'}], 'project-description': [{'description': 'Mycobacterium tuberculosis is the causative agent of tuberculosis (TB) and leads to 1.8 million deaths per year. Resistance to the currently used anti-TB drugs is growing, which will increase death rates in the future if unchecked, hence there is a high demand for new drugs. My project aims to identify how novel anti-TB molecules work, to increase our understanding of their targets and how they can be improved to increase their activity and selectivity. The protein targets will be produced and then purified, allowing the drug-protein interactions to be studied. Specific interactions will be identified, providing evidence for alterations to these drugs to increase their potency. Another section will be the identification of new drug targets, which could be taken forward for targeting by studying the protein-protein interactions occurring in the outer membrane and wall of M. tuberculosis. The main output of my work would be increased knowledge of protein-molecule interactions of novel anti-TB drugs and will allow them to be altered to increase their selectivity and activity. This would hopefully lead to these novel drugs being taken forward as potential drugs for the treatment of TB, expanding treatment options against multi-drug resistant M. tuberculosis strains.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7074-6893', 'authenticated-orcid': False, 'given': 'Alexander', 'family': 'Kingdon', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:30Z', 'timestamp': 1636383390000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220081'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205467}, 'publisher': 'Wellcome', 'award': '220981', 'DOI': '10.35802/220981', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A comprehensive study of immunopathogenesis of SARS-CoV-2 infection'}], 'project-description': [{'description': 'Since December 2019 the emergence of severe acute respiratory infections (COVID-19) in China, caused by the new coronavirus SARS-CoV-2, has posed a huge threat to global health with fatality rates up to 10% in elderly patients. Almost 100% of patients showed bilateral patchy shadows or ground glass opacity in their lungs by chest CT scans indicating acute lung injury (ALI). Therefore, understanding the underlying mechanism(s) of ALI induced by SARS-CoV-2 is very important to inform vaccine safety and immunotherapeutic strategies. In this proposal, we will investigate the host immune responses and their association with severity of ALI in patient samples and animal models. We will bring together a team of experts with complementary expertise including immunopathology in coronavirus infections, up-to-date lab technologies, and know-how to ensure the feasibility of this study with the following goals: 1) defining SARS-CoV-2 specific serum profiles (epitopes) using yeast display antigen library 2) determining antibody functions including antibody-dependent enhancement (ADE) vs neutralizing activities in vitro assays 3) studying T cell (CD4 and CD8) responses to whole SARS-CoV-2 genome 4) evaluating ALI in response to live SARS-CoV-2 infection with or without passive immunity (antibody or T cells) generated from vaccine candidates in a humanized mice model.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3549-4309', 'authenticated-orcid': False, 'given': 'Gavin', 'family': 'Screaton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7978-3815', 'authenticated-orcid': False, 'given': 'Nigel', 'family': 'Temperton', 'affiliation': [{'name': 'University of Kent', 'country': 'GB'}]}, {'given': 'Honglin', 'family': 'Chen', 'affiliation': [{'name': 'University of Hong Kong', 'country': 'CN'}]}, {'ORCID': 'http://orcid.org/0000-0002-4511-2888', 'authenticated-orcid': False, 'given': 'Zhiwei', 'family': 'Chen', 'affiliation': [{'name': 'University of Hong Kong', 'country': 'CN'}]}, {'ORCID': 'http://orcid.org/0000-0002-4392-5527', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Kelleher', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2083-1552', 'authenticated-orcid': False, 'given': 'Kwok Yung', 'family': 'Yuen', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3076-6712', 'authenticated-orcid': False, 'given': 'Xiao-Ning', 'family': 'Xu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 864564.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 5]]}, 'award-end': {'date-parts': [[2022, 5, 4]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 864564.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:59Z', 'timestamp': 1636383119000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220981'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:28Z', 'timestamp': 1636458208207}, 'publisher': 'Wellcome', 'award': '220023', 'DOI': '10.35802/220023', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Inference of selection and phylogeny from ancient DNA'}], 'project-description': [{'description': 'In this project, we will analyze the population dynamics and evolutionary history of multiple species, spanning from mammoths to bacteria, using two ancient DNA datasets. The first consists of ancient environmental DNA (aeDNA) from samples from up to 50,000 years ago collected from 1671 permafrost and lake sediment samples across the arctic. Despite the damage intrinsic to such data, we have had preliminary success in relating ancient environmental mammoth DNA to the existing mitochondrial tree using in-house software. We will improve this algorithm and expand this work to other mammals such as horses, reindeer and lemmings, and potentially bacteria. A second dataset consists of over 1500 ancient human samples from northwestern Europe, which will grow to over 10,000 samples during my thesis. These samples have been sequenced in order to capture not only the human DNA, but also the DNA of pathogens which the individual was infected with when they died. In this project, we will explore the population dynamics and evolution of these pathogens, including DNA viruses, bacteria, and parasites. We will also consider a related problem using the genetics of human centromeres, which have a very low recombination rate, making them interesting candidates for the inference of selection.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0648-4224', 'authenticated-orcid': False, 'given': 'Bianca', 'family': 'De Sanctis', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:23Z', 'timestamp': 1636383323000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220023'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:29Z', 'timestamp': 1636458209508}, 'publisher': 'Wellcome', 'award': '057964', 'DOI': '10.35802/057964', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A coordinated clinical and molecular genetic study of human autosomal recessive neurodevelopmental disorders using autozygosity mapping.'}], 'project-description': [{'description': \"I seek to determine the autosomal recessive mutant genes that can cause human neuro-developmental disorders which present in childhood. The autosomal recessive forms of these disorders are not rare, but there is difficulty in differentiating the number of genotypes with the same apparent phenotype on clinical grounds. No causative genes have presently been found. Prenatal diagnosis and carrier detection are not possible as yet. In order to dissect these complex traits I have the following facilities: established access to the ethnically diverse populations of Northern Pakistan, which for cultural reasons, have highly inbred consanguineous families; the clinical skills to ascertain, investigate and classify these families; an ability to perform linkage using autozygosity mapping; positional cloning skills using a number of established approaches, based on YAC contigs, EST's and foetal cDNA libraries, candidate genes and bio-informatics; access to further families of diverse origin to quantitate the relative clinical importance and relevance of any findings in the general population; and the capability to introduce the research findings into a clinical service for the UK and Pakistani populations.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8077-2101', 'authenticated-orcid': False, 'given': 'Geoff', 'family': 'Woods', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 907252.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 907252.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:32Z', 'timestamp': 1636382792000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/057964'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:30Z', 'timestamp': 1636458210022}, 'publisher': 'Wellcome', 'award': '061367', 'DOI': '10.35802/061367', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Influence of embryonal cytoplasm on nuclei from adult mice.'}], 'lead-investigator': [{'family': 'Graham', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 101418.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 3, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 101418.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:22Z', 'timestamp': 1636382782000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:30Z', 'timestamp': 1636458210084}, 'publisher': 'Wellcome', 'award': '060652', 'DOI': '10.35802/060652', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural correlates of emotional word recall in depersonalisation disorder patients and normal controls.'}], 'lead-investigator': [{'family': 'Kucharska-Pietura', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 14085.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 1, 1]]}, 'award-end': {'date-parts': [[2000, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 14085.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:54Z', 'timestamp': 1636382994000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060652'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:31Z', 'timestamp': 1636458211429}, 'publisher': 'Wellcome', 'award': '056163', 'DOI': '10.35802/056163', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The early development of anxiety and obsessive-compulsive symptomatology: a longitudinal behavioural genetic investigation.'}], 'investigator': [{'given': 'Thomas', 'family': \"O'Connor\", 'affiliation': [{'name': 'University Of Rochester', 'country': 'US'}]}], 'lead-investigator': [{'given': 'Derek', 'family': 'Bolton', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 181045.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 4, 1]]}, 'award-end': {'date-parts': [[2002, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 181045.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:35Z', 'timestamp': 1636382795000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/056163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:31Z', 'timestamp': 1636458211702}, 'publisher': 'Wellcome', 'award': '059696', 'DOI': '10.35802/059696', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular functions in disease.'}], 'lead-investigator': [{'given': 'Mary', 'family': 'Macleod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 103855.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 103855.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:07Z', 'timestamp': 1636383187000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059696'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212386}, 'publisher': 'Wellcome', 'award': '062016', 'DOI': '10.35802/062016', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Molecular Basis of Biological Mechanisms'}], 'lead-investigator': [{'given': 'Rebecca C', 'family': 'Zinober', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 102577.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 102577.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:06Z', 'timestamp': 1636383186000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062016'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212758}, 'publisher': 'Wellcome', 'award': '064892', 'DOI': '10.35802/064892', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Studying organogenesis in the inner ear by genetic misexpression in the zebrafish.'}], 'project-description': [{'description': \"Many genes that participate in embryonic development also influence human health. Scientists utilise specific tools to study development in model organisms. Mutagenesis screens in particular offer an unbiased means of dissecting the genetic components of development, for no prior knowledge of the participating genes is required. Alternative approaches such as reverse genetics and controlled misexpression of heterologous genes can serve to complement the analysis of mutant phenotypes in model organisms. The zebrafish has emerged as a powerful system for studies of vertebrate biology and organogenesis. External development and optical clarity allow the easy and visual analysis of early developmental processes. Short generation time, the possibility to achieve large scale mutagenesis screens and generation of thousands of individuals in a relatively inexpensive way are characteristics that make this and ideal model system. Although the zebrafish is poised to contribute greatly to our understanding of organ development, alternative well developed technologies for reverse genetic analysis are lacking. Gene redundancy due to a partially duplicated genome presents a severe hurdle that must be overcome. When the sequence of a gene is known, however, controlled misexpression using the GAL4/UAS system can link the gene's structure to its function, and this methodology is being used with the great success in Drosophila. The GAL4/UAS system is not well advanced in the zebrafish, but shows promise. Also, selective misexpression of genes allows organs to be dissected as genetic modules, leaving the remainder of the animal to develop normally. I propose to explore the process of organogenesis in the inner ear using the zebrafish (Danio rerio) as model system. This objective is dictated both by an intellectual desire to explain the ear's complexity and by an appreciation of the impact of genetic disease on human hearing: about one child in a thousand is born deaf or becomes deaf as a result of mutations in any of over 100 genes. The research group of Dr. A. J. Hudspeth, which has made seminal contributions to our understanding of the mechanism of hearing, has focussed during the past five years on deciphering the ear's development. To study the development and regeneration of the inner ear, I wish to further develop the GAL4/UAS technology and to use it to complement the current chemical-mutagenesis screen being conducted in the Hudspeth lab. This project will allow me to understand the genetics of a vertebrate system, and the development of a functional organ. Once fully developed, this methodology will enable conditional genetic alterations to study other organ systems and developmental processes.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Hernan', 'family': 'Lopez-Schier', 'affiliation': [{'name': 'Rockefeller University', 'country': 'US'}]}], 'award-amount': {'amount': 109219.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 109219.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:28Z', 'timestamp': 1636382908000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064892'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212801}, 'publisher': 'Wellcome', 'award': '064032', 'DOI': '10.35802/064032', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Manipulation of Salmonella lipid A biosynthesis genes to generate attenuated bacteria with reduced toxicity endotoxin under defined environmental conditions.'}], 'lead-investigator': [{'given': 'Duncan', 'family': 'Maskell', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 63780.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2003, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 63780.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:54Z', 'timestamp': 1636382814000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064032'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212962}, 'publisher': 'Wellcome', 'award': '070262', 'DOI': '10.35802/070262', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the cost of a symposium entitled \"First Workshop on Murine Models of Psychiatric Disorder\" to be held at Fondation des Treilles, Provence, France in April/May 2003.'}], 'project-description': [{'description': 'First Workshop on Murine Models of Psychiatric Disorder, Foundation des Treilles, Provence, France, April/May 2003 Over the next few years it is likely that genes influencing common psychiatric disorders, such as schizophrenia, manic-depressive psychosis, major depression and anxiety, will be identified. Despite the success of some molecular projects, there has been remarkably little advance in our understanding of the biology of the conditions, largely because it has proved extremely difficult to work out the normal function of the cloned genes. One approach to investigating function is to engineer mutations in the mouse homologue of the human gene and examine the resulting phenotype in the animal model. While this approach has been successful for many medical conditions, the same is not true for psychiatric conditions because it is not clear what to measure. How, for instance, are we to model speech deficits in mice? On evolutionary arguments we would expect that abilities specific to humans will have originated from neural systems present in other animals. The problem is that in most cases we do not know what those systems are. We need ways of modelling complex behaviours in animals if we are to benefit from the advances in genetics. By the end of the meeting we aim to obtain a consensus view on the limitations and value of animal models. We hope to be able to answer questions about what they can detect that would be relevant to human behaviour and which tests can be applied to the current and future transgenic models. Finally we hope to address the fundamental question of the extent to which animals provide more complex models than those currently used for learning and memory.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9427-4429', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Flint', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3450.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 4, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3450.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070262'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213001}, 'publisher': 'Wellcome', 'award': '063331', 'DOI': '10.35802/063331', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Isolation of molecules involved in haemopoietic stem cell development during embryogenesis.'}], 'lead-investigator': [{'given': 'Katrin', 'family': 'Ottersbach', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 76305.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 76305.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:22Z', 'timestamp': 1636382902000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063331'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213944}, 'publisher': 'Wellcome', 'award': '062017', 'DOI': '10.35802/062017', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Molecular Basis of Biological Mechanisms'}], 'lead-investigator': [{'family': 'Whittaker', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 105027.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 105027.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:49Z', 'timestamp': 1636383169000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062017'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213952}, 'publisher': 'Wellcome', 'award': '062123', 'DOI': '10.35802/062123', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Tissue discrimination and characterisation using a diffraction enhanced imaging system.'}], 'project-description': [{'description': 'One of the most significant problems in current diagnostic techniques is the detectability of low-contrast details; i.e. in many examples of x-ray imaging the inherent contrast in the tissues is too small to demonstrate pathology. For example, conventional screen-film mammography is currently seen as the most efficient technique for the early detection of breast disease as well as for the assessment of symptomatic malignant breast disease. Although its ability to detect microcalcifications is high, it suffers from low sensitivity and specificity for the detection of masses because of the similarity between the linear attenuation coefficient of pathological masses and breast tissue. The subject of this application is to develop an alternative approach that uses the information present in the photon beam interaction with the tissues concerned and represents unfolding of further diagnostic information from transmission imaging procedures. Current x-ray images are created by detecting transmitted beams, but the radiation scattered from the tissues is potentially more useful in differentiating disease. Using our latest research results on breast tissue scattering properties, this project involves the development of an improved method for the detection of breast masses based upon the Diffraction Enhanced Breast Imaging (DEBI) technique, which will significantly improve the sensitivity to low-contrast breast masses whilst maintaining performance in the detection of microcalcifications without increasing the radiation dose. A prototype digital imaging system will be designed and built to evaluate the potential of the diffraction-enhanced imaging and the increased detectability offered by this technique in comparison with current breast imaging modalities.This requires the use of the latest detector technology using state-of-the-art large-area, flat-panel a-Si:H arrays combined with direct magnification and thick Si-pad sensors coupled to low-noise electronics. Finally, to locate the scattering point, stereoscopic breast imaging will be helpful, and therefore, the design of the imaging system will aim at including this feature.', 'language': 'en'}], 'lead-investigator': [{'family': 'Darambara', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 280311.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 280311.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:36Z', 'timestamp': 1636382796000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062123'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214309}, 'publisher': 'Wellcome', 'award': '063006', 'DOI': '10.35802/063006', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of Ca2+ signalling in the nuclei of identified neurones.'}], 'investigator': [{'given': 'Roger', 'family': 'Thomas', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Sergy', 'family': 'Marchenko', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 92430.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 92430.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:56Z', 'timestamp': 1636382996000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063006'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214340}, 'publisher': 'Wellcome', 'award': '064110', 'DOI': '10.35802/064110', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a Laboratory Information Management System (LIMS) to support high-throughput genotyping.'}], 'project-description': [{'description': 'We propose to develop a comprehensive laboratory information management system (LIMS) to enable the rapid accumulation, quality control and interpretation of genotype data. Our aims are to: Develop a system that integrates sample tracking in the laboratory with phenotype and family information, that has access to raw experimental data collected from a variety of instruments, and that incorporates automated allele-calling and quality control (QC) procedures wherever possible. Test and validate the system using genotyping protocols and instrumentation available at the Wellcome Trust Centre for Human genetics (WTCHG). Distribute the database to the genetics community in a portable frame.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1022-9330', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Mott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 259820.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 259820.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:51Z', 'timestamp': 1636382991000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064110'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214343}, 'publisher': 'Wellcome', 'award': '069082', 'DOI': '10.35802/069082', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Serotonin depletion and vulnerability to panic attacks in panic disorder.'}], 'project-description': [{'description': 'Panic disorder (PD) is a common and serious psychiatric disorder characterised by recurrent panic attacks, disabling fear, and avoidance of panic-related situations. This project aims to extend recent studies on the role of serotonin (5-hydroxytryptamine, 5-HT) in the mechanisms of panic attacks and in the mode of action of antipanic medications. It uses the new research method of tryptophan depletion (TD) to acutely reduce tryptophan levels and so decrease the synaptic availability of5-HT in the brain. Our recent study of TD in panic patients recovered on treatment with a selective serotonin reuptake inhibitor (SSRI) and then challenged with the panicogenic agent flumazenil reveal that the therapeutic effect of SSRI was reversed. This strongly suggests that an increase in synaptic 5-HT is critical to therapeutic action of this class of medication. It is now important to determine if this finding could be replicated with another antipanic medication and using differently acting panicogneic challenge. In this work we intend to explore whether TD will reveal a loss of the antipanic action of the most selective 5-HT reuptake inhibitor citalopram to a panicogenic challenge with cholecystokinin-tetrapeptide (CCK-4). CCK-4 is an agonist of the CCK-2 subtype of brain receptors. CCK is the most abundant neuropeptide in the brain and it is strongly implicated in the regulation of anxiety. Effective antipanic treatment, including SSRI citalopram, have been shown to block the CCK-4 induced panic attacks in PD patients but it is not known if this action would be reversed by TD. For this study we will recruit 30 patients with DSM-IV diagnosis of Panic Disorder and treat them during 10 weeks with citalopram according to the standard treatment guidelines. While still on treatment, in the following 2 weeks the responders will be the intensity and rate of CCK-4 induced panic attacks after TD in comparison to placebo (sham depletion). The results of this study should significantly advance our understanding of the neurobiology of the treatment of PD.', 'language': 'en'}], 'lead-investigator': [{'given': 'Jakov', 'family': 'Shlik', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 45209.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 5, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 45209.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:55Z', 'timestamp': 1636382875000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069082'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:35Z', 'timestamp': 1636458215228}, 'publisher': 'Wellcome', 'award': '211493', 'DOI': '10.35802/211493', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'MAXIMIZING THE KNOWLEDGE GAINED FROM CALIFORNIA SENATE BILL 27'}], 'project-description': [{'description': 'On January 1, 2018, California enacted Senate Bill 27 (SB27), first-of-its-kind and potentially precedent-setting legislation, which will require a veterinarian’s prescription for use of antimicrobial drugs and ban non-therapeutic antimicrobial uses for routine disease prevention and growth promotion in livestock. To assess the effectiveness of this important legislation at reducing antimicrobial resistant bacterial infections in humans, we propose the following specific aims: Aim 1. Quantify the effect of SB27 on E. coli, Campylobacter and Salmonella resistance rates from retail meat. Aim 2. Estimate the proportion of human Campylobacter, Salmonella, and extraintestinal pathogenic E. coli infections caused by strains of food-animal origin in California. Aim 3. Characterize the effect of SB27 on the antimicrobial susceptibility of Campylobacter, Salmonella, and extraintestinal E. coli infections caused by strains of food-animal origin in California. Implementation of SB27 provides a unique natural experiment to assess the effectiveness of restrictive agricultural antimicrobial-use policies at reducing antimicrobial-resistant human infections. The proposed research will have a positive impact by prospectively measuring the effect of this policy on the antimicrobial susceptibility of E. coli (an important colonizing opportunistic pathogen) and Campylobacter and Salmonella (two frank foodborne pathogens) and thereby maximizing the information gained from this singular opportunity', 'language': 'en'}], 'lead-investigator': [{'given': 'David', 'family': 'Aanensen', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8746-5307', 'authenticated-orcid': False, 'given': 'Lance', 'family': 'Price', 'affiliation': [{'name': 'George Washington University', 'country': 'US'}]}], 'award-amount': {'amount': 2683140.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 5, 1]]}, 'award-end': {'date-parts': [[2022, 4, 30]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 2683140.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:43Z', 'timestamp': 1636382803000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211493'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:35Z', 'timestamp': 1636458215771}, 'publisher': 'Wellcome', 'award': '220075', 'DOI': '10.35802/220075', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of mitophagy regulators in neuronal cell and Drosophila models.'}], 'project-description': [{'description': 'Mitochondria are the powerhouses of the cell and are crucial for neuronal function and survival. Disruption of mechanisms governing mitochondrial integrity lead to development and progression of different neurodegenerative disorders (NDs) such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD). In fact, the accumulation of defective mitochondria in neurons is a hallmark of NDs. Mutations in genes linked to PD lead to a failure in pathways designed to rid the cell of low-quality mitochondria. Restoring this pathway offers an attractive therapeutic option. While this pathway is well characterised in cell models, less is known about this process in living organisms (in vivo). Our laboratory has engineered fruit flies (Drosophila) such that the mitochondria undergoing degradation can be directly visualised. I will develop this model system to characterise the influence of various genetic or pharmacological changes upon the mitochondrial degradation process in flies. I aim to shed light on the interplay between various genes linked to this pathway and discover new factors relevant to the process.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4382-9313', 'authenticated-orcid': False, 'given': 'Francesco Giovanni', 'family': 'Barone', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:21Z', 'timestamp': 1636383321000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220075'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:37Z', 'timestamp': 1636458217115}, 'publisher': 'Wellcome', 'award': '065739', 'DOI': '10.35802/065739', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of ATP receptors in the synaptic transmission in the neocortex.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0250-6200', 'authenticated-orcid': False, 'given': 'Yuriy', 'family': 'Pankratov', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 10610.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 10610.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:43Z', 'timestamp': 1636383043000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065739'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218012}, 'publisher': 'Wellcome', 'award': '066213', 'DOI': '10.35802/066213', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Trans-acting chemical modifiers of DNA repeat stability in vitro and in vivo - towards novel therapies in the triplet repeat expansion disorders.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 116380.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 116380.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:39Z', 'timestamp': 1636382799000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066213'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218022}, 'publisher': 'Wellcome', 'award': '061827', 'DOI': '10.35802/061827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'An investigation into the nature and functional implications of a depletable pool of adenosine in the CA1 region of the in vitro rat hippocampus.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7214-3172', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Frenguelli', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 98388.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 98388.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:54Z', 'timestamp': 1636382754000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218050}, 'publisher': 'Wellcome', 'award': '083335', 'DOI': '10.35802/083335', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structural biology: from molecules to cells.'}], 'project-description': [{'description': \"Structural biology is central to our understanding of mechanism in cell biology. Life emerges, in the form of a cell, from an assembly of 'lifeless' molecules. It is therefore essential to study the structure of biological macromolecules, and of the multi-molecular complexes they form, in order to understand the properties of complex sub-cellular and cellular assemblies. From a biomedical science perspective, understanding the relationship between molecular structure (sub-nm scale) and emergent cellular properties (µm scale) is a central activity. Mutations result in perturbations of cellular phenotypes via changes in molecular structure, and drugs interact with molecular receptors resulting in changes in cellular behaviour. Thus, the overall aim of this programme is to train a new generation of graduate students in the methods of modern Structural Biology (X-ray diffraction, NMR, electron microscopy, computational approaches) in the context of how a knowledge of biomolecular structures informs our understanding of the biology of cells. This programme will build upon our success in a previous Wellcome Trust funded programme. It will benefit from our experience in running cross-departmental programmes, and will be underpinned by existing and newly appointed chairs. A four-year programme enables us to attract excellent graduate students with e.g. a physical sciences background, and to train them in the theory and methods of Structural Biology in the broader context of biological sciences before they undertake challenging research projects leading to high quality publications and post-doctoral placements in leading research groups worldwide.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-6360-7959', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Sansom', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3426-4210', 'authenticated-orcid': False, 'given': 'David', 'family': 'Stuart', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2017, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:30Z', 'timestamp': 1636383210000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083335'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218172}, 'publisher': 'Wellcome', 'award': '062918', 'DOI': '10.35802/062918', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'An investigation of adenovirus-mediated GnRH receptor expression and receptor targeted therapy in mammary cancer cells.'}], 'investigator': [{'given': 'Eamonn', 'family': 'Kelly', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Craig', 'family': 'McArdle', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 303815.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 303815.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:30Z', 'timestamp': 1636382790000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062918'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218375}, 'publisher': 'Wellcome', 'award': '215311', 'DOI': '10.35802/215311', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating modularity in the Locus Coeruleus - Computational & Experimental approaches'}], 'project-description': [{'description': \"This research will focus on the locus coeruleus (LC), a brainstem region supplying noradrenaline to the central nervous system, controlling arousal levels and 'fight or flight' type behaviours. Experiments and computer simulations will be used to investigate how different 'modules' of cells within this region can be active independently of one another, and the biological mechanisms that enable this functional segregation. The experiments will use targeted genetic modification of locus coeruleus cells, to make them express genetically encoded calcium indicators. Changes in cell activity lead to fluctuations in calcium levels, meaning fluorescence can be recorded as a measure of cell activity. Using slices of brain containing LC, I will image cell activity and apply drugs which block specific signalling pathways believed to be functionally important for modularity within the LC. These experiments will be aided with mathematical models of LC cells, which will be used to build a simulated population of LC modules. This will be used to explore potentially important biological mechanisms, and make predictions about the effects of manipulating these biological mechanisms, which can then be tested experimentally. Together, these strategies may yield novel insights into the functional modularasation of the LC in healthy and/or disease states.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3155-0879', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Davy', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215311'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218396}, 'publisher': 'Wellcome', 'award': '222575', 'DOI': '10.35802/222575', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The mechano-biology of cell division'}], 'project-description': [{'description': 'Cell division in epithelial sheets is crucial for tissue renewal, yet unchecked division leads to tissue dysplasia and ultimately cancer. The aim of this project is to discover how cell division is regulated in normal epithelial tissue and how it is perturbed by oncogenic mutations to disrupt tissue integrity. In previous work, I showed how activation of an oncogene, Ras, directly impacts cell division by controlling the shape, contractility and mechanics of single mitotic cells. I now ask how this finding plays out in a complex tissue environment. To do this, I will employ a multi-disciplinary approach, combining imaging and quantitative cell biology with biophysical techniques to study cell division mechanics in normal epithelial monolayers and Ras-mutant pancreatic cancer tumoroids. I will ask how the actin cytoskeleton is regulated during epithelial cell division to permit dynamic cell shape changes while maintaining cell-cell adhesion and preserving barrier function. I will determine how k-Ras activation perturbs this, identifying key mechanistic links between Ras/ERK-dependent transcription and morphological phenotypes. Finally, I will address how these Ras-induced changes to cell division alter the growth and organization of 3D tissue structures in pancreatic cancer.', 'language': 'en'}, {'description': 'In the human body, cells constantly divide to maintain and repair tissues. However uncontrolled cell division leads to tissue overgrowth and ultimately, cancer. I want to understand how cell division is controlled in normal tissue and how it is altered by genetic mutations in cancer. I will focus on the role of an oncogene, Ras, as I have previously discovered that it directly controls how cells divide. Ras activation occurs in many different types of cancer, but particularly pancreatic cancer. Therefore, I will use cutting-edge microscopy techniques to image cells dividing within normal tissue and pancreatic cancer tumoroids. I will ask how Ras subverts the normal cell division process within these tissues and how abnormal cell divisions disrupt normal tissue organization to form tumours. By discovering fundamental principles of how cancer cells divide, this work will identify new molecular targets for pancreatic cancer treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6660-9685', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Matthews', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1029715.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 1]]}, 'award-end': {'date-parts': [[2026, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1029715.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:27Z', 'timestamp': 1636383507000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222575'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218579}, 'publisher': 'Wellcome', 'award': '064247', 'DOI': '10.35802/064247', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification and characterisation of the MCPH5 gene causing autosomal recessive primary microcephaly located at chromosome lq31.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8077-2101', 'authenticated-orcid': False, 'given': 'Geoff', 'family': 'Woods', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 88671.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 88671.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:32Z', 'timestamp': 1636382792000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064247'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218741}, 'publisher': 'Wellcome', 'award': '222933', 'DOI': '10.35802/222933', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The health needs and primary care engagement of Central and Eastern European nationals living within the UK'}], 'project-description': [{'description': 'Over 2 million Central and Eastern Europe (CEE) nationals live in the UK. They are at increased risk of poor mental health, stress, homelessness, alcohol overuse and suicide. It can be difficult for this community to use GP services, especially for mental health problems. I will help GPs to provide better mental health care for the UK CEE community through describing what CEE nationals think about general practice and working with community members and GP staff to develop supportive resources and recommendations. My research has four steps (WP1-4). WP1. Interviews with different CEE community members, WP2. Focus groups with GP practice healthcare, administration and reception staff. These will explore staff experiences of CEE community members using GP services, particularly for mental health problems. I will compare interview and focus group information to look for patterns. WP3. Working with community members I will develop a mental health resource package to help GPs to provide accessible care and treatments for CEE community members. WP4. I will test and improve this resource package in GP surgeries, getting feedback from community members and healthcare staff. I will share the information and resources from my project with community members, other researchers and healthcare workers.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3435-6721', 'authenticated-orcid': False, 'given': 'Aaron', 'family': 'Poppleton', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:47Z', 'timestamp': 1636383467000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222933'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218765}, 'publisher': 'Wellcome', 'award': '224052', 'DOI': '10.35802/224052', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of MeCP2 within the context of chromatin'}], 'project-description': [{'description': 'MeCP2 is a protein found in the brain which prefers binding to methylated DNA. It can then help to block gene expression through the recruitment of other factors. MeCP2 is essential for proper neurodevelopment and mutations in the protein often cause the autism-spectrum disorder Rett syndrome, which is characterised by a lack of speech and loss of motor skills. In Rett syndrome-like mutated mice these developmental problems can be reversed, suggesting that a future treatment for Rett syndrome may be possible. While a lot is known about how MeCP2 binds linear methylated DNA, this is not the natural state of DNA in cells. Instead DNA is often found wrapped around proteins called histones which package and compact it into chromatin. Initial evidence has suggested that MeCP2 can not only bind methylated DNA, but also to the histone proteins that the DNA wraps around. This project aims to investigate how exactly MeCP2 interacts with chromatin, understand the relevance of MeCP2’s proposed interaction with histone proteins, and discover if mutations that cause Rett syndrome also disrupt this interaction.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5691-1829', 'authenticated-orcid': False, 'given': 'James', 'family': 'Watson', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:15Z', 'timestamp': 1636383495000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/224052'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220108}, 'publisher': 'Wellcome', 'award': '212204', 'DOI': '10.35802/212204', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The organisation of international cooperation in relation to AMR'}], 'project-description': [{'description': \"The world has agreed to take action on Antimicrobial Resistance (AMR). The UN General Assembly Resolution on AMR commits UN Member States to addressing AMR therefore they called for the establishment of an ad hoc Inter- Agency Coordination Group (IACG). Equally importantly, both health and agriculture sectors are being brought together to address this problem. with the UN Secretary General in consultation with the WHO, the UN FAO and the OIE establishing this multidisciplinary group composed of 13 UN organisations and 13 independent experts. The IACG is mandated to report on progress and recommendations for the next steps to ensure sustained effective global action. The global governance mechanisms to deliver on an AMR strategy are crucial. Without some global coordination, none of the public or private stakeholders in this issue will move very far. To this end, as part of IACG's work an analysis of existing governance mechanisms is required by March/ April 2018 to inform the discussion on possible future governance mechanisms for AMR. The paper we are proposing will undertake these analyses and lay out how international cooperation could best be organized to manage the urgent problems emerging from AMR.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Ngaire', 'family': 'Woods', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 51000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 4, 13]]}, 'award-end': {'date-parts': [[2018, 7, 13]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 51000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:50Z', 'timestamp': 1636382810000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 4, 13]]}, 'URL': 'http://dx.doi.org/10.35802/212204'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220074}, 'publisher': 'Wellcome', 'award': '215127', 'DOI': '10.35802/215127', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Elucidating the function of an extracellular Argonaute protein secreted from the rodent-infective gastrointestinal nematode Heligmosomoides bakeri'}], 'project-description': [{'description': 'Extracellular vesicles mediate communication between cells and also within and between different organisms. Vesicles secreted from the rodent-infective gastrointestinal nematode Heligmosomoides bakeri, are internalised by mouse host cells leading to suppression of host genes involved in immunity and inflammation (Buck et al., 2014). They contain specific small RNAs and a worm-specific Argonaute protein referred to as Hb-exWAGO. This extracellular worm-specific Argonaute is highly expressed and highly conserved among other gastrointestinal nematodes, such as the human hookworm and sheep parasites, and facilitates partitioning of specific small interfering RNAs into the extracellular vesicles (Chow et al., preprint). We hypothesise that Hb-exWAGO could be involved in cross-species RNA interference, a trait which could facilitate the capacity of gastrointestinal worms for parasitism. In this proposal we focus on Hb-exWAGO and our goal is to elucidate its function and determine whether and how it mediates gene silencing in the host. To achieve our goal, we will determine the protein binding partners of Hb-exWAGO and identify its guide and target RNA interactions. We will then build a model for its functional mechanism by using cell culture experiments and in vitro assays.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4311-9776', 'authenticated-orcid': False, 'given': 'Kyriaki', 'family': 'Neophytou', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:04Z', 'timestamp': 1636383244000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215127'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220118}, 'publisher': 'Wellcome', 'award': '219941', 'DOI': '10.35802/219941', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of microglia in perinatal brain injury and repair'}], 'project-description': [{'description': 'Injury to the infant brain before, during, or after birth can lead to problems with movement, intellect, and sensation, as seen in cerebral palsy. This is due to damage to white matter, areas rich in a fatty substance called myelin that insulates nerves for their health/function. Current treatments are not suitable for all infants, are only moderately effective, and do not support white matter repair. Microglia are immune cells that control white matter repair in adult brain, yet their roles in supporting white matter formation and repair in the developing brain are not clear. I aim to understand how microglia regulate white matter formation and repair, to contribute to the development of therapies for infant brain injury. I will analyse myelin formation and repair following injury in a model where microglia are absent. As microglia are known to be composed of multiple subtypes, I will also assess how these subtypes change in white matter following experimental injury using single cell-sequencing, and examine these in injured human infant brain. Lastly, I will assess the roles of microglia subtypes by transplantation following injury. This project will identify microglia subtypes to target in order to drive white matter repair in injured infant brain.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9769-367X', 'authenticated-orcid': False, 'given': 'Niamh', 'family': 'McNamara', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219941'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220104}, 'publisher': 'Wellcome', 'award': '214369', 'DOI': '10.35802/214369', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of RAC signalling in Inflammatory Bowel Disease-associated colorectal cancer'}], 'project-description': [{'description': 'Bowel cancer is the second most common cause of cancer-related death, accounting for 44 deaths every day in the UK. Patients with Inflammatory Bowel Disease (IBD) affecting the large intestine have a 70% increased risk of developing bowel cancer compared to the general population. This risk increases to 700% in patients who are diagnosed with IBD before the age of 30. We do not currently fully understand how, or why bowel cancers develop in these patients. There are known genetic differences in cancers that develop in patients with IBD. One difference of interest is the RAC pathway, which is commonly altered in IBD associated bowel cancers. It is thought that the large intestinal inflammation that occurs in patients with IBD can somehow trigger or sustain cancer development, and this may be promoted by changes in the RAC pathway. We want to study the RAC pathway. If we can understand the RAC pathway in greater detail, we might be able to understand why patients with IBD get bowel cancers and what causes the inflammation to start. This may help find new treatments or even prevent cancer formation in this chronic disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2321-2140', 'authenticated-orcid': False, 'given': 'Antonia', 'family': 'Churchhouse', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 8, 1]]}, 'award-end': {'date-parts': [[2022, 2, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:44Z', 'timestamp': 1636383464000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/214369'}, {'indexed': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T08:45:34Z', 'timestamp': 1637052334218}, 'publisher': 'The ALS Association', 'award': '22-SI-603', 'DOI': '10.52546/pc.gr.150956', 'type': 'grant', 'created': {'date-parts': [[2021, 10, 1]], 'date-time': '2021-10-01T16:10:56Z', 'timestamp': 1633104656000}, 'source': 'Crossref', 'prefix': '10.52546', 'member': '30016', 'project': [{'project-title': [{'title': 'Neurofilament as a Fluid Biomarker of Neurodegeneration in f-FTD Project', 'language': 'en'}], 'project-description': [{'description': '', 'language': 'en'}], 'investigator': [{'given': 'Kevin', 'family': 'Klock', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Eva', 'family': 'Coyne', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Heidi', 'family': 'Blythe', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1348-3799', 'authenticated-orcid': False, 'given': 'Wesley', 'family': 'Horton', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 140000.0, 'currency': None}, 'award-start': {'date-parts': [[2021, 9, 15]]}, 'award-end': {'date-parts': [[2023, 9, 14]]}, 'funding': [{'type': 'award', 'funder': {'name': 'The ALS Association', 'id': [{'id': '10.13039/100000971', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 15]], 'date-time': '2021-11-15T16:32:45Z', 'timestamp': 1636993965000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 15]]}, 'URL': 'http://dx.doi.org/10.52546/pc.gr.150956'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T11:15:16Z', 'timestamp': 1637147716245}, 'publisher': 'The ALS Association', 'award': '22-PDF-605', 'DOI': '10.52546/pc.gr.150910', 'type': 'grant', 'created': {'date-parts': [[2021, 10, 1]], 'date-time': '2021-10-01T16:10:56Z', 'timestamp': 1633104656000}, 'source': 'Crossref', 'prefix': '10.52546', 'member': '30016', 'project': [{'project-title': [{'title': 'Pathomechanisms of ALS caused by SPTLC1 mutations', 'language': 'en'}], 'project-description': [{'description': '', 'language': 'en'}], 'investigator': [{'given': 'Jie', 'family': 'Jiang', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Tiffani', 'family': 'Patterson', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Bill', 'family': 'Lambert', 'affiliation': []}, {'given': 'Jie', 'family': 'Jiang', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Alfred', 'family': 'Merrill', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9065-3555', 'authenticated-orcid': False, 'given': 'Antonine', 'family': 'Franks', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Saturday', 'family': 'Sam', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4046-4195', 'authenticated-orcid': False, 'given': 'Devesh', 'family': 'Pant', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 150000.0, 'currency': None}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'award', 'funder': {'name': 'The ALS Association', 'id': [{'id': '10.13039/100000971', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T16:42:13Z', 'timestamp': 1637080933000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.52546/pc.gr.150910'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T14:45:19Z', 'timestamp': 1637160319995}, 'publisher': 'Office of Scientific and Technical Information (OSTI)', 'award': '60260', 'DOI': '10.46936/reso.proj.2021.60260/60007245', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T17:45:22Z', 'timestamp': 1637084722000}, 'source': 'Crossref', 'prefix': '10.46936', 'member': '960', 'project': [{'project-title': [{'title': 'Ultra-High Resolution Ion Mobility-Mass Spectrometry Metabolomics Platform'}], 'investigator': [{'given': 'Joon-Yong', 'family': 'Lee', 'affiliation': []}, {'given': 'Randolph', 'family': 'Norheim', 'affiliation': []}], 'funding': [{'type': 'award', 'funder': {'name': 'US Department of Energy', 'id': [{'id': '10.13039/100000015', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T17:45:22Z', 'timestamp': 1637084722000}, 'score': 0.0, 'issued': {'date-parts': [[None]]}, 'URL': 'http://dx.doi.org/10.46936/reso.proj.2021.60260/60007245'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T13:44:14Z', 'timestamp': 1637156654126}, 'publisher': 'Office of Scientific and Technical Information (OSTI)', 'award': '60257', 'DOI': '10.46936/reso.proj.2021.60257/60007247', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T22:38:52Z', 'timestamp': 1637102332000}, 'source': 'Crossref', 'prefix': '10.46936', 'member': '960', 'project': [{'project-title': [{'title': 'PNNL Proteomics Chemical Analysis Center for the MoTrPAC (ProMoTr)'}], 'investigator': [{'given': 'Paul', 'family': 'Piehowski', 'affiliation': []}, {'given': 'James', 'family': 'Sanford', 'affiliation': []}], 'funding': [{'type': 'award', 'funder': {'name': 'US Department of Energy', 'id': [{'id': '10.13039/100000015', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T22:38:52Z', 'timestamp': 1637102332000}, 'score': 0.0, 'issued': {'date-parts': [[None]]}, 'URL': 'http://dx.doi.org/10.46936/reso.proj.2021.60257/60007247'}]\n"
     ]
    }
   ],
   "source": [
    "foud_pubs = {}\n",
    "for wk in pubs_with_award:\n",
    "    art_authors = \"\"\n",
    "    if 'author' in wk.keys() :\n",
    "        for autr in wk['author']:\n",
    "            if art_authors == \"\":\n",
    "                art_authors = autr['family']+\", \" + (\", \"+ autr ['given'] if 'given' in autr.keys() else \"\" )\n",
    "            else:\n",
    "                art_authors += \", \" + autr['family']+ (\", \"+ autr ['given'] if 'given' in autr.keys() else \"\" )\n",
    "    fund_award = \"\"\n",
    "    for fdr in wk['funder']:\n",
    "        if 'award' in fdr.keys():\n",
    "          for awd in fdr['award']:\n",
    "               if awd in ['EP/R026939/1', 'EP/R026815/1', 'EP/R026645/1', 'EP/R027129/1', 'EP/M013219/1',\n",
    "                          'EP/K014706/2', 'EP/K014668/1', 'EP/K014854/1', 'EP/K014714/1']:\n",
    "                    if fund_award  == \"\":\n",
    "                        fund_award = awd\n",
    "                    else:\n",
    "                        fund_award += \", \" +awd\n",
    "                    \n",
    "    ol_year = 0\n",
    "    pr_year = 0\n",
    "    pub_year = 0\n",
    "    if 'published-online' in wk.keys() and 'date-parts' in wk['published-online'].keys():\n",
    "        ol_year = int(wk['published-online']['date-parts'][0][0])\n",
    "    if 'published-print' in wk.keys() and 'date-parts' in wk['published-print'].keys():\n",
    "        pr_year = int(wk['published-print']['date-parts'][0][0])\n",
    "    if pr_year > 0 and ol_year > 0:\n",
    "        if pr_year > ol_year:\n",
    "            pub_year = ol_year\n",
    "        else:\n",
    "            pub_year = pr_year\n",
    "    elif ol_year > 0:\n",
    "        pub_year = ol_year\n",
    "    elif pr_year > 0:\n",
    "        pub_year = pr_year\n",
    "        \n",
    "    print(art_authors,\"|\",pub_year,\"|\",wk['title'][0],\n",
    "          \"|\", wk['DOI'],\"|\", fund_award)     \n",
    "    this_pub = {}\n",
    "    this_pub['authors'] = art_authors\n",
    "    this_pub['year'] = pub_year\n",
    "    this_pub['title'] = wk['title'][0]\n",
    "    this_pub['DOI'] = wk['DOI']\n",
    "    if not wk['DOI'] in foud_pubs:\n",
    "         foud_pubs[wk['DOI']]= this_pub\n",
    "\n",
    "if len(foud_pubs) > 0:\n",
    "    csv_rw.write_csv_data(foud_pubs, 'cr_check_202111x.csv') \n",
    "if len(skiped_works) > 0:\n",
    "    print(skiped_works)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "fab35977",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'indexed': {'date-parts': [[2021, 11, 2]], 'date-time': '2021-11-02T17:07:03Z', 'timestamp': 1635872823737}, 'publisher': 'James S. McDonnell Foundation', 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award': '2020-1456', 'DOI': '10.37717/2020-1456', 'type': 'grant', 'created': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T15:52:55Z', 'timestamp': 1610121175000}, 'source': 'Crossref', 'prefix': '10.37717', 'member': '24568', 'project': [{'project-title': [{'title': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], 'project-description': [{'description': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Stefany', 'family': 'Moreno-Gámez', 'affiliation': [{'name': 'Massachusetts Institute of Technology'}]}], 'award-amount': {'amount': 200000.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2023, 1, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Postdoctoral Fellowship Award', 'award-amount': {'amount': 200000.0, 'currency': 'USD', 'percentage': 100}, 'funder': {'name': 'James S. McDonnell Foundation', 'id': [{'id': '10.13039/100000913', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T15:52:56Z', 'timestamp': 1610121176000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.37717/2020-1456'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513527}, 'publisher': 'Wellcome', 'award': '223024', 'DOI': '10.35802/223024', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deciphering the heterogeneity of early-onset type 2 diabetes using epidemiological and genetic approaches'}], 'project-description': [{'description': 'Background: Early-onset type 2 diabetes (diagnosed <40-years), is a severe presentation with excess risk of complications, cardiovascular events and early death, compared to later-onset disease. UK south Asian populations have an unexplained higher prevalence of this diagnosis. Studies of later-onset type 2 diabetes reveal heterogeneity in phenotype associating with complication risk, raising the possibility that targeting this variation with specific treatments could improve outcomes. These methods have not been extended to early-onset type 2 diabetes. Goal: I will decipher heterogeneity of early-onset type 2 diabetes in white and south Asian individuals using epidemiological and genetic approaches. Proposal: - Determine whether early-onset type 2 diabetes is enriched for sub-phenotypes contributing to higher risk, using analysis of large datasets to examine ethnic differences in presentation and progression by age-at-diagnosis with application of supervised and unsupervised statistical methods. - Determine if the higher risk of early-onset type 2 diabetes in south Asian individuals is driven by excess polygenic risk, by undertaking a cohort study with application of trans-ancestry polygenic scores compared to controls. Summary: This broad population-level study together with deep genotyping and phenotyping of affected individuals has the potential to produce new insights leading to better surveillance, earlier therapies, and fewer complications.', 'language': 'en'}, {'description': 'Background: Type 2 diabetes is typically diagnosed later in life but early-onset cases (before 40-years) are increasing, particularly in south Asian people. This is concerning as early-onset type 2 diabetes carries a higher risk of complications and early death. We don’t know what explains this higher risk or why some ethnicities are more affected. My approach: I will study early-onset type 2 diabetes in two ways; 1) studying large databases of cases comparing features and progression of early versus later-onset type 2 diabetes and its ethnic differences using different statistical methods; 2) by recruiting a new cohort of south Asian individuals with early-onset type 2 diabetes to determine if excess genetic risk for type 2 diabetes explains the earlier presentation. Impact: These studies will shed light on the features of early-onset type 2 diabetes and provide new insights into how we might better target prevention and treatments to improve outcomes.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2886-0726', 'authenticated-orcid': False, 'given': 'Shivani', 'family': 'Misra', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 1096432.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 1]]}, 'award-end': {'date-parts': [[2026, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1096432.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:57Z', 'timestamp': 1636383537000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223024'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513532}, 'publisher': 'Wellcome', 'award': '215105', 'DOI': '10.35802/215105', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structural studies of the galactose/N-acetylgalactosamine lectin from Entamoeba histolytica'}], 'project-description': [{'description': 'Entamoeba histolytica is a parasite which causes human amoebiasis, a common intestinal disease in countries that lack good sanitation practices. It is estimated to affect more than 50 million people and leads to around 100,000 deaths worldwide annually. Although it is considered as a major health issue, no vaccine is currently available. Originally ingested via contaminated food or water, the parasites reach the gut, attach to the mucosal wall of the epithelium and destroy the colonic tissue. The initial adhesion process is mediated by a lectin, a molecule which interacts with the sugar coat of host cells. Blocking parasites at this stage could prevent the subsequent steps of virulence. Therefore, the lectin is considered as the most promising vaccine candidate against amoebiasis. We aim at uncovering how the lectin mediates host cell adhesion at the molecular level. We will work out what the lectin looks like and how it binds to the sugar coat. We will identify the sugar recognition domains of the protein and raise antibodies against it. Eventually, solving structures of antibodies in complex with parts of the lectin that mediate virulence will help us design a vaccine against amoebiasis.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2842-0360', 'authenticated-orcid': False, 'given': 'Samuel', 'family': 'Gerard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:44Z', 'timestamp': 1636383224000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:13Z', 'timestamp': 1636456513599}, 'publisher': 'Wellcome', 'award': '221367', 'DOI': '10.35802/221367', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A multi-contrast X-ray nanoscope for multidisciplinary research'}], 'project-description': [{'description': 'We are seeking to acquire the resources to develop a unique X-ray 3D nanoscope. We will need: custom-source, isolation, manipulators, custom-detector, radiation-safe enclosure, two PDRAs (hardware- and software-focussed) and 1year system engineer for the transition to the long-term maintenance/management of the instrument. We plan to build a nano-resolution multi-contrast 3D scanner with transformative potential across diverse disciplines, including cellular structural biology, pathology, musculoskeletal and respiratory medicine, tissue engineering and child health. This will create a multi-user tool, benefitting researchers across multiple specialties. The simultaneous attainment of nano-scale resolution, unprecedented scale range (six orders of magnitude,5cm/50nm), multi-contrasts and a wide energy range will make the X-ray nanoscope proposed here a unique non-destructive 3D imaging tool. Its key advancements will be ultra-high-resolution zoom-ins on intact samples, whose entire structure is measured at a lower resolution, combined with multi-contrast modes arising from phase effects. A simple analogy of this new X-ray tomography paradigm is the way we navigate digital maps. We use coarse resolution at large scales, blowing-up in precise locations of interest. Both capabilities must be concurrently present: it would not be useful to navigate large areas at highest resolution (lost in space) and having only coarse resolution would lack invaluable insights.', 'language': 'en'}, {'description': 'We propose a technology development leading to a new paradigm in three-dimensional volumetric imaging. This new concept has an analogy in the way we navigate digital maps, where we use a coarse resolution to move efficiently over large areas, then blow up specific locations to visualise details of interest. We plan to use X-rays, for their ability to propagate through thick and opaque samples and quantitatively measure their three-dimensional internal structure. X-ray microscopy techniques were pioneered at synchrotron facilities, where they have led to significant breakthroughs in many diverse areas of science. Our aim is to develop a table-top instrument, easily deployable in a standard laboratory, which enables quantitative imaging of label-free samples across a vast range of scales. This will bridge the resolution gap between other well-established microscopy techniques, such as electron and visible light microscopy, and become a platform catalysing collaborative projects among scientists from diverse backgrounds.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2070-326X', 'authenticated-orcid': False, 'given': 'Anna', 'family': 'Franz', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4945-0171', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Lythgoe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1370-9417', 'authenticated-orcid': False, 'given': 'Rachel', 'family': 'Chambers', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Paolo', 'family': 'De Coppi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-7150-2951', 'authenticated-orcid': False, 'given': 'Alessandro', 'family': 'Olivo', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1688-5360', 'authenticated-orcid': False, 'family': 'Moosajee', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-3898-8881', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Lee', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-8054-2293', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Jacob', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Charlotte', 'family': 'Hagen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7810-2301', 'authenticated-orcid': False, 'given': 'Marco', 'family': 'Endrizzi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1288017.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 1288017.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:03Z', 'timestamp': 1636383123000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:17Z', 'timestamp': 1636456517471}, 'publisher': 'Wellcome', 'award': '052856', 'DOI': '10.35802/052856', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The functional and neural bases of human memory:Electrophysiological and functional neuroimaging studies.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Rugg', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1346694.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 1346694.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:40Z', 'timestamp': 1636382920000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/052856'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:17Z', 'timestamp': 1636456517536}, 'publisher': 'Wellcome', 'award': '051936', 'DOI': '10.35802/051936', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Purinergic control of spinal motor pattern generation.'}], 'lead-investigator': [{'given': 'Nicholas', 'family': 'Dale', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 138358.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 11, 17]]}, 'award-end': {'date-parts': [[2001, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 138358.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:06Z', 'timestamp': 1636382946000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 11, 17]]}, 'URL': 'http://dx.doi.org/10.35802/051936'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:19Z', 'timestamp': 1636456519103}, 'publisher': 'Wellcome', 'award': '060729', 'DOI': '10.35802/060729', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic and phenotypic characterisation of 1918 infuenza virus.'}], 'lead-investigator': [{'given': 'John', 'family': 'Oxford', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 145154.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 145154.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:53Z', 'timestamp': 1636382873000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060729'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:19Z', 'timestamp': 1636456519163}, 'publisher': 'Wellcome', 'award': '064827', 'DOI': '10.35802/064827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Somal translocation: a distinct mode of neuronal migration in the developing cerebral cortex.'}], 'investigator': [{'family': 'Coffin', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'John', 'family': 'Parnavelas', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 211385.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 211385.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:51Z', 'timestamp': 1636382871000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:20Z', 'timestamp': 1636456520128}, 'publisher': 'Wellcome', 'award': '063505', 'DOI': '10.35802/063505', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular characterisation of native H3 Histamine receptors expressed in the mammalian striatum.'}], 'lead-investigator': [{'given': 'Paul', 'family': 'Chazot', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'award-amount': {'amount': 48112.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 7, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 48112.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:35Z', 'timestamp': 1636382975000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063505'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522434}, 'publisher': 'Wellcome', 'award': '067383', 'DOI': '10.35802/067383', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution towards the annual meeting of the Bone and Tooth Society to be held in Cardiff on June 24 - 26, 2002.'}], 'lead-investigator': [{'family': 'Evans', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2002, 6, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:05Z', 'timestamp': 1636382825000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067383'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522462}, 'publisher': 'Wellcome', 'award': '213608', 'DOI': '10.35802/213608', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mapping dynamic trajectories of development in autism spectrum disorder: gaining new insights into aetiology and heterogeneity'}], 'project-description': [{'description': 'Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterised by substantial behavioural heterogeneity. Although differences in neurobiological functioning are found in individuals with ASD, much of the extant work has used cross-sectional designs and is therefore ill-equipped to answer questions of directionality. I will use advanced statistical techniques to model directional pathways between brain functioning, cognition and behavioural outcomes. First, I will obtain a detailed characterisation of brain functioning across the early developmental period in infants at high and low risk for developing ASD (Objective 1). I will model different trajectories of early brain development that may precede a diagnosis of ASD, and test whether these differ from those found in individuals without a diagnosis, and whether they predict later profiles of cognitive functioning and behavioural symptoms. Next, I will integrate one sample from Objective 1 with longitudinal data from a large sample of individuals with an established diagnosis of ASD to comprehensively test uni- vs. bi-directional pathways between neurobiological functioning, cognition and behavioural symptoms (Objective 2). Better understanding of these pathways may allow for interventions to be targeted towards mechanisms underpinning specific symptoms, rather than global diagnosis. Given the heterogeneity within ASD, this may lead to more effective interventions.', 'language': 'en'}, {'description': 'Autism spectrum disorder (ASD) is characterised by difficulties in social communication, repetitive behaviours and restrictive interests. The presentation of ASD can vary enormously from person to person, with variation in the types of symptoms they may display, their intellectual ability, and whether or not they experience additional psychiatric symptoms. I will combine advanced statistical models with sensitive measurements of brain functioning, to better map the links between brain functioning, cognition and behaviour in ASD across the lifespan. First, I will model pathways of early brain development in infants at risk of ASD, and map these trajectories of brain development onto later cognitive functioning and ASD symptoms in toddlerhood. Second, I will delineate the directional pathways between brain functioning, cognition and behavioural symptoms in individuals with an established diagnosis of ASD. Increased understanding of the neurobiological mechanisms that underpin the symptoms of ASD may help to identify new targets for intervention.', 'language': 'en'}], 'investigator': [{'given': 'Andrew', 'family': 'Pickles', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Mayada', 'family': 'Elsabbagh', 'affiliation': [{'name': 'McGill University', 'country': 'CA'}]}, {'given': 'Emily', 'family': 'Jones', 'affiliation': [{'name': 'Birkbeck University of London', 'country': 'GB'}]}, {'given': 'Shafali', 'family': 'Jeste', 'affiliation': [{'name': 'University of California', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7455-5514', 'authenticated-orcid': False, 'given': 'Virginia', 'family': 'Carter Leno', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:50Z', 'timestamp': 1636383050000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213608'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522626}, 'publisher': 'Wellcome', 'award': '215307', 'DOI': '10.35802/215307', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of RNMT-RAM in pluripotency gene expression'}], 'project-description': [{'description': 'Embryonic stem cells (ESCs) have the potential to become any cell in the body. They retain this potential through the expression of pluripotency factors. Capping of RNA facilitates processing and translation of the RNA to protein. RNMT-RAM, a complex involved in creating the mRNA cap has been found to have an important role during ESC differentiation. Highly expressed in ESCs, RAM downregulation during neural differentiation negatively effects expression of pluripotency factors and appears to be necessary for neural differentiation. How RNMT-RAM is controlling transcription is unknown. I aim to investigate which gene sets are being controlled by RNMT-RAM. I will also look for how RNMT-RAM is controlling transcription by investigating protein interactors. Are there interactions with transcription factors or the RNA polymerase II which may be recruiting RNMT-RAM in ESCs?', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4851-6658', 'authenticated-orcid': False, 'given': 'Lydia', 'family': 'Hepburn', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2022, 4, 14]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:24Z', 'timestamp': 1636383264000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/215307'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522631}, 'publisher': 'Wellcome', 'award': '215146', 'DOI': '10.35802/215146', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chronic imaging of the fruit fly brain : investigating sleep homeostasis'}], 'project-description': [{'description': 'All animals sleep, the question “why” is still without an answer. If there might be more than one explanation, one of the most convincing theory is about the possible role of sleep in clearing the brain from molecules that at high concentration can cause damage to the brain. The numerous family of molecules that can damage the brain can be represented by the so-called ROS: reactive oxygen species. Among all the different animal models, the fruit fly Drosophila melanogaster has been proved to be the most useful to study the mechanic of sleep homeostasis. The fundamental features that characterize sleep in mammals are found in fruit flies too. I aim to chronically image the movement of ions in some population of neurons involved in the sleep homeostasis, in Drosophila, during natural sleep: wake cycles or a period of controlled insomnia. I will then try to see if a correlation could be drawn between this movement of ions and predicted changes in the level of ROS in the brain. I will finally focus on imaging the cellular dynamic of Sandman, an ion channel responsible for the switch between the states: sleep and vigilance.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8104-4464', 'authenticated-orcid': False, 'given': 'Giacomo', 'family': 'Bertuzzi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215146'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522654}, 'publisher': 'Wellcome', 'award': '217099', 'DOI': '10.35802/217099', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental Mechanisms of Motor Network Tuning'}], 'project-description': [{'description': 'Activity is required for correct development of neural circuits and emergence of appropriate behaviour. At early stages activity is spontaneously generated, and then superseded by patterned network activity as sensory afferents become active. A period of maximal plasticity, termed critical period, generally spans these two phases. Significantly, aberrant activity during neural circuit development, especially when occurring in the critical period, can lead to network errors that become ‘locked in’ and may contribute to neurological disorders in later life. Whilst a requirement for activity is universal for circuit development, important questions remain unanswered. We have identified a comparable requirement for activity in the development of the motor circuit of Drosophila larvae. Notably, perturbation of activity leads to permanent and significant errors in circuit function. This system is composed of identifiable, tractable neurons of defined connectivity. These advantages allow us to study fundamental questions in ways not possible in higher organisms. Exploiting this exceptional level of resolution, our overall goal is: to generate detailed understanding of the cellular and molecular processes that underlie normal network tuning and lead to errors following early activity perturbation; further, to determine in this tractable circuit the capability of homeostatic mechanisms to compensate for early induced perturbations.', 'language': 'en'}, {'description': 'Developing neural circuits are reliant on activity for appropriate development. Moreover, abnormal activity levels are now believed to produce errors in development that can be ‘locked-in’ contributing to diseases such as epilepsy, autism and schizophrenia. Whilst activity is required through much of neural circuit development, periods of heightened plasticity, termed critical periods, during which activity has maximal effect have been identified. How activity tunes a developing neural circuit and the specific events that occur during a critical period, is poorly understood. The potential for neural circuits to rectify errors induced by altered activity during development is also unknown. We address these issues, using larvae of the fruitfly Drosophila. Its nervous system forms within a few hours, has a defined developmental timeline and exhibits critical periods. The tractability of this insect nervous system will allow us to identify how activity refines the development of a neural circuit to ensure appropriate function.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8571-4376', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Baines', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5142-1997', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Landgraf', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1866822.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2025, 4, 6]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 1866822.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217099'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522674}, 'publisher': 'Wellcome', 'award': '219906', 'DOI': '10.35802/219906', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Investigating Neuron-Microglia Interactions in Alzheimer's Disease\"}], 'project-description': [{'description': 'Microglia, the resident immune cells of the brain, play an important role in synapse elimination within specific brain regions at early, pre-plaque stages of Alzheimer’s disease (AD). One such region impacted is the hippocampal formation, which is vital for the production of new memories, a process adversely affected early in AD pathology. Hyperactivity of hippocampal neurons has also been observed during early AD. We hypothesize that this hyperactivity could mobilize microglia toward synaptic elimination in a circuit-specific manner in response to ‘tagging’ of synapses with the AD-associated synaptotoxic protein species, amyloid-beta (Aβ). In order to address this research question, we will first use immunohistochemistry to visualize synapse loss in AD mouse model hippocampal layers as well as synaptic engulfment by microglia via viral tracing of neurons. We will employ optogenetic techniques in wild type mice to activate specific hippocampal neurons and determine whether these overactive synapses alone are targeted for elimination by microglia. Finally, we aim to elucidate the exact mechanisms by which this microglial activation occurs using knockout genetic mouse models and pharmacological manipulation. These studies will further our understanding of the key role played by microglia during early AD and isolate new potential functions for the Aβ peptide.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0436-1332', 'authenticated-orcid': False, 'given': 'Gerard', 'family': 'Crowley', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:15Z', 'timestamp': 1636383255000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219906'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522665}, 'publisher': 'Wellcome', 'award': '215158', 'DOI': '10.35802/215158', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of tissue mechanics in (human) lung branching morphogenesis and cell fate decisions'}], 'project-description': [{'description': 'It is increasingly apparent that forces such as stretching and stiffness can affect how our organs develop. This is intuitively obvious in the developing lung where the foetus is known to make breathing movements and inhale amniotic fluid and serious congenital lung abnormalities can develop if this process is blocked. Even though these forces are clinically- important very little is known about how they actually affect lung cells leading to normal maturation and development of the lung. In this project I will use fragments of human embryonic lungs, and organoids derived from them, to assess the affects of stretching and stiffness on human lung development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8344-6299', 'authenticated-orcid': False, 'given': 'Vanesa', 'family': 'Sokleva', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:05Z', 'timestamp': 1636383305000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215158'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522803}, 'publisher': 'Wellcome', 'award': '222749', 'DOI': '10.35802/222749', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular and cellular mechanisms directing neuronal microtubule rearrangements during vertebrate CNS development'}], 'project-description': [{'description': 'Polarity, the asymmetric organisation of cellular components, is crucial for the function of many cell types. Newborn neurons in the developing spinal cord shed their tips to move to their final location, causing them to lose polarity and the ability to distinguish their front from their back. These neurons must then regain polarity to extend a long process, called an axon, which makes connections with other neurons. In the developing embryo, neurons polarise in response to external cues from the surrounding tissue, which determine the orientation in which the axon will form, and therefore the direction it will grow in, or if it forms at all. Thus, neuron polarisation is essential for the formation of neuronal circuitry; however, the mechanisms of vertebrate neuron polarisation within tissue are unclear. I will study the molecular and cellular mechanisms that direct this key cell-biological process using cutting-edge live imaging and super-resolution microscopy of developing neurons in the embryonic chick spinal cord. Not only will this work help us understand how the nervous system is built, but it will also enrich our understanding of the general cellular mechanisms of polarity transition in development and disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2457-8005', 'authenticated-orcid': False, 'given': 'Victoria', 'family': 'Higgs', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2023, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:09Z', 'timestamp': 1636383489000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222749'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522804}, 'publisher': 'Wellcome', 'award': '220083', 'DOI': '10.35802/220083', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating macrophage behaviour and interactions in normal and pathophysiological erythropoiesis'}], 'project-description': [{'description': 'Macrophages are known to be intrinsically involved in nurturing erythroid cells within the bone marrow. They regulate and enhance erythropoiesis, the production of Red Blood Cells (RBCs), through maintenance of the haematopoietic stem cell (HSC) niche and erythroblastic islands (EBIs). Understanding the cellular interactions involved in EBI formation and maintenance is crucial for investigating disease and improving in vitro erythropoiesis. Polycythemia Vera (PV) is a disease involving increased differentiation of progenitor cells towards the RBC lineage, and subsequent overproduction of RBCs. The genetic component, caused by a single acquired mutation in the tyrosine kinase JAK2, is well established. However, current treatments experience issues with resistance and intolerance, and the involvement of other cell types remains largely under-studied. Importantly, recent studies have implicated a role for macrophages in PV. I aim to further elucidate the molecular basis and cellular interactions that underly the role macrophages play in normal erythropoiesis and PV. CD14+ macrophages from PV and normal patients will be isolated to investigate phenotypic changes, including secreted cytokine profile, proteomic profile and mutations in JAK2. Image analysis will be conducted to probe whether there are changes in interactions between macrophages, progenitors, and erythroblasts within the normal and disease contexts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2618-101X', 'authenticated-orcid': False, 'given': 'Tiah', 'family': 'Oates', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:48Z', 'timestamp': 1636383288000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220083'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522854}, 'publisher': 'Wellcome', 'award': '222049', 'DOI': '10.35802/222049', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Disorders of human pubertal timing'}], 'project-description': [{'description': 'My proposal is focused on understanding the genetic basis, and consequently the pathophysiology, underpinning disordered human puberty. Pubertal disorders are common, but associated with severe comorbidities. Delayed puberty presents a diagnostic challenge in adolescence, as conditions of gonadotropin deficiency and isolated delayed puberty display the same clinical and biochemical phenotype. However, correct management is vital because the former is associated with infertility and requires intensive reproductive therapy, whereas the latter is self-limiting but associated with a shortened reproductive lifespan. The biological mechanisms of precocious puberty, a condition associated with increased long-term cardiovascular and cancer risk and thus with significant impact on public health, remain similarly opaque. The identification of causal genetic defects in disordered puberty allows interrogation of the key regulators of human puberty. I will use whole genome sequencing, comparative transcriptomics and methylomics studies in my large human cohort with disordered puberty, to define shared exonic and regulatory mutations resulting in delayed and precocious puberty. I aim to characterise the biological mechanisms underlying pubertal disorders through functional characterisation of novel genomic defects using cellular assays and animal models. These findings will ultimately translate to improved diagnostics, tailored therapeutic management and improved long-term outcomes for patients with disorders of puberty.', 'language': 'en'}, {'description': 'Puberty is the essential period of physical and psychological change from a child to an adult. Disturbances of pubertal timing are common, and are associated with increased risk of obesity, type 2 diabetes and in severe cases infertility. Moreover, both early and delayed puberty are associated with early menopause. While we know that these conditions often run in families, we still understand very little about how they occur and which gene changes are responsible. Currently, it can be difficult to distinguish which patients with early or late puberty need intensive treatment and follow up. I will use up-to-date genetic, cell and animal experiments to identify gene defects in our patient families with early and late puberty, and to understand how these inherited changes influence the timing and progress of puberty. This knowledge will enable us to improve diagnosis, allow tailored treatment and direct careful long-term follow up for our patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9295-3594', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Caulfield', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2706-8139', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Oakey', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6698-903X', 'authenticated-orcid': False, 'given': 'Sasha', 'family': 'Howard', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 611636.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 611636.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:30Z', 'timestamp': 1636383150000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222049'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:22Z', 'timestamp': 1636456522833}, 'publisher': 'Wellcome', 'award': '219979', 'DOI': '10.35802/219979', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rebuilding a superenhancer to investigate the additive and synergistic effects of its individual components'}], 'project-description': [{'description': 'Every cell in the body contains the same DNA; however each cell type \"reads\" and interprets DNA differently. Different regions of the DNA have different functions: some (genes) provide cells with instructions to make specific components, whereas others are regulatory, and simply tell cells which genes they should “read” and express. Enhancers are one category of regulatory DNA feature. They are regions of DNA which increase the expression of other specific genes, even when they are located a long way from one another. Superenhancers are groups of enhancers which combine to up-regulate expression of target genes to an even higher extent. Superenhancers often act to increase the expression of genes which are only active in certain tissues, for example we are studying the α-globin superenhancer which up-regulates α-globin, a gene which is only active in red blood cells. Currently, it is unknown exactly how the different enhancers within one superenhancer associate to increase target gene expression. We will study this by stripping down and rebuilding the α-globin superenhancer. This is particularly important, as most genetic diseases are caused by mutations in regulatory elements like enhancers, and mutations at the α-globin superenhancer are responsible for diseases such as α-thalassaemia.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6722-3215', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Blayney', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 30]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:19Z', 'timestamp': 1636383319000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 30]]}, 'URL': 'http://dx.doi.org/10.35802/219979'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:23Z', 'timestamp': 1636456523484}, 'publisher': 'Wellcome', 'award': '222528', 'DOI': '10.35802/222528', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Defining the functional basis of the enhanced survival and replication of African Salmonella in human phagocytic cells'}], 'project-description': [{'description': 'Invasive non-typhoidal Salmonella disease (iNTS) has emerged as a major killer in sub-Saharan Africa, responsible for ~500,000 deaths since 20091. The disease primarily affects people who are immunocompromised by HIV, malaria, anaemia or malnourishment2, and has a high case-fatality-rate (14.5%1). In Africa, iNTS is caused by one clade of S.Typhimurium and two clades of S.Enteritidis3–5. Despite many decades of research on gene function and infection biology of Salmonella, the pathoadaptive mutations that have driven the emergence of African clades are unknown. Such knowledge is vital to decipher iNTS pathogenesis and develop control strategies in the future. To address this knowledge gap, I will decipher the mechanisms that African and gastroenteritis-associated Salmonella employ to survive and replicate within a core niche, human phagocytic cells. I will achieve this using our powerful combination of comparative genomics and transcriptomics, plus new innovations in experimental evolution and genome-wide, high-throughput fitness assays. By understanding the molecular basis of the intra-macrophage lifestyle, I will determine whether these neglected African-Salmonella pathovariants have used common or divergent approaches to combat the antibacterial properties of human cells. My Research Question is: How do African Salmonella pathovariants survive and replicate so effectively in human macrophages?', 'language': 'en'}, {'description': 'We normally think about Salmonella as a bacterium that is responsible for severe gastroenteritis. But two new types of Salmonella called Typhimurium and Enteritidis have recently emerged in Africa, and are causing a bloodstream infection called iNTS that is currently killing about 49,000 people a year. No-one has done experimental comparisons between African Typhimurium and Enteritidis before. I will investigate the bacteria while they are growing inside human cells, and using a range of innovative approaches. Other scientists are working on prophylactic approaches, and vaccines to target iNTS are currently in development. My research will contribute fundamental knowledge concerning the ability of African Salmonella to thrive inside human cells, which may reveal an unexpected Achilles’ heel of this dangerous pathogen. how Salmonella evolved from causing gastroenteritis in Europe and USA to become a pathogen responsible for bloodstream infections in Africa, we will be better prepared for future epidemics.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2671-6026', 'authenticated-orcid': False, 'given': 'Jay', 'family': 'Hinton', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 1671997.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 5, 1]]}, 'award-end': {'date-parts': [[2027, 4, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1671997.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:32Z', 'timestamp': 1636383512000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222528'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:23Z', 'timestamp': 1636456523483}, 'publisher': 'Wellcome', 'award': '221650', 'DOI': '10.35802/221650', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of novel computational approaches for human cardiac mapping data - Improving understanding and treatment of atrial fibrillation'}], 'project-description': [{'description': 'Cardiac arrhythmias are a common pathway for multiple cardiovascular diseases, the leading cause of death in the world. Ablation of cardiac arrhythmias is a recommended and common treatment option for arrhythmia patients, but success rates are poor. Cardiac electroanatomical mapping systems (EAMs) are used to identify ablation targets. EAMs generate a wealth of raw data that is ideal for developing algorithms to tailor treatments to an individual patients’ pathophysiology and improve treatment options. However, no platform exists for developing and testing algorithms. Specific groups have developed closed-source software to identify ablation targets however, these results have not been widely reproducible. There is an acute need for an open-source and cross-vendor EAM analysis software to facilitate sharing methods, increase rigor and transparency and increase access to advanced processing tools. I will develop expandable open-source software for analysis of EAM data. I will incorporate established and novel analysis methodologies, including machine learning approaches. Algorithms will be robustly validated using clinical, pre-clinical and in silico datasets. The software I will develop will enable myself and others to utilise routinely collected clinical data, to better treat cardiac arrhythmia. I will apply these approaches to identify mechanistic drives of atrial fibrillation as an exemplar application.', 'language': 'en'}, {'description': \"Cardiac arrhythmias, diseases where the heart beats irregularly, present a huge healthcare burden. Atrial fibrillation (AF) for example is an arrhythmia that affects over 30 million people worldwide. In AF, the heart's two upper chambers contract randomly and quickly. People with AF are at higher risk of stroke, heart attack and sudden death, so live with huge anxiety. A common treatment is “ablation”. Here we stop part of the heart working. Alas, this fails approximately half the time, so AF recurs. We don’t know why this happens. Electrical maps of the heart during ablation may hold the answer. But we don’t have the tools to effectively explore these data. I aim to develop new software for this. My software will be state-of-the-art and freely available. This will help us improve AF treatment. That will make patient quality of life better and reduce stroke, heart attack and sudden death.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6237-1902', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Bishop', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Davor', 'family': 'Pavlovic', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}, {'given': 'Igor', 'family': 'Efimov', 'affiliation': [{'name': 'George Washington University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3030-7364', 'authenticated-orcid': False, 'given': 'Christopher', 'family': \"O'Shea\", 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 1]]}, 'award-end': {'date-parts': [[2025, 4, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:13Z', 'timestamp': 1636383133000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221650'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527250}, 'publisher': 'Wellcome', 'award': '092406', 'DOI': '10.35802/092406', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People Award.'}], 'lead-investigator': [{'given': 'Nigel', 'family': 'Thrift', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2010, 10, 1]]}, 'award-end': {'date-parts': [[2012, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:18Z', 'timestamp': 1636382958000}, 'score': 0.0, 'issued': {'date-parts': [[2010, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/092406'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527802}, 'publisher': 'Wellcome', 'award': '221548', 'DOI': '10.35802/221548', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A modern cryo-EM instrument for biological samples at Imperial College London'}], 'project-description': [{'description': 'The Centre for Structural Biology at Imperial College London includes a heavily-used electron microscopy facility on the South Kensington campus that features four electron microscopes for single particle and tomographic analysis of biological samples. A large and rapidly-growing Imperial- and London-based user community spanning molecular biology, chemical biology, and drug development, uses these instruments for sample screening, optimisation, and data collection. These instruments, however, are all based on 20+ year-old archetype, resulting in rising maintenance costs and risk become irreparable any day due to inability to source replacement parts. These machines are also bottlenecks, incapable of providing high-throughput screening, optimisation, and data collection needed to feed high-resolution data collection instruments such as Titan Krioses accessible at various UK-based facilities. Our community is in urgent need of a contemporary electron microscope such as a Talos Arctica capable of both single particle and tomography cryoEM, equipped with technology for rapid screening and optimisation and compatibility with Krios sample handling. The instrument will be embedded and managed within the CSB EM facility and accessible by all CSB users on an hourly user rate basis to guarantee full cost recovery, a company-based service contract, and long-term sustainability.', 'language': 'en'}, {'description': 'Imperial College London harbours a Facility for electron microscopy (EM), which allows structural analysis of biological samples down to a scale of near-atomic resolution. In the past 5-10 years, EM underwent a dramatic technical revolution with strong influence on biology, medicine and chemistry. It today allows researchers to get atomic scale-resolved structures of highly complex molecules or cellular sub-structures, in remarkably short time. Our Facility currently has four electron microscopes, which are all technically outdated (pre-2000) and which also increasingly started showing technical issues. These problems sometimes became impossible to repair, due to non-availability of spare parts or service contracts for antiquated equipment. For our very large (>70), mostly College-based crowd of EM users this makes research much less efficient and much less competitive in the fast advancing, international research context. In this application we are therefore requesting financial support for a modern electron microscope for biological samples.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9786-7038', 'authenticated-orcid': False, 'given': 'Xiaodong', 'family': 'Zhang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0786-6726', 'authenticated-orcid': False, 'given': 'Dale', 'family': 'Wigley', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6646-1692', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Speck', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1226-3217', 'authenticated-orcid': False, 'given': 'Harry', 'family': 'Low', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8241-9697', 'authenticated-orcid': False, 'given': 'Doryen', 'family': 'Bubeck', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8789-9546', 'authenticated-orcid': False, 'given': 'Alfonso', 'family': 'De Simone', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0662-6664', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Aylett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6413-9835', 'authenticated-orcid': False, 'given': 'Morgan', 'family': 'Beeby', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2716-9669', 'authenticated-orcid': False, 'given': 'Tiago', 'family': 'Costa', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3364-3320', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Meier', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 997614.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'equipment', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 997614.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:08Z', 'timestamp': 1636383128000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221548'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:27Z', 'timestamp': 1636456527782}, 'publisher': 'Wellcome', 'award': '219998', 'DOI': '10.35802/219998', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of RNA Methylation (m6A) in Chikungunya virus replication'}], 'project-description': [{'description': 'Chikungunya virus (CHIKV) is an emerging human pathogen, which is transmitted by mosquitos. CHIKV has a widening distribution due to the impact of globalization, including changing land use and international travel and trade. Viruses manipulate host cells in a variety of ways, including through gene expression. Genome modifications have been shown to play a role in a range of other viruses’ lifecycles, including the closely related Zika virus (ZIKV). We seek to build a more comprehensive understanding of CHIKV biology in both their insect and mammal hosts, from the point of RNA modifications which has been shown to regulate replication of related viruses. We aim to dissect the extent and function of virus and host-cell genome modificationson CHIKV replication, to better understand the basic biology of the virus in its varied host environments and identify potential therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4746-3331', 'authenticated-orcid': False, 'given': 'Veronica', 'family': 'DeJesus', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:06Z', 'timestamp': 1636383306000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219998'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528744}, 'publisher': 'Wellcome', 'award': '221538', 'DOI': '10.35802/221538', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Live cell imaging capability for research on pathogenic viruses'}], 'project-description': [{'description': 'We request a 75% contribution to purchase two IncuCyte S3 Live-Cell Analysis Systems, together with archive data storage capacity (£189,485). These instruments are designed to acquire real-time growth, migration, morphology, phenotypic and gene expression data from virus-infected cells in microplates. They will be located in newly-opened Biological Safety Level 3 (BSL3) and BSL2 laboratories, transforming existing capacity for real-time analysis of virus-infected cells and enabling ambitious plans for expansion of virology research. The overall aims of the research supported by these instruments are: 1) to understand the molecular mechanisms by which viruses enter cells, replicate their genomes and assemble into infectious virions, and 2) to drive early-stage development of new anti-viral therapeutics (eg screening compound libraries). The IncuCyte instruments will facilitate both work streams. They will be housed in standard cell culture incubators and can be remote controlled allowing the analysis of cell parameters over time safely without disturbance. In order to effectively train users, provide technical advice, oversee usage and manage the instruments, we also request funding for 10% of the salary of the current BSL2/BSL3 laboratory manager, and 5% of the BioImaging facility support scientist over 5 years (£31,390).', 'language': 'en'}, {'description': 'Viruses must infect living cells in order to multiply. Virus multiplication cycles take many hours, during which time they hijack cellular machinery and change the inner workings of the cell to favour their own growth. To better understand how these processes occur, it is important to study the events that occur in virus-infected cells throughout the complete multiplication cycle, and the requested IncuCyte instruments will allow us to do this. Additionally, when studying viruses that cause human or animal disease we need to work safely. At Leeds, we have just invested in state-of-the-art laboratories designed for safe work with pathogenic viruses, this is where the IncuCyte instruments will be located. As well as enabling us to better understand virus growth and effects on cells, the IncuCyte instruments will allow us to establish efficient screening programmes for the identification of new anti-viral drugs, with potential long-term benefits for patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1360-2751', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Stockley', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3866-7110', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Whitehouse', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1146-5519', 'authenticated-orcid': False, 'given': 'Nicola Jane', 'family': 'Stonehouse', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9035-2039', 'authenticated-orcid': False, 'given': 'John', 'family': 'Barr', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-5978-4693', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Macdonald', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9084-2927', 'authenticated-orcid': False, 'given': 'Juan', 'family': 'Fontana', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2524-707X', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Tuplin', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8626-6787', 'authenticated-orcid': False, 'given': 'Morgan Reece', 'family': 'Herod', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4325-3687', 'authenticated-orcid': False, 'given': 'Jamel', 'family': 'Mankouri', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9821-1003', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Harris', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 189485.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'equipment', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 189485.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:07Z', 'timestamp': 1636383127000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/221538'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528725}, 'publisher': 'Wellcome', 'award': '220472', 'DOI': '10.35802/220472', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding host restriction following bacterial phagosome rupture'}], 'project-description': [{'description': 'Professional phagocytes engulf bacteria inside phagosomes that mediate cargo degradation via lysosome fusion. Some intracellular pathogens evade this fate by disrupting the phagosomal membrane, which triggers antibacterial autophagy. While autophagy may eliminate bacteria for host defence, more recent studies have demonstrated that autophagy can also promote intracellular bacterial survival or be irrelevant for bacterial restriction. Recently, Endosomal Sorting Complex Required for Transport (ESCRT) proteins have been shown to repair small membrane disruptions, potentially providing an alternative pathway for bacterial restriction. The interplay between autophagy and ESCRT machinery during phagosomal damage, the factors triggering each pathway and their contribution to intracellular bacterial killing are poorly understood. Using the important human pathogen Staphylococcus aureus, I will: (1) investigate the interplay between autophagy and ESCRT machinery; (2) identify novel bacterial components that modulate autophagy and ESCRT recruitment; and (3) uncover unknown host regulators of autophagy, ESCRT and cell-autonomous immunity. To complete these objectives, I will use high-resolution microscopy to follow bacteria recruiting autophagy and / or ESCRT machinery at the single bacterial cell level. Additionally, I will use high-content genetic screens to discover novel bacterial (using transposon libraries) and host factors (using CRISPR/Cas9) shaping host-pathogen interactions.', 'language': 'en'}, {'description': 'Immune cells engulf and kill microorganisms inside phagosomes. However, some microorganisms avoid their destruction by damaging the phagosomal membrane. This activates autophagy, which can sometimes clear the infection, but might also be irrelevant or beneficial for bacterial survival. Potentially providing a restriction alternative is the ESCRT machinery, which has been proposed to repair membrane disruptions. I want to investigate the interplay between ESCRTs and autophagy during Staphylococcus aureus infection. Advanced optical microscopy will enable me to follow both machineries in high resolution and may help to understand factors triggering each pathway and their contribution to intracellular bacterial killing. It will also be important to identify bacterial factors that can modify autophagy and / or ESCRT recruitment. Moreover, I aim to discover unknown host regulators of autophagy, ESCRT and cellular immunity that enhance bacterial restriction and might offer potential targets for new therapeutic regimes for infection control.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2188-5659', 'authenticated-orcid': False, 'given': 'Andres', 'family': 'Floto', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6088-0711', 'authenticated-orcid': False, 'given': 'Aurelien', 'family': 'Roux', 'affiliation': [{'name': 'University of Geneva', 'country': 'CH'}]}, {'given': 'Michael', 'family': 'Otto', 'affiliation': [{'name': 'National Institute of Allergy and Infectious Diseases', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1153-4089', 'authenticated-orcid': False, 'given': 'Sina', 'family': 'Krokowski', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2024, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:45Z', 'timestamp': 1636383105000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220472'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:28Z', 'timestamp': 1636456528744}, 'publisher': 'Wellcome', 'award': '222811', 'DOI': '10.35802/222811', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Using genetics to stratify patients and improve prediction of clinically relevant outcomes in psychiatry and neurology'}], 'project-description': [{'description': 'This project investigates the genetic basis of psychiatric disorders and neurological diseases with three key goals. First, to gain insight into the molecular mechanisms underlying genetic associations with these outcomes through the integration of genome-wide association study (GWAS) summary statistics with a range of newly released functional genomic annotations. These include variant-level annotations such as the effect of genetic variation on gene expression, methylation and chromosome structure within relevant tissues and cell types, as well as gene-level annotations such as expression profiles across tissues, cell types and developmental stages. Second, functionally informed polygenic scores, such as imputed and observed gene expression risk scores, will be stratified by enriched functional genomic annotations and used for clustering patients into aetiological subtypes, which will then be characterised using sociodemographic and clinical variables. Lastly, this study will evaluate the utility of machine learning models containing functionally informed polygenic scores and cluster membership information for prediction of diagnosis, prognosis and treatment response. I will use data from a range of ancestral populations to improve the accuracy of genetic predictors in all populations. Together this project can inform novel drug development, identify clinical subgroups, and promote personalised medicine through improved prediction of clinically relevant outcomes.', 'language': 'en'}, {'description': 'Background: Many genetic variants have been linked to psychiatric and neurological problems. However, the biological mechanisms by which these genetic variants cause these problems are unclear, limiting the extent to which these findings can be used to improve clinical care. My approach: Recently, our understanding of how genetic variation affects biological processes in the brain has progressed significantly. I will use this knowledge to uncover biological processes by which genetic variation cause psychiatric and neurological problems. I will then attempt to separate patients into subgroups based on the specific biological processes driving their condition. I will then test whether this information can be used to improve prediction of clinical outcomes. Impact: My work will provide insight into the biology of neurological and psychiatric problems, allowing us to separate patients into more specific groups to provide personalised healthcare and so improve prevention, diagnosis, and treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5680-3281', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Pain', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 28]]}, 'award-end': {'date-parts': [[2025, 10, 27]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:33Z', 'timestamp': 1636383513000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222811'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:29Z', 'timestamp': 1636456529394}, 'publisher': 'Wellcome', 'award': '222842', 'DOI': '10.35802/222842', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of RUNX1 regulation in human developmental haematopoiesis and childhood leukaemia'}], 'project-description': [{'description': 'All adult blood cells are derived from prenatal blood stem cells produced in the embryo, where the process is dependent on a gene named RUNX1. Blood cell formation and the development of various blood cancers (leukaemia) are sensitive to RUNX1 levels. In my DPhil, I will characterise the mechanisms regulating RUNX1 levels in normal and malignant human blood cell formation. I will use a “test tube” experimental approach to model human fetal blood cell formation, by differentiating stem cells into immature blood cells (progenitors). I will characterize the dynamic regulatory changes in the RUNX1 genomic region at distinct blood progenitor stages. These data will form the benchmark for the examination of RUNX1 regulation in primary human blood progenitor cells and childhood acute lymphoblastic leukaemia (ALL) samples. Lastly, RUNX1 regulation will be perturbed through genetic and epigenetic engineering, to identify the contribution of aberrant RUNX1 expression to the development of childhood leukaemia. This comparative approach will help us understand not only regulatory mechanisms of normal human blood cell formation, and how well this process can be modelled in a test tube, but also how altered regulation of RUNX1 affects leukaemia development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0135-0032', 'authenticated-orcid': False, 'given': 'Alessandro', 'family': 'Cavallo', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 1, 17]]}, 'award-end': {'date-parts': [[2024, 1, 16]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:01Z', 'timestamp': 1636383481000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 17]]}, 'URL': 'http://dx.doi.org/10.35802/222842'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:31Z', 'timestamp': 1636456531519}, 'publisher': 'Wellcome', 'award': '223762', 'DOI': '10.35802/223762', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring options for government support for charity-funded medical research'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5058-2200', 'authenticated-orcid': False, 'given': 'Catriona', 'family': 'Manville', 'affiliation': [{'name': 'Association of Medical Research Charities', 'country': 'GB'}]}], 'award-amount': {'amount': 30000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 28]]}, 'award-end': {'date-parts': [[2021, 9, 9]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 30000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:39Z', 'timestamp': 1636383519000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 28]]}, 'URL': 'http://dx.doi.org/10.35802/223762'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:12Z', 'timestamp': 1636456452724}, 'publisher': 'Wellcome', 'award': '061548', 'DOI': '10.35802/061548', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional and effective connectivity within visuomotor intergration.'}], 'project-description': [{'description': 'Functional and Effective connectivity within Visuomotor Integration The everyday action of reaching and grasping an object requires the transformation of the visual information about the object in the workspace to a series of co-ordinated motor commands. Such visuomotor integration requires the coupling and coordination of many distinct cortical structures. The anatomical and physiological connections in the distributed system connecting the visual and motor cortical areas have been extensively studied. However, the functional interactions within and between these interconnected regions are still a matter of speculation. I propose to use electrophysiological (EEG) and functional neuroimaging (fMRI) techniques in normal human subjects to assess the nature and task-dependence of functional and effective connectivity within and between the neural systems involved in visuomotor integration. Kinematic and electrophysiological recordings will be carried out in the Institute of Cognitive Science, Lyon, France with Dr D Boussaoud in collaboration with Dr Y Paulignan and Prof. M Jeannerod in years 1-2. Further electroencephalography (EEG) and the functional magnetic resonance imaging (fMRI) recordings will be performed at the Wellcome Department of Cognitive Neurology, London, with Prof. K Friston in collarboration with Prof. M Rugg, in year 3. Cortical connectivity will be assessed using two different approaches. Firstly I will study synchronous and asynchronous couplings between oscillatory neuronal populations and secondly I will assess the functional and effective connectivity using nonlinear analysis techniques. Using EEG in normal human subjects a number of recent studies have reported synchronous oscillatory activity between different cortical areas. Such oscillatory activity could reflect a functional mode of brain operation, acting as an integrative mechanism that can link the processing of related neuronal information carried out in different cortical systems. Such a strategy would be ideally suited to solve the binding problem in the distributed systems serving vision and movement where hierarchical and parallel operations coexist. I propose to (i) study synchronous, linear, couplings during visuomotor tasks between distinct cortical systems, recorded using EEG, using standard first, second and third order spectral analysis. (ii) develop non-linear techniques to study asynchronous couplings among oscillatory neuronal populations involved in visuomotor integration. (iii) assess the relative contributions of synchronous and asynchronous couplings between different cortical areas and (iv) assess whether such couplings, either synchronous or asynchronous, are related to any behavioural event or are modulated by visual or motor task-dependent parameters. This work would take place during the first two years of the Fellowship. In the third and final year I will assess connectivity from time-series data recorded using both EEG and fMRI. Neuroimaging studies have been very effective in terms of elucidating functional neuroanatomy in human subjects, identifying cortical and sub-cortical structures that are engaged by different aspects of a given task. However, a critical question is how are these different structures connected and how do they interact. This is particularly pertinent to the study of visuomotor integration where it has been proposed there exist two independent visuomotor processing pathways. I propose to (i) use non-linear techniques to characterise the functional integration and to assess the effective and functional connectivity within and between the ventral and dorsal visuomotor streams. (ii) simultaneously record whole head EEG and fMRI data series and apply the effective connectivity modelling to the EEG data and (iii) study the relationship between the evoked electrical changes and the slower haemodynamic response.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6632-6797', 'authenticated-orcid': False, 'given': 'James', 'family': 'Kilner', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 111221.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 111221.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061548'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:12Z', 'timestamp': 1636456452730}, 'publisher': 'Wellcome', 'award': '059418', 'DOI': '10.35802/059418', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuroscience: four year doctoral programme.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2673-274X', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Grubb', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 99858.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 99858.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:19Z', 'timestamp': 1636383199000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059418'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:16Z', 'timestamp': 1636456456911}, 'publisher': 'Wellcome', 'award': '061064', 'DOI': '10.35802/061064', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'European study group of cardiovascular oscillations - 1st meeting in Cardiff between 30 March and 1 April 2000.'}], 'lead-investigator': [{'given': 'Tudor', 'family': 'Griffith', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 1]]}, 'award-end': {'date-parts': [[2000, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:32Z', 'timestamp': 1636382852000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061064'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:18Z', 'timestamp': 1636456458793}, 'publisher': 'Wellcome', 'award': '063342', 'DOI': '10.35802/063342', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Transgenic studies into the functional importance of hypothalamic leptin receptors in metabolism and obesity control.'}], 'lead-investigator': [{'given': 'Nina', 'family': 'Balthasar', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 82562.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82562.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:19Z', 'timestamp': 1636382959000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063342'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:18Z', 'timestamp': 1636456458799}, 'publisher': 'Wellcome', 'award': '063353', 'DOI': '10.35802/063353', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Adrenomedullin, calcitonin receptor-like, receptor activity modifying proteins and endometrial angiogenesis.'}], 'lead-investigator': [{'given': 'Constance', 'family': 'Rees', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 150215.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 17]]}, 'award-end': {'date-parts': [[2005, 2, 16]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 150215.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:46Z', 'timestamp': 1636382926000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 17]]}, 'URL': 'http://dx.doi.org/10.35802/063353'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:22Z', 'timestamp': 1636456462361}, 'publisher': 'Wellcome', 'award': '054606', 'DOI': '10.35802/054606', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular genetic analysis of the neuronal ceroid lipofuscinoses.'}], 'investigator': [{'given': 'Mark', 'family': 'Gardiner', 'affiliation': [{'name': 'Oxford Brookes University', 'country': 'GB'}]}, {'family': 'Williams', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4385-4957', 'authenticated-orcid': False, 'given': 'Sara', 'family': 'Mole', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 238556.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 8, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 238556.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:01Z', 'timestamp': 1636383001000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054606'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463265}, 'publisher': 'Wellcome', 'award': '215095', 'DOI': '10.35802/215095', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A shifting landscape: Recovering homeostasis in the intestinal crypt and the point of no return'}], 'project-description': [{'description': 'Understanding how normal, homeostatic small and large intestine crypt structures form and are regulated by the surrounding environmental pressures is important to establish a baseline for clinicians and researchers. Through the combination of experimental methodologies, bioinformatics analysis, and mechanistic, agent-based modeling I aim to elucidate the selective pressures acting in the intestine to maintain a disease-free morphology. This work will contribute to our understanding of mutational processes, burdens, and turnover as a function of the microenvironmental regulators. Establishing this baseline allows us to explore how loss/alterations of these homeostatic pressures may lead to the development of various disease states, especially lesion formation. This work consists of understanding four primary aims: (1) stabilizing selection acting during homeostasis, (2) how a shifting microenvironmental landscape alters selective pressures leading to increased incidence of intestinal cancers, (3) how does therapeutic intervention act to rescue homeostasis through selection of homeostatic cellular phenotypes, and (4) when early therapeutic interventions fail, how are the selective pressures maintaining homeostasis altered such that the epithelium is beyond rescue and is this reflected in the mutation spectra.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0294-0106', 'authenticated-orcid': False, 'given': 'Ryan', 'family': 'Schenck', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:07Z', 'timestamp': 1636383247000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215095'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463272}, 'publisher': 'Wellcome', 'award': '065423', 'DOI': '10.35802/065423', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuroscience.'}], 'lead-investigator': [{'given': 'Anh-Vu Muly', 'family': 'Tham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 78792.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2002, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 78792.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:18Z', 'timestamp': 1636383198000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065423'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463322}, 'publisher': 'Wellcome', 'award': '108869', 'DOI': '10.35802/108869', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Infection, Immunology and Translational Medicine 4 year PhD programme.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2126-5142', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'McShane', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3312-5929', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Powrie', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8366-3245', 'authenticated-orcid': False, 'given': 'Christoph', 'family': 'Tang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2809988.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2720000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:38Z', 'timestamp': 1636383218000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108869'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:23Z', 'timestamp': 1636456463494}, 'publisher': 'Wellcome', 'award': '066733', 'DOI': '10.35802/066733', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '2nd International Arylamine N-Acetyltransferase Workshop to be held in Oxfordshire on 5th and 6th October 2001.'}], 'lead-investigator': [{'given': 'Edith', 'family': 'Sim', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2001, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066733'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:24Z', 'timestamp': 1636456464836}, 'publisher': 'Wellcome', 'award': '060853', 'DOI': '10.35802/060853', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Relieving a bottleneck in structural and functional genomics: the preparation of genome-scale libraries of stably folded, expressible and affinity-tagged protein domains.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7476-4148', 'authenticated-orcid': False, 'given': 'Ernest', 'family': 'Laue', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'family': 'Davies', 'affiliation': [{'name': 'University of Sussex', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0394-3202', 'authenticated-orcid': False, 'given': 'Dek', 'family': 'Woolfson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 86557.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 27]]}, 'award-end': {'date-parts': [[2002, 10, 26]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 86557.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:40Z', 'timestamp': 1636382800000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 27]]}, 'URL': 'http://dx.doi.org/10.35802/060853'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:24Z', 'timestamp': 1636456464837}, 'publisher': 'Wellcome', 'award': '016668', 'DOI': '10.35802/016668', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A study of the pathogenic role of pore-forming toxins of the immune system.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4075-7676', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Morgan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2132684.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1987, 10, 1]]}, 'award-end': {'date-parts': [[2002, 11, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Default Stream', 'award-amount': {'amount': 2132684.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:04Z', 'timestamp': 1636382944000}, 'score': 0.0, 'issued': {'date-parts': [[1987, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/016668'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:26Z', 'timestamp': 1636456466950}, 'publisher': 'Wellcome', 'award': '108903', 'DOI': '10.35802/108903', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'the Wellcome Trust Doctoral Training Centre in Public Health Economocs and Decision Science (PHEDS)'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8645-4780', 'authenticated-orcid': False, 'given': 'John', 'family': 'Brazier', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1486-8233', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Strong', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3691-1888', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Goyder', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1025-312X', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Brennan', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Campbell', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5354-1933', 'authenticated-orcid': False, 'given': 'Petra', 'family': 'Meier', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 1465471.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2024, 2, 17]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1404000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108903'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:26Z', 'timestamp': 1636456466923}, 'publisher': 'Wellcome', 'award': '216665', 'DOI': '10.35802/216665', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How do males of South Asian origin with long-term conditions understand, experience and seek help for emotional distress?'}], 'project-description': [{'description': 'One of the greatest challenges facing healthcare today is treating people with multiple long-term health conditions, a term known as multimorbidity. People with multimorbidity of both physical and mental illness fare worse; they have a worse quality of life and die earlier. People from ethnic minority communities are more vulnerable to mental illnesses such as depression and anxiety; they are under-diagnosed, under-treated and health outcomes are worse. South Asians (SAs) are the largest minority group in the UK and are at a much higher risk of certain conditions such as diabetes and heart disease. Little is known how SAs with long-term conditions understand, experience and seek help for emotional distress, in particular for SA males. A systematic review will initially be undertaken to summarise the current research around SAs with long-term conditions and their experiences of depression of anxiety. A qualitative study will then be done, interviewing SA males with long-term conditions and primary care clinicians in areas with high numbers of SAs. The research will explore how SA males understand, experience and seek help for emotional distress, and what the facilitators and barriers are to primary care clinicians in treating them.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8025-0426', 'authenticated-orcid': False, 'given': 'Hassan', 'family': 'Awan', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 24]]}, 'award-end': {'date-parts': [[2022, 12, 23]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:06Z', 'timestamp': 1636383246000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 24]]}, 'URL': 'http://dx.doi.org/10.35802/216665'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:27Z', 'timestamp': 1636456467834}, 'publisher': 'Wellcome', 'award': '051410', 'DOI': '10.35802/051410', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Transcriptional regulation of thyroid transcription factor 1 (TTF-1)'}], 'lead-investigator': [{'given': 'Joanna', 'family': 'Whitehouse', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 192705.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2001, 6, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 192705.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:06Z', 'timestamp': 1636382886000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051410'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:27Z', 'timestamp': 1636456467829}, 'publisher': 'Wellcome', 'award': '062111', 'DOI': '10.35802/062111', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Biochemistry of cellular systems: Macromolecular Assemblies'}], 'lead-investigator': [{'given': 'Donna M', 'family': 'Fullerton', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 118092.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 118092.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:08Z', 'timestamp': 1636383188000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062111'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:28Z', 'timestamp': 1636456468559}, 'publisher': 'Wellcome', 'award': '215141', 'DOI': '10.35802/215141', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of calmodulin and L-type calcium channels in cardiac arrhythmia'}], 'project-description': [{'description': 'Long-QT syndrome (LQTS) is a disease which can cause irregular heartbeats and in the most dangerous cases even cardiac arrest. Recent studies in affected patients have identified mutations in a protein called calmodulin, suggesting that calmodulin dysfunction is responsible for the disease. However the underlying mechanisms responsible are still unclear. The aim of this project is to assess the effect of the mutations on calmodulin function. In particular, we will determine how the properties of these mutants differ from the unmutated protein and how they affect calcium channel activity, a key player in cardiac muscle contraction, as excessive calcium entry in to heart cells is known to cause LQTS. This will be achieved by using diverse cutting-edge biophysical, physiological and imaging techniques. Understanding the precise role of calmodulin in LQTS will aid in the development of new avenues of research to target and treat the condition in human patients.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3885-2500', 'authenticated-orcid': False, 'given': 'Nitika', 'family': 'Gupta', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:53Z', 'timestamp': 1636383293000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215141'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:28Z', 'timestamp': 1636456468908}, 'publisher': 'Wellcome', 'award': '070563', 'DOI': '10.35802/070563', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Highgate Place- associated costs'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Bennish', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'award-amount': {'amount': 4693.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 11, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4693.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:01Z', 'timestamp': 1636382941000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070563'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:29Z', 'timestamp': 1636456469598}, 'publisher': 'Wellcome', 'award': '059448', 'DOI': '10.35802/059448', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Predisposing factors for asthma and poor lung function in Chile.'}], 'lead-investigator': [{'family': 'Rona', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 131620.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 6, 1]]}, 'award-end': {'date-parts': [[2004, 6, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 131620.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059448'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:29Z', 'timestamp': 1636456469609}, 'publisher': 'Wellcome', 'award': '064344', 'DOI': '10.35802/064344', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The contral of polyphosphoinositide and Ca2+ release during the cell cycle in eggs and early embryos.'}], 'investigator': [{'given': 'John', 'family': 'Carroll', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-9420-4626', 'authenticated-orcid': False, 'given': 'John', 'family': 'Parrington', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Karl', 'family': 'Swann', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 162812.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2005, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 162812.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:46Z', 'timestamp': 1636382866000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064344'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470057}, 'publisher': 'Wellcome', 'award': '065067', 'DOI': '10.35802/065067', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Computer modelling of bio-material interfaces.'}], 'lead-investigator': [{'given': 'Nora', 'family': 'De Leeuw', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 38200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 1]]}, 'award-end': {'date-parts': [[2003, 1, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 38200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:06Z', 'timestamp': 1636382946000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065067'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470065}, 'publisher': 'Wellcome', 'award': '074047', 'DOI': '10.35802/074047', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell-based drug discovery against novel intracellular targets'}], 'project-description': [{'description': 'University Translation Award Cell-based Drug Discovery Against Novel Intracellular Targets It is well established that the translocation of numerous proteins between cell compartments is key to their biological function. Several Pleckstrin Homology (PH) domains confer on their cognate proteins an ability to undergo translocation from the cytoplasm to the plasma membrane where their ligand, a phosphoinositide (PI), is formed in response to PI3-kinase activation. Interfering in PI-binding by PH domains, as a method of inhibiting protein translocation, and hence activation of downstream signalling pathways, has the potential to offer novel therapeutic routes for the treatment of cancer, inflammation and other diseases. Importantly, PH domains possess deep electrostatic PI-binding pockets making them highly suited to modulation by low molecular weight drugs. ProXara has developed state-of-the-art cell-based High Content Screening technologies to measure intracellular protein translocation through the integration of proprietary image analysis techniques with advanced cell biology. In a preliminary screen of 8,000 compounds, four inhibitors of the translocation of the protein kinase Ba (PKBa/Akt1) PH domain were identified, all of which possessed core structural similarity. These inhibitors blocked PKB activation in PTEN-null tumour cells. The Company now intends to exploit this novel technology to discover drugs against therapeutically relevant intracellular signalling proteins focussing initially on inhibitors of PKB and Gab2 translocation. The Company seeks funds to screen a significantly larger compound library and undertake initial medicinal chemistry optimisation. This will result in the identification of early lead chemical series allowing the Company to secure £5m+ Series A funding in 2005.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Paul', 'family': 'England', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2034-9969', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 593852.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 2, 1]]}, 'award-end': {'date-parts': [[2005, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 593852.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:54Z', 'timestamp': 1636382874000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/074047'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470073}, 'publisher': 'Wellcome', 'award': '062768', 'DOI': '10.35802/062768', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD in Infection and Immunity'}], 'lead-investigator': [{'family': 'Brode', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 126732.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 126732.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:45Z', 'timestamp': 1636383165000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062768'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470270}, 'publisher': 'Wellcome', 'award': '216298', 'DOI': '10.35802/216298', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution of specific brain circuits to impaired awareness of hypoglycaemia'}], 'project-description': [{'description': \"Impaired awareness of hypoglycaemia or 'hypo unawareness', is a condition in which the brain cannot sense when blood glucose levels are going low - known as hypoglycaemia. In people without diabetes, a fall in blood glucose is sensed by the brain and warning symptoms are triggered. These symptoms may include hunger, sweating, tremors and alert the individual to eat something to raise their glucose levels or to seek help. Unfortunately, in a quarter of patients with type 1 diabetes, the brain no-longer senses when blood glucose falls and warning symptoms are not triggered. These patients suffer from impaired awareness of hypoglycaemia and are at an increased risk of loss of consciousness, collapse and other long-term health problems. Sadly, a cure for this condition has not been discovered and we believe that understanding how this condition occurs may provide answers. Our research focuses on uncovering the cells which are responsible for sensing low blood glucose levels in an area of the brain called the hypothalamus. We wish to understand why these cells lose their sensitivity and how this could be prevented. We hope that this work could develop new ways to prevent or treat impaired awareness of hypoglycaemia in the future.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7032-1238', 'authenticated-orcid': False, 'given': 'Adhithya', 'family': 'Sankar', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:09Z', 'timestamp': 1636383249000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216298'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470280}, 'publisher': 'Wellcome', 'award': '219980', 'DOI': '10.35802/219980', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating Centriole Positioning and Orientation Within Cells'}], 'project-description': [{'description': 'Our bodies are made of cells positioned relative to each other in order to make functioning tissues and organs. Within each cell is a pair of barrel-shaped structures called centrioles that help form the “skeleton” of each cell, giving the cell structural integrity as well as positioning information. “Top” and “bottom” of each cell is distinct (i.e. the cell is polar), therefore they are able to pattern themselves appropriately to form larger scale structures. My project centres around how centrioles orient themselves within a cell, such that the cell achieves proper polarity allowing certain structures, like cilia, to form in the right place relative to other cells. To do this I will use the Drosophilaembryo which has many centrioles, all aligned with one end facing the cell cortex with each centriole appearing as a ring. By measuring the percentage of oriented ring-like centrioles upon introduction of genetic mutations and injected drugs, I will elucidate the key proteins and/or cellular pathways that keep centrioles oriented, allowing them to then establish and maintain cell polarity.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0946-7021', 'authenticated-orcid': False, 'given': 'Nicole', 'family': 'Liew', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:27Z', 'timestamp': 1636383327000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219980'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470306}, 'publisher': 'Wellcome', 'award': '071111', 'DOI': '10.35802/071111', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '3rd Annual Meeting of the complex traits consortium to be held at the University of Oxford on 1-3rd July 2003.'}], 'project-description': [{'description': '3rd Annual Meeting of The Complex Traits Consortium The Complex Trait Consortium (CTC) was formed 3 years ago by the growing community of researchers working with animal models of complex and quantitative traits (ie quantitative phenotypes with multiple genetic basis), to promote the exchange of information and resources. A central component of this process has been a series of meetings. This application is for funding to support the 3rd annual CTC meeting of the CTC in Oxford, from 1-3 July 2003. The previous CTC meeting in Memphis, TN (May 2002) was very successful with over 100 attendees. QTL mapping is a hard but important problem; it is essential that leading researchers in the field are able to meet regularly to share their expertise and to provide a focus and leadership within the QTL mapping community. With the publication of the draft Mouse genome, mouse genetics is now at a crucial phase and it is therefore very suitable to organise such a meeting at this time, in order to set the agenda for the next 2-3 years. Four particular foci for the Oxford meeting are: (1) How best to exploit the draft mouse genome sequence. The recent publication of the sequence should help accelerate the identification of QTLs. It is therefore very timely to meet and consider how to identify the molecular basis of QTLs. (2) The design and production of shared genetic resources such as Recombinant Inbred Lines (RIL), derived from crosses between inbred mouse lines, that will enable researchers to map quantitative trait Loci (QTL) as efficiently (in terms of both time and cost, as further genotyping is unnecessary) as possible. (3) The definition of the experimental/statistical criteria necessary for publication of QTL. A major concern has been that while it is hard to establish exactly the mutations giving rise to a quantitative trait, strong supporting evidence for a particular gene being associated with the trait can be established more easily. Consequently both researchers and journal editors require appropriate guidelines. (4) Methods for identifying susceptibility loci for disease including cancer. Other topics will include: (5) Results of current QTL mapping projects. (6) Methods for QTL fine-mapping. (7) Mapping projects in non-rodents, eg cattle, plants.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9427-4429', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Flint', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1022-9330', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Mott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 7, 1]]}, 'award-end': {'date-parts': [[2003, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 5000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071111'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470349}, 'publisher': 'Wellcome', 'award': '218518', 'DOI': '10.35802/218518', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Integrative Infection Biology - Mechanisms and Control of Disease'}], 'project-description': [{'description': 'The mission of the proposed IIB Programme is to inspire the next generation of innovative world-class researchers to tackle global infection challenges. We will achieve this by shaping excellent PhD projects that build synergistic collaborations across the University of Glasgow and our partner institutes. Our aim is to give all students an exceptional experience, driving them to build their careers with the ability, confidence and integrity to make transformative contributions to global health. Our principles are promoting inquisitive and rigorous science, imparting technological and analytical skills, and reinforcing personal well-being. Our graduates will be ‘Scientists without Boundaries’ at ease with the implementation of far-reaching interdisciplinary concepts on the local and global stage. The IIB Programme is integrated around Glasgow’s core of global excellence across infectious disease research, including pathogen biology, pathogen-host interaction, epidemiology, ecology and transmission control, encompassing >25 Wellcome Trust-funded investigators. We have partnered with key institutions in Europe and Africa, to offer PhD students exceptional opportunities in all areas of infection biology. UoG funding will add 2 students from Africa each year, making 7 altogether. Students will select projects after laboratory rotations and be fully mentored through to a ‘PhD-Plus Year’ fostering the transition to their post-doctoral career.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4760-8382', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Maizels', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8900-2982', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Waters', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7007-4070', 'authenticated-orcid': False, 'given': 'Massimo', 'family': 'Palmarini', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0150-5049', 'authenticated-orcid': False, 'given': 'Annette', 'family': 'MacLeod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6654-7346', 'authenticated-orcid': False, 'given': 'Gillian', 'family': 'Douce', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1843-8580', 'authenticated-orcid': False, 'given': 'Megan', 'family': 'MacLeod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1040-9566', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Marti', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:56Z', 'timestamp': 1636383296000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218518'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470471}, 'publisher': 'Wellcome', 'award': '220108', 'DOI': '10.35802/220108', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the acute and chronic effects of E-cigarettes on human lungs, examining functional and mechanistic outcomes.'}], 'project-description': [{'description': 'E-cigarettes vaporise nicotine-containing fluid for inhalation and have become an increasingly popular alternative to tobacco. The effects of e-cigarettes on the human lung are incompletely characterised. Preliminary evidence indicates that healthy vapers and smokers have similarly protease rich lung environments. This supports evidence from our lab, demonstrating that e-cigarette exposed alveolar macrophages(AM) increase protease output. I aim to understand the effects of e-cigarettes on the cells of the human lung. Lung resection tissue from never smokers/vapers/smokers/ex-smokers will be used to source AM and type-II alveolar cells, as well as precision cut lung slices (PCLS). Effects will be assessed using techniques to assess viability, proinflammatory mediator production/ROS/protease output, wound repair, phagocytosis and efferocytosis. Simple monocultures/co-cultures will provide initial evidence of e-cigarette effects, whilst PCLS and PCLS/AM cultures will allow effects to be examined in the context of the complex cellular architecture of the lung. In addition, I aim to identify the mechanism(s) of action through which these effects are mediated. Candidate mechanisms will first be tested in co-culture models before validation using our human PCLS model. These studies will help characterise how and why e-cigarettes affect the lungs. This may help inform regulatory decisions and mitigate risks associated with e-cigarette use.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8597-7747', 'authenticated-orcid': False, 'given': 'Lauren', 'family': 'Davis', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:52Z', 'timestamp': 1636383292000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220108'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470513}, 'publisher': 'Wellcome', 'award': '220291', 'DOI': '10.35802/220291', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of reading development in deaf children'}], 'project-description': [{'description': 'Many severely and profoundly deaf children struggle to learn to read because written text is a visual representation of spoken language, to which they have limited access. I have shown that speechreading (lipreading) relates to deaf children’s reading development. Fully understanding the mechanisms underlying the speechreading-reading relationship is fundamental to harnessing speechreading as a tool to improve deaf children’s reading. My goal is to investigate this mechanism in 1) a longitudinal study, to determine the relationships between speechreading, phonological skills, language skills and reading over time and 2) in neuroimaging studies with deaf children and adults to investigate neural representations of visual speech and written text and the relationships between them. All deaf participants involved in the studies above will use speechreading. A subset will also have learned British Sign Language from an early age. Good quality early sign language exposure is beneficial to reading development in profoundly deaf children. However, the mechanism underlying this relationship is unclear. I will employ parallel methods to those used in the speechreading studies to examine 1) the longitudinal relationships between sign language, fingerspelling and reading and 2) the neural representation of these visual language inputs in deaf children and adults.', 'language': 'en'}, {'description': 'Many deaf children struggle to learn to read. This is because text is a visual representation of a spoken language, to which many deaf children have reduced access. I aim to understand the mechanisms underlying the relationships between language skills, phonological skills (understanding the structure of a spoken word), lipreading, and reading ability in deaf children. I will examine the interplay of the relationships between these factors over time, from 3yrs to 7yrs old. I will also examine the relationship between representations of these different language inputs in the brain in deaf children and adults. A better understanding of how and when different language factors impact literacy development in deaf children will mean we are better placed to intervene to improve these skills. Understanding how these broad language skills can contribute to reading development may also inform interventions with hearing children who are struggling to read.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2315-3507', 'authenticated-orcid': False, 'given': 'Mairead', 'family': 'MacSweeney', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1580335.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 12, 15]]}, 'award-end': {'date-parts': [[2026, 12, 14]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 1580335.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:40Z', 'timestamp': 1636383100000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 12, 15]]}, 'URL': 'http://dx.doi.org/10.35802/220291'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:30Z', 'timestamp': 1636456470979}, 'publisher': 'Wellcome', 'award': '064663', 'DOI': '10.35802/064663', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '10/66 Dementia Research Group China and SEAsian Regional Network meeting in Chinese University of Hong Kong 22-24 April 2001.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1379-7146', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Prince', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4800.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2001, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4800.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:49Z', 'timestamp': 1636382929000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064663'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471024}, 'publisher': 'Wellcome', 'award': '068244', 'DOI': '10.35802/068244', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The evaluation of adjunctive beta radiation for trabeculectomy in South Africa - does it enhance success in glaucoma management?'}], 'project-description': [{'description': \"Glaucoma is the most common cause of irreversible blindness worldwide and is particularly prevalent in Africa. Trabeculectomy remains the only realistic option for control of this condition. We have undertaken a randomised, placebo-controlled, double-blind surgical intervention trial of per-operative beta-irradiation in trabeculectomies for glaucoma in Africans, based in South Africa. The primary outcome measure in the trial is intraocular pressure control at 12 months. Secondary outcome measures include post-operative complications, visual function and subsequent eye-health seeking behaviour. Local ophthalmologists conduct the trail with overall coordination performed by a UK-based research ophthalmologist. To date the project is making excellent progress with three caveats; recruitment is behind schedule, follow-up rates could be improved and our primary endpoint (failure of traveculectomy) occurs less frequently than anticipated. This application is for funding to enable this study to achieve completion. Modeling of overall data illustrates the trial, if completed, has sufficient power to demonstrate a clinically important impact on surgical success (90% success vs 74% success with 80% power). This method of treatment has major health service implications for improved management of glaucoma throughout sub-Saharan Africa. It is particularly appealing because there is 20 years' use from the 'one off' investment for an applicator. A model of compliance for glaucoma therapy in those with unsuccessful primary trabeculectomy will help in the construction of cost effectiveness studies and health care provision strategies.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8087-2268', 'authenticated-orcid': False, 'given': 'Peng tee', 'family': 'Khaw', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'family': 'Stulting', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}, {'family': 'Cook', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}, {'family': 'Roux', 'affiliation': [{'name': 'Misc South Africa', 'country': 'ZA'}]}], 'lead-investigator': [{'family': 'Murdoch', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 99170.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 10, 1]]}, 'award-end': {'date-parts': [[2004, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 99170.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:29Z', 'timestamp': 1636382849000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068244'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471023}, 'publisher': 'Wellcome', 'award': '102172', 'DOI': '10.35802/102172', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cellular and molecular physiology'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8172-7513', 'authenticated-orcid': False, 'given': 'Alexei', 'family': 'Tepikin', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4055-5161', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Prior', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 2469886.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2014, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 2385000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2014, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/102172'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471800}, 'publisher': 'Wellcome', 'award': '059691', 'DOI': '10.35802/059691', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Funding for the Africa Centre research base at Somkhele.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Bennish', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'award-amount': {'amount': 1105637.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1105637.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:01Z', 'timestamp': 1636382941000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059691'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:31Z', 'timestamp': 1636456471966}, 'publisher': 'Wellcome', 'award': '216452', 'DOI': '10.35802/216452', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of anti-inflammatory drugs on emotional and reward processing'}], 'project-description': [{'description': 'The purpose of these studies is to investigate whether anti-inflammatory drugs change how the brain deals with emotional and rewarding information, with a view to improve treatments for people suffering from depression. There is growing scientific evidence that some people who do not respond to conventional antidepressants may benefit from taking anti-inflammatory drugs. Our research has previously shown that antidepressants affect how people experience certain kinds of information, for example by making them focus on positive facial expressions more than negative ones. These effects on ‘emotional processing’ can be found very early on in treatment, even before a patient ‘feels better’; however, we can measure these early changes and use this information to predict whether the treatment will actually help people feel better in the long term. The drugs we are investigating are called tofacitinib and atorvastatin. These are licensed drugs which has been shown to be generally safe and well-tolerated. We will test whether tofacitinib and atorvastatin can alter emotional processing in the same way as standard antidepressant drugs, comparing them with placebo (dummy tablet). Since reward processing and inflammation have been linked to depression, we will assess the effects of these drugs on these measures too.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5984-8696', 'authenticated-orcid': False, 'given': 'Riccardo', 'family': 'De Giorgi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:16Z', 'timestamp': 1636383256000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216452'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472040}, 'publisher': 'Wellcome', 'award': '220573', 'DOI': '10.35802/220573', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the interplay between interleukin-11 (IL-11) and senescence in cardio-renal aging.'}], 'project-description': [{'description': 'As chronological age increases, even in the absence of disease, vital organs accumulate changes which cause them to function less efficiently. Impaired efficiency of organs such as the heart or kidney are particularly common in older people causing the development of symptoms and require medical attention or hospital admissions. Cells accumulate damage to their DNA with age which causes these cells to enter a protective dormant state known as senescence. This prevents these cells from dividing and passing on the damaged DNA, however, senescent cells release molecules which cause neighbouring cells to produce scar tissue called fibrosis which impairs the efficiency of these organs. Interleukin-11 is one of these molecules which is known to cause fibrosis in multiple different diseases and blocking its effects reduces the amount of fibrosis. We plan to use treatments to block Interleukin-11 in ageing mice to identify the effect this has on the health of these mice and the amount of fibrotic tissue that they develop. We will also analyse the effects of senescent cells on the surrounding tissues to identify the benefit of treatments which specifically remove these cells or stop their contribution to scar formation.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5098-0076', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Sweeney', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 3]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:50Z', 'timestamp': 1636383470000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 3]]}, 'URL': 'http://dx.doi.org/10.35802/220573'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472209}, 'publisher': 'Wellcome', 'award': '061937', 'DOI': '10.35802/061937', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Neuroscience.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2316-7714', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Hall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 114290.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 114290.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:07Z', 'timestamp': 1636383187000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472245}, 'publisher': 'Wellcome', 'award': '053511', 'DOI': '10.35802/053511', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation and manipulation of indirect alloresponse in transplant rejection.'}], 'lead-investigator': [{'given': 'Wan', 'family': 'Ng', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 166683.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 8, 1]]}, 'award-end': {'date-parts': [[2002, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 166683.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:07Z', 'timestamp': 1636382827000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/053511'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472516}, 'publisher': 'Wellcome', 'award': '108864', 'DOI': '10.35802/108864', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mathematical genomics and medicine'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2740-8148', 'authenticated-orcid': False, 'given': 'John', 'family': 'Todd', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6883-6168', 'authenticated-orcid': False, 'given': 'Gos', 'family': 'Micklem', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-9755-1703', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Wallace', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1529-1862', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Gaffney', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9130-1006', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Durbin', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Simon', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 2602959.8, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 2490000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:17Z', 'timestamp': 1636383317000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108864'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472694}, 'publisher': 'Wellcome', 'award': '224685', 'DOI': '10.35802/224685', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developing small molecules to dissect the function and mechanism of m6Am methylation'}], 'project-description': [{'description': 'RNA are widely modified and the modifications have a range of effects. One such modification found in animals is the m6A modification. It is found in wide variety of different types of RNA & is the most common modification in messenger RNA. While the modification has been known about for 30 years, modern methods have only just identified the enzymes that create it. I aim to study a couple of these newly discovered enzymes. We will look into their enzymology making use of the existing x-ray structures. We hope to develop small molecule inhibitors for the enzymes. I hope to apply these inhibitors & the enzymology to cell assays. We might then better understand why the m6A modification is made and what effect it has.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8250-7627', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Harris', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 4, 19]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:57Z', 'timestamp': 1636383477000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 19]]}, 'URL': 'http://dx.doi.org/10.35802/224685'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:32Z', 'timestamp': 1636456472710}, 'publisher': 'Wellcome', 'award': '222391', 'DOI': '10.35802/222391', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Interplay between Nod-like receptor apoptosis inhibitory proteins and prostaglandins in colonic infection, inflammation and cancer'}], 'project-description': [{'description': 'Maintenance of gut health is dependent on the complex interactions between different cell types in the intestines and the immune system. Communication between these cells ensures that the barrier between the body and the gut contents is not disrupted and enables threats, such as harmful bacteria, to be detected by one cell subset and eliminated by another. The interactions between these cell types are disrupted during inflammation and disease, such as colitis, cancer, and infection. Understanding these signals and how they are perturbed during disease is vital. Certain bacteria are detected using receptors called NAIPs; we aim to understand how activation of NAIPs subsequently affects the rest of the immune system and how this impacts disease development. We will delete NAIPs from epithelial cells in the gut and identify resultant changes in immune cells. We will test this in models of colitis, colorectal cancer and Salmonella infection. I will look at changes in gene expression following NAIP deletion and identify the soluble mediators which influence the immune response. This project will aid our understanding of NAIPs during inflammatory disease development and thus generate potential targets for treating these diseases in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7769-2346', 'authenticated-orcid': False, 'given': 'Lisa', 'family': 'Scarfe', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:37Z', 'timestamp': 1636383397000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222391'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473183}, 'publisher': 'Wellcome', 'award': '066818', 'DOI': '10.35802/066818', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Meeting entitled 'Frontiers in ocular immunology, inflammation and transplantation', University of London, Senate House, 16-18 June 2002.\"}], 'project-description': [{'description': \"The University College London, Institute of Ophthalmology and its partner the Moorfields Eye Hospital, NHS Trust will host this symposium on Frontiers in Ocular Immunology, Inflammation and Transplantation to stimulate research in this area at the Institute/Hospital, and throughout the UK. The Institute of Ophthalmology now has eight basic and/or clinical laboratories pursuing research in all aspects of ocular immunology, and further growth in the Institute's Department of Immunology is an objective of the Institute's strategic plan. This symposium will stimulate the existing research programmes at the Institute/Hospital by bringing together the leaders in the field to London. During the invited lectures, poster sessions and informal gatherings, cutting edge information will be made available to interested investigators at the Institute/Hospital, and to any other interested groups within the UK. It is anticipated that existing collaborations will be strengthened, and new interactions formed during the symposium. The symposium will also facilitate the growth of immunology research at the Institute of Ophthalmology, University College London. New laboratory space for future immunology recruits to the Institute will become available in late 2002/early 2003, when the new research building (funded by the Trust's JIF award) is completed. Additional funding provided by Fight for Sight and GlaxoSmithKline will underwrite expenses associated with the recruitment of new researchers to the Institute. Professor Ono's recruitment from the Committee on Immunology at Harvard and its Schepens Eye Research Institute to the new GlaxoSmithKline Chair is an example of how such funds will be used to recruit other immunologists to the Institute. It is likely that future recruits in immunology will either be among the invited speakers or within their departments/laboratories. The symposium will therefore contribute directly to the growth of this department and thus the discipline. Of course, the primary objective of the symposium is to advance the field of ocular immunology, a meeting of investigators focused on issues relevant to diseases of the eye is essential due to the unique nature of immune responses in this organ. The invited speakers will discuss the following topics central to the field: The molecular and cellular basis of immune privilege and tolerance. Mechanisms of autoimmunity in the eye (focus on uveitis and keratitis). Immunologic parameters to corneal and retinal transplantation. Control of acute and late phase inflammation in vernal conjunctivitis. Mechanisms of ocular defenses to viral infection.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Santa', 'family': 'Ono', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:12Z', 'timestamp': 1636383012000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066818'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473215}, 'publisher': 'Wellcome', 'award': '063738', 'DOI': '10.35802/063738', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of post adhesive events in the pathophysiology of cerebral malaria.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1897-1978', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'White', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Kevin', 'family': 'Gatter', 'affiliation': [{'name': 'Misc Thailand', 'country': 'TH'}]}], 'lead-investigator': [{'given': 'Gareth', 'family': 'Turner', 'affiliation': [{'name': 'Misc Thailand', 'country': 'TH'}]}], 'award-amount': {'amount': 293566.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2003, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 293566.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:21Z', 'timestamp': 1636382841000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063738'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473353}, 'publisher': 'Wellcome', 'award': '222731', 'DOI': '10.35802/222731', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does wound inflammation impact on other cell lineages at the repair site – in vitro and live imaging studies in zebrafish'}], 'project-description': [{'description': 'Wound healing is the process by which skin integrity is restored following injury. At any site of tissue damage, the body activates a complex series of events to heal the wound. Each stage is necessary for effective tissue repair. Inflammation has evolved to prevent infection by pathogens. Besides killing bacteria, signals from inflammatory cells also coordinate other aspects of wound healing. However, these signals may also have negative consequences such a scarring, and if inflammation is not resolved, this can lead to chronic wounds such as diabetic foot ulcers can result. During my PhD I will investigate how inflammation impacts on three lesser studied cell types in wound healing, melanocytes (pigment cells), adipocytes (fat cells) and the cutaneous nerves in skin. It is thought these three cells could play interesting, but as yet unknown roles in wound repair, which may aid repair or be pathological. I will use live imaging in the translucent zebrafish to look at how these cells interact with inflammation, and what signals may cause this. This work could reveal the impacts of inflammation at the wound repair site, which could have impact on wound treatment in the clinic.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6822-8154', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'George', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 23]]}, 'award-end': {'date-parts': [[2023, 9, 22]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:01Z', 'timestamp': 1636383301000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 23]]}, 'URL': 'http://dx.doi.org/10.35802/222731'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:33Z', 'timestamp': 1636456473615}, 'publisher': 'Wellcome', 'award': '059601', 'DOI': '10.35802/059601', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Untitled grant'}], 'investigator': [{'given': 'Stacey', 'family': 'Efstathiou', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Philip', 'family': 'Stevenson', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 301492.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 301492.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:31Z', 'timestamp': 1636382971000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059601'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:36Z', 'timestamp': 1636456476520}, 'publisher': 'Wellcome', 'award': '220126', 'DOI': '10.35802/220126', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Protein Interactomes of Alzheimer’s Disease Risk Genes in Microglia'}], 'project-description': [{'description': \"Alzheimer's disease is a fatal condition with currently no cure. In our aging population, it is more important than ever to find ways to treat Alzheimer's, or even prevent it. Understanding the biology of Alzheimer's is a key step to understanding the disease and finding the best possible treatment and preventions. Previous research has found mutations in key genes, mostly expressed in microglia (the brain's immune cells) that increase a person's risk of developing Alzheimer's. Our work will focus on 3 of these genes (ABI3, TREM2, and PLCG2) and will look at how the proteins they code for interact with other proteins within cells. We will do this by mapping which proteins interact with our proteins of interest, both the normal and mutant versions, then compare these interactomes. We will then investigate the function of any new proteins found in these results and finally assess if these new proteins also contain mutations that carry a risk for Alzheimer's. This impact of this research will be to broaden our understanding of how these mutations increase the risk of Alzheimer's and may highlight potentially druggable targets to treat or reduce the risk of developing Alzheimer's.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2041-4361', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Widnall', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:08Z', 'timestamp': 1636383308000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220126'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:36Z', 'timestamp': 1636456476539}, 'publisher': 'Wellcome', 'award': '220597', 'DOI': '10.35802/220597', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Integration of kinases with membrane trafficking machinery'}], 'project-description': [{'description': 'Endocytosis is a highly dynamic process that determines the composition of the plasma membrane (PM). The dysfunction of endocytic pathways is a causal factor behind a number of human genetic diseases, and its dys-regulation can contribute to neurodegeneration. Despite the critical role that endocytosis plays in health and disease, surprisingly little is known about how it is regulated. A major potential regulation point is the dynamic phosphorylation of endocytic components by kinases. However, it is poorly understood which kinases (and phosphatases) control endocytosis and the PM proteome, even though they represent potential targets for disease-modifying therapies. My long-term vision is to understand the integration of protein kinases within membrane-trafficking machinery. My starting focus is on the Numb-associated kinase family (NAK). NAKs were identified as a susceptibility factor in Parkinson’s disease and neuropathic pain but the molecular mechanisms behind this are not clear. I will elucidate the key cellular functions of NAKs: (1) which cellular processes and substrates are associated with NAKs (2) the consequences of their activity for cellular physiology and (3) the regulatory processes and interaction partners which govern NAK activity states.', 'language': 'en'}, {'description': 'All living cells are surrounded by cell membranes. These are essential to keep the inside of the cell separate from its outside surroundings, but are also very dynamic, controlled structures to make sure that the cell remains healthy and functioning within its outside environment. Problems in the functioning of cell membranes can result in disease. It is therefore important to understand the complex processes which control cell membrane structure and function. I am studying the process of ‘endocytosis’ – an important way for cell membranes to transport materials from outside to inside. My research is focused on a group of proteins called ‘NAKs’. Using cells grown in dishes, I will measure the exact mechanisms of NAKs to control endocytosis. NAK proteins may also have a role in some diseases of the nervous system, and so my research will inform efforts to discover and develop new treatments targeting NAKs.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9835-1014', 'authenticated-orcid': False, 'given': 'Julian', 'family': 'Rayner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6335-1105', 'authenticated-orcid': False, 'given': 'Zuzana', 'family': 'Kadlecova', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 1178961.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 31]]}, 'award-end': {'date-parts': [[2025, 12, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1178961.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:49Z', 'timestamp': 1636383109000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 31]]}, 'URL': 'http://dx.doi.org/10.35802/220597'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:37Z', 'timestamp': 1636456477779}, 'publisher': 'Wellcome', 'award': '215170', 'DOI': '10.35802/215170', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the relationship between schizophrenia risk genes and adult hippocampal plasticity'}], 'project-description': [{'description': 'Schizophrenia is a debilitating psychiatric condition which affects around 1% of the general population. It is a highly heritable condition, and several genetic changes have been linked to the development of the disorder. Copy Number Variations, or CNVs, are one such group of genetic changes in which microscopic pieces of DNA are deleted or duplicated, leading to altered gene dosage. Previously, large-scale analyses have linked CNVs with an increased risk of developing schizophrenia. Similarly, work from our lab has found that schizophrenia associated CNVs have a particular effect on pathways activated during extinction learning in the CA1 region of the hippocampus. The aim of this project is to further investigate the association between genetic risk for schizophrenia and extinction learning, using large-scale analyses and behavioural learning in rats. I will extend previous work by examining other sub-fields of the hippocampus and the prefrontal cortex, regions which are thought to be important in schizophrenia. Further, I will directly compare RNA expression from the post-mortem brains of human patients with RNA expression from learning tasks. These studies will help to further elucidate the molecular pathways acted upon by genetic risk variants, and may provide targets for treatment development.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3272-855X', 'authenticated-orcid': False, 'given': 'Natalie', 'family': 'Wellard', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:21Z', 'timestamp': 1636383441000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215170'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478213}, 'publisher': 'Wellcome', 'award': '072854', 'DOI': '10.35802/072854', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The 12th London Muscle Conference'}], 'project-description': [{'description': 'The 12th London Muscle Conference The London Muscle Conference, which was initiated by Professor John Square about 15 years ago at Imperial College London, has been run very successfully for most years since then, with the location being shared by a few sites in London. Muscle research has progressed a long way since the initial formulation of the sliding filament model nearly 50 years ago. Not only are modern techniques throwing light on the ultrastructure of the vertebrate striated muscle sarcomere and the properties of individual muscle motors, but the latest methods of molecular biology, together with the elucidation of the human genome, are throwing light on the molecular basis of many of the well-known muscular diseases, including those of the heart such as hypertrophic cardiomyopathy and dilated cardiomyopathy. The field is moving forward an at ever increasing rate and the need to be able to keep up with the latest advances has never been stronger. Of particular importance is for those in disparate disciplines, e.g. molecular biologists, structural biologists and physiologists, to explain what they are doing to others not in the same field. Such cross-fertilisation is a natural by-product of Conferences of this kind. The London Muscle Conference, the only open annual muscle conference held in the United Kingdom, serves the essential purpose for UK scientists of presenting as invited lectures many of the latest results in particular areas. In addition there is an opportunity for a much wider scope of presentations in poster form with time set aside to study these and to have discussions with the authors of the posters. The conference also provides a set of abstracts; an excellent continuing source of information in the field. With the setting up of the Imperial Muscle Initiative, which has its own website, these abstracts (with the authors permission) can also be made available to the wider scientific community.', 'language': 'en'}], 'lead-investigator': [{'given': 'John', 'family': 'Squire', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 9, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/072854'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478430}, 'publisher': 'Wellcome', 'award': '215100', 'DOI': '10.35802/215100', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Inhibitory Superagonistic Antibodies as Novel Therapeutics'}], 'project-description': [{'description': 'The immune response is finely balanced to eliminate infection while avoiding doing damage to the body. Immune cells have receptors which fine tune their response for this purpose. These receptors come in two types activatory and inhibitory. Activatory receptors cause a more powerful immune response with a greater ability to eliminate infection. In contrast, inhibitory receptors dampen the immune response to prevent damage to the body. We aim to harness the capacity of inhibitory receptors to dampen the immune response by using antibodies to trigger this effect. This would be useful for treating diseases in which the immune system is causing damage (autoimmune diseases). More specifically we aim to make antibodies capable of binding two different targets at the same time. With this aim we hope to achieve two things. Firstly, we hope to be able to signal through inhibitory receptors which are composed of two parts. These cannot be targeted by current antibodies only able to target one half of the receptor at a time. Secondly, we will try and target the inhibitory receptors locally in the tissue being damaged by immune cells in autoimmune diseases so that the rest of the body is not left vulnerable to infection.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3432-5690', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Donat', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:49Z', 'timestamp': 1636383289000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215100'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478627}, 'publisher': 'Wellcome', 'award': '222308', 'DOI': '10.35802/222308', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution of macrophages to the different clinical manifestations of cutaneous leishmaniasis caused by Leishmania aethiopica'}], 'project-description': [{'description': 'Cutaneous leishmaniasis (CL) is a neglected tropical disease with about 1 million new cases per year. It is caused by parasites that are transmitted by sandflies. There are a number of different forms of the disease, ranging from small, self-healing lesions on the skin, to permanently disfiguring facial lesions. It is not well understood how the parasite can result in such a wide range of outcomes. Our aim is to gain a better understanding of the interaction between the human immune system and the parasite. We are doing this by investigating how key immune cells called macrophages interact with parasites isolated from different patients. This may reveal key differences between the different forms of CL. We are achieving this through a highly collaborative approach with experts in different fields. We hope that this research will shed light on our understanding of the diversity of CL as a disease and why some patients develop severe, life-changing lesions.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2805-3396', 'authenticated-orcid': False, 'given': 'Edward', 'family': 'Cruz Cervera', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 8]]}, 'award-end': {'date-parts': [[2023, 10, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:28Z', 'timestamp': 1636383388000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 8]]}, 'URL': 'http://dx.doi.org/10.35802/222308'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:38Z', 'timestamp': 1636456478651}, 'publisher': 'Wellcome', 'award': '220052', 'DOI': '10.35802/220052', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'New approach to identifying epistasis using harmonic mean p-value'}], 'project-description': [{'description': 'Epistasis refers to the phenomenon where the effect of one gene in a given trait is dependent on other genes. The effect of such interaction between genes is often ignored in studies that try to identify genetic risk factors in diseases and only the effects of individual genes are considered. Such an approach resulted in missing information and the heritability of genetic risks is only partially explained by these association studies. It is proposed that epistasis might be the missing piece of this puzzle. However, taking epistasis into account would increase the number of candidates dramatically. This presents a statistical challenge as the difficulty to find true signal grows when the number of candidates to be considered increases. In this project, we will leverage a recently published statistical method by Prof Daniel Wilson that can combine numerous signals into one representing signal and thereby reduce the number of candidates to overcome the challenge posts by epistasis. We hope to develop a framework to efficiently and flexibly identify genetic risk factors that includes epistasis in different human diseases.', 'language': 'en'}], 'lead-investigator': [{'given': 'Shang-Kuan', 'family': 'Lin', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:02Z', 'timestamp': 1636383302000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220052'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:39Z', 'timestamp': 1636456479562}, 'publisher': 'Wellcome', 'award': '062827', 'DOI': '10.35802/062827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Fourier Transform Infra Red (FTIR) and ATR (Attenuated Total Reflectance)-FTIR studies of cytochrome c oxidase.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Rich', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 130154.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 130154.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:48Z', 'timestamp': 1636382988000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482691}, 'publisher': 'Wellcome', 'award': '220711', 'DOI': '10.35802/220711', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the Role of MITOchondrial ImmunoMETAbolism in Neuroinflammation: Mechanisms and New Targets for Progressive MS Treatment (MITO_META)'}], 'project-description': [{'description': 'People with progressive multiple sclerosis (P-MS) have substantial unmet clinical needs. While current therapies for MS are focused on manipulating the activity of the adaptive immune system, they have limited applicability for P-MS where a switch towards the chronic activation of innate immune cells, such as mononuclear phagocytes (MPs), occurs. MITO_META aims to test the hypothesis that the detrimental activation of MPs in P-MS is dependent on their mitochondrial metabolism and that targeting mitochondrial complex I (CI) activity in MPs will lead to novel therapeutic approaches for P-MS. To achieve this aim, I will adopt a combination of animal models and post-mortem biological samples obtained from MS patients. I will initially use the experimental autoimmune encephalomyelitis (EAE) mouse model of MS to study the effect of removing Complex I from MPs during neuroinflammation (Aim 1). I will then analyse how the metabolism of MPs changes during neuroinflammation, and compare these findings to those obtained from post-mortem analysis of people with progressive MS (Aim 2). Elucidating the role of mitochondrial function in MPs during chronic neuroinflammation will advance our understanding of P-MS and lead to new therapies to interfere with the progression of disability.', 'language': 'en'}, {'description': 'In multiple sclerosis (MS), the immune system attacks the central nervous system causing acute clinical symptoms, or relapses. Although there are therapies to stop relapses, most patients still develop a secondary progressive form of MS (P-MS) causing chronic disability, for which there is no cure. The damage in P-MS is caused by immune cells called mononuclear phagocytes (MPs). The aim of MITO_META is to reduce the harmful activation of MPs by targeting the way they produce energy (metabolism) in their powerhouse (mitochondria). I plan to use mouse models of MS (i) to abolish the harmful expression of a mitochondrial protein in MPs, and (ii) to investigate their changes in metabolism. I will then compare these findings to post-mortem data of people with progressive MS. This multi-step approach will lead to significant advances in our understanding of P-MS and allow us to develop new therapies to stop progression.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1115-9618', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Murphy', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6267-9472', 'authenticated-orcid': False, 'given': 'Stefano', 'family': 'Pluchino', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-3293-7397', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Frezza', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0795-3467', 'authenticated-orcid': False, 'given': 'Zoltan', 'family': 'Takats', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9396-5607', 'authenticated-orcid': False, 'given': 'Luca', 'family': 'Peruzzotti-Jametti', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 446707.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2023, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 446707.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:52Z', 'timestamp': 1636383112000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220711'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482866}, 'publisher': 'Wellcome', 'award': '220105', 'DOI': '10.35802/220105', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploring the function and regulation of surface molecules in the reaction to predation by Gram-negative bacteria during predation by the predatory bacterium Bdellovibrio bacteriovorus in host-appropriate settings.'}], 'project-description': [{'description': 'The number of infections caused by bacteria that are resistant to antibiotic treatment is increasing, potentially threating the treatment of infectious disease and other illnesses. New treatment approaches are therefore desperately needed, one of which involves the application of the predatory bacteria Bdellovibrio bacteriovorus. B. bacteriovorus is a bacterium that is able to prey upon a wide range of these antibiotic resistant organisms, potentially providing an alternative treatment for infections. This work builds on previous work with other clinically relevant bacteria to further characterise the mechanisms behind the prey recognition and invasion of bacteria by B. bacteriovorus predators and how this interaction is affected by components of the host immune system (1, 2) and prey surface factors (3). By looking at the factors that may prevent or decrease predation and experimentally removing them, we can characterise the mechanisms behind this interaction further and aid the potential application of B. bacteriovorus as a novel antimicrobial therapy in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0990-3260', 'authenticated-orcid': False, 'given': 'Callum', 'family': 'Clark', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:47Z', 'timestamp': 1636383287000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:42Z', 'timestamp': 1636456482895}, 'publisher': 'Wellcome', 'award': '214560', 'DOI': '10.35802/214560', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How do people get multi-drug resistant tuberculosis?'}], 'project-description': [{'description': 'Recent data suggests that most isoniazid resistant strains have been circulating for decades. The global diagnostic focus on rifampicin resistance has meant that isoniazid mono-resistant strains are systematically being treated with first-line therapy. With MDR-TB incidence rising despite overall TB incidence falling, the concern is that we are selecting for rifampicin resistance. The alternative explanation, that MDR-TB is transmitting more successfully, seems unlikely, but possible. The hypothesis I will test is that most isoniazid resistance is acquired through transmission whereas most rifampicin resistance evolves de novoin patients with undiagnosed, pre-existing isoniazid resistance. I will investigate the following research questions in Vietnam: (i) What is the proportion of transmitted versus newly evolved MDR-TB? (ii) What is the prevalence of isoniazid resistance among patients never previously exposed to the drug, and what proportion of patients with unsuccessful treatment outcomes evolve isoniazid resistance? (iii) What is the risk of evolving rifampicin resistance by treating isoniazid resistant strains with first-line drugs? What proportion of patients who evolve rifampicin resistance after exposure to first-line drugs also evolved isoniazid resistance? (iv) Do host genotype and variable anti-tuberculosis drug pharmacokinetics contribute to evolving drug resistance? The findings will inform policy on diagnostics, treatment protocols and disease control.', 'language': 'en'}, {'description': 'Multi-Drug resistance tuberculosis (MDR-TB) is defined as resistance to the two most important TB antibiotics, isoniazid and rifampicin. It is harder to treat and patient outcomes are much worse. Unfortunately, MDR-TB rates are rising as drug-susceptible TB rates are falling. It remains unclear why. I plan to investigate whether people get MDR-TB from other infected patients, or whether drug-resistance more commonly evolves within patients after they are exposed to antibiotics. To do this I will determine the DNA sequence of all MDR-TB strains in Ho Chi Minh City, Vietnam, and build a family tree from these data to determine which strains are related through transmission. I will also focus on patients who aren’t cured by antibiotics or get disease a second time, asking whether their treatment failed because they were given too few effective antibiotics, or the wrong dose of antibiotics, and whether this in turn led to resistance.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0421-9264', 'authenticated-orcid': False, 'given': 'Timothy', 'family': 'Walker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1526714.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 6, 1]]}, 'award-end': {'date-parts': [[2024, 6, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1526714.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:27Z', 'timestamp': 1636383027000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/214560'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484859}, 'publisher': 'Wellcome', 'award': '222061', 'DOI': '10.35802/222061', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Innovations Translational Partnership Award (Manchester)'}], 'project-description': [{'description': 'Following on from our current award and informed by a University-wide survey, we will use TPA funding to address four aims: - SUPPORT translational research: by providing direct and indirect support for translational research. - CONNECT across disciplines: by removing barriers between disciplines and creating better links between science, technology and innovation. - INNOVATE with industry: by promoting commercialisation activities and enable collaborations with industry. - CHANGE the culture: by embedding translational research across the University. We will expand the TPA team (with a Support Officer and a Bioinformatician) to tackle translational research bottlenecks and enable the progression of projects along the translational research pipeline. We will directly support investigators with our pump-priming funding schemes and introduce new initiatives to engage early career researchers. We will devise a comprehensive programme of bespoke training for researchers and staff supporting researchers. Working with colleagues from Business Engagement, we will run Innovation Labs, to help researchers and industry partners forge new collaborations with seed-corn funding. Finally, we will directly support activities that facilitate access to patient data/tissues by exploiting the potential of the Translation Manchester Research Network and by developing a tool to enable researchers to identify collaborators across the University and our partner NHS trusts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3324-4955', 'authenticated-orcid': False, 'given': 'Luke', 'family': 'Georghiou', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 2397523.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 9]]}, 'award-end': {'date-parts': [[2024, 11, 8]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 2397523.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:31Z', 'timestamp': 1636383151000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 9]]}, 'URL': 'http://dx.doi.org/10.35802/222061'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484850}, 'publisher': 'Wellcome', 'award': '221574', 'DOI': '10.35802/221574', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Longitudinal Population Study COVID-19 Steering Group and Secretariat'}], 'project-description': [{'description': 'Our objective is to provide an efficient coordinating body (“secretariat”) for the continued development, deployment, collection and analysis of a shared COVID-19 questionnaire across UK cohorts. The value of undertaking this in multiple longitudinal UK cohorts is that data can be collected in extremely well characterised members of the population across a wide demographic range who are already engaged in research, who have had data and biological samples collected on them, who have an established collection of record linked data already record linked and who sit behind supported infrastructure able to undertake novel data collection and research. Each of these cohorts is research active and collectively offers a depth or domain expertise not available within any one cohort, including that of UK Biobank. In this first coordination of COVID-19 research in deeply characterised UK cohorts, we identified the added value of a core questionnaire prospectively aligned to capture data pertinent to understanding COVID-19, as well as the direct and indirect consequences of the pandemic on health, wellbeing, social and economic outcomes.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7141-9189', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Timpson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 120585.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 7, 1]]}, 'award-end': {'date-parts': [[2021, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 120585.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:09Z', 'timestamp': 1636383129000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221574'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484832}, 'publisher': 'Wellcome', 'award': '221507', 'DOI': '10.35802/221507', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Improving mental health for marginalised groups at Oxford's Wellcome Centres\"}], 'project-description': [{'description': 'This proposal will address the intersection of mental health and Equality, Diversity & Inclusion (EDI) within Oxford’s three Wellcome Centres. Mental health concerns permeate a broad range of challenges relevant to EDI, including social exclusion, chronic illness and disability, and minoritised populations (detailed below) that are disproportionately affected by mental ill-health. By identifying specific mental health challenges that different groups face, we can improve equality. Through normalisation of discussions around mental health in the workplace, and building an appreciation for how these issues affect people differently, we foster inclusion. If we can recruit and retain a broader range of researchers further into their careers, we improve diversity, and therefore our science. An increasingly inclusive, fair and kind research culture will lower the risk of mental ill-health for all our team and staff members within the high-impact but high-pressure academic environment. Our specific objectives are to: (i) Conduct an in-depth, expert review of mental health as it relates to EDI within our Centre work environments. (ii) Implement recommendations arising from this review relating to policies, communication and practices. (iii) Build a broad, cross-Centre programme promoting positive research change around mental health and EDI.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4134-9730', 'authenticated-orcid': False, 'given': 'Heidi', 'family': 'Johansen-Berg', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 77068.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2022, 7, 31]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 77068.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:06Z', 'timestamp': 1636383126000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221507'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:44Z', 'timestamp': 1636456484863}, 'publisher': 'Wellcome', 'award': '220906', 'DOI': '10.35802/220906', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Preventable axon degeneration in human disease'}], 'project-description': [{'description': 'Programmed axon degeneration (or Wallerian degeneration; WD) is a preventable and druggable mechanism of axon loss. WD is well-characterised in animals and highly conserved. Blocking WD alleviates axon loss and symptoms in multiple disease models, suggesting a common, downstream mechanism. Human data are essential to confirm the role of WD in specific human diseases, ensuring drugs under development are tested in highly-relevant disorders and patients. We reported mutations in rare human axonopathies that aberrantly activate WD, and lifelong rescue of a related mouse model. Our programme determines the wider involvement of WD in rare and common human disorders, specifically peripheral neuropathies and ALS, where axon degeneration is important. We use online resources (100,000 Genomes, Project MinE, UK Biobank, etc.) and targeted sequencing of well-phenotyped cohorts and test roles of gene variants in causation, risk and severity. We determine their functional impact using complementary human iPSC and mouse modelling and develop specific biomarkers of WD for clinical samples. This project will provide insight into pathogenic mechanisms and a firm platform for developing and testing therapeutics. Our team, a world leader in Wallerian degeneration and leading neurogeneticists in rare and common neuropathies and human iPSC modelling, is uniquely placed to deliver this.', 'language': 'en'}, {'description': 'Nerve cells have long, thin structures (axons), that project around our brain and spinal cord, and to skin, muscles and other organs. Axons make connections that control our bodies. They are lost early in many disorders causing pain, paralysis, spasticity, tremor, memory deficits or blindness. We identified, and characterised along with other scientists, a preventable axon degeneration mechanism common to many diseases. Here, we will use the extensive knowledge gained animal studies to test for human diseases involving this degeneration mechanism. This is important to known which diseases may respond to drugs that block it. We will use human genome sequences, stem cell- and neuron cultures to study rare, inherited disorders, motor neuron disease, and peripheral neuropathies caused by diabetes or cancer chemotherapy. This study, together with ongoing drug development, could result in major improvements for some rare disease patients, and may lead to widely-applicable therapies in neurodegenerative disorders.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7996-2696', 'authenticated-orcid': False, 'given': 'David', 'family': 'Bennett', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-1215-3373', 'authenticated-orcid': False, 'given': 'Ahmet', 'family': 'Hoke', 'affiliation': [{'name': 'Johns Hopkins University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-0686-905X', 'authenticated-orcid': False, 'given': 'Mary', 'family': 'Reilly', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9354-532X', 'authenticated-orcid': False, 'given': 'Michael Philip', 'family': 'Coleman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 3640891.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2026, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 3640891.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:58Z', 'timestamp': 1636383118000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220906'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485841}, 'publisher': 'Wellcome', 'award': '221410', 'DOI': '10.35802/221410', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Enabling research uptake through integrating networks and communities of practice'}], 'project-description': [{'description': 'Findings from health research should be translated into recommendations that can be implemented within policy and practice if research is to deliver its maximum impact and ability to change health outcomes. Currently research ‘success’ typically concludes with the publishing of papers in high impact journals with less attention to how, and indeed whether, those findings are made visible and accessible to those tasked with decision making that should be changing their practice on the basis of these new findings. Compounding this is the current difficulty for these practice and policy decision-makers to easily be made aware, find, access and synthesise new research recommendations. The Global Health Network seeks to address this by bringing researchers and decision makers together to find new tools and mechanisms for researchers to present their outcomes as recommendations that can be readily discoverable and put into practice. This proposal will firstly, establish a community of practice for researchers and decision-makers to share knowledge and develop resources, processes and mechanisms that can support turning results into discoverable, practical and usable recommendations. Secondly, to deliver an advanced digital database which enables rapid synthesis of the available research recommendations to drive improvements in uptake.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2273-5975', 'authenticated-orcid': False, 'given': 'Trudie', 'family': 'Lang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 285830.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 5]]}, 'award-end': {'date-parts': [[2022, 10, 4]]}, 'funding': [{'type': 'award', 'scheme': 'Social Science and Bioethics', 'award-amount': {'amount': 142915.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:04Z', 'timestamp': 1636383124000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 5]]}, 'URL': 'http://dx.doi.org/10.35802/221410'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485876}, 'publisher': 'Wellcome', 'award': '220400', 'DOI': '10.35802/220400', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the crosstalk between adipocytes and macrophages during wound repair'}], 'project-description': [{'description': 'Our immune system exists to help our bodies fight infection, heal wounds and remove unhealthy cells. In order to gain as much information as possible about this complex system, it is vital to investigate immunological processes in the context of a living animal. Despite evolutionary divergence from humans, the fruit fly Drosophila melanogaster contains a relevant immune cell type, making it an ideal model in which to investigate immune cell functions, such as damage signalling, cell corpse recognition and immune cell memory. It has recently emerged that fat cells also play a role in wound healing, and this project seeks to elucidate the mechanism by which fat cells contribute to the immune response. The tractable genetics of Drosophila will allow us to identify potential candidate genes by screening for which genes are “turned on” in cells that are responding to laser induced wounds. We will then increase or decrease the level of expression of these candidate genes and use real time imaging in the living Drosophila pupae to identify the effect that these genes have on immune cell and fat cell migration to wounds.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0744-4301', 'authenticated-orcid': False, 'given': 'Henry', 'family': 'Todd', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 5]]}, 'award-end': {'date-parts': [[2022, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:23Z', 'timestamp': 1636383443000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220400'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:45Z', 'timestamp': 1636456485887}, 'publisher': 'Wellcome', 'award': '220497', 'DOI': '10.35802/220497', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Spineless in the gut - intestinal function of the aryl hydrocarbon receptor from flies to mammals'}], 'project-description': [{'description': 'The aryl hydrocarbon receptor (AHR) has essential functions in the intestine, protecting mice from infection and cancer. However, the underlying mechanisms are still unclear as research has been hindered by the complex regulation and multiple feedback loops governing mammalian AHR. I will therefore use a simpler model system. Spineless, the homolog of AHR in Drosophila, binds the same DNA motif as AHR, but is regulated only on the gene expression level. My preliminary data suggest that Spineless may have similar functions to AHR, influencing epithelial regeneration and survival during infection. I will take advantage of this simpler pathway and the genetic tools and ease of manipulation in the fly in order to rapidly dissect how AHR/Spineless expression is regulated and to systematically analyse its target genes. I will first generate the necessary tools and then answer three main questions: what are the target genes of Spineless, how is Spineless gene expression regulated, and how does Spineless function in the context of intestinal infection. Results obtained from these experiments will be compared with existing data from the Stockinger group on AHR in mice to advance our understanding of intestinal physiology and the critical functions of AHR/Spineless that are conserved across species.', 'language': 'en'}, {'description': 'The aryl hydrocarbon receptor (AHR) has essential functions in the gut, protecting mice from infection and cancer. However, the underlying mechanisms are still unclear as research has been hindered by the complex regulation of AHR. I will therefore use a simpler model system. I found that the equivalent of AHR in fruit flies, Spineless, also seems to be important during infection in the gut, but its regulation is less complicated. I will take advantage of the ease and speed of genetic manipulation in fruit flies to answer three main questions: what are the target genes of Spineless, how is Spineless regulated, and what is the function of Spineless in the context of intestinal infection. Results obtained from these experiments will be compared with existing data from the Stockinger lab on AHR to advance our understanding of intestinal physiology and critical, evolutionary conserved functions of AHR/Spineless in this context.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8781-336X', 'authenticated-orcid': False, 'given': 'Brigitta', 'family': 'Stockinger', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7970-1667', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Lemaitre', 'affiliation': [{'name': 'ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE', 'country': 'CH', 'id': [{'id': 'https://ror.org/02s376052', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9145-5216', 'authenticated-orcid': False, 'given': 'Nicola', 'family': 'Diny', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2024, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:46Z', 'timestamp': 1636383106000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:46Z', 'timestamp': 1636456486241}, 'publisher': 'Wellcome', 'award': '223061', 'DOI': '10.35802/223061', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Elucidating the interactome and molecular pharmacology of the VEGFR-3 receptor compared to other VEGFR homodimers and heterodimers in vitro and in vivo.'}], 'project-description': [{'description': 'Vascular endothelial growth factor receptor 3 (VEGFR3) is a transmembrane protein found on the surface of cells that line the lymphatic vessels of the body. Its primary role is regulating the growth of new lymph vessels by interacting with its ligands, vascular endothelial growth factor (VEGF) C and D. Recently, VEGFR3 was reported to function in blood vessel development, particularly in cancer (cancer angiogenesis), supporting tumour growth and metastasis. However, our coverage of VEGFR3 pharmacology and signalling in living cells, is poor. Although typically assembled in homodimers, VEGFR3 can also form heterodimers with a different VEGFR isoform, VEGFR2. Comparative analyses of homodimer versus heterodimer configuration, relating to protein signalling and pharmacology is limited due to the difficulty in defining specific complexes. This project will combine the use of two powerful analytical tools, bioluminescence resonance energy transfer (BRET) and BioID to further understanding of the molecular pharmacology of the VEGFRs including Neuropilin receptors. These complementary approaches will allow the interaction of fluorescently labelled VEGF with VEGFR3 to be characterised in real time in living cells with the VEGFR3 ‘interactome’ to mapped, in vivo. Split tags of BioID and NanoBRET will also be used to define the molecular pharmacology of VEGFR2/3 heterodimers.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7142-6410', 'authenticated-orcid': False, 'given': 'George', 'family': 'Coney', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:42Z', 'timestamp': 1636383402000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223061'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:46Z', 'timestamp': 1636456486559}, 'publisher': 'Wellcome', 'award': '220031', 'DOI': '10.35802/220031', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Oligodendroglial Dysfunction in Huntington's Disease\"}], 'project-description': [{'description': 'Huntington’s disease (HD) is a genetic neurodegenerative disease causing long term disability and life-threatening complications. It is well known that the loss of particular types of nerve cells in the brain causes the main symptoms of HD, but there is evidence that a different type of brain cell, oligodendrocytes, are also involved. Recent evidence has shown that human oligodendrocytes are heterogeneous, suggesting that their functions vary and that these are altered in disease. In this project I will investigate whether oligodendrocyte states are different in HD. I will analyse and validate the heterogeneity of oligodendrocytes in post mortem brain tissue from HD patients, as well as in oligodendrocyte cultures generated from human stem cells. Furthermore, I will investigate whether certain dysfunctional oligodendrocyte states are shared across different diseases by comparing the heterogeneity of oligodendrocytes in HD and Multiple Sclerosis. Finally, I will investigate whether targeting the cause of HD, a mutation in the huntingtin gene, can change oligodendrocyte states to become more like healthy cells. Together these approaches will establish whether and how oligodendrocyte dysfunction is a pathological feature of HD and will provide insight into common oligodendrocyte states across disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1689-8583', 'authenticated-orcid': False, 'given': 'Sunniva', 'family': 'Bøstrand', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:00Z', 'timestamp': 1636383480000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220031'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:47Z', 'timestamp': 1636456487116}, 'publisher': 'Wellcome', 'award': '223541', 'DOI': '10.35802/223541', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'What influences cancer services uptake in Ghana and how can this information support policy-making?'}], 'project-description': [{'description': 'My research is about what influences people in Ghana to use cancer services. Cancer is an increasing problem in Ghana due to changes to lifestyle and population age. Many things influence cancer services use including, disease beliefs, stigma, healthcare trust, and costs. The Ghanaian health system seeks to expand cancer services in a way that benefits as many as possible, but challenges remain in understanding why some patients do not attend. I plan to use mixed methods to explore what influences cancer service use and how this information can be useful for Ghanaian policymakers. A key stage will involve surveying public members’ beliefs and behaviours. I will analyse data collected to see how information about age, gender and job relate to peoples’ views and might influence whether they would use cancer services; I also hope to build profiles of types of people to help policymakers target help to those most in need. To further understand and check the analysis, I will use narrative interviews with a range of the public to listen to what they think and why they act as they do. I will bring together the findings and discuss with policymakers how this could help inform their decision-making.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3525-6295', 'authenticated-orcid': False, 'given': 'Chloe', 'family': 'Tuck', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 2]]}, 'award-end': {'date-parts': [[2023, 9, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:04Z', 'timestamp': 1636383424000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/223541'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:47Z', 'timestamp': 1636456487122}, 'publisher': 'Wellcome', 'award': '221690', 'DOI': '10.35802/221690', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Myocardial energy starvation and ketone metabolism in patients with type 2 diabetes'}], 'project-description': [{'description': 'Patients with type 2 diabetes(T2D) are ‘cardiac energy-deficient’ and this deficiency contributes to their excess heart failure(HF) risk. The key mechanisms for cardiac energy deficiency are reduced myocardial blood flow, loss of metabolic flexibility over the choice of energy fuels and mitochondrial dysfunction. The contribution of these changes to the development of HF has not been systematically studied.Recent studies have highlighted the potential role of ketone bodies as a significant fuel source, and suggested an association between mild ketosis and improved clinical outcome in T2D. Two work packages will be performed. Work-package1 aims to: - Elucidate the mechanisms of the energy-starved state of the heart in diabetes; - Determine how alterations of cardiac energy metabolism differ between prediabetes, T2D, and concomitant T2D and HF; - Determine if ketones induce a differential response in mitochondrial respiration and whether this differential response varies along the continuum of diabetic heart disease. Data will be acquired from patients undergoing aortic valve surgery for comprehensive assessments including: cardiovascular magnetic resonance imaging and spectroscopy; coronary sinus sampling studies; high resolution respirometry and liquid chromatography-triple quadrupole-mass spectrometry metabolomics from heart samples. Work-package 2 will explore the impact of ketone infusion on cardiac energy generation and contractile function in T2D patients.', 'language': 'en'}, {'description': 'Diabetes increases the risk of heart failure. Once the heart failure is established, only one in five patients survive beyond five years. This high risk of death is alarming and highlights the importance of preventing the development of heart failure in diabetes patients. One efficient way to treat or prevent heart failure is increasing the energy available for heart muscle to pump. For this we first need to better understand why diabetes patients have low energy levels in their heart. Moreover, in diabetes, heart muscle uses more ketone as an energy fuel,but it is unknown if this change aims to improve energy generation.Seeking to answer these questions, using MR scans, heart biopsy samples and special blood tests, I will pursue the problem of excess heart failure risk in diabetes, exploring new and more efficient treatment options to mitigate this risk, with results relevant for 400 million people living with diabetes.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0997-4384', 'authenticated-orcid': False, 'given': 'Sven', 'family': 'Plein', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7683-9422', 'authenticated-orcid': False, 'given': 'David', 'family': 'Beech', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3799-7102', 'authenticated-orcid': False, 'given': 'Eylem', 'family': 'Levelt', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 807333.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 3, 1]]}, 'award-end': {'date-parts': [[2025, 2, 28]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 807333.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:15Z', 'timestamp': 1636383135000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221690'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:48Z', 'timestamp': 1636456488323}, 'publisher': 'Wellcome', 'award': '220885', 'DOI': '10.35802/220885', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Population genomic analysis of HIV transmission fitness'}], 'project-description': [{'description': 'This proposal concerns the identification of genetic polymorphisms which alter the fitness of Human Immunodeficiency Virus (HIV-1), the robust estimation of virus fitness, and the characterization of how polymorphisms influence replicative fitness within hosts versus transmission to new hosts. HIV evolves to evade the immune system, resist antiviral medications, and maximize its rate of replication within infected hosts. But at the epidemic level, natural selection promotes evolution of variants which are more transmissible. Natural selection within and between hosts can act in opposing directions, and evolutionary trends have been discerned from population based sampling of HIV such as a hypothetical transmission/virulence tradeoff. Because HIV evolves at multiple scales, the fitness of a particular polymorphism should be characterized along multiple dimensions including its impact on replication within hosts and transmission to new hosts. We will develop a framework for characterizing genetic fitness along multiple dimensions by building on theory developed for estimating state-dependent speciation rates. These methods will be applied to several large population-based samples of whole-genome deep sequencing (WGDS) of HIV. The outcome of this analysis will be an unprecedentedly detailed characterization of how particular genetic substitutions influence HIV pathogenesis and transmission at the epidemic level.', 'language': 'en'}, {'description': 'HIV evolves to maximize replication within hosts and transmit to new uninfected individuals, but we currently lack a detailed understanding of how changes in the HIV genome alter the ability of HIV to reproduce and spread. To understand how beneficial mutations spread at the epidemic level requires a deeper understanding of how mutations impact transmissibility of the virus. We will develop new bioinformatic methods to estimate fitness along multiple dimensions associated with replication and transmission. We will identify new mutations which are associated with gain or loss of transmission fitness. These methods will be applied to new large population-based samples of whole HIV genomes across sub-Saharan Africa. These findings will have relevance for vaccine design and forecasting the future evolution of the HIV epidemic, and the potential for therapeutic vaccines to modify the transmissibility of HIV will be explored.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6268-8937', 'authenticated-orcid': False, 'given': 'Erik', 'family': 'Volz', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 654391.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 654391.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:57Z', 'timestamp': 1636383117000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220885'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:49Z', 'timestamp': 1636456489397}, 'publisher': 'Wellcome', 'award': '223619', 'DOI': '10.35802/223619', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Progressing existing snake venom toxin-specific antibodies into humanised, thermostable monoclonal therapies for preclinical manufacture and clinical trials in Africa and India'}], 'project-description': [{'description': 'Antivenom treatment of snakebite is failing to reduce the annual 138,000 deaths - predominantly in impoverished tropical communities. With a focus upon the most medically-important African and Indian snake venoms, we are developing toxin-neutralising, recombinant, humanised, thermostable monoclonal antibodies (mAbs) that will be more dose- and polyspecifically-effective, affordable and safer than antivenoms, and possess critical economies of scale and manufacturing incentives to secure sustained production/delivery. We have collected sera and B cells (producing immunoglobulins of distinct structure and therapeutic/mAb-development promise) from: - multi-envenomed humans - cows, camels, baboons, mice immunised with the most pathogenic African and Indian venom toxins - horses used to manufacture African or Indian antivenoms. Using High-Throughput platforms, we will rank B cells producing these globally-unique animal and human antibodies by in vitro toxin-binding affinity and toxin-function neutralisation, prioritising cross-generic/continental functionality. Genes from top-ranked B cells will be processed into recombinant mAbs (220-500). Subsequent rounds of in vitro and in vivo (neutralisation of venom-induced lethality in a mouse model of envenoming) down-selection will output 20-40 mAbs for gene-manipulation to deliver ‘humanised’ and thermostable mAbs. A final round of in vitro/in vivo selection will deliver 5-10 mAbs/3 mAb mixtures of proven pan-Africa/India polyspecific efficacy for downstream preclinical manufacture and clinical trials.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8035-4719', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Casewell', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9354-1740', 'authenticated-orcid': False, 'given': 'Devin', 'family': 'Sok', 'affiliation': [{'name': 'International AIDS Vaccine Initiative', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-0998-1581', 'authenticated-orcid': False, 'given': 'Kartik', 'family': 'Sunagar', 'affiliation': [{'name': 'Indian Institute of Science', 'country': 'IN'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9842-5573', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Harrison', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 455998.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 7, 19]]}, 'award-end': {'date-parts': [[2023, 7, 18]]}, 'funding': [{'type': 'award', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 455998.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:34Z', 'timestamp': 1636383514000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 7, 19]]}, 'URL': 'http://dx.doi.org/10.35802/223619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:49Z', 'timestamp': 1636456489539}, 'publisher': 'Wellcome', 'award': '224075', 'DOI': '10.35802/224075', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Probing chromatin states with single molecule microscopy'}], 'project-description': [{'description': 'Recent research showed that the emergence of resistance in fungi can be linked to epigenetic mutations. Those are not changes in the DNA sequence, but rather in the chromatin environment. Some parts of the genome are packaged in heterochromatin: in those areas, the DNA is bunched up much more tightly and thus not easily accessible, so genes are repressed. We want to investigate how specific heterochromatin regions are formed and removed. I am especially interested to find out why two seemingly identical cells can acquire differences in their epigenetic landscape and thus develop different phenotypes. To visualise cell-to-cell variations, I plan on using real-time fluorescent imaging, to track different proteins that are known to regulate heterochromatin. From the amount of protein and the movement of the fluorescent molecules, we can better understand how the heterochromatin distribution in individual cells changes in response to stress. Additionally, I am developing a probe, which can differentiate between different chromatin environments at specific locations. Understanding the development of these epigenetic differences is important, as they are likely involved in the development of antifungal resistance in pathogenic fungi.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2466-400X', 'authenticated-orcid': False, 'given': 'Elisabeth', 'family': 'Gaberdiel', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 3, 29]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:33Z', 'timestamp': 1636383453000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 29]]}, 'URL': 'http://dx.doi.org/10.35802/224075'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:59Z', 'timestamp': 1636456499505}, 'publisher': 'Wellcome', 'award': '062236', 'DOI': '10.35802/062236', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'G protein-coupled receptor desensitization in mature, brain neurones.'}], 'investigator': [{'given': 'Eamonn', 'family': 'Kelly', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Graeme', 'family': 'Henderson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 261504.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 14]]}, 'award-end': {'date-parts': [[2004, 10, 13]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 261504.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:58Z', 'timestamp': 1636382818000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 14]]}, 'URL': 'http://dx.doi.org/10.35802/062236'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:14:59Z', 'timestamp': 1636456499531}, 'publisher': 'Wellcome', 'award': '057088', 'DOI': '10.35802/057088', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular responses to adenosine in genetically-modified mice lacking the adenosine A2A receptor.'}], 'lead-investigator': [{'given': 'Susanna', 'family': 'Hourani', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 184798.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 8, 1]]}, 'award-end': {'date-parts': [[2002, 9, 14]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 184798.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:08Z', 'timestamp': 1636383008000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/057088'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:00Z', 'timestamp': 1636456500706}, 'publisher': 'Wellcome', 'award': '063010', 'DOI': '10.35802/063010', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Restriction enzymes with novel reaction mechanisms.'}], 'investigator': [{'given': 'Stephen', 'family': 'Halford', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Virginijus', 'family': 'Siksnys', 'affiliation': [{'name': 'Misc Lithuania', 'country': 'LT'}]}], 'award-amount': {'amount': 108025.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 3, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 108025.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:08Z', 'timestamp': 1636383008000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063010'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:02Z', 'timestamp': 1636456502342}, 'publisher': 'Wellcome', 'award': '062443', 'DOI': '10.35802/062443', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification and functional analysis of SCL gene regulatory elements.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8342-0606', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Chapman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 179038.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 179038.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:43Z', 'timestamp': 1636382923000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062443'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:04Z', 'timestamp': 1636456504061}, 'publisher': 'Wellcome', 'award': '204300', 'DOI': '10.35802/204300', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Open Science Prize'}], 'lead-investigator': [{'given': 'Jessica', 'family': 'Chong', 'affiliation': [{'name': 'University of Washington', 'country': 'US'}]}], 'award-amount': {'amount': 55659.92, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 7, 26]]}, 'award-end': {'date-parts': [[2016, 11, 30]]}, 'funding': [{'type': 'prize', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 55659.92, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:13Z', 'timestamp': 1636382893000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 7, 26]]}, 'URL': 'http://dx.doi.org/10.35802/204300'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:15:09Z', 'timestamp': 1636456509364}, 'publisher': 'Wellcome', 'award': '215096', 'DOI': '10.35802/215096', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering genetic drivers of longitudinal electronic health records'}], 'project-description': [{'description': 'The accumulation of electronic health records (EHRs) carries great promise for accelerating clinical research, while the sequencing of a vast number of genomes provides us information to discover genetic factors affecting these health-related records. We now have EHRs containing phenotypes and the genetics of individuals which we could use find the underlying genetic structure of disease. In our project, we will be focusing on analysing the development of disease using multiple machine learning methods. We propose a multi-view deep learning framework which incorporates embedding learning, recurrent neural networks, representation learning and weighted-averaging techniques. Our goal is to find the genetic factors which impact the progression of disease, not just the onset of disease. Consequently, our model will look into the time dimension of disease using multimodal data in huge datasets like the UK Biobank. Our results will contribute to our understanding of underlying systems and processes that can impact multiple diseases, which can support clinical diagnosis and drug discovery.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6773-9182', 'authenticated-orcid': False, 'given': 'Xilin', 'family': 'Jiang', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:49Z', 'timestamp': 1636383289000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215096'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:02Z', 'timestamp': 1636443902620}, 'publisher': 'Wellcome', 'award': '060163', 'DOI': '10.35802/060163', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'NGF regulation in dorsal root ganglia neurons involved in the signalling of pain.'}], 'lead-investigator': [{'family': 'Huerta Lopez', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 100679.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 100679.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:03Z', 'timestamp': 1636382883000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:02Z', 'timestamp': 1636443902680}, 'publisher': 'Wellcome', 'award': '063086', 'DOI': '10.35802/063086', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Regulation of Rho GTPases by growth factors'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2331-4729', 'authenticated-orcid': False, 'given': 'Julian', 'family': 'Downward', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Laszlo', 'family': 'Buday', 'affiliation': [{'name': 'Cancer Research UK', 'country': 'GB'}]}], 'award-amount': {'amount': 91050.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 91050.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:08Z', 'timestamp': 1636382768000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063086'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:05Z', 'timestamp': 1636443905065}, 'publisher': 'Wellcome', 'award': '056586', 'DOI': '10.35802/056586', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A molecular analysis of Streptococcus pneumonia virulence.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5650-5361', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Brown', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 242126.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 6, 21]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 242126.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 6, 21]]}, 'URL': 'http://dx.doi.org/10.35802/056586'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:11Z', 'timestamp': 1636443911913}, 'publisher': 'Wellcome', 'award': '060937', 'DOI': '10.35802/060937', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Regional differences in excitation-contraction mechanisms in the mammalian heart.'}], 'lead-investigator': [{'family': 'Wallis', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 116852.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 116852.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:11Z', 'timestamp': 1636443911930}, 'publisher': 'Wellcome', 'award': '092421', 'DOI': '10.35802/092421', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People Award.'}], 'lead-investigator': [{'given': 'Colin', 'family': 'Riordan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 250000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2010, 10, 1]]}, 'award-end': {'date-parts': [[2012, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 250000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:32Z', 'timestamp': 1636383032000}, 'score': 0.0, 'issued': {'date-parts': [[2010, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/092421'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:23Z', 'timestamp': 1636443923667}, 'publisher': 'Wellcome', 'award': '059272', 'DOI': '10.35802/059272', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Segregation of mtDNA in oocytes and embryos in humans and in a mouse model of mtDNA disease.'}], 'investigator': [{'given': 'Richard', 'family': 'Gardner', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'David', 'family': 'Barlow', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2460-5587', 'authenticated-orcid': False, 'given': 'Joanna', 'family': 'Poulton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 204618.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 204618.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:45Z', 'timestamp': 1636382805000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059272'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:26Z', 'timestamp': 1636443926097}, 'publisher': 'Wellcome', 'award': '067037', 'DOI': '10.35802/067037', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Applying fMRI to understand pharmacological analgesia in the human brain.'}], 'lead-investigator': [{'given': 'Richard', 'family': 'Wise', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 201020.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 201020.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:43Z', 'timestamp': 1636383043000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067037'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:32Z', 'timestamp': 1636443932686}, 'publisher': 'Wellcome', 'award': '060288', 'DOI': '10.35802/060288', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Therapeutic vaccination for chronic hepatitis B virus infection in Africa.'}], 'project-description': [{'description': 'Not available', 'language': 'en'}], 'lead-investigator': [{'given': 'Samuel', 'family': 'McConkey', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}], 'award-amount': {'amount': 340926.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 340926.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:17Z', 'timestamp': 1636383017000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060288'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:38Z', 'timestamp': 1636443938434}, 'publisher': 'Wellcome', 'award': '061739', 'DOI': '10.35802/061739', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of event related functional MRI techniques to study auditory-verbal processes: overcoming confounding effects of acoustic scanner noise.'}], 'lead-investigator': [{'family': 'Amaro', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 97928.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 9]]}, 'award-end': {'date-parts': [[2003, 1, 8]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 97928.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 9]]}, 'URL': 'http://dx.doi.org/10.35802/061739'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:39Z', 'timestamp': 1636443939152}, 'publisher': 'Wellcome', 'award': '064085', 'DOI': '10.35802/064085', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structure and mechanism of the twin-arginine translocation (Tat) system.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-3893-360X', 'authenticated-orcid': False, 'given': 'Paula', 'family': 'Booth', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-8147-1127', 'authenticated-orcid': False, 'given': 'Per', 'family': 'Bullough', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Colin', 'family': 'Robinson', 'affiliation': [{'name': 'University of Kent', 'country': 'GB'}]}], 'award-amount': {'amount': 180855.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 11, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 180855.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:15Z', 'timestamp': 1636382775000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064085'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:39Z', 'timestamp': 1636443939198}, 'publisher': 'Wellcome', 'award': '066657', 'DOI': '10.35802/066657', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Meeting of the British Isles Ocular Motor Group to be held at Imperial CollegeSchool of Medicine on 3rd December 2001.'}], 'lead-investigator': [{'given': 'Christopher', 'family': 'Kennard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3045.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 12, 3]]}, 'award-end': {'date-parts': [[2002, 1, 2]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3045.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:23Z', 'timestamp': 1636382783000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 12, 3]]}, 'URL': 'http://dx.doi.org/10.35802/066657'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:48Z', 'timestamp': 1636443948209}, 'publisher': 'Wellcome', 'award': '062752', 'DOI': '10.35802/062752', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of the underlying basis for the emergence of dengue haemorrhagic fever in Cuba.'}], 'investigator': [{'given': 'William', 'family': 'James', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Ernest', 'family': 'Gould', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}, {'given': 'Gustavo', 'family': 'Kouri', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}], 'lead-investigator': [{'given': 'Maria', 'family': 'Guzman', 'affiliation': [{'name': 'Instituto De Medicina Tropical Pedro Kouri', 'country': 'CU'}]}], 'award-amount': {'amount': 158902.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 2, 1]]}, 'award-end': {'date-parts': [[2004, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 158902.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:59Z', 'timestamp': 1636382819000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062752'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:49Z', 'timestamp': 1636443949774}, 'publisher': 'Wellcome', 'award': '210789', 'DOI': '10.35802/210789', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Malaria Controlled Human Infection Model - application development'}], 'project-description': [{'description': 'We wish to apply for funds to develop the malaria CHIM application. These are for a Co-investigators/stakeholders meeting to be held in Bangkok, Thailand, on 30th and 31st January 2018 and to support a writing meeting of the PIs in February 2018 in Kilifi, Kenya.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2309-1171', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Day', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 22186.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 12, 10]]}, 'award-end': {'date-parts': [[2018, 4, 10]]}, 'funding': [{'type': 'award', 'scheme': 'Vaccines', 'award-amount': {'amount': 22186.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:16Z', 'timestamp': 1636382956000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 12, 10]]}, 'URL': 'http://dx.doi.org/10.35802/210789'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:52Z', 'timestamp': 1636443952811}, 'publisher': 'Wellcome', 'award': '063936', 'DOI': '10.35802/063936', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'To support the transfer of the parallel processing computer to Imperial College.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1154-8093', 'authenticated-orcid': False, 'given': 'Neil', 'family': 'Ferguson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'given': 'Geoff', 'family': 'Garnett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Roy', 'family': 'Anderson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 171861.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 12, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 171861.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:15Z', 'timestamp': 1636382835000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063936'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958206}, 'publisher': 'Wellcome', 'award': '069020', 'DOI': '10.35802/069020', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effect of antenatal endotoxaemia on cerebal metabolism and cell death during and after hypoxia in the chick embryo.'}], 'project-description': [{'description': 'Injury to the brain around the time of birth is an important cause of longterm disability. Epidemiological data suggest that in 25% of cases there is a combination of antenatal and intrapartum aetiological factors. This study will investigate the hypothesis that antenatal exposure to bacterial endotoxin sensitises the brain to subsequent hypoxia and reduces the hypoxic threshold at which cerebral metabolism fails and cell death occurs. We will study the effects of hypoxia of different degrees of severity and lipopolysaccharide, both individually and in combination, on the brain of the chick embryo in ovo towards the end of incubation. Preliminary studies demonstrate the feasibility of measuring changes in the cerebral concentrations of lactate, creatine and N-acetyl-aspartate using magnetic resonance (MR) proton spectroscopy and changes in apparent diffusion coefficient of water, a putative indirect marker of cellular energy metabolism, using diffusion weighted imaging in the chick embryo brain. These modalities will be used to quantify the metabolic effects of acute hypoxia and endotoxaemia. In vivo measurements will be correlated with markers of CNS inflammation including microglial cell activation, astrogliosis and granulocyte recruitment using immunohistochemistry. Dying cells will be detected using standard histological stains and TUNEL staining for DNA fragmentation.', 'language': 'en'}], 'investigator': [{'given': 'Gennadij', 'family': 'Raivich', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Roger', 'family': 'Ordidge', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'family': 'Cady', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Donald', 'family': 'Peebles', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 179011.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 7, 1]]}, 'award-end': {'date-parts': [[2006, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 179011.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:40Z', 'timestamp': 1636382800000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069020'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958265}, 'publisher': 'Wellcome', 'award': '071219', 'DOI': '10.35802/071219', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Bioarchaeology without fossils or artefacts: Every contact leaves a trace.'}], 'project-description': [{'description': 'Ancient DNA studies have promised to bring a new era to bioarchaeological research, yet due to difficulties caused by pervasive contamination of specimens with modern human DNA, and the limitations of skeletal and pathogen preservation, the impact has so far been slight. We outline a radical new approach to studies of genetic change through time that negates most of these limitations, and provides a novel and detailed way to re-examine important archaeological sites. Preliminary data has shown that frozen or cold sediments contain a genetic record of the local mammalian, plant and bacterial inhabitants over quite remarkable time periods - eg >350 Kyr. This means that DNA preservation can occur without macrofossils, and that sediment from cold archaeological sites is likely to contain high concentrations of DNA from humans, along with their domesticates and pathogens. Stratified sediments also allow DNA to be dated and placed into an archaeological context, finally allowing association of artefacts with genetic markers. Furthermore, samples removed from cores drilled deep into archaeological sediments provide a means to obtain material free from modern human DNA, and multiple cores will allow stratigraphic continuity and localised contamination to be monitored. We will use coring to retrieve DNA from sediments around important early human occupation sites in the Holarctic and New World. We will use stratigraphic data to examine the time of first appearance of humans, domesticates, and pathogens, and record their subsequent changes in genetic diversity and composition through time. We will also use the DNA to examine food (animals, plants) and paleoenvironmental changes (plants, bacteria), and relate this to cultural horizons or other archaeological markers. In recognition of the importance of this technique, we have gained permission to core some of the most important and enigmatic archaeological sites known, including very early Siberian and New World sites (Diring, Bluefish, Meadowcroft), Neanderthal caves (Mezmaiskaya, Scladina, Anghilak), and important modern archaeological sites such as Pompeii. We will use established drilling techniques to obtain and store cores (frozen or chilled as necessary), and return them for analysis at the Henry Wellcome Ancient Biomolecules Centre. The Centre is essential for providing the specialised equipment and extremely low background contamination levels necessary for such a complex study. A variety of established PCR primers (specific and general) will be used to amplify DNA, followed by extensive cloning to measure the genetic diversity and composition of targeted taxa at different points in the stratigraphic record.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7081-6748', 'authenticated-orcid': False, 'given': 'Eske', 'family': 'Willerslev', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 224664.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 8, 1]]}, 'award-end': {'date-parts': [[2006, 7, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 224664.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:05Z', 'timestamp': 1636382825000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071219'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T07:45:58Z', 'timestamp': 1636443958305}, 'publisher': 'Wellcome', 'award': '065496', 'DOI': '10.35802/065496', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of chemokines in the adhesion of monocytes to human atherosclerotic plaques: investigation by an in-vitro adhesion assay.'}], 'lead-investigator': [{'given': 'Robin', 'family': 'Poston', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 19408.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 7, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 19408.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065496'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:06Z', 'timestamp': 1636454646243}, 'publisher': 'Wellcome', 'award': '222312', 'DOI': '10.35802/222312', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating mechanisms and rescue of a novel microgliopathy caused by dysfunctional LRRC33/NRROS'}], 'project-description': [{'description': 'Recent discoveries have suggested a dysfunctional immune system of the brain plays a significant role in a set of diseases known as microgliopathies. New disorders of this type are still being identified, but ones which have so far been uncovered lead to significant brain damage and decreased lifespan. Our group has discovered a developmental microgliopathy-like disease in a patient caused by a defect in a protein named LRRC33. However, we do not fully understand the impact this defect has on the brain’s immune system, how it affects different types of brain cells, and how it leads to disease onset. We aim to investigate these questions using a combination of animal models and patient post-mortem tissue. We will also seek to determine whether we can repair brain damage in our animal disease model by suppressing the brain’s immune system. Strategies such as these, along with improved knowledge of the biology of the disease, could potentially lay the foundations for development of treatments for these microgliopathies, of which there are currently none.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0113-6551', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Sewell', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:37Z', 'timestamp': 1636383397000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222312'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:07Z', 'timestamp': 1636454647337}, 'publisher': 'Wellcome', 'award': '059897', 'DOI': '10.35802/059897', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Distribution and functional expression of two cloned mouse calcium-activated chloride channels.'}], 'investigator': [{'given': 'Paul', 'family': 'Chazot', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'John', 'family': 'Winpenny', 'affiliation': [{'name': 'University of East Anglia', 'country': 'GB'}]}], 'award-amount': {'amount': 51620.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 51620.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:10Z', 'timestamp': 1636382890000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059897'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:07Z', 'timestamp': 1636454647868}, 'publisher': 'Wellcome', 'award': '223058', 'DOI': '10.35802/223058', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding how chromatin organisation facilitates DNA virus persistence and innate immune system evasion.'}], 'project-description': [{'description': 'Many people (>95%) will be infected with Epstein Barr Virus (EBV) at some stage in their lives making it one of the most successful human-infecting viruses but accumulating evidence implicates EBV as a contributing cause of some common immune diseases. How EBV can be so successful (as a virus) but trigger immune damage in some people remains a stubborn mystery. Once EBV infects someone, it hides inside certain immune cells for the rest of that person’s life, and currently no drugs can combat the infection. In persisting, EBV needs to keep a low profile; it physically tethers itself to human-host DNA, whilst silencing most of its own genes. The virus then makes a lot of a substance called RNA, but it is not clear why. It has recently been discovered that RNA may act as a “glue” within the cells. We plan to investigate whether this viral “glue”, an understudied aspect of the biology of EBV, helps it evade detection. EBV is an expert manipulator of human cells, understanding it may lead to better understanding of some fundamental aspects of how our genes are switched on and off, and also might generate new ideas for how to treat viral infections.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0053-4200', 'authenticated-orcid': False, 'given': 'Patrick', 'family': 'Kearns', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2022, 8, 1]]}, 'award-end': {'date-parts': [[2025, 7, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:00Z', 'timestamp': 1636383420000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223058'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:08Z', 'timestamp': 1636454648501}, 'publisher': 'Wellcome', 'award': '075578', 'DOI': '10.35802/075578', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD programme costs'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3618-0843', 'authenticated-orcid': False, 'given': 'David', 'family': 'Attwell', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 500.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 7, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 500.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:24Z', 'timestamp': 1636383204000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/075578'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:12Z', 'timestamp': 1636454652964}, 'publisher': 'Wellcome', 'award': '060051', 'DOI': '10.35802/060051', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Purchase of a confocal microscope.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7631-8352', 'authenticated-orcid': False, 'given': 'Vladimir', 'family': 'Buchman', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5841-8176', 'authenticated-orcid': False, 'given': 'Alun', 'family': 'Davies', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 274493.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 274493.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:08Z', 'timestamp': 1636382768000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060051'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:12Z', 'timestamp': 1636454652977}, 'publisher': 'Wellcome', 'award': '051846', 'DOI': '10.35802/051846', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural mechanisms regulating basal and stress-induced hypothalamo-pituitary-adrenal activity: role of limbic and hypothalamic inputs to the paraventricular nucleus.'}], 'investigator': [{'given': 'Colin', 'family': 'Ingram', 'affiliation': [{'name': 'Newcastle University', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8546-9646', 'authenticated-orcid': False, 'given': 'Stafford', 'family': 'Lightman', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1058824.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 3, 1]]}, 'award-end': {'date-parts': [[2003, 10, 18]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1058824.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:10Z', 'timestamp': 1636382770000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051846'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653173}, 'publisher': 'Wellcome', 'award': '216424', 'DOI': '10.35802/216424', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Age-related changes in oocyte quality and implications for early pregnancy failure using a horse model'}], 'project-description': [{'description': \"Advanced maternal age is a highly important clinical issue in human fertility. My overall aim is to determine and then modify the age-related decline in oocyte quality, which is the primary factor for early embryonic loss. The equine is an excellent model for this, showing very comparable changes with age to human. However, the cause for the age-related changes in oocyte quality have not been identified. My first objective is to define the differences between the transcriptome of old and young equine oocytes using next generation RNA sequencing. The oocyte is reliant on support from surrounding granulosa and cumulus cells during development. Therefore, my second objective is to determine how young somatic cells modify the development of old oocytes. My third objective is to analyse pregnancy outcome using these 'modified' older eggs using in-vivo model. Modified older eggs will be fertilised by established methods and implanted into the equine uterus. The resultant embryos will be recovered and analysed at 15 days gestation to determine quality. Together, these studies will enhance our understanding of oocyte-somatic cell interactions on oocyte quality and subsequent pregnancy failure in older mothers thus making a significant contribution to equine fertility as well as translational reproductive research.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9001-661X', 'authenticated-orcid': False, 'given': 'Lindsay', 'family': 'Baxter', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2019, 5, 29]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:42Z', 'timestamp': 1636383402000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216424'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653190}, 'publisher': 'Wellcome', 'award': '070193', 'DOI': '10.35802/070193', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The interaction between surfactant proteins A and d with Mycobacterium tuberculosis.'}], 'project-description': [{'description': 'Tuberculosis is a leading cause of morbidity and mortality worldwide. Approximately one-third of the world population is infected by the causative microbial pathogen, Mycobacterium tuberculosis. Of all infected persons, only 5 to 10% develops active disease. Both innate and adaptive immunity play a role in the defense of the host against active disease. Innate immunity is most important in the early stages of the infection. Apparently, the mycobacteria are able to counter the initial innate defence mechanisms. The uptake of M. tuberculosis by alveolar macrophages is mediated through several different receptors, and is facilitated by opsonisation of the bacteria with complement component C3. Binding of mycobacterial to macrophages is also influenced by specific lectins, the so-called collectins, members of the family of C-type lectins. Human collectins include mannose-binding lectin, the complement component C1q, and the surfactant proteins A and D (SP-A and SP-D). SP-A and SP-D play an important role in the innate immune response of the lung against invading microorganisms. In summary, SP-A and SP-D bind to mycobacteria and affect the interaction of these bacteria with alveolar macrophages in opposite ways; the role of this differential interaction in the innate immune defence of the lung is as yet unknown. The binding appears mediated through the lipoglycans of the mycobacteria but here too, the role of different carbohydrate residues present on these molecules in enhancing or inhibiting the binding to the two surfactant proteins is not clear. The concentration of SP-A and SP-D in the lung is altered in lung disease and infection, and the levels of SP-A have been shown to vary widely. We hypothesize that the susceptibility to infection by M. tuberculosis and the development of active tuberculosis is determined by the balance between SP-A and SP-D in the lungs.', 'language': 'en'}], 'lead-investigator': [{'family': 'Vandenbroucke-Grauls', 'affiliation': [{'name': 'Medical Research Council', 'country': 'GB'}]}], 'award-amount': {'amount': 11740.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2003, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 11740.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:31Z', 'timestamp': 1636383031000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070193'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653235}, 'publisher': 'Wellcome', 'award': '220019', 'DOI': '10.35802/220019', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolution of cell shape: epithelial-mesenchymal transition during gastrulation in insects'}], 'project-description': [{'description': 'Cell shape plays a critical role in animal development and physiology. Consequently, shape deregulation can lead to pathological disorders. Epithelial-mesenchymal transition (EMT) is an evolutionarily conserved process in which epithelial cells, tightly connected to each other, transdifferentiate into more motile and spread mesenchymal cells. It is key to numerous developmental processes, such as heart formation, but it is also involved in cancer metastasis and organ fibrosis. The master genes controlling EMT are well characterised in many species and are relatively well conserved. However, how they drive the reorganisation of the cytoskeleton and the resulting shape change is poorly understood. Furthermore, the level of conservation of the downstream molecular pathways involved in cytoskeleton remodelling, and of the shape change itself, has not been investigated. The aim of my project is to investigate the evolutionary conservation of the morphological changes underlying EMT during mesoderm gastrulation, a process of cell internalisation in the early embryo. I will investigate cell shape changes, and cytoskeleton effectors that drive them, in two insects, to detect the level of conservation of the process. My project will shed new light on the evolution of a stereotypical cell shape crucial in both development and diseases.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4962-1305', 'authenticated-orcid': False, 'given': 'Margherita', 'family': 'Battistara', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:13Z', 'timestamp': 1636383433000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220019'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653386}, 'publisher': 'Wellcome', 'award': '215492', 'DOI': '10.35802/215492', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'SUNRISE cluster RCT: Scaling Up Nurturing care, a Radio Intervention to Stimulate Early child development in Burkina Faso'}], 'project-description': [{'description': 'The Nurturing Care Framework (NCF) launched by WHO, UNICEF and the World Bank during the 2018 World Health Assembly argued that “Investing in early child development (ECD) is one of the best investments a country can make to boost economic growth, promote peaceful and sustainable societies, and eliminate extreme poverty and inequality.” 250 million children under five in low and middle-income countries are at risk of not reaching their developmental potential with adverse consequences for their learning and adult prosperity. The NCF is a roadmap for action, focussing on pregnancy and the first 3 years of life as the foundation for wellbeing throughout the life-course. It includes interventions promoting responsive caregiving and early learning, known to improve ECD outcomes when delivered in face-to-face or group sessions with parents and children. However, doing this at the scale needed presents enormous challenges, as many health systems are over-stretched and under-resourced. Mass media may provide a more effective way forward. We plan to explore this by developing a nurturing care radio campaign built on principles of Saturation and Interactivity informed by clinical psychology, behavioural science and epidemiologic evidence, and to evaluate the impact on ECD outcomes using a cluster randomised trial design.', 'language': 'en'}, {'description': 'Almost 250 million children under-five-years of age in low and middle income countries are at risk of not reaching their developmental potential. These children are more likely to do poorly in school, have lower incomes and poorer life chances. Between 0-3 years of age the brain develops quickly, and studies have shown that improving caregiver interactions and learning opportunities at this time can positively impact child development, with effects lasting into adulthood. Although impactful, these interventions can be labour intensive and delivering them within current health systems is challenging. We plan to test whether a mass media campaign can improve care-giving behaviours, learning opportunities and consequently child development in Burkina Faso. Unlike the current interventions mass media can deliver messages to millions of people several times per day. It has the potential to shift social norms and attitudes, model skills and create an enabling environment for behaviour change.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1847-8443', 'authenticated-orcid': False, 'given': 'Pasco', 'family': 'Fearon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Zelee', 'family': 'Hill', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-8633-0208', 'authenticated-orcid': False, 'given': 'Jolene', 'family': 'Skordis-Worrall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Bassirou', 'family': 'Kagone', 'affiliation': [{'name': 'Development Media International CIC', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5274-6072', 'authenticated-orcid': False, 'given': 'Betty', 'family': 'Kirkwood', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'given': 'Roy', 'family': 'Head', 'affiliation': [{'name': 'Development Media International CIC', 'country': 'GB'}]}], 'award-amount': {'amount': 4136494.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 1]]}, 'award-end': {'date-parts': [[2025, 5, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 2068247.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:53Z', 'timestamp': 1636383053000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215492'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:13Z', 'timestamp': 1636454653406}, 'publisher': 'Wellcome', 'award': '108871', 'DOI': '10.35802/108871', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of inflammatory disease.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-5364-1838', 'authenticated-orcid': False, 'given': 'Robin', 'family': 'May', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7846-7423', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Watson', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-amount': {'amount': 2727210.2, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 25]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2640000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:40Z', 'timestamp': 1636383220000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108871'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654190}, 'publisher': 'Wellcome', 'award': '053835', 'DOI': '10.35802/053835', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dissection of the unfolding and folding pathways of microsomal cytochrome b5 using mutagenic and spectroscopic technique.'}], 'lead-investigator': [{'family': 'Whitford', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 180450.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 3, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 180450.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:42Z', 'timestamp': 1636382802000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/053835'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654249}, 'publisher': 'Wellcome', 'award': '050014', 'DOI': '10.35802/050014', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in the cellular and molecular basis of disease.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4760-8382', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Maizels', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Andrew', 'family': 'Wyllie', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Jonathan', 'family': 'Bard', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8600-0372', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Bird', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5150-6624', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Seckl', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3447-3570', 'authenticated-orcid': False, 'given': 'Eleanor', 'family': 'Riley', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8649-5408', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Millar', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-4902-5797', 'authenticated-orcid': False, 'given': 'Aziz', 'family': 'Aboobaker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Katherine', 'family': 'Giles', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'family': 'Lad', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'family': 'Millband', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 507353.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2006, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 507353.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:42Z', 'timestamp': 1636383162000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050014'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:14Z', 'timestamp': 1636454654258}, 'publisher': 'Wellcome', 'award': '058620', 'DOI': '10.35802/058620', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Influence of local production of complement on T-cell alloreactivity in renal transplantation.'}], 'investigator': [{'given': 'Stipo', 'family': 'Jurcevic', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Steven', 'family': 'Sacks', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 167569.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 6, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 167569.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:21Z', 'timestamp': 1636383021000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/058620'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656273}, 'publisher': 'Wellcome', 'award': '055257', 'DOI': '10.35802/055257', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural correlates of defective verbal self-monitoring in schizophrenia.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4313-3500', 'authenticated-orcid': False, 'given': 'Cynthia', 'family': 'Fu', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 120755.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 10, 1]]}, 'award-end': {'date-parts': [[2001, 3, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 120755.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:11Z', 'timestamp': 1636382771000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/055257'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656299}, 'publisher': 'Wellcome', 'award': '061900', 'DOI': '10.35802/061900', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Insect population control using a dominant, repressible, lethal genetic system.'}], 'lead-investigator': [{'given': 'Helen', 'family': 'White-Cooper', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 206164.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 206164.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:42Z', 'timestamp': 1636383042000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061900'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656472}, 'publisher': 'Wellcome', 'award': '066191', 'DOI': '10.35802/066191', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Symposium support for 'Brain-Immune Interactions in Stress'to be held at Bristol on 30th November 2002.\"}], 'lead-investigator': [{'given': 'David', 'family': 'Jessop', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 4000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 10]]}, 'award-end': {'date-parts': [[2002, 10, 9]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:47Z', 'timestamp': 1636382807000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 10]]}, 'URL': 'http://dx.doi.org/10.35802/066191'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656477}, 'publisher': 'Wellcome', 'award': '062450', 'DOI': '10.35802/062450', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetics studies of GAP proteins in synaptic plasticity.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8732-8735', 'authenticated-orcid': False, 'given': 'Seth', 'family': 'Grant', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 312677.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 312677.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:14Z', 'timestamp': 1636383014000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062450'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656692}, 'publisher': 'Wellcome', 'award': '061729', 'DOI': '10.35802/061729', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'X-ray diffraction and 3D modelling of vertebrate skeletal (fish) muscle in defined static states.'}], 'lead-investigator': [{'given': 'John', 'family': 'Squire', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 219957.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 219957.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:50Z', 'timestamp': 1636382870000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061729'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656723}, 'publisher': 'Wellcome', 'award': '066074', 'DOI': '10.35802/066074', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Scanning the human genome for high content screens.'}], 'project-description': [{'description': 'Not available', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Paul', 'family': 'England', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2034-9969', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Tavaré', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 574532.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 12, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 574532.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:54Z', 'timestamp': 1636382874000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066074'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656708}, 'publisher': 'Wellcome', 'award': '065813', 'DOI': '10.35802/065813', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic modifiers and phenotypic variation in hypertropic cardiomyopathy.'}], 'lead-investigator': [{'given': 'Javed', 'family': 'Ehtisham', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 141948.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 141948.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:57Z', 'timestamp': 1636382877000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065813'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:16Z', 'timestamp': 1636454656734}, 'publisher': 'Wellcome', 'award': '063228', 'DOI': '10.35802/063228', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular control of the age-dependent retardation of axonal and synaptic degeneration in Wlds mice.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9354-532X', 'authenticated-orcid': False, 'given': 'Michael Philip', 'family': 'Coleman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2670-6995', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Ribchester', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 18000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 18000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:02Z', 'timestamp': 1636382942000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063228'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660360}, 'publisher': 'Wellcome', 'award': '067614', 'DOI': '10.35802/067614', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Between epidemiology and the deep blue sea.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0611-7272', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Hay', 'affiliation': [{'name': 'University of Washington', 'country': 'US'}]}, {'given': 'Sarah', 'family': 'Randolph', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Allen', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'David', 'family': 'Rogers', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 125000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 125000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:48Z', 'timestamp': 1636382808000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/067614'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660568}, 'publisher': 'Wellcome', 'award': '209916', 'DOI': '10.35802/209916', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Unravelling the regulatory mechanisms underlying expression of COL5A1 in human cornea in health and disease'}], 'project-description': [{'description': 'Keratoconus is the most common corneal dystrophy. Patients with keratoconus experience corneal thinning and bowing of the cornea causing problems with vision. The condition usually effects both eyes where moderate to severe cases require corneal transplant to improve vision. Unfortunately, diagnosis proves as challenging, where early disease is difficult to recognise. Mild to moderate disease can be treated with glasses or contact lenses to improve vision, although subjective vision gain is variable depending on level of astigmatism. The underlying process that leads to keratoconus and corneal thinning is unknown. Research suggests that there is a strong genetic component underlying the pathogenesis of corneal thinning and disease. Recent work from the Vitart lab has identified genetic regions that may be implicated in corneal thinning and keratoconus. Some of these regions are near a gene that codes for a type of collagen called COL5A1. We are interested to see if these regions have a role in regulating this gene, thereby implicating its importance in variation of central corneal thickness and keratoconus. This research will look at unlocking those complex genetic mechanisms by use of a cell line and a mouse model.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5763-9716', 'authenticated-orcid': False, 'given': 'Zuhair', 'family': 'Mustafa', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 8, 2]]}, 'award-end': {'date-parts': [[2021, 2, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:50Z', 'timestamp': 1636383230000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 8, 2]]}, 'URL': 'http://dx.doi.org/10.35802/209916'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:20Z', 'timestamp': 1636454660596}, 'publisher': 'Wellcome', 'award': '211033', 'DOI': '10.35802/211033', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a patient reported outcome measure for polymyalgia rheumatica'}], 'project-description': [{'description': 'Polymyalgia rheumatica affects people in older age groups causing pain, stiffness and disability. It is mainly treated with steroid medication which itself can cause significant side effects.1 It is an under-researched condition with wide variations in treatment.2,3 More research is needed to inform clinical practice and improve patient care. Patient reported outcome measures (PROMs) can be used to guide assessment and treatment and support aspects of care that patients value. PMR is particularly well suited to being assessed by patient reported outcomes given the effects of the condition, its varied course and the difficult balance between benefits versus side effects of treatment. A provisional set of outcome measures to be used in clinical trials for PMR published recently highlighted the limited ability of the existing measures to assess the effects of PMR on patients’ lives.4 We carried out a study of patient experiences of having PMR5 and used data from this to develop a draft PROM. This study continues the development process, testing the validity and reliability of the questionnaire and improving it according to response data. The resulting PMR-specific PROM will be a useful outcome measure in future clinical trials, improving the evidence base for management of the condition.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8781-1268', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Twohig', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 25]]}, 'award-end': {'date-parts': [[2022, 3, 24]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:02Z', 'timestamp': 1636383422000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 25]]}, 'URL': 'http://dx.doi.org/10.35802/211033'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661257}, 'publisher': 'Wellcome', 'award': '218642', 'DOI': '10.35802/218642', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neuro-computational mechanisms of information acquisition and integration in social contexts'}], 'project-description': [{'description': 'Understanding the social cognitive mechanisms that enable people to learn from and interact with others has been of considerable interest to psychologists and neuroscientists for decades. Yet, the mechanisms underlying our ability to gather information from other people and to learn from them by integrating this information into our beliefs remain to be elucidated. Here, I proposed to use a neuro-computational approach, combining behavioural experiments, neuroimaging, brain stimulation, and computational modelling to provide an integrated framework of how information acquisition and integration are influenced by social contexts. Three key questions form the core of this proposal: How are choices of information sources influenced by social confirmation bias? How do people learn from misinformation in social contexts? How do these social influences interact with anxiety? Across four studies in three international sites, this research will (i) further our understanding of the behavioural and neural mechanistic computations underlying these processes, (ii) determine the causality of the neural mechanisms, and (iii) elucidate how these computations vary with psychiatric symptoms. Addressing these questions will not only contribute to advancing multiple disciplines, from social neuroscience to behavioural economics, but also has potential implications for wider societal questions, from mental health to policy&minus;making.', 'language': 'en'}, {'description': 'We live in a connected world where our social environment vastly shapes how we behave as individuals. Such social influences can be beneficial, allowing us to learn from others, collaborate and live in groups; but they can also be detrimental and anxiety-inducing, as seen with the rise of fake news propagation, social media abuse, and social groups polarisation. In this project, I plan to develop mathematical models of human behaviour, combined with brain imaging techniques, to understand how social influences work when we seek information from others, and when we use that information to learn and make decisions. I will also examine how these behaviours may go awry in individuals with anxiety and other psychiatric symptoms. This work has the long-term potential of contributing to issues faced by our modern societies, such as policies to reduce the spread of misinformation and interventions to improve social behaviour in mental disorders.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3555-2732', 'authenticated-orcid': False, 'given': 'Benedetto', 'family': 'De Martino', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-0016-3531', 'authenticated-orcid': False, 'given': 'John', 'family': \"O'Doherty\", 'affiliation': [{'name': 'California Institute of Technology', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-3964-2364', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Ruff', 'affiliation': [{'name': 'University of Zurich', 'country': 'CH'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7283-0738', 'authenticated-orcid': False, 'given': 'Caroline', 'family': 'Charpentier', 'affiliation': [{'name': 'California Institute of Technology', 'country': 'US'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 1]]}, 'award-end': {'date-parts': [[2024, 5, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:13Z', 'timestamp': 1636383073000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218642'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661314}, 'publisher': 'Wellcome', 'award': '222407', 'DOI': '10.35802/222407', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Manufacture of a GMP SARS-CoV-2 challenge agent'}], 'project-description': [{'description': 'In the current COVID-19 emergency, a controlled SARS-COV-2 human infection model (CHIM) has the potential to accelerate the understanding of pathogenesis, induction of immunity and immune mechanisms of resistance to disease, as well as a means to test novel diagnostics and treatments, especially between waves of the pandemic, when occurrence of natural disease is relatively uncommon. A large number of SARS-COV-2 vaccine candidates are at various stages of development internationally including those which have recently entered mid-late stage clinical testing in field studies. In order to make the greatest public health impact, there is an urgent need to select the most promising vaccines in the shortest possible timeframe. In addition, human infection challenge can contribute to the identification of correlates and mechanisms of protection against infection and shedding of virus in vaccinated volunteers. Finally, the model may be useful in the determination of the durability of protection in seropositive individuals with documented prior wild type infection. This proposal is a dose titration study to generate two GMP challenge agents and establish the safety of a wild-type SARS-COV-2 controlled infection in the upper respiratory tract of young healthy volunteers that will allow swift and robust assessment of vaccine efficacy.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3948-0895', 'authenticated-orcid': False, 'given': 'Wendy', 'family': 'Barclay', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2126-5142', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'McShane', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7220-2555', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Openshaw', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0914-920X', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Chiu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 4178641.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 2]]}, 'award-end': {'date-parts': [[2023, 7, 2]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 4178641.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:35Z', 'timestamp': 1636383575000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 2]]}, 'URL': 'http://dx.doi.org/10.35802/222407'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:21Z', 'timestamp': 1636454661873}, 'publisher': 'Wellcome', 'award': '054109', 'DOI': '10.35802/054109', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of the aetiology of obstetric cholestasis.'}], 'lead-investigator': [{'given': 'Catherine', 'family': 'Williamson', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 366231.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 18]]}, 'award-end': {'date-parts': [[2003, 4, 16]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 366231.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:18Z', 'timestamp': 1636382778000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 18]]}, 'URL': 'http://dx.doi.org/10.35802/054109'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:23Z', 'timestamp': 1636454663574}, 'publisher': 'Wellcome', 'award': '048858', 'DOI': '10.35802/048858', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Calcium microdomains and gradients in cell physiology and pathophysiology - application for a UV and argon-kryton confocal imaging system.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2548-4294', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Duchen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 354755.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 1, 1]]}, 'award-end': {'date-parts': [[2002, 3, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 354755.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:34Z', 'timestamp': 1636382914000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048858'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:23Z', 'timestamp': 1636454663627}, 'publisher': 'Wellcome', 'award': '059710', 'DOI': '10.35802/059710', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD programme in cellular and molecular physiology.'}], 'lead-investigator': [{'family': 'Mcmichael', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 115374.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 115374.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:47Z', 'timestamp': 1636383167000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059710'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664189}, 'publisher': 'Wellcome', 'award': '061307', 'DOI': '10.35802/061307', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Protection of Na,K-ATPase and other membrane proteins in red cell ghosts by a lens molecular chaperone.'}], 'lead-investigator': [{'family': 'Harding', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 87153.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2003, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 87153.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:07Z', 'timestamp': 1636382887000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061307'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664209}, 'publisher': 'Wellcome', 'award': '060800', 'DOI': '10.35802/060800', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Control of ocular HSV-1 infection using mucosal vaccination strategies which stimulate Th1 or Th2 dominated immune responses.'}], 'investigator': [{'given': 'Neil', 'family': 'Williams', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'family': 'Hill', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Claire', 'family': 'Richards', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 275762.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 7, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 275762.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:26Z', 'timestamp': 1636382786000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060800'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664450}, 'publisher': 'Wellcome', 'award': '220584', 'DOI': '10.35802/220584', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Respiratory immune responses and their interaction in control of nasal colonization with Bordetella pertussis and Staphylococcus aureus in humans'}], 'project-description': [{'description': 'This research study is designed to examine how the human immune system responds to different types of vaccines and to bacteria that commonly live in the nose, in particular Bordetella pertussis and Staphylococcus aureus. Infection with the bacteria Bordetella pertussis (‘B.pertussis’) causes whooping cough. Vaccines are routinely given in childhood to prevent whooping cough. If you received routine childhood vaccinations you will have received one of two B.pertussis vaccines depending on your year of birth. This study aims to look at how the human immune system responds to different types of B.pertussis vaccines that are or were in routine use. Another important bacteria which may cause disease in humans is Staphylococcus aureus (‘S.aureus’). Approximately 20-30% of healthy people carry these bacteria in their nose without it causing infection. This is called colonisation. However, in some people, infection with S.aureus can be potentially serious and require prompt treatment. This study aims to look at the differences in how human immune system responds in people who are colonised with S.aureus and those who are not. It is hoped that this research will contribute to future work on vaccines that may benefit vulnerable patients susceptible to serious infections with both S.aureus and B.Pertussis.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9334-1661', 'authenticated-orcid': False, 'given': 'Karen', 'family': 'McCarthy', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2019, 7, 8]]}, 'award-end': {'date-parts': [[2022, 7, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:24Z', 'timestamp': 1636383444000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 7, 8]]}, 'URL': 'http://dx.doi.org/10.35802/220584'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664484}, 'publisher': 'Wellcome', 'award': '221716', 'DOI': '10.35802/221716', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developing the next generation of anti-venoms to improve management of cobra poisonings in low and middle incoming countries'}], 'project-description': [{'description': 'We propose a different approach to antivenoms, based on recombinant nanobodies (Nbs), targeting the lethal cobra toxins, to reduce morbidity and mortality. Nbs have a high affinity for selected epitopes, allowing rapid recognition of antigens even if bound to cholinergic receptors, combined with a capacity to dislocate neurotoxin from the receptor. This COBRA-NGaV project brings together research teams with extensive experience in venomics and antivenomics to provide the proof-of-concept (PoC) for cobra toxin-specific Nb candidates as a novel generation of antivenoms and to address the dual obstacle to neutralise cobra toxins: weak immunogenicity and fast diffusion. Preliminary results have been obtained so far: i) strong and specific responses were elicited in dromedaries immunised against the toxic fractions of N. legionis, N. haje and N. oxiana; ii) phage display screenings were adopted to rescue strong Nb binders specific towards relevant N. l., N. h. and N. o. toxins; iii) several clusters of Nb sequences specifically binding cobra toxins have been identified. Herein, Nb selections and combinations for optimal synergic effects and best cross-species performances will be generated. Best-in-class candidates will be tested in a pre-clinical study in mice and sheep according to GMP rules. Cost effectiveness will be established.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4178-0763', 'authenticated-orcid': False, 'given': 'Mohamed', 'family': 'HAMMADI', 'affiliation': [{'name': 'Arid Regions Institute', 'country': 'TN'}]}, {'ORCID': 'http://orcid.org/0000-0002-9066-8666', 'authenticated-orcid': False, 'given': 'Delavar', 'family': 'Shahbazzadeh', 'affiliation': [{'name': 'Pasteur Institute of Iran', 'country': 'IR'}]}, {'ORCID': 'http://orcid.org/0000-0002-5761-1342', 'authenticated-orcid': False, 'given': 'Pierre', 'family': 'Lafaye', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Salma', 'family': 'Djilani', 'affiliation': [{'name': 'Institut Pasteur of Algeria', 'country': 'DZ'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3147-245X', 'authenticated-orcid': False, 'given': 'Balkiss', 'family': 'Bouhaouala-Zahar', 'affiliation': [{'name': 'Institut Pasteur de Tunis', 'country': 'TN'}]}], 'award-amount': {'amount': 1340491.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 1197348.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:37Z', 'timestamp': 1636383517000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221716'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:24Z', 'timestamp': 1636454664624}, 'publisher': 'Wellcome', 'award': '211166', 'DOI': '10.35802/211166', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Co-evolution of tumour mutational and CD4 T-cell differentiation landscapes'}], 'project-description': [{'description': \"Lung cancer is the second most commonly diagnosed cancer in the UK and the greatest cause of cancer-related death. A type of this disease called non-small cell lung cancer (NSCLC) accounts for the majority (85%) of cases. T-lymphocyte cells (T-cells) of the immune system patrol the body and can recognise and destroy cancer cells by recognising mutated proteins (neoantigens) on them. Despite this, the majority of patients with advanced lung cancer die of the disease, indicating the ineffective function of the immune system. In particular, little is known about the role of a particular group of immune cells called T-helper cells that are thought to be important. In chronic infections where T-cells are constantly exposed to their targets, they become less responsive as younger cells are driven to turn into later ones more rapidly. As younger cells are lost, the body's ability to fight the infection reduces. In cancer, it is possible that mutations drive a similar problem. Using lung cancer specimens from patients on a clinical trial and animal models of cancer, we propose to study the question of whether and how mutations can paralyse the ability of T-helper cells to fight the disease.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5373-5762', 'authenticated-orcid': False, 'given': 'Ehsan', 'family': 'Ghorani', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2021, 3, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:44Z', 'timestamp': 1636383224000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/211166'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665317}, 'publisher': 'Wellcome', 'award': '063952', 'DOI': '10.35802/063952', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Aciduric bacteria and root caries.'}], 'lead-investigator': [{'given': 'David', 'family': 'Beighton', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 231253.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 231253.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:46Z', 'timestamp': 1636382806000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063952'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665365}, 'publisher': 'Wellcome', 'award': '062069', 'DOI': '10.35802/062069', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The neurobiology of speech perception: functional subsystems in the human brain, the role of attention, and recovery from aphasic stroke.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7510-6297', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Scott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 358376.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 358376.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:18Z', 'timestamp': 1636383018000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062069'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665553}, 'publisher': 'Wellcome', 'award': '061104', 'DOI': '10.35802/061104', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the cost of the VIth International Workshop on scleroderma research to be held at Keble College Oxford on 31/7/00 to 2/8/00.'}], 'lead-investigator': [{'given': 'Carol', 'family': 'Black', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2000, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 5000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:09Z', 'timestamp': 1636382769000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061104'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665606}, 'publisher': 'Wellcome', 'award': '065278', 'DOI': '10.35802/065278', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deciphering the pathways that control and promote the processing of recombination intermediates in the fission yeast Schizosaccharomyces pombe.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0951-3374', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Whitby', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 165849.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 165849.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:51Z', 'timestamp': 1636382931000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065278'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665612}, 'publisher': 'Wellcome', 'award': '061962', 'DOI': '10.35802/061962', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Neuroscience'}], 'lead-investigator': [{'given': 'Laura', 'family': 'Von Hertzen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 116393.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 116393.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:22Z', 'timestamp': 1636383202000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061962'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665775}, 'publisher': 'Wellcome', 'award': '222348', 'DOI': '10.35802/222348', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovery and impact of schizophrenia rare genetic variation using next-generation sequencing'}], 'project-description': [{'description': 'Schizophrenia is a psychiatric disorder which affects around 1% of the population. There is no one single cause of schizophrenia, but genetics is known to play a substantial role. The genes involved in risk for the disorder span many different genes. Mutations thought to be linked to schizophrenia are often seen in individuals without a schizophrenia diagnosis, and I plan to investigate the impact these mutations have on an individual’s characteristics. I will use large-scale datasets in which every protein-coding base pair has been sequenced, highlighting any mutations. I will use information on an individual’s characteristics along with this genetic data to investigate the impacts of mutations in schizophrenia associated genes in both people with a schizophrenia diagnosis, and in those without. I also aim to discover new genes linked to schizophrenia, which will provide insights into the underlying biology of the disorder.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6946-5768', 'authenticated-orcid': False, 'given': 'Eilidh', 'family': 'Fenner', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2020, 10, 24]]}, 'award-end': {'date-parts': [[2023, 10, 23]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:57Z', 'timestamp': 1636383357000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 24]]}, 'URL': 'http://dx.doi.org/10.35802/222348'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:25Z', 'timestamp': 1636454665813}, 'publisher': 'Wellcome', 'award': '221575', 'DOI': '10.35802/221575', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'AVID-CC Adalimumab for COVID19 in community care'}], 'project-description': [{'description': 'While the first wave of COVID-19 is passing, we have yet to identify effective treatments. Most treatments have been used late in the illness. There is a pressing need to identify treatments delivered in community settings that avoid hospital admission. Novel immunomodulatory treatments have a well understood safety profile but are not suitable for studies such as Principle which rely on remote assessment. Hospital at home is a developing networ; teams of consultant physicians and nurses deliver high intensity care in community settings, commonly using point of care diagnostics. This provides a suitable framework for evaluation of novel therapies. This approach has parallels with healthcare systems employed in low and middle income countries and so the results will directly inform the delivery of interventions in these settings. Multiple strands of evidence identify TNFa as an important mediator of the hyperinflammatory state that is associated with poor outcome. Early intervention with anti-TNF therapy has the potential to substantially mitigate its effects and improve outcomes. Adalimumab is an established subcutaneous anti-TNF therapy. We propose a randomised dose ranging study in community settings to establish whether it can mitigate progression to respiratory failure (requirement for oxygen, non invasive and invasive ventilation) or death.', 'language': 'en'}], 'investigator': [{'given': 'Marc', 'family': 'Feldmann', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4156-6989', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Cook', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8763-6818', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Rowland', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8274-5580', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Lasserson', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8093-7084', 'authenticated-orcid': False, 'given': 'Duncan', 'family': 'Richards', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1495762.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2021, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 1495762.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:49Z', 'timestamp': 1636383049000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221575'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:26Z', 'timestamp': 1636454666065}, 'publisher': 'Wellcome', 'award': '062958', 'DOI': '10.35802/062958', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chemical neuroanatomy of the midbrain limbic system and its role in mediating serotonin levels in the raphe complex.'}], 'lead-investigator': [{'family': 'Flumerfelt', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 7213.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2000, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 7213.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:02Z', 'timestamp': 1636382762000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062958'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667279}, 'publisher': 'Wellcome', 'award': '223642', 'DOI': '10.35802/223642', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Research on Research Institute – CWTS-Leiden Costs - 2021'}], 'lead-investigator': [{'given': 'Sarah', 'family': 'de Rijcke', 'affiliation': [{'name': 'University of Leiden', 'country': 'NL'}]}], 'award-amount': {'amount': 46904.48, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2021, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 39956.11, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:40Z', 'timestamp': 1636383580000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223642'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667299}, 'publisher': 'Wellcome', 'award': '224006', 'DOI': '10.35802/224006', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'ENTHUSE Charitable Trust Proposal to The Welcome Trust, May 2021'}], 'project-description': [{'description': \"The ENTHUSE Charitable Trust's charitable purpose is to improve science education, or related subjects, for young people, through the professional development of teachers. Over the period to 2023, ENTHUSE will: - continue to provide science CPD accessible by all teachers and others from state-funded schools, with a particular focus on engaging schools, colleges, teachers and young people most in need of STEM education support so helping close the achievement gap and promote social mobility while raising standards across the board; - build strong, visionary leadership in STEM teaching across primary, secondary and post-16 settings to achieve sustained system-wide improvement, raising standards and expectations; - encourage a culture of career-long, STEM-specific professional learning across the teaching profession, raising morale, and enhancing retention; - significantly raise awareness among schools, colleges, teachers, young people and families of the value of STEM study and STEM-related research and careers, and of the academic, technical and apprentice routes into those roles. The ENTHUSE Charitable Trust is seeking a budget of £3.136m, with the deployment of Wellcome funding part of a wider mix of income, aligned to the above priorities.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Rosie', 'family': 'Bailey', 'affiliation': [{'name': 'ENTHUSE Charitable Trust', 'country': 'GB'}]}], 'award-amount': {'amount': 3136000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'award', 'scheme': 'Education', 'award-amount': {'amount': 3136000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:25Z', 'timestamp': 1636383565000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/224006'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667538}, 'publisher': 'Wellcome', 'award': '061287', 'DOI': '10.35802/061287', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic analysis of annexin function.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7304-8879', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Moss', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 329560.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 11, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 329560.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:09Z', 'timestamp': 1636383009000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061287'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667550}, 'publisher': 'Wellcome', 'award': '041392', 'DOI': '10.35802/041392', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'For a study of neural control of the cranial circulation and its implications for migraine.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3260-5904', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Goadsby', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4162769.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1995, 1, 1]]}, 'award-end': {'date-parts': [[2006, 4, 12]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 4162769.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:39Z', 'timestamp': 1636382979000}, 'score': 0.0, 'issued': {'date-parts': [[1995, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/041392'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667910}, 'publisher': 'Wellcome', 'award': '054737', 'DOI': '10.35802/054737', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular genetics of Fraser syndrome.'}], 'lead-investigator': [{'family': 'Mcgregor', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 156709.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 11]]}, 'award-end': {'date-parts': [[2002, 9, 10]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 156709.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:24Z', 'timestamp': 1636382904000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 11]]}, 'URL': 'http://dx.doi.org/10.35802/054737'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:27Z', 'timestamp': 1636454667955}, 'publisher': 'Wellcome', 'award': '050015', 'DOI': '10.35802/050015', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in molecular functions in disease.'}], 'investigator': [{'given': 'David', 'family': 'Barry', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'John', 'family': 'Coggins', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'family': 'Stewart', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'family': 'Murnaghan', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Kirsty', 'family': 'Brown', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Claire J', 'family': 'Ackerman', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'given': 'Marie A', 'family': \"O'Donnell\", 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 449105.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 449105.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:41Z', 'timestamp': 1636383161000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050015'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:28Z', 'timestamp': 1636454668148}, 'publisher': 'Wellcome', 'award': '218520', 'DOI': '10.35802/218520', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dundee Training Programme in Integrated Molecular, Cellular and Translational Biology'}], 'project-description': [{'description': 'The proposed programme reflects the vision of University of Dundee to drive social change locally and transform lives globally through the creation, sharing and application of knowledge. A diverse cohort of students will flourish in a culture of excellence, developing research skills and attaining competencies in leadership, management and communication. They will experience world-leading life sciences research in a first-class training environment, with excellent core facilities and well-funded research groups, whilst enhancing research outputs with their energy and innovation. Students will participate in multidisciplinary research in Cellular Regulation, Protein Modification, Infection and Immunity and Drug Discovery and Translation. The flexible PhD programme will provide structured training in experimental design, data handling and processing, basic bio-computational skills and ethical standards in scientific research. By the end of year 1, students will have selected their research project and will have 3 years to consolidate their core bioscience skills, carrying out and documenting their research. There is the option for a career enhancement placement in year 3, while year 4 will support students in career choices and thesis submission. After thesis submission, flexible funding may be used to facilitate paper writing/completion or allow students to undertake a project in our Drug Discovery Unit.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8135-1958', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Arthur', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-9733-2404', 'authenticated-orcid': False, 'given': 'Miratul', 'family': 'Muqit', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0808-1875', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Coulthurst', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7113-9024', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Hay', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 5]]}, 'award-end': {'date-parts': [[2028, 10, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 5]]}, 'URL': 'http://dx.doi.org/10.35802/218520'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669526}, 'publisher': 'Wellcome', 'award': '062133', 'DOI': '10.35802/062133', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of the novel Leber congenital amaurosis gene, AIPL1.'}], 'lead-investigator': [{'given': 'Jacqueline', 'family': 'van der Spuy', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 92245.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 92245.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:53Z', 'timestamp': 1636382873000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062133'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669526}, 'publisher': 'Wellcome', 'award': '063040', 'DOI': '10.35802/063040', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular Functions in Disease.'}], 'lead-investigator': [{'family': 'Mauger', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 109077.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 109077.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:10Z', 'timestamp': 1636383190000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063040'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:29Z', 'timestamp': 1636454669534}, 'publisher': 'Wellcome', 'award': '066732', 'DOI': '10.35802/066732', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell division in bacillus subtilis: genetic and structural studies of proteins involved.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4577-9479', 'authenticated-orcid': False, 'given': 'Anthony', 'family': 'Wilkinson', 'affiliation': [{'name': 'University of York', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Imrich', 'family': 'Barak', 'affiliation': [{'name': 'Misc Slovak Republic', 'country': 'SK'}]}], 'award-amount': {'amount': 84800.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 4, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 84800.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:44Z', 'timestamp': 1636382864000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066732'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:30Z', 'timestamp': 1636454670241}, 'publisher': 'Wellcome', 'award': '066294', 'DOI': '10.35802/066294', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional annotation of the human genome: developing a \"disease-locus view\" of the human genome within a distributed controlled-term environment.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-4393-0510', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'McCarthy', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Winston', 'family': 'Hide', 'affiliation': [{'name': 'University of the Western Cape', 'country': 'ZA'}]}], 'award-amount': {'amount': 94458.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 94458.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:47Z', 'timestamp': 1636382927000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066294'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671395}, 'publisher': 'Wellcome', 'award': '065310', 'DOI': '10.35802/065310', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'IoP/Univeristy of Addis Ababa collaborative mental health program.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1379-7146', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Prince', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3920.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2001, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3920.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:49Z', 'timestamp': 1636382929000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065310'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671628}, 'publisher': 'Wellcome', 'award': '220527', 'DOI': '10.35802/220527', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploiting Radiogenomics for Evaluating Intratumoural Heterogeneity and Therapy Response in Soft Tissue Sarcoma'}], 'project-description': [{'description': 'Soft tissue sarcomas (STS) are a rare group of cancers that can develop throughout the body. There are over 100 subtypes, which often exhibit different tissue compositions across a single tumour. STS tumours therefore behave variably to treatment, and predicting patient response to pre-operative therapy is challenging. Advancements in MRI provide insight into the behaviour of tumours without needing an invasive biopsy. However, we lack research comparing MRI with tumour tissue to allow confidence in MRI interpretation. This project seeks to gain a better understanding of the differences seen in STS, and establish if imaging can reflect the underlying biology of these differences. I aim to match image-guided sampling of multiple regions of STS tumours with molecular analysis. The analysis will investigate the DNA, RNA and proteins within the tumour tissues and how this relates to MRI. We will assess whether integrating molecular and imaging data can improve our understanding of whether tumours are responding to treatment. My research will increase our understanding of the complex nature of STS and why distinct tumour regions behave differently. This will impact clinical practice by enhancing our ability to accurately measure and predict responses to pre-operative therapy and facilitate delivery of precision medicine.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5087-2243', 'authenticated-orcid': False, 'given': 'Amani', 'family': 'Arthur', 'affiliation': [{'name': 'Institute of Cancer Research', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 19]]}, 'award-end': {'date-parts': [[2023, 2, 17]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:31Z', 'timestamp': 1636383331000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 19]]}, 'URL': 'http://dx.doi.org/10.35802/220527'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671638}, 'publisher': 'Wellcome', 'award': '202974', 'DOI': '10.35802/202974', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '(Pilot) Performance of EArly Retinal Laser (PEARL)'}], 'project-description': [{'description': \"The prevalence of diabetes in China has risen tenfold since 1981. Virtually all of China's 114 million diabetic persons willdevelop diabetic retinopathy (DR) eventually, and timely laser treatment reduces blindness by 50%. Still, only 10% of ruralpersons with DR in China receive treatment, partly because current care requires them to be followed for several yearsbefore reaching treatment criteria, during which many are lost.Our recent review suggests that earlier treatment, which could reduce the compliance burden, may be clinically efficaciousand cost effective, but current evidence is insufficient. Our pilot work confirms rural patients find long-term adherencedifficult, and earlier treatment is acceptable to patients and providers. We now propose a pilot randomised trial to determinewhether earlier laser treatment improves outcomes and compliance among those with diabetic retinopathy in China.Patients will be recruited from one of China's largest hospitals, and treated after training provided by the top-ranked eyehospital in the country. Participants with severe non-proliferative diabetic retinopathy (NPDR) in both eyes will berandomized to receive: pan-retinal photocoagulation (PRP) applied immediately in one eye at random and PRP in thefellow eye only when proliferative diabetic retinopathy (PDR) develops (Early Intervention-n=100) or PRP at the PDR stagein both eyes (Standard Care group-n=100). The latter group is needed in particular, to test whether early laser treatmenthas an effect on adherence.At 1 year follow-up, the primary outcome will be progression to PDR, with secondary outcomes including loss of vision,complications, quality of life and cost effectiveness. In addition to informing a full trial, this study will address questions of importance to diabetic eye care in low resourcesettings by validating physician clinical diagnosis of DR compared to more expensive technologies and testing a simplifieddefinition of severe NPDR.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9866-3416', 'authenticated-orcid': False, 'given': 'Nathan', 'family': 'Congdon', 'affiliation': [{'name': \"Queen's University Belfast\", 'country': 'GB'}]}], 'award-amount': {'amount': 29026.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 4, 1]]}, 'award-end': {'date-parts': [[2019, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 29026.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:15Z', 'timestamp': 1636382955000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/202974'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671656}, 'publisher': 'Wellcome', 'award': '068516', 'DOI': '10.35802/068516', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Long term hospital utilisation and costs of preterm and low birthweight infants.'}], 'project-description': [{'description': \"The high rates of morality and morbidity arising from preterm birth and low birthweight impose an immense burden on the health services. Additional costs to the health service associated with preterm and low birthweight infants may be between £7748 and £63,300 each in their first year (1998 prices). However, since the early 1990's when studies in this area were conducted, both the incidence and survival rates of preterm birth and low birthweight have increased. This study will estimate the utilisation and cost of hospital services for preterm and low birthweight infants born in Oxfordshire and West Berkshire between 1970-94 with follow-up of hospitalisation to 1999. This will be done using data from the Oxford Record Linkage Study (ORLS), a very large database, with linked hospital records which provide person based records of hospital admissions. Data from the ORLS include basic demographic, obstetric and neonatal data, dates, diagnoses and procedures in the initial and all subsequent hospitalisations up to age ten years, except for the recent cohorts. ORLS data will be combined with specialty specific unit costs and data from the National Reference Costs to obtain estimates of likely expenditure for different groups. The analysis will estimate hospital utilisation and costs in different gestational age and birthweight groups over time.\", 'language': 'en'}], 'investigator': [{'given': 'Stavros', 'family': 'Petrou', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}, {'family': 'Davidson', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}], 'lead-investigator': [{'family': 'Henderson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 30449.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 1, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 30449.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:56Z', 'timestamp': 1636382876000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068516'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:31Z', 'timestamp': 1636454671868}, 'publisher': 'Wellcome', 'award': '068420', 'DOI': '10.35802/068420', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of hypoxia on the response of cells to oxidised low density lipoprotein.'}], 'investigator': [{'given': 'Giovanni', 'family': 'Mann', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'David', 'family': 'Leake', 'affiliation': [{'name': 'University of Reading', 'country': 'GB'}]}], 'award-amount': {'amount': 102000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 102000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:41Z', 'timestamp': 1636382801000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068420'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673005}, 'publisher': 'Wellcome', 'award': '066920', 'DOI': '10.35802/066920', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Control of microglial neurotoxicity by modulation of metabotropic glutamate receptors - a strategy for protection in neurodegenerative disease.'}], 'lead-investigator': [{'given': 'Jennifer', 'family': 'Pocock', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 187451.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 5, 1]]}, 'award-end': {'date-parts': [[2005, 4, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 187451.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:51Z', 'timestamp': 1636382871000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066920'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673005}, 'publisher': 'Wellcome', 'award': '211022', 'DOI': '10.35802/211022', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Social anxiety in adolescents: Testing aspects of the cognitive model and developing an Internet version of Cognitive Therapy.'}], 'project-description': [{'description': 'While it is common for teenagers to report feeling somewhat self-conscious and worried about what others think of them, for some adolescents social anxiety can be overwhelming and markedly interfere with their day-to-day life. Around 4% of young people experience clinical levels of social anxiety by the age of 18. Their success at school and their relationships with family and friends are all seriously affected. It is therefore essential that we have effective treatments for this disorder. Unfortunately, evidence suggests that many young people do not get better with the talking treatments that are available. In contrast we know that Cognitive Therapy (a type of talking treatment) is very effective with socially anxious adults. Cognitive Therapy was developed to target key factors that cause and maintain the illness in adults. I would therefore like to answer two questions in my research. First, are the factors that are important in maintaining social anxiety in adults also important in adolescent social anxiety? Second, can we develop an accessible and effective version of Cognitive Therapy for adolescents online? We will test if Cognitive Therapy works by comparing its effects to online stress management.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2756-3770', 'authenticated-orcid': False, 'given': 'Eleanor', 'family': 'Leigh', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 10, 1]]}, 'award-end': {'date-parts': [[2021, 12, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:05Z', 'timestamp': 1636383245000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211022'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673031}, 'publisher': 'Wellcome', 'award': '068724', 'DOI': '10.35802/068724', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Recognition motifs for cell-surface receptors and matrix proteins within the triple-helical domains of collagens.'}], 'project-description': [{'description': 'Triple-helical peptides which mimic the secondary structure of collages have proved invaluable in locating recognition sites within collagen for the platelet receptors, integrin alpha2beta1 and glycoprotein (Gp) VI. Some progress has been made applying the same approach to non-receptor proteins, von Willebrand factor and MMP-9. As a first round of peptide synthesis, we will construct the entire sequence of the fibrillar collagens, types II and III, and use these to locate recognition sites for a series of cardiovascular and other proteins. These will include collagen receptors on platelets (CD36, GpV) and other cells (alpha10beta1, alpha11beta1, DDRs), and non-receptor collagen-binding proteins (vWf, MMP-9, decorin, opticin, matrillins, fibronectin). When binding sites have been mapped, sequence alignment and analysis will support a second round of peptide synthesis which will allow recognition motifs to be identified. This information will allow the integrin-specificity of different motifs to be determined, novel therapeutic targets to be identified, and will provide fundamental insight into the interaction of collagen-binding proteins with the triple-helical structure.', 'language': 'en'}], 'investigator': [{'family': 'Knight', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Richard', 'family': 'Farndale', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 148489.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 3, 17]]}, 'award-end': {'date-parts': [[2005, 3, 16]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 148489.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:20Z', 'timestamp': 1636382780000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 3, 17]]}, 'URL': 'http://dx.doi.org/10.35802/068724'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673029}, 'publisher': 'Wellcome', 'award': '069759', 'DOI': '10.35802/069759', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Interactions between hypercapnia and hypoxia in the pulmonary circulation.'}], 'project-description': [{'description': 'Respiratory disease can cause the patient to become hypoxemic, both in the short term and over long periods. Acute hypoxia causes the pulmonary arteries to constrict (hypoxic pulmonary vasoconstriction, HPV) and therefore increase pulmonary vascular resistance (PVR). Chronic hypoxia causes the pulmonary vasculature to remodel, causing a fixed increase in PVR that can not be immediately reversed by oxygen, and changes in vascular reactivity. The mechanisms that cause these effects are not known completely , but reactive oxygen species from mitochondria and oxidant stress are thought to play an important role in causing both the acute HPV, and tissue damage or changes associated with chronic pulmonary hypertension. Respiratory disease often however also causes hypercapnia. Recent evidence from our laboratories and elsewhere has shown that hypercapnia can protect against some of the changes associated with chronic hypoxia. Also, hypercapnia has been shown to inhibit HPV in a way that is not due to acidosis. There is published evidence that CO2 can reduce oxidant stress and release of reactive oxygen species from the mitochondria and possibly other sources. In this project I therefore wish to test the hypothesis that CO2 suppresses hypoxic pulmonary vasoconstriction by interfering with the increase in mitrochondrial reactive oxygen species generation during hypoxia in a pH independent manner. I will do this by studying the effects of CO2 in conditions of normal pH on HPV in isolated pulmonary arteries and cells, and on the intracellular level of Ca2+, reactive oxygen species and NADH during hypoxia using arteries and cells loaded with Fura-2 and DCF. Also, I will test the effect of inhibition of carbonic anhydrase on HPV, as this should increase local CO2 carbonic anhydrase inhibition has been shown to inhibit HPV.', 'language': 'en'}], 'lead-investigator': [{'given': 'Marie', 'family': 'Vankova', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 53807.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 6, 1]]}, 'award-end': {'date-parts': [[2004, 5, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 53807.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:46Z', 'timestamp': 1636382926000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069759'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673055}, 'publisher': 'Wellcome', 'award': '215165', 'DOI': '10.35802/215165', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The Synaptic Organisation of the Hippocampus : VTA loop'}], 'project-description': [{'description': 'When making decisions, it is advantageous to use past experience to help choose the best option. For example, when deciding whether to drink a strong coffee late in the evening, it is beneficial to weigh up what happened when you drank some previously: that coffee increased your alertness to help you get through that last hour or work; but also that you struggled to sleep later in the day. These kinds of decisions are thought to be determined by the activity of distinct populations of neurons. An example of this are neurons in the hippocampus and ventral tegmental area (VTA), which together have been suggested to form predictions about the results of our decisions. If this is the case, it would be extremely important, as problems in these processes result in an enormous variety of disorders including depression, anxiety and drug abuse. However, because these two areas are connected by very complex circuitry, it has been difficult to find out how they carry out their role. In this proposal our goal is to understand how the neurons in the hippocampus and VTA work together to make these decisions, so we can work out how they go wrong and cause disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0996-790X', 'authenticated-orcid': False, 'given': 'Karyna', 'family': 'Mishchanchuk', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:45Z', 'timestamp': 1636383225000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215165'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673244}, 'publisher': 'Wellcome', 'award': '218726', 'DOI': '10.35802/218726', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identifying the genetic determinants of Fusobacterium associated with diarrhoeal disease and colorectal cancer in Vietnam'}], 'project-description': [{'description': 'The gut microbiome and its dysbiosis play a central role in understanding infectious and non-infectious conditions. Evidence suggests Fusobacterium nucleatum, an oral anaerobic bacterial pathobiont, potentiates colonic tumourigenesis. My recent work in Vietnam indicates that Fusobacterium, including F. nucleatum, is also enriched in the gut microbiome of children during infectious diarrhoea. My aim is to define the role of Fusobacterium in the resolution of infectious diarrhoea and the development of colorectal cancer, through integrating 16S rRNA-based metagenomics in two distinct clinical studies in Vietnam. I will examine the impact of Fusobacterium gastrointestinal overgrowth and microbiome dysbiosis on diarrhoeal duration in children. Additionally, I will measure the prevalence and distribution of F. nucleatum in the microbiomes of gut mucosa taken from colorectal cancer patients. I will perform whole genome sequencing on the F. nucleatum isolated from collected saliva, diarrhoea stools, and colonic tumour mucosa. Using genomics and phylogenetic analyses, I aim to identify genetic factors associated with F. nucleatum colonization in different human body compartments (oral, colonic) and pathological states (tumour, non-tumour). These findings will enable future in-depth studies, contributing to the development of non-invasive diagnostic marker for colorectal cancer and targeted Fusobacterium therapies in these two diseases.', 'language': 'en'}, {'description': 'The bacterium Fusobacterium nucleatum commonly resides in the human mouth, but its presence in the gut could contribute to the development of colorectal cancer in adults and potentially the resolution of diarrhoea in children. Here, I will investigate whether Fusobacterium overgrowth in the gut affects the duration of childhood diarrhoea and measure the prevalence of F. nucleatum in the gut of colorectal cancer patients in Vietnam. I will study the bacterial communities in clinical samples (saliva, stool, gut tissue) by analysing the composition of a bacterial barcode gene (16S rRNA). I will grow F. nucleatum from collected samples and compare these organisms’ genetic content, to assess which F. nucleatum genes are associated with colonization in colorectal tumours and different human organs (mouth, gut). My project will define the role of Fusobacterium in these two critical diseases, and help designing effective therapies to counter Fusobacterium colonization in the human gut.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2858-2087', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Thwaites', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8938-5709', 'authenticated-orcid': False, 'given': 'Lindsay', 'family': 'Hall', 'affiliation': [{'name': 'Quadram Institute Bioscience', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5634-7220', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Slade', 'affiliation': [{'name': 'Virginia Tech', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4028-4074', 'authenticated-orcid': False, 'given': 'Hao', 'family': 'Chung', 'affiliation': [{'name': 'Oxford Clinical Research Unit - Vietnam', 'country': 'VN'}]}], 'award-amount': {'amount': 289561.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 6, 1]]}, 'award-end': {'date-parts': [[2023, 6, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 223772.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:22Z', 'timestamp': 1636383082000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218726'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673262}, 'publisher': 'Wellcome', 'award': '220562', 'DOI': '10.35802/220562', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Working memory impairment in temporal lobe epilepsy'}], 'project-description': [{'description': 'This project examines how temporal lobe epilepsy (TLE) disrupts specific memory processes, through the integrated study of behaviour, neurophysiology, and multi-modal imaging . This is important because, within the peak age group 60–90 years of developing TLE, up to 60% of individuals demonstrate objective memory dysfunction, before starting anti-seizure medication. At present, there are no specific treatment targets for this significant problem. Two factors which are associated with memory problems in TLE are higher number of seizures and co-existing cerebrovascular disease. However, it remains unknown how these two factors impact memory, whether they interact, and whether they both act by disrupting function of the hippocampus- our memory organ. I plan to: - use a novel cognitive task to assess how TLE perturbs two specific facets of memory that are known to be less efficient with ageing and Alzheimer’s disease. - establish the mechanistic contributions of electrical disruption and structural white matter abnormalities to memory impairment. These cognitive processes, if affected, could explain memory deficits caused by acute and long-term effects of seizures. Ultimately, this project may help inform clinical assessment and guide specific management of sub-clinical seizure activity and vascular risk factors, to improve memory co-morbidity and quality of life in TLE.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7333-2204', 'authenticated-orcid': False, 'given': 'Xin You', 'family': 'Tai', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 11, 6]]}, 'award-end': {'date-parts': [[2023, 2, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:32Z', 'timestamp': 1636383452000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 11, 6]]}, 'URL': 'http://dx.doi.org/10.35802/220562'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:33Z', 'timestamp': 1636454673658}, 'publisher': 'Wellcome', 'award': '211411', 'DOI': '10.35802/211411', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How Does the Interplay of PI3-kinases at the Phagosomal Membrane Co-ordinate Pathogen Killing?'}], 'project-description': [{'description': 'Animals (including humans) are protected from bacterial infection by patrolling innate immune cells. Neutrophils (the most abundant phagocytes) engulf their prey into membrane-bound phagosomes, enabling targeted, segregated and highly concentrated microbicidal activity. Phosphoinositide 3-hydroxykinase (PI3K) signalling regulates many aspects of neutrophil function and PI3K-derived phospholipid mediators accumulate at the phagosomal membrane to facilitate killing. However, the identity of the PI3K isoform(s) involved, the mode of delivery to the phagosome, and the extent to which pathogens subvert this process have not been determined. Our novel preliminary data show that the lipid messenger PIP3 (a product of PI3K activity) waxes and wanes at the phagosomal membrane, reflecting ‘quantal’ delivery from an unidentified cellular organelle, with subsequent changes in phagosomal pH. I will undertake a detailed exploration of this critical process using the genetically tractable zebrafish, which allows high resolution in vivo imaging of neutrophils in relevant infection models. I will determine the dynamics of PI3K signalling in response to a range of pathogens,quantifying PI3K-derived phospholipids at the phagosomal membrane. My results will inform our knowledge of PI3K signalling in neutrophil bactericidal activity, and may suggest how these processes might be manipulated to enhance pathogen killing.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4371-5976', 'authenticated-orcid': False, 'given': 'Clare', 'family': 'Muir', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 1, 2]]}, 'award-end': {'date-parts': [[2021, 1, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:46Z', 'timestamp': 1636383406000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 1, 2]]}, 'URL': 'http://dx.doi.org/10.35802/211411'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674110}, 'publisher': 'Wellcome', 'award': '220283', 'DOI': '10.35802/220283', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Long-term vascular health effects of cancer and its treatment'}], 'project-description': [{'description': 'There is increasing concern about the long-term vascular health of the large and growing population of cancer survivors. I recently showed that survivors of most types of cancer have increased risks of one or more cardiovascular diseases, beyond those explained by shared risk factors such as smoking. The key priorities now are to understand (i) the drivers of these increased risks, and thus how and when we can most effectively intervene; and (ii) whether broader vascular-related outcomes, in particular dementia and kidney disease, are also affected. In this fellowship I will address these two priorities by conducting analyses underpinned by cutting-edge statistical and epidemiological methods, and capitalising on rich UK and international e-Health datasets, including game-changing new cancer treatment data. I will investigate in detail the role of anti-cancer treatments (e.g. chemotherapies/radiotherapy) and changes in traditional vascular risk factors (e.g. blood pressure, BMI) in driving late cardiovascular risk. I will then investigate whether, and through what mechanisms, cancer history affects risk of vascular dementia, chronic kidney disease, and pre-clinical cognitive and renal outcomes (uniquely identifiable in the 500,000-strong UK Biobank cohort). Throughout, this research will contribute actionable evidence informing clinical/public health policies to improve the long-term outlook of cancer survivors.', 'language': 'en'}, {'description': 'I recently showed that survivors of most cancers have raised risks of heart/circulatory diseases. The key priorities now are to understand (i) why these risks are increased, so that we can work out how best to reduce and manage risk; and (ii) whether cancer survivors are also at increased risks of other circulation-related diseases. I will address these questions by applying cutting-edge statistical methods to analyse large-scale UK and international data sources, capturing detailed information on prescriptions, diagnoses, hospitalisations, and deaths. I will investigate the role of potentially cardio-toxic anti-cancer treatments, and changes in cardiovascular risk factors (e.g. blood pressure), in determining long-term cardiovascular risks. I will then explore whether, and through what mechanisms, having had cancer previously affects long-term risks of two key circulation-related diseases, kidney disease and dementia. These studies will help inform treatment and monitoring guidelines to improve the outlook of cancer survivors.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5364-8757', 'authenticated-orcid': False, 'given': 'Krishnan', 'family': 'Bhaskaran', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 1773692.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 3, 31]]}, 'award-end': {'date-parts': [[2026, 3, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1773692.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:27Z', 'timestamp': 1636383567000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 3, 31]]}, 'URL': 'http://dx.doi.org/10.35802/220283'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674118}, 'publisher': 'Wellcome', 'award': '220421', 'DOI': '10.35802/220421', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The NCEMA study: Neutrophils in Cerebral Malaria'}], 'project-description': [{'description': 'Every year half of the world’s population is at risk of getting malaria, caused by the Plasmodium parasite, and almost half a million people die; mostly children in sub-Saharan Africa. Some infected children are at a higher risk of death since malaria can damage their brains as part of a severe complication called cerebral malaria (CM). Neutrophils are one of the first lines of defence against fighting infections by damaging cells, yet their involvement during CM is not entirely understood. We hypothesise that neutrophils interact with Plasmodium affecting the blood vessels of the brain and initiate or promote the progression to CM. We aim to perform a detailed analysis of the role of neutrophils in CM, using prospectively collected blood from children with CM, archival post-mortem brain tissue, blood vessel cell cultures and a mouse model. With the exception of the mouse model our project will be based in Malawi, a country endemic for malaria. Our findings will allow us to understand if neutrophils cause damage to the brain blood vessels leading to CM. This could provide the basis of a search for novel prevention and treatment strategies that can potentially decrease the high rates of death of this disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6039-6586', 'authenticated-orcid': False, 'given': 'Charalampos', 'family': 'Attipa', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2023, 3, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:31Z', 'timestamp': 1636383271000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220421'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:34Z', 'timestamp': 1636454674364}, 'publisher': 'Wellcome', 'award': '223195', 'DOI': '10.35802/223195', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Finding treatments for COVID-19: A phase 2 multi-centre adaptive platform trial to assess antiviral pharmacodynamics in early symptomatic COVID-19 (PLAT-COV)'}], 'project-description': [{'description': 'We propose to set up and validate a pharmacometric platform to provide quantitative assessment of antiviral effects in low risk adult patients with recent onset uncomplicated COVID-19 and high viral burdens. This assessment is based on measurement of oropharyngeal viral clearance rates. This will be a randomised, open label, group sequential adaptive platform trial to quantitate the antiviral activity of currently available potential (i.e. repurposed) treatments in low-risk adult patients with early COVID-19, through adjusted qPCR of serial oropharyngeal samples. It will be a mainly outpatient study conducted in three locations; one each in the Americas, Europe and Asia. The interventions to be evaluated in this first phase are hydroxychloroquine, lopinavir/ritonavir, ivermectin, miglustat, remdesivir, intranasal heparin, with the Regeneron monoclonal antibody cocktail or Peginterferon-lambda as a \"positive control\". This will identify drugs with a >90% probability of accelerating virus clearance compared to no treatment and will reject drugs with <10% corresponding probability. Drugs identified as accelerating viral clearance will undergo a further nested pharmacometric evaluation to characterise exposure–response relationships and inform dosing. This study will provide a platform for choosing antiviral drugs for phase 3 clinical trials. Once validated the platform can be used to evaluate new antivirals.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2309-1171', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Day', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-6236-0464', 'authenticated-orcid': False, 'given': 'Walter', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5190-2395', 'authenticated-orcid': False, 'given': 'Arjen', 'family': 'Dondorp', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0001-5524-0325', 'authenticated-orcid': False, 'given': 'James', 'family': 'Watson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6328-8748', 'authenticated-orcid': False, 'given': 'William', 'family': 'Schilling', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0001-8393-8536', 'authenticated-orcid': False, 'given': 'Cintia', 'family': 'Cruz', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}, {'ORCID': 'http://orcid.org/0000-0002-3218-2166', 'authenticated-orcid': False, 'given': 'James', 'family': 'Callery', 'affiliation': [{'name': 'Mahidol Oxford Tropical Medicine Research Unit', 'country': 'TH'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1897-1978', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'White', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3728812.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2023, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 3728812.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:31Z', 'timestamp': 1636383571000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223195'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:55Z', 'timestamp': 1636454635731}, 'publisher': 'Wellcome', 'award': '056591', 'DOI': '10.35802/056591', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of alpha-synuclein in the pathogenesis of neuro- degeneration associated with Lewy bodies.'}], 'lead-investigator': [{'given': 'Damian', 'family': 'Crowther', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 206653.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 2, 4]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 206653.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:50Z', 'timestamp': 1636382810000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 2, 4]]}, 'URL': 'http://dx.doi.org/10.35802/056591'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:55Z', 'timestamp': 1636454635803}, 'publisher': 'Wellcome', 'award': '055887', 'DOI': '10.35802/055887', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular Initiative - four year PhD studentship.'}], 'lead-investigator': [{'family': 'Gordon', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 95253.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 10, 1]]}, 'award-end': {'date-parts': [[2002, 10, 31]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 95253.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:59Z', 'timestamp': 1636383179000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/055887'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:56Z', 'timestamp': 1636454636379}, 'publisher': 'Wellcome', 'award': '033734', 'DOI': '10.35802/033734', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'a study of the mechanisms of neurodegeneration in human motor neurone disease.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8925-2567', 'authenticated-orcid': False, 'given': 'Pamela', 'family': 'Shaw', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-amount': {'amount': 1430290.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1992, 5, 1]]}, 'award-end': {'date-parts': [[2002, 12, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 1430290.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:33Z', 'timestamp': 1636382973000}, 'score': 0.0, 'issued': {'date-parts': [[1992, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/033734'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637263}, 'publisher': 'Wellcome', 'award': '062362', 'DOI': '10.35802/062362', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Scientific Symposium on progress in Neuropathology to be held on 10 January 2001 at the Royal Institution, London.'}], 'lead-investigator': [{'family': 'Lantos', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3940.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 10]]}, 'award-end': {'date-parts': [[2001, 2, 9]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3940.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:21Z', 'timestamp': 1636382961000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 10]]}, 'URL': 'http://dx.doi.org/10.35802/062362'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637251}, 'publisher': 'Wellcome', 'award': '061244', 'DOI': '10.35802/061244', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'To provide support for Dr C D T Bratten for twenty seven months during vacation time between April 2000 and July 2002.'}], 'lead-investigator': [{'given': 'Clive', 'family': 'Orchard', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 13279.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 20]]}, 'award-end': {'date-parts': [[2002, 7, 19]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 13279.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:27Z', 'timestamp': 1636382787000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 20]]}, 'URL': 'http://dx.doi.org/10.35802/061244'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637269}, 'publisher': 'Wellcome', 'award': '060965', 'DOI': '10.35802/060965', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A role for TNF-alpha in triggering the development of gestational diabetes via metabolic programming of cytokine phenotype?'}], 'investigator': [{'given': 'Mark', 'family': 'Holness', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Mary', 'family': 'Sugden', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 98286.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 98286.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:33Z', 'timestamp': 1636382913000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060965'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637440}, 'publisher': 'Wellcome', 'award': '062258', 'DOI': '10.35802/062258', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of hypovolaemia in the acidosis of severe malaria in children.'}], 'investigator': [{'given': 'Kevin', 'family': 'Marsh', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-6999-5507', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Newton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2767-6919', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Levin', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'family': 'Nadel', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0007-0645', 'authenticated-orcid': False, 'given': 'Kathryn', 'family': 'Maitland', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 101309.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 8, 1]]}, 'award-end': {'date-parts': [[2003, 11, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 101309.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:28Z', 'timestamp': 1636382788000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062258'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:57Z', 'timestamp': 1636454637990}, 'publisher': 'Wellcome', 'award': '061366', 'DOI': '10.35802/061366', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Contribution towards the 5th meeting of the UK Glial Cell Club 'From stem cells to glia: molecules and mechanisms' to be held at Brunei Gallery at the School of Oriental and African Studies of London University.\"}], 'investigator': [{'given': 'Kristjan', 'family': 'Jessen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Rhona', 'family': 'Mirsky', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4460.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 3, 1]]}, 'award-end': {'date-parts': [[2000, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4460.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:14Z', 'timestamp': 1636382894000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061366'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638018}, 'publisher': 'Wellcome', 'award': '064624', 'DOI': '10.35802/064624', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'In vitro investigation of the antimicrobial and wound healing properties of Spathodia campanulata(Bignoniaceae), Secamone afezelii (Asclepiadaceae) and Commelina diffusa (Commelinaceae).'}], 'lead-investigator': [{'family': 'Mensah', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 40050.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 40050.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:53Z', 'timestamp': 1636382753000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064624'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638257}, 'publisher': 'Wellcome', 'award': '062414', 'DOI': '10.35802/062414', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Corticosteroid therapy and respiratory muscle strength in chronic obstructive pulmonary disease (COPD)'}], 'investigator': [{'given': 'John', 'family': 'Moxham', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Michael', 'family': 'Polkey', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 185391.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 185391.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:09Z', 'timestamp': 1636382889000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062414'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:58Z', 'timestamp': 1636454638409}, 'publisher': 'Wellcome', 'award': '217123', 'DOI': '10.35802/217123', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PRECISE-DYAD: linking maternal and infant health trajectories in sub-Saharan Africa'}], 'project-description': [{'description': 'PRECISE-DYAD will extend the ongoing PRECISE network study [PRECISEnetwork.org] of 6,000 pregnant women and their infants (dyads); it will provide a greater epidemiological and mechanistic understanding of health and disease pathways in the sub-Saharan African context (The Gambia and Kenya), following uncomplicated pregnancies and those complicated by pregnancy hypertension, fetal growth restriction, stillbirth, and/or preterm birth. For women, we aim to determine if, and how, these pregnancy events identify those more likely to avoid complications in subsequent pregnancies, mental ill-health, or early onset of cardiometabolic diseases. For their children, we will assess the impact of these pregnancy disorders on their physical, mental, and neurodevelopmental health to 2-3 years of age. We will explore the consequences for maternal health trajectories of caring for children with moderate-to-severe neurodevelopmental delay resulting from complicated pregnancies, and will interrogate interactions with social determinants of health, including environmental exposures on maternal and infant health. We will develop a rich database and a large sample biorepository for future studies. Thereby, PRECISE-DYAD aims to achieve an overarching understanding of the factors that contribute to optimal maternal and child health within these contexts. Ultimately, the goal is to design interventions to optimise health of mothers and their children.', 'language': 'en'}, {'description': 'PRECISE-DYAD extends the ongoing PRECISE study of pregnant women and their infants (dyads) in two sub-Saharan African countries, The Gambia and Kenya, especially after pregnancies complicated by high blood pressure, birth of a smaller-than-expected baby, stillbirth, or premature birth. For women, we want to know if these pregnancy events, or caring for children with delayed brain development due to these events, can cause similar complications in future pregnancies, influence mental health, or increase the risk of heart or breathing disease or diabetes. For their children, do these pregnancy complications change physical and mental health and brain development at two years of age? We will ask if these links are altered by social and environmental adversity, including environmental pollution. Our database and bank of biological samples will help us understand the processes behind whether women and their babies do well or poorly to help us design future preventative and treatment strategies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1650-3238', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Moore', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-5983-0426', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Barratt', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2579-9301', 'authenticated-orcid': False, 'given': 'Melissa', 'family': 'Gladstone', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1355-610X', 'authenticated-orcid': False, 'given': 'Laura', 'family': 'Magee', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4573-1443', 'authenticated-orcid': False, 'given': 'Joy', 'family': 'Lawn', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7220-4382', 'authenticated-orcid': False, 'given': 'Joel', 'family': 'Singer', 'affiliation': [{'name': 'University of British Columbia', 'country': 'CA'}]}, {'ORCID': 'http://orcid.org/0000-0002-3686-7904', 'authenticated-orcid': False, 'given': 'Amina', 'family': 'Abubakar', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4136-3070', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'von Dadelszen', 'affiliation': [{'name': \"King's College London School of Medicine\", 'country': 'GB'}]}], 'award-amount': {'amount': 4016242.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 2008121.0, 'currency': 'GBP', 'percentage': 50}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217123'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639472}, 'publisher': 'Wellcome', 'award': '219666', 'DOI': '10.35802/219666', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Human monoclonal antibodies against Shigella (ShiMabs), for therapy and vaccine acceleration'}], 'project-description': [{'description': 'The project is expected to contribute significantly to a flagship approach to Shigella and to accelerate the development of an ultimate remedy to shigellosis. This will be done by i) developing human monoclonal antibodies (mAbs) against Shigella that overcome antimicrobial resistance (AMR) and are affordable in low- and middle-income countries (LMIC); ii) establishing standard correlates of protection which will accelerate development and recommendation of antibodies and vaccines; iii) providing the bases for universal vaccines by identifying novel protective antigens common to all serotypes or common epitopes present in the lipopolysaccharide of all serotypes. We will take advantage of the recent possibility of high-throughput cloning of human B cells from convalescent or vaccinated people to find targets difficult or impossible to be discovered using conventional technologies. We will apply for the first time high-content confocal microscopy screening of human mAbs interacting with bacteria and we will use machine Learning and artificial intelligence to analyze high-quality digital images to detect antibodies that bind, intoxicate or kill bacteria. The development of effective mAbs and vaccines against AMR bacteria is one of the best approaches to fight AMR since they can reduce the overall use of antibiotics and decrease the incidence of resistant infections.', 'language': 'en'}, {'description': 'Shigella, a gram negative bacterium with more than 50 different serotypes, is a major global health problem in low-income countries where it causes more than 93 million episodes of diarrhea and 238,000 deaths, 92,700 of which are children under 5 years of age. The problem is exacerbated by the widespread antimicrobial resistance (AMR), which makes the bacterium increasingly difficult to treat. There are several vaccines in development, however they face the challenging need to cover a vast number of serotypes and the absence of correlates of protection. We propose to isolate human monoclonal antibodies (mAbs) from B cells collected from people previously exposed to Shigella, or vaccinated with experimental vaccines, with the overarching goal to provide new therapeutic solutions to Shigella infections. mAbs can overcome AMR and will be selected and engineered to have high potency and low cost to make them affordable to low- and middle-income countries. The project includes the establishment of correlates of protection that will facilitate vaccine development and licensure, and the identification of antigens common to all or to most of the serotypes to underpin the development of universal vaccines. To identify potent antibodies we will screen for their ability to bind, intoxicate or kill bacteria using a novel high-throughput microscopy platform that captures digital images as well as conventional technologies such as bactericidal, opsono-phagocytosis and FACS assays. The selected antibodies will be expressed as full-length molecules, engineered to maximize their therapeutic properties and tested for protection in assays that correlate with protection in humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8827-254X', 'authenticated-orcid': False, 'given': 'Rino', 'family': 'Rappuoli', 'affiliation': [{'name': 'Fondazione Toscana Life Sciences', 'country': 'IT'}]}], 'award-amount': {'amount': 4202058.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 8]]}, 'award-end': {'date-parts': [[2024, 2, 7]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 3532625.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:39Z', 'timestamp': 1636383519000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 8]]}, 'URL': 'http://dx.doi.org/10.35802/219666'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639954}, 'publisher': 'Wellcome', 'award': '204845', 'DOI': '10.35802/204845', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Institutional Strategic Support Fund'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9383-1054', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Lehner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 5000000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 1, 1]]}, 'award-end': {'date-parts': [[2021, 9, 29]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 5000000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:43Z', 'timestamp': 1636382983000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/204845'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:43:59Z', 'timestamp': 1636454639959}, 'publisher': 'Wellcome', 'award': '219812', 'DOI': '10.35802/219812', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Reducing antibiotic prescribing through a prioritized vaccination strategy'}], 'project-description': [{'description': 'Prioritizing vaccine development to focus on pathogens that drive the most antibiotic prescribing will have multiple advantages: reducing the burden of disease, reducing the extent of antibiotic use, and thus reducing the selective pressures driving antimicrobial resistance. In this proposal, we will (1) test the hypothesis that recent declines in outpatient antibiotic prescribing in the US are associated with reductions in pneumococcal disease attributable to PCV13 uptake and (2) estimate the antibiotic prescribing attributable to the most common pathogens and variation by age, demographic, and geography. To do so, we will use large representative nationwide datasets from the US, including insurance claims, public health surveillance, and a national immunization survey. The deliverables from this project will include estimates of the impact of PCV13 on outpatient prescribing and quantification of the expected reductions in antibiotic prescribing given vaccines for common pathogens. We expect that the results from these studies will establish (1) robust estimates of the reductions in outpatient antibiotic prescribing achieved by PCV13, as an exemplar of what vaccines can accomplish; and (2) priorities for vaccines to target in terms of impact on antibiotic prescribing and thus on antimicrobial resistance.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1504-9213', 'authenticated-orcid': False, 'given': 'Marc', 'family': 'Lipsitch', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-2223-1582', 'authenticated-orcid': False, 'given': 'Ateev', 'family': 'Mehrotra', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-4884-6609', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Barnett', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5646-1314', 'authenticated-orcid': False, 'given': 'Yonatan', 'family': 'Grad', 'affiliation': [{'name': 'Harvard University', 'country': 'US'}]}], 'award-amount': {'amount': 300517.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2022, 3, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 232238.8, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:34Z', 'timestamp': 1636383094000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219812'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641137}, 'publisher': 'Wellcome', 'award': '216363', 'DOI': '10.35802/216363', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The effects of antipsychotics on glial cells, neuroinflammation and demyelination.'}], 'project-description': [{'description': 'Schizophrenia is a severe mental disorder that affects how a person thinks, feels and behaves. It can be very disabling and reportedly one percent of the population is diagnosed with the condition worldwide. It, as well as other mental health conditions can be treated with antipsychotic medication. There are many different antipsychotics, all appear to function by changing the level of the neurotransmitter (a signalling chemical released by nerve cells) dopamine. However, their exact mechanism of action is still unknown. Other non-nerve cell types called glia play a role in schizophrenia and may be effected by antipsychotic medication. These cells serve many functions in the brain including supporting nerve cells, forming myelin (an insulating sheath around nerves) and influencing immune responses. I aim to examine the effects of antipsychotic medication on glial cells with the goal of understanding and exploring the ways these drugs may act via non-nerve cells. I will especially look to see whether these drugs influence the development of myelin and/or protect against demyelination. The overall ambition of this work is to elucidate new molecular and cellular pathways that may guide future antipsychotic drug research and development eventually benefiting patients with schizophrenia and other neuropsychiatric disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6980-4926', 'authenticated-orcid': False, 'given': 'Kapil', 'family': 'Sharma', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2018, 7, 9]]}, 'award-end': {'date-parts': [[2022, 1, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:15Z', 'timestamp': 1636383255000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 7, 9]]}, 'URL': 'http://dx.doi.org/10.35802/216363'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641697}, 'publisher': 'Wellcome', 'award': '220058', 'DOI': '10.35802/220058', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterising the regulators of trypanosome development and virulence in selected and natural parasite isolates'}], 'project-description': [{'description': 'Trypanosoma brucei, the causative agent of human and animal trypanosomiasis, has two distinct life stages. The proliferative ‘slender’ bloodstream-form morphs into a transmissible ‘stumpy’ form, which is adapted to surviving in its vector’s (Glossina spp.) midgut. The transition occurs in a density-dependent quorum sensing (QS) like process which is initiated by a ‘stumpy induction factor’ (SIF). I propose to use a wide diversity of pleomorphic (capable of morphing from slender to stumpy) field and laboratory strains of T. brucei to generate, via multiple passages, monomorphic cells (unable to become stumpy). I will create genomic, transcriptomic and epigenetic data from these cells at the beginning and end of the selection in an attempt to determine the cause of monomorphism, and therefore, the integral components of the QS process. By performing the study on diverse T. brucei cell lines, it will be possible to establish if the monomorphic phenotype can arise via convergent evolution. Alongside the genomes produced during this project, publicly available trypanosomatid genomes will be collated to identify conserved genes associated with increased virulence and monomorphism.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1428-0608', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Oldrieve', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:58Z', 'timestamp': 1636383418000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220058'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641730}, 'publisher': 'Wellcome', 'award': '218510', 'DOI': '10.35802/218510', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dynamic Molecular Cell Biology'}], 'project-description': [{'description': 'Identifying disease-associated genes, mutations and perturbed expression is only the first stage towards understanding human disease and the development of therapeutics. In Bristol we aspire to understand gene function and the proteins they encode across spatial scales, from the molecular level through to functional studies in cells, tissues and organisms. Since proteins, cells and tissues are all dynamic, wherever possible these processes need to be studied through multiple timescales. Advances in spatial and temporal resolution of microscopy provide opportunities to study processes at an unprecedented level across molecular and cellular scales. Only by combining these approaches will we truly understand organismal-level health, the pathoetiology of diseases and provide rational therapeutic routes to relieve them. This relies on biologists operating at the interface between molecular and cell biology. Our Wellcome programme will recruit, support and train a new generation of PhD students in Biomedical Research, with a broad base and understanding of molecular cell biology techniques coupled with world-class expertise in their PhD topic. These students will be trained to become future leaders in a wide range of careers, founded upon a holistic and rounded personal and professional development, which incorporates the best practice in PhD training.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-8186-5708', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'Ridley', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-3931-0503', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Collinson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2665-5086', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Martin', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 5488462.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 21]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 5488462.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:06Z', 'timestamp': 1636383246000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 21]]}, 'URL': 'http://dx.doi.org/10.35802/218510'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641749}, 'publisher': 'Wellcome', 'award': '218481', 'DOI': '10.35802/218481', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Four Year PhD Programme in Stem Cell Biology and Medicine'}], 'project-description': [{'description': 'Specialist post-graduate training in Stem Cell Biology and Medicine is essential to produce a stream of highly skilled and innovative investigators equipped with a deep understanding of stem cell science and its significance for future medicine. In this context, the Wellcome PhD Programme in Stem Cell Biology and Medicine is unique in the UK in focus and scope. The enduring popularity of the programme, which receives on average 200 applications per year, and the quality of research outputs and next destinations are testament to both the calibre of students we are able to recruit and to the high-quality training they receive. Our programme provides an environment that is intellectually rigorous and personally supportive for students, enabling them to set and attain research objectives. The programme is designed to develop analytical and critically-minded individuals. Since its inception in 2008, the PhD Programme has evolved in response to the expressed needs of students and continuous developments in modern Stem Cell Biology. Our overarching goal is to produce well-trained and rounded PhD graduates who have generated significant and original research findings and are fully prepared for an ambitious and challenging career, whether continuing in stem cell science or moving to another profession.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-0312-161X', 'authenticated-orcid': False, 'given': 'Brian', 'family': 'Huntly', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0231-3073', 'authenticated-orcid': False, 'given': 'Brian', 'family': 'Hendrich', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 6051821.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 6051821.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:05Z', 'timestamp': 1636383245000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218481'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641751}, 'publisher': 'Wellcome', 'award': '220343', 'DOI': '10.35802/220343', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A high-quality connectome of the complete adult Drosophila central nervous system'}], 'project-description': [{'description': 'Building on advances during our successful connectomics collaboration (2016-20), we now propose a very ambitious new goal: a complete, high-quality connectome for the male Drosophila central nervous system (CNS). With Wellcome support and leveraging Janelia’s unique electron microscopy imaging capability, we could turn image data into a fully analysed connectome. This would be the first CNS connectome of an animal with complex motor and cognitive behaviours. In contrast to existing fly datasets, it will be bilaterally complete, include brain and nerve cord and have intact sensory-motor connectivity. This connectome should have an enormous impact on the understanding of CNS-spanning circuitry underlying complex behaviour. We will publicly release initial draft and high-quality versions as soon as they are complete. We will immediately use it to study multisensory integration, memory recall, decision making, modification of brain states, the flexible organisation of motor behaviour, and sexually dimorphic circuits. It will provide a critical resource for >200 labs worldwide studying Drosophila neurobiology (with impacts on developmental biology and molecular cell atlases) and provide new opportunities for theoretical neuroscientists to study complete, biologically-defined neural networks in a richly investigated organism. We expect general principles, applicable to all nervous systems, including those of humans, to emerge.', 'language': 'en'}, {'description': 'Our brain and spinal cord contain a complex network of nerve cells that lets us feel, think and control our bodies. One powerful approach to understand how this works is mapping the connectome: the complete wiring diagram of connections in this network. However these connections are tiny (order 1/10,000th of a millimetre) and can only be revealed by powerful electron microscopes. Only 2 complete connectomes have ever been described, for tiny invertebrates with a few hundred nerve cells – our brain has 100 billion. Using the latest technology, we will obtain the brain and nerve cord connectome of a male Drosophila fly. This will be the first complete connectome for an animal with eyes and legs, whose nervous system shares many features with our own. We will rapidly share this with other scientists and use it to understand how nerve cells integrate sensory information, make decisions and control behaviour.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4503-6229', 'authenticated-orcid': False, 'given': 'Scott', 'family': 'Waddell', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-5142-1997', 'authenticated-orcid': False, 'given': 'Matthias', 'family': 'Landgraf', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7679-3639', 'authenticated-orcid': False, 'given': 'Gwyneth', 'family': 'Card', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}, {'given': 'Gerald', 'family': 'Rubin', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0587-9355', 'authenticated-orcid': False, 'given': 'Gregory', 'family': 'Jefferis', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 4119965.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 4119965.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:41Z', 'timestamp': 1636383101000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220343'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641754}, 'publisher': 'Wellcome', 'award': '222310', 'DOI': '10.35802/222310', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating microglial senescence in central nervous system health and disease'}], 'project-description': [{'description': 'Neurodegenerative diseases cause progressive loss of nerve cells in the brain, resulting in impaired cognition and/or movement. There are currently no treatments for these diseases and therefore, another approach to developing treatments is required. With ageing, dysfunctional or “senescent” cells accumulate in the body and are involved in various neurodegenerative diseases. Microglia are specialised immune cells in the brain responsible for keeping surrounding nerve cells healthy. Microglia can become senescent, meaning they struggle to maintain nerve cell health. We hypothesise that senescent microglia regulate neurodegeneration. However, how senescent microglia differ in ageing and neurodegenerative disease is unknown and it is unclear how senescent microglia contribute to neurodegeneration. I will explore this using immunofluorescence, whereby senescent microglia and associated neurodegeneration can be identified by staining cells with specific markers. I will also induce and prevent microglial senescence specifically, using two specially designed mouse models, and assess neurodegeneration. It is also unknown what causes microglial senescence but ageing and long-term inflammation throughout the body likely contribute. I will investigate how microglia become senescent in mouse models undergoing ageing or long-term inflammation. This work aims to improve understanding of the role of senescent microglia in neurodegeneration and provide alternative targets for treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8545-3724', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Kent', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:34Z', 'timestamp': 1636383394000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222310'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:01Z', 'timestamp': 1636454641776}, 'publisher': 'Wellcome', 'award': '222825', 'DOI': '10.35802/222825', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Study of the dark proteome in innate immunity'}], 'project-description': [{'description': 'Intrinsically disordered proteins/domains (IDPs/IDRs) are highly flexible and lack a defined secondary or tertiary structure. Their highly reactive and versatile interaction surface contains diverse small linear motifs that enable IDP/IDRs to act as key regulatory protein interaction and signalling hubs. In addition, a new set of small proteins have recently emerged by the identification of thousands of microproteins or smORF-encoded peptides (sPEPs) from which a few validated sPEPs play crucial regulatory roles via protein-protein interactions and add a new regulatory dimension to multiple cellular processes. Due to the size of sPEPs and high flexibility of IDPs, conventional tagging, biochemical and cell biological approaches are not suitable for the study of these type of proteins. I will overcome this by implementing a pipeline to achieve the orthogonal site-specific incorporation of minimally invasive non-canonical amino acids in IDPs and sPEPs. With this approach I aim to study the protein-protein interaction networks, localization and function of IDPs and sPEPs involved in innate immune processes such as the antiviral response or neutrophil defense mechanisms against pathogen invasion.', 'language': 'en'}, {'description': 'The innate immune system is comprised of different cell types which contain diverse evolutionary adapted protein-protein interaction networks that sense and trigger tailored responses to identified threats. These processes require a tight regulation in order to achieve an adequate immune defence and avoid immune-mediated pathology due to an uncontrolled immune response. Intrinsically disordered proteins/regions (IDP/IDRs) are highly dynamic flexible proteins that lack a defined structure and have been shown to be key signalling and protein interaction hubs due to their large interaction surface enriched in small linear binding motifs. Multiple proteins involved in the innate immune response contain IDRs of variable lengths. However, very little is known of their functional role and their interactome. I plan to use state-of-the-art chemical biology, biochemical and cell biological approaches to understand the functional relevance of IDPs in innate immunity which could lead to the finding of new therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2363-4770', 'authenticated-orcid': False, 'given': 'Iker', 'family': 'Valle Aramburu', 'affiliation': [{'name': 'The Francis Crick Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:11Z', 'timestamp': 1636383551000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222825'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:03Z', 'timestamp': 1636454643415}, 'publisher': 'Wellcome', 'award': '061839', 'DOI': '10.35802/061839', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Effect of early treatment of permanent childhood hearing impairment on outcome at 5 to 8 years.'}], 'investigator': [{'given': 'Stavros', 'family': 'Petrou', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Campbell', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'James', 'family': 'Stevenson', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Colin', 'family': 'Kennedy', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}], 'award-amount': {'amount': 371251.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 371251.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:31Z', 'timestamp': 1636382791000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061839'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:04Z', 'timestamp': 1636454644459}, 'publisher': 'Wellcome', 'award': '220776', 'DOI': '10.35802/220776', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanism of cell-to-cell transmission of flaviviruses'}], 'project-description': [{'description': 'This proposal will investigate the mechanism of cell-to-cell transmission and spread of flaviviruses using Dengue and Zika as model systems. We will therefore address a longstanding debate on how they exit from infected cells, and preferentially spread into specific cell types. Dengue and Zika are the two most prevalent flaviviruses worldwide, sharing significant overlap in their genome architecture and biology. Dengue infects >50 million people annually, causing severe pathologies. Zika too has emerged as a global threat with recent outbreaks linked to serious neuro-developmental complications in children and Guillain Barré syndrome in adults. No vaccines or therapeutics exist for these viruses, and our current understanding on mechanisms of their transmission and spread is severely limited. Viral infections spread by overcoming multiple barriers to move from cell to cell. Viral progenies can move across extracellular space either as free particles via fluid phase diffusion, within vesicles, or by cell-cell contacts. To understand transmission, we will therefore address: (i) characteristics of the extracellular virus populations, (ii) whether multiple transmission routes exist (iii) whether the viral envelope is the primary determinant of transmissibility. This proposal builds on our previously published and ongoing studies on viral manipulation of autophagy for assembly and spread.', 'language': 'en'}, {'description': 'In this study we will determine how flaviviruses, in particular Dengue and Zika, which share significant similarities are transmitted between cells and spread into specific tissues. Dengue and Zika viruses have huge health implications - Dengue alone infects >50 million people worldwide annually; Zika is a closely related emerging virus that causes severe neurological damage in new-borns and adults. How they spread into specific organs in infected individuals is not understood. Our proposal aims to address this gap in knowledge. We will determine exactly how virus progeny particles are released from infected cells and transported into neighbouring recipient cells. We will identify the host genes that are involved in this process. We will also address which viral protein determines virus transmissibility. The mechanism of transmission of virus particles dictates spread, tissue tropism and pathogenesis. We will therefore add critical information on how to target this process and block disease progression.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6230-5366', 'authenticated-orcid': False, 'given': 'Sumana', 'family': 'Sanyal', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1567546.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2025, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1567546.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:53Z', 'timestamp': 1636383113000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220776'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:04Z', 'timestamp': 1636454644498}, 'publisher': 'Wellcome', 'award': '220008', 'DOI': '10.35802/220008', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Use of 'Axon-like' Nanofibers to quantify Glioblastoma cells migration\"}], 'project-description': [{'description': 'Background: Out of all brain tumours types in adults, Glioblastoma Multiforme (GBM) is the most common and aggressive. Migrating GBM cells infiltrate brain tissue by spreading along nerves and render therapeutical intervention and surgery problematic. Novel approaches are desperately needed to target these cells and that’s our focus. Approach: My project aims to mirror the internal conditions that a cancer cell ‘experiences’ in the human brain with artificial nerve-like substrates. We will first measure the capacity of GBM cells to migrate on human nerve fibres. Then we will investigate the relevant biological signals needed for GBM cells migration. Finally, we will mirror these signals with proteins and coat plastic material in the form of fibres acting as ‘fake-nerve’ tracks for cell migration. Impact: This artificial material will enable us to study how GBM cells differ from healthy cells and from patients to patients. This will be used for future screens to identify novel therapeutics by slowing down the migration of the GBM cells. Moreover, combined with existing catheters in clinical use, the fibres will form the basis for novel medical devices. They could act as a ‘decoy nerve trap’ to extract the infiltrating cancer cells for diagnostics and for therapies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0422-7371', 'authenticated-orcid': False, 'given': 'Victoria', 'family': 'Tsang', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:48Z', 'timestamp': 1636383408000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220008'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:38Z', 'timestamp': 1636454678186}, 'publisher': 'Wellcome', 'award': '220011', 'DOI': '10.35802/220011', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Functional Characterization of Jagged1 (Jag1) Expressing Skin-resident Regulatory T Cells (Tregs) in Epithelial Stem Cell Homeostasis'}], 'project-description': [{'description': 'Regulatory T-cells (Tregs) are famous for their immunosuppressive functions and induce tolerance. Only recently, we come to realise they can also function as stem cells regulators, and maintain tissue homeostasis1. Recently, our lab has demonstrated that skin Tregs are functionally required for hair regeneration, by regulating hair follicle stem cells (HFSCs) activity via Notch ligand Jagged1 (Jag1)3, irrespective of their well-known immunosuppressive role. Yet, the functional mechanisms of this skin Treg subset (Jag1+Tregs) remain laregely unknown. We seek to understand if Jag1+Tregs directly regulate HFSCs, via Jag1-induced Notch signalling. Since Notch signalling requires direct cell-cell contact, we first ask if Jag1 regulates skin Tregs physical proximity to Notch receptor-expressing cells (such as HFSCs) using immunofluorescence staining. By comparing the transcriptome profiles of Tregs and HFSCs from wildtype control against those from Jag1 conditional knockout model, we determine how Jag1+Tregs self-regulate and HFSCs function. Finally, using a combination of immunofluorescence staining and murine knockout models, we will define tissue-resident cells induce and maintain Jag1 expression in skin Tregs. This project will advance our understanding of how Jag1 facilitates immune-stem cells crosstal,k and subsequently regulates murine hair regeneration. It may reveal if skin-resident Tregs can be used as therapeutic targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2562-5261', 'authenticated-orcid': False, 'given': 'Prudence', 'family': 'Lui', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:35Z', 'timestamp': 1636383335000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220011'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:40Z', 'timestamp': 1636454680055}, 'publisher': 'Wellcome', 'award': '222955', 'DOI': '10.35802/222955', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The genetic epidemiology of lung scarring'}], 'project-description': [{'description': 'Idiopathic Lung Fibrosis (IPF) is a disease which leads to death three years after diagnosis in half of cases. IPF is a complex genetic disease - variants of DNA that contribute to disease risk have been identified, though we have yet to fully understand how these risk factors lead to lung scarring. A Genome-Wide Association Study (GWAS) can be used to determine which regions of DNA are associated with disease. GWAS can be used to look at individual variant sites in the DNA called Single Nucleotide Polymorphisms (SNPs). By comparing the entire DNAs (Genomes) of people with and without IPF, we can narrow down the suspected sequences that may contribute to the development of the disease to very fine resolution. Once SNPs associated with IPF are identified, we then need to understand why they are associated. Determining which SNP leads to IPF requires 1) Linking SNPs to genes, 2) finding biochemical pathways associated with these genes, and 3) finding drugs that can be used to target the biochemical pathways. These steps enable us to understand the pathology of IPF and could lead to the identification of potential drug treatments for this currently incurable disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7349-895X', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Chin', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:47Z', 'timestamp': 1636383407000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222955'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:46Z', 'timestamp': 1636454686695}, 'publisher': 'Wellcome', 'award': '222911', 'DOI': '10.35802/222911', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Building positive self-concept in patients with psychosis: an interventionist-causal test.'}], 'project-description': [{'description': 'Building positive self-concept in patients with psychosis Background to the research problem Our self-concept is how we perceive ourselves. Lacking a positive self-concept is a putative contributory causal factor in mental health problems, including psychotic symptoms. Patients recognise its importance for recovery. Yet treatment is lacking. Our approach Our aim is to develop treatments that successfully target the key factors that underlie mental health problems. In this work, we will develop and test a treatment to build positive self-concept and hence reduce psychotic symptoms and improve wellbeing. We will work with people with lived experience of psychosis to develop a brief, manualised intervention. Drawing on psychological theory the treatment will 1) identify positive cognitions and generate evidence through in-vivo learning and meaningful activity; 2) strengthen cognitions via imagery; and, 3) shift attentional focus through savouring. We will use an adaptive-design to test which techniques are most effective. The 8-session intervention will be tested in a randomised trial with 80 patients. The comparator will be usual-care. Assessments will be conducted at baseline, mid-treatment, post-treatment, and follow-up. Expected impact of our work We will produce an effective treatment to increase positive self-concept. The intervention may be of benefit across mental health problems.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2749-1386', 'authenticated-orcid': False, 'given': 'Felicity', 'family': 'Waite', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:39Z', 'timestamp': 1636383399000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222911'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:48Z', 'timestamp': 1636454688969}, 'publisher': 'Wellcome', 'award': '048376', 'DOI': '10.35802/048376', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'characterisation of the polycystic disease 1 (PKD1) protien, polycys tin, and indentification of its ligands.'}], 'lead-investigator': [{'family': 'Ward', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 353997.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1996, 10, 1]]}, 'award-end': {'date-parts': [[2001, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 353997.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:40Z', 'timestamp': 1636383040000}, 'score': 0.0, 'issued': {'date-parts': [[1996, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048376'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:49Z', 'timestamp': 1636454689008}, 'publisher': 'Wellcome', 'award': '053347', 'DOI': '10.35802/053347', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of placenta growth factor (PIGF) in retinal neovascularisation.'}], 'lead-investigator': [{'given': 'Asif', 'family': 'Ahmed', 'affiliation': [{'name': 'Aston University', 'country': 'GB'}]}, {'given': 'Michael', 'family': 'Boulton', 'affiliation': [{'name': 'University Of Florida', 'country': 'US'}]}], 'award-amount': {'amount': 196231.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 8, 16]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 196231.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:50Z', 'timestamp': 1636382750000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 8, 16]]}, 'URL': 'http://dx.doi.org/10.35802/053347'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:48Z', 'timestamp': 1636454688993}, 'publisher': 'Wellcome', 'award': '052149', 'DOI': '10.35802/052149', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms of endosome to Golgi retrieval.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9916-3245', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Seaman', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 350273.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 4, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 350273.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:04Z', 'timestamp': 1636382944000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/052149'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696325}, 'publisher': 'Wellcome', 'award': '060678', 'DOI': '10.35802/060678', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Plasmodium falciparum infected erythrocyte surafce antigens: characterisation of epitopes displayed by parasites causing severe malaria.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7674-6752', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Bull', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 218022.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 9, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 218022.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:38Z', 'timestamp': 1636382978000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060678'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696324}, 'publisher': 'Wellcome', 'award': '048066', 'DOI': '10.35802/048066', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'functional studies on human patients with visual dysfunction of corticol and retinal origin.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6754-5545', 'authenticated-orcid': False, 'given': 'Antony', 'family': 'Morland', 'affiliation': [{'name': 'University of York', 'country': 'GB'}]}], 'award-amount': {'amount': 306509.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 1, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 306509.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:45Z', 'timestamp': 1636382745000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/048066'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:56Z', 'timestamp': 1636454696378}, 'publisher': 'Wellcome', 'award': '063717', 'DOI': '10.35802/063717', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of antiviral natural killer cells in atopic asthma.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7220-2555', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Openshaw', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3009-9200', 'authenticated-orcid': False, 'given': 'Sebastian', 'family': 'Johnston', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'family': 'Stanciu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 35504.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 35504.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:25Z', 'timestamp': 1636382905000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063717'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:59Z', 'timestamp': 1636454699687}, 'publisher': 'Wellcome', 'award': '063859', 'DOI': '10.35802/063859', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intracellular mechanisms underlying the interactions between nerve cells and eosinophils.'}], 'lead-investigator': [{'given': 'Richard', 'family': 'Costello', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}, {'family': 'Mclean', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 178927.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2003, 9, 26]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 178927.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:55Z', 'timestamp': 1636382995000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063859'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:44:59Z', 'timestamp': 1636454699678}, 'publisher': 'Wellcome', 'award': '066619', 'DOI': '10.35802/066619', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Study of clinical and molecular genetic pathogenesis of hypertrophic cardiomyopathy.'}], 'lead-investigator': [{'given': 'Edward', 'family': 'Blair', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 76185.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 15]]}, 'award-end': {'date-parts': [[2003, 10, 14]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 76185.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:19Z', 'timestamp': 1636382779000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 15]]}, 'URL': 'http://dx.doi.org/10.35802/066619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:00Z', 'timestamp': 1636454700341}, 'publisher': 'Wellcome', 'award': '066995', 'DOI': '10.35802/066995', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The function of the GTPase Rac-1 in pre-T cells.'}], 'lead-investigator': [{'family': 'Lightfoot', 'affiliation': [{'name': 'Cancer Research UK', 'country': 'GB'}]}], 'award-amount': {'amount': 110666.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 6, 1]]}, 'award-end': {'date-parts': [[2004, 6, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 110666.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:22Z', 'timestamp': 1636382902000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066995'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:02Z', 'timestamp': 1636454702312}, 'publisher': 'Wellcome', 'award': '067727', 'DOI': '10.35802/067727', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Chimeraplast-medicated gene targeting in mouse embryos.'}], 'investigator': [{'given': 'James', 'family': 'Owen', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Jonathan', 'family': 'Simons', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 125000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 9, 16]]}, 'award-end': {'date-parts': [[2004, 9, 15]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 125000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:50Z', 'timestamp': 1636382870000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 9, 16]]}, 'URL': 'http://dx.doi.org/10.35802/067727'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:03Z', 'timestamp': 1636454703633}, 'publisher': 'Wellcome', 'award': '206598', 'DOI': '10.35802/206598', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A cell culture model to find drugs that may be useful to treat dementia.'}], 'project-description': [{'description': 'I am an undergraduate Neuroscience Msci student studying at the University of Bristol. I am undergoing an industrial trainee year, with Alzheimer’s Research UK University College London drug discovery institute (AR-UK UCL DDI), as part of my course. The AR-UK UCL DDI is a newly established unit in UCL, with core funding from Alzheimer’s Research UK. Its goal is to discover new approaches and therapies for dementia, a core symptom of a number of important diseases (“neurodegenerative diseases” of the brain such as Alzheimer’s disease). With the increasing aging population these neurodegenerative diseases are becoming a huge individual, societal and economic problem. The AR-UK UCL DDI currently has 12 scientists and will increase to about 24, and is equipped to enable the scientific experiments and studies to be performed.My industrial trainee year with the AR-UK UCL DDI will allow me to experience neuroscience in the research setting with an opportunity to use techniques commonly used in the field. The placement will provide a very practical learning in a professional environment, challenging me both personally and academically. It will also expose me to the process of working towards developing new therapies. I will be able to develop my interpersonal skills alongside vital experience working in lab with experienced colleagues. I will take the confidence and skills built during the placement into my final year and in my future studies and career as I hope to do a PhD after my undergraduate course.Project details: Neurons are key cells of the brain. Synapses are the key points that neurons communicate to each other, and are thought to be the basis of learning and memory. In neurodegeneration the neurons and the synapses decrease in number and ability to function, leading to progressive memory loss, dementia and eventually, death. Therefore ways of protecting the neurons and synapses, and maintaining their function, could be useful therapeutic approaches. The project will involve growing neurons in a cell culture dish; it is possible to do this by obtaining the neurons from mouse brains. The neurons are able to form synapses in the culture dish, which mimic the synapses that would be naturally formed in the mouse brain. I will use these cultured neurons to develop ways of measuring the number of synapses. It will be possible to measure the number of synapses by using fluorescently tagged antibodies that bind specifically to neuronal proteins that localise to synapses, and then use microscopy to count the number of those synapses. Once I have set up this system, I will be able to add various small molecules (compounds) and drugs and identify any that are able to increase the number of the synapses. Such small molecules or drugs could be the starting point for developing new therapies for dementia.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4121-1379', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Whiting', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 7000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 3, 1]]}, 'award-end': {'date-parts': [[2017, 8, 1]]}, 'funding': [{'type': 'award', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 7000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:32Z', 'timestamp': 1636382972000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/206598'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:04Z', 'timestamp': 1636454704921}, 'publisher': 'Wellcome', 'award': '218462', 'DOI': '10.35802/218462', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Wellcome Trust Doctoral Training Centre in Public Health, Economics and Decision Science (PHEDS): Assessing the effectiveness and cost-effectiveness of policies and prevention strategies that reduce noncommunicable disease burden and health inequity'}], 'project-description': [{'description': 'With ever scarcer resources for public health policies and programmes, high-quality scientific evidence on the cost-effectiveness and long-term benefits of alternative public health intervention options will become increasingly important for future decision-making. To our knowledge, PHEDS is one of just a handful of Doctoral Training Centres dedicated to Public Health Economics and Decision Science in the world. Wellcome Trust investment will allow us to grow, focus and strengthen ScHARR’s doctoral training in this area, broadening its scientific remit from health behaviours to also include research into the cost-effectiveness of policy options that address the social determinants of health (e.g. economic conditions, housing, employment) to reduce NCD and tackle health inequalities. Through the synergy of several cohorts of PhD researchers conducting cutting-edge research into these challenges at the same time with expert supervision, the programme aims to substantially increase the momentum of scientific discovery. Equipped with 4 years of experience in interdisciplinary collaborative working environments and with strong analytic skills, our graduates will be excellently placed to forge influential careers as leaders in academia and governmental and non-governmental organisations promoting evidence-based decisions about resource allocation in public health and tackling disease burden in the UK and beyond.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1486-8233', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Strong', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3691-1888', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Goyder', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1025-312X', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Brennan', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8467-0471', 'authenticated-orcid': False, 'given': 'Tracey', 'family': 'Bradburn', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'given': 'Penny', 'family': 'Breeze', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-8024-7801', 'authenticated-orcid': False, 'given': 'Tessa', 'family': 'Peagood', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9283-2151', 'authenticated-orcid': False, 'given': 'John', 'family': 'Holmes', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-amount': {'amount': 5249785.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2028, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 5249785.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:04Z', 'timestamp': 1636383244000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218462'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:07Z', 'timestamp': 1636454707623}, 'publisher': 'Wellcome', 'award': '220071', 'DOI': '10.35802/220071', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The use of machine learning techniques to assess the quality of mammalian pre-implantation embryos'}], 'project-description': [{'description': 'The popularity of in vitro fertilisation (IVF) is growing with techniques improving over the last few decades. Nevertheless, current success rates remain low, which is partly due to difficulty in selecting the best embryos to be used, as we lack a comprehensive understanding of the visual attributes of a healthy embryo. The aim of this PhD is to develop techniques that will improve the chances of selecting a healthy embryo after IVF procedures, based on a video of the first 5 days of its life. We plan to achieve this using machine learning, an artificial intelligence approach that allows computers to learn from available data. We will follow two approaches; 1) attempt to predict the quality of a human embryo using videos provided by an IVF clinic, and 2) create mouse embryos with abnormalities in genetic material, record their development and develop an algorithm capable of identifying the reasons behind developmental failure from image / video data. If we can correctly predict the viability of an embryo and genetic issues impacting on this, it will pave the way for the development of improved detection and diagnosis systems to support human IVF treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0600-4526', 'authenticated-orcid': False, 'given': 'Camilla', 'family': 'Mapstone', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:20Z', 'timestamp': 1636383440000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220071'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:09Z', 'timestamp': 1636454709610}, 'publisher': 'Wellcome', 'award': '220260', 'DOI': '10.35802/220260', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Towards a thorough mechanistic understanding of endosomal cargo sorting.'}], 'project-description': [{'description': 'An intracellular nexus for regulating the membrane trafficking of many of the 5,000+ integral proteins encoded by the human genome is the endosomal network. Composed of vesicular and tubular early and late endosomes, the network’s principal role is to sort integral proteins (termed ‘cargoes’) arriving from the cell surface and the biosynthetic pathway between two fates: either sorting to the lysosome for degradation, or retrieval from this fate for export to the cell surface, the biosynthetic pathway or other specialised organelles. Whilst the molecular details of degradative cargo sorting have been well documented, those events that conduct cargo retrieval and export remain poorly understood. Our research has sought to fill this fundamental void in metazoan cell biology. A master conductor of endosomal retrieval and export is the retromer pathway - in human cells this orchestrates the sorting of >900 cargoes. Establishing how this pathway functions is central to understanding the evolution, organisation and activity of endosomal sorting. With Wellcome support we will address two integrated questions: - The fundamental question of how the retromer pathway is organised and integrated with other pathways to orchestrate global endosomal cargo sorting. - How understanding of retromer pathway function may provide vital insight into neurodegenerative diseases.', 'language': 'en'}, {'description': \"For over ten years my laboratory has been identifying the mechanistic basis by which proteins and lipids are sorted through a specific aspect of the human cell's intracellular membraneous maze, the endosomal network. We have studied a number of ancient, highly conserved protein complexes that act as molecular machines to orchestrate protein and lipid transport through this network. One of these is the retromer complex. Our research, and that of others, is defining retromer function and is revealing its importance in a variety of cellular processes that are vital for normal cell function. Furthermore, it has become apparent that defects in retromer underlie a variety of human diseases including age-related neurodegenerative diseases such as Parkinson disease and Alzheimer disease. With Wellcome funding we will address new fundamental questions arising from this research, thereby providing greater fundamental insight into retromer's many roles in normal physiology and its deregulation in pathophysiology.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9070-8349', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Cullen', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1914685.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2025, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1914685.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:39Z', 'timestamp': 1636383099000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220260'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:14Z', 'timestamp': 1636454714232}, 'publisher': 'Wellcome', 'award': '220514', 'DOI': '10.35802/220514', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Proof-of-Concept for α5-GABAAR PAMs in the treatment of psychosis'}], 'project-description': [{'description': 'This project aims to validate the hypothesis that a small molecule that is a positive allosteric modulator (PAM) of α5-subunit-containing GABAARs (α5-GABAARs) can attenuate striatal dopaminergic hyperfunction in the methylazoxymethanol (MAM) rat model of schizophrenia. If successful, this project will then form the platform to secure additional funding for the further preclinical drug discovery and development activities required to identify a first-in-human-ready drug. At that point, we will seek the additional funding (either by partnering with a pharma company or securing VC investment to form a spin-out company) required for the clinical development of a novel, first-in-class antipsychotic with a mechanism that is clearly differentiated from existing dopamine D2 receptor antagonist-based antipsychotics. Such a drug is expected to deliver patient benefit for those individuals with psychoses in whom existing antipsychotics are either poorly tolerated and/or have significant side effects or have limited efficacy.', 'language': 'en'}, {'description': 'Recent evidence suggests that a part of the brain called the hippocampus is responsible for the increase in dopamine in a different part of the brain, the striatum, known to cause psychosis. Our hypothesis is that by attenuating activity within the hippocampus, we will then be able to reduce the increase in dopamine associated with psychosis. In order to do this, we plan to target the GABA chemical signalling pathway which inhibitis nerve cell excitability. More specifically, we aim to increase the inhibitory actions of the so-called α5-GABAAR protein, which is highly expressed within the hippocampus and is therefore ideally placed to control overall hippocampal activity. In this proposal, we will identify molecules that selectively enhance the function of GABA at α5-GABAARs and then test representative compounds in an animal model of schizophrenia to see if they do indeed attenuate increased dopamine activity.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-4204-3602', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Lambert', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8745-8377', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Ward', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1067-1230', 'authenticated-orcid': False, 'given': 'Olivera', 'family': 'Grubisha', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3410-791X', 'authenticated-orcid': False, 'given': 'John', 'family': 'Atack', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 500971.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 500971.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:47Z', 'timestamp': 1636383107000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220514'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T10:45:15Z', 'timestamp': 1636454715236}, 'publisher': 'Wellcome', 'award': '222546', 'DOI': '10.35802/222546', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Unravelling the whipworm niche at the host intestinal epithelia'}], 'project-description': [{'description': 'Whipworms infect hundreds of millions of people causing trichuriasis, a major neglected disease. Whipworms are large metazoan parasites that inhabit a multi-intracellular niche within their host caecal epithelia, where they manipulate mucosal physiology and inflammation through interactions with the intestinal epithelial cells and stem cell niche. These interactions enable chronic infections where whipworms are tolerated for years; but at a mechanistic level, how they operate is not understood. My research aims to define these interactions and bring a mechanistic understanding to how they underpin whipworm invasion, colonisation and persistence in their mucosal niche. This work will build upon a novel model I developed using caecal organoids (termed caecaloids), the first to reproduce whipworm infections in vitro, to address two fundamental aims. First, to determine how whipworms invade and colonise intestinal epithelia using imaging and transcriptomic analyses of infected caecaloids. Second, to define how whipworms impact stem cell niche remodelling to promote their persistence using microscopy, FACS and transcriptomics of infected caecaloids and chronically-infected mice. This research will transform our understanding of the whipworm mucosal niche potentially yielding new targets for anti-parasitic therapies, and provide novel insights into how the intestinal epithelia repairs damage with relevant application toward intestinal inflammatory diseases.', 'language': 'en'}, {'description': 'Whipworms are parasites that live inside the gut lining of 500 million people worldwide causing the disease Trichuriasis. Whipworms remain in their host for years by interacting with the gut lining and surrounding cells to manipulate gut structure and immune responses. How the parasite mediates these interactions is not understood. I aim to determine how whipworms invade, colonise and persist in the gut. Using a new model I developed based on “mini-guts”, the first to mimic whipworm infections in a lab dish, together with microscopy and sequencing, I will characterise: 1) the molecular and cellular changes that happen in the whipworm and the gut lining and surrounding cells when the parasite enters and colonises the gut and; 2) the interactions that allow the parasite to persist and the gut lining to repair during chronic infections. This knowledge will open new avenues to eradicate whipworm infections and control gut inflammatory diseases.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9581-0377', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Berriman', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0567-0412', 'authenticated-orcid': False, 'given': 'Maria', 'family': 'Duque Correa', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 1176163.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 1, 10]]}, 'award-end': {'date-parts': [[2027, 1, 9]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 1176163.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:41Z', 'timestamp': 1636383521000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 1, 10]]}, 'URL': 'http://dx.doi.org/10.35802/222546'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:05Z', 'timestamp': 1636460045486}, 'publisher': 'Wellcome', 'award': '035783', 'DOI': '10.35802/035783', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'For a study of the molecular basis of Salmonella virulence.'}], 'lead-investigator': [{'given': 'Gordon', 'family': 'Dougan', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1643264.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1992, 9, 1]]}, 'award-end': {'date-parts': [[2002, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1643264.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:23Z', 'timestamp': 1636382843000}, 'score': 0.0, 'issued': {'date-parts': [[1992, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/035783'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:07Z', 'timestamp': 1636460047571}, 'publisher': 'Wellcome', 'award': '051008', 'DOI': '10.35802/051008', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of WNT factors in developing neurons.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5748-083X', 'authenticated-orcid': False, 'given': 'Patricia', 'family': 'Salinas', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 241262.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2002, 3, 14]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 241262.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:30Z', 'timestamp': 1636382970000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/051008'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:09Z', 'timestamp': 1636460049452}, 'publisher': 'Wellcome', 'award': '220887', 'DOI': '10.35802/220887', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rhomboid-like proteins: from molecular principles to pathophysiological significance'}], 'project-description': [{'description': 'The goal of this proposal is to transform our understanding of both the molecular mechanisms and the pathophysiological roles of members of the rhomboid-like superfamily. At the mechanistic level, our long-term research into this group of polytopic membrane proteins has led us to the hypothesis that the core function of the rhomboid-like domain is specific TMD recognition of substrates (of the rhomboid intramembrane serine proteases) and clients (of the non-protease members of the clan). Using a structural and biochemical approach, we seek to understand the molecular details of how this specific recognition is achieved. Biologically, rhomboid-like proteins have many functions, but we still have little understanding of their role in mammals, particularly of the rhomboid proteases. Building on our mechanistic aims, we plan to break this log-jam by pioneering systematic methods of substrate identification. We already know that iRhoms, catalytically inactive homologues of rhomboids, regulate inflammation, growth factor signalling and, as we have recently discovered, tumour growth. We plan to further elucidate these roles, both at the level of fundamental cell biology but also with a goal to reveal their potential medical significance. By the end of this work we expect to know which rhomboid-like proteins are useful therapeutic targets.', 'language': 'en'}, {'description': 'Cells are the fundamental unit which form all organisms. They are responsible for how animals work, and their malfunction underlies almost all human disease. Our overall goal is to understand the molecular details of how cells communicate with each other, and how this signalling controls their behaviour. We focus on the rhomboid-like family of proteins, which we discovered. Our discovery was important because these proteins are present in all organisms. Since then we have researched how they work and their biological role in cell communication – both as a basic biological problem but also because there is good evidence that they are relevant to a wide range of human diseases. In this proposal we aim to answer questions about both their fundamental biology and their medical relevance, with a particular goal of transforming our understanding of rhomboid-like proteins in mammals, including humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0410-5451', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Freeman', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2276736.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2025, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 2276736.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:57Z', 'timestamp': 1636383117000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220887'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:15Z', 'timestamp': 1636460055056}, 'publisher': 'Wellcome', 'award': '213542', 'DOI': '10.35802/213542', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Advancing Implementation of Market Incentives for Antimicrobials'}], 'project-description': [{'description': 'To help facilitate progress on a path to implementation and global coordination of promising market entry rewards, such as the PAVE Award, or other incentive models, Duke-Margolis proposes to advance the conversations and develop implementation approaches. This project has three primary goals: 1) to develop and refine technical details for incentive models, such as the PAVE Award, needed for implementation in the United States (US) market, 2) to identify broader options to support the sustainability of such reward models, and 3) to support development of principles and approaches for global coordination.', 'language': 'en'}], 'lead-investigator': [{'given': 'Gregory', 'family': 'Daniel', 'affiliation': [{'name': 'Duke University', 'country': 'US'}]}], 'award-amount': {'amount': 302591.94, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 8, 1]]}, 'award-end': {'date-parts': [[2020, 2, 1]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 302591.94, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:31Z', 'timestamp': 1636382851000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213542'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058410}, 'publisher': 'Wellcome', 'award': '060263', 'DOI': '10.35802/060263', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Adaptive control in the respiratory system: implications for understanding long-term regulation of basal ventilation and the sensitivity of the chemoreflexes.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Robbins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 498964.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 498964.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:41Z', 'timestamp': 1636382981000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060263'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058419}, 'publisher': 'Wellcome', 'award': '060686', 'DOI': '10.35802/060686', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms of Pelizaeus-Merzbacher disease caused by dosage effects of the PLP gene.'}], 'lead-investigator': [{'given': 'Peter', 'family': 'Scambler', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 166747.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 7]]}, 'award-end': {'date-parts': [[2004, 10, 6]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 166747.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:31Z', 'timestamp': 1636382971000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 7]]}, 'URL': 'http://dx.doi.org/10.35802/060686'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058433}, 'publisher': 'Wellcome', 'award': '060492', 'DOI': '10.35802/060492', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Sequencing the genome of the human gastrointestinal pathogen Yersinia enterocloitica 8081 (serotype 0:8 biotype IB).'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-1117-2388', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Prentice', 'affiliation': [{'name': 'University College Cork', 'country': 'IE'}]}], 'lead-investigator': [{'given': 'Barclay', 'family': 'Barrell', 'affiliation': [{'name': 'Wellcome Trust Sanger Institute', 'country': 'GB'}]}], 'award-amount': {'amount': 393752.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 393752.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:00Z', 'timestamp': 1636382760000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060492'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058447}, 'publisher': 'Wellcome', 'award': '060551', 'DOI': '10.35802/060551', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Signal transduction mechanisms in the regulation of cyclooxygenase-2 expression in human myometrium.'}], 'investigator': [{'given': 'Giovanni', 'family': 'Mann', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Phillip', 'family': 'Bennett', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Simon', 'family': 'Bartlett', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 174090.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 174090.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:27Z', 'timestamp': 1636382847000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060551'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058767}, 'publisher': 'Wellcome', 'award': '071922', 'DOI': '10.35802/071922', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Towards revealling new metabolic pathways involved in neuronal maintenance: a Drosophila model for infantile onset.'}], 'project-description': [{'description': 'Many hereditary human neurological disorders result from progressive degeneration of specific neuronal subpopulations. Identifying single gene and thereafter protein defects in them forms the basis for modelling the disease mechanisms in experimental organisms, in turn providing clues of molecular backgrounds leading to pathogenic states. Studying the consequences of disease-causing mutations in molecular, cellular and tissue levels in animal models thus improves our basic understanding on the function of the nervous system and on the pathogenesis of the disorders in question, and finally is expected to reveal new therapeutic targets. The major aim of this research work is to identify molecular and cellular mechanisms involved in neuronal development and maintenance, by studying a gene defective in a severe recessive human neurodegenerative disease, infantile onset spinocerebellar ataxia (IOSCA; MIM 271245). Recently , we have cloned the human gene mutated in IOSCA, based on its location in the human genome. The human IOSCA gene codes for a protein with a putative role in the mitochondrial function. It has been highly conserved during evolution, reflecting the fact that the gene and the protein it encodes play an important role in the maintenance of specific neuronal cells. For revealing the basic cellular roles of the gene and the protein it encodes, and the functional consequences of the major IOSCA mutation, the gene function should now be modelled in the fruit fly Drosophila melanogaster, currently an organism of choice in neuronal research. The fly being a multicellular organism with the genome thoroughly sequenced, the knowledge obtained from fly models is easily applied for studying the gene and protein in higher organisms also.', 'language': 'en'}], 'lead-investigator': [{'given': 'Anna-Kaisu', 'family': 'Nikali', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 67989.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 1, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 67989.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:16Z', 'timestamp': 1636382896000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/071922'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:18Z', 'timestamp': 1636460058823}, 'publisher': 'Wellcome', 'award': '215309', 'DOI': '10.35802/215309', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the function of intraepithelial lymphocytes (IEL) in the small intestine'}], 'project-description': [{'description': 'Intraepithelial lymphocytes (IEL) are a highly specialised, diverse group of T lymphocytes residing in the intestinal epithelium. Evidence suggests that they are important in early protection against foodborne pathogens, however the exact function of IEL remains incompletely understood. I will use a novel mouse model that allows for inducible deletion of all IEL subsets from the small intestine, which has not been possible to date. We will then challenge these IEL-depleted mice with oral infections to dissect the importance of IEL in protection against such infections. These studies will give us a clearer understanding of the mechanisms of IEL activation and function in the gut. In addition to serving as an immunological barrier against pathogens, IEL may also be directly or indirectly regulated by dietary composition such as fat, fibre and starch. Evidence suggests that crucial immune-relevant molecules that are necessary for maintaining IEL are missing from research diets and therefore the role of IEL in obesity and metabolic research may be underestimated. I will use highly defined research diets to explore diet-induced effects on IEL function and composition in the gut, allowing me to address how these cells contribute to metabolic and obesity-related disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4294-7855', 'authenticated-orcid': False, 'given': 'Olivia', 'family': 'James', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 4]]}, 'award-end': {'date-parts': [[2022, 3, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:53Z', 'timestamp': 1636383233000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/215309'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:14:20Z', 'timestamp': 1636460060014}, 'publisher': 'Wellcome', 'award': '220218', 'DOI': '10.35802/220218', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Ivermectin Safety in Small Children'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4807-9681', 'authenticated-orcid': False, 'given': 'Kevin', 'family': 'Kobylinski', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 510000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2023, 4, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 510000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:37Z', 'timestamp': 1636383097000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220218'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:45Z', 'timestamp': 1636460025354}, 'publisher': 'Wellcome', 'award': '097827', 'DOI': '10.35802/097827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Institutional Strategic Support Fund 2011/12.'}], 'project-description': [{'description': '- Capacity building through our investment in people, supporting our very best non-clinical and clinical post-doctoral fellows through transition funding - Interdisciplinary secondments through discipline-hopping schemes that will cross between Universities and industry or medical technology partners - Underpinning resource to maximize opportunities around our recent successes in capital infrastructure funding where support staff with core skills are essential for success - Patient and Public Engagement activity in Biomedical research and Medical Humanities, the latter part of the University’s new broad commitment to incorporating Arts/Humanities and Social Sciences within medical research', 'language': 'en'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Arthur', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1500000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2011, 10, 1]]}, 'award-end': {'date-parts': [[2016, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 1500000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:46Z', 'timestamp': 1636382986000}, 'score': 0.0, 'issued': {'date-parts': [[2011, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/097827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:45Z', 'timestamp': 1636460025402}, 'publisher': 'Wellcome', 'award': '062204', 'DOI': '10.35802/062204', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Dynamics of ionotropic glutamate receptor subunits expression in organotypic hippocampal slice cultures.'}], 'lead-investigator': [{'given': 'Cezar', 'family': 'Tigaret', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 48030.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 8, 1]]}, 'award-end': {'date-parts': [[2001, 7, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 48030.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:16Z', 'timestamp': 1636382776000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062204'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:46Z', 'timestamp': 1636460026331}, 'publisher': 'Wellcome', 'award': '060588', 'DOI': '10.35802/060588', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Role of B-cells in the modulation of T-cell dependent acquired resistance of salmonella infections.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3838-4962', 'authenticated-orcid': False, 'given': 'Pietro', 'family': 'Mastroeni', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 196068.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 196068.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:45Z', 'timestamp': 1636382985000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060588'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027646}, 'publisher': 'Wellcome', 'award': '221521', 'DOI': '10.35802/221521', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Expanding the proteomics and establishing top-down capabilities for the UCL Mass Spectrometry Science Technology Platform.'}], 'project-description': [{'description': 'The requested equipment is the ThermoFisher Orbitrap Eclipse Tribrid Mass Spectrometer with an Ultimate3000 LC system. This new instrument is designed for high-end proteomics, top-down protein characterisation, and crosslinking analysis and is equipped with the latest Orbitrap analyser, which offers higher resolution, sensitivity and acquisition rates compared to previous Orbitraps. These features result in improvements to both limit of detection and quantification of peptides, ultimately leading to enhanced quantitative proteomics and crosslinking analysis. Its atypical geometry allows multistage fragmentation of ions (MSn), which is necessary for multiplexed proteomics experiments and for advanced crosslinking analyses using cleavable crosslinkers. Combined with a novel in-built real-time search algorithm, fragment ions of interest e.g. crosslinked peptides can be preferentially selected, further increasing the depth of analysis. The Eclipse is also capable of top-down proteomics experiments which is an ideal method for the study of proteoforms and labile post-translational modifications. We will use the Eclipse to study the biological processes underpinning viral secondary envelopment, type 2 diabetes, cell responses to protein misfolding and cell competition; these studies are challenging due to the low amounts of sample available. The sensitivity and robustness in protein quantitation provided by the requested instrument will be key for their success.', 'language': 'en'}, {'description': 'Proteins are a crucial class of biomolecules which carry out most of the essential functions within our cells. The amount of each protein, how they interact with other proteins, and whether they are modified, comprises important information that enable us to understand how cells and organisms work and how perturbation in any of these can lead to disease. Mass spectrometry is one of the best methods to study proteins, their interactions and modifications. Improvements in mass spectrometry instrumentation, namely speed, selectivity and sensitivity, will allow us to study more proteins than ever before. We propose to purchase the latest such mass spectrometry instrument, Orbitrap Eclipse, capable of such analyses. We will use it to increase our understanding of several pathologies such as Huntington’s disease, neuropathies as well as fundamental biological processes such as cell competition and protein trafficking between cells.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-6429-654X', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Cheetham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4319-8745', 'authenticated-orcid': False, 'given': 'Giampietro', 'family': 'Schiavo', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2716-2045', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Tabrizi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-3248-7493', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Raleigh', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-1334-9258', 'authenticated-orcid': False, 'given': 'Frances', 'family': 'Brodsky', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-0558-3597', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Lowe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5072-8428', 'authenticated-orcid': False, 'given': 'Konstantinos', 'family': 'Thalassinos', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 674756.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 11, 1]]}, 'award-end': {'date-parts': [[2025, 10, 31]]}, 'funding': [{'type': 'equipment', 'scheme': 'Molecular Basis of Cell Function', 'award-amount': {'amount': 674756.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:06Z', 'timestamp': 1636383126000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221521'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027627}, 'publisher': 'Wellcome', 'award': '220463', 'DOI': '10.35802/220463', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Artificial intelligence for rapid epidemic analysis'}], 'project-description': [{'description': 'The aim of this fellowship is to accelerate detection of and response to infectious disease outbreaks, particularly where surveillance, diagnosis, and control are under-resourced. My first goal is to develop and validate machine learning methods to rapidly infer outbreak properties. I have demonstrated proof-of-concept for this approach, and I expect to be able to train machine learning models on synthetic outbreak data to infer outbreak properties almost instantaneously from data. By building on this approach, understanding its validity and weaknesses from application to historical data, and creating a database of simulations and trained models, I hope to allow outbreak data to be interpreted more quickly and simply than currently possible. My second goal is to complete and test—first against historical data and then prospectively—algorithms for aetiological identification of outbreaks. These algorithms have the potential to allow outbreaks to be detected and controlled faster, as well as to improve guidelines for syndromic surveillance. Finally, I plan to integrate these analytics for outbreak identification and analysis into lightweight software tools. After testing them in collaboration with field epidemiologists, I hope to enable public health officials to take advantage of epidemiological insights with minimal training, supporting capacity of public health systems.', 'language': 'en'}, {'description': 'Early detection of infectious disease outbreaks can prevent small clusters of cases from becoming costly epidemics. However, many under-resourced health systems lack adequate capacity for rapid laboratory diagnosis, especially for rare and emerging diseases. Instead, many outbreaks are only identified based on symptoms and only fully verified after many months. Furthermore, analytical tools to track and forecast outbreaks are rarely fit for use in low-resource settings. I will develop analytical methods and tools to help identify outbreak causes and respond to outbreaks more quickly and effectively, including by combining public health and data science approaches to rapidly predict the causes and properties of infectious disease outbreaks. Over the course of this fellowship, I will develop these methods, validate them against historical outbreak data, and finally build and field test software tools to be used by public health officials, empowering them to control outbreaks locally without international outbreak responses.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0258-3188', 'authenticated-orcid': False, 'given': 'James', 'family': 'Wood', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2842-3406', 'authenticated-orcid': False, 'given': 'Sebastian', 'family': 'Funk', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9540-1998', 'authenticated-orcid': False, 'given': 'Emma', 'family': 'Glennon', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:45Z', 'timestamp': 1636383105000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220463'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027637}, 'publisher': 'Wellcome', 'award': '068693', 'DOI': '10.35802/068693', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the costs of a symposium entitled \"Workshop on function and dysfunction in the basal ganglia\" to be held at the Institute of Neurology, University College London on 3rd October 2002.'}], 'project-description': [{'description': \"Workshop on function and dysfunction in the basal ganglia, Institute of Neurology, University College London, 3rd October 2002. Findings from basic research into the basal ganglia have proved critical in informing and directing clinical research and practice as exemplified by the development in animal models of a new target for the neurosurgical treatment of Parkinson's disease, -the subthalamic nucleus. Conversely, studies of patients operated in the basal ganglia may provide unique information about the functions of these nuclei in humans. Examples are the direct recording of the basal ganglia activity or clinical observations of the motor and non-motor effects of surgical procedures. This research field is also very fast moving. It is therefore essential for clinicians working and researching in the field of functional neurosurgery and basic scientists working on the basal ganglia of animals to meet the exchange information. The format of this meeting, with a small group of people from various backgrounds, will allow informal and interactive discussion. The overall aim is to provide a forum for integrating findings from basic science and clinical investigation related to basal ganglia function and dysfunction. The following topics will be covered: Recordings from basal ganglia in animals and humans Teaching signals and information processing in the basal ganglia networks of normal and Parkinsonian primates (Prof H Bergman, Israel), Movement related activity in the human basal ganglia (Dr P Brown, London). Functional localisation within the basal ganglia (Prof P Bolam, Oxford). Surgical target localisation of basal ganglia targets in the human Localising functional targets for deep brain stimulation in the basal ganglia (Dr J Yelnik, Paris). Imaging the basal ganglia (Prof T Yousry, London) Function and dysfunction of surgical navigations within the basal ganglia, lessons from the literature (Prof M Hariz, Umea, London). Functions of the basal ganglia Interactions between basal ganglia and frontal cortex (Prof D Passingham, Oxford) Role of basal ganglia in reward processes (Prof W Schultz, Cambridge) Effects of STN lesions in rats (Prof T Robins, Cambridge) Effects of STN stimulation on motor, cognitive and limbic loops in Parkinsonian patients (Dr P Dowsey-Limousin, London).\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5201-3044', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Brown', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2002, 7, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 1200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:38Z', 'timestamp': 1636382978000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/068693'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:47Z', 'timestamp': 1636460027809}, 'publisher': 'Wellcome', 'award': '060122', 'DOI': '10.35802/060122', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification of imprinted genes on human chromosome 7.'}], 'investigator': [{'given': 'Philip', 'family': 'Stanier', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2099-3420', 'authenticated-orcid': False, 'given': 'Gudrun', 'family': 'Moore', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 176233.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 9, 4]]}, 'award-end': {'date-parts': [[2004, 5, 3]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 176233.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:32Z', 'timestamp': 1636382852000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 9, 4]]}, 'URL': 'http://dx.doi.org/10.35802/060122'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028003}, 'publisher': 'Wellcome', 'award': '215240', 'DOI': '10.35802/215240', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Forecasting the spread of antibiotic resistance, and targeting public health interventions to counter it'}], 'project-description': [{'description': 'Throughout the 1900s many different varieties of antibiotics, which are used to treat infections with bacteria, were created. However, following the introduction of each antibiotic class, bacteria which were resistant to treatment with that antibiotic emerged. Currently, the prevalence of antibiotic resistant bacteria is increasing rapidly and very few new antibiotics are being produced. The Philippines has a sophisticated surveillance programme for monitoring the spread of antibiotic resistance. The objective of this project is to use data collected by the Filipino Antimicrobial Resistance Surveillance Programme (ARSP) to make predictions about how antibiotic resistance will spread in the future in the country. I will begin by applying techniques developed for economic forecasting to these data and then incorporate data describing the usage of antibiotics in the Philippines to refine my estimates of the future spread of antibiotic resistance. Finally, I will construct a mathematical model of bacterial evolution and use this to experiment with different interventions that could limit the predicted spread of antibiotic resistance. The Sanger Institute is also involved in developing similar surveillance programmes in Colombia, Nigeria and India, and where possible I will test my methods on data from these projects as well.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5757-3278', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Jeffrey', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 10, 7]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:48Z', 'timestamp': 1636383228000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215240'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028410}, 'publisher': 'Wellcome', 'award': '067784', 'DOI': '10.35802/067784', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Symposium entitled 'Australasian Thalassaemia Workshop' to be held in Perth, Australia, 21-22 March 2002.\"}], 'lead-investigator': [{'given': 'Wendy', 'family': 'Erber', 'affiliation': [{'name': 'University of Western Australia', 'country': 'AU'}]}], 'award-amount': {'amount': 3000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 21]]}, 'award-end': {'date-parts': [[2002, 4, 20]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:41Z', 'timestamp': 1636383041000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 21]]}, 'URL': 'http://dx.doi.org/10.35802/067784'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028456}, 'publisher': 'Wellcome', 'award': '204017', 'DOI': '10.35802/204017', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'University of Cambridge PhD Programme for Clinicians'}], 'project-description': [{'description': 'This programme recruits clinicians of outstanding calibre nationwide. With the largest concentration of biomedical science in Europe in laboratories on the Campus or wider Cambridge, we offer research training of highest quality that spans the spectrum from basic science through experimental medicine to epidemiology and public health. Strong, ongoing, mentorship is central to our programme; this, coupled with carefully chosen placements in laboratories empowers fellows to make better-informed choices of research and supervisor, including interdisciplinary projects. During PhD training, we aim to maximise their potential to acquire research skills and achieve a doctorate linked to significant discoveries and publications. With continued, intensive, guidance postdoctorally via established mechanisms, we guide fellows into pathways (e.g. higher research fellowships, clinical lecturer posts) that are tailored to individual progress, balancing re-entry into clinical training with maintaining research momentum. Our vision is to strengthen and broaden this model to include fellowships at veterinary and MBPhD level; and, in partnership with the University of East Anglia, extend opportunities to trainees throughout the region and add research diversity with a new theme in Gastroenterology, Nutrition and Microbiology. The longterm aim of the programme is to produce the next generation of clinical academics.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9383-1054', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Lehner', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2654-8854', 'authenticated-orcid': False, 'given': 'Krishna', 'family': 'Chatterjee', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 11175030.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 8, 1]]}, 'award-end': {'date-parts': [[2024, 8, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 6397500.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:41Z', 'timestamp': 1636383221000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/204017'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028646}, 'publisher': 'Wellcome', 'award': '059924', 'DOI': '10.35802/059924', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cardiovascular Initiative - 4 year PhD programme.'}], 'lead-investigator': [{'given': 'David', 'family': \"O'Regan\", 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 111615.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 111615.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:00Z', 'timestamp': 1636383180000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059924'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029031}, 'publisher': 'Wellcome', 'award': '102161', 'DOI': '10.35802/102161', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'OXION - Membrane Transport in Health and Disease'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6970-1767', 'authenticated-orcid': False, 'given': 'Frances', 'family': 'Ashcroft', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8996-2000', 'authenticated-orcid': False, 'given': 'Stephen', 'family': 'Tucker', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 2383719.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2014, 10, 1]]}, 'award-end': {'date-parts': [[2023, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 2228000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:38Z', 'timestamp': 1636383218000}, 'score': 0.0, 'issued': {'date-parts': [[2014, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/102161'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029207}, 'publisher': 'Wellcome', 'award': '221647', 'DOI': '10.35802/221647', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intravital imaging as a platform for screening checkpoint and focal adhesion kinase inhibitors as potential treatment for cancer metastasis'}], 'project-description': [{'description': 'Despite new developments in treatment, cancer remains the second leading cause of death worldwide. Breast cancer is the most common cancer within the UK, with death generally caused by the formation of metastasis. I intend to investigate the hypothesis that immune responses at the metastatic site determine the long-term outcome of therapy. I will compare immune responses at the primary and metastatic sites upon administration of checkpoint inhibitors that have different clinical success rates. Flow cytometry and t-SNE analysis will provide insight into the affected cell populations and timings. I will then utilise newly developed intravital imaging technologies to visualise immune responses in vivo at multiple cancer sites. I will measure cytotoxic cell activity and tumour cell death as indicators for anti-cancer response. Further, I will examine the ability of a combination of checkpoint inhibitor and focal adhesion kinase inhibitor to fully eradicate tumour cells. An inhibitor will be fluorescently tagged to study its access to tissue and interaction with immune cells dependent on combination therapy. The proposed research will help to elucidate the role of immunotherapy on the metastatic foci and will provide the first insights into the benefit and limitations of combination therapy on secondary site immune responses.', 'language': 'en'}, {'description': 'One in six lives are cut short by cancer, with approximately 90% of mortality caused by spreading of the tumour, also called metastasis. I propose to investigate whether cells from our immune system found in secondary tumours contribute to the efficacy of drugs used in breast cancer patients. I will utilise newly developed techniques to visualise how immune cells function in living animal models of breast cancer, and will compare the efficacy of drugs in primary and secondary tumours. I will measure the anti-tumour activity of immune cells as well as how well they bind to tumour cells. Further, I will investigate how therapies that use more than one drug simultaneously act to eradicate metastatic tumours, studying how clinical treatments enter the metastatic site and fulfil their role. My studies will provide insight into the limitations of current therapies to support the design of new, more effective therapies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7778-8794', 'authenticated-orcid': False, 'given': 'Valerie', 'family': 'Brunton', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0422-7264', 'authenticated-orcid': False, 'given': 'David', 'family': 'Entenberg', 'affiliation': [{'name': 'Albert Einstein College Of Medicine', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0605-4582', 'authenticated-orcid': False, 'given': 'Nicole', 'family': 'Barth', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 1]]}, 'award-end': {'date-parts': [[2025, 4, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:13Z', 'timestamp': 1636383133000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221647'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:49Z', 'timestamp': 1636460029226}, 'publisher': 'Wellcome', 'award': '215149', 'DOI': '10.35802/215149', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Viral infection and immunomodulation: The implications on ageing, viral serostatus, and vaccine efficacy'}], 'project-description': [{'description': 'Cytomegalovirus (CMV) is a persistent, lifelong infection that is prevalent in 60-100% individuals. CMV infection usually doesn’t cause disease, although can cause serious illness in people with a weakened immune system. Recent research suggests that CMV infection and age reduce vaccine efficacy, and that vaccine trials conducted in Africa show diminished immune responses because of a higher burden of CMV infection. Although this correlation has been identified, there is no mechanism to explain this phenomenon. My project will investigate how CMV infection affects how vaccines work. I will begin by looking at natural killer (NK) cells, of which certain populations are known to expand during CMV infection. This will be conducted in vaccine trial samples from different age categories and worldwide locations. I will also research the immunology of how CMV reduces vaccine efficacy. This will involve infecting mice with murine CMV to develop a model of CMV-associated immune phenotypes in response to vaccination. I will also create an MVA-vectored vaccine that has CMV-like properties. This will aim to use features of CMV that induce non-canonically-restricted T cells. This research will further our understanding into improving vaccine efficacy, and how latent infections reduce vaccine responses.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1194-2429', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Sharpe', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 2]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:16Z', 'timestamp': 1636383376000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/215149'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:44Z', 'timestamp': 1636460024836}, 'publisher': 'Wellcome', 'award': '054525', 'DOI': '10.35802/054525', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular basis of cell behaviour during Drosophila segmentation.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2782-4195', 'authenticated-orcid': False, 'given': 'Bénédicte', 'family': 'Sanson', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 494021.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1998, 11, 1]]}, 'award-end': {'date-parts': [[2005, 6, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 494021.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:07Z', 'timestamp': 1636382767000}, 'score': 0.0, 'issued': {'date-parts': [[1998, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054525'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028559}, 'publisher': 'Wellcome', 'award': '060352', 'DOI': '10.35802/060352', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The origin of signals transferred through gap junctions during mechanotransduction in tendon cell structures.'}], 'investigator': [{'family': 'Benjamin', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'family': 'Ralphs', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 167088.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 5, 1]]}, 'award-end': {'date-parts': [[2003, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 167088.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:02Z', 'timestamp': 1636382762000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060352'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:48Z', 'timestamp': 1636460028594}, 'publisher': 'Wellcome', 'award': '081392', 'DOI': '10.35802/081392', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'VALUE IN PEOPLE AWARD.'}], 'lead-investigator': [{'given': 'Michael', 'family': 'Arthur', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2006, 10, 1]]}, 'award-end': {'date-parts': [[2007, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:48Z', 'timestamp': 1636382988000}, 'score': 0.0, 'issued': {'date-parts': [[2006, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/081392'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:13:52Z', 'timestamp': 1636460032428}, 'publisher': 'Wellcome', 'award': '222425', 'DOI': '10.35802/222425', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of Genomic instability and R-Loops in treatment resistance of HPV positive and HPV negative Oropharyngeal Squamous Cell Carcinoma (OPSCC).'}], 'project-description': [{'description': 'Throat cancer, also known as oropharyngeal cancer, is a common type of cancer that has increased in prevalence over the last few decades. There are two forms of this type of cancer, one associated with a viral infection known as Human Papilloma Virus (shortened to HPV-positive) and one that shows no association with this virus (HPV-negative). HPV-negative cancer typically has a poorer response to treatment compared to HPV-positive cancer, however, there are also reports of patients with HPV-positive cancer whose cancer returns after treatment. All cells contain DNA which provide the instructions for a cell to grow and divide by producing a messenger known as RNA. During production of this message the RNA can become incorrectly stuck on the DNA forming a structure known as a R-loop. R-loops can make the DNA more susceptible to damage and interfere with the instructions from the DNA. The aim of this project is to investigate the role of R-loops in treatment resistance in oropharyngeal cancer. I will use cancer cells grown in the laboratory to investigate the role of R-loops in cells which develop resistance to treatment and investigate potential therapies that could be used in this situation in the future.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1129-0413', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Crane', 'affiliation': [{'name': 'University of Sheffield', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 2]]}, 'award-end': {'date-parts': [[2023, 9, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:49Z', 'timestamp': 1636383409000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/222425'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:19Z', 'timestamp': 1636465459237}, 'publisher': 'Wellcome', 'award': '218497', 'DOI': '10.35802/218497', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'UCL Wellcome 4-year PhD in Mental Health Science'}], 'project-description': [{'description': 'Mental illness is a major public health problem, with poorly understood causes and highly variable treatment outcomes. While mental health research training has strength within disciplines, these typically operate in parallel, greatly impeding progress in improving clinical outcomes. The UCL Wellcome 4-Year PhD in Mental Health Science is an interdisciplinary, student-centred programme, which aims to train the next generation of research and policy leaders to succeed within mental health research fields, and foster greater cross-disciplinarity in future researchers. It leverages UCL’s outstanding mental health research environment across three broad Themes: Mechanism, Population Mental Health, and Intervention. In Year 1, students will obtain experience in these different Themes through short rotation projects and courses, including areas outside their academic background; through this they will be exposed to new concepts and techniques, learn to “speak the language” of the different disciplines, and spot the synergistic connections between them. For the main PhD project in Years 2-4, students will select a supervisory team and Thesis Committee across all three Themes, enabling interdisciplinary mentorship. A strong emphasis will be placed on developing a distinct and supportive cohort identity, with continual skills development and preparation for transition following the Programme, whether within or outside academia.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2777-7616', 'authenticated-orcid': False, 'given': 'Claudia', 'family': 'Cooper', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-1847-8443', 'authenticated-orcid': False, 'given': 'Pasco', 'family': 'Fearon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8269-1228', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Roiser', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 5757810.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2028, 3, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 5757810.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:02Z', 'timestamp': 1636383302000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/218497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:19Z', 'timestamp': 1636465459245}, 'publisher': 'Wellcome', 'award': '065650', 'DOI': '10.35802/065650', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the British Society for Population Studies Annual Conference to be held in Leeds during September 2001.'}], 'lead-investigator': [{'given': 'Heather', 'family': 'Joshi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2001, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:36Z', 'timestamp': 1636382856000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065650'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:22Z', 'timestamp': 1636465462528}, 'publisher': 'Wellcome', 'award': '060558', 'DOI': '10.35802/060558', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Recombinant multimers of Kv1 a/B subunits/ZIP (zeta-PKC interacting- protein) that mimic neuronal K+ channel subtypes: do these signalling complexes act as redox sensors or voltage-dependent enzymes?'}], 'lead-investigator': [{'given': 'Gordon', 'family': 'Dougan', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 326453.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 326453.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:24Z', 'timestamp': 1636382844000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060558'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:23Z', 'timestamp': 1636465463241}, 'publisher': 'Wellcome', 'award': '066216', 'DOI': '10.35802/066216', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Myocardial viability determined by MR imaging.'}], 'project-description': [{'description': 'Myocardial viability determined by MR imaging Determination of myocardial viability, the differentiation between hibernating/stunned myocardium and scar, remains a diagnostic problem. Current methods, such as nuclear T1 scintigraphy, PET or stress echocardiography have major limitations related to sensitivity, specificity , availability, and costs. Cardiac MR has been used to show that recruitment of inotropic reserve by low-dose dobutamine is a viability criterion with a sensitivity/specificity in the 90% range. Another promising method for viability detection is the determination of \"late signal enhancement\" on 10-15 min post-contrast (Gd-DTPA) MR images, where non-viable myocardium shows signal hyper-enhancement, but viable myocardium does not. A new method for viability detection using intrinsic MR contrast, non-stress and non-contrast agent is Na-MRI. Na MRI allows for cardiac imaging with a resolution in the range of 500 µ1. In the infarcted rat heart, scar tissue exhibits significantly increased total Na content compared to viable myocardium, establishing a biochemical base for viability detection. Dr Selva will implement Na-MRI in patient cohorts with akinetic myocardial regions undergoing PTCA or bypass surgery with comparison to recovery of regional function 6 months after revascularisation. He will evaluate sensitivity and specificity for viability detection for 23Na-MRI and post-Gd DTPA late hyperenhancement images in comparison to T1-scintigraphy. In short, Dr Selva will develop Na MRI into a safe and contrast agent-independent reliable method for clinical viability assessment.', 'language': 'en'}], 'lead-investigator': [{'given': 'Joseph', 'family': 'Selva-Nayagam', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 164334.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 2, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 164334.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:14Z', 'timestamp': 1636383014000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066216'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:25Z', 'timestamp': 1636465465828}, 'publisher': 'Wellcome', 'award': '222954', 'DOI': '10.35802/222954', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Must the relatives be told? Legal and ethical issues in relation to the non-disclosure of genetic information by healthcare professionals to relatives'}], 'project-description': [{'description': \"Genetic information is becoming increasingly utilised by healthcare professionals in order to provide patients with more precise diagnosis and treatments. An individual's genetic information may show their risk of inheriting a genetic disorder, and although most individuals would consent to healthcare professionals sharing their genetic information with relatives who may also be at risk, some individuals refuse. It can be argued that a failure to disclose the risks of inheriting genetic disorders to relatives is ethically wrong, because it restricts the autonomy of individuals to make life choices. Alternatively, it can be contended that it is legally wrong for a healthcare professional to not adhere to the duty of confidentiality that they owe to patients. This debate demonstrates the conflict of duties that healthcare professionals face as the use of genetic information in medicine develops, and highlights the need to develop a new legal framework which takes into account the needs of patients, relatives, and healthcare professionals. In order to create an appropriate legal framework, I aim to assess academic commentary, examine case law, and conduct qualitative interviews with healthcare professionals in order to assess scientific opinion, and potentially inform new policy guidance.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7280-0531', 'authenticated-orcid': False, 'given': 'Jasmine', 'family': 'Blow', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:11Z', 'timestamp': 1636383311000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222954'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:25Z', 'timestamp': 1636465465970}, 'publisher': 'Wellcome', 'award': '219880', 'DOI': '10.35802/219880', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of rat Posterior Parietal Cortex in statistical learning'}], 'project-description': [{'description': 'The world around us is complex, but at the same time full of meaningful regularities. We can detect, learn and exploit these regularities automatically in an unsupervised manner, i.e. without any direct instruction or explicit reward. For example, we effortlessly estimate the average tallness of people in a room, or the boundaries between words in a language. These regularities, once learned, can affect the way we acquire and interpret new information to build and update our internal model of the world for future decision-making processes. Despite the ubiquity of passively learning from the structured information in the environment, the mechanisms that support learning from real-world experience are largely unknown. By combining sophisticated cognitive tasks in human and rats, neuronal measurements and perturbations in rat and network modelling, we aim to build a multi-level description of how sensory history is utilised in inferring regularities in temporally extended tasks. The ability to use sensory statistics to update the internal models may be impaired in individuals with dyslexia or with neurodevelopmental disorders, such as autism, or psychosis, such as schizophrenia. Our findings can have immediate application in better understanding and designing more accurate treatments for these disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0324-4222', 'authenticated-orcid': False, 'given': 'Elena', 'family': 'Menichini', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:55Z', 'timestamp': 1636383295000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219880'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:26Z', 'timestamp': 1636465466024}, 'publisher': 'Wellcome', 'award': '060478', 'DOI': '10.35802/060478', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Leucocyte mediated endothelial dysfunction: identification and manipulation of damage and repair mediators.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4974-0344', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Henriksen', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-amount': {'amount': 140075.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 140075.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:37Z', 'timestamp': 1636382857000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060478'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:29Z', 'timestamp': 1636465469332}, 'publisher': 'Wellcome', 'award': '062350', 'DOI': '10.35802/062350', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Accession into NCYC of yeast deletion mutants for functional genomic studies.'}], 'investigator': [{'given': 'Ian', 'family': 'Roberts', 'affiliation': [{'name': 'Quadram Institute Bioscience', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Stephen', 'family': 'Oliver', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 286298.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 29]]}, 'award-end': {'date-parts': [[2004, 11, 28]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 286298.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:43Z', 'timestamp': 1636382863000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 29]]}, 'URL': 'http://dx.doi.org/10.35802/062350'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:33Z', 'timestamp': 1636465473158}, 'publisher': 'Wellcome', 'award': '220041', 'DOI': '10.35802/220041', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': \"Circuit mechanisms underlying spatial navigation deficits in early Alzheimer's disease\"}], 'project-description': [{'description': 'Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions worldwide. AD can only be diagnosed late in its progression, when cognitive symptoms such as memory loss are prominent. Many years before this, the pathological AD processes are active and damaging the brain, but the symptoms at this early stage are subtle, making diagnosis challenging. Focusing on early affected areas in AD could hold the key to early diagnosis. An early affected area is the entorhinal cortex (EC), which supports spatial navigation. Damage here causes spatial navigation deficits. In early AD, these deficits are subtle and require the development of sensitive tests. Our goal is to help inform the development of these tests by understanding how the EC carries out spatial computations, and how they are altered in AD. To do this, we will reverse engineer the EC circuitry using optogenetics and electrophysiology during navigation tasks performed by healthy and AD mice. In conjunction, we will build computational models (virtual EC circuits) that simulate AD pathology and task performance. These studies will help explain how the EC carries out computations that underlie spatial navigation, and how they go wrong during AD, informing the development of sensitive tests for AD.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3574-7812', 'authenticated-orcid': False, 'given': 'Ian', 'family': 'Hawes', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:41Z', 'timestamp': 1636383341000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220041'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:37Z', 'timestamp': 1636465477309}, 'publisher': 'Wellcome', 'award': '211161', 'DOI': '10.35802/211161', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of progression to invasive lung cancer: a systems biology approach'}], 'project-description': [{'description': 'Lung cancer remains the leading cancer-related cause of death in the UK. Early detection and treatment are critical to improving outcomes. Our lab has collected a unique set of lung tissue samples from patients with pre-cancerous disease, some of whom have gone on to develop cancer. By studying the genetic and molecular profiles of these samples we aim to elucidate the mechanisms of progression from pre-cancerous disease to invasive cancer. By doing so we can identify future methods of treatment and prevention. My work focuses on analysis of vast quantities of data produced by this program. We have recently studied the genetics of these samples, including which genes are expressed, which are mutated, and how they are regulated. From these complex networks we identify key signals of instability in the genome, which we believe are driving progression to cancer. These data provide a snapshot of early cancer. The first aim of this project is to investigate the dynamics of this process using longitudinally collected samples, and new techniques which can probe these samples on a single-cell level. The second aim is to study the immunological mechanisms by which some pre-invasive lesions regress and do not become invasive cancer.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5836-0250', 'authenticated-orcid': False, 'given': 'Adam', 'family': 'Pennycuick', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 10, 4]]}, 'award-end': {'date-parts': [[2020, 10, 3]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:28Z', 'timestamp': 1636383328000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 4]]}, 'URL': 'http://dx.doi.org/10.35802/211161'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:51Z', 'timestamp': 1636465431981}, 'publisher': 'Wellcome', 'award': '216353', 'DOI': '10.35802/216353', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolution of modern H3N2 influenza A viruses'}], 'project-description': [{'description': 'Influenza poses a significant burden to public heath and the economy. The ability of influenza to escape prior immunity and vaccine response is due to continual evolution of the virus. Deciding which strains of the virus to include in the annual vaccine requires accurate information about the character of the evolving viruses. The more information we can provide, the more likely it is that the choice will result in a vaccine that is well matched against the predominant circulating strains. Mismatch erodes public confidence in vaccination policy and increases the disease burden. Currently the decision is largely based on traditional tests that measure how related the strains are to each other, in other words do antibodies raised to last year’s vaccine cross react with this year’s viruses? But there are other important factors that will determine which of the many different strains will evolve to predominate, such as how well the virus transmits through the air. We propose to generate information that could aid selection of virus strains for the annual influenza vaccine. We will improve experimental models of influenza transmission and incorporate genetic sequencing of the virus and mathematical modelling to enhance our understanding of influenza evolution.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4591-6026', 'authenticated-orcid': False, 'given': 'Ruthiran', 'family': 'Kugathasan', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 17]]}, 'award-end': {'date-parts': [[2022, 3, 2]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:07Z', 'timestamp': 1636383307000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 17]]}, 'URL': 'http://dx.doi.org/10.35802/216353'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:53Z', 'timestamp': 1636465433171}, 'publisher': 'Wellcome', 'award': '222958', 'DOI': '10.35802/222958', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Assessing the contribution of common and rare short tandem repeats (STRs) to the risk of developing idiopathic pulmonary fibrosis (IPF).'}], 'project-description': [{'description': 'Idiopathic Pulmonary Fibrosis (IPF) affects around five people in every 100,000 in the UK and is amongst the most devastating of lung diseases, with a median survival time of 3 years and variable progression. Comparable disease prevalence (6.8 per 100,000 persons) has also been reported in other countries such as the USA, Italy, and Canada. About 5000 cases are detected annually in the UK, and there is rising disease prevalence globally. Despite the substantial disease burden, there is little understanding of the disease etiology, and it has a poor prognosis. Other than a lung transplant, the available drugs are not curative. The majority of cases are diagnosed in patients >50 years and males are disproportionately affected than females. Both genetic and environmental factors have been associated with IPF. The genetic mutations described so far only account for about 19% of genetic risk associated with IPF. Therefore, the analysis of other types of genetic variations is pertinent. In particular, our study will use whole-genome sequences in case-control cohorts to identify other genetic mutations associated with IPF susceptibility. Identifying risky mutations can help understand disease etiology and develop more targeted therapies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8020-0787', 'authenticated-orcid': False, 'given': 'John', 'family': 'Oketch', 'affiliation': [{'name': 'University of Leicester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 29]]}, 'award-end': {'date-parts': [[2024, 9, 28]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:26Z', 'timestamp': 1636383326000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 29]]}, 'URL': 'http://dx.doi.org/10.35802/222958'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:54Z', 'timestamp': 1636465434533}, 'publisher': 'Wellcome', 'award': '062873', 'DOI': '10.35802/062873', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of the novel RHO GTPase, Rif'}], 'lead-investigator': [{'given': 'Harry', 'family': 'Mellor', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 140464.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 22]]}, 'award-end': {'date-parts': [[2004, 4, 21]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 140464.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 22]]}, 'URL': 'http://dx.doi.org/10.35802/062873'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:55Z', 'timestamp': 1636465435185}, 'publisher': 'Wellcome', 'award': '220553', 'DOI': '10.35802/220553', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering the Genetic Basis of Epilepsies through Computational Analysis of Clinical Phenotype'}], 'project-description': [{'description': \"Background Epilepsy affects 1% of people and empirical treatment benefits only a third. Seizures and their treatments have serious health and socioeconomic consequences. Over a third of epilepsy is thought to arise from variation in the person’s genetic code. However, currently we can only rarely identify what this is, a necessary step towards using it to improve treatment. Studying people grouped by the symptoms of their epilepsy has successfully defined, and discovered the genetic causes of distinctive but rare epilepsies such as Dravet Syndrome, facilitating research that has improved their treatment. Approach The yield of large genetic studies of epilepsy is currently limited by the challenges of combining and interpreting vast quantities of complex information about participants' epilepsy symptoms. We will develop computational methods to make information about the symptoms of participants in Epi25 (the largest ever epilepsy study) more tractable. We will use these to identify new patterns of symptoms and their associated genetic causes. Expected Impact Identifying new genetic causes of epilepsy could help to us to personalise the selection of existing treatments more successfully within a few years, and to design new, precise treatments based upon newly discovered mechanisms. Our methods may be applicable to other diseases.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1735-8178', 'authenticated-orcid': False, 'given': 'David', 'family': 'Lewis-Smith', 'affiliation': [{'name': 'Newcastle University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 8, 1]]}, 'award-end': {'date-parts': [[2022, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:17Z', 'timestamp': 1636383317000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220553'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:43:59Z', 'timestamp': 1636465439930}, 'publisher': 'Wellcome', 'award': '061150', 'DOI': '10.35802/061150', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Human complement regulator subversion for virus infection and protection of viruses and infected cells.'}], 'lead-investigator': [{'given': 'Owen', 'family': 'Spiller', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 330265.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2005, 2, 28]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Infection and Immuno-Biology', 'award-amount': {'amount': 330265.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:19Z', 'timestamp': 1636383019000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061150'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:01Z', 'timestamp': 1636465441503}, 'publisher': 'Wellcome', 'award': '054939', 'DOI': '10.35802/054939', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Analysis of the cell signalling molecules that control the phosphorylation of type A gamma-aminobutyric acid receptors.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2748-743X', 'authenticated-orcid': False, 'given': 'Jasmina', 'family': 'Jovanovic', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 124428.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 1, 1]]}, 'award-end': {'date-parts': [[2001, 11, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 124428.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:49Z', 'timestamp': 1636382869000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/054939'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141891}, 'publisher': 'Wellcome', 'award': '222397', 'DOI': '10.35802/222397', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Intratracheal Valve device for intractable aspiration: ITV'}], 'project-description': [{'description': 'We will create the Intra-Tracheal Valve (ITV), a safe and well-tolerated soft robotic intra-tracheal device for persons with failing laryngeal sphincter function. The device will be based on cutting-edge bioengineering, soft robotics and implant technology and comprise a responsive vocal cord unit replacement valve, inserted/replaced endoscopically. The valve will be electromagnetically actuated via novel power transmission, autonomously controlled by sensors that detect decisions to swallow, with full manual override (Fig3). Our device will transform the quality and duration of life of those unable to swallow safely and create a pathway to clinic for a generation of soft-robotics-based solutions to common sphincter disorders such as incontinence. We will (a) trial internal and external power solutions; (b) develop an intelligent control strategy; (c) develop an efficient electrically controlled actuator solution with anti-microbial packaging; (d) include patients and healthcare workers in project planning and management; (e) map a regulatory pathway to the first in human use of this novel implantable device (Fig4). This project will deliver the world’s first soft-robotics-based implantable healthcare solution and provide proof-of-concept for a family of novel solutions to other, diverse and common unmet patient needs, especially those involving sphincters (e.g. urinary and faecal incontinence).', 'language': 'en'}, {'description': 'The larynx is principally a sphincter that prevents food, drink and saliva passing onto the lungs. Common neuromuscular and mechanical disturbances of laryngeal function lead to problems managing secretions, food and drink, causing recurrent pneumonia by “aspiration” (Fig1). 30% of persons with stroke develop aspiration, and it is the commonest cause of death in throat cancer survivors5,7 and those with neuromuscular diseases, including motor neurone and Parkinson’s diseases. We aim to transform the lives of those losing laryngeal sphincter function, by combining the cutting-edge technologies of bioengineering and soft robotics, to create an implantable Intra-Tracheal Valve (ITV). The ITV will enable safe swallowing through intelligent airway protection. Our team partners leading surgeons, engineers and scientists with patients, regulatory and business experts. We combine our implantable sphincter-like valve device and electrical biosensing systems, capable of accurately detecting swallowing, with our biomaterials and clinical expertise to deliver a unique prototype ITV device.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7244-5864', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'Vanhoestenberghe', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-8406-472X', 'authenticated-orcid': False, 'given': 'Wenhui', 'family': 'Song', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Justin', 'family': 'Perkins', 'affiliation': [{'name': 'Royal Veterinary College', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-2732-4200', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Conn', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-9109-9987', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Rossiter', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'given': 'Miss', 'family': 'Paulraj', 'affiliation': [{'name': 'UCL Business', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9211-1722', 'authenticated-orcid': False, 'given': 'Martin', 'family': 'Birchall', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 756386.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 8, 1]]}, 'award-end': {'date-parts': [[2023, 7, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 756386.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:29Z', 'timestamp': 1636383569000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222397'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141895}, 'publisher': 'Wellcome', 'award': '050013', 'DOI': '10.35802/050013', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'for a four-year PhD studentship programme in neuroscience.'}], 'investigator': [{'given': 'John', 'family': 'Stein', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Cowey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Susan', 'family': 'Greenfield', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Jeremy', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4134-9730', 'authenticated-orcid': False, 'given': 'Heidi', 'family': 'Johansen-Berg', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Nicholas', 'family': 'Rawlins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Ganter', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Dorette N', 'family': 'Breitkreuz', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Stephanie', 'family': 'Frackowiak', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Bampton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 492394.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1997, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 492394.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:42Z', 'timestamp': 1636383162000}, 'score': 0.0, 'issued': {'date-parts': [[1997, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/050013'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141884}, 'publisher': 'Wellcome', 'award': '216362', 'DOI': '10.35802/216362', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Genetic mechanisms of human ovary development and function: A life course approach'}], 'project-description': [{'description': 'This research focuses on conditions affecting human female reproductive function. These conditions include rare disorders of ovary development in babies, problems with entering puberty in adolescence, and impaired fertility and early menopause in adult women. We aim to enhance our understanding of these conditions by investigating important genetic events underlying their development. Our first aim is to study the dynamic genetic events that occur in the early developing ovary. We then plan to study genetic differences in ovarian follicles before and after puberty, to help us understand how reproductive function changes over a lifecourse and how we may need to adapt our fertility preservation approaches to suit girls and women of different ages. We also intend to perform detailed genetic testing on girls and women with two different reproductive health conditions: Turner syndrome (a condition where a woman has one, rather than two, X chromosomes) and primary ovarian insufficiency (a condition where a woman’s ovaries do not function well). We aim to detect new genetic mechanisms underlying these conditions. This research will allow a more individualised approach to the diagnosis of women with a variety of reproductive health conditions, and pave the way for new treatment approaches.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4289-0852', 'authenticated-orcid': False, 'given': 'Sinead', 'family': 'McGlacken-Byrne', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 4]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:14Z', 'timestamp': 1636383434000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216362'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:21Z', 'timestamp': 1636467141884}, 'publisher': 'Wellcome', 'award': '216348', 'DOI': '10.35802/216348', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Sampling the human gut-liver axis to probe the role of gamma-delta T-cells in cirrhosis'}], 'project-description': [{'description': 'Non-alcoholic fatty liver disease is estimated to occur in 24% of the global population. The progressive form of disease, non-alcoholic steatohepatitis (NASH), develops in a quarter of these patients, which can lead to irreversible liver damage. Increasing evidence suggests that microbes residing in the gut, collectively termed the gut microbiota, may drive the development of NASH. However, the role that immune cells play within this link has not been defined. Gamma-delta T-cells are immune cells that are enriched in the gut and liver, providing local protection from infection. Recent studies in mice have demonstrated specialised subsets of these immune cells present in the liver but not the blood, that were dependent on the gut microbiota, and accelerated the development of NASH. Through sampling human liver tissue and blood entering and leaving the liver, I aim to study the role that these immune cells play in the progression of NASH, and investigate whether microbes or microbial products that migrate into the liver from the gut are able to alter the immune cells’ function. This could help to explain the link between the gut microbiota and liver disease severity in patients with NASH, providing targets for the development of future treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1167-1160', 'authenticated-orcid': False, 'given': 'Nekisa', 'family': 'Zakeri', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2018, 9, 3]]}, 'award-end': {'date-parts': [[2022, 3, 2]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:06Z', 'timestamp': 1636383426000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 3]]}, 'URL': 'http://dx.doi.org/10.35802/216348'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:34Z', 'timestamp': 1636467154104}, 'publisher': 'Wellcome', 'award': '211163', 'DOI': '10.35802/211163', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Irritability, Reward Processing and Adolescent Depression'}], 'project-description': [{'description': 'Depression is a common mental health problem and a leading cause of disability. Rates of depression increase throughout adolescence, with most adult disorders beginning during this time. Despite this, we do not fully understand why depression increases during adolescence or why some people are more vulnerable than others. Depressed adults show changes in processing of reward related information, which potentially contribute to their risk of depression. Children who are more irritable (i.e. more prone to anger in response to frustration e.g. omission of an expected reward) are more likely to develop depression when older. Such children also show changes in processing of reward. Adolescence is a time of significant social, emotional and cognitive development both biologically and environmentally. I hypothesise that irritability in childhood is a consequence of differences in reward processing that lead to depression in adolescence in the context of the developmental and environmental changes. This study aims to investigate these relationships by looking at childhood irritability, reward processing and depressive symptoms. Depression has a complex multi-factorial aetiology; studying childhood risks for depression will improve our understanding of the mechanisms underlying depression, allowing development of more targeted interventions and preventive strategies.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1478-2018', 'authenticated-orcid': False, 'given': 'Ramya', 'family': 'Srinivasan', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 9, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:05Z', 'timestamp': 1636383425000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:35Z', 'timestamp': 1636467155729}, 'publisher': 'Wellcome', 'award': '222991', 'DOI': '10.35802/222991', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the impact of mass drug administration on Plasmodium falciparum population structure in the Bijagos Archipelago of Guinea-Bissau.'}], 'project-description': [{'description': 'The World Health Organisation is committed to help reduce malaria deaths by 90% by 2030. Although long-lasting insecticide treated bed nets (LLINs), rapid diagnostic tests (RDTs) and artemisinin-based medicines (ACT) are essential in reducing the death toll, they are insufficient. A cluster randomised trial will assess the impact of mass drug administration (MDA) of an ACT (dihydroartemisinin-piperaquine, DP) and the mosquito-killing drug ivermectin (IVM) to tackle both human and mosquito reservoirs of malaria infection in Guinea-Bissau. Nested within the trial, the proposed study aims to investigate (1) the origins, diversity, and drug resistance of P.falciparum, the malaria parasite, at the trial site before MDA is given, (2) the impact of MDA on parasite transmission and (3) characterisation and tracking of remaining parasites post-MDA. Whole genome sequencing and genotyping - methods to read parasite genes - will be used to characterise and track parasites after MDA. Antibodies to the parasite will also be investigated as a cost-effective alternative endpoint and sustainable surveillance tool. The study hypothesis is that MDA will decrease P.falciparum transmission to very low levels leading to a decrease in the diversity and numbers of different types of P.falciparum parasites at the trial site.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6257-1250', 'authenticated-orcid': False, 'given': 'David', 'family': 'McGregor', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 6, 28]]}, 'award-end': {'date-parts': [[2024, 6, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:14Z', 'timestamp': 1636383494000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222991'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:38Z', 'timestamp': 1636467158791}, 'publisher': 'Wellcome', 'award': '220589', 'DOI': '10.35802/220589', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the contribution of gamma-delta T-cells to immunosurveillance of cancer and response to immunotherapy'}], 'project-description': [{'description': 'Gamma-delta T-cells are critical for protecting against carcinogenesis in mice but clinical associations have been equivocal and human trials of gamma-delta T-cell therapy have been disappointing. Previous studies have been limited by unavailable technologies to describe these cells with sufficient granularity whilst clinical trials have largely focussed on the more numerous V-delta-2 subtype. Using contemporary methods such as TCR-sequencing and ex vivo culture systems to extract gamma-delta T-cells from human tissues, we recently demonstrated that only certain subtypes of these cells, namely the V-delta-1 subtype, are associated with survival in triple-negative breast cancers. This proposal aims to extend our previous findings to a pan-cancer setting by mapping, with greater and necessary detail, these cells in melanoma, breast, lung and other cancers with a particular focus on V-delta subtyping, differential effector functions and cell regulatory axes. Importantly, we will also map gamma-delta T-cell interactions with alpha-beta T-cells as these cells have been established as being critical to cancer immunosurveillance. We will stratify our findings to clinical outcomes to build a novel reference human tumour gamma-delta T-cell atlas to guide ongoing translational efforts in adoptive gamma-delta T-cell therapy. Hence, this proposal may lead to rapid translation into clinical benefit.', 'language': 'en'}, {'description': 'Modifying the immune system, particularly T-cells, can now cure some patients with stage-4 cancer. However, most patients do not benefit. T-cells are white blood cells which can be further divided into alpha-beta and gamma-delta T-cells. Most current therapies work on alpha-beta T-cells. Gamma-delta T-cells can control cancers in mice, but remain under-utilised in human therapy as clinical trials involving these cells have been disappointing. Using modern sequencing and cell-growing technologies previously not widely available, we recently demonstrated that only certain gamma-delta T-cells, the V-delta-1 subtype, predict survival in aggressive breast cancers. Here we will extend the characterisation of these cells, in far greater detail, into a pan-cancer setting to include melanoma, lung, breast and other cancers. By defining what makes these V-delta-1 cells protective, we will instruct ongoing and future gamma-delta T-cell therapy trials and thus open up effective immunotherapy to those who do not benefit from alpha-beta T-cell therapies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9495-5793', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Hayday', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-4299-3018', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Swanton', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4080-3935', 'authenticated-orcid': False, 'given': 'Yin', 'family': 'Wu', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 698120.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 698120.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:48Z', 'timestamp': 1636383108000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220589'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:41Z', 'timestamp': 1636467161111}, 'publisher': 'Wellcome', 'award': '215317', 'DOI': '10.35802/215317', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Visualising Mitochondrial Import Defects in Neurodegeneration'}], 'project-description': [{'description': 'Mitochondria are powerful, dynamic organelles that, among other things, provide energy for the cell. To do this, most of their proteins, which are nuclear encoded, must be imported from the cytosol via highly regulated import pathways. This mitochondrial import is a conserved process vital for the correct functioning of the cell. It is especially important in energy intensive cells like nerve cells. Thus, mitochondrial dysfunction and defects in mitochondrial import have been implicated in many neurodegenerative diseases and dementias, including Alzheimer’s and Parkinson’s. Despite these identified links, the precise mechanisms by which mitochondrial import defects lead to neurodegeneration, or indeed how neurodegeneration impacts on mitochondrial function, are poorly understood. This project aims to develop new systems to investigate mitochondrial import in models of neurodegeneration. We will use these systems to investigate the effects of blocking import on neuronal function, and of modelling neurodegeneration on mitochondrial function. We anticipate that this will provide mechanistic details that will allow these pathways to be targeted for therapeutic intervention.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1161-3294', 'authenticated-orcid': False, 'given': 'Hope', 'family': 'Needs', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:33Z', 'timestamp': 1636383273000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215317'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:13:25Z', 'timestamp': 1636467205268}, 'publisher': 'Wellcome', 'award': '220580', 'DOI': '10.35802/220580', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Understanding the gene expression dynamics that regulate glioma stem cell transitions'}], 'project-description': [{'description': 'It is believed that glioblastoma multiforme (GBM), the most aggressive form of adult primary brain cancer, arises from abnormal cells of origin (stem cells) in the brain known as glioma stem cells (GSCs). There is no cure for GBM. Importantly, GSCs can assume either an \"active\" or \"dormant\" state. Research suggests that GSCs in the \"dormant\" state are especially resistant to treatment and when made \"active\" again, result in deadly regrowth of cancer. Findings from my host laboratory suggest that such cell-state transitions are controlled by unique patterns of gene expression (\\'expression\\' being the process by which a gene is converted to its relevant protein) as opposed to genes simply being turned on or off. My research will use cutting edge tools to label genes of interest with markers that give off a fluorescent glow. This will allow us to identify patterns of gene expression that causes changes in GSC states. If this research is successful, future treatments could be developed to give doctors control over these cell states. For example, we might be able to prevent \"dormant\" cells from becoming re-activated. By doing so, we can hopefully change what is currently a deadly disease into a chronic manageable condition.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5473-6038', 'authenticated-orcid': False, 'given': 'Richard Zhiming', 'family': 'Fu', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 2]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:04Z', 'timestamp': 1636383484000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220580'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:13:26Z', 'timestamp': 1636467206295}, 'publisher': 'Wellcome', 'award': '222497', 'DOI': '10.35802/222497', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does the purine metabolic checkpoint FAMIN prevent immunopathology?'}], 'project-description': [{'description': \"Children with Still's disease, the paradigm of autoinflammation-cum-autoimmunity, are predisposed to developing a cytokine storm with excessive activation of T lymphocytes upon viral infection. Loss-of-function of FAMIN is the sole known cause for monogenic Still's disease. We de-orphaned FAMIN as an unprecedented purine nucleoside enzyme that combines ADA-, PNP- and MTAP-like activities with adenosine phosphorolysis – challenging fundamental principles of purine metabolism. Dendritic cells with absent FAMIN activity prime for excess antigen-specific cytotoxicity, IFNγ secretion, and T cell expansion, resulting in exaggerated virus-specific T cell responses and immunopathology. Enhanced priming is already manifest with hypomorphic FAMIN-I254V, for which ~6.3% of mankind is homozygous, and which predisposes for Crohn's disease and leprosy. Here we will address FAMIN biology from virtually atomic to organismal resolution: We will explore how FAMIN operates in a cell, and how it controls energy metabolism, ascertaining redox and pH homeostasis. We will investigate how FAMIN in dendritic cells potently restrains T cell priming, and whether the FAMIN-coordinated biochemical mechanisms are involved in often fatal virus-induced cytokine release syndromes. This work will reveal an ancient biochemical mechanism that potently controls adaptive immune activation at a very fundamental level, providing insight into immunity to pathogens, autoinflammation and autoimmunity.\", 'language': 'en'}, {'description': \"Still's disease is a severe disease in children that starts with daily recurring high fever, a rash and lymph node enlargement, and morphs over weeks into a debilitating arthritis. Worse, virus infection can lead to an often fatal cytokine storm. Loss-of-function of FAMIN is the sole known cause for familial Still's disease. We discovered that FAMIN is an unprecedented enzyme involved in the metabolism of adenine and guanine, hence the nucleobases of the genetic code and energy currency of the cell. FAMIN is very ancient, with predecessors already present in bacteria. Its discovery changes our understanding of a very fundamental process of life. A partially active genetic variant of FAMIN is carried by ~6% of the population, and predisposes for Crohn's disease, an inflammatory bowel disease, and leprosy, a chronic infection. Here we explore how FAMIN defects predispose for these conditions, and how that might be prevented and treated.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1419-3344', 'authenticated-orcid': False, 'given': 'Arthur', 'family': 'Kaser', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 2444805.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2444805.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:28Z', 'timestamp': 1636383568000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222497'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:40Z', 'timestamp': 1636465480933}, 'publisher': 'Wellcome', 'award': '222939', 'DOI': '10.35802/222939', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Exploiting Trained-Immunity and Immunometabolism in Tuberculosis (EXTINCT)'}], 'project-description': [{'description': \"Tuberculosis is a bacterial infection that kills more people than any other infection. It spreads from one person to another through the air when they cough. Treating tuberculosis with antibiotics takes at least six months and sometimes two years. Treatment is becoming more difficult because the antibiotics have stopped working for resistant tuberculosis. The current vaccine does not work well at preventing tuberculosis. We need to find new ways to prevent and treat tuberculosis. Our immune system kills tuberculosis most of the time. The most important part of our immune system for killing tuberculosis are macrophages. Macrophages are cells that live in our lungs. Macrophages ‘eat’ and try to ‘digest’ tuberculosis, which kills it. It might be possible to improve the macrophage's ability to kill tuberculosis. My project will try to improve the macrophage’s ability to kill tuberculosis by changing its energy system, or treating them with vitamin A. This might lead to better treatments. My project also will try to train the macrophages before they encounter tuberculosis. This might lead to a better vaccine.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4930-1560', 'authenticated-orcid': False, 'given': 'Conor', 'family': 'Grant', 'affiliation': [{'name': 'Trinity College Dublin', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2020, 7, 12]]}, 'award-end': {'date-parts': [[2023, 7, 11]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:27Z', 'timestamp': 1636383327000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 12]]}, 'URL': 'http://dx.doi.org/10.35802/222939'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:40Z', 'timestamp': 1636465480963}, 'publisher': 'Wellcome', 'award': '213555', 'DOI': '10.35802/213555', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Discovering how transcription factors define human B cell fate decisions in vivo.'}], 'project-description': [{'description': 'The development of antibody-producing plasma cells and memory B cells (MBCs) is essential for immunological memory, yet the transcriptional mechanisms that regulate these different B cell fates are poorly understood. One reason for this is the highly dynamic and heterogeneous nature of B cell maturation and differentiation. This challenge can be overcome using single-cell genomics approaches to examine gene expression networks within rare transitional cell states and hence identify regulatory transcription factors (TFs) that shape B cell fate decisions. I will therefore apply single-cell approaches to primary human B cells to discover the gene regulatory mechanisms that drive human B cell fate choices. Briefly, I will: - Discover TFs linked with B cell fate decisions in vivo using single-cell genomics - Determine how these TFs compete or work together during cell fate commitment by mapping their genome-binding patterns - Functionally dissect how these TFs drive gene expression to define MBC differentiation This will comprehensively identify the TFs and regulatory mechanisms that define gene expression patterns associated with human B cell fate decisions in vivo and will therefore represent an important advance in our understanding of human B cell biology and how immunological memory is achieved.', 'language': 'en'}, {'description': 'B cells are immune cells that are important to human health. When B cells respond to pathogens they can differentiate to plasma cells, which make antibody, or memory B cells, which protect against future infections. The decision to make a memory B cell or a plasma cell is controlled by transcription factors that regulate gene expression. However, we don’t fully understand the mechanisms by which transcription factors do this. I will use cutting-edge single-cell genomics methods to examine transcription factor activity during human B cell development at unprecedented resolution. This will allow me to discover how different transcription factors regulate gene expression to control B cell fate decisions (ie. memory B cell vs plasma cell) and reveal how different transcription factors work together or compete with another during this process. This will be important to develop methods to modify B cell development to improve vaccine efficiency or treat auto-immune disorders.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5972-8926', 'authenticated-orcid': False, 'given': 'Hamish', 'family': 'King', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 1, 17]]}, 'award-end': {'date-parts': [[2023, 1, 17]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:33Z', 'timestamp': 1636382853000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 1, 17]]}, 'URL': 'http://dx.doi.org/10.35802/213555'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:43Z', 'timestamp': 1636465483670}, 'publisher': 'Wellcome', 'award': '061530', 'DOI': '10.35802/061530', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Evolutionary theory of natural and experimental population of microbes.'}], 'project-description': [{'description': \"Although we are confident that evolution has occurred, and continues to occur, we cannot in general observe evolutionary processes directly. We can only make inferences, based on observations of a few special cases such as laboratory evolution experiments with bacteria and viruses. In generalising these inferences, and for understanding evolutionary processes which we cannot observe at all, we rely on evolutionary theory. Evolutionary theory is based on a few empirically determined principles (e.g. Mendel's laws of segregation) and statistical concepts (e.g. fitness). Much of our classical theory is built upon models of diploid sexual organisms, but recently more attention has focused on evolution of predominantly asexual species. In 1930, Fisher pointed out that in an asexual population, if several different adaptive mutations occur in different individuals, then one ultimately must become established in the population at the expense of the others. It is striking that we still have a poor quantitative understanding of this phenomenon. Severe mathematical difficulties arise in modelling the frequencies of many genotypes which fluctuate randomly and non-independently. Models of asexual evolution have yet to fully incorporate the complexities of natural populations: spatial structure, diverse resources to exploit, and population sizes and environmental conditions which fluctuate irregularly in space and time. In addition, many 'asexual' microbes have 'sex', in the sense that they exchange genes by a variety of mechanisms. This project will develop an improved and more realistic framework of evolutionary theory, and apply it to problems concerning how fast, and in which ways, microbial populations evolve. This body of theory will improve the reliability and generality of conclusions drawn from laboratory evolution experiments, surveys of natural populations, and genome sequence data. An improved theoretical understanding of adaptation in microbial populations is important in tackling problems directly relevant to human health, such as the evolution of novel pathogenic and antibiotic resistant bacterial strains.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Toby', 'family': 'Johnson', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 94430.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 94430.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:24Z', 'timestamp': 1636383024000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061530'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T13:44:45Z', 'timestamp': 1636465485778}, 'publisher': 'Wellcome', 'award': '222934', 'DOI': '10.35802/222934', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Defining the pathophysiological mechanisms underlying Low VWF in the Low VWF in Ireland Cohort (LoVIC) study'}], 'project-description': [{'description': 'Von Willebrand Factor (VWF) is a protein that blood needs to clot normally. VWF is made by cells that line our blood vessels called endothelial cells. About 1 in 100 people inherit low levels of Von Willebrand Factor. This means that they have a lifelong bleeding disorder known as Von Willebrand Disease (VWD). People with this disease bruise easily and suffer from nosebleeds. They also sometimes bleed after surgery or after having a tooth removed. We do not fully understand why these patients have low levels of VWF. This is especially true for patients whose levels are only slightly less than usual. This group of patients is known as ‘Low VWF’. People with ‘Low VWF’ also often have bleeding that is more than would be expected. To better understand this disorder, we will study why these patients have low VWF levels. We will study if they are making less VWF or clearing VWF from their circulation too quickly. Finally, we will study why these patients bleed by looking at other parts of the clotting system. This will help improve how we diagnose and treat these patients.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9759-062X', 'authenticated-orcid': False, 'given': 'Dearbhla', 'family': 'Doherty', 'affiliation': [{'name': 'Royal College of Surgeons in Ireland', 'country': 'IE'}]}], 'award-start': {'date-parts': [[2021, 1, 11]]}, 'award-end': {'date-parts': [[2024, 1, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Physiology in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:33Z', 'timestamp': 1636383333000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222934'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T12:43:25Z', 'timestamp': 1636461805415}, 'publisher': 'Wellcome', 'award': '083345', 'DOI': '10.35802/083345', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental and Stem Cell Biology.'}], 'project-description': [{'description': 'Medicine is changing, most significantly by the onset of new applications of cell and molecular biology to the clinic not only for diagnostic purposes, but more importantly to develop new gene- and cell-based therapies. This defines a growing new area of \"regenerative medicine\". At the root of this new discipline is developmental and stem cell biology. This field is united by the overall aim of understanding, and thus learning to control, the changes in gene expression that govern how cells choose from among a multitude of different fates as well as how they organise themselves into functional tissues and organs (\"tissue and organ engineering\"). Although there has been considerable hope placed upon the uses of stem cells for these purposes, a major challenge remains to be able to control both their differentiation and their proliferation, to obtain the desired cell types and the resulting organs/tissues as well as to prevent them from dividing and differentiating uncontrollably when placed into patients. Although much effort is currently spent on surveys of factors able to regulate stem cell self-renewal, proliferation and developmental potency, it is quickly becoming apparent that considerably more fundamental knowledge of stem cell biology is required before we will be able fully to control their behaviour. As stem cells have many characteristics in common with embryonic cells, the discipline of developmental biology is at the centre of this effort. We will need to understand not only the external signals that can regulate cell behaviour but also the transcription factors, chromatin-remodelling and other epigenetic changes that result in key gene regulators being turned on or off. At present we do not even know what most of the regulatory gene targets are, let alone which factors control them. In addition, since stem cells can be isolated from adults, as well as cultured and maintained indefinitely in vitro, this offers an opportunity to use them as a platform for testing of drugs and other treatments which may be tailored specifically to each patient, as there is huge individual diversity in how patients respond to different treatments.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2544-9117', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Copp', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9907-889X', 'authenticated-orcid': False, 'given': 'Claudio', 'family': 'Stern', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2020, 5, 9]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:27Z', 'timestamp': 1636383207000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083345'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:05Z', 'timestamp': 1636467065190}, 'publisher': 'Wellcome', 'award': '061817', 'DOI': '10.35802/061817', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular dynamics typhoon phosph- and fluorimager.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2104-5430', 'authenticated-orcid': False, 'given': 'David', 'family': 'Sherratt', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Penelope', 'family': 'Handford', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-0951-3374', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Whitby', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1395-7173', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Chalmers', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-amount': {'amount': 50000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2001, 12, 31]]}, 'funding': [{'type': 'equipment', 'award-amount': {'amount': 50000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:48Z', 'timestamp': 1636382808000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061817'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:23Z', 'timestamp': 1636467083820}, 'publisher': 'Wellcome', 'award': '063185', 'DOI': '10.35802/063185', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Calcium signalling in cardiac Purkinje and ventricular cells.'}], 'investigator': [{'given': 'Karin', 'family': 'Sipido', 'affiliation': [{'name': 'KATHOLIEKE UNIVERSITEIT LEUVEN', 'country': 'BE', 'id': [{'id': 'https://ror.org/05f950310', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'David', 'family': 'Eisner', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'award-amount': {'amount': 18000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 18000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:01Z', 'timestamp': 1636382821000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063185'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:35Z', 'timestamp': 1636467095992}, 'publisher': 'Wellcome', 'award': '222400', 'DOI': '10.35802/222400', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Determining the role of ubiquitin in transmission stage Plasmodium'}], 'project-description': [{'description': 'Approximately half of the global population is currently at risk of malaria infection, with an estimated 0.5 million deaths annually. Malaria is caused by Plasmodium parasites, which have a complex life cycle involving a vertebrate host and mosquito vector. Blood stage parasites cause the symptoms of malaria in humans, and are therefore the target of most current therapies. In order to reduce the incidence of malaria, and therefore global disease burden, a drug to block transmission between the host and vector is needed. The complex regulation required in transmission stage parasites remains poorly understood. Ubiquitylation is a well-researched post-translational modification which is commonly associated with protein degradation, but also has a range of effects from protein re-localisation to induction or arrest of cell signalling events. The role of ubiquitin in transmission stage parasite development is unknown. We aim firstly to identify the ‘ubiquitome’ of Plasmodium bergheiparasites during transmission stage development using ubiquitin capture systems and mass spectrometry. We subsequently aim to investigate the role of these ubiquitylated proteins during transmission using genetic engineering. These results will improve our understanding of the role ubiquitin may play in the regulation of transmission stage parasite development, and inform future drug discovery efforts.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2496-5053', 'authenticated-orcid': False, 'given': 'Nila', 'family': 'Johnson', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222400'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:44Z', 'timestamp': 1636467104389}, 'publisher': 'Wellcome', 'award': '067802', 'DOI': '10.35802/067802', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Synaptic Plasticity: A Sytems Viewpoint'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2129-2060', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Warburton', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 4550.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 11]]}, 'award-end': {'date-parts': [[2002, 8, 10]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4550.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:57Z', 'timestamp': 1636382817000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 11]]}, 'URL': 'http://dx.doi.org/10.35802/067802'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:46Z', 'timestamp': 1636467106956}, 'publisher': 'Wellcome', 'award': '066577', 'DOI': '10.35802/066577', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A new strategy to identify X-linked disease genes, with particular reference to X-linked mental retardation: Proposal for a pilot study.'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2444-3247', 'authenticated-orcid': False, 'given': 'Douglas', 'family': 'Easton', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'given': 'Martin', 'family': 'Bobrow', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Lucy', 'family': 'Raymond', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 28297.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 11, 1]]}, 'award-end': {'date-parts': [[2003, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 28297.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:52Z', 'timestamp': 1636382812000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066577'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:11:49Z', 'timestamp': 1636467109972}, 'publisher': 'Wellcome', 'award': '222381', 'DOI': '10.35802/222381', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Hydrodynamic interactions in molecular simulations at the biological mesoscale'}], 'project-description': [{'description': 'Macromolecules under flow at the biological mesoscale (10 nm < L < 1 μm, 1 μs < t < 1 ms) can influence the dynamics of each other via hydrodynamic interactions (HIs), however, there is a dearth of mesoscale simulation tools that consider them. Most simulations that include HIs occupy continuum scales (L > 1 μm, t > 1 μs) whereas atomistic scales (L < 50 nm, t < 1 μs) are too small to model long range effects. Using a test-driven development methodology, I aim to address this capability gap by implementing HIs in the Fluctuating Finite Element Analysis (FFEA) software, which represents biological macromolecules as 3D viscoelastic continuum objects that thermally fluctuate. I will validate FFEA simulations of fibrinogen and ribosome macromolecules by exposing them to large viscous forces in extensional flow device (EFD) experiments. This work will improve our simulation capability at the biological mesoscale, which will complement the burgeoning range of experimental imaging techniques such as cryo-electron microscopy (cryoEM) and x-ray crystallography. Furthering our understanding of HIs is crucial in biomedical topics such as fibrin network formation in blood clots, as well as improving the industrial production of biopharmaceuticals and biomimetic fibres.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9142-8261', 'authenticated-orcid': False, 'given': 'Ryan', 'family': 'Cocking', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:58Z', 'timestamp': 1636383478000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222381'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T14:12:12Z', 'timestamp': 1636467132232}, 'publisher': 'Wellcome', 'award': '046122', 'DOI': '10.35802/046122', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD studentship programme in neuroscience.'}], 'investigator': [{'given': 'John', 'family': 'Stein', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Cowey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Susan', 'family': 'Greenfield', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Jeremy', 'family': 'Taylor', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'family': 'Guillery', 'affiliation': [{'name': 'University of Wisconsin-Madison', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6844-4984', 'authenticated-orcid': False, 'given': 'Colin', 'family': 'Akerman', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8947-408X', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Mrsic-Flogel', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'John', 'family': 'Chilton', 'affiliation': [{'name': 'Peninsula College of Medicine & Dentistry', 'country': 'GB'}]}, {'given': 'Nicholas', 'family': 'Rawlins', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Emma L', 'family': 'Harvey', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Nicole K', 'family': 'Mather', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 484343.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1996, 10, 1]]}, 'award-end': {'date-parts': [[2000, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 484343.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:40Z', 'timestamp': 1636383160000}, 'score': 0.0, 'issued': {'date-parts': [[1996, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/046122'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:35Z', 'timestamp': 1636438355538}, 'publisher': 'Wellcome', 'award': '220799', 'DOI': '10.35802/220799', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular mechanisms determining the polarised synaptic distribution and molecular function of the retrograde endocannabinoid signalling system'}], 'project-description': [{'description': 'The endocannabinoid system (ECS) acts as a negative feedback mechanism to suppress excitatory and inhibitory synaptic transmission. This is critically important for a wide range of brain functions including appetite, pain, and cognition. Moreover, ECS dysfunction is implicated in multiple neuropathologies, and there is increasing scientific and public interest in drugs that target the ECS, including medical marijuana. The molecular organisation of the ECS is highly unusual because, in reverse to other neurotransmitter systems, endocannabinoids are released from the postsynaptic membrane to activate receptors at the presynaptic membrane. Despite its importance, remarkably little is known about how the enzymes and receptors essential for ECS ‘backwards’ transmission are targeted to, and retained at, opposing sides of the synapse. Focusing on the primary cannabinoid receptor CB1R and the major endocannabinoid synthesising enzyme diacylglycerol lipase α (DAGLα) as prototypic examples, we will investigate the protein interactions and pathways that determine the architecture and organisation of the ECS. Our goal is to define how the differentially polarised trafficking of ECS components to synapses is orchestrated. This mechanistic knowledge of the ECS will advance understanding of neuronal protein polarisation and inform the design of future strategies to modulate ECS signalling for therapeutic benefit.', 'language': 'en'}, {'description': \"Cannabis has been used as a medicine for thousands of years. Chemicals in cannabis work by activating a protein in the brain called cannabinoid receptor 1 (CB1R), which is part of a network of proteins called the endocannabinoid signalling system (ECS). The ECS dampens-down brain activity by reducing the amount of neurotransmitter released at connections between nerve cells called synapses. This is a vitally important feedback loop that prevents synaptic activity from spiralling out of control. We want to explore the biochemical 'nuts and bolts' of the cellular machinery that controls proteins critical for ECS function. This will provide important new information on how the ECS works, and how it can go wrong. Because a major role of the ECS is to prevent excessive activity which can kill nerve cells, our findings could eventually lead to new ways of enhancing ECS signalling to protect nerve cells in conditions like epilepsy.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3589-8335', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Henley', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 1104076.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2026, 1, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 1104076.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:55Z', 'timestamp': 1636383115000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220799'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:48Z', 'timestamp': 1636438368877}, 'publisher': 'Wellcome', 'award': '220991', 'DOI': '10.35802/220991', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigation of pre-existing immunity to coronaviruses; implications for immunopathology and pathophysiology of COVID-19 disease'}], 'project-description': [{'description': 'Background; It is unknown how prior exposure to commonly circulating human coronaviruses (HCoV) impacts immunity against highly-pathogenic species (SARS, SARS-CoV-2 & MERS). There are limited data, across Europe, Asia and Africa, on the prevalence of infection and seroconversion against widely circulating and mildly symptomatic HCoVs (229E, NL63, OC43, and HKU1). There is a current supposition that antibody-dependent-enhancement (ADE) may play a role in the pathophysiology of COVID-19. ADE occurs when non-neutralizing antiviral proteins facilitate virus entry into host cells, leading to increased infectivity in the cells. In such cases, higher viremia has been measured and the clinical course of disease can be more severe. In preclinical animal models, immunopathology was observed after challenge following vaccination with some SARS vaccines. Therefore, concerns have been raised regarding the impact of immunopathology and ADE on prophylactic vaccination against SARS and possibly SARS-CoV-2. Goals: to perform detailed systems serology of pre-existing immunity, in children and adults, from the UK and Africa, towards novel and commonly circulating coronaviruses. Impact: These studies highlight the limited knowledge in the field and a need for a systematic approach to investigate cross-reactive humoral immunity against HCoV to inform the immunopathology and pathophysiology of COVID-19.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-0900-9629', 'authenticated-orcid': False, 'given': 'Adrian', 'family': 'Hill', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7361-719X', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Pollard', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2160-567X', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Agoti', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}, {'ORCID': 'http://orcid.org/0000-0002-4911-6333', 'authenticated-orcid': False, 'given': 'George', 'family': 'Warimwe', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}, {'ORCID': 'http://orcid.org/0000-0001-9827-9836', 'authenticated-orcid': False, 'given': 'Katie', 'family': 'Ewer', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Tandakha', 'family': 'Dieye', 'affiliation': [{'name': 'IRESSEF', 'country': 'SN'}]}, {'given': 'Jennifer', 'family': 'Hill', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7711-897X', 'authenticated-orcid': False, 'given': 'Teresa', 'family': 'Lambe', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 1217834.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 7, 1]]}, 'award-end': {'date-parts': [[2022, 6, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 755818.1, 'currency': 'GBP', 'percentage': 62}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:59Z', 'timestamp': 1636383119000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220991'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:49Z', 'timestamp': 1636438369613}, 'publisher': 'Wellcome', 'award': '220429', 'DOI': '10.35802/220429', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Making social change happen: What inspires collective action for health and gender equality?'}], 'project-description': [{'description': 'Motivation: Interventions mobilising communities in collective action for their own health are some of the most effective known global health interventions. However, they do not always succeed and we cannot presently predict or explain why this happens. Aim: Taking as an example a community mobilisation programme to prevent violence against women in urban slums in Mumbai, India, I will test theory concerning the drivers of collective action from behavioural economics and social psychology. Method: (1) To unpack how a community mobilisation programme may stimulate collective action in urban India, I will collect and analyse qualitative interview, media and observational data. (2) To uncover the determinants of participation in collective action, I will conduct cross-sectional and difference-in-differences analysis of secondary data from a randomised controlled trial of the same community mobilisation programme. (3) To produce causal evidence for the drivers of collective action, I will conduct a behavioural experiment to test the behavioural effects of changing key messages on programme participants. I will use the answers to (1) and (2) to guide message design. Impact: The study results will be able to guide policy-makers and practitioners on when, how and why complex participatory interventions work to promote health and gender equality.', 'language': 'en'}, {'description': 'Whether to address violence against women, prevent newborns from dying, or hold clinic staff to account for low performance, research shows interventions engaging local people in developing countries in collective action for the common good can have enormous impact. However, results have varied widely. Sometimes, whole communities have rallied in protest and solidarity. At other times, interventions have been abandoned because nobody turned up. We cannot currently predict or explain what happens, because we do not have enough evidence. I aim to find out what inspires people to participate in collective action for their health. Taking as an example a community-based programme to mobilise residents to take action against violence against women in urban slums in Mumbai, India, I will test hypotheses informed by social science using qualitative, survey and experimental methods. My findings will help governments, NGOs and researchers design better programmes to improve people’s health through community participation.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-0370-1430', 'authenticated-orcid': False, 'given': 'Ibrahim', 'family': 'Abubakar', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-9691-9684', 'authenticated-orcid': False, 'given': 'David', 'family': 'Osrin', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Nayreen', 'family': 'Daruwalla', 'affiliation': [{'name': 'Society for Nutrition, Education and Health Action (Sneha)', 'country': 'IN'}]}, {'ORCID': 'http://orcid.org/0000-0002-6296-4644', 'authenticated-orcid': False, 'given': 'Beniamino', 'family': 'Cislaghi', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7757-5625', 'authenticated-orcid': False, 'given': 'Matteo', 'family': 'Galizzi', 'affiliation': [{'name': 'London School of Economics and Political Science (LSE)', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3905-0465', 'authenticated-orcid': False, 'given': 'Lu', 'family': 'Gram', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 1]]}, 'award-end': {'date-parts': [[2024, 11, 30]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:43Z', 'timestamp': 1636383103000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220429'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:50Z', 'timestamp': 1636438370318}, 'publisher': 'Wellcome', 'award': '215676', 'DOI': '10.35802/215676', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a cholera rapid diagnostic test that targets both Vibrio cholerae and vibriophage'}], 'project-description': [{'description': 'Rapid diagnostic tests (RDTs) for Vibrio cholerae are screening tools that provide essential data to guide cholera outbreak response and elimination campaigns in settings that do not have access to a conventional microbiology laboratory. Commercial V. cholerae RDTs are immunochromatographic immunoassays that target V. cholerae O1 (and O139) lipopolysaccharide antigens. The sensitivity of theses RDTS is variable for unknown reasons. We have found that lytic vibriophage that can kill V. cholerae during human infection are associated with a failure of RDTs. To address the negative impact of the lytic vibriophage, we propose to develop a new RDT that targets both V. choleare and the dominant lytic vibriophage ICP1 as a proxy for V. cholerae when the bacterium cannot be directly detected. To do this we propose the following specific aims: (i) Identify lytic vibriophage structural and non-structural proteins that are antigenically unique in diarrheal stool matrix. (ii) Produce mAbs against unique lytic vibriophage protein and V. cholerae LPS, and (iii) Produce, test and compare candidate RDTs for highest performance metrics. This proposal will provide a critical tool to the collaborative effort to combat and eliminate cholera as well as set a precedent for similar approaches for other diseases.', 'language': 'en'}, {'description': 'Rapid diagnostic tests (RDTs) for Vibrio cholerae are tools that provide essential data to guide cholera outbreak response and elimination campaigns in settings that do not have access to a conventional microbiology laboratory. However, existing commercial cholera RDTs have had variable perfomance for unknown reason. We have found that a virus (lytic vibriophage) that can kill V. cholerae during human infection is also associated with a failure of RDTs. We propose to develop a new RDT that targets V. choleare and also includes detection for the virus as a proxy for V. cholerae when the bacterium cannot be directly detected. To do this we proposed to develop antibodies that target unique and conserved phage proteins, add these to the RDT, and then validate the new RDT in a clinical study of cholera patients.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8928-9888', 'authenticated-orcid': False, 'given': 'Firdausi', 'family': 'Qadri', 'affiliation': [{'name': 'International Centre for Diarrhoeal Disease Research, Bangladesh', 'country': 'BD'}]}, {'given': 'Ashraful', 'family': 'Khan', 'affiliation': [{'name': 'International Centre for Diarrhoeal Disease Research, Bangladesh', 'country': 'BD'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2649-2624', 'authenticated-orcid': False, 'given': 'Eric', 'family': 'Nelson', 'affiliation': [{'name': 'University Of Florida', 'country': 'US'}]}], 'award-amount': {'amount': 797228.25, 'currency': 'USD'}, 'award-start': {'date-parts': [[2019, 11, 15]]}, 'award-end': {'date-parts': [[2022, 11, 14]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 582464.2, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:55Z', 'timestamp': 1636383055000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 11, 15]]}, 'URL': 'http://dx.doi.org/10.35802/215676'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:51Z', 'timestamp': 1636438371596}, 'publisher': 'Wellcome', 'award': '221589', 'DOI': '10.35802/221589', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a Universal Group A Streptococcus Glycoconjugate Vaccine'}], 'project-description': [{'description': 'We have recently made the seminal discovery that the Rhamnose-Polysaccharide (RhaPS), a validated vaccine candidate from Group A Streptococcus (GAS), can be recombinantly synthesised using our engineered bacterial glyco-conjugation system. Our vision for the Innovator Award is to translate our proof-of-principle study into late preclinical trials and to develop and validate the first ‘double-hit’ GAS glycoconjugate vaccine candidates. The molecular biology and synthetic biology program focus on optimising protein stability and carbohydrate conjugation to produce for the first-time recombinant GAS glycoconjugate vaccines. The key advantages of our modular designed ‘double-hit’ vaccines include (i) efficacy, (ii) universal protection against all GAS strains and (iii) low-cost production. Lead candidates will be tested for their immunogenicity and the best candidates will be evaluated in two mouse models of GAS infection. We aim to produce at least two vaccine candidates that fulfil the criteria for safety and efficacy. Our vision beyond this 2-year program is to test the best two candidates in clinical trials. We have access to the UCL Vaccine Manufacturing Hub and support from the MSD Wellcome Trust Hillemann Laboratories (for clinical trials and Good Manufacturing Practices for vaccines). We will continue to actively interact with existing industrial partners, including GSK vaccines.', 'language': 'en'}, {'description': 'Group A Streptococcal (GAS) infections kill >500,000 people annually worldwide and currently no vaccine exists. Antimicrobial resistance is emerging globally, and a GAS vaccine is a current global imperative that the WHO has included in its vaccine priority list. An effective GAS vaccine needs to cover all >150 variant strains known and has to be low-cost to be deployed in low income countries where it is most needed. Recently the polyrhamnose sugar backbone that coats GAS cells was validated as vaccine candidate. Sugars are excellent vaccine candidates, particularly when conjugated to carrier proteins, but current methods to achieve this are complex and costly. Using our novel technology, we will conjugate the polyrhamnose sugar to conserved GAS proteins developing a vaccine against all GAS strains. We will use simple E. coli cells that act as mini factories to produce the low-cost vaccine providing the first robust global solution to GAS infection.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6140-9489', 'authenticated-orcid': False, 'given': 'Brendan', 'family': 'Wren', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1288-044X', 'authenticated-orcid': False, 'given': 'Helge', 'family': 'Dorfmueller', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-amount': {'amount': 402298.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 402298.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:10Z', 'timestamp': 1636383130000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221589'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:51Z', 'timestamp': 1636438371618}, 'publisher': 'Wellcome', 'award': '221749', 'DOI': '10.35802/221749', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The dynamics of cell entry and genome replication in a model complex virus'}], 'project-description': [{'description': 'Bluetongue virus (BTV), a complex non-enveloped virus with a genome of ten double-stranded RNA segments, is an important pathogen and model for many similar large non-enveloped viruses (including the medically important rotaviruses). Previous studies have provided a well-understood replication cycle, a large range of research reagents and many novel assay systems, all complemented by high resolution atomic structures of many viral proteins. Notably, the recent structure of the viral polymerase in situ, a critical point of replication, has provided a unique opportunity to investigate many details involved in the virus life cycle. To achieve this we will will use state-of-the-art techniques such as cryoEM, cryo-ET, FCS and FRET in addition to our established in vitro and in vivo assays to determine how BTV entry to the cell causes the polymerase to initiate genome transcription from the 10 genomic dsRNAs and how this process differs from the later process of genome replication which follows the packaging of RNA during assembly. We will define how these processes link to the maturation of newly assembled virus particles and their exit from the cell. Our findings will have the potential to develop laboratory data to translational applications in future design of antiviral and vaccines.', 'language': 'en'}, {'description': 'Viruses enter host cells to establish infection and replicate, i.e. make more copies of their components and assemble into progeny viruses in order to spread. Preventing steps in this process offers the opportunity to control virus disease. Here we focus on Bluetongue virus (a member of a large family of viruses) as a model for complex capsid viruses, to provide answers to fundamental questions of cell entry, genome replication and the generation of new infectious particles. BTV is a pathogenic virus causing economic losses in livestock and the closely related rotavirus causes over 500,000 deaths worldwide through childhood diarrhoea. Using multidisciplinary approaches including state-of-the-art techniques in molecular biology, mutagenesis, super resolution microscopy and cryoEM/ET, we will define the entry and replication processes of these viruses. The results will provide insights into the molecular and structural basis of virus replication and inform rational novel future treatments.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6535-6911', 'authenticated-orcid': False, 'given': 'Polly', 'family': 'Roy', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 1793281.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 1793281.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:16Z', 'timestamp': 1636383136000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/221749'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:08Z', 'timestamp': 1636438328351}, 'publisher': 'Wellcome', 'award': '221401', 'DOI': '10.35802/221401', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Single Cell Expression Atlas'}], 'project-description': [{'description': 'Single Cell Expression Atlas (https://www.ebi.ac.uk/gxa/sc) is an open science resource that offers powerful searches for a gene expression data in different cell types, across tissues, species and conditions. Since its launch in May 2018, the Single Cell Expression Atlas has annotated and reanalysed 132 single cell RNA-Seq (scRNA-Seq) experiments across 12 different species that can be searched and visualised through its web interfaces. The SCEA is unique in that it reprocesses raw scRNA-Seq data in a standardised way. This proposal aims to keep up with the rapid technology development, expand the resource with new data modalities, continue expanding the species coverage and cross-species mapping and expand the functionality of the resource. In particular, we will integrate single cell data sets from spatial and in-situ transcriptomics technologies, as well as emerging single cell omics protocols. Additionally, we will expand the types of analyses performed to facilitate study integration, cell type discovery and annotation. Finally, we will develop anatomograms at the organ, tissue and cell type level to enable intuitive interpretation of the experimental results and easily integrate the different types of data on the user interface.', 'language': 'en'}, {'description': 'Single Cell Expression Atlas is an open access database providing the ability to perform powerful searches and analysis of single cell gene expression data. Data is generated by re-analysing raw experimental data to high standards. To meet growing demand, we will develop new analysis pipelines to ensure robust results and extend the level of annotation for genes and cell types in new areas of research. Continued web interface improvement will allow researchers to visualise ever more complex data in an easy way to understand. This provides any biological researcher with the ability to reliably reanalyse data from multiple experiments and further progress their research. Increasing numbers of datasets requires changing from a study specific view to that of whole biology. This will be developed alongside a user interface enabling easy interpretation of gene changes at cell level between health and disease and so enable more rapid progress in research areas.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7270-5470', 'authenticated-orcid': False, 'given': 'Irene', 'family': 'Papatheodorou', 'affiliation': [{'name': 'EMBL-EBI', 'country': 'GB', 'id': [{'id': 'https://ror.org/02catss52', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1560990.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1560990.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:04Z', 'timestamp': 1636383124000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/221401'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:11Z', 'timestamp': 1636438331217}, 'publisher': 'Wellcome', 'award': '219762', 'DOI': '10.35802/219762', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Epidemiological and mechanistic studies on the role of pneumococcal conjugate vaccine in antimicrobial resistance in Laos'}], 'project-description': [{'description': 'PCVs prevent pneumonia and invasive pneumococcal disease (IPD). The serotypes contained within PCV are those which carry most antimicrobial resistance (AMR). PCVs reduce the carriage of PCV serotypes, and also limit the use of antibiotics by preventing pneumococcal infections. In the US, the 13-valent PCV (PCV13) reduced childhood IPD AMR by >75%. Despite a high pneumonia burden in Asia, very few countries have adopted PCV into their national immunisation programs. PCV may have a substantial role in reducing AMR and it is vital that the role of PCV in reducing AMR in this region is determined. PCV introduction has also led to serotype replacement with serotypes that are not included in the vaccine (NVTs). It is therefore important to define pneumococcal population changes and identify emergent clones in the post-PCV era. In 2013, we commenced pneumococcal carriage surveillance in Laos in children aged 2- 59 months with acute respiratory infection (ARI). Our proposed study in Laos will: a) determine the PCV13 effectiveness against AMR in pneumococcal carriage isolates; b) determine the AMR and virulence of emerging NVTs; and c) investigate using a life-like system the recombination frequency for the acquisition of resistance genes, and secondary chromosomal insertions, in pneumococcal NVTs.', 'language': 'en'}], 'investigator': [{'given': 'Mayfong', 'family': 'Mayxay', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0002-7620-4822', 'authenticated-orcid': False, 'given': 'Elizabeth', 'family': 'Ashley', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0599-8645', 'authenticated-orcid': False, 'given': 'Cattram', 'family': 'Nguyen', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0003-1239-0782', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Simpson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3164-8849', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'Satzke', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}, {'ORCID': 'http://orcid.org/0000-0003-0573-5658', 'authenticated-orcid': False, 'given': 'Jorge', 'family': 'Vidal', 'affiliation': [{'name': 'University of Mississippi', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3077-9639', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Russell', 'affiliation': [{'name': \"Murdoch Children's Research Institute\", 'country': 'AU'}]}], 'award-amount': {'amount': 760056.0, 'currency': 'AUD'}, 'award-start': {'date-parts': [[2020, 3, 1]]}, 'award-end': {'date-parts': [[2023, 3, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 404672.6, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:33Z', 'timestamp': 1636383093000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219762'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:12Z', 'timestamp': 1636438332274}, 'publisher': 'Wellcome', 'award': '215619', 'DOI': '10.35802/215619', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Deep conditioning using CRISPR edited T cells'}], 'project-description': [{'description': 'T cells modified to express chimeric antigen receptors (CAR) have been successfully applied to treat B cell malignancies and are now being made more widely available as the first licenced products become available. The application of similar strategies against acute myeloid leukaemia have been challenging, in particular in infants and young children. Mortality is anticipated to be >70% for children who relapse after a first allogeneic transplant in high risk AML, and this reflects a failure to eliminate residual disease with chemotherapy or by anti-leukaemia transplant effects. We propose applying CRISPR base editing tools to generate ‘off the shelf’ T cells expressing CARs against different antigens and aim to secure deep molecular remission during pre-transplant conditioning in children who otherwise face a dismal prognosis. This application seeks to complete preclinical stage investigations of targeted base-conversion by cytidine deamination to disrupt critical genes required to overcome HLA-barriers and allow expression of CARs specific for shared T and myeloid lineage antigens. We propose translational advancement and rapid deployment into a Phase 1 trial in UK and Germany of the most effective available reagents to address unmet clinical need, while continuing development work on additional target antigens and improved editing tools.', 'language': 'en'}, {'description': \"Acute myeloid leukaemia (AML) is a cancer of white blood cells and is treated with chemotherapy, followed by bone marrow transplant from a suitably matched donor. Unfortunately if AML persists through these treatments, the outlook is very poor, with most children succumbing to the disease. We have developed genome engineering techniques to collect and modify healthy donor immune cells (T cells) so that they don't need to be matched to a specific patient, but are armed against AML and can help clear out a patient's bone marrow. This form of 'deep conditioning' uses multiple CARs (Chimeric antigen receptors) to eliminate any AML cells remaining after chemotherapy, and this will then be followed by a second transplant to repopulate the blood and immune system. A similar approach has shown promise against other forms of leukaemia and we believe early application in the highest risk AML children is now justified.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9275-2415', 'authenticated-orcid': False, 'given': 'Farzin', 'family': 'Farzaneh', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Paul', 'family': 'Veys', 'affiliation': [{'name': 'Great Ormond Street Hospital for Children', 'country': 'GB'}]}, {'given': 'Axel', 'family': 'Schambach', 'affiliation': [{'name': 'Hannover Medical School', 'country': 'DE'}]}, {'given': 'Martin', 'family': 'Sauer', 'affiliation': [{'name': 'Hannover Medical School', 'country': 'DE'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8353-4494', 'authenticated-orcid': False, 'given': 'Waseem', 'family': 'Qasim', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4114118.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 12, 1]]}, 'award-end': {'date-parts': [[2023, 12, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 4114118.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:55Z', 'timestamp': 1636383055000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215619'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T06:12:15Z', 'timestamp': 1636438335836}, 'publisher': 'Wellcome', 'award': '220422', 'DOI': '10.35802/220422', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The evolution of mobile genetic elements in Gram-negative bacteria'}], 'project-description': [{'description': 'I will explore how structural variation can be used to understand the evolution of antimicrobial resistance (AMR) on mobile genetic elements (MGEs). Most previous research is biased towards nucleotide-level variations in the core genome (high-effect SNPs). Now, the availability of complete genomes means that resolving the larger structural variation of MGEs is both possible and increasingly relevant for the spread of AMR. I will develop a framework to model the non-mutational processes which generate this variation, then apply this to the linked evolution of MGEs and their ‘host’ genomes. During this fellowship, I will sequentially: - Aim 1. Develop a tool to quantify structural variation and resolve common blocks around the flanking region of AMR genes, which I have previously shown can be used for phylogenetic reconstruction. - Aim 2. Apply this to longitudinal datasets and obtain rate estimates for non-mutational processes. - Aim 3. Investigate the compensatory evolution of MGEs as they move between genomic backgrounds. Two major applications will be: - Application 1. Small transposons, leading on from my pioneering work on the mcr-1 transposon. - Application 2. Clinical class 1 integrons, which carry multiple AMR genes. This proposal tackles questions of fundamental importance for the evolution of flexible genomes.', 'language': 'en'}, {'description': 'Bacterial genomes can adapt by small changes in individual genes and by structural rearrangements, including new genes which travel between genomes on mobile genetic elements. Structural variation is of particular importance for antimicrobial resistance (AMR). With older DNA sequencing technologies, genomes were incomplete and fragmented. Now, complete genomes are common: the challenge is to understand structural variation. I will use structural variation in bacterial genomes to help us understand their recent evolutionary history. I have developed a promising approach to extract shared sequence patterns from diverse regions around AMR genes. I will extend this and develop models of the underlying processes. I will test specific hypotheses about natural selection in bacterial genomes: between mobile ‘parasites’ and their genome ‘hosts’. By using my computational methods for clinically relevant examples, I will help to understand the evolution and spread of AMR. Making software freely available will allow others to do the same.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-7941-813X', 'authenticated-orcid': False, 'given': 'Craig', 'family': 'MacLean', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'given': 'Richard', 'family': 'Neher', 'affiliation': [{'name': 'University of Basel', 'country': 'CH'}]}, {'given': 'Eduardo', 'family': 'Pimentel Cachapuz Rocha', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7332-0820', 'authenticated-orcid': False, 'given': 'Liam', 'family': 'Shaw', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 5]]}, 'award-end': {'date-parts': [[2025, 1, 4]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Pathogen Biology and Disease Transmission', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:43Z', 'timestamp': 1636383103000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220422'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:12Z', 'timestamp': 1636458252794}, 'publisher': 'Wellcome', 'award': '223535', 'DOI': '10.35802/223535', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'RSTMH small grants for snakebite 2021-23'}], 'project-description': [{'description': 'Snakebite is a strategic priority for RSTMH given its high levels of death and disability. Although there has been an increase in research funding recently, there is still an unmet need to encourage junior researchers to undertake a career in snakebite research. The RSTMH Small Grants Programme is a unique grant funding programme open to early career researchers from anywhere in the world that aims to fill a gap in the research career pathway. RSTMH grants are for up to £5,000 to those early in their careers (e.g. researchers, healthcare professionals, NGO workers, health economists, social scientists) who are working in a field relevant to tropical medicine or global health. These grants typically represent the first time someone has received funding in their own name and helps develop their research and management skills. In 2020, Wellcome piloted a partnership with RSMTH to fund 10 grants in snakebite research. With Wellcome funding, RSTMH awarded grants to African, Asian, South American and European nationals across various snakebite research areas. Following on from the success of the pilot, RSTMH is seeking funding for a 3-year partnership with Wellcome to fund 10 projects per year and up to 30 in total in snakebite research.', 'language': 'en'}], 'lead-investigator': [{'given': 'Tamar', 'family': 'Ghosh', 'affiliation': [{'name': 'Royal Society of Tropical Medicine and Hygiene', 'country': 'GB'}]}], 'award-amount': {'amount': 166200.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 6, 18]]}, 'award-end': {'date-parts': [[2024, 6, 17]]}, 'funding': [{'type': 'award', 'scheme': 'Snakebite Priority Area', 'award-amount': {'amount': 166200.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:37Z', 'timestamp': 1636383517000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 6, 18]]}, 'URL': 'http://dx.doi.org/10.35802/223535'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:12Z', 'timestamp': 1636458252812}, 'publisher': 'Wellcome', 'award': '220118', 'DOI': '10.35802/220118', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Atomistic Simulations of Cardiac Troponin'}], 'project-description': [{'description': \"Troponin plays an essential role in the skeletal and cardiac muscle contraction process which is mediated by sarcomeric Ca2+ concentration. Phosphorylation on cardiac troponin complex changes troponin's Ca2+ sensitivity hence modulates heart rate. Several point mutations on thin filament disrupt the heart’s normal contractile functionality and eventually lead to inherited cardiomyopathies. It was shown that in the mutated troponin tissues the myofilament Ca2+ sensitivity is not reduced upon phosphorylation by protein kinase A, and this relationship is termed the uncoupling phenomenon. In a recent study of small molecules related to the natural products EGCG and Silybin we found 22 small molecules that were capable of specifically restoring the coupled relationship between Ca2+ sensitivity and phosphorylation state, and these compounds are termed recouplers. In previous studies, our group has attempted at elucidating the changes in protein dynamics introduced by phosphorylation and TNNC1 G159D mutation. In this project, we aim to use molecular dynamics simulations to reveal the underlying mechanisms of recouplers. We hope that with a deeper understanding of the molecular mechanisms of both the disease-causing mutations and the recouplers, we can take a rational approach in designing novel therapeutic compounds that are effective in treating cardiomyopathies while having minimal side-effects.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2957-8063', 'authenticated-orcid': False, 'given': 'Zeyu', 'family': 'Yang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:42Z', 'timestamp': 1636383342000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220118'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:13Z', 'timestamp': 1636458253284}, 'publisher': 'Wellcome', 'award': '223771', 'DOI': '10.35802/223771', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mental Health Science Summit Bursaries'}], 'project-description': [{'description': \"The MQ Mental Health Science Summit, in collaboration with Wellcome, is an interdisciplinary mental health science conference. It brings together people from all disciplines and sectors, focused on transforming mental health. Key to this is the involvement of people with lived experience of mental illness, early career researchers, and delegates from LMICs. Attendance at the Summit is ticketed. Many delegates are attending in a work capacity, and so are both salaried and have their costs covered by their organisation. For certain groups of key delegates, the ticket price is prohibitive. This is particularly true for people with lived experience who often attend such events in a voluntary capacity and some of whom are insecurely employed, early career researchers who often do not have research grants available to cover conference attendance, and delegates from LMICs who are economically less able to have such funds available. Following Wellcome' Cat Sebastian’s contributions to the organising committee, we are applying for £4,000 to enable subsidised places for delegates from these three groups to attend the Summit. This will enable 30 delegates to attend. Aa agreed, any funds not spent on bursaries for this year’s Summit will be used to widen access at subsequent events.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Emily', 'family': 'Wheeler', 'affiliation': [{'name': 'MQ Transforming Mental Health', 'country': 'GB'}]}], 'award-amount': {'amount': 6880.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 5, 12]]}, 'award-end': {'date-parts': [[2021, 6, 11]]}, 'funding': [{'type': 'award', 'scheme': 'Mental Health Priority Area', 'award-amount': {'amount': 6880.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:32Z', 'timestamp': 1636383512000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 5, 12]]}, 'URL': 'http://dx.doi.org/10.35802/223771'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:14Z', 'timestamp': 1636458254914}, 'publisher': 'Wellcome', 'award': '223718', 'DOI': '10.35802/223718', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'DECIPHER'}], 'project-description': [{'description': \"DECIPHER’s mission is to lead an international collaborative effort to collect, annotate, share and aggregate genotypic and phenotypic data on rare disease patients in order to catalyse the discovery of new disorders and to improve clinical diagnostic interpretation of genome variation. It is the only online data-sharing platform which provides live, rich contextualisation of genomic variation and phenotype data in patients undergoing research and diagnostic testing globally, including for underserved areas of the world. Since 2004, collaborating rare disease genomics projects and clinical genetic diagnostic centres have uploaded and openly shared consented data on more than 38,000 patients. Our plans to improve DECIPHER include driving increased global sharing and aggregation of clinical and research data; integrating relevant new research datasets to accelerate discovery science; developing functionality to support variant interpretation of the non-coding genome; and improving gene-phenotype-disease modelling to drive discovery research and drug development. We will migrate DECIPHER from the Wellcome Sanger Institute to EMBL's European Bioinformatics Institute (EMBL-EBI), taking advantage of EMBL-EBI's rich resource environment and expertise in delivering web services and training. DECIPHER will operate and grow in an efficient and sustainable manner, providing an essential bridge to research resources to strengthen their clinical impact.\", 'language': 'en'}, {'description': 'About 6% of individuals have rare genetic disorders, sometimes affecting only dozens of people globally. DECIPHER’s main aims are to enable doctors and researchers worldwide to work together to understand these disorders, to identify new disease-associated genes and potentially to develop new therapies. Our website lets clinical geneticists enter patient data securely and search existing data to find matches amongst other patients with similar rare genetic changes or disorders. A match can provide information on patient outcomes and sometimes a diagnosis or possible treatment. As more genomes are sequenced, we have increased opportunities to find matches between individuals with genetic disorders. Furthermore, we can use information on genetic variation in the wider population so common genetic changes can be ruled out as causes of particular disorders. Our project is truly global: currently, geneticists across more than 200 approved centres in around 40 countries are contributing their patient data to DECIPHER.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-6410-0882', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Firth', 'affiliation': [{'name': 'Cambridge University Hospitals NHS Foundation Trust', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7445-2419', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Cunningham', 'affiliation': [{'name': 'European Molecular Biology Laboratory', 'country': 'GB', 'id': [{'id': 'https://ror.org/03mstc592', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1560057.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 4, 1]]}, 'award-end': {'date-parts': [[2026, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1560057.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:28Z', 'timestamp': 1636383568000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223718'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:42Z', 'timestamp': 1636458222054}, 'publisher': 'Wellcome', 'award': '064775', 'DOI': '10.35802/064775', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Electron microscope studies on biological macromolecules.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9445-0069', 'authenticated-orcid': False, 'given': 'Louise', 'family': 'Johnson', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 193172.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 193172.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:29Z', 'timestamp': 1636382909000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064775'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:42Z', 'timestamp': 1636458222069}, 'publisher': 'Wellcome', 'award': '083434', 'DOI': '10.35802/083434', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular functions in disease.'}], 'project-description': [{'description': 'Disease may result as a consequence of genetic variation, be acquired through infection, or developed through other interactions with the environment. However, the disease state invariably involves many of these factors interacting in complex interrelated pathways. Understanding the totality of the disease state therefore requires knowledge of the detailed molecular changes that occur and how these impact on cell biology, the tissue and the organism(s). Traditionally, biomedical research has been discipline led and frequently confined within narrow specialisms that offer only a limited perspective. As our understanding of the complexity and interrelatedness of biological systems has increased, it has become clear that a focus on a narrow research field is no longer a tenable approach. It has thus been, and remains, the primary objective of the Molecular Functions in Disease programme to inspire the next generation of biomedical research leaders trained in a broad range of interdisciplinary subjects that will allow them to contribute effectively to research efforts across traditional boundaries.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-7857-4520', 'authenticated-orcid': False, 'given': 'Olwyn', 'family': 'Byron', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2018, 1, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:23Z', 'timestamp': 1636383203000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083434'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225183}, 'publisher': 'Wellcome', 'award': '213494', 'DOI': '10.35802/213494', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Spatiotemporal dynamics of arbovirus transmission: implications for disease control and elimination'}], 'project-description': [{'description': 'This project will better characterise the transmission dynamics of dengue, Chikungunya and Zika viruses, their persistence in the global human population and use the insights gained to refine assessments of the potential impact of interventions. I will develop evidence-synthesis models linking multiple streams of surveillance data to estimate spatiotemporal variations in the reproduction number of Chikungunya and Zika viruses from the recent epidemics in Colombia and Brazil and use age-stratified dengue incidence data to estimate the transmission intensity of dengue. Analyses of geospatial correlation between transmission intensity estimates of the arboviruses will provide insight into transmission similarities and potential immune-mediated interactions. Using advanced inferential techniques, I will characterise climate-dependent entomological and epidemiological parameters, which will be used to produce global dynamic maps of arbovirus transmission intensity. I will then add spatial structure to the dynamical models of arbovirus transmission to explore the extent to which seasonality, immune-mediated interactions, human movement and zoonotic reintroduction determine arbovirus persistence and the feasibility of elimination. Analyses of clinical trial data will provide insights into the immunogenicity, efficacy and mode of action of the Takeda dengue vaccine and inform the targeting and optimisation of vaccination alone and in combination with other interventions in specific locations.', 'language': 'en'}, {'description': 'Every year, hundreds of millions of people are infected by mosquito-borne dengue, Chikungunya, and Zika viruses. New promising vaccines, drugs and other interventions (e.g. making mosquitoes resistant to infection) are in advanced development, but to make best use of these we need to improve our understanding of how these infections are transmitted. We do not yet fully understand how and why transmission varies from place to place and is affected by climate. My research will address these knowledge gaps and will assess how different interventions might reduce or stop disease transmission. I will use mathematics and statistics to analyse case data collected in Latin America to better understand how seasonal changes in climate affect transmission and thus the geographic spread of epidemics and to predict the impact of vaccination alone and in combination with other interventions. This research will inform policymakers on how to best use interventions to prevent disease.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1154-8093', 'authenticated-orcid': False, 'given': 'Neil', 'family': 'Ferguson', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9959-0706', 'authenticated-orcid': False, 'given': 'Ilaria', 'family': 'Dorigatti', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 1015573.75, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 9, 1]]}, 'award-end': {'date-parts': [[2025, 3, 1]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 918513.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:49Z', 'timestamp': 1636383049000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/213494'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225193}, 'publisher': 'Wellcome', 'award': '220593', 'DOI': '10.35802/220593', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Measuring unmet need in sexual and reproductive health among women under the age of 25'}], 'project-description': [{'description': 'When designing and evaluating health policies, there is a particular challenge that often arises - how do we work out the number of people who need healthcare but haven’t received it? This is often referred to as ‘unmet need’. Although a lot of data are collected regarding the use of healthcare services, by definition, the people who aren’t receiving the services that they require do not contribute to these datasets. My thesis will look at the concept of unmet need through the lens of sexual and reproductive health, attempting to ascertain whether we can calculate levels of unmet need across England using the data that we already have available. Through this project I will attempt to calculate the number of women in England under the age of 25 who did not receive the sexual and reproductive healthcare that they needed between 2010 and 2020. I will then use financial data to work out whether this unmet need was greater in areas that had smaller budgets for sexual and reproductive health during this period.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4177-1832', 'authenticated-orcid': False, 'given': 'Danielle', 'family': 'Solomon', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2019, 9, 2]]}, 'award-end': {'date-parts': [[2022, 12, 20]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:30Z', 'timestamp': 1636383330000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 9, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220593'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225798}, 'publisher': 'Wellcome', 'award': '216324', 'DOI': '10.35802/216324', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'International Brain Laboratory'}], 'project-description': [{'description': 'Understanding the neural circuit basis of behaviour is one of the great challenges in biology. Yet no single laboratory can study the many brain regions, connections, and cell types working together o coordinate decision-making. There is thus a disparity between the capacity of individual laboratories and the complexity of problems being addressed. The International Brain Laboratory orchestrates the efforts of 21 experimental and theoretical laboratories to understand a single behavior. By standardizing experimental procedures and data pipelines, we enable the data acquired by different laboratories to be assembled into a large combined dataset. Our mouse decision-making task requires valuation of different choices based on sensory evidence, choice selection based on this valuation, and integration of prior experience to update a model of the world. We seek a comprehensive understanding of the neural mechanisms underlying these functions, at scales ranging from single neurons to local microcircuits to inter-area communication. To do so we will harness powerful electrophysiological, optical, and genetic tools, and exploit the rich set of theories and analytical approaches developed in recent years. This large-scale effort will provide the first end-to-end “standard model” of a complex mammalian behavior, and inspire new ways to collaborate on difficult problems in neuroscience.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8947-408X', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Mrsic-Flogel', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-3476-1839', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Dayan', 'affiliation': [{'name': 'Max Planck Institute for Biological Cybernetics', 'country': 'DE'}]}, {'ORCID': 'http://orcid.org/0000-0003-4880-7682', 'authenticated-orcid': False, 'given': 'Matteo', 'family': 'Carandini', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-4921-8521', 'authenticated-orcid': False, 'given': 'Sonja', 'family': 'Hofer', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-5930-6456', 'authenticated-orcid': False, 'given': 'Kenneth', 'family': 'Harris', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7913-9109', 'authenticated-orcid': False, 'given': 'Zachary', 'family': 'Mainen', 'affiliation': [{'name': 'Centro Champalimaud', 'country': 'PT'}]}, {'given': 'Peter', 'family': 'Latham', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Alexandre', 'family': 'Pouget', 'affiliation': [{'name': 'University of Geneva', 'country': 'CH'}]}, {'given': 'Jonathan', 'family': 'Pillow', 'affiliation': [{'name': 'Princeton University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0003-4738-2539', 'authenticated-orcid': False, 'given': 'Ila', 'family': 'Fiete', 'affiliation': [{'name': 'Massachusetts Institute of Technology', 'country': 'US', 'id': [{'id': 'https://ror.org/042nb2s44', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Dora E', 'family': 'Angelaki', 'affiliation': [{'name': 'New York University', 'country': 'US'}]}, {'given': 'Larry', 'family': 'Abbott', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-9318-9636', 'authenticated-orcid': False, 'given': 'Sophie', 'family': 'Deneve', 'affiliation': [{'name': 'Institut National De La Sante Et Recherche Medicale (INSERM)', 'country': 'FR'}]}, {'given': 'Anthony', 'family': 'Zador', 'affiliation': [{'name': 'Cold Spring Harbor Laboratory', 'country': 'US'}]}, {'given': 'Anne', 'family': 'Churchland', 'affiliation': [{'name': 'Cold Spring Harbor Laboratory', 'country': 'US'}]}, {'given': 'Ilana', 'family': 'Witten', 'affiliation': [{'name': 'Princeton University', 'country': 'US'}]}, {'given': 'Liam', 'family': 'Paninski', 'affiliation': [{'name': 'Columbia University', 'country': 'US'}]}, {'given': 'Yang', 'family': 'Dan', 'affiliation': [{'name': 'University of California, Berkeley', 'country': 'US'}]}, {'ORCID': 'http://orcid.org/0000-0002-6670-7362', 'authenticated-orcid': False, 'given': 'Karel', 'family': 'Svoboda', 'affiliation': [{'name': 'Howard Hughes Medical Institute', 'country': 'US'}]}, {'given': 'Surya', 'family': 'Ganguli', 'affiliation': [{'name': 'Stanford University', 'country': 'US'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2673-8957', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Hausser', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 9599726.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2025, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cellular and Molecular Neuroscience', 'award-amount': {'amount': 9599726.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:00Z', 'timestamp': 1636383060000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/216324'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225757}, 'publisher': 'Wellcome', 'award': '222781', 'DOI': '10.35802/222781', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Multiscale computational and experimental investigation of ventricular arrhythmogenesis in diabetes'}], 'project-description': [{'description': 'Ventricular arrhythmia is the leading cause of death in diabetes, but its mechanisms remain poorly understood, leading to suboptimal therapy. I propose an interdisciplinary project to address this unmet need, combining multiscale human cardiac simulations and experimental studies. I will use my recent computational model of a human myocyte ToR-ORd, which was extensively validated for arrhythmia research, disease representation, and drug assessment. Goal 1) To build a computational model of a single diabetic myocyte and use it to elucidate how distinct aspects of diabetic remodelling contribute to arrhythmia, also investigating the role of glucose level disturbance. Goal 2) To demonstrate how remodelling of cardiac sympathetic signalling at the myocyte level affects diabetic arrhythmia vulnerability using simulations informed by newly collected FRET imaging data. Goal 3) To integrate the single-cell results into 3D models of ventricles based on patient-specific clinical imaging data, investigating the diabetic remodelling of cardiac conduction properties. Goal 4) To produce a computational tool to search for new drugs with promising antiarrhythmic effects in diabetes and to assess existing therapies, suggesting their optimisation. In summary, the project is likely to impact future diabetic therapy and to bring new insights into the so-far poorly understood area of diabetic arrhythmogenesis.', 'language': 'en'}, {'description': 'Diabetes mellitus, a metabolic disease characterised by high blood sugar levels, affects 463 million people worldwide. The leading cause of death in diabetes is ventricular arrhythmia, a disturbance of cardiac electrical activity, which remains poorly understood given the difficulty of clinical investigation and lack of translational animal models. I propose to tackle this problem by combining state-of-the-art human-specific computational simulations with new experiments. Building on my recent successful computational model of a human cardiac cell, I will aim to elucidate which aspects of diabetic remodelling promote arrhythmia and how. I will investigate factors such as cell-level remodelling, blood sugar levels, brain-heart communication, and clinically informed structural changes. Ultimately, I will develop new computational methodology to search for promising therapies to treat diabetic arrhythmogenesis. This project will improve our understanding of diabetic arrhythmia and is expected to lead to population-level and personalised translational applications, potentially positively impacting millions of people worldwide.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0157-4386', 'authenticated-orcid': False, 'given': 'Jakub', 'family': 'Tomek', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 300000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2025, 8, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Physiology in Health and Disease', 'award-amount': {'amount': 300000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:04Z', 'timestamp': 1636383544000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222781'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225762}, 'publisher': 'Wellcome', 'award': '222490', 'DOI': '10.35802/222490', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A Suite of Studies Exploring the Impact of Vision Care on Achieving the Sustainable Development Goals in Low and Middle-Income Countries'}], 'project-description': [{'description': \"The following will extend our previous successful trials on impact of vision care on children's education and adult productivity: - CLEVER (Cognitive Level Enhancement through Vision Exams and Refraction): The first randomized trial to assess impact of eye care delivery (near and distance spectacles) on reducing rates of cognitive decline with aging, enrolling 874 participants >= 60 years in Hyderabad, India. - Piloting and delivery of STABLE (Slashing Two-wheeled Accidents By Leveraging Eyecare): The first randomized trial on the impact of vision care (distance spectacles) on traffic safety in a lower-middle income country (Vietnam), involving 875 young myopic motorcycle users. - Piloting and delivery of THRIFT (Transforming Households with Refraction and Innovative Financial Technology): A randomized trial on the impact of free reading glasses to support use of smartphone banking apps in Bangladesh among 400 elderly recipients of government Old Age Allowance payments. - ZEAL (Zimbabwe Eyecare And Learning) formative research on hyperopia and educational outcomes in Zimbabwe: . This work involving 2000 school-aged children in order to prepare for an eventual randomized trial will assess a novel, low cost vision test we have designed to screen for hyperopia, while examining the impact of uncorrected hyperopia on children’s current reading levels.\", 'language': 'en'}, {'description': \"Background: Our past studies have shown that free glasses improve children's studies and adult's work productivity, helping launch large government and industry programs to provide glasses in China and India. We will expand studies to new areas where vision transforms lives. Approach: We will study the impact of giving glasses on: - Slowing cognitive decline in Indian nursing home residents. Three-quarters of them need glasses, and there is evidence vision loss may be linked to cognitive decline, but definite proof is needed. - Improving safety of young motorcycle drivers in Vietnam, who have high rates of both poor vision and accidents. - Enhancing use of smartphone banking apps among the elderly in Bangladesh receiving digital government benefits, who cannot see to use smartphones - Improving learning among far-sighted children in Zimbabwe. Impact: Vision programs launched by successful studies can deliver better mental health in aging, safer streets, enhanced financial resilience and improved children's learning.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9866-3416', 'authenticated-orcid': False, 'given': 'Nathan', 'family': 'Congdon', 'affiliation': [{'name': \"Queen's University Belfast\", 'country': 'GB'}]}], 'award-amount': {'amount': 3100312.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 9, 1]]}, 'award-end': {'date-parts': [[2026, 8, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 3100312.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:37Z', 'timestamp': 1636383577000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222490'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:45Z', 'timestamp': 1636458225785}, 'publisher': 'Wellcome', 'award': '222583', 'DOI': '10.35802/222583', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The roles of modern and ancestral visual pathways in the mammalian brain, for defensive behaviours and spatial navigation'}], 'project-description': [{'description': 'In order to survive, animals need to avoid predators and skillfully navigate the environment. These behaviors critically depend on the sense of vision. In mammals, two distinct systems process visual information: the evolutionarily ancient \"superior colliculus\" and the modern \"visual cortex\". We will define their relative functions in two natural behaviors essential for survival: (1)innate defensive responses and (2)spatial navigation. 1)We will study the visual cortex\\'s role in controlling innate defensive behaviors triggered by the superior colliculus. We will focus on the mouse postrhinal-cortex (POR), capitalizing on my discovery that the superior colliculus has, through POR, a dedicated cortical space from which it receives direct excitatory feedback.(Beltramo,Science,2020). We will test the hypothesis that POR, relaying contextual information about the estimated threatening nature of visual stimuli, controls collicular function\\'s plasticity. By silencing distinct cortico-collicular projections, we will determine how the visual cortex shapes the flexibility of colliculus-mediated innate behaviors. 2)We will investigate the contributions of the two visual pathways in spatial navigation, studying how visual input is transformed into the spatial maps found in the entorhinal/hippocampal formation. Perturbing the activity of distinct visual streams, we will establish how the superior colliculus and visual cortex influence the internal maps that guide navigation.', 'language': 'en'}, {'description': 'Our brain is the result of a long evolution. Over time, new brain regions superseded functions originally performed by preexisting areas. Newer structures did not replace older ones but rather integrated with them, increasing circuit complexity. What roles ancient and modern, functionally similar brain regions play in behavior? The visual system offers an ideal model for studying this question. Mammals have two coexisting brain structures processing visual information: the ancient “superior colliculus” and the phylogenetically newer “visual cortex”. We will determine their relative roles in two natural behaviors crucial for survival: (1)innate defensive responses and (2)spatial navigation. Visually-evoked innate defensive behaviors, such as freezing upon detection of distant predators, critically increases survival chances. Equally important is the ability to navigate adroitly, creating internal “spatial maps” of the environment. This project will provide crucial insight into how evolutionarily ancient and modern visual pathways interact to generate complex behaviors essential for survival.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3125-2089', 'authenticated-orcid': False, 'given': 'Riccardo', 'family': 'Beltramo', 'affiliation': [{'name': 'University of California, San Francisco', 'country': 'US'}]}], 'award-amount': {'amount': 1578744.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 7, 15]]}, 'award-end': {'date-parts': [[2026, 7, 14]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 1578744.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:00Z', 'timestamp': 1636383540000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 7, 15]]}, 'URL': 'http://dx.doi.org/10.35802/222583'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:46Z', 'timestamp': 1636458226001}, 'publisher': 'Wellcome', 'award': '222335', 'DOI': '10.35802/222335', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Rational engineering of antibody binding kinetics'}], 'project-description': [{'description': 'Therapeutic antibodies – drugs made from defence molecules produced by the body – are becoming increasingly important in treatment of diseases ranging from cancer to hepatitis. These drugs work by binding to the molecules they target called antigens. In order to be effective, an antibody must bind its antigen tightly and this depends in part on how fast it binds the antigen. For example, it has been shown in a set of antibodies against malaria that the ability of antibodies to neutralise the pathogen is highly dependent on the binding rate. Our research will use a multidisciplinary approach to engineer antibodies with the aim of achieving faster binding. Using both computational tools and experiments that characterise the physical properties of antibodies, we aim to identify factors that contribute to the rate of binding. Next, we would like to use this knowledge to generate software to predict changes that can be introduced to an antibody to increase its binding rate. As a way to validate our conclusions, we plan to improve antibodies against malaria. These studies will provide us with insight into the factors that make good therapeutic antibodies and also provide a tool for use by the wider scientific community.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-4180-4940', 'authenticated-orcid': False, 'given': 'Bora', 'family': 'Guloglu', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:32Z', 'timestamp': 1636383392000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222335'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227154}, 'publisher': 'Wellcome', 'award': '062242', 'DOI': '10.35802/062242', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Four year PhD programme in cellular and molecular physiology.'}], 'lead-investigator': [{'family': 'Dolman', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-amount': {'amount': 112596.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 112596.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:46Z', 'timestamp': 1636383166000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062242'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227157}, 'publisher': 'Wellcome', 'award': '060960', 'DOI': '10.35802/060960', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Biological characterisation of cellular senescence.'}], 'lead-investigator': [{'given': 'David', 'family': 'Beach', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 912515.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 912515.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:52Z', 'timestamp': 1636382812000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060960'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227295}, 'publisher': 'Wellcome', 'award': '209513', 'DOI': '10.35802/209513', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of the Durham Centre for Medical Humanities'}], 'project-description': [{'description': 'With the support of the Wellcome Trust, the Durham Centre for Medical Humanities will become a nexus for world class medical humanities research. Spanning disciplines and periods, this research seeks to improve human health through an enhanced understanding of human experience. Over the next five years we will extend the significance and impact of existing medical humanities initiatives at Durham, while also fostering new ideas and projects within four distinct strands of work. Our central goals are to develop more effective ways of understanding human experience; to build interdisciplinary research projects that will enable us to influence clinical and health research, practice and policy; to transform views about and approaches to health care research by involving multiple stakeholders; and to promote and champion our approach across disciplinary, institutional and wider research contexts. Key to achieving these ambitious and longer-term goals will be an application for Wellcome Trust Centre status to continue our work beyond the period of this award.', 'language': 'en'}], 'investigator': [{'given': 'Sarah', 'family': 'McLusky', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7289-4037', 'authenticated-orcid': False, 'given': 'Jane', 'family': 'Macnaughton', 'affiliation': [{'name': 'University Of Durham', 'country': 'GB'}]}], 'award-amount': {'amount': 2032905.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 11, 1]]}, 'award-end': {'date-parts': [[2024, 4, 1]]}, 'funding': [{'type': 'grant', 'scheme': 'Medical Humanities', 'award-amount': {'amount': 2006948.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:48Z', 'timestamp': 1636383048000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/209513'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:47Z', 'timestamp': 1636458227284}, 'publisher': 'Wellcome', 'award': '069242', 'DOI': '10.35802/069242', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The proteome as a multicomponent mixture.'}], 'project-description': [{'description': 'The cytoplasm is a solution of thousands of proteins, as well as other substances such as ions, sugars, etc. Recently, in colloid and polymer physics, theoretical tools have been developed to study solutions with many different species. These solutions with many components are an example of what are called polydisperse mixtures. In parallel with these developments in theoretical physics, information has been obtained through genome projects on the many thousands of different proteins in cells. It is proposed to combine this information, the product of genomics, with theoretical tools developed for polydisperse mixtures, in order to study and understand the basic physical properties of the cytoplasm. Genome data can be used to obtain estimates of the net charges on the proteins in the cytoplasm and the effect of these charges on the thermodynamic stability of the cytoplasm can be calculated using statistical mechanics. As an example of a possible application we suggest the problem of cataracts. At least some cataracts form when some of the protein in the cells of the lens of the eye crystallises. Crystallisation is of course a phase transition, here occurring in vivo. The study of a phase transition in the cytoplasm requires both genomic information about features of the proteins present and the theory developed for polydisperse mixture.', 'language': 'en'}], 'investigator': [{'given': 'Jose', 'family': 'Cuesta', 'affiliation': [{'name': 'Misc Spain', 'country': 'ES'}]}], 'lead-investigator': [{'family': 'Sear', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 12210.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 12, 1]]}, 'award-end': {'date-parts': [[2004, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 12210.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:31Z', 'timestamp': 1636382791000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069242'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:48Z', 'timestamp': 1636458228325}, 'publisher': 'Wellcome', 'award': '222367', 'DOI': '10.35802/222367', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The present is saturated with the past and pregnant with the future: continuous temporal integration of past and future events in the brain'}], 'project-description': [{'description': 'The environment is continuously changing. Our nervous system is capable of integrating these changes over time, facilitating an adaptive interaction with the world. At any moment, our brains are retaining past experiences and estimating future events. In the words of the philosopher Gottfried Leibniz: the present is saturated with the past and pregnant with the future. For example, when two people are having a conversation, retentions of what has just been said are needed in order to construct what will be said in the immediate future. During my doctoral research, I will try to answer the question of whether retention of immediately past events and anticipation of future ones influences present perception both in the visual and in the auditory domains. By manipulating task demands, I also hope to explore whether such effects are flexible and context dependent. To explore how different brain regions across the visual and auditory systems allow for retention and anticipation, I will record electrical brain activity of participants while they observe learned and unlearned sequences of stimuli, such that we can manipulate their anticipation of what is coming . This work will advance the understanding of how events in the environment are integrated in time.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6840-5712', 'authenticated-orcid': False, 'given': 'Irene', 'family': 'Echeverria Altuna', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 11]]}, 'award-end': {'date-parts': [[2023, 10, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:26Z', 'timestamp': 1636383326000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:48Z', 'timestamp': 1636458228338}, 'publisher': 'Wellcome', 'award': '209879', 'DOI': '10.35802/209879', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'How does in utero exposure to “adverse environments” affect the fetal brain epigenome?'}], 'project-description': [{'description': 'Approximately 10% of pregnant women have diabetes during pregnancy and this is increasing with increasing maternal obesity. Offspring of obese mothers or those with diabetes during pregnancy have increased risk of developing psychiatric disorders and cognitive impairment. However, the mechanism underlying how exposure to maternal diabetes disrupts offspring neurodevelopment remains poorly understood. Epigenetics is a study of changes in gene expression without a change in the primary DNA sequence or cell identity. Epigenetic modification has been shown to occur in offspring of women who are obese or have diabetes in pregnancy, as well as in individuals affected by psychiatric disorders. This project aims to interrogate how the development of the fetus’ brain is affected by exposure to maternal diabetes during pregnancy. Specifically, I will be investigating how gene expression is affected by exposure to hyperglycaemia. I will be using mouse models as well as cell culture models for the study and next-generation sequencing techniques will be used to perform detailed analysis of the epigenome. The findings of my study will be important to further understand how maternal health during pregnancy affects their offspring’s mental health in the short and long term.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3995-0655', 'authenticated-orcid': False, 'given': 'Kahyee', 'family': 'Hor', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2017, 9, 6]]}, 'award-end': {'date-parts': [[2021, 3, 5]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:19Z', 'timestamp': 1636383319000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 9, 6]]}, 'URL': 'http://dx.doi.org/10.35802/209879'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229644}, 'publisher': 'Wellcome', 'award': '083832', 'DOI': '10.35802/083832', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Value in People award.'}], 'lead-investigator': [{'given': 'Colin', 'family': 'Riordan', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 200000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2007, 11, 1]]}, 'award-end': {'date-parts': [[2009, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 200000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:33Z', 'timestamp': 1636383033000}, 'score': 0.0, 'issued': {'date-parts': [[2007, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083832'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229981}, 'publisher': 'Wellcome', 'award': '065515', 'DOI': '10.35802/065515', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The source of excitatory input to the ventral striatal gabaergic local circuit neurons.'}], 'lead-investigator': [{'given': 'Susan', 'family': 'Totterdell', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 200484.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 27]]}, 'award-end': {'date-parts': [[2005, 11, 26]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 200484.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:23Z', 'timestamp': 1636383023000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 27]]}, 'URL': 'http://dx.doi.org/10.35802/065515'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:49Z', 'timestamp': 1636458229983}, 'publisher': 'Wellcome', 'award': '215129', 'DOI': '10.35802/215129', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Examining the cumulative effects of stress and immune challenge in early life on the risk of mood disorders in adulthood'}], 'project-description': [{'description': 'Childhood adversity is associated with a raised risk of psychiatric illness, including mood disorders, in adulthood. This is detrimental to the wellbeing and productivity of affected individuals, and costly to health and social services. The type of early-life stress associated with adverse childhood experiences has been found to suppress the immune system, leaving it more vulnerable to illness and infection. Mood disorders are linked to whole-body inflammation. Inflammatory changes in the body are associated with onset of depression; also, depressed people have a higher level of inflammatory markers in their blood than non-depressed people. This suggests that inflammation may play a role in causing and maintaining mood disorders. This makes it possible that as well as directly contributing to the risk of adult mood disorders, childhood adversity makes you vulnerable to illness, which adds a second burden of risk through inflammatory pathways. Identifying the changes in the brain associated with this ‘cumulative risk’ could help identify the best treatment for patients with a history of both childhood adversity and inflammatory illness. This PhD project aims to identify those brain changes at a cellular and molecular level in an animal model, and on a structural level using brain imaging from humans.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1617-3822', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Madden', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:57Z', 'timestamp': 1636383237000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215129'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:51Z', 'timestamp': 1636458231729}, 'publisher': 'Wellcome', 'award': '222311', 'DOI': '10.35802/222311', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural mechanisms of attachment in early life.'}], 'project-description': [{'description': \"Kin recognition is an organism's ability to distinguish between genetically close or distant individuals1, which facilitates social attachment among kin2. This is crucial after birth when parental care is needed. Kin responsive neurons have been identified in the rat lateral septum3, a brain structure associated with human kin-affiliation4,5. Human and animal data suggest that endogenous opioids in the brain mediate social attachment and an endogenous opioid-releasing circuit extends from the hypothalamus to the lateral septum. 6–8 In my project, I will test to see if this circuit mediates maternal attachment in early life. I will first confirm preliminary findings from our team that opioid action in the septum is necessary for maternal attachment by activating/inhibiting the lateral septal opioid system and characterising the resulting effects on maternal attachment behaviour in rat pups. To understand the cellular mechanisms involved, I will characterise the activity of lateral septum neurons when endogenous opioids are released. Finally, to explore if the findings are translatable to humans, I will investigate associations between attachment types and septal structure and connectivity in infants. These studies may help elucidate the physiology of early attachment and ultimately provide a rationale for improving the environment of care in early life.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9461-0675', 'authenticated-orcid': False, 'given': 'Lorena', 'family': 'Jiménez Sánchez', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:13Z', 'timestamp': 1636383493000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222311'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:52Z', 'timestamp': 1636458232914}, 'publisher': 'Wellcome', 'award': '222326', 'DOI': '10.35802/222326', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Telomeric chromatin and VSG allelic exclusion in African trypanosomes'}], 'project-description': [{'description': 'Trypanosomes are single-celled parasites that causes lethal diseases in humans and livestock. The parasite is covered in variable surface glycoprotein (VSG) that enables host immune system evasion. VSG is often swapped by ‘antigen switching’, which is central for the parasite’s virulence. My group found that the active VSG suppresses expression of other VSGs. As VSG genes are located near the ends of chromosomes, we hypothesise that the characteristic and highly repetitive sequences at chromosome ends are important for suppression. To facilitate studying this, I will manipulate the dosage of these sequences using new genome editing tools (CRISPR/Cas9). Also, I will explore the function of the proteins that package these regions. Again, I will use CRISPR/Cas9 to create parasites with a single copy of each gene encoding these packaging proteins, allowing me to manipulate those genes as well. These proteins impact DNA repair, DNA replication and gene regulation. This project will provide new insight into how chromosome ‘caps’ function, how VSG genes behave at these locations and may also reveal potential drug targets.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9760-9119', 'authenticated-orcid': False, 'given': 'Marketa', 'family': 'Novotna', 'affiliation': [{'name': 'University of Dundee', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 22]]}, 'award-end': {'date-parts': [[2023, 9, 21]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:31Z', 'timestamp': 1636383451000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 22]]}, 'URL': 'http://dx.doi.org/10.35802/222326'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235511}, 'publisher': 'Wellcome', 'award': '066918', 'DOI': '10.35802/066918', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Ist international workshop on simultaneous EEG and fMRI held at the Institute of Neurology on 2nd March 2002.'}], 'lead-investigator': [{'given': 'Louis', 'family': 'Lemieux', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 4970.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 3, 2]]}, 'award-end': {'date-parts': [[2002, 4, 1]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 4970.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:24Z', 'timestamp': 1636382904000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 3, 2]]}, 'URL': 'http://dx.doi.org/10.35802/066918'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235557}, 'publisher': 'Wellcome', 'award': '215845', 'DOI': '10.35802/215845', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Pathophysiology and prognosis of septic and dengue shock in Vietnam'}], 'project-description': [{'description': 'Shock occurs when severe infection causes low blood pressure and it is life threatening without treatment. In high-income countries shock is usually caused by bacterial infection. But in low/middle-income countries bacteria and viruses like dengue cause shock. In these infections shock occurs, in part, due to fluid leaking from the blood vessels into the tissues. I will investigate whether we can predict which patients are most at risk of developing from dengue shock when they first come to the outpatient clinic. I will then investigate what drives fluid to leak from blood vessels to cause low blood pressure, and whether the mechanisms are different between patients with bacterial versus dengue shock. I will do this by studying 250 adults admitted to intensive care in Vietnam with both conditions. I will measure how leaky their blood vessels are, using blood tests, ultrasound and a specially designed monitor of blood vessel function. I will also calculate the costs of the illness, and follow the patients for 6-months to see if they have persisting ill health, disability or abnormal blood vessel function after discharge. My results may highlight possibilities for new treatments to reduce fluid-leak and thereby reduce deaths from infectious shock.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5507-0415', 'authenticated-orcid': False, 'given': 'Angela', 'family': 'McBride', 'affiliation': [{'name': 'Brighton and Sussex Medical School', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 9, 3]]}, 'award-end': {'date-parts': [[2022, 11, 25]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:44Z', 'timestamp': 1636383464000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 9, 3]]}, 'URL': 'http://dx.doi.org/10.35802/215845'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:55Z', 'timestamp': 1636458235983}, 'publisher': 'Wellcome', 'award': '217135', 'DOI': '10.35802/217135', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Fractures in Sub-Saharan Africa: epidemiology, economic impact and ethnography'}], 'project-description': [{'description': 'Sub-Saharan African (SSA) already has twice the number of older adults than northern Europe, with life expectancy rising rapidly. Ageing exponentially increases fracture risk. The WHO have called for action to prevent and manage fragility fractures in SSA in the next decade; there is an urgent and compelling need for research to inform actions to improve healthcare provision. We will establish vertebral fracture prevalence (the commonest fragility fracture), hip fracture incidence (the most life-challenging fragility fracture) and, over 12-months, their impact on survival, disability and health costs. We will examine the contribution of risk factors of importance in the context of SSA, e.g. HIV, body composition. Ethnographic research will inform understanding of fracture care pathways, patient’s beliefs, patterns of health service delivery and factors influencing implementation of fracture services. To ensure success, our collaboration encompasses international expertise in epidemiology, health economics, anthropology/qualitative methodology, HIV medicine, orthopaedic surgery, gerontology, skeletal imaging, and country-specific research experience within Gambia, Zimbabwe and South Africa. This application builds on our recently-completed South African hip fracture incidence study. The myth that fragility fractures are not an African problem is out-dated; high-quality research is needed, to enable a response to the WHO’s call to be realised.', 'language': 'en'}, {'description': 'Background Africa is changing rapidly: people are living longer which brings risks e.g. fractures. Fractures cause pain, disability and sometimes death. HIV infection increases fracture risk and hampers recovery. Fractures strain healthcare services and are expensive. For countries to plan healthcare services they need to understand the scale of the problem and its costs and the resources currently in place. Approach In South Africa, Zimbabwe and The Gambia we will establish how frequently two key age-related fractures occur: spine fractures (the commonest) and hip fractures (the most life-challenging). We will assess recovery, disability and death rates following hip fracture, identifying factors that improve outcomes. We will calculate current and future health service costs for fractures. By talking with patients and healthcare workers we will learn of their experiences, understanding how future care can be improved. Impact Greater understanding of fracture care will inform health service policy and planning in Africa.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-3353-2882', 'authenticated-orcid': False, 'given': 'Rachael', 'family': 'Gooberman-Hill', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7660-9176', 'authenticated-orcid': False, 'given': 'Rashida', 'family': 'Ferrand', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0003-3644-1388', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Costa', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0001-7034-6750', 'authenticated-orcid': False, 'given': 'Kate', 'family': 'Ward', 'affiliation': [{'name': 'University of Southampton', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8011-0722', 'authenticated-orcid': False, 'given': 'Sian', 'family': 'Noble', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-0859-868X', 'authenticated-orcid': False, 'given': 'Bilkish', 'family': 'Cassim', 'affiliation': [{'name': 'University of KwaZulu Natal', 'country': 'ZA'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6414-0529', 'authenticated-orcid': False, 'given': 'Celia', 'family': 'Gregson', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 3687583.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 4, 1]]}, 'award-end': {'date-parts': [[2025, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 1802255.0, 'currency': 'GBP', 'percentage': 49}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:02Z', 'timestamp': 1636383062000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217135'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:00Z', 'timestamp': 1636458240013}, 'publisher': 'Wellcome', 'award': '223082', 'DOI': '10.35802/223082', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'TREAT-HD: Delivering therapies to prevent neurodegeneration in Huntington’s disease'}], 'project-description': [{'description': 'Our overarching hypothesis is that mechanistic insights from preclinical models of Huntington’s disease (HD) and their genetic treatment are valid for early human pathogenesis and can therefore be realised as the foundation for transformative, preventive, clinical trials. A major obstacle to treatment is that degenerative conditions are usually diagnosed once compensatory mechanisms have been exhausted and irrecoverable cell death has occurred. TREAT-HD shifts the focus to mechanisms underlying earlier and asymptomatic stages of pathogenesis as a better time to initiate treatment. We test our hypothesis through three inter-linked aims (Figure 1) that establish the earliest consequences of mutant huntingtin protein (mHTT) in cells, mice and humans with the aim of developing novel therapeutics to delay or prevent symptom onset. Aims: 1. Determine molecular mechanisms associated with somatic CAG-repeat expansion as targets for novel therapeutics by examining agents targeting DNA repair pathways in cellular and mouse models of HD 2. Determine early systems-level pathology and impact on symptomatology in young adult HD mutation carriers to test the hypothesis that neurodevelopmental effects on brain structure occur before progressive neurodegeneration 3. Integrate molecular and systems-level insights for therapeutic benefit by identifying and validating target engagement and efficacy markers for future clinical trials', 'language': 'en'}, {'description': 'Huntington’s disease (HD) is caused by a faulty gene resulting in the build-up of a toxic protein. This damages brain cells, leading to problems with movement, thinking and behaviour. We know that the earliest signs of damage occur more than 20 years before the appearance of clinical symptoms. We believe this will be the optimum time to intervene with treatments. To find out if this is true we will: - Examine cell and mouse models to investigate how variability within the HD gene drives disease and whether drugs directed at these celluar processes have therapeutic benefit. - Study a group of young adult gene carriers decades before we expect symptoms to begin. Using brain imaging and assessments of behaviour we will obtain a detailed understanding of how the disease affects the brain over time. - Combine this information to develop measures which will help us determine whether future treatments are effective.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4041-6305', 'authenticated-orcid': False, 'given': 'Gillian', 'family': 'Bates', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0002-9623-7007', 'authenticated-orcid': False, 'given': 'Geraint', 'family': 'Rees', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7216-8679', 'authenticated-orcid': False, 'given': 'James', 'family': 'Rowe', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-5426-2140', 'authenticated-orcid': False, 'given': 'Hui', 'family': 'Zhang', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-2716-2045', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Tabrizi', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 3313863.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2022, 1, 1]]}, 'award-end': {'date-parts': [[2026, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'award-amount': {'amount': 3313863.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:59:33Z', 'timestamp': 1636383573000}, 'score': 0.0, 'issued': {'date-parts': [[2022, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/223082'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241303}, 'publisher': 'Wellcome', 'award': '222937', 'DOI': '10.35802/222937', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mental and Cognitive Health Effects of Ketamine on Lateral Habenula Activity in Treatment Resistant Depression'}], 'project-description': [{'description': 'Clinical depression often involves by a pessimistic view of things which have happened in the past and an impairment in the ability to experience pleasure or looking forward to things. A licensed drug called ketamine affects the levels of glutamate, a chemical messenger in the brain, and has been used as a treatment particularly for depression which hasn’t got better with other types of medication. Glutamate plays a role in learning and memory so we are interested in understanding how ketamine can affect how we remember our past negative and positive memories processes. We are conducting a series of studies in both depressed participants and healthy volunteers to improve our understanding on how ketamine can influence memory and the way people learn from rewards and punishments. Study participants will undergo medical and psychiatric health screening, drug administration (ketamine or saline), questionnaires and computer tasks, and MRI scans before and after the administration of the study drug. MRI is a type of brain scan that allows us to see how the brain responds during for example memories of things which have happened in the past. This project will help us understand how ketamine may work in depression.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-7937-8596', 'authenticated-orcid': False, 'given': 'Sara', 'family': 'Costi', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 11]]}, 'award-end': {'date-parts': [[2023, 10, 10]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cognitive Neuroscience and Mental Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:17Z', 'timestamp': 1636383377000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 11]]}, 'URL': 'http://dx.doi.org/10.35802/222937'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241291}, 'publisher': 'Wellcome', 'award': '222949', 'DOI': '10.35802/222949', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Synthesis and evaluation of novel antagonists and fluorescent ligands for the human P2Y2 receptor'}], 'project-description': [{'description': 'The human P2Y2 receptor is one of a large and diverse family of disease-relevant drug targets called G protein-coupled receptors. The P2Y2 receptor is a promising therapeutic target for important conditions, including metastatic cancer. However, no drugs which block the P2Y2 receptor have ever entered clinical trials. The research group recently published an initial study where novel P2Y2 receptor inhibitors, that prevent the action of the receptor, with good biological activity were produced. The project will build on this previous work to design, synthesise and evaluate further inhibitors with improved biological activity and \"drug-like\" properties to make them more clinically viable. The design of these inhibitors will be driven by visualisation of key interactions with the P2Y2 receptor in computational models. Another subsequent part of the project will involve equipping these novel inhibitors with a light emitting fluorescent dye that can be used to investigate their interaction with the P2Y2 receptor in cell and tissue-based experiments with state of the art imaging equipment. Novel, high affinity and drug-like P2Y2 receptor inhibitors and their fluorescently-labelled counterparts would provide a vital tool to further validate the role of P2Y2 in disease and aid in the development of clinically viable drugs.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8344-654X', 'authenticated-orcid': False, 'given': 'Rebecca', 'family': 'Knight', 'affiliation': [{'name': 'University of Nottingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:16Z', 'timestamp': 1636383436000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222949'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:01Z', 'timestamp': 1636458241302}, 'publisher': 'Wellcome', 'award': '222963', 'DOI': '10.35802/222963', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Emergency Efforts to Sustain UK Government Support for ODA'}], 'project-description': [{'description': 'In the 2020 Spending Review HMG signaled its intent to renege on a manifesto commitment and cut ODA form 0.7 to 0.5% of GNI (on top of the budget cut that happened automatically due to economic contraction). To do this, HMG wishes to repeal the relevant in coming months. Work to sustain the Government’s support for ODA is already delivering results with an increasingly credible threat of a government rebellion and sustained media interest. However, increasingly our political intel says we may be at risk of winning the vote and losing the argument. Put simply, ‘hard whipping’ of a rebellion, combined with some horse-trading between different groups, might be enough to carry a vote but it won’t stop the debate flaring back up. This grant would allow us to scale the emergency effort around the legislation while also creating a more enabling environment for the longer team: - by bolstering our public affairs capability in Qs 1/ 2, - by expanding our local organising effort to an additional ten constituencies from Q1-4 and - by expanding our comms plans from Q1-4. A key part of this partnership would be Wellcome’s inclusion in regular political updates, intel and learning sessions.', 'language': 'en'}], 'lead-investigator': [{'given': 'Kirsty', 'family': 'McNeill', 'affiliation': [{'name': 'Save the Children (ELHRA)', 'country': 'GB'}]}], 'award-amount': {'amount': 150000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 4, 1]]}, 'award-end': {'date-parts': [[2022, 2, 28]]}, 'funding': [{'type': 'award', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 150000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:35Z', 'timestamp': 1636383515000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222963'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243535}, 'publisher': 'Wellcome', 'award': '060632', 'DOI': '10.35802/060632', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Contribution towards a meeting'}], 'lead-investigator': [{'family': 'Collard', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2384.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 4, 1]]}, 'award-end': {'date-parts': [[2000, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 2384.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:33Z', 'timestamp': 1636382913000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060632'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243569}, 'publisher': 'Wellcome', 'award': '060565', 'DOI': '10.35802/060565', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Hypoxic pulmonary vasconstriction: the role of an endothelium derived constricting factor.'}], 'investigator': [{'given': 'Philip', 'family': 'Aaronson', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7037-4268', 'authenticated-orcid': False, 'given': 'Jeremy', 'family': 'Ward', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 48106.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 2, 1]]}, 'award-end': {'date-parts': [[2001, 1, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 48106.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060565'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:03Z', 'timestamp': 1636458243573}, 'publisher': 'Wellcome', 'award': '062772', 'DOI': '10.35802/062772', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'PhD in Infection and Immunity.'}], 'lead-investigator': [{'given': 'Judith', 'family': 'Philip', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 117049.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 117049.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:08Z', 'timestamp': 1636383188000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062772'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245048}, 'publisher': 'Wellcome', 'award': '061458', 'DOI': '10.35802/061458', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Pathogenesis of Varicella-Zoster virus infection in skin: Glycoprotein C as a virulence determinant and viral immunomodulatory effects on MHC Class 1.'}], 'lead-investigator': [{'family': 'Hinchliffe', 'affiliation': [{'name': 'Stanford University', 'country': 'US'}]}], 'award-amount': {'amount': 82418.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2002, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82418.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:22Z', 'timestamp': 1636383022000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061458'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245202}, 'publisher': 'Wellcome', 'award': '208465', 'DOI': '10.35802/208465', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'William Grey Walter and the Burden Neurological Institute'}], 'project-description': [{'description': 'This secondment project seeks to improve the organisation, accessibility, and public knowledge of the objects and papers held by the Science Museum relating to the work of William Grey Walter and his colleagues at the Burden Neurological Institute (BNI). Documenting pioneering work that has left a profound mark on clinical research and practice, the BNI collection constitutes one of the richest archival and material resources in Britain for understanding the development of twentieth-century neuroscience. This project aims to raise the profile of this unique resource in three ways. Firstly, the project will digitise and expand the existing catalogues of the BNI collection, empowering researchers to locate and use materials in new and innovative ways. Secondly, the project will provide fully researched biographies of key personnel for the \\'creators\\' records on the Science Museum\\'s Collections online website. These will provide comprehensive yet accessible introductions to the careers and personalities that shaped the BNI\\'s work. Finally, the project will produce an online visual resource open to both researchers and the public. Using the recorded \"brain waves\" of the electroencephalograph (EEG) as a model, this resource will help users to visualise how the documents, objects, and personalities of the BNI interacted.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4248-5491', 'authenticated-orcid': False, 'given': 'David', 'family': 'Saunders', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 12046.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2017, 10, 25]]}, 'award-end': {'date-parts': [[2018, 1, 25]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Medical Humanities', 'award-amount': {'amount': 12577.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:47Z', 'timestamp': 1636383047000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 10, 25]]}, 'URL': 'http://dx.doi.org/10.35802/208465'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245201}, 'publisher': 'Wellcome', 'award': '065105', 'DOI': '10.35802/065105', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The roles of cytosolic free Ca2+ concentration and PI3kinase gamma in signalling neutrophil shape change.'}], 'lead-investigator': [{'family': 'Tian', 'affiliation': [{'name': 'Cardiff University', 'country': 'GB', 'id': [{'id': 'https://ror.org/03kk7td41', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 82276.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2003, 12, 2]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 82276.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:26Z', 'timestamp': 1636383026000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065105'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:05Z', 'timestamp': 1636458245234}, 'publisher': 'Wellcome', 'award': '205000', 'DOI': '10.35802/205000', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Open Science Prize'}], 'lead-investigator': [{'given': 'Roberto', 'family': 'Toro', 'affiliation': [{'name': 'Institut Pasteur', 'country': 'FR', 'id': [{'id': 'https://ror.org/0495fxg12', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 58340.4, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 7, 4]]}, 'award-end': {'date-parts': [[2016, 11, 30]]}, 'funding': [{'type': 'prize', 'scheme': 'Cross-Remit', 'award-amount': {'amount': 58340.4, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:03Z', 'timestamp': 1636383003000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 7, 4]]}, 'URL': 'http://dx.doi.org/10.35802/205000'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247725}, 'publisher': 'Wellcome', 'award': '220099', 'DOI': '10.35802/220099', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A global model for the evolutionary dynamics of seasonal influenza'}], 'project-description': [{'description': 'Influenza epidemics infect between 10% and 20% of the global population each year. Infection typically infers a lifetime immunity on an individual, but due to the gradual accumulation of mutations new strains can emerge that evade the host’s immunity and allow repeat infection. This ‘antigenic drift’ of influenza has been well characterised, but the origins of the observations are not well understood. A limited number of models have attempted to explain the observed effects. However, none of the models has included a realistic spatial component or realistic population sizes. The aim of this project will be to develop a computational model of influenza evolution that incorporates realistic population sizes and spatial spread at a global scale. The model will be based on individuals and allow spatially dependent transmission. The model will include a probability of mutation of a strain upon infection of an individual. By tracking each individual’s immune status based on previous infections evolution will naturally occur in the model to evade population immunity. This model will lead to a greater understanding on the complex relationship between human ecology and the evolutionary dynamics of influenza. It is possible it may also inform future surveillance and vaccine protocol.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8086-4495', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Eales', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 2]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:14Z', 'timestamp': 1636383374000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 2]]}, 'URL': 'http://dx.doi.org/10.35802/220099'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247767}, 'publisher': 'Wellcome', 'award': '219624', 'DOI': '10.35802/219624', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Full-Waveform Imaging of the Human Brain'}], 'project-description': [{'description': \"The requested funding will enable us to develop, test, refine and deliver a prototype device, generating the world's first three-dimensional in-vivo high-resolution ultrasound image of the adult human brain. We will achieve this by applying full-waveform inversion, a technique well-established in geophysics, to non-invasive transmitted-and-reflected ultrasound data acquired using a three-dimensional stereotactic array of transducers surrounding the head. Our long-term goal is to introduce a new brain-imaging modality with the potential to transform clinical and research practice. This will uniquely enable whole-brain, high-resolution, high-contrast, structural, functional, and angiographic imaging that is fast, safe, portable, universally applicable, and deployable continuously, and of a quality that matches magnetic resonance imaging. Though our method is potentially transformative across the whole of healthcare and neuroscience, we will initially target three key areas of rapid, large-scale impact: - hospital management of acute neurological disorders – stroke, head injury and delirium; - pre-hospital assessment of brain integrity – in the ambulance, and on the sports, industrial or military field; - continuous brain monitoring – intra-operatively and during intensive care. Our vision coheres with the increasing availability, driven by the artificial-intelligence revolution, of high-performance computing within healthcare, enabling high-fidelity biological signals to be extracted from safe, established, well-understood physical methods.\", 'language': 'en'}, {'description': 'Rapid brain imaging is central to the diagnosis and treatment of acute neurological conditions, but existing imaging methods require large, immobile, high-power instruments that are near-impossible to deploy outside specialized environments. We will create a device that can be simply and rapidly applied to any patient, any time, any place, exploiting advances that have already revolutionised imaging in geophysics. We will image the brain using sound waves, transmitted across the head, applying advanced computer modelling to remove the distorting effects of the skull, thereby enabling high-resolution high-contrast imaging of the brain unachievable by conventional ultrasound. Safe, fast, universally applicable, deployable continuously, and above all portable by paramedics, our device will revolutionise brain imaging, in health and disease. The technology has particular relevance to stroke – globally the second-commonest cause of premature death and a major, growing cause of adult disability – and to brain imaging in resource-limited and inaccessible environments.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-2718-4423', 'authenticated-orcid': False, 'given': 'Parashkev', 'family': 'Nachev', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7686-425X', 'authenticated-orcid': False, 'given': 'MengXing', 'family': 'Tang', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-1858-218X', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Warner', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'given': 'Joanna', 'family': 'Morgan', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0526-0640', 'authenticated-orcid': False, 'given': 'Lluis', 'family': 'Guasch', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 755414.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 12, 1]]}, 'award-end': {'date-parts': [[2022, 11, 30]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 755414.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:31Z', 'timestamp': 1636383091000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219624'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247749}, 'publisher': 'Wellcome', 'award': '214622', 'DOI': '10.35802/214622', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Examining the economic burden, experiences and coping strategies for patients with hypertension in Kenya'}], 'project-description': [{'description': 'The growing burden of non-communicable diseases (NCDs) has been identified as one of the leading threats to economic growth. Mortality and morbidity due to NCDs result in significant economic impact on households, health systems and societies through draining of household incomes, straining of health system resources, and losses in income, productivity and capital formation. To galvanize support for and inform responses to tackling NCDs, evidence on the economic burden, patient experiences with the health system and coping strategies for these illnesses is needed. In Kenya, this evidence is limited. My proposed study will fill this knowledge gap. I intend to use a mixed-methods approach; employing both quantitative economic methods, and qualitative inquiry through in-depth interviews (IDIs) to examine the economic burden of hypertension to Kenyan households and to assess the experiences and coping strategies for individuals diagnosed with hypertension. To estimate the economic burden of hypertension to households, the study will employ the cost-of-illness approach. To explore the experiences and coping strategies of hypertensive patients, I will collect narratives through in-depth non-structured interviews with participants drawn from different socio-economic quintiles. Evidence from this study will inform health system policy and practice in Kenya and similar settings.', 'language': 'en'}, {'description': 'High blood pressure (hypertension) is increasingly becoming an important health problem in Kenya. Anecdotal evidence suggests that living with hypertension can be a difficult experience. I would like to understand the consequences of living with hypertension for individuals and their families. I will consider what impact the illness has on their personal well-being and financial status, and whether or how they are exposed to financial hardship. I will also examine the strategies they use to cope with their illness. I will ask patients about their health-seeking behavior, associated costs and coping strategies used. I plan to collect data such as medication costs and income loss by patients. Using different methods of data collection will enrich my analysis of the issues at hand. I anticipate that the results will be useful to policy makers seeking to address hypertension in low resource settings like Kenya.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-8768-6014', 'authenticated-orcid': False, 'given': 'Robinson', 'family': 'Omondi', 'affiliation': [{'name': 'Kemri-Wellcome Trust Research Programme', 'country': 'KE'}]}], 'award-amount': {'amount': 120000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2019, 1, 14]]}, 'award-end': {'date-parts': [[2021, 7, 14]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 120000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:04Z', 'timestamp': 1636383004000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 1, 14]]}, 'URL': 'http://dx.doi.org/10.35802/214622'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:07Z', 'timestamp': 1636458247771}, 'publisher': 'Wellcome', 'award': '217163', 'DOI': '10.35802/217163', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'C-type lectins in antifungal immunity'}], 'project-description': [{'description': 'I have established that C-type lectin receptors (CLRs) play a central role in antifungal immunity. In this proposal, I will capitalize on our exciting recent discoveries to address two questions that represent novel aspects of CLR biology: - How do CLRs regulate antifungal adaptive immunity? We discovered dendritic cell expressed CLRs, the KLRs, which regulate the development of adaptive immunity during fungal infection. Our objective is to determine the physiological role of the KLRs, elucidating their cellular expression and function, the nature of their T-cell ligand(s), their influence on T-cell immunity and their importance in anti-fungal immunity. - What is the impact of fungal secondary metabolite recognition by CLRs? We identified two novel CLRs that recognise fungal secondary metabolites, including secreted toxins such as aflatoxin (a major clinically significant fungal-derived carcinogen). Our objective is to gain a definitive understanding of the functions of these receptors and the immunological and physiological impact of their ability to recognise these secreted fungal products. Using a variety of in vivo and in vitro approaches, this research programme will significantly advance our knowledge of the underlying mechanisms of antifungal immunity, and will open new fields of investigation in the areas of adaptive immunity and medical mycology.', 'language': 'en'}, {'description': 'Fungi have a huge impact on human morbidity and mortality. I discovered that C-type lectin receptors (CLRs) are important for controlling these infections, although we do not yet fully understand how these receptors mediate their protective effects. I aim to determine how new CLRs that we have recently identified are able to regulate adaptive immune responses, which are critical for protecting against fungal infections, and mediate responses to secreted fungal products, including carcinogenic compounds such as aflatoxin. Using a variety of cell-based and biochemical approaches, along with comparative in vivo analyses of wild type versus genetically altered mice, I will determine the cellular and immunological roles of these novel receptors. This research programme will significantly advance our understanding of the physiological functions of CLR in antifungal immunity, and open new fields of investigation in immunology and medical mycology.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0287-5383', 'authenticated-orcid': False, 'given': 'Gordon', 'family': 'Brown', 'affiliation': [{'name': 'University of Exeter', 'country': 'GB'}]}], 'award-amount': {'amount': 2275853.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 1, 1]]}, 'award-end': {'date-parts': [[2024, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 2275853.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:03Z', 'timestamp': 1636383063000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/217163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:11Z', 'timestamp': 1636458251660}, 'publisher': 'Wellcome', 'award': '220788', 'DOI': '10.35802/220788', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Engineering genomic features to better understand the molecular basis of immune mediated diseases and their treatment'}], 'project-description': [{'description': 'Genetic and transcriptional studies have demonstrated that shared aetiology between immune-mediated diseases (IMD) is reflected in shared patterns in both data types, and suggested new targets for treatment. However, the huge number of variants and genes measured mean that only a minority of potential information in these data has been harnessed, and disease prognosis and treatment success remains variable and unpredictable. My goal is to overcome this dimensional challenge by developing genomic feature engineering which exploits these shared patterns, to extract new insight from jointly analysing over a hundred existing datasets. I will generate summary features by tailoring dimension-reduction strategies and applying them to genetic and transcriptomic data from patients and cohorts with related traits measured. I will investigate how each feature contributes to rare and common IMD risk, and prognostic variability within diseases. I will correlate features with molecular measurements and clinical data to understand the gene products they represent, and the situations (cell type, disease state/subtype) in which they are relevant. Finally, through predictive modeling, I will explore the expected impact of targeting these gene products in different diseases and subtypes, to generate, and test, hypotheses about which targets might modify specific IMD activity or progression.', 'language': 'en'}, {'description': 'Genetic and transcriptional studies of immune-mediated diseases (IMD) have demonstrated complex sharing of features between these diseases, suggested new treatments, and collectively generated data on 100,000s of IMD patients. However, successes have been limited because huge sample sizes are required to robustly assess the millions of genetic variants or thousands of genes measured. Disease prognosis and treatment success in IMD remain variable and unpredictable. I will mine these data across diseases, to generate orders of magnitude fewer summary features describing shared IMD factors in a more parsimonious manner. I will use molecular measurements and clinical data to understand the gene products the features represent, and their relevant contexts (cell type, disease state/subtype). Through this targeted feature engineering, I aim to describe the relationships between different IMD, both common and rare, and identify new therapeutic treatment targets or diseases/disease-subtypes where existing treatments may be newly applicable.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9755-1703', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Wallace', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 1243595.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2026, 1, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Genetics, Genomics and Population Research', 'award-amount': {'amount': 1243595.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:54Z', 'timestamp': 1636383114000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 2, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220788'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:44:11Z', 'timestamp': 1636458251698}, 'publisher': 'Wellcome', 'award': '220536', 'DOI': '10.35802/220536', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The implementation of atrial fibrillation screening in primary care: a mixed-methods process evaluation of the SAFER trial'}], 'project-description': [{'description': 'In atrial fibrillation (AF), the heart beats irregularly. This may produce no symptoms but can cause stroke: 1 in 10 strokes occur in people who do not know that they have AF. Subsequently, there are calls for screening for AF but we first need information on whether screening reduces strokes and is cost-effective. The SAFER trial will study this by comparing the rates of stroke (and other conditions) in general practices that screen to those that do not. Some practices will be given training to perform screening but how they implement it will affect whether screening improves health. I will review evidence for how practices can best implement screening. I will observe how practices implement AF screening by examining training, day-to-day running, consultations, communications, and interviewing staff. I will send quarterly surveys to practices that perform and do not perform screening to see how they differ. I will finally combine my research to discover how best to implement AF screening. My results will guide practitioners and researchers on screening. It will help the trial run AF screening more successfully and explain the trial results more clearly. We can then recommend to screening agencies how AF screening programmes should be run.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9651-6690', 'authenticated-orcid': False, 'given': 'Rakesh', 'family': 'Modi', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:36Z', 'timestamp': 1636383336000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220536'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:15Z', 'timestamp': 1636458195779}, 'publisher': 'Wellcome', 'award': '061390', 'DOI': '10.35802/061390', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Prevention of consequences of upper gastrointestinal bleed in cirrhosis.'}], 'lead-investigator': [{'given': 'Rajiv', 'family': 'Jalan', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 14175.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2005, 3, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 14175.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:50Z', 'timestamp': 1636382990000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061390'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:15Z', 'timestamp': 1636458195762}, 'publisher': 'Wellcome', 'award': '083428', 'DOI': '10.35802/083428', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A Clinical PhD Programme at Liverpool University: Health Priorities in the Developing World.'}], 'project-description': [{'description': \"Recent Government papers set out the UK's position concerning Global Health. In the last 12 years, Liverpool has established North-South partnerships and trained clinician-scientists through its Wellcome Trust Tropical Centre (WTTC; 21 Fellows; 23 Fellowships [two people progressed to Intermediate Level Fellowships]; 7/21 completed Doctorates, 7 are in progress, and 7 had Doctorates at the start). Recent Government papers set out the UK's position concerning Global Health. In the last 12 years, Liverpool has established North-South partnerships and trained clinician-scientists through its Wellcome Trust Tropical Centre (WTTC; 21 Fellows; 23 Fellowships [two people progressed to Intermediate Level Fellowships]; 7/21 completed Doctorates, 7 are in progress, and 7 had Doctorates at the start). The Trust has recently affirmed its desire to see the WTTC scheme develop into partnerships with Southern Hemisphere Institutions - Liverpool wishes to participate in this. Our PhD Programme: Rests on WTTC infrastructure. Is integrated into Modernising Medical Careers. Ensures external quality control of Projects. Comprises a year of taught provision and three research years. Ensures preparation of Students for research, and their empowerment to make informed choices in Y1.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-4573-449X', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Heyderman', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7680-2200', 'authenticated-orcid': False, 'given': 'David', 'family': 'Lalloo', 'affiliation': [{'name': 'Liverpool School of Tropical Medicine', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2019, 2, 28]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:22Z', 'timestamp': 1636383202000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083428'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199268}, 'publisher': 'Wellcome', 'award': '083473', 'DOI': '10.35802/083473', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Developmental Biology'}], 'project-description': [{'description': 'Developmental Biology is a rapidly expanding, cross-disciplinary area of research that seeks to understand how organisms construct themselves. It is, and will remain, one of the most challenging areas of research because most of the genome is involved in development, much of evolution is expressed through developmental programmes, and a significant component of neural circuitry arises through developmental processes. Furthermore, studies of development continue to shed light on a multitude of human diseases. For example, three key developmental signalling pathways (Wnt, EGFR and Notch) have emerged as major factors in a high proportion of cancers. That Developmental Biology will continue to be a fundamentally interesting challenge into the future should be evident from the tremendous progress over even the past 5 years, such as the recent discovery that microRNAs are key players in regulating the activities of developmentally important genes. Developmental studies will be essential for the elucidation of the pleiotropic activities of genes in the context of the whole organism, and will be invaluable if we are to reap the benefits of the wealth of new sequence information and its implications for our understanding of disease processes.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-1642-599X', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Bray', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-5582-3301', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'St Johnston', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2019, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cross-Remit', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:24Z', 'timestamp': 1636383204000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083473'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199691}, 'publisher': 'Wellcome', 'award': '062626', 'DOI': '10.35802/062626', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular Functions in Disease.'}], 'lead-investigator': [{'family': 'Day', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 109077.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 109077.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:20Z', 'timestamp': 1636383200000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062626'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199718}, 'publisher': 'Wellcome', 'award': '083337', 'DOI': '10.35802/083337', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell Biology.'}], 'project-description': [{'description': 'The Wellcome Trust Centre for Cell Biology contains outstanding research groups who are performing cutting edge analyses in many aspects of cell biology. In order to broaden the range of expertise available to the students, the teaching staff on the proposed Cell Biology programme will also include several key scientists from outside the Centre with particular expertise in structural biology, chemical biology, systems biology and translational research. Students in this programme will develop a well-rounded understanding of cellular processes and methods of analysis. We anticipate that these topics will be of increasing importance for future Cell Biologists. The proposal includes three 10-week rotation projects, since it is our opinion that the students learn a great deal more by being exposed to diverse research problems and methodologies. At the end of the first year they will be much better equipped to take on a PhD project - both in terms of their intellectual skills in data assimilation and interpretation, and in their ability to make an informed choice of research topic. To enhance their skills, the programme for the first year includes a symposium series that incorporates a high degree of student participation and a series of courses on important advanced techniques and approaches.', 'language': 'en'}], 'lead-investigator': [{'given': 'Jean', 'family': 'Beggs', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2008, 10, 1]]}, 'award-end': {'date-parts': [[2019, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:28Z', 'timestamp': 1636383208000}, 'score': 0.0, 'issued': {'date-parts': [[2008, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083337'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:19Z', 'timestamp': 1636458199717}, 'publisher': 'Wellcome', 'award': '074170', 'DOI': '10.35802/074170', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a novel vaccine for periodontopathogen Porphyromonas gingivalis'}], 'project-description': [{'description': 'University Translation Award Development of a novel vaccine for periodontopathogen Porphyromonas gingivalis Porphyromonas gingivalis is an important aetiological agent in destructive periodontal disease. We have characterised a major outer membrane protein of 55kDa in this bacterium, RagB, the expression of which is essential for the pathogenicity of this organism. Hence we believe that RagB may be a potential vaccine candidate for prevention of disease. The rag locus consists of ragB and a co-transcribed upstream gene ragA. Inactivation of ragA or P. gingivalis W50 leads to loss of expression of both proteins and the resultant mutant is significantly attenuated in a murine model of soft tissue destruction. Analysis of restriction enzyme profiles of the rag locus, recently confirmed by sequence analysis, in a wide range of clinical isolates has demonstrated high degree of allelic variation and a similarity of approximately 60%. However, analysis of our worldwide P. gingivalis strain collection and PCR analysis of clinical material from the local periodontal patient population strain indicates that four alleles of this locus predominate. The objectives of this application are to determine the efficacy of immunisation with recombinant RagB from P. gingivalis W50 against challenge with the homologous strain and to establish whether this immunisation will also protect against challenge by P. gingivalis carrying alternative rag alleles. Subsequent experiments will examine whether an immunisation with a mixture of the four major allelic forms of RagB will afford protection against representative strains carrying the different rag loci. The data will establish the potential for RagB to be a candidate immunogen to prevent colonisation by this bacterium in humans and hence act as a vaccine for periodontal disease.', 'language': 'en'}], 'investigator': [{'given': 'Xiaoju', 'family': 'Shi', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'given': 'Michael', 'family': 'Curtis', 'affiliation': [{'name': 'Queen Mary University of London', 'country': 'GB', 'id': [{'id': 'https://ror.org/026zzn846', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 49758.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2004, 4, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 49758.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:31Z', 'timestamp': 1636382911000}, 'score': 0.0, 'issued': {'date-parts': [[2004, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/074170'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:20Z', 'timestamp': 1636458200601}, 'publisher': 'Wellcome', 'award': '108874', 'DOI': '10.35802/108874', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Cell therapies and regenerative medicine.'}], 'investigator': [{'given': 'Steven', 'family': 'Sacks', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0003-2069-4743', 'authenticated-orcid': False, 'given': 'Graham', 'family': 'Lord', 'affiliation': [{'name': 'University of Manchester', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-9151-5154', 'authenticated-orcid': False, 'given': 'Fiona', 'family': 'Watt', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'ORCID': 'http://orcid.org/0000-0001-7094-8188', 'authenticated-orcid': False, 'given': 'Francesca', 'family': 'Spagnoli', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 2943936.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2016, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 19]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 2850000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:35Z', 'timestamp': 1636383335000}, 'score': 0.0, 'issued': {'date-parts': [[2016, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/108874'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:22Z', 'timestamp': 1636458202318}, 'publisher': 'Wellcome', 'award': '222304', 'DOI': '10.35802/222304', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Role of the bone marrow niche in regulating the haematopoietic stem cell response to infection'}], 'project-description': [{'description': 'During infections, such as malaria, which is caused by plasmodium parasites, platelets and red blood cells are destroyed. Hematopoietic stem cells, which are responsible for the production of all the cell types of the blood system, are then put under stress to produce high numbers of platelets and red blood cells. Hematopoietic stem cells are found in the bone marrow, surrounded by many types of other cells. This project aims to investigate how only a specific subset of stem cells becomes activated to replenish the platelet cell counts. I will study the expression and function of specific genes in cells of the environment of stem cells and in stem cells themselves using microscopy-based assays on tissue slices and genetically edited cells implanted into mice. I will use intravital microscopy to study behaviours of stem cells such as cell division and movement, in the bone marrow in the skull. The results of this project could lead to the development of improved treatments for malaria patients and patients with bone marrow transplants.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2061-585X', 'authenticated-orcid': False, 'given': 'Marine', 'family': 'Secchi', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2023, 9, 27]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:08Z', 'timestamp': 1636383488000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/222304'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204485}, 'publisher': 'Wellcome', 'award': '215706', 'DOI': '10.35802/215706', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Artificial intelligence to automate the use of radiotherapy to treat acute oncological conditions such as severe pain, bleeding and neurological symptoms in patients with advanced cancers'}], 'project-description': [{'description': 'With this funding, we intend to fully automate radiotherapy for the treatment of acute oncological conditions such as severe pain, bleeding and neurological symptoms in patients with a diverse range of advanced cancers. These treatments, which are currently prepared manually, make up around 80% of the indications for radiotherapy in patients presenting for treatment in low- and middle-income countries. Our tools, which include artificial intelligence, will use automated quality assurance to ensure safe, effective, and timely treatments – minimizing reliance on manual checks which are time-consuming and can be inefficient. It is expected that patients can be treated very quickly after receiving a CT scan (minutes), rather than waiting days or weeks. Overall, this project is synergistic with ongoing work in our group focused on automating other radiotherapy planning tasks. Our goal is to make these services available as a cloud-based service for minimal cost for clinics in low- and middle-income countries to rapidly scale up and help deliver affordable and equitable cancer treatment. This supports the overall long term goal of making radiotherapy available to all patients who could benefit (both treating urgent and emergency presentations, as in this proposal, and curative treatments), irrespective of financial status.', 'language': 'en'}, {'description': 'Radiotherapy is both inaccessible and unaffordable for the majority of patients diagnosed with cancer in low and middle income countries due to shortfalls in basic infrastructure, equipment and specialist manpower. Eighty-percent of patients in these settings are diagnosed with locally advanced or widely disseminated cancers. We will use artificial intelligence to automate radiotherapy plan preparation for acute oncological conditions in patients with a diverse range of advanced cancers that are endemic in these country settings such as cervical, breast and head and neck cancers. This will mean that patients can be treated very quickly after receiving a CT scan (10 minutes), rather than waiting days or weeks as is the current norm. This will directly benefit patients in LMICs by increasing the likelihood of palliating symptoms of disseminated malignancy (pain, bleeding, shortness of breath, spinal cord compression), improving long term control of cancer, and reducing the cost of treatment.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-9645-6659', 'authenticated-orcid': False, 'given': 'Ajay', 'family': 'Aggarwal', 'affiliation': [{'name': \"Guy's & St Thomas' Hospital Trust\", 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-4442-6068', 'authenticated-orcid': False, 'given': 'Hannah', 'family': 'Simonds', 'affiliation': [{'name': 'University of Stellenbosch', 'country': 'ZA'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3241-6145', 'authenticated-orcid': False, 'given': 'Laurence', 'family': 'Court', 'affiliation': [{'name': 'University of Texas MD Anderson Cancer Center', 'country': 'US'}]}], 'award-amount': {'amount': 1214894.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 6, 1]]}, 'award-end': {'date-parts': [[2022, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Innovations', 'award-amount': {'amount': 913385.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:57Z', 'timestamp': 1636383057000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 6, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215706'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204495}, 'publisher': 'Wellcome', 'award': '220094', 'DOI': '10.35802/220094', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of a host receptor for Plasmodium falciparum-infected erythrocyte rosette formation'}], 'project-description': [{'description': 'Rosetting, the binding of two or more uninfected erythrocytes to an infected erythrocyte, is associated with severe P. falciparum malaria. Therefore, anti-rosetting therapies that reduce microvascular obstruction may be beneficial as adjunctive therapy to reduce severe malaria deaths. Rosettes are formed by an interaction between parasite-derived Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) and host erythrocyte membrane receptors. PfEMP1 is highly polymorphic and therefore a challenging target for vaccines. Recent work by the Rowe lab suggests that PfEMP1 mediates rosetting by an interaction with the Wrightb antigen formed by Band 3 and Glycophorin A. An antibody targeting Wrightb has disrupted rosettes in all P. falciparum strains tested to date, suggesting that this small antibody fragment (BRIC14) has therapeutic potential. I propose to test BRIC14 across a panel of rosetting P. falciparum strains to determine the efficacy of BRIC14 in severe disease states. I aim to characterise the interaction between PfEMP 1 and Wrightb to determine if BRIC14 reduces rosetting by direct inhibition of a ligand-receptor interaction or by altering erythrocyte deformability. The present study aims to characterise a key receptor-ligand interaction implicated in rosetting and determine if a rosette-disrupting antibody has potential as a therapy against disease-causing P. falciparum strains.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-6917-3917', 'authenticated-orcid': False, 'given': 'Molly', 'family': 'Carlier', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:39Z', 'timestamp': 1636383339000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220094'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204522}, 'publisher': 'Wellcome', 'award': '222280', 'DOI': '10.35802/222280', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The mechanical regulation of chemical signaling in axon pathfinding in the developing Xenopus laevis brain'}], 'project-description': [{'description': 'During nervous system development, neurons extend their axons over long distances to predefined targets. Research from the last decade has revealed a plethora of chemical signals that are involved in instructing axon guidance. However, it is now becoming increasingly evident that axons also respond to the mechanical environment that they grow in and this affects axon guidance. Moreover, crosstalk occurs between chemical and mechanical signalling. Thus, a holistic understanding of axon guidance would involve understanding both chemical and mechanical guidance cues and the crosstalk between them. A variety of chemical signalling cues which mediate attraction or repulsion are known to regulate axon pathfinding. These include Slits, Semaphorins, Netrins and Ephrins. However, chemical guidance cues do not act alone. The mechanical environment that the axons grow in, also influences axon pathfinding. One of the ways axons respond to the mechanical environment is through mechanosensitive ion channels (e.g. Piezo1). My PhD project aims at exploring the crosstalk between mechanical and chemical signalling in axon pathfinding, using the optic tract (OT) of Xenopus laevis as a model system.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3209-7399', 'authenticated-orcid': False, 'given': 'Sudipta', 'family': 'Mukherjee', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:03Z', 'timestamp': 1636383423000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222280'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:24Z', 'timestamp': 1636458204516}, 'publisher': 'Wellcome', 'award': '211162', 'DOI': '10.35802/211162', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating prevention of cervical cancer, disease burden, and opportunities for improvement in inclusion health women (IHW)'}], 'project-description': [{'description': 'Cervical cancer is preventable due to screening and vaccination against human papillomavirus (HPV), the main cause of cervical cancer. However, there were 3,224 new cases and 890 deaths in the UK in 2014. By 2035, this is predicted to rise by 43% due to screening non-attendance. Living in a deprived area increases cervical cancer rates and non-attendance at screening. Inclusion health addresses needs of groups frequently underserved by health services who have worse overall health than people in deprived areas. These include homeless people, migrants, substance misusers, prisoners, and sex workers. It is likely that they engage the least with cervical cancer prevention and have the greatest need for intervention. Unfortunately, they are rarely included in cervical cancer prevention research. This fellowship will fill this knowledge gap. I will measure disease levels, engagement in prevention, and find ways to improve outcomes in inclusion health women. This is needed to eliminate cervical cancer. I will achieve this in three ways: (1) a review of existing studies on inclusion health and cervical cancer (2) a study linking information on 1.6 million migrants to cervical screening and vaccination data and (3) a survey and HPV testing of inclusion health women attending outreach services.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1077-5358', 'authenticated-orcid': False, 'given': 'Neha', 'family': 'Pathak', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-start': {'date-parts': [[2017, 12, 1]]}, 'award-end': {'date-parts': [[2021, 5, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:00Z', 'timestamp': 1636383240000}, 'score': 0.0, 'issued': {'date-parts': [[2017, 12, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211162'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205429}, 'publisher': 'Wellcome', 'award': '220658', 'DOI': '10.35802/220658', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Optimising seasonal malaria chemoprevention and seasonal vaccination in childhood to address the resurgent malaria burden in Africa'}], 'project-description': [{'description': 'Almost half of the 435,000 malaria deaths each year occur in countries of the Sahel region of Africa, and the majority of these deaths occur during the three-four month rainy season. Monthly seasonal malaria chemoprevention (SMC) is highly effective in these areas, reducing malaria cases by 75-80% in trials, and malaria-specific mortality by 40-50% under programmatic conditions. However, malaria remains a leading cause of disease and death in several countries deploying SMC. The key goals are therefore to understand how to 1) maximise the impact of SMC as currently designed (e.g. by timing it more accurately in different areas), 2) modify the SMC strategy to make it more effective (e.g. by identifying the causes of severe malaria in the context of SMC), 3) use other control tools, including seasonally-targeted vaccination, alongside SMC and 4) understand how improving malaria prevention in childhood would affect naturally-acquired immunity. Analysis of data from a comprehensive evaluation of SMC in 7 countries, an SMC trial in 20,000 children, and the first-ever trial of seasonally-targeted vaccination alongside SMC provides a unique opportunity to answer these questions. Mathematical models incorporating these results will enable malaria prevention packages to be optimised according to the local epidemiology.', 'language': 'en'}, {'description': 'Around 400,000 malaria deaths occur worldwide each year. About half of these occur in the Sahel region of Africa, mostly during a short, intense rainy season. Monthly courses of antimalarial drugs (seasonal malaria chemoprevention, SMC) is highly effective in these areas. However, malaria remains a leading cause of child deaths in several countries with SMC programmes. I will analyse data from a large SMC programme across seven countries and two large clinical trials of SMC to understand 1) exactly when SMC should be delivered in different areas to maximise its impact, 2) which children get malaria despite SMC (which will indicate how SMC could be improved), 3) how best to use seasonally-targeted malaria vaccination alongside SMC and 4) how improved malaria prevention might affect naturally-acquired immunity. Development of computer-based simulations incorporating these results will enable malaria prevention packages to be targeted to local transmission patterns, maximising their impact on malaria.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-9168-6022', 'authenticated-orcid': False, 'given': 'Liam', 'family': 'Smeeth', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-1068-9713', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Cairns', 'affiliation': [{'name': 'London School of Hygiene & Tropical Medicine', 'country': 'GB'}]}], 'award-amount': {'amount': 916159.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 1, 4]]}, 'award-end': {'date-parts': [[2026, 1, 3]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Population and Public Health', 'award-amount': {'amount': 916159.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:50Z', 'timestamp': 1636383110000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 1, 4]]}, 'URL': 'http://dx.doi.org/10.35802/220658'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205421}, 'publisher': 'Wellcome', 'award': '220704', 'DOI': '10.35802/220704', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterization of the phenotypic and transcriptional profiles of B cells that encode broadly neutralizing antibodies against HIV'}], 'project-description': [{'description': 'HIV induces B-cell defects that could impair the development of effective antibody responses, such as broadly neutralizing antibodies (bNAbs). However, some rare patients still develop anti-HIV bNAbs. Such responses can be mimicked with vaccines for protection against HIV. The B cells that develop breadth despite the ongoing HIV-induced immune defects could have unique profiles that enable their survival and functionality. The aim of this work is to characterize the transcriptional and phenotypic profiles of B cells that encode for anti-HIV bNAbs and their precursors/intermediates. I will use longitudinal clinical samples from well characterized HIV-infected individuals who have broadly neutralizing sera. I have already isolated a bNAb from this cohort by FACS-sorting of epitope specific memory B cells and cloning the immunoglobulin genes. I am currently isolating bNAbs from the other individuals. This will create a platform for subsequent characterization of the B cells that encode for the bNAbs. I will then characterize the phenotypic and transcriptional profiles of epitope specific memory B cells that encode for the bNAbs lineages using paired flow cytometry, cloning and single cell RNA-seq. This will reveal the profiles that, if induced with appropriate adjuvants, could promote elicitation of protective anti-HIV bNAbs after vaccination.', 'language': 'en'}, {'description': 'HIV impairs multiple aspects of the immune response to evade immune-mediated clearance. As such, broadly neutralizing anti-HIV antibodies are rare. HIV-induced B-cell defects are thought to impair the development of broadly neutralizing antibodies. However, a rare group of patients still make highly effective broadly neutralizing antibodies that could protect uninfected individuals if induced with a vaccine before exposure to HIV. The relevant B cells in such individuals could have special characteristics that enable good responses despite HIV-induced impairments. I will utilize clinical samples from individuals who make broadly neutralizing antibodies to study the nature of the B cells that can produce broadly neutralizing antibodies. Together with traditional methods, I will utilize a cutting edge technology, single cell RNA-seq, to determine their global gene expression patterns. The new knowledge will reveal immune profiles that can be induced with appropriate vaccine adjuvants in HIV vaccine strategies to elicit broadly neutralizing antibodies.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0003-2962-3992', 'authenticated-orcid': False, 'given': 'Thumbi', 'family': \"Ndung'u\", 'affiliation': [{'name': 'Africa Health Research Institute', 'country': 'ZA'}]}, {'given': 'Alex', 'family': 'Shalek', 'affiliation': [{'name': 'Massachusetts Institute of Technology', 'country': 'US', 'id': [{'id': 'https://ror.org/042nb2s44', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7995-1682', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Muema', 'affiliation': [{'name': 'Africa Health Research Institute', 'country': 'ZA'}]}], 'award-amount': {'amount': 298082.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2020, 9, 1]]}, 'award-end': {'date-parts': [[2023, 8, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'award-amount': {'amount': 241244.7, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:51Z', 'timestamp': 1636383111000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220704'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205423}, 'publisher': 'Wellcome', 'award': '220081', 'DOI': '10.35802/220081', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mycobacterial drug target deconvolution using Genetic, Phenotypic and Proteomic approaches'}], 'project-description': [{'description': 'Mycobacterium tuberculosis is the causative agent of tuberculosis (TB) and leads to 1.8 million deaths per year. Resistance to the currently used anti-TB drugs is growing, which will increase death rates in the future if unchecked, hence there is a high demand for new drugs. My project aims to identify how novel anti-TB molecules work, to increase our understanding of their targets and how they can be improved to increase their activity and selectivity. The protein targets will be produced and then purified, allowing the drug-protein interactions to be studied. Specific interactions will be identified, providing evidence for alterations to these drugs to increase their potency. Another section will be the identification of new drug targets, which could be taken forward for targeting by studying the protein-protein interactions occurring in the outer membrane and wall of M. tuberculosis. The main output of my work would be increased knowledge of protein-molecule interactions of novel anti-TB drugs and will allow them to be altered to increase their selectivity and activity. This would hopefully lead to these novel drugs being taken forward as potential drugs for the treatment of TB, expanding treatment options against multi-drug resistant M. tuberculosis strains.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7074-6893', 'authenticated-orcid': False, 'given': 'Alexander', 'family': 'Kingdon', 'affiliation': [{'name': 'University of Birmingham', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:56:30Z', 'timestamp': 1636383390000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220081'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:25Z', 'timestamp': 1636458205467}, 'publisher': 'Wellcome', 'award': '220981', 'DOI': '10.35802/220981', 'type': 'grant', 'created': {'date-parts': [[2021, 3, 12]], 'date-time': '2021-03-12T14:27:57Z', 'timestamp': 1615559277000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A comprehensive study of immunopathogenesis of SARS-CoV-2 infection'}], 'project-description': [{'description': 'Since December 2019 the emergence of severe acute respiratory infections (COVID-19) in China, caused by the new coronavirus SARS-CoV-2, has posed a huge threat to global health with fatality rates up to 10% in elderly patients. Almost 100% of patients showed bilateral patchy shadows or ground glass opacity in their lungs by chest CT scans indicating acute lung injury (ALI). Therefore, understanding the underlying mechanism(s) of ALI induced by SARS-CoV-2 is very important to inform vaccine safety and immunotherapeutic strategies. In this proposal, we will investigate the host immune responses and their association with severity of ALI in patient samples and animal models. We will bring together a team of experts with complementary expertise including immunopathology in coronavirus infections, up-to-date lab technologies, and know-how to ensure the feasibility of this study with the following goals: 1) defining SARS-CoV-2 specific serum profiles (epitopes) using yeast display antigen library 2) determining antibody functions including antibody-dependent enhancement (ADE) vs neutralizing activities in vitro assays 3) studying T cell (CD4 and CD8) responses to whole SARS-CoV-2 genome 4) evaluating ALI in response to live SARS-CoV-2 infection with or without passive immunity (antibody or T cells) generated from vaccine candidates in a humanized mice model.', 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0002-3549-4309', 'authenticated-orcid': False, 'given': 'Gavin', 'family': 'Screaton', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-7978-3815', 'authenticated-orcid': False, 'given': 'Nigel', 'family': 'Temperton', 'affiliation': [{'name': 'University of Kent', 'country': 'GB'}]}, {'given': 'Honglin', 'family': 'Chen', 'affiliation': [{'name': 'University of Hong Kong', 'country': 'CN'}]}, {'ORCID': 'http://orcid.org/0000-0002-4511-2888', 'authenticated-orcid': False, 'given': 'Zhiwei', 'family': 'Chen', 'affiliation': [{'name': 'University of Hong Kong', 'country': 'CN'}]}, {'ORCID': 'http://orcid.org/0000-0002-4392-5527', 'authenticated-orcid': False, 'given': 'Peter', 'family': 'Kelleher', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-2083-1552', 'authenticated-orcid': False, 'given': 'Kwok Yung', 'family': 'Yuen', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-3076-6712', 'authenticated-orcid': False, 'given': 'Xiao-Ning', 'family': 'Xu', 'affiliation': [{'name': 'Imperial College London', 'country': 'GB'}]}], 'award-amount': {'amount': 864564.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2020, 5, 5]]}, 'award-end': {'date-parts': [[2022, 5, 4]]}, 'funding': [{'type': 'grant', 'scheme': 'Vaccines', 'award-amount': {'amount': 864564.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:51:59Z', 'timestamp': 1636383119000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 5, 5]]}, 'URL': 'http://dx.doi.org/10.35802/220981'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:28Z', 'timestamp': 1636458208207}, 'publisher': 'Wellcome', 'award': '220023', 'DOI': '10.35802/220023', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Inference of selection and phylogeny from ancient DNA'}], 'project-description': [{'description': 'In this project, we will analyze the population dynamics and evolutionary history of multiple species, spanning from mammoths to bacteria, using two ancient DNA datasets. The first consists of ancient environmental DNA (aeDNA) from samples from up to 50,000 years ago collected from 1671 permafrost and lake sediment samples across the arctic. Despite the damage intrinsic to such data, we have had preliminary success in relating ancient environmental mammoth DNA to the existing mitochondrial tree using in-house software. We will improve this algorithm and expand this work to other mammals such as horses, reindeer and lemmings, and potentially bacteria. A second dataset consists of over 1500 ancient human samples from northwestern Europe, which will grow to over 10,000 samples during my thesis. These samples have been sequenced in order to capture not only the human DNA, but also the DNA of pathogens which the individual was infected with when they died. In this project, we will explore the population dynamics and evolution of these pathogens, including DNA viruses, bacteria, and parasites. We will also consider a related problem using the genetics of human centromeres, which have a very low recombination rate, making them interesting candidates for the inference of selection.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-0648-4224', 'authenticated-orcid': False, 'given': 'Bianca', 'family': 'De Sanctis', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Genetics, Genomics and Population Research', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:23Z', 'timestamp': 1636383323000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220023'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:29Z', 'timestamp': 1636458209508}, 'publisher': 'Wellcome', 'award': '057964', 'DOI': '10.35802/057964', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A coordinated clinical and molecular genetic study of human autosomal recessive neurodevelopmental disorders using autozygosity mapping.'}], 'project-description': [{'description': \"I seek to determine the autosomal recessive mutant genes that can cause human neuro-developmental disorders which present in childhood. The autosomal recessive forms of these disorders are not rare, but there is difficulty in differentiating the number of genotypes with the same apparent phenotype on clinical grounds. No causative genes have presently been found. Prenatal diagnosis and carrier detection are not possible as yet. In order to dissect these complex traits I have the following facilities: established access to the ethnically diverse populations of Northern Pakistan, which for cultural reasons, have highly inbred consanguineous families; the clinical skills to ascertain, investigate and classify these families; an ability to perform linkage using autozygosity mapping; positional cloning skills using a number of established approaches, based on YAC contigs, EST's and foetal cDNA libraries, candidate genes and bio-informatics; access to further families of diverse origin to quantitate the relative clinical importance and relevance of any findings in the general population; and the capability to introduce the research findings into a clinical service for the UK and Pakistani populations.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8077-2101', 'authenticated-orcid': False, 'given': 'Geoff', 'family': 'Woods', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 907252.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 907252.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:32Z', 'timestamp': 1636382792000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/057964'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:30Z', 'timestamp': 1636458210022}, 'publisher': 'Wellcome', 'award': '061367', 'DOI': '10.35802/061367', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Influence of embryonal cytoplasm on nuclei from adult mice.'}], 'lead-investigator': [{'family': 'Graham', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 101418.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 3, 1]]}, 'award-end': {'date-parts': [[2003, 10, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 101418.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:22Z', 'timestamp': 1636382782000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 3, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061367'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:30Z', 'timestamp': 1636458210084}, 'publisher': 'Wellcome', 'award': '060652', 'DOI': '10.35802/060652', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Neural correlates of emotional word recall in depersonalisation disorder patients and normal controls.'}], 'lead-investigator': [{'family': 'Kucharska-Pietura', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 14085.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 1, 1]]}, 'award-end': {'date-parts': [[2000, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 14085.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:54Z', 'timestamp': 1636382994000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/060652'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:31Z', 'timestamp': 1636458211429}, 'publisher': 'Wellcome', 'award': '056163', 'DOI': '10.35802/056163', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The early development of anxiety and obsessive-compulsive symptomatology: a longitudinal behavioural genetic investigation.'}], 'investigator': [{'given': 'Thomas', 'family': \"O'Connor\", 'affiliation': [{'name': 'University Of Rochester', 'country': 'US'}]}], 'lead-investigator': [{'given': 'Derek', 'family': 'Bolton', 'affiliation': [{'name': \"King's College London\", 'country': 'GB', 'id': [{'id': 'https://ror.org/0220mzb33', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 181045.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 4, 1]]}, 'award-end': {'date-parts': [[2002, 5, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 181045.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:35Z', 'timestamp': 1636382795000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/056163'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:31Z', 'timestamp': 1636458211702}, 'publisher': 'Wellcome', 'award': '059696', 'DOI': '10.35802/059696', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Molecular functions in disease.'}], 'lead-investigator': [{'given': 'Mary', 'family': 'Macleod', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 103855.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[1999, 10, 1]]}, 'award-end': {'date-parts': [[2003, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 103855.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:07Z', 'timestamp': 1636383187000}, 'score': 0.0, 'issued': {'date-parts': [[1999, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/059696'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212386}, 'publisher': 'Wellcome', 'award': '062016', 'DOI': '10.35802/062016', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Molecular Basis of Biological Mechanisms'}], 'lead-investigator': [{'given': 'Rebecca C', 'family': 'Zinober', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 102577.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'training-grant', 'award-amount': {'amount': 102577.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:06Z', 'timestamp': 1636383186000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062016'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212758}, 'publisher': 'Wellcome', 'award': '064892', 'DOI': '10.35802/064892', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Studying organogenesis in the inner ear by genetic misexpression in the zebrafish.'}], 'project-description': [{'description': \"Many genes that participate in embryonic development also influence human health. Scientists utilise specific tools to study development in model organisms. Mutagenesis screens in particular offer an unbiased means of dissecting the genetic components of development, for no prior knowledge of the participating genes is required. Alternative approaches such as reverse genetics and controlled misexpression of heterologous genes can serve to complement the analysis of mutant phenotypes in model organisms. The zebrafish has emerged as a powerful system for studies of vertebrate biology and organogenesis. External development and optical clarity allow the easy and visual analysis of early developmental processes. Short generation time, the possibility to achieve large scale mutagenesis screens and generation of thousands of individuals in a relatively inexpensive way are characteristics that make this and ideal model system. Although the zebrafish is poised to contribute greatly to our understanding of organ development, alternative well developed technologies for reverse genetic analysis are lacking. Gene redundancy due to a partially duplicated genome presents a severe hurdle that must be overcome. When the sequence of a gene is known, however, controlled misexpression using the GAL4/UAS system can link the gene's structure to its function, and this methodology is being used with the great success in Drosophila. The GAL4/UAS system is not well advanced in the zebrafish, but shows promise. Also, selective misexpression of genes allows organs to be dissected as genetic modules, leaving the remainder of the animal to develop normally. I propose to explore the process of organogenesis in the inner ear using the zebrafish (Danio rerio) as model system. This objective is dictated both by an intellectual desire to explain the ear's complexity and by an appreciation of the impact of genetic disease on human hearing: about one child in a thousand is born deaf or becomes deaf as a result of mutations in any of over 100 genes. The research group of Dr. A. J. Hudspeth, which has made seminal contributions to our understanding of the mechanism of hearing, has focussed during the past five years on deciphering the ear's development. To study the development and regeneration of the inner ear, I wish to further develop the GAL4/UAS technology and to use it to complement the current chemical-mutagenesis screen being conducted in the Hudspeth lab. This project will allow me to understand the genetics of a vertebrate system, and the development of a functional organ. Once fully developed, this methodology will enable conditional genetic alterations to study other organ systems and developmental processes.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Hernan', 'family': 'Lopez-Schier', 'affiliation': [{'name': 'Rockefeller University', 'country': 'US'}]}], 'award-amount': {'amount': 109219.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 109219.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:28Z', 'timestamp': 1636382908000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064892'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212801}, 'publisher': 'Wellcome', 'award': '064032', 'DOI': '10.35802/064032', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Manipulation of Salmonella lipid A biosynthesis genes to generate attenuated bacteria with reduced toxicity endotoxin under defined environmental conditions.'}], 'lead-investigator': [{'given': 'Duncan', 'family': 'Maskell', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 63780.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 10, 1]]}, 'award-end': {'date-parts': [[2003, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 63780.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:54Z', 'timestamp': 1636382814000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064032'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:32Z', 'timestamp': 1636458212962}, 'publisher': 'Wellcome', 'award': '070262', 'DOI': '10.35802/070262', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'A contribution towards the cost of a symposium entitled \"First Workshop on Murine Models of Psychiatric Disorder\" to be held at Fondation des Treilles, Provence, France in April/May 2003.'}], 'project-description': [{'description': 'First Workshop on Murine Models of Psychiatric Disorder, Foundation des Treilles, Provence, France, April/May 2003 Over the next few years it is likely that genes influencing common psychiatric disorders, such as schizophrenia, manic-depressive psychosis, major depression and anxiety, will be identified. Despite the success of some molecular projects, there has been remarkably little advance in our understanding of the biology of the conditions, largely because it has proved extremely difficult to work out the normal function of the cloned genes. One approach to investigating function is to engineer mutations in the mouse homologue of the human gene and examine the resulting phenotype in the animal model. While this approach has been successful for many medical conditions, the same is not true for psychiatric conditions because it is not clear what to measure. How, for instance, are we to model speech deficits in mice? On evolutionary arguments we would expect that abilities specific to humans will have originated from neural systems present in other animals. The problem is that in most cases we do not know what those systems are. We need ways of modelling complex behaviours in animals if we are to benefit from the advances in genetics. By the end of the meeting we aim to obtain a consensus view on the limitations and value of animal models. We hope to be able to answer questions about what they can detect that would be relevant to human behaviour and which tests can be applied to the current and future transgenic models. Finally we hope to address the fundamental question of the extent to which animals provide more complex models than those currently used for learning and memory.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9427-4429', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Flint', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 3450.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 4, 1]]}, 'award-end': {'date-parts': [[2003, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 3450.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:01Z', 'timestamp': 1636382881000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/070262'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213001}, 'publisher': 'Wellcome', 'award': '063331', 'DOI': '10.35802/063331', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Isolation of molecules involved in haemopoietic stem cell development during embryogenesis.'}], 'lead-investigator': [{'given': 'Katrin', 'family': 'Ottersbach', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 76305.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2004, 9, 30]]}, 'funding': [{'type': 'fellowship', 'award-amount': {'amount': 76305.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:48:22Z', 'timestamp': 1636382902000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063331'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213944}, 'publisher': 'Wellcome', 'award': '062017', 'DOI': '10.35802/062017', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': '4 year PhD programme in Molecular Basis of Biological Mechanisms'}], 'lead-investigator': [{'family': 'Whittaker', 'affiliation': [{'name': 'University of Leeds', 'country': 'GB'}]}], 'award-amount': {'amount': 105027.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 105027.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:52:49Z', 'timestamp': 1636383169000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062017'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:33Z', 'timestamp': 1636458213952}, 'publisher': 'Wellcome', 'award': '062123', 'DOI': '10.35802/062123', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Tissue discrimination and characterisation using a diffraction enhanced imaging system.'}], 'project-description': [{'description': 'One of the most significant problems in current diagnostic techniques is the detectability of low-contrast details; i.e. in many examples of x-ray imaging the inherent contrast in the tissues is too small to demonstrate pathology. For example, conventional screen-film mammography is currently seen as the most efficient technique for the early detection of breast disease as well as for the assessment of symptomatic malignant breast disease. Although its ability to detect microcalcifications is high, it suffers from low sensitivity and specificity for the detection of masses because of the similarity between the linear attenuation coefficient of pathological masses and breast tissue. The subject of this application is to develop an alternative approach that uses the information present in the photon beam interaction with the tissues concerned and represents unfolding of further diagnostic information from transmission imaging procedures. Current x-ray images are created by detecting transmitted beams, but the radiation scattered from the tissues is potentially more useful in differentiating disease. Using our latest research results on breast tissue scattering properties, this project involves the development of an improved method for the detection of breast masses based upon the Diffraction Enhanced Breast Imaging (DEBI) technique, which will significantly improve the sensitivity to low-contrast breast masses whilst maintaining performance in the detection of microcalcifications without increasing the radiation dose. A prototype digital imaging system will be designed and built to evaluate the potential of the diffraction-enhanced imaging and the increased detectability offered by this technique in comparison with current breast imaging modalities.This requires the use of the latest detector technology using state-of-the-art large-area, flat-panel a-Si:H arrays combined with direct magnification and thick Si-pad sensors coupled to low-noise electronics. Finally, to locate the scattering point, stereoscopic breast imaging will be helpful, and therefore, the design of the imaging system will aim at including this feature.', 'language': 'en'}], 'lead-investigator': [{'family': 'Darambara', 'affiliation': [{'name': 'University of Surrey', 'country': 'GB'}]}], 'award-amount': {'amount': 280311.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2000, 10, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 280311.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:36Z', 'timestamp': 1636382796000}, 'score': 0.0, 'issued': {'date-parts': [[2000, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062123'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214309}, 'publisher': 'Wellcome', 'award': '063006', 'DOI': '10.35802/063006', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Mechanisms of Ca2+ signalling in the nuclei of identified neurones.'}], 'investigator': [{'given': 'Roger', 'family': 'Thomas', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Sergy', 'family': 'Marchenko', 'affiliation': [{'name': 'University of Cambridge', 'country': 'GB'}]}], 'award-amount': {'amount': 92430.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 4, 1]]}, 'award-end': {'date-parts': [[2004, 3, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 92430.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:56Z', 'timestamp': 1636382996000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 4, 1]]}, 'URL': 'http://dx.doi.org/10.35802/063006'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214340}, 'publisher': 'Wellcome', 'award': '064110', 'DOI': '10.35802/064110', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Development of a Laboratory Information Management System (LIMS) to support high-throughput genotyping.'}], 'project-description': [{'description': 'We propose to develop a comprehensive laboratory information management system (LIMS) to enable the rapid accumulation, quality control and interpretation of genotype data. Our aims are to: Develop a system that integrates sample tracking in the laboratory with phenotype and family information, that has access to raw experimental data collected from a variety of instruments, and that incorporates automated allele-calling and quality control (QC) procedures wherever possible. Test and validate the system using genotyping protocols and instrumentation available at the Wellcome Trust Centre for Human genetics (WTCHG). Distribute the database to the genetics community in a portable frame.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1022-9330', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Mott', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 259820.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 1, 1]]}, 'award-end': {'date-parts': [[2004, 12, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Molecules, Genes and Cells', 'award-amount': {'amount': 259820.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:49:51Z', 'timestamp': 1636382991000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064110'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:34Z', 'timestamp': 1636458214343}, 'publisher': 'Wellcome', 'award': '069082', 'DOI': '10.35802/069082', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Serotonin depletion and vulnerability to panic attacks in panic disorder.'}], 'project-description': [{'description': 'Panic disorder (PD) is a common and serious psychiatric disorder characterised by recurrent panic attacks, disabling fear, and avoidance of panic-related situations. This project aims to extend recent studies on the role of serotonin (5-hydroxytryptamine, 5-HT) in the mechanisms of panic attacks and in the mode of action of antipanic medications. It uses the new research method of tryptophan depletion (TD) to acutely reduce tryptophan levels and so decrease the synaptic availability of5-HT in the brain. Our recent study of TD in panic patients recovered on treatment with a selective serotonin reuptake inhibitor (SSRI) and then challenged with the panicogenic agent flumazenil reveal that the therapeutic effect of SSRI was reversed. This strongly suggests that an increase in synaptic 5-HT is critical to therapeutic action of this class of medication. It is now important to determine if this finding could be replicated with another antipanic medication and using differently acting panicogneic challenge. In this work we intend to explore whether TD will reveal a loss of the antipanic action of the most selective 5-HT reuptake inhibitor citalopram to a panicogenic challenge with cholecystokinin-tetrapeptide (CCK-4). CCK-4 is an agonist of the CCK-2 subtype of brain receptors. CCK is the most abundant neuropeptide in the brain and it is strongly implicated in the regulation of anxiety. Effective antipanic treatment, including SSRI citalopram, have been shown to block the CCK-4 induced panic attacks in PD patients but it is not known if this action would be reversed by TD. For this study we will recruit 30 patients with DSM-IV diagnosis of Panic Disorder and treat them during 10 weeks with citalopram according to the standard treatment guidelines. While still on treatment, in the following 2 weeks the responders will be the intensity and rate of CCK-4 induced panic attacks after TD in comparison to placebo (sham depletion). The results of this study should significantly advance our understanding of the neurobiology of the treatment of PD.', 'language': 'en'}], 'lead-investigator': [{'given': 'Jakov', 'family': 'Shlik', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 45209.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2003, 5, 1]]}, 'award-end': {'date-parts': [[2004, 10, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Neuroscience and Mental Health', 'award-amount': {'amount': 45209.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:47:55Z', 'timestamp': 1636382875000}, 'score': 0.0, 'issued': {'date-parts': [[2003, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/069082'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:35Z', 'timestamp': 1636458215228}, 'publisher': 'Wellcome', 'award': '211493', 'DOI': '10.35802/211493', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'MAXIMIZING THE KNOWLEDGE GAINED FROM CALIFORNIA SENATE BILL 27'}], 'project-description': [{'description': 'On January 1, 2018, California enacted Senate Bill 27 (SB27), first-of-its-kind and potentially precedent-setting legislation, which will require a veterinarian’s prescription for use of antimicrobial drugs and ban non-therapeutic antimicrobial uses for routine disease prevention and growth promotion in livestock. To assess the effectiveness of this important legislation at reducing antimicrobial resistant bacterial infections in humans, we propose the following specific aims: Aim 1. Quantify the effect of SB27 on E. coli, Campylobacter and Salmonella resistance rates from retail meat. Aim 2. Estimate the proportion of human Campylobacter, Salmonella, and extraintestinal pathogenic E. coli infections caused by strains of food-animal origin in California. Aim 3. Characterize the effect of SB27 on the antimicrobial susceptibility of Campylobacter, Salmonella, and extraintestinal E. coli infections caused by strains of food-animal origin in California. Implementation of SB27 provides a unique natural experiment to assess the effectiveness of restrictive agricultural antimicrobial-use policies at reducing antimicrobial-resistant human infections. The proposed research will have a positive impact by prospectively measuring the effect of this policy on the antimicrobial susceptibility of E. coli (an important colonizing opportunistic pathogen) and Campylobacter and Salmonella (two frank foodborne pathogens) and thereby maximizing the information gained from this singular opportunity', 'language': 'en'}], 'lead-investigator': [{'given': 'David', 'family': 'Aanensen', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}, {'ORCID': 'http://orcid.org/0000-0002-8746-5307', 'authenticated-orcid': False, 'given': 'Lance', 'family': 'Price', 'affiliation': [{'name': 'George Washington University', 'country': 'US'}]}], 'award-amount': {'amount': 2683140.5, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 5, 1]]}, 'award-end': {'date-parts': [[2022, 4, 30]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 2683140.5, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:43Z', 'timestamp': 1636382803000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/211493'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:35Z', 'timestamp': 1636458215771}, 'publisher': 'Wellcome', 'award': '220075', 'DOI': '10.35802/220075', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of mitophagy regulators in neuronal cell and Drosophila models.'}], 'project-description': [{'description': 'Mitochondria are the powerhouses of the cell and are crucial for neuronal function and survival. Disruption of mechanisms governing mitochondrial integrity lead to development and progression of different neurodegenerative disorders (NDs) such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD). In fact, the accumulation of defective mitochondria in neurons is a hallmark of NDs. Mutations in genes linked to PD lead to a failure in pathways designed to rid the cell of low-quality mitochondria. Restoring this pathway offers an attractive therapeutic option. While this pathway is well characterised in cell models, less is known about this process in living organisms (in vivo). Our laboratory has engineered fruit flies (Drosophila) such that the mitochondria undergoing degradation can be directly visualised. I will develop this model system to characterise the influence of various genetic or pharmacological changes upon the mitochondrial degradation process in flies. I aim to shed light on the interplay between various genes linked to this pathway and discover new factors relevant to the process.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4382-9313', 'authenticated-orcid': False, 'given': 'Francesco Giovanni', 'family': 'Barone', 'affiliation': [{'name': 'University of Liverpool', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:55:21Z', 'timestamp': 1636383321000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/220075'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:37Z', 'timestamp': 1636458217115}, 'publisher': 'Wellcome', 'award': '065739', 'DOI': '10.35802/065739', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:59:26Z', 'timestamp': 1608231566000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The role of ATP receptors in the synaptic transmission in the neocortex.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-0250-6200', 'authenticated-orcid': False, 'given': 'Yuriy', 'family': 'Pankratov', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 10610.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 9, 1]]}, 'award-end': {'date-parts': [[2002, 2, 28]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 10610.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:50:43Z', 'timestamp': 1636383043000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 9, 1]]}, 'URL': 'http://dx.doi.org/10.35802/065739'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218012}, 'publisher': 'Wellcome', 'award': '066213', 'DOI': '10.35802/066213', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Trans-acting chemical modifiers of DNA repeat stability in vitro and in vivo - towards novel therapies in the triplet repeat expansion disorders.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8298-8264', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Monckton', 'affiliation': [{'name': 'University of Glasgow', 'country': 'GB'}]}], 'award-amount': {'amount': 116380.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 7, 1]]}, 'award-end': {'date-parts': [[2004, 8, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 116380.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:39Z', 'timestamp': 1636382799000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 7, 1]]}, 'URL': 'http://dx.doi.org/10.35802/066213'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218022}, 'publisher': 'Wellcome', 'award': '061827', 'DOI': '10.35802/061827', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'An investigation into the nature and functional implications of a depletable pool of adenosine in the CA1 region of the in vitro rat hippocampus.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-7214-3172', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Frenguelli', 'affiliation': [{'name': 'University of Warwick', 'country': 'GB'}]}], 'award-amount': {'amount': 98388.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 1, 1]]}, 'award-end': {'date-parts': [[2003, 12, 31]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 98388.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:54Z', 'timestamp': 1636382754000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 1, 1]]}, 'URL': 'http://dx.doi.org/10.35802/061827'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218050}, 'publisher': 'Wellcome', 'award': '083335', 'DOI': '10.35802/083335', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Structural biology: from molecules to cells.'}], 'project-description': [{'description': \"Structural biology is central to our understanding of mechanism in cell biology. Life emerges, in the form of a cell, from an assembly of 'lifeless' molecules. It is therefore essential to study the structure of biological macromolecules, and of the multi-molecular complexes they form, in order to understand the properties of complex sub-cellular and cellular assemblies. From a biomedical science perspective, understanding the relationship between molecular structure (sub-nm scale) and emergent cellular properties (µm scale) is a central activity. Mutations result in perturbations of cellular phenotypes via changes in molecular structure, and drugs interact with molecular receptors resulting in changes in cellular behaviour. Thus, the overall aim of this programme is to train a new generation of graduate students in the methods of modern Structural Biology (X-ray diffraction, NMR, electron microscopy, computational approaches) in the context of how a knowledge of biomolecular structures informs our understanding of the biology of cells. This programme will build upon our success in a previous Wellcome Trust funded programme. It will benefit from our experience in running cross-departmental programmes, and will be underpinned by existing and newly appointed chairs. A four-year programme enables us to attract excellent graduate students with e.g. a physical sciences background, and to train them in the theory and methods of Structural Biology in the broader context of biological sciences before they undertake challenging research projects leading to high quality publications and post-doctoral placements in leading research groups worldwide.\", 'language': 'en'}], 'investigator': [{'ORCID': 'http://orcid.org/0000-0001-6360-7959', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Sansom', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3426-4210', 'authenticated-orcid': False, 'given': 'David', 'family': 'Stuart', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2009, 10, 1]]}, 'award-end': {'date-parts': [[2017, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Molecular Basis of Cell Function', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:53:30Z', 'timestamp': 1636383210000}, 'score': 0.0, 'issued': {'date-parts': [[2009, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/083335'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218172}, 'publisher': 'Wellcome', 'award': '062918', 'DOI': '10.35802/062918', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'An investigation of adenovirus-mediated GnRH receptor expression and receptor targeted therapy in mammary cancer cells.'}], 'investigator': [{'given': 'Eamonn', 'family': 'Kelly', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'lead-investigator': [{'given': 'Craig', 'family': 'McArdle', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-amount': {'amount': 303815.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2001, 5, 1]]}, 'award-end': {'date-parts': [[2005, 5, 31]]}, 'funding': [{'type': 'grant', 'scheme': 'Physiological Sciences', 'award-amount': {'amount': 303815.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:30Z', 'timestamp': 1636382790000}, 'score': 0.0, 'issued': {'date-parts': [[2001, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/062918'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218375}, 'publisher': 'Wellcome', 'award': '215311', 'DOI': '10.35802/215311', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating modularity in the Locus Coeruleus - Computational & Experimental approaches'}], 'project-description': [{'description': \"This research will focus on the locus coeruleus (LC), a brainstem region supplying noradrenaline to the central nervous system, controlling arousal levels and 'fight or flight' type behaviours. Experiments and computer simulations will be used to investigate how different 'modules' of cells within this region can be active independently of one another, and the biological mechanisms that enable this functional segregation. The experiments will use targeted genetic modification of locus coeruleus cells, to make them express genetically encoded calcium indicators. Changes in cell activity lead to fluctuations in calcium levels, meaning fluorescence can be recorded as a measure of cell activity. Using slices of brain containing LC, I will image cell activity and apply drugs which block specific signalling pathways believed to be functionally important for modularity within the LC. These experiments will be aided with mathematical models of LC cells, which will be used to build a simulated population of LC modules. This will be used to explore potentially important biological mechanisms, and make predictions about the effects of manipulating these biological mechanisms, which can then be tested experimentally. Together, these strategies may yield novel insights into the functional modularasation of the LC in healthy and/or disease states.\", 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3155-0879', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Davy', 'affiliation': [{'name': 'University of Bristol', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215311'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218396}, 'publisher': 'Wellcome', 'award': '222575', 'DOI': '10.35802/222575', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The mechano-biology of cell division'}], 'project-description': [{'description': 'Cell division in epithelial sheets is crucial for tissue renewal, yet unchecked division leads to tissue dysplasia and ultimately cancer. The aim of this project is to discover how cell division is regulated in normal epithelial tissue and how it is perturbed by oncogenic mutations to disrupt tissue integrity. In previous work, I showed how activation of an oncogene, Ras, directly impacts cell division by controlling the shape, contractility and mechanics of single mitotic cells. I now ask how this finding plays out in a complex tissue environment. To do this, I will employ a multi-disciplinary approach, combining imaging and quantitative cell biology with biophysical techniques to study cell division mechanics in normal epithelial monolayers and Ras-mutant pancreatic cancer tumoroids. I will ask how the actin cytoskeleton is regulated during epithelial cell division to permit dynamic cell shape changes while maintaining cell-cell adhesion and preserving barrier function. I will determine how k-Ras activation perturbs this, identifying key mechanistic links between Ras/ERK-dependent transcription and morphological phenotypes. Finally, I will address how these Ras-induced changes to cell division alter the growth and organization of 3D tissue structures in pancreatic cancer.', 'language': 'en'}, {'description': 'In the human body, cells constantly divide to maintain and repair tissues. However uncontrolled cell division leads to tissue overgrowth and ultimately, cancer. I want to understand how cell division is controlled in normal tissue and how it is altered by genetic mutations in cancer. I will focus on the role of an oncogene, Ras, as I have previously discovered that it directly controls how cells divide. Ras activation occurs in many different types of cancer, but particularly pancreatic cancer. Therefore, I will use cutting-edge microscopy techniques to image cells dividing within normal tissue and pancreatic cancer tumoroids. I will ask how Ras subverts the normal cell division process within these tissues and how abnormal cell divisions disrupt normal tissue organization to form tumours. By discovering fundamental principles of how cancer cells divide, this work will identify new molecular targets for pancreatic cancer treatment.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0001-6660-9685', 'authenticated-orcid': False, 'given': 'Helen', 'family': 'Matthews', 'affiliation': [{'name': 'University College London', 'country': 'GB', 'id': [{'id': 'https://ror.org/02jx3x895', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 1029715.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2021, 11, 1]]}, 'award-end': {'date-parts': [[2026, 10, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Cell and Developmental Biology', 'award-amount': {'amount': 1029715.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:27Z', 'timestamp': 1636383507000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 11, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222575'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218579}, 'publisher': 'Wellcome', 'award': '064247', 'DOI': '10.35802/064247', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Identification and characterisation of the MCPH5 gene causing autosomal recessive primary microcephaly located at chromosome lq31.'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-8077-2101', 'authenticated-orcid': False, 'given': 'Geoff', 'family': 'Woods', 'affiliation': [{'name': 'Cambridge Institute for Medical Research', 'country': 'GB'}]}], 'award-amount': {'amount': 88671.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2002, 5, 1]]}, 'award-end': {'date-parts': [[2004, 4, 30]]}, 'funding': [{'type': 'grant', 'award-amount': {'amount': 88671.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:32Z', 'timestamp': 1636382792000}, 'score': 0.0, 'issued': {'date-parts': [[2002, 5, 1]]}, 'URL': 'http://dx.doi.org/10.35802/064247'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218741}, 'publisher': 'Wellcome', 'award': '222933', 'DOI': '10.35802/222933', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The health needs and primary care engagement of Central and Eastern European nationals living within the UK'}], 'project-description': [{'description': 'Over 2 million Central and Eastern Europe (CEE) nationals live in the UK. They are at increased risk of poor mental health, stress, homelessness, alcohol overuse and suicide. It can be difficult for this community to use GP services, especially for mental health problems. I will help GPs to provide better mental health care for the UK CEE community through describing what CEE nationals think about general practice and working with community members and GP staff to develop supportive resources and recommendations. My research has four steps (WP1-4). WP1. Interviews with different CEE community members, WP2. Focus groups with GP practice healthcare, administration and reception staff. These will explore staff experiences of CEE community members using GP services, particularly for mental health problems. I will compare interview and focus group information to look for patterns. WP3. Working with community members I will develop a mental health resource package to help GPs to provide accessible care and treatments for CEE community members. WP4. I will test and improve this resource package in GP surgeries, getting feedback from community members and healthcare staff. I will share the information and resources from my project with community members, other researchers and healthcare workers.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-3435-6721', 'authenticated-orcid': False, 'given': 'Aaron', 'family': 'Poppleton', 'affiliation': [{'name': 'Keele University', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2024, 9, 30]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Population and Public Health', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:47Z', 'timestamp': 1636383467000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/222933'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:38Z', 'timestamp': 1636458218765}, 'publisher': 'Wellcome', 'award': '224052', 'DOI': '10.35802/224052', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of MeCP2 within the context of chromatin'}], 'project-description': [{'description': 'MeCP2 is a protein found in the brain which prefers binding to methylated DNA. It can then help to block gene expression through the recruitment of other factors. MeCP2 is essential for proper neurodevelopment and mutations in the protein often cause the autism-spectrum disorder Rett syndrome, which is characterised by a lack of speech and loss of motor skills. In Rett syndrome-like mutated mice these developmental problems can be reversed, suggesting that a future treatment for Rett syndrome may be possible. While a lot is known about how MeCP2 binds linear methylated DNA, this is not the natural state of DNA in cells. Instead DNA is often found wrapped around proteins called histones which package and compact it into chromatin. Initial evidence has suggested that MeCP2 can not only bind methylated DNA, but also to the histone proteins that the DNA wraps around. This project aims to investigate how exactly MeCP2 interacts with chromatin, understand the relevance of MeCP2’s proposed interaction with histone proteins, and discover if mutations that cause Rett syndrome also disrupt this interaction.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-5691-1829', 'authenticated-orcid': False, 'given': 'James', 'family': 'Watson', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2020, 9, 28]]}, 'award-end': {'date-parts': [[2024, 10, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cell and Developmental Biology', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:58:15Z', 'timestamp': 1636383495000}, 'score': 0.0, 'issued': {'date-parts': [[2020, 9, 28]]}, 'URL': 'http://dx.doi.org/10.35802/224052'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220108}, 'publisher': 'Wellcome', 'award': '212204', 'DOI': '10.35802/212204', 'type': 'grant', 'created': {'date-parts': [[2020, 12, 17]], 'date-time': '2020-12-17T18:55:46Z', 'timestamp': 1608231346000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'The organisation of international cooperation in relation to AMR'}], 'project-description': [{'description': \"The world has agreed to take action on Antimicrobial Resistance (AMR). The UN General Assembly Resolution on AMR commits UN Member States to addressing AMR therefore they called for the establishment of an ad hoc Inter- Agency Coordination Group (IACG). Equally importantly, both health and agriculture sectors are being brought together to address this problem. with the UN Secretary General in consultation with the WHO, the UN FAO and the OIE establishing this multidisciplinary group composed of 13 UN organisations and 13 independent experts. The IACG is mandated to report on progress and recommendations for the next steps to ensure sustained effective global action. The global governance mechanisms to deliver on an AMR strategy are crucial. Without some global coordination, none of the public or private stakeholders in this issue will move very far. To this end, as part of IACG's work an analysis of existing governance mechanisms is required by March/ April 2018 to inform the discussion on possible future governance mechanisms for AMR. The paper we are proposing will undertake these analyses and lay out how international cooperation could best be organized to manage the urgent problems emerging from AMR.\", 'language': 'en'}], 'lead-investigator': [{'given': 'Ngaire', 'family': 'Woods', 'affiliation': [{'name': 'University of Oxford', 'country': 'GB'}]}], 'award-amount': {'amount': 51000.0, 'currency': 'GBP'}, 'award-start': {'date-parts': [[2018, 4, 13]]}, 'award-end': {'date-parts': [[2018, 7, 13]]}, 'funding': [{'type': 'award', 'scheme': 'Drug Resistant Infections', 'award-amount': {'amount': 51000.0, 'currency': 'GBP', 'percentage': 100}, 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:46:50Z', 'timestamp': 1636382810000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 4, 13]]}, 'URL': 'http://dx.doi.org/10.35802/212204'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220074}, 'publisher': 'Wellcome', 'award': '215127', 'DOI': '10.35802/215127', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Elucidating the function of an extracellular Argonaute protein secreted from the rodent-infective gastrointestinal nematode Heligmosomoides bakeri'}], 'project-description': [{'description': 'Extracellular vesicles mediate communication between cells and also within and between different organisms. Vesicles secreted from the rodent-infective gastrointestinal nematode Heligmosomoides bakeri, are internalised by mouse host cells leading to suppression of host genes involved in immunity and inflammation (Buck et al., 2014). They contain specific small RNAs and a worm-specific Argonaute protein referred to as Hb-exWAGO. This extracellular worm-specific Argonaute is highly expressed and highly conserved among other gastrointestinal nematodes, such as the human hookworm and sheep parasites, and facilitates partitioning of specific small interfering RNAs into the extracellular vesicles (Chow et al., preprint). We hypothesise that Hb-exWAGO could be involved in cross-species RNA interference, a trait which could facilitate the capacity of gastrointestinal worms for parasitism. In this proposal we focus on Hb-exWAGO and our goal is to elucidate its function and determine whether and how it mediates gene silencing in the host. To achieve our goal, we will determine the protein binding partners of Hb-exWAGO and identify its guide and target RNA interactions. We will then build a model for its functional mechanism by using cell culture experiments and in vitro assays.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4311-9776', 'authenticated-orcid': False, 'given': 'Kyriaki', 'family': 'Neophytou', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 10, 1]]}, 'award-end': {'date-parts': [[2022, 3, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Pathogen Biology and Disease Transmission', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:54:04Z', 'timestamp': 1636383244000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/215127'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220118}, 'publisher': 'Wellcome', 'award': '219941', 'DOI': '10.35802/219941', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Investigating the role of microglia in perinatal brain injury and repair'}], 'project-description': [{'description': 'Injury to the infant brain before, during, or after birth can lead to problems with movement, intellect, and sensation, as seen in cerebral palsy. This is due to damage to white matter, areas rich in a fatty substance called myelin that insulates nerves for their health/function. Current treatments are not suitable for all infants, are only moderately effective, and do not support white matter repair. Microglia are immune cells that control white matter repair in adult brain, yet their roles in supporting white matter formation and repair in the developing brain are not clear. I aim to understand how microglia regulate white matter formation and repair, to contribute to the development of therapies for infant brain injury. I will analyse myelin formation and repair following injury in a model where microglia are absent. As microglia are known to be composed of multiple subtypes, I will also assess how these subtypes change in white matter following experimental injury using single cell-sequencing, and examine these in injured human infant brain. Lastly, I will assess the roles of microglia subtypes by transplantation following injury. This project will identify microglia subtypes to target in order to drive white matter repair in injured infant brain.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-9769-367X', 'authenticated-orcid': False, 'given': 'Niamh', 'family': 'McNamara', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2019, 10, 1]]}, 'award-end': {'date-parts': [[2022, 12, 31]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Cellular and Molecular Neuroscience', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:12Z', 'timestamp': 1636383432000}, 'score': 0.0, 'issued': {'date-parts': [[2019, 10, 1]]}, 'URL': 'http://dx.doi.org/10.35802/219941'}, {'indexed': {'date-parts': [[2021, 11, 9]], 'date-time': '2021-11-09T11:43:40Z', 'timestamp': 1636458220104}, 'publisher': 'Wellcome', 'award': '214369', 'DOI': '10.35802/214369', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:45:42Z', 'timestamp': 1636382742000}, 'source': 'Crossref', 'prefix': '10.35802', 'member': '13928', 'project': [{'project-title': [{'title': 'Characterisation of RAC signalling in Inflammatory Bowel Disease-associated colorectal cancer'}], 'project-description': [{'description': 'Bowel cancer is the second most common cause of cancer-related death, accounting for 44 deaths every day in the UK. Patients with Inflammatory Bowel Disease (IBD) affecting the large intestine have a 70% increased risk of developing bowel cancer compared to the general population. This risk increases to 700% in patients who are diagnosed with IBD before the age of 30. We do not currently fully understand how, or why bowel cancers develop in these patients. There are known genetic differences in cancers that develop in patients with IBD. One difference of interest is the RAC pathway, which is commonly altered in IBD associated bowel cancers. It is thought that the large intestinal inflammation that occurs in patients with IBD can somehow trigger or sustain cancer development, and this may be promoted by changes in the RAC pathway. We want to study the RAC pathway. If we can understand the RAC pathway in greater detail, we might be able to understand why patients with IBD get bowel cancers and what causes the inflammation to start. This may help find new treatments or even prevent cancer formation in this chronic disease.', 'language': 'en'}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-2321-2140', 'authenticated-orcid': False, 'given': 'Antonia', 'family': 'Churchhouse', 'affiliation': [{'name': 'University of Edinburgh', 'country': 'GB'}]}], 'award-start': {'date-parts': [[2018, 8, 1]]}, 'award-end': {'date-parts': [[2022, 2, 1]]}, 'funding': [{'type': 'training-grant', 'scheme': 'Immune System in Health and Disease', 'funder': {'name': 'Wellcome Trust', 'id': [{'id': '10.13039/100010269', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T14:57:44Z', 'timestamp': 1636383464000}, 'score': 0.0, 'issued': {'date-parts': [[2018, 8, 1]]}, 'URL': 'http://dx.doi.org/10.35802/214369'}, {'indexed': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T08:45:34Z', 'timestamp': 1637052334218}, 'publisher': 'The ALS Association', 'award': '22-SI-603', 'DOI': '10.52546/pc.gr.150956', 'type': 'grant', 'created': {'date-parts': [[2021, 10, 1]], 'date-time': '2021-10-01T16:10:56Z', 'timestamp': 1633104656000}, 'source': 'Crossref', 'prefix': '10.52546', 'member': '30016', 'project': [{'project-title': [{'title': 'Neurofilament as a Fluid Biomarker of Neurodegeneration in f-FTD Project', 'language': 'en'}], 'project-description': [{'description': '', 'language': 'en'}], 'investigator': [{'given': 'Kevin', 'family': 'Klock', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Eva', 'family': 'Coyne', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Heidi', 'family': 'Blythe', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0002-1348-3799', 'authenticated-orcid': False, 'given': 'Wesley', 'family': 'Horton', 'affiliation': [{'name': 'Foundation for the National Institutes of Health, Inc', 'id': [{'id': 'https://ror.org/00k86s890', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 140000.0, 'currency': None}, 'award-start': {'date-parts': [[2021, 9, 15]]}, 'award-end': {'date-parts': [[2023, 9, 14]]}, 'funding': [{'type': 'award', 'funder': {'name': 'The ALS Association', 'id': [{'id': '10.13039/100000971', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 15]], 'date-time': '2021-11-15T16:32:45Z', 'timestamp': 1636993965000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 9, 15]]}, 'URL': 'http://dx.doi.org/10.52546/pc.gr.150956'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T11:15:16Z', 'timestamp': 1637147716245}, 'publisher': 'The ALS Association', 'award': '22-PDF-605', 'DOI': '10.52546/pc.gr.150910', 'type': 'grant', 'created': {'date-parts': [[2021, 10, 1]], 'date-time': '2021-10-01T16:10:56Z', 'timestamp': 1633104656000}, 'source': 'Crossref', 'prefix': '10.52546', 'member': '30016', 'project': [{'project-title': [{'title': 'Pathomechanisms of ALS caused by SPTLC1 mutations', 'language': 'en'}], 'project-description': [{'description': '', 'language': 'en'}], 'investigator': [{'given': 'Jie', 'family': 'Jiang', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Tiffani', 'family': 'Patterson', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Bill', 'family': 'Lambert', 'affiliation': []}, {'given': 'Jie', 'family': 'Jiang', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Alfred', 'family': 'Merrill', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9065-3555', 'authenticated-orcid': False, 'given': 'Antonine', 'family': 'Franks', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}, {'given': 'Saturday', 'family': 'Sam', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'lead-investigator': [{'ORCID': 'http://orcid.org/0000-0003-4046-4195', 'authenticated-orcid': False, 'given': 'Devesh', 'family': 'Pant', 'affiliation': [{'name': 'Emory University', 'id': [{'id': 'https://ror.org/03czfpz43', 'id-type': 'ROR', 'asserted-by': 'publisher'}]}]}], 'award-amount': {'amount': 150000.0, 'currency': None}, 'award-start': {'date-parts': [[2021, 10, 1]]}, 'award-end': {'date-parts': [[2023, 9, 30]]}, 'funding': [{'type': 'award', 'funder': {'name': 'The ALS Association', 'id': [{'id': '10.13039/100000971', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T16:42:13Z', 'timestamp': 1637080933000}, 'score': 0.0, 'issued': {'date-parts': [[2021, 10, 1]]}, 'URL': 'http://dx.doi.org/10.52546/pc.gr.150910'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T14:45:19Z', 'timestamp': 1637160319995}, 'publisher': 'Office of Scientific and Technical Information (OSTI)', 'award': '60260', 'DOI': '10.46936/reso.proj.2021.60260/60007245', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T17:45:22Z', 'timestamp': 1637084722000}, 'source': 'Crossref', 'prefix': '10.46936', 'member': '960', 'project': [{'project-title': [{'title': 'Ultra-High Resolution Ion Mobility-Mass Spectrometry Metabolomics Platform'}], 'investigator': [{'given': 'Joon-Yong', 'family': 'Lee', 'affiliation': []}, {'given': 'Randolph', 'family': 'Norheim', 'affiliation': []}], 'funding': [{'type': 'award', 'funder': {'name': 'US Department of Energy', 'id': [{'id': '10.13039/100000015', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T17:45:22Z', 'timestamp': 1637084722000}, 'score': 0.0, 'issued': {'date-parts': [[None]]}, 'URL': 'http://dx.doi.org/10.46936/reso.proj.2021.60260/60007245'}, {'indexed': {'date-parts': [[2021, 11, 17]], 'date-time': '2021-11-17T13:44:14Z', 'timestamp': 1637156654126}, 'publisher': 'Office of Scientific and Technical Information (OSTI)', 'award': '60257', 'DOI': '10.46936/reso.proj.2021.60257/60007247', 'type': 'grant', 'created': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T22:38:52Z', 'timestamp': 1637102332000}, 'source': 'Crossref', 'prefix': '10.46936', 'member': '960', 'project': [{'project-title': [{'title': 'PNNL Proteomics Chemical Analysis Center for the MoTrPAC (ProMoTr)'}], 'investigator': [{'given': 'Paul', 'family': 'Piehowski', 'affiliation': []}, {'given': 'James', 'family': 'Sanford', 'affiliation': []}], 'funding': [{'type': 'award', 'funder': {'name': 'US Department of Energy', 'id': [{'id': '10.13039/100000015', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 11, 16]], 'date-time': '2021-11-16T22:38:52Z', 'timestamp': 1637102332000}, 'score': 0.0, 'issued': {'date-parts': [[None]]}, 'URL': 'http://dx.doi.org/10.46936/reso.proj.2021.60257/60007247'}]\n",
      "408\n"
     ]
    }
   ],
   "source": [
    "if len(skiped_works) > 0:\n",
    "    print(skiped_works)\n",
    "    print(len(skiped_works))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "28450521",
   "metadata": {},
   "outputs": [],
   "source": [
    "ukch_wks =[]\n",
    "aw = result[6]['message']['items']\n",
    "for wk in aw:      \n",
    "    awd_list = []\n",
    "    if 'funder' in wk.keys():\n",
    "        for fdr in wk['funder']:\n",
    "            if 'award' in wk.keys():\n",
    "               awds = 0\n",
    "               for awd in fdr['award']:\n",
    "                    if awd in ['EP/R026939/1', 'EP/R026815/1', 'EP/R026645/1', 'EP/R027129/1', 'EP/M013219/1',\n",
    "                              'EP/K014706/2', 'EP/K014668/1', 'EP/K014854/1', 'EP/K014714/1']:\n",
    "                        awd_list.append(awd)\n",
    "        if len(awd_list) > 0:\n",
    "            ukch_wks.append(wk)\n",
    "    else: \n",
    "        print(wk)\n",
    "    \n",
    "ukch_wks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9647b0cc",
   "metadata": {},
   "outputs": [],
   "source": [
    "{'indexed': {'date-parts': [[2021, 11, 2]], \n",
    "             'date-time': '2021-11-02T17:07:03Z', 'timestamp': 1635872823737}, \n",
    " 'publisher': 'James S. McDonnell Foundation', \n",
    " 'award-start': {'date-parts': [[2021, 2, 1]]}, \n",
    " 'award': '2020-1456', 'DOI': '10.37717/2020-1456', 'type': 'grant', \n",
    " 'created': {'date-parts': [[2021, 1, 8]], 'date-time': '2021-01-08T15:52:55Z', 'timestamp': 1610121175000},\n",
    " 'source': 'Crossref',\n",
    " 'prefix': '10.37717', \n",
    " 'member': '24568', \n",
    " 'project': [{'project-title': [{'title': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], 'project-description': [{'description': \"In support of the postdoctoral fellow's salary, fringe benefits and research plan.\", 'language': 'en'}], \n",
    "              'lead-investigator': [{'given': 'Stefany', 'family': 'Moreno-Gámez', 'affiliation': [{'name': 'Massachusetts Institute of Technology'}]}], 'award-amount': {'amount': 200000.0, 'currency': 'USD'}, 'award-start': {'date-parts': [[2021, 2, 1]]}, 'award-end': {'date-parts': [[2023, 1, 31]]}, 'funding': [{'type': 'fellowship', 'scheme': 'Postdoctoral Fellowship Award', 'award-amount': {'amount': 200000.0, 'currency': 'USD', 'percentage': 100}, 'funder': {'name': 'James S. McDonnell Foundation', 'id': [{'id': '10.13039/100000913', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}}]}], 'deposited': {'date-parts': [[2021, 1, 8]], \n",
    "              'date-time': '2021-01-08T15:52:56Z', 'timestamp': 1610121176000}, \n",
    " 'score': 0.0, \n",
    " 'issued': {'date-parts': [[2021, 2, 1]]},\n",
    " 'URL': 'http://dx.doi.org/10.37717/2020-1456'}"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
